e8vk
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
November 9, 2010 (November 5, 2010)
Date of Report (date of earliest event reported)
COMMUNITY HEALTH SYSTEMS, INC.
(Exact name of Registrant as specified in charter)
         
Delaware
(State or other jurisdiction
of incorporation)
  001-15925
(Commission File Number)
  13-3893191
(I.R.S. Employer
Identification No.)
4000 Meridian Boulevard
Franklin, Tennessee 37067
(Address of principal executive offices)
Registrant’s telephone number, including area code: (615) 465-7000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (l7 CFR 240.13e-4(c))
 
 

 


 

Item 1.01.   Entry into a Material Definitive Agreement.
On November 5, 2010, Community Health Systems, Inc. (the “Company”) and its wholly-owned subsidiary CHS/Community Health Systems, Inc. (the “Borrower”) entered into an amendment and restatement (the “Amendment”) of their existing credit agreement, dated as of July 25, 2007, among the Company, the Borrower, the lenders party thereto and Credit Suisse AG, as administrative agent and collateral agent (as amended and restated, the “Credit Agreement”).
The Amendment extends by two and a half years (until January 25, 2017, subject to customary acceleration events) the maturity date of $1.5 billion of the existing term loans under the Credit Agreement of lenders who elected to extend or, if more than $50,000,000 of the Borrower’s 8.875% Senior Notes due 2015 are outstanding on April 15, 2015, until April 15, 2015. The maturity date (July 25, 2014) of the balance of the term loans, approximately $4.5 billion, is unchanged by the Amendment. The Amendment increases the pricing on the extended term loans to LIBOR + 350 basis points.
The Amendment increases the Borrower’s ability to issue additional indebtedness under the uncommitted incremental facility to $1,000,000,000 from $600,000,000 and permits the Borrower to issue Term A term loans under the incremental facility. The Amendment also includes changes to certain covenants, including permitting the Borrower to incur or assume additional secured indebtedness on a pari passu basis with the Credit Agreement, provided that a required ratio of aggregate secured indebtedness to consolidated EBITDA is met.
The Amendment was effected pursuant to the terms of an amendment and restatement agreement, dated as of November 5, 2010 (the “Amendment and Restatement Agreement”), among the Borrower, the Company, certain of the Borrower’s subsidiaries acting as guarantors, the lenders party thereto and Credit Suisse AG, as administrative agent and collateral agent. In connection with the Amendment, on November 5, 2010, the Company and the Borrower entered into an amendment and restatement of their existing guarantee and collateral agreement, dated as of July 25, 2007, among the Borrower, the Company, certain of the Borrower’s subsidiaries acting as guarantors and Credit Suisse AG, as collateral agent (as amended and restated, the “Guarantee and Collateral Agreement”) in order to, among other things, conform the terms of the prior guarantee and collateral agreement to the terms of the Credit Agreement.
The foregoing summary of the Amendment and Restatement Agreement, the Credit Agreement and the Guarantee and Collateral Agreement and the transactions contemplated thereby does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Amendment and Restatement Agreement, the Credit Agreement and the Guarantee and Collateral Agreement which are filed as Exhibit 10.1 Exhibit 10.2 and Exhibit 10.3, respectively, hereto and incorporated into this report by reference.
Item 2.03.   Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
     The disclosures under Item 1.01 of this report are also responsive to Item 2.03 of this report and are incorporated by reference into this Item 2.03.
Item 9.01.   Financial Statements and Exhibits.
(d) Exhibits.
         
Exhibit No.   Description
  10.1    
Amendment and Restatement Agreement, dated as of November 5, 2010, to the Credit Agreement dated as of July 25, 2007, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the subsidiaries of CHS/Community Health Systems, Inc. party thereto, the lenders party thereto and Credit Suisse AG, as Administrative Agent and Collateral Agent.

 


 

         
Exhibit No.   Description
  10.2    
Amended and Restated Credit Agreement, dated as of July 25, 2007, as amended and restated as of November 5, 2010, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the lenders party thereto and Credit Suisse AG, as Administrative Agent and Collateral Agent.
  10.3    
Amended and Restated Guarantee and Collateral Agreement, dated as of July 25, 2007, as amended and restated as of November 5, 2010, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the subsidiaries of CHS/Community Health Systems, Inc. from time to time party thereto and Credit Suisse AG, as Collateral Agent.
  99.1    
Press release issued by Community Health Systems, Inc., dated November 8, 2010.

 


 

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
         
Date: November 9, 2010  COMMUNITY HEALTH SYSTEMS, INC.
(Registrant)
 
 
  By:   /s/ Wayne T. Smith    
    Wayne T. Smith   
    Chairman of the Board, President and Chief Executive Officer (principal executive officer)   
 
     
  By:   /s/ W. Larry Cash    
    W. Larry Cash   
    Executive Vice President, Chief Financial Officer and Director (principal financial officer)   
 

 

exv10w1
Exhibit 10.1
EXECUTION COPY
     AMENDMENT AND RESTATEMENT AGREEMENT dated as of November 5, 2010 (this “Agreement”), to the CREDIT AGREEMENT dated as of July 25, 2007 (the “Original Credit Agreement”), among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation, the Subsidiary Guarantors listed on the signature pages hereto, the Lenders listed on the signature pages hereto and CREDIT SUISSE AG, as Administrative Agent and Collateral Agent.
PRELIMINARY STATEMENT
     The Borrower has requested that the Original Credit Agreement be amended and restated in the form attached hereto as Exhibit A (as so amended and restated, the “Restated Credit Agreement”), to, among other things (a) extend the maturity of, and modify the pricing terms with respect to, a portion of the Existing Term Loans and (b) permit the Borrower and its Subsidiaries, subject to conditions set forth in the Restated Credit Agreement, to incur Indebtedness that is secured on a pari passu basis with the Obligations.
     On the Restatement Effective Date (as defined below), certain of the terms of the Existing Term Loans of each Term Lender that approves this Agreement and elects to convert all (or a portion) of its Existing Term Loans into Extended Term Loans by executing and delivering to the Administrative Agent (or its counsel), on or prior to 6:00 p.m., New York City time, on November 4, 2010 (the “Delivery Time”), a signature page to this Agreement designating itself as an “Extended Term Loan Lender” will be modified as set forth herein.
     Accordingly, in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:
          SECTION 1. Defined Terms. Capitalized terms used but not otherwise defined herein (including the preliminary statement hereto) shall have the meanings assigned thereto in the Restated Credit Agreement. The provisions of Section 1.02 of the Restated Credit Agreement are hereby incorporated by reference herein, mutatis mutandis.
          SECTION 2. Amendment and Restatement of the Credit Agreement. Effective as of the Restatement Effective Date, the Original Credit Agreement is hereby amended and restated in the form attached hereto as Exhibit A.
          SECTION 3. Amendment and Restatement of the Guarantee and Collateral Agreement. Effective as of the Restatement Effective Date, the Guarantee and Collateral Agreement (as in effect immediately prior to the Restatement Effective Date,

 


 

the “Existing Guarantee and Collateral Agreement”) is hereby amended and restated in the form attached hereto as Exhibit B (as so amended and restated, the “Restated Guarantee and Collateral Agreement”).
          SECTION 4. Concerning the Term Loans. (a) Subject to the terms and conditions set forth herein and in the Restated Credit Agreement, as of the Restatement Effective Date, each Extended Term Loan Lender agrees that (i) 100% of its Existing Term Loans or (ii) such lesser principal amount of its Existing Term Loans as may be specified by such Extended Term Loan Lender on its executed counterpart of this Agreement will be converted into Extended Term Loans of like outstanding principal amount, provided that, in the event that the aggregate principal amount of the Existing Term Loans which Extended Term Loan Lenders agree to convert into Extended Term Loans in accordance with the foregoing clauses (i) or (ii) (such aggregate Existing Term Loans so agreed to be extended, the “Designated Existing Term Loans”) immediately prior to such conversion is greater than $1,500,000,000, the Borrower may (but shall not be obligated to) elect, by written notice to the Administrative Agent, to cause less than all (but not less than $1,500,000,000 aggregate principal amount) of the Designated Existing Term Loans to become Extended Term Loans, such allocation to be made on a pro rata basis among the Extended Term Loan Lenders, such that the same proportion of each Extended Term Loan Lender’s Designated Existing Term Loans are so converted into Extended Term Loans (such election, a “Pro Rata Allocation Election”).
          (b) In the event the Borrower makes a Pro Rata Allocation Election, if any Extended Term Loan Lender holds, immediately prior to the conversion of such Lender’s Existing Term Loans into Extended Term Loans, both (i) Existing Funded Term Loans and (ii) Existing Delayed Draw Term Loans, then a portion of each shall be converted into Extended Term Loans, such that (A) the ratio of Non-Extended Funded Term Loans to Non-Extended Delayed Draw Term Loans held by such Lender immediately following such conversion is the same as (B) the ratio of Existing Funded Term Loans to Existing Delayed Draw Term Loans held by such Lender had been immediately prior to such conversion.
          (c) In the event the Borrower makes a Pro Rata Allocation Election, then, if any Extended Term Loan Lender holds, immediately prior to the conversion of such Lender’s Existing Term Loans into Extended Term Loans, Existing Funded Term Loans or Existing Delayed Draw Term Loans (i) of more than one Type or (ii) in the case of Eurodollar Loans, having more than one Interest Period, then a portion of such Existing Funded Term Loans or Existing Delayed Draw Term Loans, as applicable, (A) of each such Type and (B) if applicable, subject to each such Interest Period, shall be converted into Extended Term Loans, in each case such that, (1) the proportion of such Extended Term Loan Lender’s aggregate Non-Extended Funded Term Loans or Non-Extended Delayed Draw Term Loans, as applicable, constituted by any Loans that are of the same Type and subject to the same Interest Period immediately following such conversion shall be the same as (2) the proportion of such Extended Term Loan Lender’s total Existing Funded Term Loans or Existing Delayed Draw Term Loans, as applicable, constituted by Loans of such Type and subject to such Interest Period had been immediately prior to such conversion.

 


 

          (d) The Existing Funded Term Loans of any Lender that are not converted into Extended Term Loans shall constitute “Non-Extended Funded Term Loans”, and the Existing Delayed Draw Term Loans of any Lender that are not converted into Extended Term Loans shall constitute “Non-Extended Delayed Draw Term Loans”, and shall in each case, following the Restatement Effective Date, continue to be in effect and outstanding under the Restated Credit Agreement on the terms and conditions set forth therein.
          (e) None of the transactions set forth in this Section 4 shall be deemed to be a conversion of any Term Loan into a Loan of a different Type or with a different Interest Period or a payment or prepayment of any Term Loan, and the parties hereto hereby agree that no breakage or similar costs will accrue solely as a result of the transactions contemplated by this Section 4.
          SECTION 5. Representations and Warranties. Each of Parent, the Borrower and each Subsidiary Guarantor hereby represents and warrants to each other party hereto that:
          (a) The representations and warranties set forth in Article III of the Restated Credit Agreement and in each other Loan Document are true and correct in all material respects on and as of the Restatement Effective Date as though made on and as of such date, except to the extent that such representations and warranties expressly relate to an earlier date, in which case such representations and warranties were true and correct in all material respects as of such earlier date.
          (b) No Default or Event of Default has occurred and is continuing.
          (c) None of the Security Documents in effect on the Restatement Effective Date will be rendered invalid, non-binding or unenforceable against any Loan Party as a result of this Agreement. The Guarantees created under such Security Documents will continue to guarantee the Obligations (as the Obligations are modified hereunder) to the same extent as they guaranteed the Obligations immediately prior to the Restatement Effective Date. The Liens created under such Security Documents will continue to secure the Obligations (as the Obligations are modified hereunder), and, subject to clause (g) below, will continue to be perfected, in each case, to the same extent as they secured the Obligations or were perfected immediately prior to the Restatement Effective Date.
          SECTION 6. Effectiveness. This Agreement shall become effective on and as of the date on which each of the following conditions precedent is satisfied (such date, the “Restatement Effective Date”):
          (a) The Administrative Agent shall have received counterparts hereof duly executed and delivered by Parent, the Borrower, each Subsidiary Loan Party and the Required Lenders.
          (b) The Administrative Agent shall have received a favorable written opinion of (i) Kirkland & Ellis LLP, counsel for Parent and the Borrower, substantially to

 


 

the effect set forth on Exhibit C-1 and (ii) the general counsel of Parent, substantially to the effect set forth in Exhibit C-2.
          (c) The Administrative Agent shall have received (i) a certificate as to the good standing of each Loan Party as of a recent date, from the Secretary of State of its state of organization; (ii) a certificate of the Secretary or Assistant Secretary of each Loan Party dated the Restatement Effective Date and certifying (A) that attached thereto is a true and complete copy of (1) the by-laws (or equivalent thereof) and (2) the certificate or articles of incorporation, certified as of a recent date by the Secretary of State of the applicable state of organization, in each case of such Loan Party as in effect on the Restatement Effective Date and at all times since a date prior to the date of the resolutions described in clause (B) below, (or, if such by-laws (or equivalent thereof) or certificate or articles of incorporation have not been amended or modified since any delivery thereof to the Administrative Agent on the Closing Date, certifying that no such amendment or modification has occurred), (B) that attached thereto is a true and complete copy of resolutions duly adopted by the Board of Directors (or equivalent thereof) of such Loan Party authorizing the execution, delivery and performance of the Loan Documents to which such person is a party, and that such resolutions have not been modified, rescinded or amended and are in full force and effect and (C) as to the incumbency and specimen signature of each officer executing this Agreement or any other document delivered in connection herewith on behalf of such Loan Party; (iii) a certificate of another officer as to the incumbency and specimen signature of the Secretary or Assistant Secretary executing the certificate pursuant to clause (ii) above; and (iv) such other documents as the Administrative Agent may reasonably request.
          (d) The Administrative Agent shall have received a certificate, dated the Restatement Effective Date and signed by a Financial Officer of the Borrower, confirming compliance with the conditions precedent set forth in paragraphs (b) and (c) of Section 4.01 of the Restated Credit Agreement.
          (e) The Administrative Agent shall have received all Fees and other amounts due and payable on or prior to the Restatement Effective Date, including, to the extent invoiced, reimbursement or payment of all out-of-pocket expenses required to be reimbursed or paid by the Borrower hereunder or under any other Loan Document.
          (f) The Security Documents shall be in full force and effect on the Restatement Effective Date, and the Collateral Agent on behalf of the Secured Parties shall have a security interest in the Collateral of the type and priority described in each Security Document.
          (g) Each of the Security Documents relating to each of the Mortgaged Properties shall be in full force and effect, each of such Mortgaged Properties shall not be subject to any Lien other than those permitted under Section 6.02 of the Restated Credit Agreement, each of such Security Documents shall have been filed and recorded in the recording office as specified on Schedule 3.19(c) of the Restated Credit Agreement (or a lender’s title insurance policy, in form and substance reasonably acceptable to the Collateral Agent, insuring such Security Document as a first lien on such Mortgaged

 


 

Property (subject to any Lien permitted by Section 6.02 of the Restated Credit Agreement) shall have been received by the Collateral Agent) and, in connection therewith, the Collateral Agent shall have received evidence reasonably satisfactory to it of each such filing and recordation and the Collateral Agent shall have received such other documents, including a policy or policies of title insurance issued by a nationally recognized title insurance company, together with such endorsements, coinsurance and reinsurance as may be requested by the Collateral Agent, insuring the Mortgages as valid first liens on the Mortgaged Properties, free of Liens other than those permitted under Section 6.02 of the Restated Credit Agreement, together with such legal opinions as are required to be furnished pursuant to the terms of the Mortgages or as may be reasonably requested by the Collateral Agent. Notwithstanding the foregoing, this paragraph (g) may be satisfied on or prior to the date occurring 90 days after the Restatement Effective Date, or such later date as determined in the sole discretion of the Administrative Agent.
          (h) The Administrative Agent shall have received payment from the Borrower, for the account of each Lender that transmits its executed counterpart of this Agreement to the Administrative Agent (or its counsel) on or prior to the Delivery Time, of an amendment fee in an amount equal to 0.10% of the aggregate principal amount of the outstanding Loans and unused Commitments of such Lender as of the Restatement Effective Date. Such fees shall be payable in immediately available funds and, once paid, shall not be refundable in whole or in part.
The Administrative Agent shall notify the parties hereto of the Restatement Effective Date and such notice shall be conclusive and binding. Notwithstanding the foregoing, this Agreement shall not become effective unless each of the foregoing conditions is satisfied at or prior to 5:00 p.m. New York City time on November 5, 2010.
          SECTION 7. Effect of this Agreement. (a) Except as expressly set forth herein, this Agreement shall not by implication or otherwise limit, impair, constitute a waiver of, or otherwise affect the rights and remedies of the Administrative Agent, the Lenders or any other Secured Party under the Restated Credit Agreement or any other Loan Document, and shall not alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the Restated Credit Agreement or any other Loan Document, all of which are ratified and affirmed in all respects and shall continue in full force and effect. Nothing herein shall be deemed to entitle any Loan Party to a consent to, or a waiver, amendment, modification or other change of, any of the terms, conditions, obligations, covenants or agreements contained in the Original Credit Agreement or any other Loan Document in similar or different circumstances.
          (b) On and after the Restatement Effective Date, each reference in the Restated Credit Agreement to “this Agreement”, “hereunder”, “hereof”, “herein” or words of like import, and each reference to the ‘Credit Agreement” in any other Loan Document, shall be deemed a reference to the Restated Credit Agreement. Additionally, each reference in the Restated Guarantee and Collateral Agreement to “this Agreement”, “hereunder”, “hereof”, “herein” or words of like import, and each reference to the

 


 

Guarantee and Collateral Agreement in any other Loan Document, shall be deemed a reference to the Restated Guarantee and Collateral Agreement.
          (c) This Agreement shall constitute a “Loan Document” for all purposes of the Original Credit Agreement, the Restated Credit Agreement and the other Loan Documents.
          SECTION 8. Reaffirmation. Each of Parent, the Borrower and each of the Subsidiary Guarantors identified on the signature pages hereto (collectively, Parent, the Borrower and such Subsidiary Guarantors, the “Reaffirming Loan Parties”) hereby acknowledges that it expects to receive substantial direct and indirect benefits as a result of this Agreement and the transactions contemplated hereby. Each Reaffirming Loan Party hereby consents to this Agreement and the transactions contemplated hereby, and hereby confirms its respective guarantees, pledges and grants of security interests, as applicable, under each of the Loan Documents to which it is party, and agrees that, notwithstanding the effectiveness of this Agreement and the transactions contemplated hereby, such guarantees, pledges and grants of security interests shall continue to be in full force and effect and shall accrue to the benefit of the Secured Parties. Each of the Reaffirming Loan Parties further agrees to take any action that may be required or that is reasonably requested by the Administrative Agent to effect the purposes of this Agreement, the transactions contemplated hereby or the Loan Documents and hereby reaffirms its obligations under each provision of each Loan Document to which it is party.
          SECTION 9. Expenses. The Borrower agrees to reimburse the Administrative Agent for its reasonable out-of-pocket expenses in connection with the Loan Documents (including the preparation of this Agreement), including the reasonable fees, charges and disbursements of counsel for the Administrative Agent.
          SECTION 10. Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery by electronic transmission of an executed counterpart of a signature page to this Agreement shall be effective as delivery of an original executed counterpart of this Agreement.
          SECTION 11. No Novation. Neither this Agreement nor the effectiveness of the Restated Credit Agreement or the Restated Guarantee and Collateral Agreement shall extinguish the obligations for the payment of money outstanding under the Original Credit Agreement or discharge or release the Lien or priority of any Loan Document or any other security therefor or any guarantee thereof. Nothing herein contained shall be construed as a substitution or novation of the Obligations outstanding under the Original Credit Agreement or instruments guaranteeing or securing the same, which shall remain in full force and effect, except as modified hereby or by instruments executed concurrently herewith. Nothing expressed or implied in this Agreement, the Restated Credit Agreement, the Restated Guarantee and Collateral Agreement or any other document contemplated hereby or thereby shall be construed as a release or other discharge of the Borrower under the Original Credit Agreement or any Loan Party under

 


 

the Existing Guarantee and Collateral Agreement or any other Loan Document from any of its obligations and liabilities thereunder. The Original Credit Agreement, the Existing Guarantee and Collateral Agreement and each of the other Loan Documents shall remain in full force and effect, until and except as modified hereby or thereby in connection herewith or therewith.
          SECTION 12. Governing Law. (a) THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.
          (b) EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO (I) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (II) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.
          SECTION 13. Headings. Section headings used herein are for convenience of reference only, are not part of this Agreement and shall not affect the construction of, or be taken into consideration in interpreting, this Agreement.
[Remainder of page intentionally left blank]

 


 

     IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized officers as of the day and year first above written.
         
  CHS/COMMUNITY HEALTH SYSTEMS, INC.
 
 
  By:   /s/ W. Larry Cash    
    Name:   W. Larry Cash   
    Title:   Executive Vice President and Chief
Financial Officer 
 
 
  COMMUNITY HEALTH SYSTEMS, INC.
 
 
  By:   /s/ W. Larry Cash    
    Name:   W. Larry Cash   
    Title:   Executive Vice President and Chief
Financial Officer 
 

 


 

     IN WITNESS WHEREOF, the undersigned has executed this Agreement on behalf of each Company as of the date above first written.
         
  Abilene Hospital, LLC
Abilene Merger, LLC
Anna Hospital Corporation
Arizona DH, LLC
Berwick Hospital Company, LLC
BH Trans Company, LLC
Big Bend Hospital Corporation
Big Spring Hospital Corporation
Birmingham Holdings, LLC
Birmingham Holdings II, LLC
Bluefield Holdings, LLC
Bluefield Hospital Company, LLC
Bluffton Health System, LLC
Brownsville Hospital Corporation
Brownwood Hospital, L.P.
Brownwood Medical Center, LLC
Carlsbad Medical Center, LLC
Centre Hospital Corporation
CHHS Holdings, LLC
CHS Kentucky Holdings, LLC
CHS Pennsylvania Holdings, LLC
CHS Virginia Holdings, LLC
CHS Washington Holdings, LLC
Claremore Regional Hospital, LLC
Clarksville Holdings, LLC
Cleveland Hospital Corporation
Cleveland Regional Medical Center, L.P.
Cleveland Tennessee Hospital Company, LLC
Clinton Hospital Corporation
Coatesville Hospital Corporation
College Station Hospital, L.P.
College Station Medical Center, LLC
College Station Merger, LLC
Community GP Corp.
Community Health Investment Company, LLC
Community LP Corp.
CP Hospital GP, LLC
CPLP, LLC
Crestwood Hospital, LP, LLC
Crestwood Hospital, LLC
CSMC, LLC
CSRA Holdings, LLC

 
 
  By:   /s/ James W. Doucette    
    Name:   James W. Doucette   
    Title:   Vice President, Finance and Treasurer   

 


 

         
  Deaconess Holdings, LLC
Deaconess Hospital Holdings, LLC
Deming Hospital Corporation
Desert Hospital Holdings, LLC
Detar Hospital, LLC
DHSC, LLC
DHFW Holdings, LLC
Dukes Health System, LLC
Dyersburg Hospital Corporation
Emporia Hospital Corporation
Evanston Hospital Corporation
Fallbrook Hospital Corporation
Foley Hospital Corporation
Forrest City Arkansas Hospital Company, LLC
Forrest City Clinic Company, LLC
Forrest City Hospital Corporation
Fort Payne Hospital Corporation
Frankfort Health Partner, Inc.
Franklin Hospital Corporation
Gadsden Regional Medical Center, LLC
Galesburg Hospital Corporation
Granbury Hospital Corporation
Granite City Hospital Corporation
Granite City Illinois Hospital Company, LLC
Greenville Hospital Corporation
GRMC Holdings, LLC
Hallmark Healthcare Company, LLC
Hobbs Medco, LLC
Hospital of Barstow, Inc.
Hospital of Fulton, Inc.
Hospital of Louisa, Inc.
Hospital of Morristown, Inc.
Jackson Hospital Corporation (KY)
Jackson Hospital Corporation (TN)
Jourdanton Hospital Corporation
Kay County Hospital Corporation
Kay County Oklahoma Hospital Company, LLC
Kirksville Hospital Company, LLC
Lakeway Hospital Corporation
Lancaster Hospital Corporation
Las Cruces Medical Center, LLC
Lea Regional Hospital, LLC
Lexington Hospital Corporation
Longview Merger, LLC
LRH, LLC
Lutheran Health Network of Indiana, LLC

 
 
  By:   /s/ James W. Doucette    
    Name:   James W. Doucette   
    Title:   Vice President, Finance and Treasurer   

 


 

         
  Marion Hospital Corporation
Martin Hospital Corporation
Massillon Community Health System LLC
Massillon Health System LLC
Massillon Holdings, LLC
McKenzie Tennessee Hospital Company, LLC
McNairy Hospital Corporation
MCSA, L.L.C.
Medical Center of Brownwood, LLC
Merger Legacy Holdings, LLC
MMC of Nevada, LLC
Moberly Hospital Company, LLC
MWMC Holdings, LLC
National Healthcare of Leesville, Inc.
National Healthcare of Mt. Vernon, Inc.
National Healthcare of Newport, Inc.
Navarro Hospital, L.P.
Navarro Regional, LLC
NC-DSH, LLC
Northampton Hospital Company, LLC
Northwest Hospital, LLC
NOV Holdings, LLC
NRH, LLC
Oak Hill Hospital Corporation
Oro Valley Hospital, LLC
Palmer-Wasilla Health System, LLC
Payson Hospital Corporation
Pennsylvania Hospital Company, LLC
Phillips Hospital Corporation
Phoenixville Hospital Company, LLC
Pottstown Hospital Company, LLC
QHG Georgia Holdings, Inc.
QHG Georgia Holdings II, LLC
QHG Georgia, LP
QHG of Barberton, Inc.
QHG of Bluffton Company, LLC
QHG of Clinton County, Inc.
QHG of Enterprise, Inc.
QHG of Forrest County, Inc.
QHG of Fort Wayne Company, LLC
QHG of Hattiesburg, Inc.
QHG of Massillon, Inc.
QHG of South Carolina, Inc.
QHG of Spartanburg, Inc.
QHG of Springdale, Inc.
QHG of Warsaw Company, LLC
Quorum Health Resources, LLC

 
 
  By:   /s/ James W. Doucette    
    Name:   James W. Doucette   
    Title:   Vice President, Finance and Treasurer   

 


 

         
  Red Bud Hospital Corporation
Red Bud Illinois Hospital Company, LLC
Regional Hospital of Longview, LLC
River Region Medical Corporation
Roswell Hospital Corporation
Russell County Medical Center, Inc.
Ruston Hospital Corporation
Ruston Louisiana Hospital Company, LLC
SACMC, LLC
Salem Hospital Corporation
San Angelo Community Medical Center, LLC
San Angelo Medical, LLC
San Miguel Hospital Corporation
Shelbyville Hospital Corporation
Siloam Springs Arkansas Hospital Company, LLC
Siloam Springs Holdings, LLC
SouthCrest, L.L.C.
Southern Texas Medical Center, LLC
Spokane Valley Washington Hospital Company, LLC
Spokane Washington Hospital Company, LLC
Tennyson Holdings, LLC
Tooele Hospital Corporation
Triad Healthcare Corporation
Triad Holdings III, LLC
Triad Holdings IV, LLC
Triad Holdings V, LLC
Triad Nevada Holdings, LLC
Triad of Alabama, LLC
Triad of Oregon, LLC
Triad-ARMC, LLC
Triad-Denton Hospital GP, LLC
Triad-Denton Hospital, L.P.
Triad-El Dorado, Inc.
Triad-Navarro Regional Hospital Subsidiary, LLC
Triad-South Tulsa Hospital Company, Inc.
VHC Medical, LLC
Vicksburg Healthcare, LLC
Victoria Hospital, LLC
Victoria of Texas, L.P.
Virginia Hospital Company, LLC

 
 
  By:   /s/ James W. Doucette    
    Name:   James W. Doucette   
    Title:   Vice President, Finance and Treasurer   

 


 

         
  Warren Ohio Hospital Company, LLC
Warren Ohio Rehab Hospital Company, LLC
Watsonville Hospital Corporation
Waukegan Hospital Corporation
Waukegan Illinois Hospital Company, LLC
Weatherford Hospital Corporation
Weatherford Texas Hospital Company, LLC
Webb Hospital Corporation
Webb Hospital Holdings, LLC
Wesley Health System, LLC
West Grove Hospital Company, LLC
WHMC, LLC
Wilkes-Barre Behavioral Hospital Company, LLC
Wilkes-Barre Holdings, LLC
Wilkes-Barre Hospital Company, LLC
Williamston Hospital Corporation
Women & Children’s Hospital, LLC
Woodland Heights Medical Center, LLC
Woodward Health System, LLC
Youngstown Ohio Hospital Company, LLC

 
 
  By:   /s/ James W. Doucette    
    Name:   James W. Doucette   
    Title:   Vice President, Finance and Treasurer   

 


 

         
         
  CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, individually and as Administrative Agent, Collateral Agent, Swingline Lender and Issuing Bank,
 
 
  By:   /s/ Robert Hetu    
    Name:   Robert Hetu   
    Title:   Managing Director   
 
     
  By:   /s/ Rahul Parmar    
    Name:   Rahul Parmar   
    Title:   Associate   

 


 

         
EXHIBIT A
Form of Amended and Restated Credit Agreement
See Exhibit 10.2 to Community Health Systems, Inc.’s Form 8-K filed on November 9, 2010

 


 

EXHIBIT B
Form of Amended and Restated Guarantee and Collateral Agreement
See Exhibit 10.3 to Community Health Systems, Inc.’s Form 8-K filed on November 9, 2010

 


 

EXHIBIT C-1
Form of Kirkland & Ellis LLP Opinion

 


 

November 5, 2010
Credit Suisse AG,
   as Administrative Agent, Collateral
   Agent, and Issuing Bank
Credit Suisse Securities (USA) LLC,
   as Sole Book Runner
   and Sole Lead Arranger,
Wells Fargo Bank, N.A.,
   as Syndication Agent,
JPMorgan Chase Bank, N.A.,
   as Co-Documentation Agent,
Bank of America, N.A.,
   as Co-Documentation Agent, and
Each of the Lenders party to
   the Credit Agreement described below
Ladies and Gentlemen:
          We are issuing this opinion letter in our capacity as special legal counsel to: (i) CHS/Community Health Systems, Inc., a Delaware corporation (“Borrower”), (ii) Community Health Systems, Inc., a Delaware corporation (“Parent”), and (iii) each of the Subsidiaries listed on the Schedule of Guarantors attached hereto as Schedule E (collectively, the “Guarantors” and each a “Guarantor”) in response to the requirement in Section 6(b) of the Amendment and Restatement Agreement, dated as of even date herewith (the “Amendment Agreement”), among Parent, Borrower, the Guarantors and Credit Suisse, as Administrative Agent and Collateral Agent (the “Agent”), and the Lenders listed on the signature pages thereto, which Amendment Agreement amends and restates (A) the Credit Agreement, dated as of July 25, 2007 (the “Existing Credit Agreement”), among Parent, Borrower, Agent, and the Lenders party thereto (the Existing Credit Agreement, as amended and restated by the Amendment Agreement, the “Credit Agreement”) and (B) the Guarantee and Collateral Agreement, dated as of July 25, 2007 (the “Existing Guarantee and Collateral Agreement”), among Parent, Borrower, the Guarantors and Agent (the Existing Guarantee and Collateral Agreement as amended and restated by the Amendment, the “Guarantee and Collateral Agreement”). Parent, Borrower and the Guarantors are collectively referred to herein as the “Credit Parties” and each a “Credit Party”. References herein to the “Delaware Credit Parties” means each of Parent and Borrower.

 


 

November 5, 2010
Page 2
     Capitalized terms used and not otherwise defined herein have the meanings ascribed to such terms in the Credit Agreement. The Agent, the Sole Bookrunner and Sole Lead Arranger, the Syndication Agent, the Co-Documentation Agents, and the Lenders are sometimes referred to herein as “you”. The term “Credit Documents” whenever it is used in this letter means the Amendment Agreement, the Credit Agreement and the Guarantee and Collateral Agreement, in each case in the form executed by the parties thereto on the date hereof.
     The term “Organization Documents” whenever it is used in this letter means the certificate of incorporation and the bylaws of the relevant entity, in each case, as amended through the date hereof.
     Subject to the assumptions, qualifications, exclusions and other limitations that are identified in this letter and in the schedules attached to this letter, we advise you, and, with respect to each legal issue addressed in this letter, it is our opinion, that:
1.   Each of the Delaware Credit Parties is a corporation existing and in good standing under the Delaware General Corporation Law, as in effect on the date hereof (the “DGCL”).
2.   Each of the Delaware Credit Parties has the corporate power to execute and deliver the Amendment Agreement and perform its respective obligations under the Credit Documents to which it is a party.
3.   Each of the boards of directors of each of the Delaware Credit Parties has adopted by requisite vote or action, in accordance with the applicable provisions of its Organization Documents granting such authority to the board of directors, the resolutions necessary to authorize (a) such Delaware Credit Party’s execution and delivery of the Amendment Agreement, and the performance of such Delaware Credit Party’s obligations under, the Credit Documents to which it is a party and (b) the grant by each Delaware Credit Party of the security interests pursuant to the Guarantee and Collateral Agreement.
4.   Each Delaware Credit Party has duly executed and delivered the Amendment Agreement.
5.   Each of the Credit Documents executed by each Credit Party is a valid and binding obligation of each such Credit Party that is a party thereto, and is enforceable against such Credit Party in accordance with its terms.
6.   The execution and delivery by each of the Delaware Credit Parties and, except in the case of paragraph (a), each of the other Credit Parties, of the Amendment Agreement, and the performance of its obligations under each Credit Document, will not (a) violate any existing provisions of the Organization Documents of such Delaware Credit Party, (b) constitute a violation by such Credit Party of any applicable provision of existing statutory law or governmental regulation applicable to such Credit Party and covered by

 


 

November 5, 2010
Page 3
this letter or (c) result in the creation or imposition of (or obligation to create or impose) any Lien on any property of any Credit Party (other than Liens created pursuant to the Loan Documents) under, or result in a breach or other violation of, or constitute a default under, any agreement listed on the Schedule I attached hereto (the “Specified Agreements”) (except we express no opinion with respect to conflicts, breaches or defaults under any agreement which is not a Specified Agreement or with respect to financial covenants or tests).
7.   No Credit Party is presently required to obtain any consent, approval, authorization or order of any State of New York or United States federal court or governmental agency in order to obtain the right to execute and deliver the Amendment Agreement and perform any of the Credit Documents to which it is a party, except for: (a) those obtained or made on or prior to the date hereof, (b) any actions or filings necessary to perfect the liens and security interests granted under the Security Documents or to release existing liens, (c) consents, approvals, authorizations, orders, actions or filings required in connection with ordinary course conduct by such Credit Party of its respective businesses and ownership or operation by such Credit Parties of its assets, (d) consents, approvals, authorizations, orders, actions or filings required under any laws, regulations or governmental requirements as set forth on Schedule C hereto, and (e) any actions or filings that may be required by any banking, insurance or other regulatory statute to which you may be subject (as to which matters we express no opinion).
8.   The execution and delivery of the Amendment Agreement will not, in and of itself, result in the loss of perfection (if any) of any security interest arising under Article 9 of the UCC to the extent that such security interest was and remained perfected under the Existing Guarantee and Collateral Agreement under Article 9 of the UCC immediately prior to such execution and delivery. For the avoidance of doubt, we express no opinion regarding (i) the creation, priority or enforcement of any such security interest, (ii) the effect on such priority of the execution and delivery of the Amendment Agreement, or (iii) the perfection of any such security interest.
     In preparing this letter, we have relied without any independent verification upon the assumptions recited in Schedule B to this letter and upon: (i) information contained in certificates obtained from governmental authorities; (ii) factual information represented to be true in the Credit Agreement and the other Credit Documents; (iii) factual information provided to us in a support certificate executed by one or more of the Credit Parties; and (iv) factual information we have obtained from such other sources as we have deemed reasonable. We have examined the originals or copies certified to our satisfaction, of such other corporate records of the Delaware Credit Parties as we deem necessary for or relevant to our opinions, certificates of public officials and the officers of the Delaware Credit Parties and we have assumed without investigation that there has been no relevant change or development between the dates as of which the information cited in the preceding sentence was given and the date of this letter and

 


 

November 5, 2010
Page 4
that the information upon which we have relied is accurate and does not omit disclosures necessary to prevent such information from being misleading.
     While we have not conducted any independent investigation to determine facts upon which our opinions are based or to obtain factual information about which this letter advises you, we confirm that we do not have any actual knowledge that has caused us to conclude that our reliance and assumptions cited in the preceding paragraph are unwarranted or that any information supplied to us in connection with the preparation of this letter is wrong. The terms “actual knowledge”, “knowledge”, “aware” or similar terms wherever they are used in this letter with respect to our firm mean conscious awareness at the time this letter is delivered on the date it bears by the following Kirkland & Ellis LLP lawyers who have had significant involvement with negotiation or preparation of the Credit Agreement (herein called “our Designated Transaction Lawyers”): Ashley Gregory.
     Except as set forth in the following sentences of this paragraph, our opinion on every legal issue addressed in this letter (collectively, “our opinions”) is based exclusively on such internal law of the State of New York or such federal law of the United States, which, in each case, is in our experience normally applicable to general business entities not engaged in regulated business activities and to transactions of the type contemplated between the Credit Parties, on the one hand, and you, on the other hand, in the Credit Documents, but without our having made any special investigation as to any other laws. We express no opinion or advice as to any law (a) to which the Credit Parties may be subject as a result of your legal or regulatory status, your sale or transfer of any Loans or other obligations or interests therein or your (as opposed to any other lender’s) involvement in the transactions contemplated by the Credit Documents, (b) identified on Schedule C, or (c) which might be violated by any misrepresentation or omission or a fraudulent act. For purposes of the opinion in paragraph 1, as to existence and good standing, we have relied exclusively upon certificates issued by a governmental authority in each relevant jurisdiction and such opinion is not intended to provide any conclusion or assurance beyond that conveyed by such certificates. For purposes of paragraphs 2 through 4 and 6(a), such opinions are based on the DGCL and we have rendered such opinions based exclusively on our review of the statutory provisions of such statutes as published by Aspen Law & Business, as supplemented through October 15, 2010, without regard to any regulations promulgated thereunder or any judicial or administrative interpretations thereof. We advise you that issues addressed by this letter may be governed in whole or in part by other laws, but we express no opinion as to whether any relevant difference exists between the laws upon which our opinions are based and any other laws which may actually govern. Our opinions are subject to all qualifications in Schedule A and do not cover or otherwise address any law or legal issue that is identified in the attached Schedule C or any provision in the Credit Agreement or any of the other Credit Documents of any type identified in Schedule D. Provisions in the Credit Documents that are not excluded by Schedule D or any other part of this letter or its attachments are called the “Relevant Agreement Terms.”

 


 

November 5, 2010
Page 5
     Except to the extent set forth in the preceding paragraph, each of our opinions on each legal issue addressed in this letter represents our opinion as to how the issue addressed in such opinion would be resolved were it to be considered by the highest court of the jurisdiction upon whose law our opinion on that issue is based. The manner in which any particular issue would be treated in any actual court case would depend in part on facts and circumstances particular to the case, and this letter is not intended to guarantee the outcome of any legal dispute that may arise in the future. It is possible that some Relevant Agreement Terms may not prove enforceable for reasons other than those cited in this letter should an actual enforcement action be brought, but (subject to all the exceptions, qualifications, exclusions and other limitations contained in this letter) such unenforceability would not in our opinion prevent you from realizing the principal benefits purported to be provided by the Relevant Agreement Terms of a remedial nature contained in the Credit Documents.
     This letter speaks as of the time of its delivery on the date it bears. We do not assume any obligation to provide you with any subsequent opinion or advice by reason of any fact about which our Designated Transaction Lawyers did not have actual knowledge at such time, by reason of any change subsequent to such time in any law covered by any of our opinions, or for any other reason. The attached schedules are an integral part of this letter, and any term defined in this letter or any schedule has that defined meaning wherever it is used in this letter or in any schedule to this letter.
     You may rely upon this letter only for the purposes served by the provisions in the Amendment Agreement cited in the initial paragraph of this letter in response to which it has been delivered. Without our written consent: (i) no person other than you may rely on this letter for any purpose; (ii) this letter may not be cited or quoted in any financial statement, prospectus, private placement memorandum or other similar document; (iii) this letter may not be cited or quoted in any other document or communication that might encourage reliance upon this letter by any person or for any purpose excluded by the restrictions in this paragraph; and (iv) copies of this letter or any portion hereof may not be furnished to anyone for purposes of encouraging or in a manner that might encourage such reliance; provided, however, that financial institutions that subsequently become Lenders under the Credit Agreement in accordance with the assignment provisions thereof may rely on this letter as of the date hereof as if this letter were addressed to them.
Sincerely,

 


 

Schedule A
General Qualifications
     The opinions in the letter to which this Schedule is attached (“our letter”) are subject to the qualifications as set forth in this Schedule A.
1.   Bankruptcy and Insolvency Exception. Each of our opinions of our letter is subject to the effect of bankruptcy, insolvency, reorganization, receivership, moratorium and other similar laws. This exception includes:
  (a)   the Federal Bankruptcy Code and thus comprehends, among others, matters of turn-over, automatic stay, avoiding powers, fraudulent transfer, preference, discharge, conversion of a non-recourse obligation into a recourse claim, limitations on ipso facto and anti-assignment clauses and the coverage of pre-petition security agreements applicable to property acquired after a petition is filed;
 
  (b)   all other Federal and state bankruptcy, insolvency, reorganization, receivership, moratorium, arrangement and assignment for the benefit of creditors laws that affect the rights of creditors generally or that have reference to or affect only creditors of specific types of debtors;
 
  (c)   state fraudulent transfer and conveyance laws; and
 
  (d)   judicially developed doctrines in this area, such as substantive consolidation of entities and equitable subordination and the recharacterization of debt.
2.   Equitable Principles Limitation. Each of our opinions is subject to the effect of general principles of equity, whether applied by a court of law or equity. This limitation includes principles:
  (a)   governing the availability of specific performance, injunctive relief or other equitable remedies, which generally place the award of such remedies, subject to certain guidelines, in the discretion of the court to which application for such relief is made;
 
  (b)   affording equitable defenses (e.g., waiver, laches, and estoppel) against a party seeking enforcement;
 
  (c)   requiring good faith and fair dealing in the performance and enforcement of a contract by the party seeking its enforcement;
 
  (d)   requiring reasonableness in the performance and enforcement of an agreement by the party seeking enforcement of the contract;
 
  (e)   requiring consideration of the materiality of (i) a breach and (ii) the consequences of the breach to the party seeking enforcement;

A-1


 

  (f)   requiring consideration of the impracticability or impossibility of performance at the time of attempted enforcement; and
 
  (g)   affording defenses based upon the unconscionability of the enforcing party’s conduct after the parties have entered into the contract.
3.   Other Common Qualifications. Each of our opinions of our letter is subject to the effect of rules of law that:
  (a)   limit or affect the enforcement of provisions of a contract that purport to waive, or to require waiver of, the obligations of good faith, fair dealing, diligence and reasonableness;
 
  (b)   provide that forum selection (and not choice of law) clauses in contracts are not necessarily binding on the court(s) in the forum selected (except to the extent provided in Section 5-1402 of the New York General Obligations Law);
 
  (c)   limit the availability of a remedy under certain circumstances where another remedy has been elected;
 
  (d)   provide a time limitation after which a remedy may not be enforced;
 
  (e)   limit the right of a creditor to use force or cause a breach of the peace in enforcing rights;
 
  (f)   relate to the sale or disposition of collateral by a secured creditor or the requirements of a commercially reasonable sale;
 
  (g)   limit the enforceability of provisions releasing, exculpating or exempting a party from, or requiring indemnification of a party for, liability for its own action or inaction, to the extent the action or inaction involves negligence, recklessness, willful misconduct, unlawful conduct, violation of public policy, or for strict product liability or litigation against another party determined adversely to such party or for liabilities arising under the securities laws, or which limit the enforceability of provisions requiring indemnification of a party with respect to litigation between such party and another party from whom indemnification is sought which is determined adversely to the party seeking indemnification;
 
  (h)   may, where less than all of a contract may be unenforceable, limit the enforceability of the balance of the contract to circumstances in which the unenforceable portion is not an essential part of the agreed exchange;
 
  (i)   govern and afford judicial discretion regarding the determination of damages and entitlement to attorneys’ fees and other costs;
 
  (j)   may permit a party that has materially failed to render or offer performance required by the contract to cure that failure unless (i) permitting a cure would unreasonably hinder the aggrieved party from making substitute arrangements for

A-2


 

      performance or (ii) it was important in the circumstances to the aggrieved party that performance occur by the date stated in the contract;
  (k)   may render guarantees or similar instruments or agreements unenforceable under circumstances where your actions, failures to act or waivers, amendments or replacement of the Credit Documents (i) so radically change the essential nature of the terms and conditions of the guaranteed obligations and the related transactions that, in effect, a new relationship has arisen between the beneficiary and the Credit Parties that is substantially and materially different from that presently contemplated by the Credit Documents, (ii) release a primary obligor, or (iii) impair a guarantor’s recourse against the primary obligor; and
 
  (l)   render unenforceable requirements in the Credit Documents that provisions therein may only be waived or amended in writing, to the extent that an oral agreement or an implied agreement by trade practice or course of conduct has been created modifying any such provision.
4.   Referenced Provision Qualification. Each opinion regarding the validity, binding effect, or enforceability of a provision (the “First Provision”) in any of the Credit Documents requiring any party to perform its obligations under, or to cause any other person to perform its obligations under, any other provision (the “Second Provision”) of any Credit Document, or stating that any action will be taken as provided in or in accordance with any such Second Provision, are subject to the same qualifications as the corresponding opinion in this letter relating to the validity, binding effect, and enforceability of such Second Provision.
5.   Collateral Qualifications. The opinions and advice contained in our letter are subject to the following advice (terms used herein that are defined in the New York UCC or any other applicable UCC having the meanings for purposes hereof are used herein in accordance with the meanings given to them therein):
  (a)   rights of debtors and obligors and duties of secured parties referred to in Sections 1-102(3) and 9-602 of the New York UCC (and the corresponding sections of any other applicable Uniform Commercial Code) may not be waived, released, varied, or disclaimed by agreement, and our opinions regarding any such waivers, releases, variations, and disclaimers are limited accordingly;
 
  (b)   we express no opinion with respect to any self-help remedies with respect to the Collateral to the extent they vary from those available under the New York UCC or other applicable Uniform Commercial Code or with respect to any remedies otherwise inconsistent with the New York UCC (to the extent that the New York UCC is applicable thereto) or other applicable law (including, without limitation, any other applicable Uniform Commercial Code);
 
  (c)   a substantial body of case law treats guarantors as “debtors” under the New York UCC, thereby according guarantors rights and remedies of debtors established by the New York UCC:

A-3


 

  (d)   we note that your remedies under the Collateral Agreement with regard to the sale or after the sale of (i) any securities subject to any security interest are subject to compliance with state and federal securities law or (ii) any interest in a limited liability company or partnership interest is subject to compliance with applicable law;
 
  (e)   we express no opinion with respect to the enforceability of any provision of any Credit Document that purports to authorize you to purchase at a private sale the Collateral, which is not subject to widely distributed standard price quotations or sold on a recognized market;
 
  (f)   we express no opinion regarding the characterization of a transaction as one involving the creation of a lien on real property, the characterization of a contract as one in a form sufficient to create a lien or a security interest in real property, the creation, perfection, priority or enforcement of a lien on real property or matters involving ownership or title to any real property;
 
  (g)   we express no opinion regarding the enforceability of any pre-default waiver of notification of disposition of the Collateral, mandatory disposition of the Collateral or redemption rights;
 
  (h)   we express no opinion regarding the enforceability of any provisions asserting that the Collateral is owned by or is property of a secured party prior to such secured party’s foreclosure of such Collateral in accordance with the applicable Uniform Commercial Code or, in the case of cash Collateral, the application of such cash Collateral in payment of the secured obligations;
 
  (i)   we note that our opinions as to the validity, binding effect or enforceability of any Credit Document do not constitute opinions as to the creation, perfection, effect of perfection or priority of any lien or security interest purported to be granted thereunder; as to which matters we express no opinion, except to the extent specifically set forth in opinion paragraph 8;
 
  (j)   we express no opinion as to the enforceability of cumulative remedies to the extent such cumulative remedies purport to or would have the effect of compensating the party entitled to the benefits thereof in amounts in excess of the actual loss suffered by such party or would violate applicable laws concerning real estate or mixed collateral foreclosures or elections of remedies;
 
  (k)   we express no opinion with respect to the adequacy of the waivers set forth in any guaranty insofar as they might not be broad enough for all situations which might arise for which you would find a waiver desirable; and
 
  (l)   we express no opinion with respect to the enforceability of any provision of any Credit Document which purports to authorize you to sign or file financing statements or other documents under circumstances not authorized under the applicable Uniform Commercial Code.

A-4


 

6.   Lender’s Regulatory Qualification. We express no opinion with respect to, and all our opinions are subject to, the effect of the compliance or noncompliance of each of you with any state or federal laws or regulations applicable to you because of your legal or regulatory status or the nature of your business or requiring you to qualify to conduct business in any jurisdiction.
7.   Usury Qualification. We express no opinion with regard to usury or other laws limiting or regulating the maximum amount of interest that may be charged, collected, received or contracted for other than the internal laws of the State of New York, and, without limiting the foregoing, we expressly disclaim any opinion as to the usury or other such laws of any other jurisdiction (including laws of other states made applicable through principles of federal preemption or otherwise) that may be applicable to the transactions contemplated by the Credit Documents.
8.   We express no opinion regarding the enforceability of any “fraudulent conveyance or fraudulent transfer savings clause” in the Guarantee and Collateral Agreement and any similar provision in any other document or agreement to the extent such provisions purport to limit the amount of the obligations of any party or the right to contribution of any other party with respect to such obligations.

A-5


 

Schedule B
Assumptions
     For purposes of our letter, we have relied, without investigation, upon each of the following assumptions:
1.   Each of the Credit Parties (i) has the requisite title and rights to any property involved in the transactions effected under the Credit Documents (herein called the “Transactions”) including without limiting the generality of the foregoing, each item of Collateral existing on the date hereof and (ii) will have the requisite title and rights to each item of Collateral arising after the date hereof.
 
2.   You are existing and in good standing in your jurisdiction of organization.
 
3.   You have the corporate power or, if you are not a corporation, other requisite power (including, without limitation, under the laws of your jurisdiction of organization) to execute, deliver and to perform your obligations under each of the Credit Documents, and each of the Credit Documents to which you are a party has been duly authorized by all necessary action on your part and, to the extent you are a party, has been duly executed and duly delivered by you.
 
4.   The Credit Documents to which you are a party constitute valid and binding obligations of yours and are enforceable against you in accordance with their terms (subject to qualifications, exclusions, and other limitations similar to those applicable to our letter).
 
5.   You have satisfied those legal requirements that are applicable to you to the extent necessary to make the Credit Documents enforceable against you.
 
6.   You have complied with all legal requirements pertaining to your status as such status relates to your rights to enforce the Credit Documents against the Credit Parties.
 
7.   Each of the Credit Parties (other than the Delaware Credit Parties) is a corporation or other entity existing and in good standing under the law of their respective state of organization.
 
8.   Each of the Credit Parties’ (other than the Delaware Credit Parties’) stock holders, board of directors or equivalent governing body has adopted by requisite vote the resolutions or approvals necessary to authorize such Credit Party’s execution, delivery and performance by it of each such Credit Document to which it is a party.
 
9.   Each of the Credit Documents, including the powers of attorney related to the execution thereof, have been duly executed and delivered by each of the Credit Parties (other than the Delaware Credit Parties) that is a party thereto on the date hereof.
 
10.   The execution and delivery by each Credit Party (other than the Delaware Credit Parties) of the Credit Documents to which it is a party, and the consummation by it of the lending transactions contemplated by each Credit Document to which it is a party to occur on the date hereof in accordance with the terms thereof will not (a) violate any existing

B-1


 

    provisions of the Organization Documents of such Credit Party, (b) constitute a violation by such Credit Party of any applicable provision of existing laws or governmental regulation or (c) violate any existing order, writ, injunction, judgment, determination, award or decree of any court or governmental instrumentality applicable to such Credit Party.
 
11.   No Credit Party (other than the Delaware Credit Parties) is presently required by any law to obtain any consent, approval, authorization or order of any court or governmental agency in order to obtain the right to enter into any of the Credit Documents to which it is a party or to take any of the actions taken by it in connection with the consummation of the lending transactions contemplated by such Credit Documents to occur on the date hereof in accordance with the terms thereof.
12.   Each document submitted to us for review is accurate and complete, each such document that is an original is authentic, each such document that is a copy conforms to an authentic original, and all signatures on each such document are genuine.
13.   Each Public Authority Document is accurate, complete and authentic and all official public records (including their proper indexing and filing) are accurate and complete. The term (“Public Authority Documents”) means a certificate issued by any secretary of state of any other government official, office or agency concerning a person’s property or status, such as a certificate of corporate or partnership existence or good standing, a certificate concerning tax status, a certificate concerning Uniform Commercial Code filings or a certificate concerning title registration or ownership.
14.   There has not been any mutual mistake of fact or misunderstanding, fraud, duress or undue influence.
15.   The conduct of the parties to the Credit Documents has complied with any requirement of good faith, fair dealing, and conscionability.
16.   You have acted in good faith and without notice of any defense against the enforcement of any rights created by, or adverse claim to any property or security interest transferred or created as part of, the Transactions.
17.   There are no agreements or understandings among the parties, written or oral (other than the Credit Documents), and there is no usage of trade or course or prior dealing among the parties that would, in either case, define, supplement or qualify the terms of the Credit Agreement or any of the other Credit Documents.
18.   The constitutionality or validity of a relevant statute, rule, regulation or agency action is not in issue.
19.   All parties to the Transactions will act in accordance with, and will refrain from taking any actions that are forbidden by, the terms and conditions of the Credit Documents.

B-2


 

20.   All agreements other than the Credit Documents (if any) with respect to which we have provided advice in our letter or reviewed in connection with our letter would be enforced as written.
21.   None of the Credit Parties will in the future take any discretionary action (including a decision not to act) permitted under the Credit Documents that would result in a violation of law or constitute a breach or default under any other agreements or court orders to which such entity may be subject.
22.   The Credit Parties will in the future obtain all permits and governmental approvals required, and will in the future take all actions required, relevant to the consummation of the Transactions or performance of the Credit Documents.
23.   The representations made by each Credit Party in the Credit Documents to which it is a party with respect to its jurisdiction or organization, chief executive office and location of equipment and inventory are and will remain true and correct.
24.   Each natural person who is executing any Credit Document on behalf of any Credit Party has sufficient legal capacity to enter into such Credit Document, and we have no actual knowledge of any such incapacity.
25.   No Lender is subject to Regulation T of the Board of Governors of the Federal Reserve System; and no proceeds of the Loans will be used for any purpose which would violate or be inconsistent with terms of the Credit Agreement.
26.   All information required to be disclosed in connection with any consent or approval by the Credit Parties’ respective board of directors, board of managers, or manager, as applicable, or their stockholders (or equivalent governing or ownership group) and all other information required to be disclosed in connection with any issue relevant to our opinions or any matter relevant to any legal issue covered by our opinions has been fully and fairly disclosed to all persons to whom it is required to be disclosed and no such disclosure contained any relevant error or omission.
27.   Each person who has taken any action relevant to any of our opinions in the capacity of director, management committee member, or officer was duly elected to that director, management committee member, or officer position and held that position when such action was taken.
28.   Each of the Credit Parties’ Organization Documents, all amendments to each such Organization Document, all resolutions adopted establishing classes or series of stock or other equity interests under such Organization Documents have been adopted in accordance with all applicable legal requirements.
29.   The transactions contemplated by the Credit Documents are directly or indirectly related to the business interests of each Credit Party party thereto and the transactions were fair and reasonable to each such entity at the time each such transaction was authorized by

B-3


 

    such Credit Party, and the transactions were necessary or convenient to the conduct, promotion, or attainment of the business of the Credit Parties.
 
30.   Immediately prior to the effectiveness of the Amendment Agreement, each of the Existing Credit Agreement, the Existing Guarantee and Collateral Agreement and the other “Loan Documents” (as defined in the Credit Agreement) remains in full force and effect and has not been amended, modified, supplemented (other than to join any Guarantor as a party thereto) or replaced since the Closing Date.

B-4


 

Schedule C
Excluded Law and Legal Issues
     None of the opinions or advice contained in our letter covers or otherwise addresses any of the following laws, regulations or other governmental requirements or legal issues:
1.   Federal securities laws and regulations (including all other laws and regulations administered by the United States Securities and Exchange Commission), state “Blue Sky” laws and regulations, and laws and regulations relating to commodity (and other) futures and indices and other similar instruments.
2.   Pension and employee benefit laws and regulations (e.g., ERISA).
3.   Federal and state antitrust and unfair competition laws and regulations.
4.   Federal and state laws and regulations concerning filing and notice requirements (such as the Hart-Scott-Rodino Antitrust Improvements Act of 1986, as amended, and the Exon-Florio Act, as amended) other than requirements applicable to charter-related documents such as a certificate of merger.
5.   Compliance with fiduciary duty requirements.
6.   The statutes and ordinances, the administrative decisions and the rules and regulations of counties, towns, municipalities and special political subdivisions and judicial decisions to the extent that they deal with any of the foregoing.
7.   Fraudulent transfer and fraudulent conveyance laws.
8.   Federal and state environmental, land use and subdivision, tax, racketeering (e.g., RICO), health and safety and labor laws and regulations.
9.   To the extent not otherwise specified in this Schedule C, applicable zoning and building laws, ordinances, code, rules or regulations (e.g., OSHA).
10.   Federal patent, trademark and copyright, state trademark, and other federal and state intellectual property laws and regulations.
11.   Federal and state laws, regulations and policies concerning (i) national and local emergency, (ii) possible judicial deference to acts of sovereign states, and (iii) criminal and civil forfeiture laws.
12.   Other federal and state statutes of general application to the extent they provide for criminal prosecution (e.g., mail fraud and wire fraud statutes).
13.   Any laws, regulations, directives and executive orders that prohibit or limit the enforceability of obligations based on attributes of the party seeking enforcement (e.g., the Trading with the Enemy Act and the International Emergency Economic Powers Act).

C-1


 

14.   The Anti-Terrorism Order, including Executive Order No. 13224 on Terrorism Financing, effective September 24, 2001 and the United and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (together, the “Anti-Terrorism Order”) as amended, all rules and regulations promulgated thereunder and all federal, state and local laws, statutes, ordinances, orders, governmental rules, regulations, licensing requirements and policies relating to the Anti-Terrorism Order, the foreign assets control regulations of the United States Treasury Department, and to the extent the following relate to any Anti-Terrorism Law such anti-terrorism law or regulation (including without limitation the Executive order of September 23, 2001 Blocking Property and Prohibiting Transactions and Persons Who Commit and Threaten to Commit or Support Terrorism) or the Anti-Terrorism Order: the ownership and operation of, or otherwise regulation of, companies which conduct, operate or otherwise pursue the business or businesses now and in the future conducted, operated or otherwise pursued by any of the Credit Parties including, without limitation, the importation, transportation, manufacturing, dealing, purchase, use or storage of explosive materials.
15.   The Communications Act and the rules, regulations and policies of the Federal Communications Commission promulgated thereunder.
16.   The Federal Power Act, as amended, and the regulations implementing the Federal Power Act, all rules and regulations promulgated under any of the foregoing statutes, the rules, regulations and policies of the Federal Energy Regulatory Commission and any other federal or any state or local regulatory authority, and all other federal state and local laws, orders, regulations, licensing requirements and policies regulating, public utilities, electric utilities or energy facilities or services (and including without limitation any requirement under any such federal, state or local law or regulation that any Credit Party obtain any consent, approval, authorization or order in order to enter into the Credit Documents and perform the transactions contemplated thereby or the effect of any failure to obtain any such consent, approval, authorization or order).
17.   The Fair Packaging and Labeling Act, as amended, the Food, Drug and Cosmetic Act, as amended, the Food Security Act of 1985, as amended, the Perishable Agricultural Commodities Act, as amended, the Food, Agriculture, Conservation and Trade Act of 1990, as amended, the Nutritional Labeling and Education Act, as amended, all rules, policies and regulations promulgated under any of the foregoing statutes, and all other federal, state and local laws, orders, regulations, licensing requirements and policies relating to the ownership, operation, processing, production, distribution, purchase or provisions of, or otherwise regulating, food or farm products or animals.
18.   Federal, state and local liquor licensing laws and regulations.
19.   Title to any property.
20.   The Federal Reserve Board margin regulations.
21.   Any insurance, HMO, health insurance laws, hospital, regulations, directives or executive orders.

C-2


 

22.   Federal, state and local laws, regulations, licensing requirements and policies relating to health care, hospitals, Medicare, Medicaid or CHAMPUS (including those of any state regulatory agency or Centers for Medicare and Medicaid Services).
23.   Federal, state, or local regulation or order, of any authority, which relates to or otherwise imposes liability or standards of conduct concerning the licensure, certification, qualification, or operation of a clinical or pathology laboratory, medical practice or other aspect of a Person’s business subject to such laws, including but not limited to laws governing Medicare and Medicaid laboratories, laws regarding the professional standards of health care professionals; laws governing patient confidentiality and privacy; laws governing the corporate practice of medicine; laws governing laboratories; laws relating to kickbacks, self-referrals and access to health care, as well as the Employee Health Care Access Act; 21 U.S.C. ‘301-392, the Federal Food Drug and Cosmetic Act; 21 U.S.C. 821 et seq., the Federal Drug Abuse Act; Sections 1128, 1128A and 1128B of the Social Security Act; The Clinical Laboratory Improvement Amendments of 1988; 42 U.S.C. 1320a-7b, 42 C.F.R. Part 1001, 42 CFR Chapter IV, Subchapter C; Sections 1876 or 1903 of the Social Security Act; 45 CFR, Part 74; 45 CFR, Part 92; 42 CFR 455.109 Section 306 of the Clean Air Act; 42 U.S.C. ‘1857(h) et seq., Section 508 of the Clean Water Act; 33 U.S.C. ‘1368 et seq., Executive Order 11738 and Environmental Protection Agency regulations; 40 CFR Part 15, Title VI of the Civil Rights Act of 1964; 42 U.S.C. ‘2000 d et seq., Section 504 of the Rehabilitation Act of 1933; 29 U.S.C. ‘7940; Title IX of the Education Amendments of 1972, 20 U.S.C. ‘1681 et seq., the Age Discrimination Act of 1975; 42 U.S.C. ‘6101 et seq., Section 654 of OBRA ‘81; 42 U.S.C. ‘9849 and the Americans with Disabilities Act of 1990; P.L. 101-336, OBRAs 1986 through 1993, as amended, the Health Insurance Portability and Accountability Act, as amended, and any other similar Federal, state or local Regulations.
24.   The effect of any law, regulation or order which becomes effective after the date hereof.
     We have not undertaken any research for purposes of determining whether any of the Credit Parties or any of the Transactions that may occur in connection with the Credit Agreement or any of the other Credit Documents is subject to any law or other governmental requirement other than to those laws and requirements that in our experience would generally be recognized as applicable to the general business corporations which are engaged in transactions of the type contemplated by the Credit Documents and which are not engaged in regulated business activities in the absence of research by lawyers in the State of New York, and none of our opinions covers any such law or other requirement unless (i) one of our Designated Transaction Lawyers had actual knowledge of its applicability at the time our letter is or was delivered on the date it bears and (ii) it is not excluded from coverage by other provisions in our letter or in any Schedule to our letter.

C-3


 

Schedule D
Excluded Provisions
     None of the opinions in the letter to which this Schedule is attached covers or otherwise addresses any of the following types of provisions which may be contained in the Credit Documents:
1.   Covenants not to compete, including without limitation covenants not to interfere with business or employee relations, covenants not to solicit customers, and covenants not to solicit or hire employees.
2.   Indemnification for negligence, bad faith, willful misconduct or wrongdoing or strict product liability or any indemnification for liabilities arising under securities laws.
3.   Provisions mandating contribution towards judgments or settlements among various parties.
4.   Waivers of (i) legal or equitable defenses, (ii) rights to damages, (iii) rights to counter claim or set off, (iv) statutes of limitations, (v) rights to notice, (vi) the benefits of statutory, regulatory, or constitutional rights, unless and to the extent the statute, regulation, or constitution explicitly allows waiver, (vii) broadly or vaguely stated rights, and (viii) other benefits to the extent they cannot be waived under applicable law.
5.   Provisions providing for forfeitures or the recovery of amounts deemed to constitute penalties, or for liquidated damages, acceleration of future amounts due (other than principal) without appropriate discount to present value, late charges, prepayment charges, interest upon interest, and increased interest rates upon default.
6.   Time-is-of-the-essence clauses.
7.   Provisions that provide a time limitation after which a remedy may not be enforced.
8.   Confession of judgment clauses.
9.   Agreements to submit to the jurisdiction of any particular court or other governmental authority (either as to personal jurisdiction or subject matter jurisdiction); provisions restricting access to courts; waiver of the right to jury trial; waiver of service of process requirements which would otherwise be applicable; and provisions otherwise purporting to affect the jurisdiction and venue of courts.
10.   Provisions that attempt to change or waive rules of evidence or fix the method or quantum of proof to be applied in litigation or similar proceedings.
11.   Provisions appointing one party as an attorney-in-fact for an adverse party or providing that the decision of any particular person will be conclusive or binding on others.
12.   Provisions purporting to limit rights of third parties who have not consented thereto or purporting to grant rights to third parties.

D-1


 

13.   Provisions that purport to award attorneys’ fees solely to one party.
14.   Arbitration agreements.
15.   Provisions purporting to create a trust or constructive trust without compliance with applicable trust law.
16.   Provisions relating to the application of insurance proceeds and condemnation awards.
17.   Provisions that provide for the appointment of a receiver or the taking of possession by the Agent.
18.   Provisions or agreements regarding proxies, shareholders agreements, shareholder voting rights, voting trusts, and the like.
19.   Confidentiality agreements.
20.   Provisions, if any, which are contrary to the public policy of jurisdictions covered by our opinions.
21.   Choice of law provisions, other than, under New York statutory choice-of-law rules, those provisions in the Credit Documents that provide that the laws of the State of New York shall govern.
22.   Provisions in any of the Credit Documents requiring any Credit Party to perform its obligations under, or cause any other person to perform its obligations under, or stating that any action will be taken as provided in or in accordance with, any agreement or other document that is not a Credit Document.
23.   Provisions of the Credit Documents insofar as they authorize you or your affiliates to setoff and apply deposits at any time held, and any other indebtedness at anytime owing by you to or for the account of any Credit Party.
24.   With your permission, Section 9.20(e) of the Credit Agreement.

D-2


 

Schedule E
Schedule of Guarantors
1. Abilene Hospital, LLC
2. Abilene Merger, LLC
3. Anna Hospital Corporation
4. Arizona DH, LLC
5. Berwick Hospital Company, LLC
6. BH Trans Company, LLC
7. Big Bend Hospital Corporation
8. Big Spring Hospital Corporation
9. Birmingham Holdings, LLC
10. Birmingham Holdings II, LLC
11. Bluefield Holdings, LLC
12. Bluefield Hospital Company, LLC
13. Bluffton Health System LLC
14. Brownsville Hospital Corporation
15. Brownwood Hospital, L.P.
16. Brownwood Medical Center, LLC
17. Carlsbad Medical Center, LLC
18. Centre Hospital Corporation
19. CHHS Holdings, LLC
20. CHS Kentucky Holdings, LLC
21. CHS Pennsylvania Holdings, LLC
22. CHS Virginia Holdings, LLC
23. CHS Washington Holdings, LLC
24. Claremore Regional Hospital, LLC
25. Clarksville Holdings, LLC
26. Cleveland Hospital Corporation
27. Cleveland Regional Medical Center, L.P.
28. Cleveland Tennessee Hospital Company, LLC
29. Clinton Hospital Corporation
30. Coatesville Hospital Corporation
31. College Station Hospital, L.P.
32. College Station Medical Center, LLC
33. College Station Merger, LLC
34. Community GP Corp.
35. Community Health Investment Company, LLC
36. Community LP Corp.
37. CP Hospital GP, LLC
38. CPLP, LLC
39. Crestwood Hospital, LP, LLC
40. Crestwood Hospital, LLC
41. CSMC, LLC
42. CSRA Holdings, LLC
43. Deaconess Holdings, LLC

E-1


 

44. Deaconess Hospital Holdings, LLC
45. Deming Hospital Corporation
46. Desert Hospital Holdings, LLC
47. Detar Hospital, LLC
48. DHSC, LLC
49. DHFW Holdings, LLC
50. Dukes Health System, LLC
51. Dyersburg Hospital Corporation
52. Emporia Hospital Corporation
53. Evanston Hospital Corporation
54. Fallbrook Hospital Corporation
55. Foley Hospital Corporation
56. Forrest City Arkansas Hospital Company, LLC
57. Forrest City Clinic Company, LLC
58. Forrest City Hospital Corporation
59. Fort Payne Hospital Corporation
60. Frankfort Health Partner, Inc.
61. Franklin Hospital Corporation
62. Gadsden Regional Medical Center, LLC
63. Galesburg Hospital Corporation
64. Granbury Hospital Corporation
65. Granite City Hospital Corporation
66. Granite City Illinois Hospital Company, LLC
67. Greenville Hospital Corporation
68. GRMC Holdings, LLC
69. Hallmark Healthcare Company, LLC
70. Hobbs Medco, LLC
71. Hospital of Barstow, Inc.
72. Hospital of Fulton, Inc.
73. Hospital of Louisa, Inc.
74. Hospital of Morristown, Inc.
75. Jackson Hospital Corporation (KY)
76. Jackson Hospital Corporation (TN)
77. Jourdanton Hospital Corporation
78. Kay County Hospital Corporation
79. Kay County Oklahoma Hospital Company, LLC
80. Kirksville Hospital Company, LLC
81. Lakeway Hospital Corporation
82. Lancaster Hospital Corporation
83. Las Cruces Medical Center, LLC
84. Lea Regional Hospital, LLC
85. Lexington Hospital Corporation
86. Longview Merger, LLC
87. LRH, LLC
88. Lutheran Health Network of Indiana, LLC
89. Marion Hospital Corporation

E-2


 

90. Martin Hospital Corporation
91. Massillon Community Health System LLC
92. Massillon Health System LLC
93. Massillon Holdings, LLC
94. McKenzie Tennessee Hospital Company, LLC
95. McNairy Hospital Corporation
96. MCSA, L.L.C.
97. Medical Center of Brownwood, LLC
98. Merger Legacy Holdings, LLC
99. MMC of Nevada, LLC
100. Moberly Hospital Company, LLC
101. MWMC Holdings, LLC
102. National Healthcare of Leesville, Inc.
103. National Healthcare of Mt. Vernon, Inc.
104. National Healthcare of Newport, Inc.
105. Navarro Hospital, L.P.
106. Navarro Regional, LLC
107. NC-DSH, LLC
108. Northampton Hospital Company, LLC
109. Northwest Hospital, LLC
110. NOV Holdings, LLC
111. NRH, LLC
112. Oak Hill Hospital Corporation
113. Oro Valley Hospital, LLC
114. Palmer-Wasilla Health System, LLC
115. Payson Hospital Corporation
116. Pennsylvania Hospital Company, LLC
117. Phillips Hospital Corporation
118. Phoenixville Hospital Company, LLC
119. Pottstown Hospital Company, LLC
120. QHG Georgia Holdings, Inc.
121. QHG Georgia Holdings II, LLC
122. QHG Georgia, LP
123. QHG of Barberton, Inc.
124. QHG of Bluffton Company, LLC
125. QHG of Clinton County, Inc.
126. QHG of Enterprise, Inc.
127. QHG of Forrest County, Inc.
128. QHG of Fort Wayne Company, LLC
129. QHG of Hattiesburg, Inc.
130. QHG of Massillon, Inc.
131. QHG of South Carolina, Inc.
132. QHG of Spartanburg, Inc.
133. QHG of Springdale, Inc.
134. QHG of Warsaw Company, LLC
135. Quorum Health Resources, LLC

E-3


 

136. Red Bud Hospital Corporation
137. Red Bud Illinois Hospital Company, LLC
138. Regional Hospital of Longview, LLC
139. River Region Medical Corporation
140. Roswell Hospital Corporation
141. Russell County Medical Center, Inc.
142. Ruston Hospital Corporation
143. Ruston Louisiana Hospital Company, LLC
144. SACMC, LLC
145. Salem Hospital Corporation
146. San Angelo Community Medical Center, LLC
147. San Angelo Medical, LLC
148. San Miguel Hospital Corporation
149. Shelbyville Hospital Corporation
150. Siloam Springs Arkansas Hospital Company, LLC
151. Siloam Springs Holdings, LLC
152. SouthCrest, L.L.C.
153. Southern Texas Medical Center, LLC
154. Spokane Valley Washington Hospital Company, LLC
155. Spokane Washington Hospital Company, LLC
156. Tennyson Holdings, LLC
157. Tooele Hospital Corporation
158. Triad Healthcare Corporation
159. Triad Holdings III, LLC
160. Triad Holdings IV, LLC
161. Triad Holdings V, LLC
162. Triad Nevada Holdings, LLC
163. Triad of Alabama, LLC
164. Triad of Oregon, LLC
165. Triad-ARMC, LLC
166. Triad-Denton Hospital GP, LLC
167. Triad-Denton Hospital, L.P.
168. Triad-El Dorado, Inc.
169. Triad-Navarro Regional Hospital Subsidiary, LLC
170. Triad-South Tulsa Hospital Company, Inc.
171. VHC Medical, LLC
172. Vicksburg Healthcare, LLC
173. Victoria Hospital, LLC
174. Victoria of Texas, L.P.
175. Virginia Hospital Company, LLC
176. Warren Ohio Hospital Company, LLC
177. Warren Ohio Rehab Hospital Company, LLC
178. Watsonville Hospital Corporation
179. Waukegan Hospital Corporation
180. Waukegan Illinois Hospital Company, LLC
181. Weatherford Hospital Corporation

E-4


 

182. Weatherford Texas Hospital Company, LLC
183. Webb Hospital Corporation
184. Webb Hospital Holdings, LLC
185. Wesley Health System, LLC
186. West Grove Hospital Company, LLC
187. WHMC, LLC
188. Wilkes-Barre Behavioral Hospital Company, LLC
189. Wilkes-Barre Holdings, LLC
190. Wilkes-Barre Hospital Company, LLC
191. Williamston Hospital Corporation
192. Women & Children’s Hospital, LLC
193. Woodland Heights Medical Center, LLC
194. Woodward Health System, LLC
195. Youngstown Ohio Hospital Company, LLC

E-5


 

Schedule I
Specified Agreements
1. Indenture dated as of July 25, 2007 among Borrower, the Subsidiary Guarantors and U.S. Bank National Association, as Trustee, relating to the sale by the Borrower of $3,021,331,000 8 7/8% Senior Notes due 2015.

 


 

EXHIBIT C-2
Form of Opinion of General Counsel of Parent
November 5, 2010
The Lenders and the Agent Referred to Below
c/o Credit Suisse AG
as Administrative Agent, Collateral Agent and Issuing Bank
Eleven Madison Avenue
New York, New York 10010
          RE: Amendment and Restatement Agreement, dated as of November 5, 2010
Ladies and Gentlemen:
     I am Executive Vice President, Secretary and General Counsel of CHS/Community Health Systems, Inc., a Delaware corporation (the “Borrower”), and have acted as Counsel for the Borrower, Community Health Systems, Inc. (“Parent”) and each of the Subsidiaries listed on the Schedule of Guarantors attached hereto as Schedule A (collectively, the “Guarantors” and each a “Guarantor” and together with the Borrower and Parent, the “Credit Parties”) in connection with the Amendment and Restatement Agreement, dated as of even date herewith (the “Amendment Agreement”), among Parent, Borrower, the Guarantors, and Credit Suisse AG, as Administrative Agent and Collateral Agent (the “Agent”), and the Lenders listed on the signature pages thereto, which Amendment Agreement amends and restates (A) the Credit Agreement, dated as of July 25, 2007 (the “Existing Credit Agreement”), among Parent, Borrower, Agent, and the Lenders party thereto (the Existing Credit Agreement, as amended and restated by the Amendment Agreement, the “Amended and Restated Credit Agreement”) and (B) the Guarantee and Collateral Agreement, dated as of July 25, 2007 (the “Existing Guarantee and Collateral Agreement”), among Parent, Borrower, the Guarantors and Agent (the Existing Guarantee and Collateral Agreement as amended and restated by the Amendment Agreement, the “Amended and Restated Guarantee and Collateral Agreement”).
     This opinion is delivered to you pursuant to subsection Section 6(b) of the Amendment Agreement. All capitalized terms used herein that are defined in, or by reference in, the Amended and Restated Credit Agreement have the meanings assigned to such terms therein, or by reference therein, unless otherwise defined herein. With your permission, all assumptions and statements of reliance herein have been made without any independent investigation or verification on my part except to the extent otherwise expressly stated, and I express no opinion with respect to the subject matter or accuracy of such assumptions or items relied upon.
     In connection with this opinion, I have (i) investigated such questions of law, (ii) examined originals or certified, conformed or reproduction copies of such agreements, instruments, documents, and records of the Credit Parties, such certificates of public officials and such other documents, and (iii) received such information from officers and representatives of

 


 

the Credit Parties, as I have deemed necessary or appropriate for the purposes of this opinion. I have examined, among other documents, the following (in each case dated as of the date of the Amendment Agreement):
     (a) an executed copy of the Amendment Agreement;
     (b) a copy of the Amended and Restated Credit Agreement; and
     (c) a copy of the Amended and Restated Guarantee and Collateral Agreement.
     The documents referred to in items (a) through (c) above, inclusive, are referred to herein as the “Transaction Documents”.
     In all such examinations, I have assumed the legal capacity of all natural persons executing documents, the genuineness of all signatures on original or certified, conformed or reproduction copies of documents of all parties (other than with respect to the Credit Parties to the extent signed in my presence), the authenticity of original and certified documents and the conformity to original or certified documents of all copies submitted to me as conformed or reproduction copies. As to various questions of fact relevant to the opinions expressed herein, I have relied upon, and assume the accuracy of certificates and oral or written statements and other information of or from public officials and others, and assume compliance on the part of all parties to the Transaction Documents with their covenants and agreements contained therein.
     With respect to the opinions expressed in clauses (ii) and (iv) of paragraph (b) below, my opinions are limited (x) to my actual knowledge of the respective business activities and properties of the Credit Parties in respect of such matters and without any independent investigation or verification on my part and (y) to my review of only those laws and regulations that, in my experience, are normally applicable to transactions of the type contemplated by the Transaction Documents.
     To the extent it may be relevant to the opinions expressed herein, I have assumed that the parties to the Transaction Documents, other than Parent, Borrower and the Guarantors, have the corporate power to enter into and perform such documents and that (except as set forth in paragraph (b) below) such documents have been duly authorized, executed and delivered by, and constitute legal, valid and binding obligations of, such parties.
     Based upon the foregoing, and subject to the limitations, qualifications and assumptions set forth therein, I am of the opinion that:
     (a) Each Guarantor is a corporation, limited liability company, or limited partnership validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization and has all power and authority necessary to execute, deliver and perform its obligations under the Transaction Documents.
     (b) The execution and delivery by each Credit Party of the Amendment Agreement and the performance by each Credit Party of its respective obligations under each of the Transaction Documents and the borrowings by the Borrower and the grant by each Credit Party of the security interests pursuant to the Transaction Documents to which it is a party (i) have

 


 

been authorized, in the case of each Guarantor, by all necessary action by such Guarantor, (ii) do not require under present law any filing or registration by any Credit Party with, or approval or consent to any Credit Party of, any governmental agency or authority of the State of Tennessee that has not been made or obtained, except those required in the ordinary course of business in connection with the future performance, if any, by each Credit Party of its respective obligations under certain covenants contained in the Transaction Documents to which it is a party or pursuant to securities or other laws that may be applicable to the disposition of any collateral subject thereto, (iii) do not contravene any provision of the certificate of incorporation or bylaws or similar organizational document of any Guarantor, (iv) do not violate any present law, or present regulation of any governmental agency or authority, of the State of Tennessee known by me to be applicable to any Credit Party or their respective properties, (v) breach or cause a default under any agreement or violate any court decree or order binding upon such Credit Party or its property (this opinion being limited (x) to those agreements, decrees or orders that have been filed as exhibits (or are incorporated by reference as exhibits) to the Form 10-K of Parent for the year ended December 31, 2009 and (y) in that I express, no opinion with respect to any breach, default or violation not readily ascertainable from the face of any such agreement, decree or order, or arising under or based upon any cross default provision insofar as it relates to a default under an agreement not so identified to me, or arising under or based upon any covenant of a financial or numerical nature or requiring computation), and (vi) will not result in or require the creation or imposition of any Lien upon any properties of a Credit Party pursuant to the provisions of any agreement (this opinion being limited to those agreements that have been filed as exhibits (or are incorporated by reference as exhibits) to the Form 10-K of Parent for the year ended December 31, 2009.
     (c) The Amendment Agreement has been duly executed and delivered on behalf of each Guarantor that is a party thereto.
     To my actual knowledge, I am not aware of any pending legal proceeding before, or pending investigation by, any court or administrative agency or authority, or any arbitration tribunal, against or directly affecting the Credit Parties, or any of their respective properties, which seeks to enjoin or otherwise prevent the consummation of, or to recover any damages or obtain relief in connection with or which would adversely affect the legality, validity or enforceability of, any of the Transaction Documents or the transactions contemplated thereby.
     I have issued certain limited opinions above as to the corporate, limited liability company, or limited partnership organization, existence, good standing and authority of the Guarantors under the law of their respective states of organization. I do not purport to be an expert in matters of law of jurisdictions other than the State of Tennessee and the federal law of the United States of America, and have issued my opinions based solely upon my review of the corporate record of each Guarantor.
     The opinions set forth above are subject to the following qualifications and limitations:
     (a) I express no opinion regarding the application of federal or state securities laws to the transactions contemplated in the Transaction Documents;

 


 

     (b) I express no opinion regarding (i) the effect of fraudulent conveyance, fraudulent transfer and other similar laws relating to or affecting the rights of creditors and (ii) restrictions relating to capital adequacy that may be applicable to any Guarantor to the extent any Transaction Document may be deemed a dividend or distribution; and
     (c) to the extent that section 8.31 of the Revised Model Business Corporation Act (as adopted in any state in which a Credit Party is incorporated) or other corporation law analogous thereto may apply, I have assumed the transactions described in the Transaction Documents are fair to the Credit Parties.
     I am qualified to practice law in the State of Tennessee, and I am no expert in and express no opinions as to the laws of other jurisdictions other than to the federal laws of the United States of America and the laws of the State of Tennessee, as currently in effect. I assume no obligation to supplement this opinion if any applicable laws change after the date hereof or if I become aware of any facts that might change the opinions expressed herein after the date hereof.
[Remainder of page intentionally left blank.]

 


 

     The opinions expressed herein are solely for the benefit of the Lenders and the Agent and may not be relied on in any manner or for any purpose by any other person or entity.
         
  Very truly yours,
 
 
     
     
     

 


 

         
Schedule A
Schedule of Guarantors
Abilene Hospital, LLC
Abilene Merger, LLC
Anna Hospital Corporation
Arizona DH, LLC
Berwick Hospital Company, LLC
BH Trans Company, LLC
Big Bend Hospital Corporation
Big Spring Hospital Corporation
Birmingham Holdings, LLC
Birmingham Holdings II, LLC
Bluefield Holdings, LLC
Bluefield Hospital Company, LLC
Bluffton Health System, LLC
Brownsville Hospital Corporation
Brownwood Hospital, L.P.
Brownwood Medical Center, LLC
Carlsbad Medical Center, LLC
Centre Hospital Corporation
CHHS Holdings, LLC
CHS Kentucky Holdings, LLC
CHS Pennsylvania Holdings, LLC
CHS Virginia Holdings, LLC
CHS Washington Holdings, LLC
Claremore Regional Hospital, LLC
Clarksville Holdings, LLC
Cleveland Hospital Corporation
Cleveland Regional Medical Center, L.P.
Cleveland Tennessee Hospital Company, LLC
Clinton Hospital Corporation
Coatesville Hospital Corporation
College Station Hospital, L.P.
College Station Medical Center, LLC
College Station Merger, LLC
Community GP Corp.
Community Health Investment Company, LLC
Community LP Corp.
CP Hospital GP, LLC
CPLP, LLC
Crestwood Hospital, LP, LLC
Crestwood Hospital, LLC
CSMC, LLC
CSRA Holdings, LLC
Deaconess Holdings, LLC

 


 

Deaconess Hospital Holdings, LLC
Deming Hospital Corporation
Desert Hospital Holdings, LLC
Detar Hospital, LLC
DHSC, LLC
DHFW Holdings, LLC
Dukes Health System, LLC
Dyersburg Hospital Corporation
Emporia Hospital Corporation
Evanston Hospital Corporation
Fallbrook Hospital Corporation
Foley Hospital Corporation
Forrest City Arkansas Hospital Company, LLC
Forrest City Clinic Company, LLC
Forrest City Hospital Corporation
Fort Payne Hospital Corporation
Frankfort Health Partner, Inc.
Franklin Hospital Corporation
Gadsden Regional Medical Center, LLC
Galesburg Hospital Corporation
Granbury Hospital Corporation
Granite City Hospital Corporation
Granite City Illinois Hospital Company, LLC
Greenville Hospital Corporation
GRMC Holdings, LLC
Hallmark Healthcare Company, LLC
Hobbs Medco, LLC
Hospital of Barstow, Inc.
Hospital of Fulton, Inc.
Hospital of Louisa, Inc.
Hospital of Morristown, Inc.
Jackson Hospital Corporation (KY)
Jackson Hospital Corporation (TN)
Jourdanton Hospital Corporation
Kay County Hospital Corporation
Kay County Oklahoma Hospital Company, LLC
Kirksville Hospital Company, LLC
Lakeway Hospital Corporation
Lancaster Hospital Corporation
Las Cruces Medical Center, LLC
Lea Regional Hospital, LLC
Lexington Hospital Corporation
Longview Merger, LLC
LRH, LLC
Lutheran Health Network of Indiana, LLC
Marion Hospital Corporation

 


 

Martin Hospital Corporation
Massillon Community Health System LLC
Massillon Health System LLC
Massillon Holdings, LLC
McKenzie Tennessee Hospital Company, LLC
McNairy Hospital Corporation
MCSA, L.L.C.
Medical Center of Brownwood, LLC
Merger Legacy Holdings, LLC
MMC of Nevada, LLC
Moberly Hospital Company, LLC
MWMC Holdings, LLC
National Healthcare of Leesville, Inc.
National Healthcare of Mt. Vernon, Inc.
National Healthcare of Newport, Inc.
Navarro Hospital, L.P.
Navarro Regional, LLC
NC-DSH, LLC
Northampton Hospital Company, LLC
Northwest Hospital, LLC
NOV Holdings, LLC
NRH, LLC
Oak Hill Hospital Corporation
Oro Valley Hospital, LLC
Palmer-Wasilla Health System, LLC
Payson Hospital Corporation
Pennsylvania Hospital Company, LLC
Phillips Hospital Corporation
Phoenixville Hospital Company, LLC
Pottstown Hospital Company, LLC
QHG Georgia Holdings, Inc.
QHG Georgia Holdings II, LLC
QHG Georgia, L.P.
QHG of Barberton, Inc.
QHG of Bluffton Company, LLC
QHG of Clinton County, Inc.
QHG of Enterprise, Inc.
QHG of Forrest County, Inc.
QHG of Fort Wayne Company, LLC
QHG of Hattiesburg, Inc.
QHG of Massillon, Inc.
QHG of South Carolina, Inc.
QHG of Spartanburg, Inc.
QHG of Springdale, Inc.
QHG of Warsaw Company, LLC
Quorum Health Resources, LLC

 


 

Red Bud Hospital Corporation
Red Bud Illinois Hospital Company, LLC
Regional Hospital of Longview, LLC
River Region Medical Corporation
Roswell Hospital Corporation
Russell County Medical Center, Inc.
Ruston Hospital Corporation
Ruston Louisiana Hospital Company, LLC
SACMC, LLC
Salem Hospital Corporation
San Angelo Community Medical Center, LLC
San Angelo Medical, LLC
San Miguel Hospital Corporation
Shelbyville Hospital Corporation
Siloam Springs Arkansas Hospital Co., LLC
Siloam Springs Holdings, LLC
SouthCrest, L.L.C.
Southern Texas Medical Center, LLC
Spokane Valley Washington Hospital Co., LLC
Spokane Washington Hospital Company, LLC
Tennyson Holdings, LLC
Toelle Hospital Corporation
Triad Healthcare Corporation
Triad Holdings III, LLC
Triad Holdings IV, LLC
Triad Holdings V, LLC
Triad Nevada Holdings, LLC
Triad of Alabama, LLC
Triad of Oregon, LLC
Triad-ARMC, LLC
Triad-Denton Hospital GP, LLC
Triad-Denton Hospital, L.P.
Triad-El Dorado, Inc.
Triad-Navarro Regional Hospital Subsidiary, LLC
Triad-South Tulsa Hospital Company, Inc.
VHC Medical, LLC
Vicksburg Healthcare, LLC
Victoria Hospital, LLC
Victoria of Texas, L.P.
Virginia Hospital Company, LLC
Warren Ohio Hospital Company, LLC
Warren Ohio Rehab Hospital Company, LLC
Watsonville Hospital Corporation
Waukegan Hospital Corporation
Waukegan Illinois Hospital Company, LLC
Weatherford Hospital Corporation

 


 

Weatherford Texas Hospital Company, LLC
Webb Hospital Corporation
Webb Hospital Holdings, LLC
Wesley Health System, LLC
West Grove Hospital Company, LLC
WHMC, LLC
Wilkes-Barre Behavioral Hospital Company, LLC
Wilkes-Barre Holdings, LLC
Wilkes-Barre Hospital Company, LLC
Williamston Hospital Corporation
Women & Children’s Hospital, LLC
Woodland Heights Medical Center, LLC
Woodward Health System, LLC
Youngstown Ohio Hospital Company, LLC

 

exv10w2
Exhibit 10.2
 
 
AMENDED AND RESTATED CREDIT AGREEMENT
dated as of
July 25, 2007,
as amended and restated as of November 5, 2010
among
CHS/COMMUNITY HEALTH SYSTEMS, INC.,
COMMUNITY HEALTH SYSTEMS, INC.,
THE LENDERS PARTY HERETO
and
CREDIT SUISSE AG,
as Administrative Agent and Collateral Agent
CREDIT SUISSE SECURITIES (USA) LLC
as Sole Bookrunner and Sole Lead Arranger
WELLS FARGO BANK, N.A.
as Syndication Agent
JPMORGAN CHASE BANK, N.A.
and
BANK OF AMERICA, N.A.,
as Co-Documentation Agents
 
 


 

Table of Contents
             
        Page  
ARTICLE I

Definitions
 
           
SECTION 1.01.
  Defined Terms     1  
SECTION 1.02.
  Terms Generally     36  
SECTION 1.03.
  Pro Forma Calculations     36  
SECTION 1.04.
  Classification of Loans and Borrowings     37  
 
           
ARTICLE II

The Credits
 
           
SECTION 2.01.
  Commitments     37  
SECTION 2.02.
  Loans     38  
SECTION 2.03.
  Borrowing Procedure     40  
SECTION 2.04.
  Evidence of Debt; Repayment of Loans     40  
SECTION 2.05.
  Fees     41  
SECTION 2.06.
  Interest on Loans     42  
SECTION 2.07.
  Default Interest     42  
SECTION 2.08.
  Alternate Rate of Interest     42  
SECTION 2.09.
  Termination and Reduction of Commitments     43  
SECTION 2.10.
  Conversion and Continuation of Borrowings     43  
SECTION 2.11.
  Repayment of Term Borrowings     45  
SECTION 2.12.
  Optional Prepayment     46  
SECTION 2.13.
  Mandatory Prepayments     47  
SECTION 2.14.
  Reserve Requirements; Change in Circumstances     49  
SECTION 2.15.
  Change in Legality     50  
SECTION 2.16.
  Indemnity     51  
SECTION 2.17.
  Pro Rata Treatment     52  
SECTION 2.18.
  Sharing of Setoffs     52  
SECTION 2.19.
  Payments     53  
SECTION 2.20.
  Taxes     53  
SECTION 2.21.
  Assignment of Commitments Under Certain        
 
  Circumstances; Duty to Mitigate     55  
SECTION 2.22.
  Swingline Loans     56  
SECTION 2.23.
  Letters of Credit     58  
SECTION 2.24.
  Incremental Term Loans     62  
SECTION 2.25.
  Revolving Credit Loan Modification Offers     64  

 


 

             
        Page  
 
           
ARTICLE III

Representations and Warranties
 
           
SECTION 3.01.
  Organization; Powers     66  
SECTION 3.02.
  Authorization     66  
SECTION 3.03.
  Enforceability     66  
SECTION 3.04.
  Governmental Approvals     67  
SECTION 3.05.
  Financial Statements     67  
SECTION 3.06.
  No Material Adverse Change     67  
SECTION 3.07.
  Title to Properties; Possession Under Leases     67  
SECTION 3.08.
  Subsidiaries     68  
SECTION 3.09.
  Litigation; Compliance with Laws     68  
SECTION 3.10.
  Agreements     68  
SECTION 3.11.
  Federal Reserve Regulations     68  
SECTION 3.12.
  Investment Company Act     69  
SECTION 3.13.
  Use of Proceeds     69  
SECTION 3.14.
  Tax Returns     69  
SECTION 3.15.
  No Material Misstatements     69  
SECTION 3.16.
  Employee Benefit Plans     69  
SECTION 3.17.
  Environmental Matters     70  
SECTION 3.18.
  Insurance     70  
SECTION 3.19.
  Security Documents     70  
SECTION 3.20.
  Location of Real Property and Leased Premises     71  
SECTION 3.21.
  Labor Matters     71  
SECTION 3.22.
  Solvency     72  
SECTION 3.23.
  Sanctioned Persons     72  
 
           
ARTICLE IV

Conditions of Lending
 
           
SECTION 4.01.
  All Credit Events     72  
SECTION 4.02.
  [Intentionally Omitted.]     73  
 
           
ARTICLE V

Affirmative Covenants
 
           
SECTION 5.01.
  Existence; Compliance with Laws; Businesses and Properties     73  
SECTION 5.02.
  Insurance     74  
SECTION 5.03.
  Obligations and Taxes     74  
SECTION 5.04.
  Financial Statements, Reports, etc     75  
SECTION 5.05.
  Litigation and Other Notices     76  
SECTION 5.06.
  Information Regarding Collateral     77  

 


 

             
        Page  
 
           
SECTION 5.07.
  Maintaining Records; Access to Properties and        
 
  Inspections; Maintenance of Ratings     77  
SECTION 5.08.
  Use of Proceeds     77  
SECTION 5.09.
  Employee Benefits     77  
SECTION 5.10.
  Compliance with Environmental Laws     78  
SECTION 5.11.
  Preparation of Environmental Reports     78  
SECTION 5.12.
  Further Assurances     78  
SECTION 5.13.
  Proceeds of Certain Dispositions     79  
SECTION 5.14.
  Operation of Facilities     80  
 
           
ARTICLE VI

Negative Covenants
 
           
SECTION 6.01.
  Indebtedness     80  
SECTION 6.02.
  Liens     81  
SECTION 6.03.
  Sale and Lease-Back Transactions     81  
SECTION 6.04.
  Investments, Loans and Advances     81  
SECTION 6.05.
  Mergers, Consolidations, Sales of Assets and Acquisitions     81  
SECTION 6.06.
  Restricted Payments; Restrictive Agreements     81  
SECTION 6.07.
  Transactions with Affiliates     81  
SECTION 6.08.
  Business of Parent, Borrower and Subsidiaries     81  
SECTION 6.09.
  Other Indebtedness     81  
SECTION 6.10.
  Practice Guarantees     81  
SECTION 6.11.
  Capital Expenditures     81  
SECTION 6.12.
  Interest Coverage Ratio     81  
SECTION 6.13.
  Maximum Leverage Ratio     81  
SECTION 6.14.
  Fiscal Year     81  
 
           
ARTICLE VII

Events of Default
 
           
ARTICLE VIII

The Administrative Agent and the Collateral Agent
 
           
ARTICLE IX

Miscellaneous
 
           
SECTION 9.01.
  Notices     81  
SECTION 9.02.
  Survival of Agreement     81  
SECTION 9.03.
  Binding Effect     81  

 


 

             
        Page  
 
           
SECTION 9.04.
  Successors and Assigns     81  
SECTION 9.05.
  Expenses; Indemnity     81  
SECTION 9.06.
  Right of Setoff     81  
SECTION 9.07.
  Applicable Law     81  
SECTION 9.08.
  Waivers; Amendment     81  
SECTION 9.09.
  Certain Releases of Guarantees and Security Interests     81  
SECTION 9.10.
  Interest Rate Limitation     81  
SECTION 9.11.
  Entire Agreement     81  
SECTION 9.12.
  WAIVER OF JURY TRIAL     81  
SECTION 9.13.
  Severability     81  
SECTION 9.14.
  Counterparts     81  
SECTION 9.15.
  Headings     81  
SECTION 9.16.
  Jurisdiction; Consent to Service of Process     81  
SECTION 9.17.
  Confidentiality     81  
SECTION 9.18.
  USA PATRIOT Act Notice     81  
SECTION 9.19.
  Effect of Certain Inaccuracies     81  
SECTION 9.20.
  Pari Passu Obligations     81  

 


 

SCHEDULES
         
Schedule 1.01(a)
  -   Existing Letters of Credit
Schedule 1.01(b)
  -   Subsidiary Guarantors
Schedule 1.01(c)
  -   Mortgaged Property
Schedule 1.01(d)
  -   Hospitals
Schedule 1.01(e)
  -   Certain Permitted Joint Ventures
Schedule 1.01(f)
  -   Certain Subsidiaries
Schedule 2.01
  -   Initial Lenders and Commitments
Schedule 3.08
  -   Subsidiaries
Schedule 3.18
  -   Insurance
Schedule 3.19(a)
  -   UCC Filing Offices
Schedule 3.19(c)
  -   Mortgage Filing Offices
Schedule 3.21
  -   Collective Bargaining Agreements
Schedule 6.01
  -   Existing Indebtedness
Schedule 6.02
  -   Existing Liens
Schedule 6.04(h)
  -   Certain Permitted Acquisitions
Schedule 6.05(b)
  -   Certain Syndication Transactions
Schedule 6.07
  -   Certain Affiliate Transactions
EXHIBITS
         
Exhibit A
  -   Form of Administrative Questionnaire
Exhibit B
  -   Form of Assignment and Acceptance
Exhibit C
  -   Form of Borrowing Request
Exhibit D
  -   Form of Mortgage

 


 

     CREDIT AGREEMENT dated as of July 25, 2007, as amended and restated as of November 5, 2010, among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation (the “Borrower”), COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation (“Parent”), the Lenders (as defined in Article I), and CREDIT SUISSE AG, as administrative agent (in such capacity, the “Administrative Agent”) and as collateral agent (in such capacity, the “Collateral Agent”) for the Lenders.
PRELIMINARY STATEMENT
     The Borrower, Parent, the lenders party thereto and Credit Suisse AG (formerly known as Credit Suisse), as administrative agent and collateral agent, have previously entered into a Credit Agreement dated as of July 25, 2007 (the “Original Credit Agreement”).
     On the Restatement Effective Date, (a) certain Existing Funded Term Loans and Existing Delayed Draw Term Loans will be converted to Extended Term Loans pursuant to the Amendment and Restatement Agreement, and all other Existing Funded Term Loans and Existing Delayed Draw Term Loans will be redesignated as Non-Extended Funded Term Loans or Non-Extended Delayed Draw Term Loans, as applicable, and (b) the Original Credit Agreement will be amended and restated in the form of this Agreement.
     The proceeds of the Existing Term Loans were used for the purposes set forth in the Original Credit Agreement. The proceeds of the Revolving Loans and the Swingline Loans are to be used by the Borrower and the Subsidiaries from time to time for working capital and other general corporate purposes, including permitted investments and Capital Expenditures and to repay Indebtedness. Letters of Credit will be used for general corporate purposes of the Borrower and the Subsidiaries.
     Accordingly, the parties hereto agree as follows:
ARTICLE I
Definitions
     SECTION 1.01. Defined Terms. As used in this Agreement, the following terms shall have the meanings specified below:
     “ABR”, when used in reference to any Loan or Borrowing, refers to whether such Loan, or the Loans comprising such Borrowing, are bearing interest at a rate determined by reference to the Alternate Base Rate.
     “Accepting Revolving Credit Lenders” shall have the meaning assigned to such term in Section 2.25(a).
     “Adjusted LIBO Rate” shall mean, with respect to any Eurodollar Borrowing for any Interest Period, an interest rate per annum equal to the product of (a) the LIBO Rate in effect for such Interest Period and (b) Statutory Reserves.

 


 

     “Administrative Agent Fees” shall have the meaning assigned to such term in Section 2.05(b).
     “Administrative Questionnaire” shall mean an Administrative Questionnaire in the form of Exhibit A, or such other form as may be supplied from time to time by the Administrative Agent.
     “Affiliate” shall mean, when used with respect to a specified person, another person that directly, or indirectly through one or more intermediaries, Controls or is Controlled by or is under common Control with the person specified; provided, however, that, for purposes of Section 6.07, the term “Affiliate” shall also include any person that directly or indirectly owns 10% or more of any class of Equity Interests of the person specified.
     “Aggregate Revolving Credit Exposure” shall mean the aggregate amount of the Lenders’ Revolving Credit Exposures.
     “Alternate Base Rate” shall mean, for any day, a rate per annum equal to the greatest of (a) the Prime Rate in effect on such day, (b) the Federal Funds Effective Rate in effect on such day plus 1/2 of 1% and (c) the Adjusted LIBO Rate on such day for a three month Interest Period commencing on the second Business Day after such day plus 1%. If the Administrative Agent shall have determined (which determination shall be conclusive absent manifest error) that it is unable to ascertain the Federal Funds Effective Rate or the Adjusted LIBO Rate for any reason, including the inability or failure of the Administrative Agent to obtain sufficient quotations in accordance with the terms of the definition of Federal Funds Effective Rate the Alternate Base Rate shall be determined without regard to clause (b) or (c), as applicable, of the preceding sentence until the circumstances giving rise to such inability no longer exist. Any change in the Alternate Base Rate due to a change in the Prime Rate, the Federal Funds Effective Rate or the Adjusted LIBO Rate shall be effective on the effective date of such change in the Prime Rate, the Federal Funds Effective Rate or the Adjusted LIBO Rate, as the case may be.
     “Amendment and Restatement Agreement” shall mean the Amendment and Restatement Agreement dated as of the Restatement Effective Date among Parent, the Borrower, the Subsidiary Guarantors party thereto, the Lenders party thereto and the Administrative Agent.
     “Applicable Percentage” shall mean, for any day (a) with respect to any (i) Eurodollar Non-Extended Term Loan, 2.25% per annum, or (ii) Eurodollar Extended Term Loan, 3.50% per annum, (b) with respect to any (i) ABR Non-Extended Term Loan, 1.25% per annum or (ii) ABR Extended Term Loan, 2.50% per annum, and (c) (i) with respect to any Eurodollar Revolving Loan or ABR Revolving Loan, the applicable percentage set forth below under the caption “Eurodollar Spread—Revolving Loans” or “ABR Spread—Revolving Loans”, as the case may be, and (ii) with respect to the Revolving Credit Commitment Fee, the applicable rate set forth below under the caption “Revolving Credit Commitment Fee Rate”, in each case based upon the Leverage Ratio as of the relevant date of determination:

 


 

                         
    Eurodollar           Revolving
    Spread—   ABR Spread—   Credit
Leverage   Revolving   Revolving   Commitment
Ratio   Loans   Loans   Fee Rate
Category 1
    2.25 %     1.25 %     0.50 %
 
                       
Greater than or equal to 4.5 to 1.00
                       
 
                       
Category 2
    2.00 %     1.00 %     0.50 %
 
                       
Less than 4.5 to 1.00 and greater than or equal to 3.5 to 1.00
                       
 
                       
Category 3
    1.75 %     0.75 %     0.375 %
 
                       
Less than 3.5 to 1.00
                       
Each change in the Applicable Percentage resulting from a change in the Leverage Ratio shall be effective with respect to all Loans and Letters of Credit outstanding on and after the date of delivery to the Administrative Agent of the financial statements and certificates required by Section 5.04(a) or (b) and Section 5.04(c), respectively, indicating such change until the date immediately preceding the next date of delivery of such financial statements and certificates indicating another such change. Notwithstanding the foregoing, (a) at any time during which the Borrower has failed to deliver the financial statements and certificates required by Section 5.04(a) or (b) and Section 5.04(c), respectively (until the time of the delivery thereof), or (b) at any time after the occurrence and during the continuance of an Event of Default, the Leverage Ratio shall be deemed to be in Category 1 for purposes of determining the Applicable Percentage.
     “Arranger” shall mean Credit Suisse Securities (USA) LLC.
     “Asset Sale” shall mean the sale, transfer or other disposition (by way of merger, casualty, condemnation or otherwise) by Parent, the Borrower or any of the Subsidiaries to any person other than the Borrower or any Subsidiary Guarantor of (a) any Equity Interests of any of the Subsidiaries (other than directors’ qualifying shares) or (b) any other assets of Parent, the Borrower or any of the Subsidiaries, other than:
          (i) inventory, damaged, obsolete or worn out assets, scrap, surplus and Permitted Investments, in each case disposed of in the ordinary course of business;
          (ii) donations of assets by the Borrower or any Subsidiary (whether of real or personal property (including cash)) to state or local municipalities (or other Governmental Authorities), nonprofit organizations, foundations, charities or similar entities of the Borrower’s or such Subsidiary’s choice, with an aggregate fair market value not to exceed $30,000,000 in any fiscal year of Parent;

 


 

          (iii) dispositions by any Subsidiary that is not a Subsidiary Guarantor to the Borrower or any other Subsidiary;
          (iv) sales or other dispositions of (x) Receivables of the Borrower or any of the Subsidiaries that are more than 180 days past due or are written-off at the time of such sale or disposition or (y) any Receivables of the Borrower or any of the Subsidiaries that are self-pay accounts receivable and that are reasonably determined by the Borrower to be unable to be paid in full within 150 days of the related service date, provided that the face value of all such Receivables sold or disposed of on or after the Closing Date does not exceed $200,000,000;
          (v) sales or other dispositions of property (including like-kind exchanges) to the extent that (x) such property is exchanged for credit against the purchase price of similar replacement property or (y) the proceeds of such sale or disposition are applied to the purchase price of such replacement property, in each case under Section 1031 of the Code or otherwise, provided that, if the property so sold or exchanged constituted Collateral, then the property so received shall also constitute Collateral;
          (vi) leases or sub-leases of any real property or personal property in the ordinary course of business;
          (vii) dispositions of investments in joint ventures to the extent required by, or made pursuant to, customary buy/sell arrangements between the joint venture parties set forth in the joint venture arrangements and similar binding arrangements;
          (viii) licensings and sublicensings of intellectual property of the Borrower or any Subsidiary in the ordinary course of business;
          (ix) sales, transfers, leases or other dispositions of property in the ordinary course of business consisting of the abandonment of intellectual property rights which, in the reasonable good faith determination of the Borrower, are not material to the conduct of the business of Parent, the Borrower and the Subsidiaries; and
          (x) any sale, transfer or other disposition or series of related sales, transfers or other dispositions having a value not in excess of $5,000,000.
     “Assignment and Acceptance” shall mean an assignment and acceptance entered into by a Lender and an assignee, and accepted by the Administrative Agent, in the form of Exhibit B or such other form as shall be approved by the Administrative Agent.
     “Available Amount” shall mean, as at any date of determination, an amount (if positive) equal to (a) for each fiscal year of Parent commencing with the fiscal year ending December 31, 2010 for which Excess Cash Flow shall have been positive, 50% of Excess Cash Flow for such years, minus (b) the aggregate amount of all Restricted Payments made in reliance on Section 6.06(a)(vii) prior to such date, minus (c) the aggregate amount paid in reliance on Section 6.09(b)(iv) prior to such date.
     “Board” shall mean the Board of Governors of the Federal Reserve System of the United States of America.
     “Borrower Materials” shall have the meaning assigned to such term in Section 9.01.

 


 

     “Borrowing” shall mean (a) Loans of the same Class and Type made, converted or continued on the same date and, in the case of Eurodollar Loans, as to which a single Interest Period is in effect, or (b) a Swingline Loan.
     “Borrowing Request” shall mean a request by the Borrower in accordance with the terms of Section 2.03 and substantially in the form of Exhibit C, or such other form as shall be approved by the Administrative Agent.
     “Business Day” shall mean any day other than a Saturday, Sunday or day on which banks in New York City are authorized or required by law to close; provided, however, that when used in connection with a Eurodollar Loan, the term “Business Day” shall also exclude any day on which banks are not open for dealings in dollar deposits in the London interbank market.
     “CapEx Pull-Forward Amount” shall have the meaning assigned to such term in Section 6.11.
     “Capital Expenditures” shall mean, for any period, the additions to property, plant and equipment and other capital expenditures of Parent, the Borrower and its consolidated subsidiaries (including all amounts expended or capitalized under Capital Lease Obligations, but excluding any amount representing capitalized interest) that are (or should be) set forth in a consolidated statement of cash flows of Parent for such period prepared in accordance with GAAP, but excluding in each case any such expenditure (i) made with insurance proceeds, condemnation awards or damage recovery proceeds, (ii) made with the proceeds of the issuance of Equity Interests, (iii) to the extent such expenditure is made with proceeds that would have constituted Net Cash Proceeds under clause (a) of the definition of the term “Net Cash Proceeds” (but for the application of the second proviso to such clause (a)), (iv) to the extent of the credit against the gross purchase price of newly acquired equipment granted by the seller of such newly acquired equipment for other equipment that is simultaneously traded-in at the time of purchase of such newly acquired equipment, (v) is accounted for as a capital expenditure pursuant to GAAP but that actually is paid for by a third party (excluding Parent, the Borrower or any Subsidiary) and for which none of Parent, the Borrower or any Subsidiary has provided or is required to provide or incur, directly or indirectly, any consideration or obligation to such third party or any other person (whether before, during or after such period) or (vi) constituting the purchase price of any Permitted Acquisition or any investment permitted under Sections 6.04(a), 6.04(i), 6.04(j), 6.04(k) or 6.04(v).
     “Capital Lease Obligations” of any person shall mean the obligations of such person to pay rent or other amounts under any lease of (or other arrangement conveying the right to use) real or personal property, or a combination thereof, which obligations are required to be classified and accounted for as capital leases on a balance sheet of such person under GAAP (excluding any lease that would be required to be so classified as a result of a change in GAAP after the Restatement Effective Date), and the amount of such obligations shall be the capitalized amount thereof determined in accordance with GAAP.
     “Captive Insurance Subsidiary” shall mean a Subsidiary established for the purpose of insuring the healthcare businesses or Facilities owned or operated by the Borrower or any of the Subsidiaries, any joint venture of the Borrower or any of the Subsidiaries or any physician or other personnel employed by or on the medical staff of any such business or Facility.

 


 

     “Cash Management Obligations” shall mean the obligations owed by Parent, the Borrower or any Subsidiary to the Administrative Agent, the Arranger, any Lender or an Affiliate of any of the foregoing in respect of any overdraft protections, netting services and similar arrangements arising from treasury, depository and cash management services, any automated clearing house transfers of funds or any credit card or similar services, in each case in the ordinary course of business.
     A “Change in Control” shall be deemed to have occurred if (a) any “person” or “group” (within the meaning of Rule 13d-5 of the Securities Exchange Act of 1934 as in effect on the Closing Date), shall own, directly or indirectly, beneficially or of record, shares representing more than 40% of the aggregate ordinary voting power represented by the issued and outstanding capital stock of Parent, (b) a majority of the seats (other than vacant seats) on the board of directors of Parent shall at any time be occupied by persons who were neither (i) nominated by the board of directors of Parent nor (ii) appointed by directors so nominated, (c) any change in control (or similar event, however denominated) with respect to Parent, the Borrower or any Subsidiary shall occur under and as defined in any indenture or agreement in respect of Material Indebtedness to which Parent, the Borrower or any Subsidiary is a party (other than, under any indenture or agreement in respect of Material Indebtedness assumed in connection with a Permitted Acquisition, any change in control triggered by the Permitted Acquisition pursuant to which such Indebtedness was assumed), or (d) Parent shall cease to directly own, beneficially and of record, 100% of the issued and outstanding Equity Interests of the Borrower.
     “Change in Law” shall mean (a) the adoption of any law, rule or regulation after the Closing Date , (b) any change in any law, rule or regulation or in the interpretation or application thereof by any Governmental Authority after the Closing Date or (c) compliance by any Lender or the Issuing Bank (or, for purposes of Section 2.14, by any lending office of such Lender or by such Lender’s or Issuing Bank’s holding company, if any) with any policy, guideline or directive (whether or not having the force of law) of any Governmental Authority made or issued after the Closing Date.
     “Class”, when used in reference to any Loan or Borrowing, refers to whether such Loan, or the Loans comprising such Borrowing, are Revolving Loans, Extended Term Loans, Non-Extended Funded Term Loans, Non-Extended Delayed Draw Term Loans, Other Term Loans or Swingline Loans and, when used in reference to any Commitment, refers to whether such Commitment is a Revolving Credit Commitment, any Incremental Term Loan Commitment or Swingline Commitment.
     “Closing Date” shall mean July 25, 2007.
     “Code” shall mean the Internal Revenue Code of 1986, as amended from time to time.
     “Collateral” shall mean all the “Collateral” as defined in any Security Document and shall also include the Mortgaged Properties.
     “Commitment” shall mean, with respect to any Lender, such Lender’s Revolving Credit Commitment, Incremental Term Loan Commitment and Swingline Commitment.
     “Commitment Fees” shall mean the Revolving Credit Commitment Fees.

 


 

     “Confidential Information Memorandum” shall mean the Confidential Information Memorandum of the Borrower dated June 2007.
     “Consolidated EBITDA” shall mean, for any period, Consolidated Net Income for such period plus (a) without duplication and (except in the case of clause (a)(x) below) to the extent deducted in determining such Consolidated Net Income, the sum of
          (i) interest expense (net of interest income), including amortization and write offs of debt discount and debt issuance costs and commissions, discounts and other fees and charges associated with (x) letters of credit, (y) obtaining or unwinding Hedging Agreements or (z) surety bonds for financing activities, in each case for such period,
          (ii) provision for taxes based on income, profits or capital and franchise taxes, including Federal, foreign, state, franchise, excise and similar taxes and foreign withholding taxes paid or accrued during such period, including any penalties and interest relating to any tax examinations for such period,
          (iii) depreciation and amortization expenses including acceleration thereof and including the amortization of the increase in inventory resulting from the application of Statement of Financial Accounting Standards No. 141 (“FASB 141”) for transactions contemplated hereby, including Permitted Acquisitions, for such period,
          (iv) non-cash compensation expenses arising from the sale of Equity Interests, the granting of options to purchase Equity Interests, the granting of appreciation rights in respect of Equity Interests and similar arrangements for such period,
          (v) the excess of the expense in respect of post-retirement benefits and post-employment benefits accrued under Statement of Financial Accounting Standards No. 106 (“FASB 106”) and Statement of Financial Accounting Standards No. 112 (“FASB 112”) over the cash expense in respect of such post-retirement benefits and post-employment benefits for such period,
          (vi) minority interest (to the extent distributions are not required to be made and are not made in respect thereof),
          (vii) upfront fees or charges arising from any Permitted Receivables Transaction for such period, and any other amounts for such period comparable to or in the nature of interest under any Permitted Receivables Transaction, and losses on dispositions of Receivables and related assets in connection with any Permitted Receivables Transaction for such period,
          (viii) fees and expenses for such period incurred or paid in connection with the Transactions,
          (ix) to the extent covered by insurance and actually reimbursed, or, so long as the Borrower has made a determination that such amount is reasonably likely to be reimbursed by the insurer and only to the extent that such amount is (A) not denied by the applicable carrier in writing within 180 days and (B) in fact reimbursed within 365 days of the date of the relevant event (with a deduction for any amount so added back to the extent not so reimbursed within such 365 days), expenses with respect to liability or casualty events,

 


 

          (x) proceeds of received business interruption insurance,
          (xi) any fees and expenses incurred during such period in connection with any acquisition, investment, recapitalization, asset disposition, issuance or repayment of debt, issuance of Equity Interests, refinancing transaction or amendment or other modification of any debt instrument (in each case, including any such transaction consummated prior to the Closing Date and any such transaction undertaken but not completed),
          (xii) any (w) severance costs, relocation costs, integration and Facilities opening costs, signing costs, retention or completion bonuses and transition costs incurred during such period, (x) cash restructuring related or nonrecurring cash merger costs and expenses incurred during such period as a result of any acquisition, investment, recapitalization, or asset disposition permitted hereunder, (y) other nonrecurring cash losses and charges for such period and (z) cash payments made during such period in respect of litigation that was pending against the Borrower, Triad or any of their subsidiaries, or any Acquired Entity or other obligations (contingent or otherwise) of the Borrower, Triad or any of their subsidiaries or any Acquired Entity, in each case prior to the Closing Date (or, with respect to an Acquired Entity, the closing date of the relevant Permitted Acquisition) and for which a liability would not be, in accordance with GAAP, recognized on Parent’s consolidated balance sheet as of the Closing Date (or, with respect to an Acquired Entity, the closing date of the relevant Permitted Acquisition) in each case to the extent that the aggregate amount of all such costs, expenses and payments added to Consolidated Net Income pursuant to this clause (a)(xii), together with all cash payments made during such period and referred to in clause (b)(ii) below, does not exceed 10.0% of Consolidated EBITDA for such period, and
          (xiii) other non-cash charges for such period (other than the write down of current assets, unless such assets are acquired pursuant to a Permitted Acquisition, in which case any such write down shall (A) occur on or before the first anniversary of the date on which the applicable Permitted Acquisition was consummated and (B) result from (1) a change in accounting policies or (2) a revision in the estimated value of such assets), and minus
     (b) without duplication, (i) non-recurring gains and (ii) to the extent the amount thereof, when combined with the aggregate amount of all costs, expenses and payments added to Consolidated Net Income during such period pursuant to clause (a)(xii) above exceeds 10.0% of Consolidated EBITDA for such period, all cash payments made during such period on account of reserves, restructuring charges and other non-cash charges added to Consolidated Net Income pursuant to clause (a)(xiii) above in a previous period.
     “Consolidated Interest Expense” shall mean, for any period, the sum of (a) the interest expense paid in cash (including imputed interest expense in respect of Capital Lease Obligations and Synthetic Lease Obligations) of Parent, the Borrower and the Subsidiaries for such period, net of interest income, determined on a consolidated basis in accordance with GAAP and (b) the dividends paid in cash during such period by Parent, the Borrower and the Subsidiaries on a consolidated basis in respect of Disqualified Stock, but excluding, however, to the extent otherwise included therein, (i) fees and expenses associated with the consummation of the Transactions, (ii) annual agency fees paid to the Administrative Agent, (iii) costs associated with obtaining or unwinding any Hedging Agreements, (iv) fees and expenses associated with any investment permitted pursuant to Section 6.04, issuances of Equity Interests or Indebtedness (whether or not consummated) or amendments of any Indebtedness, (v) penalties and interest

 


 

relating to Taxes and (vi) all non-recurring cash interest expense consisting of liquidated damages for failure to timely comply with registration rights obligations and financing fees. For purposes of the foregoing, interest expense shall be determined after giving effect to any net payments made or received by Parent, the Borrower or any Subsidiary with respect to interest rate Hedging Agreements.
     “Consolidated Net Income” shall mean, for any period, the net income or loss ((i) excluding extraordinary gains and losses, and gains and losses arising from the proposed or actual disposition of material assets and (ii) excluding the cumulative effect of changes in accounting principles) of Parent, the Borrower and the Subsidiaries for such period determined on a consolidated basis in accordance with GAAP; provided that there shall be excluded the income of any Subsidiary to the extent that the declaration or payment of dividends or similar distributions by the Subsidiary of that income is not at the time permitted by operation of the terms of its charter or any agreement, instrument, judgment, decree, statute, rule or governmental regulation applicable to such Subsidiary. Notwithstanding the foregoing, the amount of any cash dividends paid by any Unrestricted Subsidiary and received by Parent, the Borrower or the Subsidiaries during any such period shall be included, without duplication, in the calculation of Consolidated Net Income for such period. There shall be excluded from Consolidated Net Income for any period (i) gains and losses, including unrealized gains and losses, for such period attributable to (v) the early extinguishment of Indebtedness, (w) discontinued operations, (x) Facilities to be closed within one year of the date of recognition of such gain or loss, (y) obtaining or unwinding Hedging Agreements and (z) except as provided above, interests in Unrestricted Subsidiaries, and (ii) the effects of purchase accounting adjustments to inventory, property, equipment and intangible assets and deferred revenue in component amounts required or permitted by GAAP, as a result of the Transactions, any Permitted Acquisition or acquisition consummated before the Closing Date, or the amortization or write-off of any amounts thereof.
     “Contractual Obligation” shall mean, as to any person, any provision of any security issued by such person or of any agreement, instrument or undertaking to which such person is a party or by which it or any of the property owned by it is bound.
     “Control” shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of a person, whether through the ownership of voting securities, by contract or otherwise, and the terms “Controlling” and “Controlled” shall have meanings correlative thereto.
     “Credit Event” shall have the meaning assigned to such term in Section 4.01.
     “Credit Facilities” shall mean the revolving credit, swingline, letter of credit and term loan facilities provided for by this Agreement.
     “Current Assets” shall mean, at any time, the consolidated current assets (other than cash and cash equivalents, current and deferred tax assets and Permitted Investments) of Parent, the Borrower and the Subsidiaries.
     “Current Liabilities” shall mean, at any time, the consolidated current liabilities of Parent, the Borrower and the Subsidiaries at such time, but excluding, without duplication, (a) the current portion of any long-term Indebtedness, (b) current accrued and deferred income taxes and accrued interest and (c) outstanding Revolving Loans and Swingline Loans.

 


 

     “Default” shall mean any event or condition which upon notice, lapse of time or both would constitute an Event of Default.
     “Defaulting Lender” shall mean any Lender that (a) defaults in its obligation to make any Loan or fulfill any obligation required to be made or fulfilled by it hereunder, (b) has notified the Administrative Agent or any Loan Party in writing that it does not intend to satisfy any such obligations or (c) has become the subject of a bankruptcy or insolvency proceeding, or has had a receiver, conservator, trustee, custodian, administrator, assignee for the benefit of creditors or similar Person charged with the reorganization or liquidation of its business, appointed for it, or has taken any action in furtherance of, or indicating its consent to, approval of or acquiescence in any such proceeding or appointment or has a parent company that has become the subject of a bankruptcy or insolvency proceeding, or has had a receiver, conservator, trustee, custodian, administrator, assignee for the benefit of creditors or similar Person charged with the reorganization or liquidation of its business, appointed for it, or has taken any action in furtherance of, or indicating its consent to, approval of or acquiescence in any such proceeding or appointment; provided that if a Lender would be a “Defaulting Lender” solely by reason of events relating to a parent company of such Lender or solely because a Governmental Authority has been appointed as receiver, conservator, trustee or custodian for such Lender, such Lender shall not be a “Defaulting Lender” if and for so long as such Lender confirms in writing, upon request by the Administrative Agent, that it will continue to comply with its obligations to make Loans and fulfill all other obligations required to be made and fulfilled by it hereunder.
     “Disqualified Stock” shall mean any Equity Interest that, by its terms (or by the terms of any security into which it is convertible or for which it is exchangeable), or upon the happening of any event, (a) matures (excluding any maturity as the result of an optional redemption by the issuer thereof) or is mandatorily redeemable, pursuant to a sinking fund obligation or otherwise (except (i) as a result of a change of control or asset sale so long as any rights of the holders thereof upon the occurrence of a change of control or asset sale shall be subject to the prior repayment in full of the Loans and all other Obligations that are accrued and payable and the termination of the Commitments or (ii) pursuant to any put option with respect to any Equity Interests of a Permitted Syndication Subsidiary granted in favor of any Permitted Syndication Transaction Partner), or is redeemable at the option of the holder thereof, in whole or in part, or requires the payment of any cash dividend or any other scheduled payment constituting a return of capital in cash (other than, in the case of Equity Interests of a Subsidiary issued to a Permitted Syndication Transaction Partner or held by a Subsidiary Guarantor, periodic distributions of available cash (determined in good faith by the Borrower)), in each case at any time on or prior to the first anniversary of the Extended Term Loan Maturity Date, or (b) is convertible into or exchangeable (unless at the sole option of the issuer thereof) for (i) Indebtedness or (ii) any Equity Interest referred to in clause (a) above, in each case at any time prior to the first anniversary of the Extended Term Loan Maturity Date.
     “dollars” or “$” shall mean lawful money of the United States of America.
     “Domestic Subsidiaries” shall mean all Subsidiaries incorporated or organized under the laws of the United States of America, any State thereof or the District of Columbia.
     “Eligible Assignee” shall mean any commercial bank, insurance company, investment or mutual fund or other entity (but not any natural person) that is an “accredited investor” (as defined in Regulation D under the Securities Act of 1933, as amended) that extends credit or

 


 

invests in bank loans as one of its businesses; provided that neither the Borrower nor any of its Affiliates shall be an Eligible Assignee.
     “Environmental Laws” shall mean all former, current and future Federal, state, local and foreign laws (including common law), treaties, regulations, rules, ordinances, codes, decrees, judgments, directives, orders (including consent orders), and legally binding agreements in each case, relating to protection of the environment, natural resources, occupational health and safety or Hazardous Materials.
     “Environmental Liability” shall mean all liabilities, obligations, damages, losses, claims, actions, suits, judgments, orders, fines, penalties, fees, expenses and costs (including administrative oversight costs, natural resource damages and remediation costs), whether contingent or otherwise, arising out of or relating to (a) compliance or non-compliance with any Environmental Law, (b) the generation, use, handling, transportation, storage, treatment, recycling, arrangement for disposal, or disposal of any Hazardous Materials, (c) exposure to any Hazardous Materials, (d) the presence or Release of any Hazardous Materials or (e) any contract, agreement or other consensual arrangement pursuant to which liability is assumed or imposed with respect to any of the foregoing.
     “Equity Interests” shall mean shares of capital stock, partnership interests, membership interests in a limited liability company, beneficial interests in a trust or other equity interests in any person, and any option, warrant or other right entitling the holder thereof to purchase or otherwise acquire any such equity interest.
     “ERISA” shall mean the Employee Retirement Income Security Act of 1974, as the same may be amended from time to time.
     “ERISA Affiliate” shall mean any trade or business (whether or not incorporated) that, together with the Borrower, is treated as a single employer under Section 414(b) or (c) of the Code, or, solely for purposes of Section 302 of ERISA and Section 412 of the Code, is treated as a single employer under Section 414 of the Code.
     “ERISA Event” shall mean (a) any “reportable event”, as defined in Section 4043 of ERISA or the regulations issued thereunder, with respect to a Plan (other than an event for which the 30-day notice period is waived), (b) a failure by any Plan to meet the minimum funding standards (within the meaning of Section 412 of the Code or Section 302 of ERISA) applicable to such Plan, in each case whether or not waived, (c) the filing pursuant to Section 412(c) of the Code or Section 302(c) of ERISA, of an application for a waiver of the minimum funding standard with respect to any Plan, (d) a determination that any Plan is, or is expected to be, in “at-risk” status (as defined in Section 303(i)(4) of ERISA or Section 430(i)(4) of the Code), (e) the incurrence by Parent or any of its ERISA Affiliates of any liability under Title IV of ERISA with respect to the termination of any Plan or the withdrawal or partial withdrawal of the Borrower or any of its ERISA Affiliates from any Plan or Multiemployer Plan, (f) the receipt by Parent or any of its ERISA Affiliates from the PBGC or a plan administrator of any notice relating to the intention to terminate any Plan or Plans or to appoint a trustee to administer any Plan, (g) the receipt by Parent or any of its ERISA Affiliates of any notice, or the receipt by any Multiemployer Plan from Parent or any of its ERISA Affiliates of any notice, concerning the imposition of Withdrawal Liability or a determination that a Multiemployer Plan is, or is expected to be, insolvent or in reorganization, within the meaning of Title IV of ERISA or in

 


 

endangered or critical status, within the meaning of Section 432 of the Code or Section 305 of ERISA, (h) the occurrence of a “prohibited transaction” with respect to which the Borrower or any of the Subsidiaries is a “disqualified person” (within the meaning of Section 4975 of the Code) or with respect to which the Borrower or any such Subsidiary could otherwise be liable or (i) any other event or condition with respect to a Plan or Multiemployer Plan that could result in liability of the Borrower or any Subsidiary.
     “Eurodollar” when used in reference to any Loan or Borrowing, refers to whether such Loan, or the Loans comprising such Borrowing, are bearing interest at a rate determined by reference to the Adjusted LIBO Rate.
     “Event of Default” shall have the meaning assigned to such term in Article VII.
     “Excess Cash Flow” shall mean, for any fiscal year of Parent, the excess of (a) the sum, without duplication, of (i) Consolidated Net Income for such fiscal year, (ii) an amount equal to the amount of all non-cash charges or losses to the extent deducted in arriving at such Consolidated Net Income, (iii) an amount equal to the provision for Taxes based on income, profits or capital of Parent, the Borrower and the Subsidiaries, including Federal, foreign, state, franchise, excise and similar taxes and foreign withholding taxes paid or accrued during such period to the extent deducted in arriving at such Consolidated Net Income, (iv) the proceeds of business interruption insurance received by Parent, the Borrower and the Subsidiaries during such fiscal year to the extent not otherwise included in such Consolidated Net Income, and (v) reductions to noncash working capital of Parent, the Borrower and the Subsidiaries for such fiscal year (i.e., the decrease, if any, in Current Assets minus Current Liabilities from the beginning to the end of such fiscal year, excluding decreases resulting from any Permitted Acquisition or disposition occurring during such fiscal year) over (b) the sum, without duplication, of (i) the amount of any Taxes (including penalties and interest) payable in cash by Parent, the Borrower and the Subsidiaries with respect to such fiscal year, (ii) Capital Expenditures made in cash during such fiscal year, except to the extent financed with the proceeds of Indebtedness, equity issuances, casualty proceeds or condemnation proceeds to the extent such proceeds would not be included in Consolidated Net Income, (iii) permanent repayments of Indebtedness (other than mandatory prepayments of Loans under Section 2.13 and Voluntary Prepayments) made in cash by Parent, the Borrower and the Subsidiaries during such fiscal year, but only to the extent that the Indebtedness so prepaid by its terms cannot be reborrowed or redrawn and such prepayments do not occur in connection with a refinancing of all or any portion of such Indebtedness, (iv) payments by Parent, the Borrower and the Subsidiaries during such fiscal year in respect of long-term liabilities of Parent, the Borrower and the Subsidiaries other than Indebtedness, (v) the aggregate amount of cash consideration paid by Parent, the Borrower and the Subsidiaries (on a consolidated basis) in connection with Permitted Acquisitions or other investments permitted pursuant to Section 6.04 (other than Section 6.04(b)), except to the extent any such Permitted Acquisition or investment is financed with the proceeds of Indebtedness or equity issuances, to the extent such proceeds would not be included in Consolidated Net Income, (vi) the aggregate amount of any premium, make-whole or penalty payments actually paid in cash by Parent, the Borrower or the Subsidiaries during such period that are required to be made in connection with any prepayment of Indebtedness to the extent not deducted in determining Consolidated Net Income for such fiscal year, (vii) cash expenditures in respect of Hedging Agreements to the extent not deducted in determining Consolidated Net Income for such fiscal year, (viii) additions to noncash working capital for

 


 

such fiscal year (i.e., the increase, if any, in Current Assets minus Current Liabilities from the beginning to the end of such fiscal year, excluding increases resulting from any Permitted Acquisition or disposition occurring during such fiscal year), and (ix) an amount equal to the amount of all non-cash credits or gains to the extent included in arriving at such Consolidated Net Income and cash charges described in clauses (i) (x) through (y) of the third sentence of the definition of Consolidated Net Income and included in arriving at such Consolidated Net Income; provided that in no event shall the calculation of Excess Cash Flow include any insurance proceeds (other than business interruption insurance) or proceeds of any condemnation, taking or similar occurrence.
     “Excluded Taxes” shall mean, with respect to the Administrative Agent, any Lender, the Issuing Bank or any other recipient of any payment to be made by or on account of any obligation of the Borrower hereunder, (a) income or franchise taxes imposed on (or measured by) its net income by the United States of America, or by the jurisdiction under the laws of which such recipient is organized or in which its principal office is located or, in the case of any Lender, in which its applicable lending office is located, (b) any branch profits taxes imposed by the United States of America or any similar tax imposed by any other jurisdiction described in clause (a) above and (c) in the case of the Administrative Agent or a Foreign Lender (other than an assignee pursuant to a request by the Borrower under Section 2.21(a)), any withholding tax that is imposed on amounts payable to such Administrative Agent or Foreign Lender as a result of any law in effect (including FATCA) at the time such Administrative Agent or Foreign Lender becomes a party to this Agreement (or designates a new lending office) or is attributable to such Administrative Agent or Foreign Lender’s failure to comply with Section 2.20(e), except to the extent that such Administrative Agent or Foreign Lender (or its assignor, if any) was entitled, at the time of designation of a new lending office (or assignment), to receive additional amounts from the Borrower with respect to such withholding tax pursuant to Section 2.20(a).
     “Existing Delayed Draw Term Loans” shall mean “Delayed Draw Term Loans” as defined in the Original Credit Agreement.
     “Existing Funded Term Loans” shall mean “Funded Term Loans” as defined in the Original Credit Agreement.
     “Existing Letter of Credit” shall mean each Letter of Credit previously issued for the account of the Borrower or Triad that (a) was outstanding on the Closing Date and (b) is listed on Schedule 1.01(a).
     “Existing Term Loans” shall mean the “Existing Funded Term Loans” and the “Existing Delayed Draw Term Loans”.
     “Extended Term Loan” shall mean an Existing Term Loan that has been converted to an “Extended Term Loan” pursuant to the Amendment and Restatement Agreement.
     “Extended Term Loan Lender” shall mean, at any time, any Lender that has an Extended Term Loan at such time.
     “Extended Term Loan Maturity Date” shall mean January 25, 2017, provided that the Extended Term Loan Maturity Date shall instead be April 15, 2015 unless, on or prior to April 15, 2015, all but $50,000,000 aggregate principal amount of the Senior Notes shall have been

 


 

repaid, redeemed, defeased or otherwise satisfied in full, provided further that if such repayment, redemption, defeasance or other satisfaction shall have been financed, in whole or in part, with the proceeds of Indebtedness, such Indebtedness shall have a maturity date that is at least 91 days after January 25, 2017.
     “Extended Term Loan Repayment Date” shall have the meaning assigned to such term in Section 2.11(a)(iii).
     “Facility” shall mean any Hospital, outpatient clinic, long-term care facility, ambulatory center, nursing home or rehabilitation center and related medical office building or other facility owned or used by the Borrower or any Subsidiary in connection with their respective business.
     “FATCA” shall mean Sections 1471 through 1474 of the Code, as of the date of this Agreement, and any regulations or official interpretations thereof issued after the date of this Agreement.
     “Federal Funds Effective Rate” shall mean, for any day, the weighted average of the rates on overnight Federal funds transactions with members of the Federal Reserve System arranged by Federal funds brokers, as published on the next succeeding Business Day by the Federal Reserve Bank of New York, or, if such rate is not so published for any day that is a Business Day, the average of the quotations for the day for such transactions received by the Administrative Agent from three Federal funds brokers of recognized standing selected by it.
     “Fee Letter” shall mean the Fee Letter dated March 16, 2007, among Parent, Credit Suisse Securities (USA) LLC, the Administrative Agent, Wachovia Capital Markets LLC, Wachovia Bank, National Association and Wachovia Investment Holdings, LLC.
     “Fees” shall mean the Commitment Fees, the Administrative Agent Fees, the L/C Participation Fees and the Issuing Bank Fees.
     “Financial Officer” of any person shall mean the chief financial officer, principal accounting officer, treasurer or controller of such person.
     “Foreign Lender” shall mean any Lender that is organized under the laws of a jurisdiction other than that in which the Borrower is located. For purposes of this definition, the United States of America, each State thereof and the District of Columbia shall be deemed to constitute a single jurisdiction.
     “Foreign Subsidiary” shall mean any Subsidiary that is not a Domestic Subsidiary.
     “GAAP” shall mean United States generally accepted accounting principles.
     “Governmental Authority” shall mean any Federal, state, local or foreign court or governmental agency, authority, instrumentality or regulatory body.
     “Granting Lender” shall have the meaning assigned to such term in Section 9.04(i).
     “Guarantee” of or by any person shall mean any obligation, contingent or otherwise, of such person guaranteeing or having the economic effect of guaranteeing any Indebtedness of any other person (the “primary obligor”) in any manner, whether directly or indirectly, and including

 


 

any obligation of such person, direct or indirect, (a) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness or to purchase (or to advance or supply funds for the purchase of) any security for the payment of such Indebtedness, (b) to purchase or lease property, securities or services for the purpose of assuring the owner of such Indebtedness of the payment of such Indebtedness or (c) to maintain working capital, equity capital or any other financial statement condition or liquidity of the primary obligor so as to enable the primary obligor to pay such Indebtedness; provided, however, that the term “Guarantee” shall not include (i) endorsements for collection or deposit in the ordinary course of business or (ii) Practice Guarantees. The amount of any Guarantee shall be deemed to be an amount equal to the stated or determinable amount (based on the maximum reasonably anticipated net liability in respect thereof as determined by the Borrower in good faith) of the primary obligation or portion thereof in respect of which such Guarantee is made or, if not stated or determinable, the maximum reasonably anticipated net liability in respect thereof (assuming such person is required to perform thereunder) as determined by the Borrower in good faith.
     “Guarantee and Collateral Agreement” shall mean the Guarantee and Collateral Agreement, dated as of July 25, 2007, as amended and restated as of the Restatement Effective Date, among the Borrower, Parent, the Subsidiaries party thereto and the Collateral Agent for the benefit of the Secured Parties, substantially in the form attached as Exhibit (B) to the Amendment and Restatement Agreement.
     “Guarantors” shall mean Parent and the Subsidiary Guarantors.
     “Hazardous Materials” shall mean (a) any petroleum products or byproducts and all other hydrocarbons, coal ash, radon gas, asbestos and asbestos-containing materials, urea formaldehyde foam insulation, polychlorinated biphenyls, chlorofluorocarbons and all other ozone-depleting substances, medical, biological and animal wastes and (b) without limitation of the foregoing, any other chemical, material, substance or waste that is prohibited, limited or regulated by or pursuant to any Environmental Law.
     “Health Care Associates” shall have the meaning assigned to such term in Section 6.04(e).
     “Hedging Agreement” shall mean any interest rate protection agreement, foreign currency exchange agreement, commodity price protection agreement or other interest or currency exchange rate or commodity price hedging arrangement.
     “Hospital” shall mean each hospital now or hereafter owned, leased or operated by the Borrower or any of the Subsidiaries or in which the Borrower or any of the Subsidiaries owns an equity interest. Set forth on Schedule 1.01(d) is a list of all Hospitals in existence on the Restatement Effective Date owned or used by the Borrower and the Subsidiaries.
     “Incremental Asset Sale Termination Date” shall mean July 24, 2009.
     “Incremental Term Borrowing” shall mean a Borrowing comprised of Incremental Term Loans.
     “Incremental Term Lender” shall mean a Lender with an Incremental Term Loan Commitment or an outstanding Incremental Term Loan.

 


 

     “Incremental Term Loan Amount” shall mean, at any time, the excess, if any, of (a) $1,000,000,000 over (b) the aggregate amount of all Incremental Term Loan Commitments established prior to such time pursuant to Section 2.24.
     “Incremental Term Loan Assumption Agreement” shall mean an Incremental Term Loan Assumption Agreement among, and in form and substance reasonably satisfactory to, the Borrower, the Administrative Agent and one or more Incremental Term Lenders.
     “Incremental Term Loan Commitment” shall mean the commitment of any Lender, established pursuant to Section 2.24, to make Incremental Term Loans to the Borrower.
     “Incremental Term Loan Maturity Date” shall mean the final maturity date of any Incremental Term Loan, as set forth in the applicable Incremental Term Loan Assumption Agreement.
     “Incremental Term Loan Repayment Dates” shall mean the dates scheduled for the repayment of principal of any Incremental Term Loan, as set forth in the applicable Incremental Term Loan Assumption Agreement.
     “Incremental Term Loans” shall mean Term Loans made by one or more Lenders to the Borrower pursuant to Section 2.01(b). Incremental Term Loans may be made in the form of additional Extended Term Loans or, to the extent permitted by Section 2.24 and provided for in the relevant Incremental Term Loan Assumption Agreement, Other Term Loans.
     “Indebtedness” of any person shall mean, without duplication, (a) all obligations of such person for borrowed money or with respect to deposits or advances of any kind (other than customer deposits and interest payable thereon in the ordinary course of business), (b) all obligations of such person evidenced by bonds, debentures, notes or similar instruments, (c) all obligations of such person under conditional sale or other title retention agreements relating to property or assets purchased by such person, (d) all obligations of such person issued or assumed as the deferred purchase price of property or services (excluding trade accounts payable and accrued obligations incurred in the ordinary course of business and deferred payment for services to employees or former employees incurred in the ordinary course of business and payable in accordance with customary practices and other deferred compensation arrangements), (e) all Indebtedness of others secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any Lien on property owned or acquired by such person, whether or not the obligations secured thereby have been assumed, (f) all Guarantees by such person of Indebtedness of others, (g) all Capital Lease Obligations and Synthetic Lease Obligations of such person, (h) all obligations of such person as an account party in respect of letters of credit, (i) all obligations of such person in respect of bankers’ acceptances, (j) all obligations of such person pursuant to any Permitted Receivables Transaction and (k) the aggregate liquidation preference of all outstanding Disqualified Stock issued by such person; provided that in all cases (w) Practice Guarantees, (x) wholly contingent earnouts and working capital adjustments under acquisition or disposition agreements, (y) deferred or prepaid revenue and (z) purchase price holdbacks in respect of a portion of the purchase price of an asset to satisfy warranty or other unperformed obligations of the respective seller, shall be excluded from the definition of “Indebtedness”. The Indebtedness of any person shall include the Indebtedness of any partnership in which such person is a general partner.

 


 

     “Indemnified Taxes” shall mean Taxes other than Excluded Taxes.
     “Interest Coverage Ratio” shall mean, for any period, the ratio of (a) Consolidated EBITDA for such period to (b) Consolidated Interest Expense for such period.
     “Interest Payment Date” shall mean (a) with respect to any ABR Loan (including any Swingline Loan), the last Business Day of each March, June, September and December, and (b) with respect to any Eurodollar Loan, the last day of the Interest Period applicable to the Borrowing of which such Loan is a part and, in the case of a Eurodollar Borrowing with an Interest Period of more than three months’ duration, each day that would have been an Interest Payment Date had successive Interest Periods of three months’ duration been applicable to such Borrowing.
     “Interest Period” shall mean, with respect to any Eurodollar Borrowing, the period commencing on the date of such Borrowing and ending on the numerically corresponding day (or, if there is no numerically corresponding day, on the last day) in the calendar month that is 1, 2, 3 or 6 months thereafter or, with the consent of each applicable Lender, 9 or 12 months thereafter, as the Borrower may elect; provided, however, that if any Interest Period would end on a day other than a Business Day, such Interest Period shall be extended to the next succeeding Business Day unless such next succeeding Business Day would fall in the next calendar month, in which case such Interest Period shall end on the next preceding Business Day. Interest shall accrue from and including the first day of an Interest Period to but excluding the last day of such Interest Period. For purposes hereof, the date of a Borrowing initially shall be the date on which such Borrowing is made and thereafter shall be the effective date of the most recent conversion or continuation of such Borrowing.
     “Issuing Bank” shall mean, as the context may require, (a) Credit Suisse AG, acting through any of its Affiliates or branches, in its capacity as an issuer of Letters of Credit hereunder, (b) Wachovia Bank, National Association, acting through any of its Affiliates or branches, in its capacity as an issuer of Letters of Credit hereunder, (c) with respect to each Existing Letter of Credit, the Lender that issued such Existing Letter of Credit, and (d) any other Lender that may become an Issuing Bank pursuant to Section 2.23(i) or 2.23(k), with respect to Letters of Credit issued by such Lender. The Issuing Bank may, in its discretion, arrange for one or more Letters of Credit to be issued by Affiliates or branches of the Issuing Bank, in which case the term “Issuing Bank” shall include any such Affiliate or branch with respect to Letters of Credit issued by such Affiliate or branch.
     “Issuing Bank Fees” shall have the meaning assigned to such term in Section 2.05(c).
     “L/C Commitment” shall mean the commitment of the Issuing Bank to issue Letters of Credit pursuant to Section 2.23.
     “L/C Disbursement” shall mean a payment or disbursement made by the Issuing Bank pursuant to a Letter of Credit.
     “L/C Exposure” shall mean at any time the sum of (a) the aggregate undrawn amount of all outstanding Letters of Credit at such time and (b) the aggregate amount of all L/C Disbursements that have not yet been reimbursed by or on behalf of the Borrower at such time.

 


 

The L/C Exposure of any Revolving Credit Lender at any time shall equal its Pro Rata Percentage of the aggregate L/C Exposure at such time.
     “L/C Participation Fee” shall have the meaning assigned to such term in Section 2.05(c).
     “Lenders” shall mean (a) the persons listed on Schedule 2.01 (other than any such person that has ceased to be a party hereto pursuant to an Assignment and Acceptance) and (b) any person that has become a party hereto pursuant to an Assignment and Acceptance. Unless the context clearly indicates otherwise, the term “Lenders” shall include the Swingline Lender.
     “Letter of Credit” shall mean any letter of credit issued pursuant to Section 2.23 and any Existing Letter of Credit.
     “Leverage Ratio” shall mean, on any date, the ratio of Total Debt on such date to Consolidated EBITDA for the period of four consecutive fiscal quarters most recently ended on or prior to such date for which financial statements have been delivered (or were required to be delivered) pursuant to Section 5.04(a) or (b). In any period of four consecutive fiscal quarters in which any Permitted Acquisition or Significant Asset Sale occurs, the Leverage Ratio shall be determined on a pro forma basis in accordance with Section 1.03.
     “Leverage Ratio Condition” shall mean, on any date, after giving pro forma effect to any Specified Transaction to occur on such date as contemplated by Section 1.03, that the Leverage Ratio on such date would be 0.25 to 1.00 lower than the maximum Leverage Ratio permitted to be maintained by Parent on such date pursuant to Section 6.13.
     “LIBO Rate” shall mean, with respect to any Eurodollar Borrowing for any Interest Period, the rate per annum determined by the Administrative Agent at approximately 11:00 a.m. (London time) on the date that is two Business Days prior to the commencement of such Interest Period by reference to the British Bankers’ Association Interest Settlement Rates for deposits in dollars (as set forth by any service selected by the Administrative Agent that has been nominated by the British Bankers’ Association as an authorized information vendor for the purpose of displaying such rates) for a period equal to such Interest Period; provided that, to the extent that an interest rate is not ascertainable pursuant to the foregoing provisions of this definition, the “LIBO Rate” shall be the interest rate per annum determined by the Administrative Agent to be the average of the rates per annum at which deposits in dollars are offered for such relevant Interest Period to major banks in the London interbank market in London, England by the Administrative Agent at approximately 11:00 a.m. (London time) on the date that is two Business Days prior to the beginning of such Interest Period.
     “Lien” shall mean, with respect to any asset, (a) any mortgage, deed of trust, lien, pledge, encumbrance, charge or security interest in or on such asset and (b) the interest of a vendor or a lessor under any conditional sale agreement, capital lease or title retention agreement (or any financing lease having substantially the same economic effect as any of the foregoing) relating to such asset. For the avoidance of doubt, the term “Lien” shall not be deemed to include any license of intellectual property.
     “Liquidity Condition” shall mean, on any date, after giving pro forma effect to any Specified Transaction to occur on such date, that the sum of the aggregate unused and available

 


 

Revolving Credit Commitments and unrestricted cash on hand at Parent and its subsidiaries would exceed $250,000,000.
     “Loan Documents” shall mean this Agreement, the Amendment and Restatement Agreement, the Letters of Credit, the Security Documents, each Incremental Term Loan Assumption Agreement, any Pari Passu Intercreditor Agreement, any Revolving Credit Loan Modification Agreement and the promissory notes, if any, executed and delivered pursuant to Section 2.04(e).
     “Loan Parties” shall mean Parent, the Borrower and the Guarantors.
     “Loans” shall mean the Revolving Loans, the Term Loans and the Swingline Loans.
     “Margin Stock” shall have the meaning assigned to such term in Regulation U.
     “Material Adverse Effect” shall mean (a) a materially adverse effect on the business, assets, operations, financial condition or operating results of the Borrower and the Subsidiaries, taken as a whole, (b) a material impairment of the ability of the Loan Parties, taken as a whole, to perform their obligations under the Loan Document to which they are or will be a party or (c) a material impairment of the rights and remedies of or benefits available to the Lenders under the Loan Documents.
     “Material Indebtedness” shall mean Indebtedness (other than the Loans and Letters of Credit and intercompany loans), or obligations in respect of one or more Hedging Agreements, of any one or more of Parent, the Borrower or any Subsidiary in an aggregate principal amount exceeding $50,000,000. For purposes of determining Material Indebtedness, the “principal amount” of the obligations of Parent, the Borrower or any Subsidiary in respect of any Hedging Agreement at any time shall be the maximum aggregate amount (giving effect to any netting agreements) that Parent, the Borrower or such Subsidiary would be required to pay if such Hedging Agreement were terminated at such time.
     “Material Subsidiary” shall mean any Subsidiary other than any (a) Permitted Joint Venture Subsidiary, (b) Permitted Syndication Subsidiary, (c) Securitization Subsidiary, (d) Foreign Subsidiary, (e) Captive Insurance Subsidiary or (f) Non-Significant Subsidiary.
     “Moody’s” shall mean Moody’s Investors Service, Inc., or any successor thereto.
     “Mortgaged Properties” shall mean, initially, the owned real properties of the Loan Parties specified on Schedule 1.01(c), and shall include each other parcel of real property and improvements thereto with respect to which a Mortgage is granted pursuant to Section 5.12.
     “Mortgages” shall mean the mortgages, deeds of trust, assignments of leases and rents, modifications and other security documents delivered pursuant to clause (i) of Section 4.02(g) or pursuant to Section 5.12, each substantially in the form of Exhibit E.
     “Multiemployer Plan” shall mean a multiemployer plan as defined in Section 4001(a)(3) of ERISA.
     “Net Cash Proceeds” shall mean (a) with respect to any Asset Sale (other than Receivables sold in a Permitted Receivables Transaction), the aggregate cash proceeds received

 


 

in respect of such Asset Sale, and any cash payments received in respect of promissory notes or other non-cash consideration delivered in respect of such Asset Sale, net of (without duplication) (i) the reasonable expenses (including legal fees and brokers’ and underwriters’ commissions paid to third parties which are not Subsidiaries or Affiliates of Parent) incurred in effecting such Asset Sale, (ii) any taxes reasonably attributable to such Asset Sale and, in case of an Asset Sale in a foreign jurisdiction, any taxes reasonably attributable to the repatriation of the proceeds of such Asset Sale reasonably estimated by the Borrower to be actually payable, (iii) any amounts payable to a Governmental Authority triggered as a result of any such Asset Sale, (iv) any Indebtedness or Contractual Obligation of Parent, the Borrower and the Subsidiaries (other than the Loans and other Obligations) required to be paid or retained in connection with such Asset Sale and (v) the aggregate amount of reserves required in the reasonable judgment of the Borrower or the applicable Subsidiary to be maintained on the books of the Borrower or such Subsidiary in order to pay contingent liabilities with respect to such Asset Sale (so long as amounts deducted from aggregate proceeds pursuant to this clause (v) and not actually paid by the Borrower or any of the Subsidiaries in liquidation of such contingent liabilities shall be deemed to be Net Cash Proceeds received at such time as such contingent liabilities shall cease to be obligations of the Borrower or any of the Subsidiaries); provided, however, that, except with respect to the Net Cash Proceeds of Asset Sales made pursuant to Section 6.05(b)(x), if (x) the Borrower intends to reinvest such proceeds in assets of a kind then used or usable in the business of the Borrower and the Subsidiaries or in Permitted Acquisitions or other investments permitted pursuant to Section 6.04 (other than Section 6.04(b)) within 15 months of receipt of such proceeds and (y) no Default or Event of Default shall have occurred and shall be continuing at the time of such receipt, such proceeds (but not to exceed $800,000,000 in the aggregate in the case of all such Asset Sales (the “Asset Sale Reinvestment Amount”)) shall not constitute Net Cash Proceeds except to the extent not so used at the end of such 15-month period, at which time such proceeds shall be deemed to be Net Cash Proceeds; provided further that if during such 15-month period Parent, the Borrower or a Subsidiary enters into a written agreement committing it to so apply all or a portion of such proceeds, such 15-month period will be extended with respect to the amount of proceeds for an additional six months, at which time such proceeds shall be deemed to be Net Cash Proceeds (it being understood and agreed that, (A) from the Closing Date until the Incremental Asset Sale Termination Date, the Asset Sale Reinvestment Amount shall (1) include the first $300,000,000 of proceeds described above that the Borrower intends to reinvest pursuant to this definition, (2) not include the next $750,000,000 of such proceeds (less the amount of such proceeds that the Borrower previously used to prepay Term Loans) (i.e., the next $750,000,000 of such proceeds (less the amount of such proceeds that the Borrower previously used to prepay Term Loans) shall automatically be deemed Net Cash Proceeds and applied to the prepayment of Term Loans to the extent required by Section 2.13(b)) and (3) include the next $500,000,000 of such proceeds that the Borrower intends to reinvest pursuant to this definition and (B) after the Incremental Asset Sale Termination Date, the Asset Sale Reinvestment Amount shall include the amount (if positive) of such proceeds equal to (1) $800,000,000 less (2)  the aggregate amount of all such proceeds received prior to the Incremental Asset Sale Termination Date (other than proceeds referred to in clause (A)(2) above) to the extent such proceeds were reinvested in accordance with this definition); and (b) with respect to any issuance or incurrence of Indebtedness or the sale of Receivables in a Permitted Receivables Transaction, the cash proceeds thereof, net of all taxes and customary fees, commissions, costs and other expenses incurred in connection therewith.

 


 

     “Non-Extended Delayed Draw Term Loan” shall mean an Existing Delayed Draw Term Loan that shall not have been converted to an “Extended Term Loan” pursuant to the Amendment and Restatement Agreement.
     “Non-Extended Delayed Draw Term Loan Lender” shall mean a Lender with an outstanding Non-Extended Delayed Draw Term Loan.
     “Non-Extended Delayed Draw Term Loan Repayment Date” shall have the meaning assigned to such term in Section 2.11(a)(ii).
     “Non-Extended Funded Term Loan” shall mean an Existing Funded Term Loan that shall not have been converted to an “Extended Term Loan” pursuant to the Amendment and Restatement Agreement.
     “Non-Extended Funded Term Loan Lender” shall mean a Lender with an outstanding Non-Extended Funded Term Loan.
     “Non-Extended Funded Term Loan Repayment Date” shall have the meaning assigned to such term in Section 2.11(a)(i).
     “Non-Extended Term Loan” shall mean an Existing Term Loan that shall not have been converted to an “Extended Term Loan” pursuant to the Amendment and Restatement Agreement.
     “Non-Extended Term Loan Maturity Date” shall mean July 25, 2014.
     “Non-Significant Subsidiary” shall mean at any time, any Subsidiary (a) which at such time has total assets book value (including the total assets book value of any subsidiaries of such Subsidiary), or for which the Borrower or any of the Subsidiaries shall have paid (including the assumption of Indebtedness) in connection with the acquisition of Equity Interests or the total assets of such Subsidiary, less than $10,000,000 or (b) which does not and will not itself or through its subsidiaries own a Hospital or an interest in a Hospital or manage or operate a Hospital and which is listed on Schedule 1.01(d) hereto (or on any updates to such Schedule subsequently furnished by the Borrower to the Administrative Agent) as a “Non-Significant Subsidiary”, provided that the total assets of all Non-Significant Subsidiaries at any time does not exceed 5.0% of the total assets of Parent, the Borrower and the Subsidiaries on a consolidated basis.
     “Obligations” shall mean all obligations defined as “Bank Loan Obligations” in the Guarantee and Collateral Agreement and the other Security Documents.
     “Original Credit Agreement” shall have the meaning assigned to such term in the Preliminary Statement.
     “Other Taxes” shall mean any and all present or future stamp or documentary taxes or any other excise or property taxes, charges or similar levies arising from any payment made under any Loan Document or from the execution, delivery or enforcement of, or otherwise with respect to, any Loan Document.

 


 

     “Other Term A Loans” shall mean Other Term Loans which (a) amortize at a rate per annum of not less than 5.00% in each period of four consecutive fiscal quarters commencing on or after the effectiveness of such Other Term Loans and ending on or prior to the applicable Incremental Term Loan Maturity Date and (b) have a weighted average life to maturity, when incurred, of five years or less.
     “Other Term Loans” shall have the meaning assigned to such term in Section 2.24(a).
     “Pari Passu Debt” shall mean Indebtedness which (a) is issued, incurred, created, assumed or guaranteed by any Loan Party, (b) is not an obligation of, or otherwise Guaranteed by, any Subsidiary of Parent that is not a Loan Party, (c) is not secured by any Lien on any asset of Parent, the Borrower or any Subsidiary other than any asset constituting Collateral, (d) does not amortize at a rate per annum in excess of 1.00% during any period of four consecutive fiscal quarters commencing on or after the date such Pari Passu Debt is incurred by any Loan Party, (e) is subject to a Pari Passu Intercreditor Agreement and (f) is issued, incurred, created or assumed (i) to finance, or otherwise in connection with, a Permitted Acquisition, (ii) in order to extend, renew, refinance or replace existing Pari Passu Debt, provided that (A) the principal amount of such Pari Passu Debt is not increased (except by an amount not to exceed (1) the amount of unpaid accrued interest and premium on the existing Pari Passu Debt so extended, renewed, refinanced or replaced, plus (2) other reasonable amounts paid and fees and expenses incurred in connection with such extension, renewal, refinancing or replacement) and (B) neither the final maturity nor the weighted average life to maturity of such Pari Passu Debt is decreased thereby or (iii) in order to obtain Net Cash Proceeds, 100% of which (if not used in the manner set forth in the foregoing clauses (i) and (ii)) are used by the Borrower, not later than the fifth Business Day following the receipt thereof, to prepay outstanding Term Loans in the manner set forth in Section 2.13(g).
     “Pari Passu Debt Obligations” shall have the meaning assigned to such term in the Guarantee and Collateral Agreement.
     “Pari Passu Intercreditor Agreement” shall mean any intercreditor agreement, collateral trust agreement or similar agreement governing the relative priorities of the holders of the Obligations, on the one hand, and the holders of the Pari Passu Debt Obligations, on the other hand, provided that such agreement (a) contains terms that are not less favorable to the holders of the Obligations than to the holders of the Pari Passu Debt Obligations, (b) provides for the Pari Passu Debt Obligations to be secured by Liens on the Collateral having the same priority as, or junior priority to, the Liens securing the Obligations and (c) is otherwise on terms reasonably acceptable to the Administrative Agent.
     “PBGC” shall mean the Pension Benefit Guaranty Corporation referred to and defined in ERISA and any successor entity performing similar functions.
     “Pension Act” shall mean the Pension Protection Act of 2006, as amended from time to time.
     “Permitted Acquisition” shall have the meaning assigned to such term in Section 6.04(h).
     “Permitted Additional Debt” of any Loan Party shall mean any unsecured Indebtedness of such Loan Party or an unsecured or subordinated Guarantee of or by such Loan Party, in each

 


 

case which (a) matures on or after, and requires no scheduled payments of principal prior to, January 15, 2018 (other than pursuant to customary offers to purchase upon a change of control, payments required to prevent any such Indebtedness from being treated as an “applicable high yield discount obligation” with the meaning of Section 163(i)(1) of the Code, asset sale or event of loss and customary acceleration rights after an event of default), (b) contains no financial maintenance covenants and (c) to the extent the same is subordinated to any Indebtedness, is subordinate or junior in right of payment to the Obligations, pursuant to a written agreement on terms customary for similar Indebtedness at the time of issuance.
     “Permitted Amendments” shall have the meaning assigned to such term in Section 2.25(c).
     “Permitted Capital Expenditure Amount” shall have the meaning assigned to such term in Section 6.11.
     “Permitted Interest Transfer” shall mean a sale, issuance or other transfer of securities of a Subsidiary or of assets of any Subsidiary to a new Subsidiary, if after such sale or other transfer, such Subsidiary shall meet the applicable requirements of the definition of “Permitted Joint Venture Subsidiary”, “Non-Significant Subsidiary” or “Permitted Syndication Subsidiary”; provided that (a) the aggregate fair market value (determined at the time of and after giving effect to any Permitted Interest Transfer) of all Permitted Interest Transfers made to, or in connection with the establishment of, a Permitted Joint Venture shall not exceed $1,000,000,000 and (b) at the time of and after giving effect to any Permitted Interest Transfer the total book value of the assets, calculated as of the date of the applicable Permitted Interest Transfer, of all Subsidiaries (other than Loan Parties) that become Permitted Joint Venture Subsidiaries or Permitted Syndication Subsidiaries after the Closing Date as a result of a Permitted Interest Transfer made after the Closing Date shall not exceed (i) 10% of the total book value of the assets of Parent, the Borrower and the Subsidiaries on a consolidated basis, calculated as of the date of the applicable Permitted Interest Transfer, in the case of Permitted Joint Venture Subsidiaries, and (ii) 10% of the total book value of the assets of Parent, the Borrower and the Subsidiaries on a consolidated basis, calculated as of the date of the applicable Permitted Interest Transfer, in the case of Permitted Syndication Subsidiaries.
     “Permitted Investments” shall mean:
     (a) direct obligations of, or obligations the principal of and interest on which are unconditionally guaranteed by, the United States of America (or by any agency thereof to the extent such obligations are backed by the full faith and credit of the United States of America), in each case maturing within one year from the date of acquisition thereof;
     (b) investments in commercial paper maturing within 270 days from the date of acquisition thereof and having, at such date of acquisition, the highest credit rating obtainable from S&P or from Moody’s;
     (c) investments in certificates of deposit, banker’s acceptances and time deposits maturing within one year from the date of acquisition thereof issued or guaranteed by or placed with, and money market deposit accounts issued or offered by, the Administrative Agent or any domestic office of any commercial bank organized under the laws of the United States of

 


 

America or any State thereof that has a combined capital and surplus and undivided profits of not less than $500,000,000;
     (d) fully collateralized repurchase agreements with a term of not more than 30 days for securities described in clause (a) above and entered into with a financial institution satisfying the criteria of clause (c) above;
     (e) investments in “money market funds” within the meaning of Rule 2a-7 of the Investment Company Act of 1940, as amended, substantially all of whose assets are invested in investments of the type described in clauses (a) through (d) above; and
     (f) other short-term investments utilized by Foreign Subsidiaries in accordance with normal investment practices for cash management in investments of a type analogous to the foregoing.
     “Permitted Joint Venture Subsidiary” shall mean a partially owned Subsidiary pursuant to which the Borrower or such Subsidiary conducts a Permitted Joint Venture.
     “Permitted Joint Ventures” shall mean acquisitions (by merger, purchase, lease (including any lease that contains upfront payments or buy out options) or otherwise), not constituting Permitted Acquisitions, by Parent, the Borrower or any of the Subsidiaries of interests in any of the assets of, or shares of the capital stock of or other Equity Interests in, a person or division or line of business of any person engaged in the same business as the Borrower and the Subsidiaries or in a related business; provided that (a) no Default or Event of Default shall have occurred and be continuing, and the Borrower shall have delivered to the Administrative Agent an officers’ certificate to such effect, together with all relevant financial information for such corporation or other entity or acquired assets and (b) except for the Permitted Joint Ventures listed on Schedule 1.01(e), to the extent (i) the aggregate value of the investments, loans and advances made by Parent, the Borrower and the Subsidiaries in (including assets transferred to) any Permitted Joint Venture, in each case, measured as of the date of each such investment, loan or advance (net of any repayments or return of capital in respect thereof actually received in cash by Parent, the Borrower or the Subsidiaries (net of applicable Taxes) after the Closing Date) (the “Net Investment Amount”), when added to the aggregate Net Investment Amounts of all Permitted Joint Ventures consummated after the Closing Date, would exceed $300,000,000, the Leverage Ratio Condition and the Liquidity Condition would each be satisfied and (ii) to the extent such aggregate Net Investment Amounts would exceed $500,000,000, the Borrower shall have received in writing, prior to effecting any such Permitted Joint Venture, a Ratings Agency Confirmation in respect of such Permitted Joint Venture and any financing therefor, and shall have furnished such Ratings Agency Confirmation to the Administrative Agent.
     “Permitted Real Estate Indebtedness” shall have the meaning assigned to such term in Section 6.01(f).
     “Permitted Receivables Transaction” shall have the meaning assigned to such term in Section 6.05(b).

 


 

     “Permitted Syndication Subsidiary” shall mean a partially owned Subsidiary of the Borrower which, after giving effect to a Permitted Syndication Transaction, owns, leases or operates the Hospital which is the subject of such Permitted Syndication Transaction.
     “Permitted Syndication Transaction” shall have the meaning assigned to such term in Section 6.05(b).
     “Permitted Syndication Transaction Partner” shall mean one or more persons (other than Parent, the Borrower or any Subsidiary) that owns a minority interest in a Permitted Syndication Subsidiary.
     “person” shall mean any natural person, corporation, business trust, joint venture, association, company, limited liability company, partnership, Governmental Authority or other entity.
     “Plan” shall mean any employee pension benefit plan (other than a Multiemployer Plan) subject to the provisions of Title IV of ERISA or Section 412 of the Code or Section 302 of ERISA, sponsored, maintained or contributed to by the Borrower or any ERISA Affiliate.
     “Platform” shall have the meaning assigned to such term in Section 9.01.
     “Practice Guarantees” shall mean admitting physician practice guarantees pursuant to which Parent, the Borrower or any of the Subsidiaries guarantees to pay an admitting physician on the medical staff of a Hospital the difference between such admitting physician’s monthly net revenue from professional fees and a minimum monthly guaranteed amount.
     “Prime Rate” shall mean the rate of interest per annum determined from time to time by Credit Suisse AG as its prime rate in effect at its principal office in New York City and notified to the Borrower.
     “Pro Rata Percentage” of any Revolving Credit Lender at any time shall mean the percentage of the Total Revolving Credit Commitment represented by such Lender’s Revolving Credit Commitment. In the event the Revolving Credit Commitments shall have expired or been terminated, the Pro Rata Percentages shall be determined on the basis of the Revolving Credit Commitments most recently in effect, giving effect to any subsequent assignments.
     “Public Lender” shall have the meaning assigned to such term in Section 9.01.
     “Qualified Capital Stock” of any person shall mean any Equity Interest of such person that is not Disqualified Stock.
     “Ratings Agency Confirmation” shall mean, with respect to any transaction or matter in question, confirmation from each of Moody’s and S&P that such transaction or matter will not result in a downgrade, qualification or withdrawal of the then current corporate credit ratings of the Borrower.
     “Receivables” shall mean a right to receive payment arising from a sale or lease of goods or the performance of services by a person pursuant to an arrangement with another person by which such other person is obligated to pay for goods or services under terms that permit the purchase of such goods and services on credit, and all proceeds thereof and rights (contractual or

 


 

other) and collateral related thereto, and shall include, in any event, any items of property that would be classified as accounts receivable on the balance sheet of the Borrower or any of the Subsidiaries prepared in accordance with GAAP or an “account”, “chattel paper”, an “instrument”, a “general intangible” or a “payment intangible” under the Uniform Commercial Code as in effect in the State of New York and any “supporting obligations” or “proceeds” (as so defined) of any such items.
     “Receivables Transaction” shall mean, with respect to the Borrower and/or any of the Subsidiaries, any transaction or series of transactions of sales, factoring or securitizations involving Receivables pursuant to which the Borrower or any Subsidiary may sell, convey or otherwise transfer to a Securitization Subsidiary or any other Person, and may grant a corresponding security interest in, any Receivables (whether now existing or arising in the future) of the Borrower or any Subsidiary, and any assets related thereto including collateral securing such Receivables, contracts and all Guarantees or other obligations in respect of such Receivables, the proceeds of such Receivables and other assets which are customarily transferred, or in respect of which security interests are customarily granted, in connection with sales, factoring or securitizations involving Receivables.
     “Receivables Transaction Amount” shall mean (a) in the case of any Receivables securitization (but excluding any sale or factoring of Receivables), the amount of obligations outstanding under the legal documents entered into as part of such Receivables securitization on any date of determination that would be characterized as principal if such Receivables securitization were structured as a secured lending transaction rather than as a purchase and (b) in the case of any sale or factoring of Receivables, the cash purchase price paid by the buyer in connection with its purchase of Receivables (including any bills of exchange) less the amount of collections received in respect of such Receivables and paid to such buyer, excluding any amounts applied to purchase fees or discount or in the nature of interest, in each case as determined in good faith and in a consistent and commercially reasonable manner by the Borrower (provided that if such method of calculation is not applicable to such sale or factoring of Receivables, the amount of Receivables Transaction Amount associated therewith shall be determined in a manner mutually acceptable to the Borrower and the Administrative Agent).
     “Received Exercise Proceeds Amount” shall mean, as at any date of determination, an amount equal to (a) the aggregate net cash proceeds received by the Borrower in respect of any issuance of Equity Interests to employees or directors after the Closing Date, including payments in connection with the exercise of stock options, minus (b) the aggregate amount of all Restricted Payments made in reliance on Section 6.06(a)(vii) prior to such date.
     “Register” shall have the meaning assigned to such term in Section 9.04(d).
     “Regulation T” shall mean Regulation T of the Board as from time to time in effect and all official rulings and interpretations thereunder or thereof.
     “Regulation U” shall mean Regulation U of the Board as from time to time in effect and all official rulings and interpretations thereunder or thereof.
     “Regulation X” shall mean Regulation X of the Board as from time to time in effect and all official rulings and interpretations thereunder or thereof.

 


 

     “Related Fund” shall mean, with respect to any Lender that is a fund or commingled investment vehicle that invests in bank loans, any other fund that invests in bank loans and is managed or advised by the same investment advisor as such Lender or by an Affiliate of such investment advisor.
     “Related Parties” shall mean, with respect to any specified person, such person’s Affiliates and the respective directors, trustees, officers, employees, agents and advisors of such person and such person’s Affiliates.
     “Release” shall mean any release, spill, emission, leaking, dumping, injection, pouring, deposit, disposal, discharge, dispersal, leaching or migration into or through the environment or within or upon any building, structure, facility or fixture.
     “Repayment Date” shall mean an Extended Term Loan Repayment Date, a Non-Extended Delayed Draw Term Loan Repayment Date, a Non-Extended Funded Term Loan Repayment Date or an Incremental Term Loan Repayment Date.
     “Replacement Capital Expenditures” shall mean Capital Expenditures on or after the Closing Date made in connection with (i) the replacement of a Hospital as required by the agreements pursuant to which such Hospital, or the entity owning such Hospital, was acquired by the Borrower or any of the Subsidiaries from a third-party, whether pursuant to such agreement existing as of the Closing Date or entered into thereafter, (ii) the replacement of the Hospitals (owned, leased or operated by the Borrower or any of the Subsidiaries or in which the Borrower or any of the Subsidiaries owns an Equity Interest as of the Closing Date) in Birmingham, Alabama and Barstow, California.
     “Required Lenders” shall mean, at any time, Lenders having Loans (excluding Swingline Loans), L/C Exposure, Swingline Exposure and unused Revolving Credit Commitments and Term Loan Commitments representing more than 50% of the sum of all Loans outstanding (excluding Swingline Loans), L/C Exposure, Swingline Exposure and unused Revolving Credit Commitments and Term Loan Commitments at such time; provided that the Revolving Loans, L/C Exposure, Swingline Exposure and unused Revolving Credit Commitments of any Defaulting Lender shall be disregarded in the determination of the Required Lenders at any time.
     “Responsible Officer” of any person shall mean any executive officer, executive vice president or Financial Officer of such person and any other officer or similar official thereof responsible for the administration of the obligations of such person in respect of this Agreement.
     “Restatement Effective Date” shall have the meaning assigned to such term in the Amendment and Restatement Agreement.
     “Restricted Indebtedness” shall mean Indebtedness of Parent, the Borrower or any Subsidiary, the payment, prepayment, repurchase or defeasance of which is restricted under Section 6.09(b).
     “Restricted Payment” shall mean any dividend or other distribution (whether in cash, securities or other property (other than Qualified Capital Stock)) with respect to any Equity Interests in Parent, the Borrower or any Subsidiary, or any payment (whether in cash, securities or other property (other than Qualified Capital Stock)), including any sinking fund or similar

 


 

deposit, on account of the purchase, redemption, retirement, acquisition, cancellation or termination of any Equity Interests in Parent, the Borrower or any Subsidiary.
     “Revolving Credit Borrowing” shall mean a Borrowing comprised of Revolving Loans.
     “Revolving Credit Commitment” shall mean, with respect to each Lender, the commitment of such Lender to make Revolving Loans hereunder (and to acquire participations in Swingline Loans and Letters of Credit as provided for herein) as set forth on Schedule 2.01, or in the Assignment and Acceptance pursuant to which such Lender assumed its Revolving Credit Commitment, as applicable, as the same may be (a) reduced from time to time pursuant to Section 2.09 and (b) reduced or increased from time to time pursuant to assignments by or to such Lender pursuant to Section 9.04.
     “Revolving Credit Commitment Fee” shall have the meaning assigned to such term in Section 2.05(a).
     “Revolving Credit Commitment Fee Rate” shall have the meaning assigned to such term in the definition of the term “Applicable Percentage”.
     “Revolving Credit Exposure” shall mean, with respect to any Lender at any time, the aggregate principal amount at such time of all outstanding Revolving Loans of such Lender, plus the aggregate amount at such time of such Lender’s L/C Exposure, plus the aggregate amount at such time of such Lender’s Swingline Exposure.
     “Revolving Credit Lender” shall mean a Lender with a Revolving Credit Commitment or an outstanding Revolving Loan.
     “Revolving Credit Loan Modification Agreement” shall mean a Revolving Credit Loan Modification Agreement in form and substance reasonably satisfactory to the Administrative Agent and the Borrower, among the Borrower, the other Loan Parties, one or more Accepting Revolving Credit Lenders and the Administrative Agent.
     “Revolving Credit Loan Modification Offer” shall have the meaning specified in Section 2.25(a).
     “Revolving Credit Maturity Date” shall mean July 25, 2013.
     “Revolving Loans” shall mean the revolving loans made by the Lenders to the Borrower pursuant to Section 2.01.
     “S&P” shall mean Standard & Poor’s Ratings Service, or any successor thereto.
     “SEC” shall mean the U.S. Securities and Exchange Commission or any Governmental Authority succeeding to any or all of its functions.
     “Secured Leverage Ratio” shall mean, on any date, the ratio of (a) Total Secured Debt to (b) Consolidated EBITDA for the period of four consecutive fiscal quarters most recently ended on or prior to such date for which financial statements have been delivered (or were required to be delivered) pursuant to Section 5.04(a) or (b). In any period of four consecutive fiscal quarters

 


 

in which any Permitted Acquisition or Significant Asset Sale occurs, the Secured Leverage Ratio shall be determined on a pro forma basis in accordance with Section 1.03.
     “Secured Leverage Ratio Condition” shall mean, on any date, after giving pro forma effect to any Specified Transaction to occur on such date as contemplated by Section 1.03, that the Secured Leverage Ratio shall not be greater than 3.5 to 1.0.
     “Secured Parties” shall have the meaning assigned to such term in the Guarantee and Collateral Agreement.
     “Securitization Subsidiary” shall mean any special purpose Subsidiary that acquires Receivables generated by the Borrower or any of the Subsidiaries and that engages in no operations or activities other than those related to a Permitted Receivables Transaction.
     “Security Documents” shall mean the Mortgages, the Guarantee and Collateral Agreement and each of the security agreements, mortgages and other instruments and documents executed and delivered pursuant to any of the foregoing or pursuant to Section 5.12 or 9.20.
     “Senior Note Indenture” shall mean the indenture under which the Senior Notes are issued, as the same may be amended, restated, substituted, replaced, refinanced, supplemented or otherwise modified from time to time in accordance with Section 6.01(h).
     “Senior Notes” shall mean the Borrower’s 8.875% Senior Notes due 2015, in an initial aggregate principal amount of $3,021,331,000, as the same may be amended, restated, substituted, replaced, refinanced, supplemented or otherwise modified from time to time pursuant to Section 6.01(h).
     “Shared Collateral Agent” shall have the meaning assigned to such term in Section 9.20.
     “Significant Asset Sale” shall mean the sale, transfer, lease or other disposition by Parent, the Borrower or any Subsidiary to any person other than the Borrower or a Subsidiary Guarantor of all or substantially all of the assets of, or a majority of the Equity Interests in, a person, or a division or line of business or other business unit of a person.
     “SPC” shall have the meaning assigned to such term in Section 9.04(i).
     “Specified Transaction” shall mean (a) the consummation of a Permitted Acquisition, (b) the investment in a Permitted Joint Venture or an Unrestricted Subsidiary or (c) the incurrence or assumption of Indebtedness pursuant to Section 6.01(m) or (v) and the use of proceeds thereof.
     “Spinout Subsidiary” shall mean an Unrestricted Subsidiary that is formed for the purpose of acquiring the real property of Parent, the Borrower or any Subsidiary in connection with a Spinout Transaction.
     “Spinout Transaction” shall mean the sale, transfer or other disposition by Parent, the Borrower or any Subsidiary of real property owned by it to any Spinout Subsidiary in a transaction permitted by Section 6.05(b)(i) and the subsequent distribution of the Equity Interests of such Spinout Subsidiary to the equity holders of Parent.

 


 

     “Statutory Reserves” shall mean a fraction (expressed as a decimal), the numerator of which is the number one and the denominator of which is the number one minus the aggregate of the maximum reserve percentages (including any marginal, special, emergency or supplemental reserves) expressed as a decimal established by the Board and any other banking authority, domestic or foreign, to which the Administrative Agent or any Lender (including any branch, Affiliate or other fronting office making or holding a Loan) is subject for Eurocurrency Liabilities (as defined in Regulation D of the Board). Eurodollar Loans shall be deemed to constitute Eurocurrency Liabilities (as defined in Regulation D of the Board) and to be subject to such reserve requirements without benefit of or credit for proration, exemptions or offsets that may be available from time to time to any Lender under such Regulation D. Statutory Reserves shall be adjusted automatically on and as of the effective date of any change in any reserve percentage.
     “subsidiary” shall mean, as to any person, a corporation, partnership or other entity of which Equity Interests having ordinary voting power (other than Equity Interests having such power only by reason of the happening of a contingency) to elect a majority of the board of directors or other managers of such corporation, partnership or other entity are at the time owned, directly or indirectly, or the management of which is otherwise Controlled, directly or indirectly, or both, by such person.
     “Subsidiary” shall mean any subsidiary of the Borrower; provided, however, that Unrestricted Subsidiaries shall be deemed not to be Subsidiaries for any purpose of this Agreement or the other Loan Documents.
     “Subsidiary Guarantor” shall mean each Subsidiary listed on Schedule 1.01(b), and each other Subsidiary that is or becomes a party to the Guarantee and Collateral Agreement pursuant to Section 5.12 (it being understood and agreed that no (i) Foreign Subsidiary, (ii) Non-Significant Subsidiary, (iii) Permitted Syndication Subsidiary, (iv) Securitization Subsidiary, (v) Captive Insurance Subsidiary, (vi) Permitted Joint Venture Subsidiary or (vii) Subsidiary listed on Schedule 1.01(f), shall, in any case, be required to enter into the Guarantee and Collateral Agreement pursuant to Section 5.12).
     “Swingline Commitment” shall mean the commitment of the Swingline Lender to make loans pursuant to Section 2.22, as the same may be reduced from time to time pursuant to Section 2.09.
     “Swingline Exposure” shall mean at any time the aggregate principal amount at such time of all outstanding Swingline Loans. The Swingline Exposure of any Revolving Credit Lender at any time shall equal its Pro Rata Percentage of the aggregate Swingline Exposure at such time.
     “Swingline Lender” shall mean Credit Suisse AG, acting through any of its Affiliates or branches, in its capacity as lender of Swingline Loans hereunder.
     “Swingline Loan” shall mean any loan made by the Swingline Lender pursuant to Section 2.22.
     “Syndication Proceeds” shall have the meaning assigned to such term in Section 6.05(b).

 


 

     “Syndication Transaction” shall mean a transaction (or series of transactions) whereby the Borrower or a Subsidiary sells part, but not all, of its interest in a Subsidiary that owns, leases or operates a Hospital to one or more third parties or of its interest in a Hospital to a partially owned Subsidiary.
     “Synthetic Lease” shall mean, as to any person, any lease (including leases that may be terminated by the lessee at any time) of any property (whether real, personal or mixed) (a) that is accounted for as an operating lease under GAAP and (b) in respect of which the lessee retains or obtains ownership of the property so leased for U.S. federal income tax purposes, other than any such lease under which such person is the lessor.
     “Synthetic Lease Obligations” shall mean, as to any person, an amount equal to the capitalized amount of the remaining lease payments under any Synthetic Lease that would appear on a balance sheet of such person in accordance with GAAP if such obligations were accounted for as Capital Lease Obligations.
     “Synthetic Purchase Agreement” shall mean any swap, derivative or other agreement or combination of agreements pursuant to which Parent, the Borrower or any Subsidiary is or may become obligated to make (a) any payment in connection with a purchase by any third party from a person other than Parent, the Borrower or any Subsidiary of any Equity Interest or Restricted Indebtedness or (b) any payment (other than on account of a permitted purchase by it of any Equity Interest or Restricted Indebtedness) the amount of which is determined by reference to the price or value at any time of any Equity Interest or Restricted Indebtedness; provided that no phantom stock or similar plan providing for payments only to current or former directors, officers or employees of Parent, the Borrower or the Subsidiaries (or to their heirs and estates) shall be deemed to be a Synthetic Purchase Agreement.
     “Taxes” shall mean any and all present or future taxes, levies, imposts, duties, deductions, charges or withholdings imposed by any Governmental Authority.
     “Term Borrowing” shall mean a Borrowing comprised of Extended Term Loans, Non-Extended Term Loans or Incremental Term Loans.
     “Term Lender” shall mean a Lender with a Term Loan Commitment or an outstanding Term Loan.
     “Term Loan Commitments” shall have the meaning assigned to such term in the Original Credit Agreement. Unless the context shall otherwise require, the term “Term Loan Commitments” shall include the Incremental Term Loan Commitments.
     “Term Loans” shall mean the Extended Term Loans and the Non-Extended Term Loans. Unless the context shall otherwise require, the term “Term Loans” shall include any Incremental Term Loans.
     “Total Debt” shall mean, at any time, (a) the total Indebtedness of Parent, the Borrower and the Subsidiaries at such time (excluding Indebtedness of the type described in clause (h) of the definition of such term or under performance or surety bonds, in each case except to the extent of any unreimbursed drawings thereunder) minus (b) the aggregate amount of unrestricted

 


 

cash and cash equivalents that is included on the consolidated balance sheet of Parent, the Borrower and the Subsidiaries at such time.
     “Total Revolving Credit Commitment” shall mean, at any time, the aggregate amount of the Revolving Credit Commitments, as in effect at such time. As of the Restatement Effective Date, the Total Revolving Credit Commitment is $750,000,000.
     “Total Secured Debt” shall mean, at any time the total Indebtedness of Parent, the Borrower and the Subsidiaries at such time (excluding Indebtedness of the type described in clause (h) of the definition of such term or under performance or surety bonds, in each case except to the extent of any unreimbursed drawings thereunder) that is secured by Liens on any property or asset of Parent, the Borrower and the Subsidiaries at such time.
     “Transactions” shall have the meaning assigned to such term in the Original Credit Agreement.
     “Triad” shall mean Triad Healthcare Corporation (f/k/a Triad Hospitals, Inc.), a Delaware corporation and a wholly owned Subsidiary of the Borrower.
     “Type”, when used in respect of any Loan or Borrowing, shall refer to the Rate by reference to which interest on such Loan or on the Loans comprising such Borrowing is determined. For purposes hereof, the term “Rate” shall mean the Adjusted LIBO Rate and the Alternate Base Rate.
     “Unrestricted Subsidiary” shall mean any Subsidiary organized or acquired directly or indirectly by Parent after the Closing Date that Parent designates as an “Unrestricted Subsidiary” by written notice to the Administrative Agent. No Unrestricted Subsidiary may own any Equity Interests of a Subsidiary; provided that, so long as no Default or Event of Default shall have occurred and be continuing or would result therefrom, Parent may redesignate any Unrestricted Subsidiary as a “Subsidiary” by written notice to the Administrative Agent and by complying with the applicable provisions of Section 5.12.
     “USA PATRIOT Act” shall mean The Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (Title III of Pub. L. No. 107-56 (signed into law October 26, 2001)).
     “Voluntary Prepayment” shall mean a prepayment of principal of Term Loans pursuant to Section 2.12 in any year to the extent that such prepayment reduces the scheduled installments of principal due in respect of Term Loans in any subsequent year.
     “wholly owned Subsidiary” of any person shall mean a subsidiary of such person of which securities (except for directors’ qualifying shares) or other ownership interests representing 100% of the Equity Interests are, at the time any determination is being made, owned, Controlled or held by such person or one or more wholly owned Subsidiaries of such person or by such person and one or more wholly owned Subsidiaries of such person.
     “Withdrawal Liability” shall mean liability to a Multiemployer Plan as a result of a complete or partial withdrawal from such Multiemployer Plan, as such terms are defined in Part I of Subtitle E of Title IV of ERISA.

 


 

     “Withholding Agent” shall mean any Loan Party or the Administrative Agent.
     SECTION 1.02. Terms Generally. The definitions in Section 1.01 shall apply equally to both the singular and plural forms of the terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The words “include”, “includes” and “including” shall be deemed to be followed by the phrase “without limitation”. The word “will” shall be construed to have the same meaning and effect as the word “shall”; and the words “asset” and “property” shall be construed as having the same meaning and effect and to refer to any and all tangible and intangible assets and properties, including cash, securities, accounts and contract rights. All references herein to Articles, Sections, Exhibits and Schedules shall be deemed references to Articles and Sections of, and Exhibits and Schedules to, this Agreement unless the context shall otherwise require. Except as otherwise expressly provided herein, (a) any reference in this Agreement to any Loan Document shall mean such document as amended, restated, supplemented or otherwise modified from time to time and (b) all terms of an accounting or financial nature shall be construed in accordance with GAAP, as in effect from time to time; provided, however, that if the Borrower notifies the Administrative Agent that the Borrower wishes to amend any covenant in Article VI or any related definition to eliminate the effect of any change in GAAP occurring after the date of this Agreement on the operation of such covenant (or if the Administrative Agent notifies the Borrower that the Required Lenders wish to amend Article VI or any related definition for such purpose), then the Borrower’s compliance with such covenant shall be determined on the basis of GAAP in effect immediately before the relevant change in GAAP became effective, until either such notice is withdrawn or such covenant is amended in a manner satisfactory to the Borrower and the Required Lenders.
     SECTION 1.03. Pro Forma Calculations. With respect to any period of four consecutive fiscal quarters during which any Permitted Acquisition or Significant Asset Sale occurs, each of the Leverage Ratio and the Secured Leverage Ratio shall, for all purposes set forth herein, be calculated with respect to such period on a pro forma basis after giving effect to such Permitted Acquisition or Significant Asset Sale (including, without duplication, (a) all pro forma adjustments permitted or required by Article 11 of Regulation S-X under the Securities Act of 1933, as amended, and (b) pro forma adjustments for cost savings (net of continuing associated expenses) to the extent such cost savings are factually supportable, are expected to have a continuing impact and have been realized or are reasonably expected to be realized within 12 months following any such Permitted Acquisition; provided that at the election of Parent, such pro forma adjustment shall not be required to be determined for any Permitted Acquisition if the aggregate consideration paid in connection with such acquisition is less than $100,000,000; provided further that all such adjustments shall be set forth in a reasonably detailed certificate of a Financial Officer of Parent), using, for purposes of making such calculations, the historical financial statements of Parent, the Borrower and the Subsidiaries which shall be reformulated as if such Permitted Acquisition or Significant Asset Sale, and any other Permitted Acquisitions and Significant Asset Sales that have been consummated during the period, had been consummated on the first day of such period. In addition, solely for purposes of determining whether a Specified Transaction is permitted hereunder (including whether such Specified Transaction would result in a Default or Event of Default and whether the Leverage Ratio Condition or the Secured Leverage Ratio Condition would be met), the Leverage Ratio and the Secured Leverage Ratio shall be calculated on a pro forma basis as provided in the preceding sentence.

 


 

     SECTION 1.04. Classification of Loans and Borrowings. For purposes of this Agreement, Loans may be classified and referred to by Class (e.g., a “Revolving Loan”) or by Type (e.g., a “Eurodollar Loan”) or by Class and Type (e.g., a “Eurodollar Revolving Loan”). Borrowings also may be classified and referred to by Class (e.g., a “Revolving Borrowing”) or by Type (e.g., a “Eurodollar Borrowing”) or by Class and Type (e.g., a “Eurodollar Revolving Borrowing”).
ARTICLE II
The Credits
     SECTION 2.01. Commitments. (a) The Borrower and the Term Lenders acknowledge the making of the Existing Term Loans under the Original Credit Agreement and agree that, to the extent outstanding on the Restatement Effective Date, the Existing Term Loans shall continue to be outstanding as Extended Term Loans or Non-Extended Term Loans, as applicable under this Agreement and the other Loan Documents. Subject to the terms and conditions and relying upon the representations and warranties herein set forth, each Revolving Credit Lender agrees, severally and not jointly, to make Revolving Loans to the Borrower, at any time and from time to time after the Closing Date, and until the earlier of the Revolving Credit Maturity Date and the termination of the Revolving Credit Commitment of such Lender in accordance with the terms hereof, in an aggregate principal amount at any time outstanding that will not result in such Lender’s Revolving Credit Exposure exceeding such Lender’s Revolving Credit Commitment. Within the limits set forth in the preceding sentence and subject to the terms, conditions and limitations set forth herein, the Borrower may borrow, pay or prepay and reborrow Revolving Loans. Amounts paid or prepaid in respect of Term Loans may not be reborrowed.
     (b) Subject to the terms and conditions and relying upon the representations and warranties set forth herein and in the applicable Incremental Term Loan Assumption Agreement, each Lender having an Incremental Term Loan Commitment agrees, severally and not jointly, to make Incremental Term Loans to the Borrower, in an aggregate principal amount not to exceed its Incremental Term Loan Commitment. Amounts paid or prepaid in respect of Incremental Term Loans may not be reborrowed.
     SECTION 2.02. Loans. (a) Each Loan (other than Swingline Loans) shall be made as part of a Borrowing consisting of Loans made by the Lenders ratably in accordance with their applicable Commitments; provided, however, that the failure of any Lender to make any Loan shall not in itself relieve any other Lender of its obligation to lend hereunder (it being understood, however, that no Lender shall be responsible for the failure of any other Lender to make any Loan required to be made by such other Lender). Except for Loans deemed made pursuant to Section 2.02(f), the Loans comprising any Borrowing shall be in an aggregate principal amount that is (i) an integral multiple of $1,000,000 and not less than $3,000,000 (except, with respect to any Incremental Term Borrowing, to the extent otherwise provided in the related Incremental Term Loan Assumption Agreement) or (ii) equal to the remaining available balance of the applicable Commitments.
     (b) Subject to Sections 2.02(f), 2.08 and 2.15, each Borrowing shall be comprised entirely of ABR Loans or Eurodollar Loans as the Borrower may request pursuant to Section 2.03. Each Lender may at its option make any Eurodollar Loan by causing any domestic or foreign branch or Affiliate of such Lender to make such Loan; provided that any exercise of

 


 

such option shall not affect the obligation of the Borrower to repay such Loan in accordance with the terms of this Agreement. Borrowings of more than one Type may be outstanding at the same time; provided, however, that the Borrower shall not be entitled to request any Borrowing that, if made, would result in more than fifteen Eurodollar Borrowings outstanding hereunder at any time. For purposes of the foregoing, Borrowings having different Interest Periods, regardless of whether they commence on the same date, shall be considered separate Borrowings.
     (c) Except with respect to Loans made pursuant to Section 2.02(f), each Lender shall make each Loan to be made by it hereunder on the proposed date thereof by wire transfer of immediately available funds to such account in New York City as the Administrative Agent may designate not later than 1:00 p.m., New York City time, and the Administrative Agent shall promptly credit the amounts so received to an account designated by the Borrower in the applicable Borrowing Request or, if a Borrowing shall not occur on such date because any condition precedent herein specified shall not have been met, return the amounts so received to the respective Lenders.
     (d) Unless the Administrative Agent shall have received notice from a Lender prior to the date of any Borrowing that such Lender will not make available to the Administrative Agent such Lender’s portion of such Borrowing, the Administrative Agent may assume that such Lender has made such portion available to the Administrative Agent on the date of such Borrowing in accordance with paragraph (c) above and the Administrative Agent may, in reliance upon such assumption, make available to the Borrower on such date a corresponding amount. If the Administrative Agent shall have so made funds available then, to the extent that such Lender shall not have made such portion available to the Administrative Agent, such Lender agrees to repay to the Administrative Agent forthwith on demand such corresponding amount together with interest thereon, for each day from the date such amount is made available to the Borrower to but excluding the date such amount is repaid to the Administrative Agent at a rate determined by the Administrative Agent to represent its cost of overnight or short-term funds (which determination shall be conclusive absent manifest error). If such Lender shall not repay to the Administrative Agent such corresponding amount within three Business Days after demand by the Administrative Agent, then the Administrative Agent shall be entitled to recover such amount with interest thereon at the rate per annum equal to the interest rate applicable at the time to the Loans comprising such Borrowing, on demand, from the Borrower. If such Lender shall repay to the Administrative Agent such corresponding amount, such amount shall constitute such Lender’s Loan as part of such Borrowing for purposes of this Agreement.
     (e) Notwithstanding any other provision of this Agreement, the Borrower shall not be entitled to request any Revolving Credit Borrowing if the Interest Period requested with respect thereto would end after the Revolving Credit Maturity Date.
     (f) If the Issuing Bank shall not have received from the Borrower the payment required to be made by Section 2.23(e) within the time specified in such Section, the Issuing Bank will promptly notify the Administrative Agent of the L/C Disbursement and the Administrative Agent will promptly notify each Revolving Credit Lender of such L/C Disbursement and its Pro Rata Percentage thereof. Each Revolving Credit Lender shall pay by wire transfer of immediately available funds to the Administrative Agent not later than 2:00 p.m., New York City time, on such date (or, if such Revolving Credit Lender shall have received such notice later than 12:00 (noon), New York City time, on any day, not later than 10:00 a.m., New York City time, on the immediately following Business Day), an amount equal to such Lender’s Pro Rata Percentage of

 


 

such L/C Disbursement (it being understood that (i) if the conditions precedent to borrowing set forth in Sections 4.01(b) and (c) have been satisfied, such amount shall be deemed to constitute an ABR Revolving Loan of such Lender and, to the extent of such payment, the obligations of the Borrower in respect of such L/C Disbursement shall be discharged and replaced with the resulting ABR Revolving Credit Borrowing, and (ii) if such conditions precedent to borrowing have not been satisfied, then any such amount paid by any Revolving Credit Lender shall not constitute a Loan and shall not relieve the Borrower from its obligation to reimburse such L/C Disbursement), and the Administrative Agent will promptly pay to the Issuing Bank amounts so received by it from the Revolving Credit Lenders. The Administrative Agent will promptly pay to the Issuing Bank any amounts received by it from the Borrower pursuant to Section 2.23(e) prior to the time that any Revolving Credit Lender makes any payment pursuant to this paragraph (f); any such amounts received by the Administrative Agent thereafter will be promptly remitted by the Administrative Agent to the Revolving Credit Lenders that shall have made such payments and to the Issuing Bank, as their interests may appear. If any Revolving Credit Lender shall not have made its Pro Rata Percentage of such L/C Disbursement available to the Administrative Agent as provided above, such Lender and the Borrower severally agree to pay interest on such amount, for each day from and including the date such amount is required to be paid in accordance with this paragraph to but excluding the date such amount is paid, to the Administrative Agent for the account of the Issuing Bank at (i) in the case of the Borrower, a rate per annum equal to the interest rate applicable to Revolving Loans pursuant to Section 2.06(a), and (ii) in the case of such Lender, for the first such day, the Federal Funds Effective Rate, and for each day thereafter, the Alternate Base Rate.
     SECTION 2.03. Borrowing Procedure. In order to request a Borrowing (other than a Swingline Loan or a deemed Borrowing pursuant to Section 2.02(f), as to which this Section 2.03 shall not apply), the Borrower shall notify the Administrative Agent of such request by telephone (a) in the case of a Eurodollar Borrowing, not later than 12:00 (noon), New York City time, three Business Days before a proposed Borrowing, and (b) in the case of an ABR Borrowing, not later than 12:00 (noon), New York City time, one Business Day before a proposed Borrowing. Each such telephonic Borrowing Request shall be irrevocable, and shall be confirmed promptly by hand delivery or fax to the Administrative Agent of a written Borrowing Request and shall specify the following information: (i) whether the Borrowing then being requested is to be an Extended Term Borrowing, a Non-Extended Delayed Draw Term Borrowing, a Non-Extended Funded Term Borrowing, an Incremental Term Borrowing or a Revolving Credit Borrowing, and whether such Borrowing is to be a Eurodollar Borrowing or an ABR Borrowing; (ii) the date of such Borrowing (which shall be a Business Day); (iii) the number and location of the account to which funds are to be disbursed; (iv) the amount of such Borrowing; and (v) if such Borrowing is to be a Eurodollar Borrowing, the Interest Period with respect thereto; provided, however, that, notwithstanding any contrary specification in any Borrowing Request, each requested Borrowing shall comply with the requirements set forth in Section 2.02. If no election as to the Type of Borrowing is specified in any such notice, then the requested Borrowing shall be an ABR Borrowing. If no Interest Period with respect to any Eurodollar Borrowing is specified in any such notice, then the Borrower shall be deemed to have selected an Interest Period of one month’s duration. The Administrative Agent shall promptly advise the applicable Lenders of any notice given pursuant to this Section 2.03 (and the contents thereof), and of each Lender’s portion of the requested Borrowing.

 


 

     SECTION 2.04. Evidence of Debt; Repayment of Loans. (a) The Borrower hereby unconditionally promises to pay to the Administrative Agent for the account of each Lender (i) the principal amount of each Term Loan of such Lender as provided in Section 2.11 and (ii) the then unpaid principal amount of each Revolving Loan of such Lender on the Revolving Credit Maturity Date. The Borrower hereby promises to pay to the Swingline Lender the then unpaid principal amount of each Swingline Loan on the earlier of the Revolving Credit Maturity Date and the 15th day after such Swingline Loan is made.
     (b) Each Lender shall maintain in accordance with its usual practice an account or accounts evidencing the indebtedness of the Borrower to such Lender resulting from each Loan made by such Lender from time to time, including the amounts of principal and interest payable and paid to such Lender from time to time under this Agreement.
     (c) The Administrative Agent shall maintain accounts in which it will record (i) the amount of each Loan made hereunder, the Class and Type thereof and, if applicable, the Interest Period applicable thereto, (ii) the amount of any principal or interest due and payable or to become due and payable from the Borrower to each Lender hereunder and (iii) the amount of any sum received by the Administrative Agent hereunder from the Borrower or any Guarantor and each Lender’s share thereof.
     (d) The entries made in the accounts maintained pursuant to paragraphs (b) and (c) above shall be prima facie evidence of the existence and amounts of the obligations therein recorded; provided, however, that the failure of any Lender or the Administrative Agent to maintain such accounts or any error therein shall not in any manner affect the obligations of the Borrower to repay the Loans in accordance with their terms.
     (e) Any Lender may request that Loans made by it hereunder be evidenced by a promissory note. In such event, the Borrower shall execute and deliver to such Lender a promissory note payable to such Lender and its registered assigns and in a form and substance reasonably acceptable to the Administrative Agent and the Borrower. Notwithstanding any other provision of this Agreement, in the event any Lender shall request and receive such a promissory note, the interests represented by such note shall at all times (including after any assignment of all or part of such interests pursuant to Section 9.04) be represented by one or more promissory notes payable to the payee named therein or its registered assigns.
     SECTION 2.05. Fees. (a) The Borrower agrees to pay to each Revolving Credit Lender, through the Administrative Agent, on the last Business Day of March, June, September and December in each year and on each date on which any Revolving Credit Commitment of such Lender shall expire or be terminated as provided herein, a commitment fee (a “Revolving Credit Commitment Fee”) equal to the Revolving Credit Commitment Fee Rate per annum on the daily unused amount of the Revolving Credit Commitment of such Lender during the preceding quarter (or other period ending with the Revolving Credit Maturity Date or the date on which the Revolving Credit Commitments of such Lender shall expire or be terminated). All Commitment Fees shall be computed on the basis of the actual number of days elapsed in a year of 360 days. For purposes of calculating Revolving Credit Commitment Fees, no portion of the Revolving Credit Commitments shall be deemed utilized as a result of outstanding Swingline Loans.

 


 

     (b) The Borrower agrees to pay to the Administrative Agent, for its own account, the administrative fees set forth in the Fee Letter at the times and in the amounts specified therein (the “Administrative Agent Fees”).
     (c) The Borrower agrees to pay (i) to each Revolving Credit Lender, through the Administrative Agent, on the last Business Day of March, June, September and December of each year and on the date on which the Revolving Credit Commitment of such Lender shall be terminated as provided herein, a fee (an “L/C Participation Fee”) calculated on such Lender’s Pro Rata Percentage of the daily aggregate L/C Exposure (excluding the portion thereof attributable to unreimbursed L/C Disbursements) during the preceding quarter (or shorter period ending with the Revolving Credit Maturity Date or the date on which all Letters of Credit have been canceled or have expired and the Revolving Credit Commitments of all Lenders shall have been terminated) at a rate per annum equal to the Applicable Percentage from time to time used to determine the interest rate on Revolving Credit Borrowings comprised of Eurodollar Loans pursuant to Section 2.06, and (ii) to the Issuing Bank with respect to each Letter of Credit the standard fronting, issuance and drawing fees specified from time to time by the Issuing Bank (the “Issuing Bank Fees”); provided that each such fronting fee charged from time to time shall not exceed 0.25% per annum of the aggregate undrawn face amount of the then outstanding Letters of Credit. All L/C Participation Fees and Issuing Bank Fees shall be computed on the basis of the actual number of days elapsed in a year of 360 days.
     (d) All Fees shall be paid on the dates due, in immediately available funds, to the Administrative Agent for distribution, if and as appropriate, among the Lenders, except that the Issuing Bank Fees shall be paid directly to the Issuing Bank. Once paid, none of the Fees shall be refundable under any circumstances.
     SECTION 2.06. Interest on Loans. (a) Subject to the provisions of Section 2.07, the Loans comprising each ABR Borrowing, including each Swingline Loan, shall bear interest (computed on the basis of the actual number of days elapsed over a year of 365 or 366 days, as the case may be, when the Alternate Base Rate is determined by reference to the Prime Rate and over a year of 360 days at all other times and calculated from and including the date of such Borrowing to but excluding the date of repayment thereof) at a rate per annum equal to the Alternate Base Rate plus the Applicable Percentage in effect from time to time.
     (b) Subject to the provisions of Section 2.07, the Loans comprising each Eurodollar Borrowing shall bear interest (computed on the basis of the actual number of days elapsed over a year of 360 days) at a rate per annum equal to the Adjusted LIBO Rate for the Interest Period in effect for such Borrowing plus the Applicable Percentage in effect from time to time.
     (c) Interest on each Loan shall be payable on the Interest Payment Dates applicable to such Loan except as otherwise provided in this Agreement. The applicable Alternate Base Rate or Adjusted LIBO Rate for each Interest Period or day within an Interest Period, as the case may be, shall be determined by the Administrative Agent, and such determination shall be conclusive absent manifest error.
     SECTION 2.07. Default Interest. If the Borrower shall default in the payment of any principal of or interest on any Loan or any other amount due hereunder, by acceleration or otherwise, or under any other Loan Document, then, until such defaulted amount shall have been paid in full, to the extent permitted by law, such defaulted amount shall bear interest (after as

 


 

well as before judgment), payable on demand, (a) in the case of principal, at the rate otherwise applicable to such Loan pursuant to Section 2.06 plus 2.00% per annum and (b) in all other cases, at a rate per annum (computed on the basis of the actual number of days elapsed over a year of 365 or 366 days, as the case may be, when determined by reference to the Prime Rate and over a year of 360 days at all other times) equal to the rate that would be applicable to an ABR Loan of the applicable Class plus 2.00% per annum.
     SECTION 2.08. Alternate Rate of Interest. In the event, and on each occasion, that on the day two Business Days prior to the commencement of any Interest Period for a Eurodollar Borrowing the Administrative Agent shall have determined that dollar deposits in the principal amounts of the Loans comprising such Borrowing are not generally available in the London interbank market, or that the rates at which such dollar deposits are being offered will not adequately and fairly reflect the cost to any Lender of making or maintaining its Eurodollar Loan during such Interest Period, or that reasonable means do not exist for ascertaining the Adjusted LIBO Rate, the Administrative Agent shall, as soon as practicable thereafter, give written or fax notice of such determination to the Borrower and the Lenders. In the event of any such determination, until the Administrative Agent shall have advised the Borrower and the Lenders that the circumstances giving rise to such notice no longer exist, any request by the Borrower for a Eurodollar Borrowing pursuant to Section 2.03 or 2.10 shall be deemed to be a request for an ABR Borrowing. Each determination by the Administrative Agent under this Section 2.08 shall be conclusive absent manifest error.
     SECTION 2.09. Termination and Reduction of Commitments. (a) The Incremental Term Loan Commitments shall terminate as provided in the related Incremental Term Loan Assumption Agreement. The Revolving Credit Commitments and the Swingline Commitment shall automatically terminate on the Revolving Credit Maturity Date. The L/C Commitment shall automatically terminate on the earlier to occur of (i) the termination of the Revolving Credit Commitments and (ii) the date 10 Business Days prior to the Revolving Credit Maturity Date.
     (b) Upon at least three Business Days’ prior written or fax notice to the Administrative Agent, the Borrower may at any time in whole permanently terminate, or from time to time in part permanently reduce, the Revolving Credit Commitments or the Swingline Commitment; provided, however, that (i) each partial reduction of the Revolving Credit Commitments shall be in an integral multiple of $1,000,000 and in a minimum amount of $3,000,000, (ii) each partial reduction of the Swingline Commitment shall be in an integral multiple of $250,000 and in a minimum amount of $1,000,000 and (iii) the Total Revolving Credit Commitment shall not be reduced to an amount that is less than the Aggregate Revolving Credit Exposure at the time. Each notice delivered by the Borrower pursuant to this Section 2.09 shall be irrevocable; provided that a notice of termination of the Revolving Credit Commitments or the Swingline Commitment delivered by the Borrower may state that such notice is conditioned upon the effectiveness of other credit facilities, indentures or similar agreements or any other event, in which case such notice may be revoked by the Borrower (by notice to the Administrative Agent on or prior to the specified effective date) if such condition is not satisfied.
     (c) Each reduction in the Revolving Credit Commitments hereunder shall be made ratably among the Lenders in accordance with their respective applicable Commitments. The Borrower shall pay to the Administrative Agent for the account of the applicable Lenders, on the date of each termination or reduction, the Commitment Fees on the amount of the Commitments so terminated or reduced accrued to but excluding the date of such termination or reduction.

 


 

     SECTION 2.10. Conversion and Continuation of Borrowings. The Borrower shall have the right at any time upon prior irrevocable notice to the Administrative Agent (a) not later than 12:00 (noon), New York City time, one Business Day prior to conversion, to convert any Eurodollar Borrowing into an ABR Borrowing, (b) not later than 12:00 (noon), New York City time, three Business Days prior to conversion or continuation, to convert any ABR Borrowing into a Eurodollar Borrowing or to continue any Eurodollar Borrowing as a Eurodollar Borrowing for an additional Interest Period, and (c) not later than 12:00 (noon), New York City time, three Business Days prior to conversion, to convert the Interest Period with respect to any Eurodollar Borrowing to another permissible Interest Period, subject in each case to the following:
     (i) each conversion or continuation shall be made pro rata among the Lenders in accordance with the respective principal amounts of the Loans comprising the converted or continued Borrowing;
     (ii) if less than all the outstanding principal amount of any Borrowing shall be converted or continued, then each resulting Borrowing shall satisfy the limitations specified in Sections 2.02(a) and 2.02(b) regarding the principal amount and maximum number of Borrowings of the relevant Type;
     (iii) each conversion shall be effected by each Lender and the Administrative Agent by recording for the account of such Lender the new Loan of such Lender resulting from such conversion and reducing the Loan (or portion thereof) of such Lender being converted by an equivalent principal amount; accrued interest on any Eurodollar Loan (or portion thereof) being converted shall be paid by the Borrower at the time of conversion;
     (iv) if any Eurodollar Borrowing is converted at a time other than the end of the Interest Period applicable thereto, the Borrower shall pay, upon demand, any amounts due to the Lenders pursuant to Section 2.16;
     (v) any portion of a Borrowing maturing or required to be repaid in less than one month may not be converted into or continued as a Eurodollar Borrowing;
     (vi) any portion of a Eurodollar Borrowing that cannot be converted into or continued as a Eurodollar Borrowing by reason of the immediately preceding clause shall be automatically converted at the end of the Interest Period in effect for such Borrowing into an ABR Borrowing;
     (vii) no Interest Period may be selected for any Eurodollar Term Borrowing that would end later than a Repayment Date occurring on or after the first day of such Interest Period if, after giving effect to such selection, the aggregate outstanding amount of (A) the Eurodollar Term Borrowings comprised of Extended Term Loans, Non-Extended Delayed Draw Term Loans, Non-Extended Funded Term Loans or Other Term Loans, as applicable, with Interest Periods ending on or prior to such Repayment Date and (B) the ABR Term Borrowings comprised of Extended Term Loans, Non-Extended Delayed Draw Term Loans, Non-Extended Funded Term Loans or Other Term Loans, as applicable, would not be at least equal to the principal amount of Term Borrowings to be paid on such Repayment Date; and

 


 

     (viii) upon notice to the Borrower from the Administrative Agent given at the request of the Required Lenders, after the occurrence and during the continuance of a Default or Event of Default, no outstanding Loan may be converted into, or continued as, a Eurodollar Loan.
     Each notice pursuant to this Section 2.10 shall be irrevocable and shall refer to this Agreement and specify (i) the identity and amount of the Borrowing that the Borrower requests be converted or continued, (ii) whether such Borrowing is to be converted to or continued as a Eurodollar Borrowing or an ABR Borrowing, (iii) if such notice requests a conversion, the date of such conversion (which shall be a Business Day) and (iv) if such Borrowing is to be converted to or continued as a Eurodollar Borrowing, the Interest Period with respect thereto. If no Interest Period is specified in any such notice with respect to any conversion to or continuation as a Eurodollar Borrowing, the Borrower shall be deemed to have selected an Interest Period of one month’s duration. The Administrative Agent shall advise the Lenders of any notice given pursuant to this Section 2.10 and of each Lender’s portion of any converted or continued Borrowing. If the Borrower shall not have given notice in accordance with this Section 2.10 to continue any Borrowing into a subsequent Interest Period (and shall not otherwise have given notice in accordance with this Section 2.10 to convert such Borrowing), such Borrowing shall, at the end of the Interest Period applicable thereto (unless repaid pursuant to the terms hereof), automatically be continued into an ABR Borrowing.
     SECTION 2.11. Repayment of Term Borrowings. (a) (i) The Borrower shall pay to the Administrative Agent, for the account of the Non-Extended Funded Term Loan Lenders, (A) on the last Business Day of each March, June, September and December, commencing with the last Business Day of December 2010 (each such date being called a “Non-Extended Funded Term Loan Repayment Date”), a principal amount of the Non-Extended Funded Term Loans (as adjusted from time to time pursuant to Sections 2.12 and 2.13(g)) equal to (1) the amount that would have been payable on such date in respect of the Existing Funded Term Loans pursuant to Section 2.11(a)(i) of the Original Credit Agreement multiplied by (2) a fraction, the numerator of which is the aggregate amount of all Non-Extended Funded Term Loans outstanding on the Restatement Effective Date immediately after the effectiveness of the Amendment and Restatement Agreement, and the denominator of which is the aggregate amount of all Existing Funded Term Loans outstanding on the Restatement Effective Date immediately prior to the effectiveness of the Amendment and Restatement Agreement and (B) on the Non-Extended Term Loan Maturity Date, the aggregate principal amount of all Non-Extended Funded Term Loans outstanding on such date, together in each case with accrued and unpaid interest on the principal amount to be paid to but excluding the date of such payment.
     (ii) The Borrower shall pay to the Administrative Agent, for the account of the Non-Extended Delayed Draw Term Loan Lenders, (A) on the last Business Day of each March, June, September and December, commencing with the last Business Day of December 2010 (each such date being called a “ Non-Extended Delayed Draw Term Loan Repayment Date”), a principal amount of the Non-Extended Delayed Draw Term Loans (as adjusted from time to time pursuant to Sections 2.12 and 2.13(g)) equal to (1) the amount that would have been payable on such date in respect of the Existing Delayed Draw Term Loans pursuant to Section 2.11(a)(ii) of the Original Credit Agreement multiplied by (2) a fraction, the numerator of which is the aggregate amount of all Non-Extended Delayed Draw Term Loans outstanding on the Restatement Effective Date immediately after the effectiveness of the Amendment and

 


 

Restatement Agreement, and the denominator of which is the aggregate amount of all Existing Delayed Draw Term Loans outstanding on the Restatement Effective Date immediately prior to the effectiveness of the Amendment and Restatement Agreement and (B) on the Non-Extended Term Loan Maturity Date, the aggregate principal amount of all Non-Extended Delayed Draw Term Loans outstanding on such date, together in each case with accrued and unpaid interest on the principal amount to be paid to but excluding the date of such payment.
     (iii) The Borrower shall pay to the Administrative Agent, for the account of the Extended Term Loan Lenders, (A) on the last Business Day of each March, June, September and December, commencing with the last Business Day of December 2010 (each such date being called an “Extended Term Loan Repayment Date”), a principal amount of the Extended Term Loans (as adjusted from time to time pursuant to Sections 2.12, 2.13(g) and 2.24(d)) equal to 0.25% of the aggregate principal amount of all Extended Term Loans outstanding on the Restatement Effective Date and (B) on the Extended Term Loan Maturity Date, the aggregate principal amount of all Extended Term Loans outstanding on such date, together in each case with accrued and unpaid interest on the principal amount to be paid to but excluding the date of such payment.
     (iv) The Borrower shall pay to the Administrative Agent, for the account of the Incremental Term Lenders, on each Incremental Term Loan Repayment Date, a principal amount of the Other Term Loans (as adjusted from time to time pursuant to Sections 2.12, 2.13(g) and 2.24(d)) equal to the amount set forth for such date in the applicable Incremental Term Loan Assumption Agreement, together in each case with accrued and unpaid interest on the principal amount to be paid to but excluding the date of such payment.
     (b) To the extent not previously paid, (i) all Non-Extended Term Loans shall be due and payable on the Non-Extended Term Loan Maturity Date, (ii) all Extended Term Loans shall be due and payable on the Extended Term Loan Maturity Date and (iii) all Other Term Loans shall be due and payable on the Incremental Term Loan Maturity Date applicable thereto, in each case together with accrued and unpaid interest on the principal amount to be paid to but excluding the date of payment.
     (c) All repayments pursuant to this Section 2.11 shall be subject to Section 2.16, but shall otherwise be without premium or penalty.
     SECTION 2.12. Optional Prepayment. (a) The Borrower shall have the right at any time and from time to time to prepay any Borrowing, in whole or in part, upon at least three Business Days’ prior written or fax notice (or telephone notice promptly confirmed by written or fax notice) in the case of Eurodollar Loans, or written or fax notice (or telephone notice promptly confirmed by written or fax notice) at least one Business Day prior to the date of prepayment in the case of ABR Loans, to the Administrative Agent before 11:00 a.m., New York City time; provided, however, that each partial prepayment shall be in an amount that is an integral multiple of $1,000,000 and not less than $3,000,000.
     (b) Optional prepayments of Term Loans shall be applied as directed by the Borrower, and if no such direction is provided, pro rata against the remaining scheduled installments of principal due in respect of the Term Loans under Section 2.11, provided that no prepayment of the Extended Term Loans shall be made pursuant to this Section unless the remaining Non-Extended Term Loans, if any, shall be prepaid at least ratably.

 


 

     (c) Each notice of prepayment shall specify the prepayment date and the principal amount of each Borrowing (or portion thereof) to be prepaid, shall be irrevocable and shall commit the Borrower to prepay such Borrowing by the amount stated therein on the date stated therein; provided that a notice of prepayment may state that such notice is conditioned upon the effectiveness of other credit facilities, indentures or similar agreements or any other event, in which case such notice may be revoked by the Borrower (by notice to the Administrative Agent on or prior to the specified effective date) if such condition is not satisfied. All prepayments under this Section 2.12 shall be subject to Section 2.16 but otherwise without premium or penalty. All prepayments under this Section 2.12 (other than prepayments of ABR Revolving Loans that are not made in connection with the termination or permanent reduction of the Revolving Credit Commitments) shall be accompanied by accrued and unpaid interest on the principal amount to be prepaid to but excluding the date of payment.
     SECTION 2.13. Mandatory Prepayments. (a) In the event of any termination of all the Revolving Credit Commitments, the Borrower shall, on the date of such termination, repay or prepay all its outstanding Revolving Credit Borrowings and all outstanding Swingline Loans and replace or cause to be canceled (or make other arrangements satisfactory to the Administrative Agent and the Issuing Bank with respect to) all outstanding Letters of Credit. If, after giving effect to any partial reduction of the Revolving Credit Commitments or at any other time, the Aggregate Revolving Credit Exposure would exceed the Total Revolving Credit Commitment, then the Borrower shall, on the date of such reduction or at such other time, repay or prepay Revolving Credit Borrowings or Swingline Loans (or a combination thereof) and, after the Revolving Credit Borrowings and Swingline Loans shall have been repaid or prepaid in full, replace or cause to be canceled (or make other arrangements satisfactory to the Administrative Agent and the Issuing Bank with respect to) Letters of Credit in an amount sufficient to eliminate such excess.
     (b) Not later than the fifth Business Day after the earlier of (i) the receipt of aggregate Net Cash Proceeds in respect of Asset Sales (other than, for the avoidance of doubt, sales of Receivables in a Permitted Receivables Transaction, which such sales shall be subject to Section 2.13(e) below) in excess of $50,000,000 and (ii) the first anniversary of the Borrower’s most recent prepayment pursuant to this Section 2.13(b), the Borrower shall apply 100% of the Net Cash Proceeds so received (and not yet used to prepay Term Loans pursuant to this Section 2.13(b)) to prepay outstanding Term Loans in accordance with Section 2.13(g); provided that the Borrower may use a portion of such Net Cash Proceeds to prepay or repurchase Pari Passu Debt secured by Liens on the Collateral having the same priority as the Liens securing the Obligations to the extent any applicable credit agreement, indenture or other agreement governing such Pari Passu Debt requires the Borrower to prepay or make an offer to purchase such Pari Passu Debt with the proceeds of such Asset Sale, in each case in an amount not to exceed the product of (A) the amount of such Net Cash Proceeds and (B) a fraction, the numerator of which is the outstanding principal amount of such Pari Passu Debt and the denominator of which is the sum of the outstanding principal amount of such Pari Passu Debt and the outstanding principal amount of Term Loans.
     (c) No later than 95 days after the end of each fiscal year of the Borrower, the Borrower shall prepay outstanding Term Loans in accordance with Section 2.13(g) in an aggregate principal amount equal to (x) 50% of Excess Cash Flow for the fiscal year then ended minus (y) Voluntary Prepayments made during such fiscal year; provided that such percentage shall be

 


 

reduced to 25% if the Leverage Ratio as of the end of such fiscal year was less than 4.50 to 1.00 but equal to or greater than 3.50 to 1.00 and such percentage shall be reduced to zero (i.e., no payments shall be required pursuant to this Section 2.13(c)) if the Leverage Ratio as of the end of such fiscal year was less than 3.50 to 1.00.
     (d) In the event that Parent or any of its subsidiaries shall receive Net Cash Proceeds from the issuance or incurrence of Indebtedness for money borrowed (other than any cash proceeds from the issuance of Indebtedness for money borrowed permitted pursuant to Section 6.01 (other than Sections 6.01(f) and 6.01(o) (except for refinancing Indebtedness incurred thereunder), the Borrower shall, substantially simultaneously with (and in any event not later than the fifth Business Day next following) the receipt of such Net Cash Proceeds by Parent or such subsidiary, apply an amount equal to 100% of such Net Cash Proceeds (or, in the case of Permitted Additional Debt, 75% of the Net Cash Proceeds thereof in excess of $200,000,000) to prepay outstanding Term Loans in accordance with Section 2.13(g).
     (e) To the extent Parent or any of its subsidiaries shall receive aggregate Net Cash Proceeds in excess of $300,000,000 from the consummation of Permitted Receivables Transactions, the Borrower shall, substantially simultaneously with (and in any event not later than the fifth Business Day next following) the receipt of such Net Cash Proceeds by Parent or such subsidiary, apply an amount equal to 100% of the amount of such Net Cash Proceeds so in excess of $300,000,000 to prepay outstanding Term Loans in accordance with Section 2.13(g), provided that, the Borrower may use a portion of such Net Cash Proceeds to prepay or repurchase Pari Passu Debt secured by Liens on the Collateral having the same priority as the Liens securing the Obligations to the extent any applicable credit agreement, indenture or other agreement governing such Pari Passu Debt requires the Borrower to prepay or make an offer to purchase such Pari Passu Debt with the proceeds of such transaction, in each case in an amount not to exceed the product of (i) the amount of such Net Cash Proceeds and (ii) a fraction, the numerator of which is the outstanding principal amount of such Pari Passu Debt and the denominator of which is the sum of the outstanding principal amount of such Pari Passu Debt and the outstanding principal amount of Term Loans.
     (f) [Intentionally Omitted].
     (g) Mandatory prepayments of outstanding Term Loans under this Agreement shall be allocated pro rata among the Extended Term Loans, the Non-Extended Term Loans and the Other Term Loans and first applied in order of maturity of the scheduled installments of principal due in respect of the Non-Extended Term Loans, the Extended Term Loans and the Other Term Loans under Sections 2.11(a)(i), (ii) and (iii) for the first eight installments following such mandatory prepayment (commencing with the first such scheduled installment pursuant to Sections 2.11(a)(i), (ii) and (iii)) and, if applicable, thereafter applied pro rata against the remaining scheduled installments of principal due in respect of the Non-Extended Term Loans, the Extended Term Loans, and the Other Term Loans under Sections 2.11(a)(i), (ii) and (iii), respectively, the amount of such mandatory prepayment shall be applied first to Term Loans that are ABR Loans to the full extent thereof before application to Term Loans that are Eurodollar Loans in a manner that minimizes the amount of any payments required to be made by the Borrower pursuant to Section 2.16.
     (h) The Borrower shall deliver to the Administrative Agent, at the time of each prepayment required under this Section 2.13(b), (c), (d) or (e), as applicable, (i) a certificate

 


 

signed by a Financial Officer of the Borrower setting forth in reasonable detail the calculation of the amount of such prepayment and (ii) to the extent practicable, at least two days prior written notice of such prepayment. Each notice of prepayment shall specify the prepayment date, the Type of each Loan being prepaid and the principal amount of each Loan (or portion thereof) to be prepaid. All prepayments of Borrowings under this Section 2.13 shall be subject to Section 2.16, but shall otherwise be without premium or penalty, and shall be accompanied by accrued and unpaid interest on the principal amount to be prepaid to but excluding the date of payment (which interest amounts shall reduce the amount of Net Cash Proceeds required to be applied to prepay the Loans).
     SECTION 2.14. Reserve Requirements; Change in Circumstances. (a) Notwithstanding any other provision of this Agreement, if any Change in Law shall impose, modify or deem applicable any reserve, special deposit or similar requirement against assets of, deposits with or for the account of or credit extended by any Lender or the Issuing Bank (except any such reserve requirement which is reflected in the Adjusted LIBO Rate) or shall impose on such Lender or the Issuing Bank or the London interbank market any other condition affecting this Agreement or Eurodollar Loans made by such Lender or any Letter of Credit or participation therein, and the result of any of the foregoing shall be to increase the cost to such Lender or the Issuing Bank of making or maintaining any Eurodollar Loan or increase the cost to any Lender of issuing or maintaining any Letter of Credit or purchasing or maintaining a participation therein or to reduce the amount of any sum received or receivable by such Lender or the Issuing Bank hereunder (whether of principal, interest or otherwise) by an amount deemed by such Lender or the Issuing Bank to be material, then the Borrower will pay to such Lender or the Issuing Bank, as the case may be, from time to time such additional amount or amounts as will compensate such Lender or the Issuing Bank, as the case may be, for such additional costs incurred or reduction suffered.
     (b) If any Lender or the Issuing Bank shall have determined that any Change in Law regarding capital adequacy has or would have the effect of reducing the rate of return on such Lender’s or the Issuing Bank’s capital or on the capital of such Lender’s or the Issuing Bank’s holding company, if any, as a consequence of this Agreement or the Loans made or participations in Letters of Credit purchased by such Lender pursuant hereto or the Letters of Credit issued by the Issuing Bank pursuant hereto to a level below that which such Lender or the Issuing Bank or such Lender’s or the Issuing Bank’s holding company could have achieved but for such Change in Law (taking into consideration such Lender’s or the Issuing Bank’s policies and the policies of such Lender’s or the Issuing Bank’s holding company with respect to capital adequacy) by an amount deemed by such Lender or the Issuing Bank to be material, then from time to time the Borrower shall pay to such Lender or the Issuing Bank, as the case may be, such additional amount or amounts as will compensate such Lender or the Issuing Bank or such Lender’s or the Issuing Bank’s holding company for any such reduction suffered.
     (c) A certificate of a Lender or the Issuing Bank setting forth the amount or amounts necessary to compensate such Lender or the Issuing Bank or its holding company, as applicable, as specified in paragraph (a) or (b) above shall be delivered to the Borrower and shall be conclusive absent manifest error. The Borrower shall pay such Lender or the Issuing Bank the amount shown as due on any such certificate delivered by it within 30 days after its receipt of the same.

 


 

     (d) Failure or delay on the part of any Lender or the Issuing Bank to demand compensation for any increased costs or reduction in amounts received or receivable or reduction in return on capital shall not constitute a waiver of such Lender’s or the Issuing Bank’s right to demand such compensation; provided that the Borrower shall not be under any obligation to compensate any Lender or the Issuing Bank under paragraph (a) or (b) above with respect to increased costs or reductions with respect to any period prior to the date that is 120 days prior to such request if such Lender or the Issuing Bank knew or could reasonably have been expected to know of the circumstances giving rise to such increased costs or reductions and of the fact that such circumstances would result in a claim for increased compensation by reason of such increased costs or reductions; provided further that the foregoing limitation shall not apply to any increased costs or reductions arising out of the retroactive application of any Change in Law within such 120-day period. The protection of this Section shall be available to each Lender and the Issuing Bank regardless of any possible contention of the invalidity or inapplicability of the Change in Law that shall have occurred or been imposed.
     SECTION 2.15. Change in Legality. (a) Notwithstanding any other provision of this Agreement, if any Change in Law shall make it unlawful for any Lender to make or maintain any Eurodollar Loan or to give effect to its obligations as contemplated hereby with respect to any Eurodollar Loan, then, by written notice to the Borrower and to the Administrative Agent:
     (i) such Lender may declare that Eurodollar Loans will not thereafter (for the duration of such unlawfulness) be made by such Lender hereunder (or be continued for additional Interest Periods) and ABR Loans will not thereafter (for such duration) be converted into Eurodollar Loans, whereupon any request for a Eurodollar Borrowing (or to convert an ABR Borrowing to a Eurodollar Borrowing or to continue a Eurodollar Borrowing for an additional Interest Period) shall, as to such Lender only, be deemed a request for an ABR Loan (or a request to continue an ABR Loan as such for an additional Interest Period or to convert a Eurodollar Loan into an ABR Loan, as the case may be), unless such declaration shall be subsequently withdrawn; and
     (ii) such Lender may require that all outstanding Eurodollar Loans made by it be converted to ABR Loans, in which event all such Eurodollar Loans shall be automatically converted to ABR Loans as of the effective date of such notice as provided in paragraph (b) below.
In the event any Lender shall exercise its rights under (i) or (ii) above, all payments and prepayments of principal that would otherwise have been applied to repay the Eurodollar Loans that would have been made by such Lender or the converted Eurodollar Loans of such Lender shall instead be applied to repay the ABR Loans made by such Lender in lieu of, or resulting from the conversion of, such Eurodollar Loans.
     (b) For purposes of this Section 2.15, a notice to the Borrower by any Lender shall be effective as to each Eurodollar Loan made by such Lender, if lawful, on the last day of the Interest Period then applicable to such Eurodollar Loan; in all other cases such notice shall be effective on the date of receipt by the Borrower.
     SECTION 2.16. Indemnity. The Borrower shall indemnify each Lender against any loss or expense (but not against any lost profits) that such Lender may sustain or incur as a consequence of (a) any event, other than a default by such Lender in the performance of its

 


 

obligations hereunder, which results in (i) such Lender receiving or being deemed to receive any amount on account of the principal of any Eurodollar Loan prior to the end of the Interest Period in effect therefor, (ii) the conversion of any Eurodollar Loan to an ABR Loan, or the conversion of the Interest Period with respect to any Eurodollar Loan, in each case other than on the last day of the Interest Period in effect therefor, or (iii) any Eurodollar Loan to be made by such Lender (including any Eurodollar Loan to be made pursuant to a conversion or continuation under Section 2.10) not being made after notice of such Loan shall have been given by the Borrower hereunder (any of the events referred to in this clause (a) being called a “Breakage Event”) or (b) any default in the making of any payment or prepayment of any Eurodollar Loan required to be made hereunder. In the case of any Breakage Event, such loss shall include an amount equal to the excess, as reasonably determined by such Lender, of (i) its cost of obtaining funds for the Eurodollar Loan that is the subject of such Breakage Event for the period from the date of such Breakage Event to the last day of the Interest Period in effect (or that would have been in effect) for such Loan over (ii) the amount of interest likely to be realized by such Lender in redeploying the funds released or not utilized by reason of such Breakage Event for such period. A certificate of any Lender setting forth any amount or amounts which such Lender is entitled to receive pursuant to this Section 2.16 shall be delivered to the Borrower and shall be conclusive absent manifest error.
     SECTION 2.17. Pro Rata Treatment. Except as provided below in this Section 2.17 with respect to Swingline Loans and as required under Section 2.13(f) or 2.15, each Borrowing, each payment or prepayment of principal of any Borrowing, each payment of interest on the Loans, each payment of the Commitment Fees, each reduction of the Term Loan Commitments or the Revolving Credit Commitments and each conversion of any Borrowing to or continuation of any Borrowing as a Borrowing of any Type shall be allocated pro rata among the Lenders in accordance with their respective applicable Commitments (or, if such Commitments shall have expired or been terminated, in accordance with the respective principal amounts of their outstanding Loans). For purposes of determining the available Revolving Credit Commitments of the Lenders at any time, each outstanding Swingline Loan shall be deemed to have utilized the Revolving Credit Commitments of the Lenders (including those Lenders which shall not have made Swingline Loans) pro rata in accordance with such respective Revolving Credit Commitments. Each Lender agrees that in computing such Lender’s portion of any Borrowing to be made hereunder, the Administrative Agent may, in its discretion, round each Lender’s percentage of such Borrowing to the next higher or lower whole dollar amount.
     SECTION 2.18. Sharing of Setoffs. Each Lender agrees that if it shall, through the exercise of a right of banker’s lien, setoff or counterclaim against the Borrower or any other Loan Party, or pursuant to a secured claim under Section 506 of Title 11 of the United States Code or other security or interest arising from, or in lieu of, such secured claim, received by such Lender under any applicable bankruptcy, insolvency or other similar law or otherwise, or by any other means (excluding means expressly contemplated elsewhere in this Agreement), obtain payment (voluntary or involuntary) in respect of any Loan or Loans or L/C Disbursement as a result of which the unpaid principal portion of its Loans and participations in L/C Disbursements shall be proportionately less than the unpaid principal portion of the Loans and participations in L/C Disbursements of any other Lender, it shall be deemed simultaneously to have purchased from such other Lender at face value, and shall promptly pay to such other Lender the purchase price for, a participation in the Loans and L/C Exposure of such other Lender, so that the aggregate unpaid principal amount of the Loans and L/C Exposure and participations in Loans

 


 

and L/C Exposure held by each Lender shall be in the same proportion to the aggregate unpaid principal amount of all Loans and L/C Exposure then outstanding as the principal amount of its Loans and L/C Exposure prior to such exercise of banker’s lien, setoff or counterclaim or other event was to the principal amount of all Loans and L/C Exposure outstanding prior to such exercise of banker’s lien, setoff or counterclaim or other event; provided, however, that if any such purchase or purchases or adjustments shall be made pursuant to this Section 2.18 and the payment giving rise thereto shall thereafter be recovered, such purchase or purchases or adjustments shall be rescinded to the extent of such recovery and the purchase price or prices or adjustment restored without interest. The Borrower and Parent expressly consent to the foregoing arrangements and agree that any Lender holding a participation in a Loan or L/C Disbursement deemed to have been so purchased may exercise any and all rights of banker’s lien, setoff or counterclaim with respect to any and all moneys owing by the Borrower and Parent to such Lender by reason thereof as fully as if such Lender had made a Loan directly to the Borrower in the amount of such participation.
     SECTION 2.19. Payments. (a) The Borrower shall make each payment (including principal of or interest on any Borrowing or any L/C Disbursement or any Fees or other amounts) hereunder and under any other Loan Document not later than 1:00 p.m., New York City time, on the date when due in immediately available dollars, without setoff, defense or counterclaim. Each such payment (other than (i) Issuing Bank Fees, which shall be paid directly to the Issuing Bank, and (ii) principal of and interest on Swingline Loans, which shall be paid directly to the Swingline Lender except as otherwise provided in Section 2.22(e)) shall be made to the Administrative Agent at its offices at Eleven Madison Avenue, New York, NY 10010. The Administrative Agent shall promptly distribute to each Lender any payments received by the Administrative Agent on behalf of such Lender.
     (b) Except as otherwise expressly provided herein, whenever any payment (including principal of or interest on any Borrowing or any Fees or other amounts) hereunder or under any other Loan Document shall become due, or otherwise would occur, on a day that is not a Business Day, such payment may be made on the next succeeding Business Day, and such extension of time shall in such case be included in the computation of interest or Fees, if applicable.
     (c) Unless the Administrative Agent shall have received notice from the Borrower prior to the date on which any payment is due to the Administrative Agent for the account of the Lenders or the Issuing Bank hereunder that the Borrower will not make such payment, the Administrative Agent may assume that the Borrower has made such payment on such date in accordance herewith and may, in reliance upon such assumption, distribute to the Lenders or the Issuing Bank, as the case may be, the amount due. In such event, if the Borrower does not in fact make such payment, then each of the Lenders or the Issuing Bank, as the case may be, severally agrees to repay to the Administrative Agent forthwith on demand the amount so distributed to such Lender, and to pay interest thereon, for each day from and including the date such amount is distributed to it to but excluding the date of payment to the Administrative Agent, at a rate determined by the Administrative Agent to represent its cost of overnight or short-term funds (which determination shall be conclusive absent manifest error).
     SECTION 2.20. Taxes. (a) Any and all payments by or on account of any obligation of the Borrower or any other Loan Party hereunder or under any other Loan Document shall be made free and clear of and without deduction for any Indemnified Taxes or Other Taxes;

 


 

provided that, if the Borrower or any other Loan Party shall be required to deduct any Indemnified Taxes or Other Taxes from such payments, then (i) the sum payable shall be increased as necessary so that after making all required deductions (including deductions applicable to additional sums payable under this Section) the Administrative Agent, Lender or Issuing Bank (as the case may be) receives an amount equal to the sum it would have received had no such deductions been made, (ii) the Borrower or such Loan Party shall make such deductions and (iii) the Borrower or such Loan Party shall pay the full amount deducted to the relevant Governmental Authority in accordance with applicable law.
     (b) In addition, the Borrower shall pay any Other Taxes to the relevant Governmental Authority in accordance with applicable law.
     (c) The Borrower shall indemnify the Administrative Agent, each Lender and the Issuing Bank, within 10 days after written demand therefor, for the full amount of any Indemnified Taxes or Other Taxes paid by the Administrative Agent, such Lender or the Issuing Bank, as the case may be, on or with respect to any payment by or on account of any obligation of the Borrower or any other Loan Party hereunder or under any other Loan Document (including Indemnified Taxes or Other Taxes imposed or asserted on or attributable to amounts payable under this Section) and any penalties, interest and reasonable expenses arising therefrom or with respect thereto; provided that the Borrower shall not be obligated to so indemnify any Lender, the Administrative Agent or the Issuing Bank in respect of interest or penalties attributable to any Indemnified Taxes or Other Taxes to the extent that such interest or penalties resulted solely from the gross negligence or willful misconduct of the Administrative Agent or such Lender or the Issuing Bank. A certificate as to the amount of such payment or liability delivered to the Borrower by a Lender or the Issuing Bank, or by the Administrative Agent on behalf of itself, a Lender or the Issuing Bank, shall be conclusive absent manifest error.
     (d) As soon as practicable after any payment of Indemnified Taxes or Other Taxes by the Borrower or any other Loan Party to a Governmental Authority, the Borrower shall deliver to the Administrative Agent the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of the return reporting such payment or other evidence of such payment reasonably satisfactory to the Administrative Agent.
     (e) (i) Any Foreign Lender that is entitled to an exemption from or reduction of withholding tax under the law of the jurisdiction in which the Borrower is located, or any treaty to which such jurisdiction is a party, with respect to payments under this Agreement shall deliver to the Borrower (with a copy to the Administrative Agent), at the time or times prescribed by applicable law, such properly completed and executed documentation prescribed by applicable law or reasonably requested by the Borrower as will permit such payments to be made without withholding or at a reduced rate.
     (ii) If a payment made to a Lender or Issuing Bank under this Agreement or any Loan Document would be subject to U.S. Federal withholding Tax imposed by FATCA if such Lender or Issuing Bank were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472((b) of the Code, as applicable), such Lender or Issuing Bank shall deliver to the Withholding Agent, at the time or times prescribed by law and at such other time or times reasonably requested by the Withholding Agent, such documentation prescribed by applicable law (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Withholding Agent

 


 

as may be necessary for the Withholding Agent to comply with its obligations under FATCA, to determine that such Lender or Issuing Bank has complied with such Lender or Issuing Bank’s obligations under FATCA or to determine the amount to deduct and withhold from such payment.
     SECTION 2.21. Assignment of Commitments Under Certain Circumstances; Duty to Mitigate. (a) In the event (i) any Lender or the Issuing Bank delivers a certificate requesting compensation pursuant to Section 2.14, (ii) any Lender or the Issuing Bank delivers a notice described in Section 2.15, (iii) the Borrower is required to pay any additional amount to any Lender or the Issuing Bank or any Governmental Authority on account of any Lender or the Issuing Bank pursuant to Section 2.20, (iv) any Lender refuses to consent to any amendment, waiver or other modification of any Loan Document requested by the Borrower that requires the consent of a greater percentage of the Lenders than the Required Lenders and such amendment, waiver or other modification is consented to by the Required Lenders, or (v) any Lender becomes a Defaulting Lender, then, in each case, the Borrower may, at its sole expense and effort (including with respect to the processing and recordation fee referred to in Section 9.04(b)), upon notice to such Lender or the Issuing Bank, as the case may be, and the Administrative Agent, require such Lender or the Issuing Bank to transfer and assign, without recourse (in accordance with and subject to the restrictions contained in Section 9.04), all of its interests, rights and obligations under this Agreement (or, in the case of clause (iv) or (v) above, all of its interests, rights and obligations with respect to the Class of Loans or Commitments that is the subject of the related consent, amendment, waiver or other modification or in respect of which such Lender is a Defaulting Lender, as the case may be) to an Eligible Assignee that shall assume such assigned obligations and, with respect to clause (iv) above, shall consent to such requested amendment, waiver or other modification of any Loan Document (which Eligible Assignee may be another Lender, if a Lender accepts such assignment); provided that (x) such assignment shall not conflict with any law, rule or regulation or order of any court or other Governmental Authority having jurisdiction, (y) the Borrower shall have received the prior written consent of the Administrative Agent (and, if a Revolving Credit Commitment is being assigned, of the Issuing Bank and the Swingline Lender), which consents shall not unreasonably be withheld or delayed, and (z) the Borrower or such Eligible Assignee shall have paid to the affected Lender or the Issuing Bank in immediately available funds an amount equal to the sum of the principal of and interest accrued to the date of such payment on the outstanding Loans or L/C Disbursements of such Lender or the Issuing Bank, respectively, plus all Fees (except, in the case of a Defaulting Lender, any Fees not required to be paid to such Defaulting Lender pursuant to the express provisions of this Agreement) and other amounts accrued for the account of such Lender or the Issuing Bank hereunder with respect thereto (including any amounts under Sections 2.14 and 2.16); provided further that, if prior to any such transfer and assignment the circumstances or event that resulted in such Lender’s or the Issuing Bank’s claim for compensation under Section 2.14, notice under Section 2.15 or the amounts paid pursuant to Section 2.20, as the case may be, cease to cause such Lender or the Issuing Bank to suffer increased costs or reductions in amounts received or receivable or reduction in return on capital, or cease to have the consequences specified in Section 2.15, or cease to result in amounts being payable under Section 2.20, as the case may be (including as a result of any action taken by such Lender or the Issuing Bank pursuant to paragraph (b) below), or if such Lender or the Issuing Bank shall waive its right to claim further compensation under Section 2.14 in respect of such circumstances or event or shall withdraw its notice under Section 2.15 or shall waive its right to further payments under Section 2.20 in respect of such circumstances or event or shall consent to

 


 

the proposed amendment, waiver, consent or other modification or shall cease to be a Defaulting Lender, as the case may be, then such Lender or the Issuing Bank shall not thereafter be required to make any such transfer and assignment hereunder. Each Lender hereby grants to the Administrative Agent an irrevocable power of attorney (which power is coupled with an interest) to execute and deliver, on behalf of such Lender as assignor, any Assignment and Acceptance necessary to effectuate any assignment of such Lender’s interests hereunder in the circumstances contemplated by this Section 2.21(a).
     (b) If (i) any Lender or the Issuing Bank shall request compensation under Section 2.14, (ii) any Lender or the Issuing Bank delivers a notice described in Section 2.15 or (iii) the Borrower is required to pay any additional amount to any Lender or the Issuing Bank or any Governmental Authority on account of any Lender or the Issuing Bank, pursuant to Section 2.20, then such Lender or the Issuing Bank shall use reasonable efforts (which shall not require such Lender or the Issuing Bank to incur an unreimbursed loss or unreimbursed cost or expense or otherwise take any action inconsistent with its internal policies or legal or regulatory restrictions or suffer any disadvantage or burden deemed by it to be significant) (x) to file any certificate or document reasonably requested in writing by the Borrower or (y) to assign its rights and delegate and transfer its obligations hereunder to another of its offices, branches or affiliates, if such filing or assignment would reduce its claims for compensation under Section 2.14 or enable it to withdraw its notice pursuant to Section 2.15 or would reduce amounts payable pursuant to Section 2.20, as the case may be, in the future. The Borrower hereby agrees to pay all reasonable costs and expenses incurred by any Lender or the Issuing Bank in connection with any such filing or assignment, delegation and transfer.
     SECTION 2.22. Swingline Loans. (a) Swingline Commitment. Subject to the terms and conditions and relying upon the representations and warranties herein set forth, the Swingline Lender agrees to make loans to the Borrower at any time and from time to time on and after the Closing Date and until the earlier of the Revolving Credit Maturity Date and the termination of the Revolving Credit Commitments, in an aggregate principal amount at any time outstanding that will not result in (i) the aggregate principal amount of all Swingline Loans exceeding $50,000,000 in the aggregate or (ii) the Aggregate Revolving Credit Exposure, after giving effect to any Swingline Loan, exceeding the Total Revolving Credit Commitment. Each Swingline Loan shall be in a principal amount that is an integral multiple of $250,000. The Swingline Commitment may be terminated or reduced from time to time as provided herein. Within the foregoing limits, the Borrower may borrow, pay or prepay and reborrow Swingline Loans hereunder, subject to the terms, conditions and limitations set forth herein.
     (b) Swingline Loans. The Borrower shall notify the Swingline Lender by fax, or by telephone (promptly confirmed by fax), not later than 12:00 (noon), New York City time, on the day of a proposed Swingline Loan. Such notice shall be delivered on a Business Day, shall be irrevocable and shall refer to this Agreement and shall specify the requested date (which shall be a Business Day) and amount of such Swingline Loan and the wire transfer instructions for the account of the Borrower to which the proceeds of the Swingline Loan should be disbursed. The Swingline Lender shall make each Swingline Loan by wire transfer to the account specified in such request.
     (c) Prepayment. The Borrower shall have the right at any time and from time to time to prepay any Swingline Loan, in whole or in part, upon giving written or fax notice (or telephone notice promptly confirmed by written, or fax notice) to the Swingline Lender before

 


 

12:00 (noon), New York City time, on the date of prepayment at the Swingline Lender’s address for notices specified in Section 9.01.
     (d) Interest. Each Swingline Loan shall be an ABR Loan and, subject to the provisions of Section 2.07, shall bear interest as provided in Section 2.06(a).
     (e) Participations. The Swingline Lender may by written notice given to the Administrative Agent not later than 1:00 p.m., New York City time, on any Business Day require the Revolving Credit Lenders to acquire participations on such Business Day in all or a portion of the Swingline Loans outstanding. Such notice shall specify the aggregate amount of Swingline Loans in which Revolving Credit Lenders will participate. The Administrative Agent will, promptly upon receipt of such notice, give notice to each Revolving Credit Lender, specifying in such notice such Lender’s Pro Rata Percentage of such Swingline Loan or Loans. In furtherance of the foregoing, each Revolving Credit Lender hereby absolutely and unconditionally agrees, upon receipt of notice as provided above, to pay to the Administrative Agent, for the account of the Swingline Lender, such Revolving Credit Lender’s Pro Rata Percentage of such Swingline Loan or Loans. Each Revolving Credit Lender acknowledges and agrees that its obligation to acquire participations in Swingline Loans pursuant to this paragraph is absolute and unconditional and shall not be affected by any circumstance whatsoever, including the occurrence and continuance of a Default or an Event of Default, and that each such payment shall be made without any offset, abatement, withholding or reduction whatsoever. Each Revolving Credit Lender shall comply with its obligation under this paragraph by wire transfer of immediately available funds, in the same manner as provided in Section 2.02(c) with respect to Loans made by such Lender (and Section 2.02(c) shall apply, mutatis mutandis, to the payment obligations of the Lenders) and the Administrative Agent shall promptly pay to the Swingline Lender the amounts so received by it from the Lenders. The Administrative Agent shall notify the Borrower of any participations in any Swingline Loan acquired pursuant to this paragraph and thereafter payments in respect of such Swingline Loan shall be made to the Administrative Agent and not to the Swingline Lender. Any amounts received by the Swingline Lender from the Borrower (or other person on behalf of the Borrower) in respect of a Swingline Loan after receipt by the Swingline Lender of the proceeds of a sale of participations therein shall be promptly remitted to the Administrative Agent; any such amounts received by the Administrative Agent shall be promptly remitted by the Administrative Agent to the Lenders that shall have made their payments pursuant to this paragraph and to the Swingline Lender, as their interests may appear. The purchase of participations in a Swingline Loan pursuant to this paragraph shall not relieve the Borrower (or other person liable for obligations of the Borrower) of any default in the payment thereof.
     (f) Defaulting Lenders. If, at any time, a Lender becomes a Defaulting Lender, then (i) if any Swingline Exposure exists at such time, (A) all or any part of the Swingline Exposure of such Defaulting Lender shall be reallocated among the non-Defaulting Lenders in accordance with their respective Pro Rata Percentages, but only to the extent the sum of all non-Defaulting Lenders’ Revolving Credit Exposures plus such Defaulting Lender’s Swingline Exposure and L/C Exposure does not exceed the total of all non-Defaulting Lenders’ Revolving Credit Commitments and (B) if the reallocation described in clause (A) above cannot, or can only partially, be effected, the Borrower shall, within one Business Day following notice by the Administrative Agent, prepay such Swingline Exposure and (ii) so long as such Lender is a Defaulting Lender, (A) the Swingline Lender shall not be required to fund any Swingline Loan,

 


 

unless it is satisfied that the related exposure will be 100% covered by the Commitments of the non-Defaulting Lenders and/or cash collateralized, and (B) participating interests in any newly made Swingline Loan shall be allocated among non-Defaulting Lenders in a manner consistent with clause (i)(A) above (and such Defaulting Lender shall not participate therein).
     SECTION 2.23. Letters of Credit. (a) General. Subject to the terms and conditions herein set forth, the Borrower may request the issuance of a Letter of Credit for its own account or for the account of any of the Subsidiaries (in which case the Borrower and such Subsidiary shall be co-applicants with respect to such Letter of Credit), in a form reasonably acceptable to the Administrative Agent and the Issuing Bank, at any time and from time to time while the L/C Commitment remains in effect. This Section shall not be construed to impose an obligation upon the Issuing Bank to issue any Letter of Credit that is inconsistent with the terms and conditions of this Agreement. Notwithstanding anything to the contrary contained in this Section 2.23 or elsewhere in this Agreement, in the event that a Revolving Credit Lender is a Defaulting Lender, no Issuing Bank shall be required to issue any Letter of Credit unless such Issuing Bank has entered into arrangements reasonably satisfactory to it and the Borrower to eliminate such Issuing Bank’s risk with respect to the participation in Letters of Credit by all such Defaulting Lenders, including by cash collateralizing each such Defaulting Lender’s Pro Rata Percentage of the applicable L/C Exposure.
     (b) Notice of Issuance, Amendment, Renewal, Extension; Certain Conditions. In order to request the issuance of a Letter of Credit (or to amend, renew or extend an existing Letter of Credit), the Borrower shall hand deliver or fax to the Issuing Bank and the Administrative Agent (reasonably in advance of the requested date of issuance, amendment, renewal or extension) a notice requesting the issuance of a Letter of Credit, or identifying the Letter of Credit to be amended, renewed or extended, the date of issuance, amendment, renewal or extension, the date on which such Letter of Credit is to expire (which shall comply with paragraph (c) below), the amount of such Letter of Credit, the name and address of the beneficiary thereof and such other information as shall be necessary to prepare such Letter of Credit. A Letter of Credit shall be issued, amended, renewed or extended only if, and upon issuance, amendment, renewal or extension of each Letter of Credit the Borrower shall be deemed to represent and warrant that, after giving effect to such issuance, amendment, renewal or extension (i) the L/C Exposure shall not exceed $350,000,000 and (ii) the Aggregate Revolving Credit Exposure shall not exceed the Total Revolving Credit Commitment.
     (c) Expiration Date. Each Letter of Credit shall expire at the close of business on the earlier of the date one year after the date of the issuance of such Letter of Credit and the date that is five Business Days prior to the Revolving Credit Maturity Date, unless such Letter of Credit expires by its terms on an earlier date; provided, however, that a Letter of Credit may, upon the request of the Borrower, include a provision whereby such Letter of Credit shall be renewed automatically for additional consecutive periods of 12 months or less (but not beyond the date that is five Business Days prior to the Revolving Credit Maturity Date) unless the Issuing Bank notifies the beneficiary thereof at least 30 days (or such longer period as may be specified in such Letter of Credit) prior to the then-applicable expiration date that such Letter of Credit will not be renewed.
     (d) Participations. By the issuance of a Letter of Credit and without any further action on the part of the Issuing Bank or the Lenders, the Issuing Bank hereby grants to each Revolving Credit Lender, and each such Lender hereby acquires from the Issuing Bank, a participation in

 


 

such Letter of Credit equal to such Lender’s Pro Rata Percentage of the aggregate amount available to be drawn under such Letter of Credit, effective upon the issuance of such Letter of Credit or, in the case of the Existing Letters of Credit, effective upon the Restatement Effective Date. In consideration and in furtherance of the foregoing, each Revolving Credit Lender hereby absolutely and unconditionally agrees to pay to the Administrative Agent, for the account of the Issuing Bank, such Lender’s Pro Rata Percentage of each L/C Disbursement made by the Issuing Bank and not reimbursed by the Borrower (or, if applicable, another party pursuant to its obligations under any other Loan Document) forthwith on the date due as provided in Section 2.02(f). Each Revolving Credit Lender acknowledges and agrees that its obligation to acquire participations pursuant to this paragraph in respect of Letters of Credit is absolute and unconditional and shall not be affected by any circumstance whatsoever, including the occurrence and continuance of a Default or an Event of Default, and that each such payment shall be made without any offset, abatement, withholding or reduction whatsoever.
     (e) Reimbursement. If the Issuing Bank shall make any L/C Disbursement in respect of a Letter of Credit, the Borrower shall pay to the Administrative Agent an amount equal to such L/C Disbursement not later than 1:00 p.m., New York City time, on the immediately following Business Day after the Issuing Bank notifies the Borrower thereof.
     (f) Obligations Absolute. The Borrower’s obligations to reimburse L/C Disbursements as provided in paragraph (e) above shall be absolute, unconditional and irrevocable, and shall be performed strictly in accordance with the terms of this Agreement, under any and all circumstances whatsoever, and irrespective of:
     (i) any lack of validity or enforceability of any Letter of Credit or any Loan Document, or any term or provision therein;
     (ii) any amendment or waiver of or any consent to departure from all or any of the provisions of any Letter of Credit or any Loan Document;
     (iii) the existence of any claim, setoff, defense or other right that the Borrower, any other party guaranteeing, or otherwise obligated with, the Borrower, any Subsidiary or other Affiliate thereof or any other person may at any time have against the beneficiary under any Letter of Credit, the Issuing Bank, the Administrative Agent or any Lender or any other person, whether in connection with this Agreement, any other Loan Document or any other related or unrelated agreement or transaction;
     (iv) any draft or other document presented under a Letter of Credit proving to be forged, fraudulent, invalid or insufficient in any respect or any statement therein being untrue or inaccurate in any respect;
     (v) payment by the Issuing Bank under a Letter of Credit against presentation of a draft or other document that does not comply with the terms of such Letter of Credit; and
     (vi) any other act or omission to act or delay of any kind of the Issuing Bank, the Lenders, the Administrative Agent or any other person or any other event or circumstance whatsoever, whether or not similar to any of the foregoing, that might, but for the provisions of this Section, constitute a legal or equitable discharge of the Borrower’s obligations hereunder.

 


 

     Without limiting the generality of the foregoing, it is expressly understood and agreed that the absolute and unconditional obligation of the Borrower hereunder to reimburse L/C Disbursements will not be excused by the gross negligence or willful misconduct of the Issuing Bank. However, the foregoing shall not be construed to excuse the Issuing Bank from liability to the Borrower to the extent of any direct damages (as opposed to consequential damages, claims in respect of which are hereby waived by the Borrower to the extent permitted by applicable law) suffered by the Borrower that are caused by the Issuing Bank’s gross negligence, bad faith or willful misconduct in determining whether drafts and other documents presented under a Letter of Credit comply with the terms thereof. It is further understood and agreed that the Issuing Bank may accept documents that appear on their face to be in order, without responsibility for further investigation, regardless of any notice or information to the contrary and, in making any payment under any Letter of Credit (i) the Issuing Bank’s exclusive reliance on the documents presented to it under such Letter of Credit as to any and all matters set forth therein, including reliance on the amount of any draft presented under such Letter of Credit, whether or not the amount due to the beneficiary thereunder equals the amount of such draft and whether or not any document presented pursuant to such Letter of Credit proves to be insufficient in any respect, if such document on its face appears to be in order, and whether or not any other statement or any other document presented pursuant to such Letter of Credit proves to be forged or invalid or any statement therein proves to be inaccurate or untrue in any respect whatsoever and (ii) any noncompliance in any immaterial respect of the documents presented under such Letter of Credit with the terms thereof shall, in each case, be deemed not to constitute gross negligence or willful misconduct of the Issuing Bank.
     (g) Disbursement Procedures. The Issuing Bank shall, promptly following its receipt thereof, examine all documents purporting to represent a demand for payment under a Letter of Credit. The Issuing Bank shall as promptly as possible give telephonic notification, confirmed by fax, to the Administrative Agent and the Borrower of such demand for payment and whether the Issuing Bank has made or will make an L/C Disbursement thereunder; provided that any failure to give or delay in giving such notice shall not relieve the Borrower of its obligation to reimburse the Issuing Bank and the Revolving Credit Lenders with respect to any such L/C Disbursement.
     (h) Interim Interest. If the Issuing Bank shall make any L/C Disbursement in respect of a Letter of Credit, then, unless the Borrower shall reimburse such L/C Disbursement in full on such date, the unpaid amount thereof shall bear interest for the account of the Issuing Bank, for each day from and including the date of such L/C Disbursement, to but excluding the earlier of the date of payment by the Borrower or the date on which interest shall commence to accrue thereon as provided in Section 2.02(f), at the rate per annum that would apply to such amount if such amount were an ABR Revolving Loan.
     (i) Resignation or Removal of the Issuing Bank. The Issuing Bank may resign at any time by giving 30 days’ prior written notice to the Administrative Agent, the Lenders and the Borrower, and may be removed at any time by the Borrower by notice to the Issuing Bank, the Administrative Agent and the Lenders. Upon the acceptance of any appointment as the Issuing Bank hereunder by a Lender that shall agree to serve as successor Issuing Bank, such successor shall succeed to and become vested with all the interests, rights and obligations of the retiring Issuing Bank. At the time such removal or resignation shall become effective, the Borrower shall pay all accrued and unpaid fees pursuant to Section 2.05(c)(ii). The acceptance of any

 


 

appointment as the Issuing Bank hereunder by a successor Lender shall be evidenced by an agreement entered into by such successor, in a form satisfactory to the Borrower and the Administrative Agent, and, from and after the effective date of such agreement, (i) such successor Lender shall have all the rights and obligations of the previous Issuing Bank under this Agreement and the other Loan Documents and (ii) references herein and in the other Loan Documents to the term “Issuing Bank” shall be deemed to refer to such successor or to any previous Issuing Bank, or to such successor and all previous Issuing Banks, as the context shall require. After the resignation or removal of the Issuing Bank hereunder, the retiring Issuing Bank shall remain a party hereto and shall continue to have all the rights and obligations of an Issuing Bank under this Agreement and the other Loan Documents with respect to Letters of Credit issued by it prior to such resignation or removal, but shall not be required to issue additional Letters of Credit.
     (j) Cash Collateralization. If any Event of Default shall occur and be continuing, the Borrower shall, on the Business Day it receives notice from the Administrative Agent or the Required Lenders (or, if the maturity of the Loans has been accelerated, Revolving Credit Lenders holding participations in outstanding Letters of Credit representing greater than 50% of the aggregate undrawn amount of all outstanding Letters of Credit) thereof and of the amount to be deposited, deposit in an account with the Collateral Agent, for the benefit of the Revolving Credit Lenders, an amount in cash equal to the L/C Exposure as of such date. Such deposit shall be held by the Collateral Agent as collateral for the payment and performance of the Obligations. The Collateral Agent shall have exclusive dominion and control, including the exclusive right of withdrawal, over such account. Other than any interest earned on the investment of such deposits in Permitted Investments, which investments shall be made at the option and sole discretion of the Collateral Agent, such deposits shall not bear interest. Interest or profits, if any, on such investments shall accumulate in such account. Moneys in such account shall (i) automatically be applied by the Administrative Agent to reimburse the Issuing Bank for L/C Disbursements for which it has not been reimbursed, (ii) be held for the satisfaction of the reimbursement obligations of the Borrower for the L/C Exposure at such time and (iii) if the maturity of the Loans has been accelerated (but subject to the consent of Revolving Credit Lenders holding participations in outstanding Letters of Credit representing greater than 50% of the aggregate undrawn amount of all outstanding Letters of Credit), be applied to satisfy the Obligations. If the Borrower is required to provide an amount of cash collateral hereunder as a result of the occurrence of an Event of Default, such amount (to the extent not applied as aforesaid) shall be returned to the Borrower within three Business Days after all Events of Default have been cured or waived. Notwithstanding the foregoing, following the incurrence by the Borrower or any Subsidiary of any Pari Passu Debt, the treatment and application of any amounts provided by the Borrower as cash collateral hereunder shall be subject to the terms and provisions of any applicable Pari Passu Intercreditor Agreement and, in the event of any conflict between the terms of such Pari Passu Intercreditor Agreement and the terms of this paragraph (j), the terms of such Pari Passu Intercreditor Agreement shall govern.
     (k) Additional Issuing Banks. The Borrower may, at any time and from time to time with the consent of the Administrative Agent (which consent shall not be unreasonably withheld or delayed) and such Lender, designate one or more additional Lenders to act as an issuing bank under the terms of this Agreement. Any Lender designated as an issuing bank pursuant to this paragraph (k) shall be deemed to be an “Issuing Bank” (in addition to being a Lender) in respect

 


 

of Letters of Credit issued or to be issued by such Lender, and, with respect to such Letters of Credit, such term shall thereafter apply to the other Issuing Bank and such Lender.
     SECTION 2.24. Incremental Term Loans. (a) The Borrower may, by written notice to the Administrative Agent from time to time, request Incremental Term Loan Commitments in an amount not to exceed the Incremental Term Loan Amount from one or more Incremental Term Lenders, which may include any existing Lender; provided that each Incremental Term Lender, if not already a Lender hereunder, shall be subject to the approval of the Administrative Agent (which approval shall not be unreasonably withheld or delayed). Such notice shall set forth (i) the amount of the Incremental Term Loan Commitments being requested (which shall be in minimum increments of $1,000,000 and a minimum amount of $25,000,000 or such lesser amount equal to the remaining Incremental Term Loan Amount), (ii) the date on which such Incremental Term Loan Commitments are requested to become effective (which shall not be less than 10 days nor more than 60 days after the date of such notice, unless otherwise agreed to by the Administrative Agent), and (iii) whether such Incremental Term Loan Commitments are commitments to make additional Extended Term Loans or commitments to make term loans with terms different from the Extended Term Loans, including Other Term A Loans (“Other Term Loans”).
     (b) The Borrower and each Incremental Term Lender shall execute and deliver to the Administrative Agent an Incremental Term Loan Assumption Agreement and such other documentation as the Administrative Agent shall reasonably specify to evidence the Incremental Term Loan Commitment of each Incremental Term Lender. Each Incremental Term Loan Assumption Agreement shall specify the terms of the Incremental Term Loans to be made thereunder; provided that, without the prior written consent of the Required Lenders, (i) the final maturity date of any Other Term Loans (other than any Other Term A Loans) shall be no earlier than the Extended Term Loan Maturity Date, (ii) the average life to maturity of the Other Term Loans (other than any Other Term A Loans) shall be no shorter than the average life to maturity of the Term Loans and (iii) if the initial yield (excluding upfront or arrangement fees payable to the arranger, if any, of such loan) on such Other Term Loans (as determined by the Administrative Agent to be equal to the sum of (x) the margin above the Adjusted LIBO Rate on such Other Term Loans (which shall be increased by the amount that any “LIBOR floor” applicable to such Other Term Loans on the date such Other Term Loans are made would exceed the Adjusted LIBO Rate that would be in effect for a three-month Interest Period commencing on such date and (y) if such Other Term Loans are initially made at a discount or the Lenders making the same (as opposed to the arranger, if any, thereof) receive a fee directly or indirectly from Parent, the Borrower or any Subsidiary for doing so (the amount of such discount or fee, expressed as a percentage of the Other Term Loans, being referred to herein as “OID”), the amount of such OID divided by the lesser of (A) the average life to maturity of such Other Term Loans and (B) four) exceeds by more than 50 basis points the sum of (1) the margin then in effect for Eurodollar Term Loans of any Class (other than Other Term A Loans) (which shall be the sum of the Applicable Percentage for Eurodollar Term Loans of such Class increased by the amount that any “LIBOR floor” applicable to such Eurodollar Term Loans on such date would exceed the Adjusted LIBO Rate that would be in effect for a three-month Interest Period commencing on such date) plus (2) the OID (if any) initially paid in respect of such Term Loans (for any Class of Term Loans, the applicable amount of such excess above 50 basis points being referred to herein as the “Yield Differential”) then the Applicable Percentage then in effect for Eurodollar Term Loans of any Class, then the Applicable Percentage then in effect for such Class

 


 

of Term Loans shall automatically be increased by the applicable Yield Differential, effective upon the making of the Other Term Loans. The Administrative Agent shall promptly notify each Lender as to the effectiveness of each Incremental Term Loan Assumption Agreement. Each of the parties hereto hereby agrees that, upon the effectiveness of any Incremental Term Loan Assumption Agreement, this Agreement shall be deemed amended to the extent (but only to the extent) necessary to reflect the existence and terms of the Incremental Term Loan Commitment and the Incremental Term Loans evidenced thereby.
     (c) Notwithstanding the foregoing, no Incremental Term Loan Commitment shall become effective under this Section 2.24 unless (i) on the date of such effectiveness, the conditions set forth in paragraphs (b) and (c) of Section 4.01 shall be satisfied and the Administrative Agent shall have received a certificate to that effect dated such date and executed by a Financial Officer of the Borrower, (ii) except as otherwise specified in the applicable Incremental Term Loan Assumption Agreement, the Administrative Agent shall have received legal opinions, board resolutions and other closing certificates reasonably requested by the Administrative Agent and consistent with those delivered on the Closing Date under Section 4.02 of the Original Credit Agreement and (iii) immediately after giving effect to the incurrence of such Incremental Term Loans and the use of the proceeds thereof, the Secured Leverage Ratio Condition would be satisfied.
     (d) Each of the parties hereto hereby agrees that the Administrative Agent may, in consultation with the Borrower, take any and all action as may be reasonably necessary to ensure that all Incremental Term Loans (other than Other Term Loans), when originally made, are included in each Borrowing of outstanding Extended Term Loans on a pro rata basis. This may be accomplished by requiring each outstanding Eurodollar Extended Term Borrowing to be converted into an ABR Term Borrowing on the date of each Incremental Term Loan, or by allocating a portion of each Incremental Term Loan to each outstanding Eurodollar Extended Term Borrowing on a pro rata basis. Any conversion of Eurodollar Term Loans to ABR Term Loans required by the preceding sentence shall be subject to Section 2.16. If any Incremental Term Loan is to be allocated to an existing Interest Period for a Eurodollar Term Borrowing, then the interest rate thereon for such Interest Period and the other economic consequences thereof shall be as set forth in the applicable Incremental Term Loan Assumption Agreement. In addition, to the extent any Incremental Term Loans are not Other Term Loans, the scheduled amortization payments under Section 2.11(a)(iii) required to be made after the making of such Incremental Term Loans shall be ratably increased by the aggregate principal amount of such Incremental Term Loans.
     SECTION 2.25. Revolving Credit Loan Modification Offers. (a) The Borrower may, by written notice to the Administrative Agent from time to time, make one or more offers (each, a “Revolving Credit Loan Modification Offer”) to all the Revolving Credit Lenders to make one or more Permitted Amendments pursuant to procedures reasonably specified by the Administrative Agent and reasonably acceptable to the Borrower. Such notice shall set forth (i) the terms and conditions of the requested Permitted Amendment and (ii) the date on which such Permitted Amendment is requested to become effective (which shall not be less than 10 Business Days nor more than 30 Business Days after the date of such notice, unless otherwise agreed to by the Administrative Agent). Permitted Amendments shall become effective only with respect to the Loans and Commitments of the Revolving Credit Lenders that accept the

 


 

applicable Revolving Credit Loan Modification Offer (such Lenders, the “Accepting Revolving Credit Lenders”).
     (b) The Borrower and each Accepting Revolving Credit Lender shall execute and deliver to the Administrative Agent a Revolving Credit Loan Modification Agreement and such other documentation as the Administrative Agent shall reasonably specify to evidence the acceptance of the Permitted Amendments and the terms and conditions thereof. The Administrative Agent shall promptly notify each Lender as to the effectiveness of each Revolving Credit Loan Modification Agreement. Each of the parties hereto hereby agrees that, upon the effectiveness of any Revolving Credit Loan Modification Agreement, this Agreement shall be deemed amended to the extent (but only to the extent) necessary to reflect the existence and terms of the Permitted Amendment evidenced thereby and only with respect to the Loans and Commitments of the Accepting Revolving Credit Lenders, including any amendments necessary to treat the applicable Loans and/or Commitments of the Accepting Revolving Credit Lenders as a new “Class” of loans and/or commitments hereunder. Notwithstanding the foregoing, no Permitted Amendment shall become effective unless the Administrative Agent, to the extent reasonably requested by the Administrative Agent, shall have received legal opinions, board resolutions, officer’s and secretary’s certificates and other documentation consistent with those delivered on the Restatement Effective Date under the Amendment and Restatement Agreement.
     (c) “Permitted Amendments” means any or all of the following: (i) an extension of the Revolving Credit Maturity Date applicable to the Loans and/or Commitments of the Accepting Revolving Credit Lenders, (ii) an increase in the Applicable Percentage with respect to the Loans and/or Commitments of the Accepting Revolving Credit Lenders, (iii) the inclusion of additional fees to be payable to the Accepting Revolving Credit Lenders, (iv) such amendments to this Agreement and the other Loan Documents as shall be appropriate, in the reasonable judgment of the Administrative Agent, to provide the rights and benefits of this Agreement and other Loan Documents to each new “Class” of loans and/or commitments resulting therefrom, provided that (A) the allocation of the participation exposure with respect to any then-existing or subsequently issued or made Letter of Credit or Swingline Loan as between the commitments of such new “Class” and the Commitments of the then-existing Revolving Credit Lenders shall be made on a ratable basis as between the commitments of such new “Class” and the Commitments of the then-existing Revolving Credit Lenders and (B) the L/C Commitment and Swingline Commitment may not be extended without the prior written consent of the Issuing Bank or the Swingline Lender, as applicable, and (v) such other amendments to this Agreement and the other Loan Documents as shall be appropriate, in the judgment of the Administrative Agent, to give effect to the foregoing Permitted Amendments.
ARTICLE III
Representations and Warranties
     Each of Parent and the Borrower represents and warrants to the Administrative Agent, the Collateral Agent, the Issuing Bank and each of the Lenders that:
     SECTION 3.01. Organization; Powers. Each of the Loan Parties (a) is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization, except, with respect to Loan Parties other than Parent or the Borrower, to the extent that the failure of such Loan Parties to be in good standing could not reasonably be expected to have a

 


 

Material Adverse Effect, (b) has all requisite power and authority to own its property and assets and to carry on its business as now conducted and as proposed to be conducted, except to the extent that the failure to possess such power and authority could not reasonably be expected to result in a Material Adverse Effect, (c) is qualified to do business in, and is in good standing in, every jurisdiction where such qualification is required, except where the failure so to qualify could not reasonably be expected to result in a Material Adverse Effect, and (d) has the power and authority to execute, deliver and perform its obligations under each of the Loan Documents and each other agreement or instrument contemplated thereby to which it is or will be a party and, in the case of the Borrower, to borrow hereunder.
     SECTION 3.02. Authorization. The execution, delivery and performance by the Loan Parties of the Loan Documents to which they are a party and the making of the Borrowings hereunder (a) have been duly authorized by all requisite corporate and, if required, stockholder action and (b) will not (i) violate (A) any provision of law, statute, rule or regulation, or of the certificate or articles of incorporation or other constitutive documents or by-laws of Parent, the Borrower or any Subsidiary, (B) any order of any Governmental Authority or (C) any provision of any indenture, agreement or other instrument to which Parent, the Borrower or any Subsidiary is a party or by which any of them or any of their property is or may be bound, except as could not reasonably be expected to result in a Material Adverse Effect, (ii) be in conflict with, result in a breach of or constitute (alone or with notice or lapse of time or both) a default under, or give rise to any right to accelerate or to require the prepayment, repurchase or redemption of any obligation under any such indenture, agreement or other instrument, except as could not reasonably be expected to result in a Material Adverse Effect or (iii) result in the creation or imposition of any Lien upon or with respect to any property or assets now owned or hereafter acquired by Parent, the Borrower or any Subsidiary (other than any Lien created hereunder or under the Security Documents or permitted pursuant to Section 6.02).
     SECTION 3.03. Enforceability. This Agreement has been duly executed and delivered by Parent and the Borrower and constitutes, and each other Loan Document when executed and delivered by each Loan Party thereto will constitute, a legal, valid and binding obligation of such Loan Party enforceable against such Loan Party in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, or similar laws affecting creditors’ rights generally and by general principles of equity (regardless of whether enforcement is sought in a proceeding in equity or at law).
     SECTION 3.04. Governmental Approvals. No action, consent or approval of, registration or filing with or any other action by any Governmental Authority is or will be required in connection with the execution, delivery and performance by the Loan Parties of the Loan Documents to which they are a party and the making of the Borrowings hereunder, except for (a) the filing of Uniform Commercial Code financing statements and filings with the United States Patent and Trademark Office and the United States Copyright Office, (b) recordation of the Mortgages and other filings and recordings in respect of Liens created pursuant to the Security Documents, (c) such as have been made or obtained and are in full force and effect and (d) such actions, consents, approvals, registrations or filings which the failure to obtain or make could not reasonably be expected to result in a Material Adverse Effect.
     SECTION 3.05. Financial Statements. Parent has heretofore furnished to the Lenders its consolidated balance sheets and related statements of income, stockholders’ equity and cash flows of Parent as of and for the 2009 fiscal year, audited by and accompanied by the opinion of

 


 

Deloitte & Touche LLP, independent public accountant, and (ii) as of and for each 2010 fiscal quarter of Parent thereafter ended at least 45 days prior to the Restatement Effective Date. Such financial statements present fairly in all material respects the financial condition and results of operations and cash flows of Parent and its consolidated subsidiaries as of such dates and for such periods. Such balance sheets and the notes thereto disclose all material liabilities, direct or contingent, of Parent and its consolidated subsidiaries as of the dates thereof in accordance with GAAP in all material respects. Such financial statements were prepared in accordance with GAAP applied on a consistent basis in all material respects, subject, in the case of unaudited financial statements, to year-end audit adjustments and the absence of footnotes.
     SECTION 3.06. No Material Adverse Change. No event, change or condition has occurred that has had, or could reasonably be expected to have, a material adverse effect on the business, assets, operations, financial condition or operating results of Parent, the Borrower and the Subsidiaries, taken as a whole, since December 31, 2009.
     SECTION 3.07. Title to Properties; Possession Under Leases. (a) Each of Parent, the Borrower and the Subsidiaries has good and marketable title to, or valid leasehold interests in, or a right to use, all its material properties and assets (including all Mortgaged Property), except for minor defects in title that do not interfere with its ability to conduct its business as currently conducted or to utilize such properties and assets for their intended purposes. All such material properties and assets are free and clear of Liens, other than Liens expressly permitted by Section 6.02.
     (b) As of the Restatement Effective Date, neither Parent nor the Borrower has received any notice of, nor has any knowledge of, any pending or contemplated material condemnation proceeding affecting the Mortgaged Properties in any material respect or any sale or disposition thereof in lieu of condemnation.
     (c) As of the Restatement Effective Date, none of Parent, the Borrower or any of the Subsidiaries is obligated under any right of first refusal, option or other contractual right to sell, assign or otherwise dispose of any Mortgaged Property or any material interest therein, except for customary rights of first refusal granted to the prior owners of such Mortgaged Property or their Affiliates.
     SECTION 3.08. Subsidiaries. Schedule 3.08 sets forth as of the Restatement Effective Date a list of all Subsidiaries and the percentage ownership interest of Parent or the Borrower therein. The shares of capital stock or other ownership interests so indicated on Schedule 3.08 are, in the case of corporations, fully paid and non-assessable and are owned by Parent or the Borrower, directly or indirectly, free and clear of all Liens (other than Liens created under the Security Documents or permitted pursuant to Section 6.02).
     SECTION 3.09. Litigation; Compliance with Laws. (a) Except as disclosed in the periodic and other reports, proxy statements and other materials filed by Parent, the Borrower or any Subsidiary with the SEC prior to the Restatement Effective Date, there are no actions, suits or proceedings at law or in equity or by or before any Governmental Authority now pending or, to the knowledge of Parent or the Borrower through receipt of written notice or proceeding, threatened against or affecting Parent or the Borrower or any Subsidiary or any business, property or rights of any such person as to which there is a reasonable possibility of an adverse

 


 

determination and that, if adversely determined, could reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect.
     (b) None of Parent, the Borrower or any of the Subsidiaries or any of their respective material properties or assets is in violation of, nor will the continued operation of their material properties and assets as currently conducted violate, any law, rule or regulation (including any occupational safety and health, health care, pension, certificate of need, Medicare, Medicaid, insurance fraud or similar law, zoning, building, Environmental Law, ordinance, code or approval or any building permits) or any restrictions of record or agreements affecting the Mortgaged Property, or is in default with respect to any judgment, writ, injunction, decree or order of any Governmental Authority, where such violation or default could reasonably be expected to result in a Material Adverse Effect.
     SECTION 3.10. Agreements. None of Parent, the Borrower or any of the Subsidiaries is in default in any manner under any provision of any indenture or other agreement or instrument evidencing Indebtedness, or any other material agreement or instrument to which it is a party or by which it or any of its properties or assets are or may be bound, where such default could reasonably be expected to result in a Material Adverse Effect.
     SECTION 3.11. Federal Reserve Regulations. (a) None of Parent, the Borrower or any of the Subsidiaries is engaged principally, or as one of its important activities, in the business of extending credit for the purpose of buying or carrying Margin Stock.
     (b) No part of the proceeds of any Loan or any Letter of Credit will be used, whether directly or indirectly, and whether immediately, incidentally or ultimately, for any purpose that entails a violation of, or that is inconsistent with, the provisions of the Regulations of the Board, including Regulation T, U or X.
     SECTION 3.12. Investment Company Act. None of Parent, the Borrower or any Subsidiary is an “investment company” as defined in, or subject to regulation under, the Investment Company Act of 1940.
     SECTION 3.13. Use of Proceeds. The Borrower will (a) use the proceeds of the Loans and will request the issuance of Letters of Credit only for the purposes specified in the preliminary statement to this Agreement and (b) use the proceeds of Incremental Term Loans only for the purposes specified in the applicable Incremental Term Loan Assumption Agreement.
     SECTION 3.14. Tax Returns. Each of Parent, the Borrower and the Subsidiaries has filed or caused to be filed, or has timely requested an extension to file or has received an approved extension to file, all Federal, state, local and foreign tax returns or materials that to the Borrower’s best knowledge are required to have been filed by it and has paid or caused to be paid all taxes due and payable by it and all assessments received by it, except taxes that are being contested in good faith by appropriate proceedings and for which Parent, the Borrower or such Subsidiary, as applicable, shall have set aside on its books reserves in accordance with GAAP and except any such filings or taxes, fees or charges, the failure of which to make or pay, could not reasonably be expected to have a Material Adverse Effect.
     SECTION 3.15. No Material Misstatements. None of (a) the Confidential Information Memorandum or (b) any other written information, report, financial statement, exhibit or

 


 

schedule (other than estimates and information of a general economic or general industry nature) heretofore or contemporaneously furnished by or on behalf of Parent or the Borrower to the Administrative Agent or any Lender in connection with the negotiation of any Loan Document or included therein or delivered pursuant thereto, when furnished and taken as a whole, contained, contains or will contain any material misstatement of fact or omitted, omits or will omit to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were, are or will be made, not materially misleading in light of the circumstances under which such statements were made; provided that to the extent any such information, report, financial statement, exhibit or schedule was based upon or constitutes a forecast or projection, each of Parent and the Borrower represents only that it acted in good faith and utilized assumptions that each of Parent and the Borrower believed to be reasonable at the time made.
     SECTION 3.16. Employee Benefit Plans. Each of the Borrower and its ERISA Affiliates is in compliance in all material respects with the applicable provisions of ERISA and the Code and the regulations and published interpretations thereunder. No ERISA Event has occurred or is reasonably expected to occur that, when taken together with all other such ERISA Events, could reasonably be expected to result in material liability of the Borrower or any of its ERISA Affiliates. The present value of all benefit liabilities under each Plan (based on the assumptions used for purposes of Statement of Financial Accounting Standards Board Accounting Standards Codification Topic 715) did not, as of the last annual valuation date applicable thereto, exceed the fair market value of the assets of such Plan in such amount that could reasonably be expected to result in a Material Adverse Effect, and the present value of all benefit liabilities of all underfunded Plans (based on the assumptions used for purposes of Financial Accounting Standards Board Accounting Standards Codification Topic 715) did not, as of the last annual valuation dates applicable thereto, exceed the fair market value of the assets of all such underfunded Plans in such amount that could reasonably be expected to result in a Material Adverse Effect.
     SECTION 3.17. Environmental Matters. Except with respect to any matters that, individually or in the aggregate, could not reasonably be expected to result in a Material Adverse Effect, none of Parent, the Borrower or any of the Subsidiaries (i) has failed to comply with any Environmental Law or to obtain, maintain or comply with any permit, license or other approval required under any Environmental Law, (ii) has become subject to any Environmental Liability, (iii) has received notice of any claim with respect to any Environmental Liability or (iv) knows of any basis for any Environmental Liability.
     SECTION 3.18. Insurance. Schedule 3.18 sets forth a true, complete and correct description, in all material respects, of all insurance maintained by Parent or by Parent or the Borrower for itself or the Subsidiaries as of the Restatement Effective Date. As of the Restatement Effective Date, such insurance is in full force and effect and all premiums have been duly paid. Parent, the Borrower and the Subsidiaries have insurance in such amounts and covering such risks and liabilities as are in accordance with normal industry practice.
     SECTION 3.19. Security Documents. (a) The Guarantee and Collateral Agreement, upon execution and delivery thereof by the parties thereto, will create in favor of the Collateral Agent, for the ratable benefit of the Secured Parties, a legal, valid and enforceable security interest in the Collateral (as defined in the Guarantee and Collateral Agreement) and the proceeds thereof, subject to the effects of bankruptcy, insolvency or similar laws affecting

 


 

creditors’ rights generally and general equitable principles, and (i) when the Pledged Collateral (as defined in the Guarantee and Collateral Agreement) is delivered to the Collateral Agent, the Lien created under the Guarantee and Collateral Agreement shall constitute a fully perfected first priority Lien on, and security interest in, all right, title and interest of the Loan Parties in such Pledged Collateral as to which perfection may be obtained by such actions, in each case prior and superior in right to any other person, and (ii) when financing statements in appropriate form are filed in the offices specified on Schedule 3.19(a) (as such schedule may be updated from time to time; provided, that such schedules shall be deemed to be updated when the Borrower provides the relevant information in accordance with the Guarantee and Collateral Agreement), the Lien created under the Guarantee and Collateral Agreement will constitute a fully perfected Lien on, and security interest in, all right, title and interest of the Loan Parties in such Collateral (other than Intellectual Property, as defined in the Guarantee and Collateral Agreement) as to which perfection may be obtained by such filings, in each case prior and superior in right to any other person, other than with respect to Liens expressly permitted by Section 6.02.
     (b) Upon the timely recordation of the Guarantee and Collateral Agreement (or a short-form security agreement in form and substance reasonably satisfactory to the Borrower and the Collateral Agent) with the United States Patent and Trademark Office and the United States Copyright Office, together with the financing statements in appropriate form filed in the offices specified on Schedule 3.19(a) (as such schedule may be updated from time to time; provided, that such schedules shall be deemed to be updated when the Borrower provides the relevant information in accordance with the Guarantee and Collateral Agreement), the Lien created under the Guarantee and Collateral Agreement shall constitute a fully perfected Lien on, and security interest in, all right, title and interest of the Loan Parties in the Intellectual Property (as defined in the Guarantee and Collateral Agreement) in which a security interest may be perfected by filing security agreements in the United States and its territories and possessions, in each case prior and superior in right to any other person other than with respect to Liens permitted pursuant to Section 6.02 (it being understood that subsequent recordings in the United States Patent and Trademark Office and the United States Copyright Office may be necessary to perfect a Lien on registered trademarks and patents, trademark and patent applications and registered copyrights acquired by the Loan Parties after the Closing Date).
     (c) The Mortgages are effective to create in favor of the Collateral Agent, for the ratable benefit of the Secured Parties a legal, valid and enforceable Lien on all of the Loan Parties’ right, title and interest in and to the Mortgaged Property thereunder and the proceeds thereof, and when the Mortgages are filed in the offices specified on Schedule 3.19(c), the Mortgages shall constitute a fully perfected Lien on, and security interest in, all right, title and interest of the Loan Parties in such Mortgaged Property and the proceeds thereof, in each case prior and superior in right to any other person, other than with respect to the rights of persons pursuant to Liens expressly permitted by Section 6.02.
     SECTION 3.20. Location of Real Property and Leased Premises. (a) Schedule 1.01(d) lists completely and correctly as of the Restatement Effective Date all Hospitals owned by Parent, the Borrower and the Subsidiaries and the addresses thereof. The Borrower and the Subsidiaries own in fee all the real property set forth on Schedule 1.01(d).
     (b) Schedule 1.01(d) lists completely and correctly as of the Restatement Effective Date all Hospitals leased by Parent, the Borrower and the Subsidiaries and the addresses thereof. The

 


 

Borrower and the Subsidiaries have valid leases in all the material real property set forth on Schedule 1.01(d).
     SECTION 3.21. Labor Matters. Except as set forth on Schedule 3.21, as of the Restatement Effective Date, there are no strikes, lockouts or slowdowns against Parent, the Borrower or any Subsidiary pending or, to the knowledge of Parent or the Borrower by delivery of written notice or proceeding, threatened. The consummation of the Transactions will not give rise to any right of termination or right of renegotiation on the part of any union under any collective bargaining agreement to which Parent, the Borrower or any Subsidiary is bound. Except as set forth on Schedule 3.21, as of the Restatement Effective Date, none of Parent, the Borrower or any Subsidiary is a party to any collective bargaining agreement or other labor contract applicable to persons employed by it at any Facility.
     SECTION 3.22. Solvency. Immediately after the consummation of the Transactions on the Closing Date, as of the Closing Date (a) the fair value of the assets of Parent, the Borrower and the Subsidiaries, on a consolidated basis, at a fair valuation, will exceed their debts and liabilities, subordinated, contingent or otherwise; (b) the present fair saleable value of the property of Parent, the Borrower and the Subsidiaries, on a consolidated basis, will be greater than the amount that will be required to pay the probable liability of their debts and other liabilities, subordinated, contingent or otherwise, as such debts and other liabilities become absolute and matured; (c) Parent, the Borrower and the Subsidiaries, on a consolidated basis, will be able to pay their debts and liabilities, subordinated, contingent or otherwise, as such debts and liabilities become absolute and matured; and (d) Parent, the Borrower and the Subsidiaries, on a consolidated basis, will not have unreasonably small capital with which to conduct the business in which they are engaged as such business is now conducted and is proposed to be conducted following the Closing Date.
     SECTION 3.23. Sanctioned Persons. None of Parent, the Borrower, or any Subsidiary or any Unrestricted Subsidiary nor, to the knowledge of the Borrower, any director, officer, agent, employee or Affiliate of Parent, the Borrower, any Subsidiary or any Unrestricted Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”) and each is currently in compliance with all rules and regulations promulgated by OFAC; and the Borrower will not directly or indirectly use the proceeds of the Loans or the Letters of Credit or otherwise make available such proceeds to any person, for the purpose of financing the activities of any person currently subject to any U.S. sanctions administered by OFAC.
ARTICLE IV
Conditions of Lending
     The obligations of the Lenders to make Loans and of the Issuing Bank to issue Letters of Credit hereunder are subject to the satisfaction of the following conditions:
     SECTION 4.01. All Credit Events. On the date of each Borrowing (other than a conversion or a continuation of a Borrowing), including each Borrowing of a Swingline Loan and on the date of each issuance of or increase to a Letter of Credit (each such event being called a “Credit Event”):

 


 

     (a) The Administrative Agent shall have received a notice of such Borrowing as required by Section 2.03 (or such notice shall have been deemed given in accordance with Section 2.02) or, in the case of the issuance of or increase to a Letter of Credit, the Issuing Bank and the Administrative Agent shall have received a notice requesting the issuance of or increase to such Letter of Credit as required by Section 2.23(b) or, in the case of the Borrowing of a Swingline Loan, the Swingline Lender and the Administrative Agent shall have received a notice requesting such Swingline Loan as required by Section 2.22(b).
     (b) The representations and warranties set forth in Article III and in each other Loan Document shall be true and correct in all material respects on and as of the date of such Credit Event with the same effect as though made on and as of such date, except to the extent such representations and warranties expressly relate to an earlier date.
     (c) At the time of and immediately after such Credit Event, no Default or Event of Default shall have occurred and be continuing.
     Each Credit Event shall be deemed to constitute a representation and warranty by the Borrower and Parent on the date of such Credit Event as to the matters specified in paragraphs (b) and (c) of this Section 4.01.
     SECTION 4.02. [Intentionally Omitted.]
ARTICLE V
Affirmative Covenants
     Each of Parent and the Borrower covenants and agrees with each Lender that so long as this Agreement shall remain in effect and until the Commitments have been terminated and the principal of and interest on each Loan, all Fees and all other expenses or amounts payable under any Loan Document shall have been paid in full and all Letters of Credit have been canceled or have expired and all amounts drawn thereunder have been reimbursed in full or other arrangements acceptable to the Issuing Bank and the Administrative Agent have been made with respect thereto, unless the Required Lenders shall otherwise consent in writing, each of Parent and the Borrower will, and will cause (i) in the case of Sections 5.01 and 5.02, each of the Material Subsidiaries, and (ii) in the case of Sections 5.03 through 5.15, each of the Subsidiaries to:
     SECTION 5.01. Existence; Compliance with Laws; Businesses and Properties. (a) Do or cause to be done all things necessary to preserve, renew and keep in full force and effect its legal existence, except as otherwise expressly permitted under Section 6.05.
     (b) (i) Do or cause to be done all things necessary to obtain, preserve, renew, extend and keep in full force and effect the rights, licenses, permits, franchises and authorizations, material to the conduct of its business, except as could not reasonably be expected to have a Material Adverse Effect; (ii) comply in all material respects with all applicable laws, rules, regulations and decrees and orders of any Governmental Authority, whether now in effect or hereafter enacted, except as could not reasonably be expected to have a Material Adverse Effect; and (iii) at all times maintain and preserve all tangible property material to the conduct of such business and keep such property in good repair, working order and condition (subject to ordinary wear

 


 

and tear, casualty and condemnation) and from time to time make, or cause to be made, all needful and proper repairs, renewals, additions, improvements and replacements thereto necessary in order that the business carried on in connection therewith may be properly conducted at all times, except as could not reasonably be expected to have a Material Adverse Effect.
     SECTION 5.02. Insurance. (a) Maintain with financially sound and reputable insurers insurance, to such extent and against such risks, including fire and other risks insured against by extended coverage, as is customary with companies in the same or similar businesses operating in the same or similar locations, including hospital liability (which shall include general liability, medical professional liability, contractual liability and druggists’ liability), workers’ compensation, employers’ liability, automobile liability and physical damage coverage, environmental impairment liability, all risk property, business interruption, fidelity and crime insurance and public liability insurance against claims for personal injury or death or property damage occurring upon, in, about or in connection with the use of any properties owned, occupied or controlled by it; provided that the Borrower may implement programs of self insurance in the ordinary course of business and in accordance with industry standards for a company of similar size so long as reserves are maintained in accordance with GAAP for the liabilities associated therewith.
     (b) Cause all casualty and property policies covering any Collateral to name the Collateral Agent as loss payee or mortgagee, and/or additional insured, and each provider of any such insurance shall agree, by endorsement upon such policies issued by it, that it will give the Administrative Agent 30 days prior written notice before any such policy or policies shall be altered or canceled.
     (c) If at any time the area in which the Premises (as defined in the Mortgages) are located is designated a “flood hazard area” in any Flood Insurance Rate Map published by the Federal Emergency Management Agency (or any successor agency), obtain flood insurance in such total amount as the Administrative Agent, the Collateral Agent or the Required Lenders may from time to time require, and otherwise comply with the National Flood Insurance Program as set forth in the Flood Disaster Protection Act of 1973, as it may be amended from time to time.
     SECTION 5.03. Obligations and Taxes. Pay and discharge promptly when due all taxes, assessments and governmental charges or levies imposed upon it or upon its income or profits or in respect of its property, before the same shall become delinquent, as well as all lawful claims for labor, materials and supplies or otherwise that, if unpaid, could reasonably be expected to give rise to a Lien upon such properties or any part thereof; provided, however, that such payment and discharge shall not be required with respect to any such tax, assessment, charge, levy or claim so long as (i) the validity or amount thereof shall be contested in good faith by appropriate proceedings and the Borrower shall have set aside on its books adequate reserves with respect thereto in accordance with GAAP or (ii) the failure to pay and discharge such tax, assessment, charge, levy or claim could not reasonably be expected to have a Material Adverse Effect.
     SECTION 5.04. Financial Statements, Reports, etc. In the case of Parent, furnish to the Administrative Agent, which shall furnish to each Lender:

 


 

     (a) within 90 days after the end of each fiscal year, its consolidated balance sheet and related statements of income, stockholders’ equity and cash flows showing the financial condition of Parent and its consolidated subsidiaries as of the close of such fiscal year and the results of its operations and the operations of such subsidiaries during such year, together with comparative figures for the immediately preceding fiscal year, all audited by Deloitte & Touche LLP or other independent public accountants of recognized national standing and accompanied by an opinion of such accountants (which opinion shall be without a “going concern” or like qualification or exception or any qualification or exception as to the scope of such audit) to the effect that such consolidated financial statements fairly present in all material respects the financial condition and results of operations of Parent and its consolidated subsidiaries on a consolidated basis in accordance with GAAP;
     (b) within 50 days after the end of each of the first three fiscal quarters of each fiscal year, its consolidated balance sheet and related statements of income, stockholders’ equity and cash flows showing the financial condition of Parent and its consolidated subsidiaries as of the close of such fiscal quarter and the results of its operations and the operations of such subsidiaries during such fiscal quarter and the then elapsed portion of the fiscal year, and comparative figures for the same periods in the immediately preceding fiscal year all certified by one of its Financial Officers as fairly presenting in all material respects the financial condition and results of operations of Parent and its consolidated subsidiaries on a consolidated basis in accordance with GAAP, subject to normal year-end audit adjustments;
     (c) concurrently with any delivery of financial statements under paragraph (a) or (b) above, a certificate of a Financial Officer of the Borrower (i) certifying that no Event of Default or Default has occurred or, if such an Event of Default or Default has occurred, specifying the nature and extent thereof and any corrective action taken or proposed to be taken with respect thereto, (ii) setting forth computations in reasonable detail satisfactory to the Administrative Agent demonstrating compliance with the covenants contained in Sections 6.11, 6.12 and 6.13, and (iii) setting forth the identity and value of any Hospital acquired in fee by Parent or any Subsidiary during the preceding quarter and not previously identified to the Administrative Agent if the fair market value thereof is in excess of $10,000,000 and, in the case of a certificate delivered with the financial statements required by paragraph (a) above, setting forth Parent’s calculation of Excess Cash Flow;
     (d) within 90 days after the beginning of each fiscal year of Parent, a detailed consolidated budget for such fiscal year (including a projected consolidated balance sheet and related statements of projected operations and cash flows as of the end of and for such fiscal year and setting forth the assumptions used for purposes of preparing such budget) and, promptly when available, any significant revisions of such budget;
     (e) promptly after the same become publicly available, copies of all periodic and other reports, proxy statements and other materials filed by Parent, the Borrower or any Subsidiary with the SEC, or with any national securities exchange, or distributed to its shareholders, as the case may be;
     (f) promptly after the request by any Lender (made through the Administrative Agent), all documentation and other information that such Lender reasonably requests in order to comply with its ongoing obligations under applicable “know your customer” and anti-money laundering rules and regulations, including the USA PATRIOT Act;

 


 

     (g) promptly after the request by the Administrative Agent or any Lender, copies of (i) any documents described in Section 101(k)(1) of ERISA that the Borrower or any of its ERISA Affiliates may request with respect to any Multiemployer Plan and (ii) any notices described in Section 101(l)(1) of ERISA that the Borrower or any of its ERISA Affiliates may request with respect to any Multiemployer Plan; provided that if the Borrower or any of its ERISA Affiliates has not requested such documents or notices from the administrator or sponsor of the applicable Multiemployer Plan, the Borrower or the applicable ERISA Affiliate shall promptly make a request for such documents or notices from such administrator or sponsor and shall provide copies of such documents and notices promptly after receipt thereof;
     (h) promptly, from time to time, such other information regarding the operations, business affairs and financial condition of Parent, the Borrower or any Subsidiary, or compliance with the terms of any Loan Document, as the Administrative Agent may reasonably request (on behalf of itself or any Lender); and
     (i) substantially contemporaneously with each designation of a Subsidiary as an “Unrestricted Subsidiary” and each redesignation of an Unrestricted Subsidiary as a “Subsidiary”, provide written notice of such designation or redesignation, as applicable, to the Administrative Agent (who shall promptly notify the Lenders).
     SECTION 5.05. Litigation and Other Notices. Furnish to the Administrative Agent prompt written notice of the following:
     (a) any Event of Default or Default, specifying the nature and extent thereof and the corrective action (if any) taken or proposed to be taken with respect thereto;
     (b) the filing or commencement of, or any threat or notice of intention of any person to file or commence, any action, suit or proceeding, whether at law or in equity or by or before any Governmental Authority, against Parent, the Borrower or any Subsidiary that could reasonably be expected to result in a Material Adverse Effect; and
     (c) any event or occurrence that has resulted in, or could reasonably be expected to result in, a Material Adverse Effect.
     SECTION 5.06. Information Regarding Collateral. Furnish to the Administrative Agent prompt written notice of any change (i) in any Loan Party’s corporate name, (ii) in any Loan Party’s jurisdiction of organization or formation, (iii) in any Loan Party’s identity or corporate structure or (iv) in any Loan Party’s Federal Taxpayer Identification Number. Parent and the Borrower agree not to effect or permit any change referred to in the preceding sentence unless all filings have been made under the Uniform Commercial Code or otherwise that are required in order for the Collateral Agent to continue at all times following such change to have a valid, legal and perfected security interest in all the Collateral. Parent and the Borrower also agree promptly to notify the Administrative Agent if any material portion of the Collateral is damaged or destroyed.
     SECTION 5.07. Maintaining Records; Access to Properties and Inspections; Maintenance of Ratings. (a) Keep books of record and account in which full, true and correct entries in all material respects are made of all dealings and transactions in relation to its business and activities which permit financial statements to be prepared in conformity with GAAP and all

 


 

requirements of law. Each Loan Party will, and will cause each of its subsidiaries to, permit any representatives designated by the Administrative Agent or the Required Lenders to visit and inspect the financial records and the properties of such person at reasonable times and as often as reasonably requested upon reasonable notice and to make extracts from and copies of such financial records (in each case excluding patient medical records and any other material which is confidential pursuant to any laws, rules, regulations and decrees and orders of any Governmental Authority) and permit any representatives designated by the Administrative Agent or the Required Lenders to discuss the affairs, finances and condition of such person with the officers thereof and independent accountants therefor (with a senior officer of the Borrower present); provided that, excluding any such visits and inspections during the continuation of an Event of Default, only one such visit during any fiscal year shall be at the Borrower’s expense.
     (b) In the case of Parent and the Borrower, use commercially reasonable efforts to cause the Credit Facilities to be continuously rated by S&P and Moody’s, and to maintain a corporate rating from S&P and a corporate family rating from Moody’s, in each case in respect of Parent.
     SECTION 5.08. Use of Proceeds. Use the proceeds of the Loans and request the issuance of Letters of Credit only for the purposes specified in the preliminary statement to this Agreement.
     SECTION 5.09. Employee Benefits. (a) Comply in all material respects with the applicable provisions of ERISA and the Code and (b) furnish to the Administrative Agent as soon as possible after, and in any event within ten days after any Responsible Officer of Parent, the Borrower or any ERISA Affiliate knows or has reason to know that, any ERISA Event has occurred that, alone or together with any other ERISA Event could reasonably be expected to result in liability of the Borrower or any ERISA Affiliate in an aggregate amount exceeding $10,000,000, a statement of a Financial Officer of Parent or the Borrower setting forth details as to such ERISA Event and the action, if any, that Parent or the Borrower proposes to take with respect thereto.
     SECTION 5.10. Compliance with Environmental Laws. Comply and cause all lessees and other persons occupying its properties to comply, in all material respects with all Environmental Laws applicable to its operations and properties; obtain and renew all material environmental permits necessary for its operations and properties; and promptly conduct any remedial action in accordance with Environmental Laws; provided, however, that none of Parent, the Borrower or any Subsidiary shall be required to undertake any remedial action required by Environmental Laws to the extent that its obligation to do so is being contested in good faith and by proper proceedings and appropriate reserves are being maintained with respect to such circumstances in accordance with GAAP.
     SECTION 5.11. Preparation of Environmental Reports. If a Default caused by reason of a breach of Section 3.17 or Section 5.10 shall have occurred and be continuing for more than 20 days without Parent, the Borrower or any Subsidiary commencing activities reasonably likely to cure such Default, at the written request of the Required Lenders through the Administrative Agent, the Borrower shall provide to the Lenders within 45 days after receipt of such request, at the expense of the Loan Parties, environmental site assessment reports (Phase I, Phase II and/or compliance audits) regarding the matters which are the subject of such Default prepared by an environmental consulting firm reasonably acceptable to the Administrative Agent and indicating

 


 

the compliance matter and/or the presence or absence of Hazardous Materials and the estimated cost of any compliance or remedial action in connection with such Default.
     SECTION 5.12. Further Assurances. Execute any and all further documents, financing statements, agreements and instruments, and take all further action (including filing Uniform Commercial Code and other financing statements, mortgages and deeds of trust) that may be required under applicable law, or that the Required Lenders, the Administrative Agent or the Collateral Agent may reasonably request, in order to effectuate the transactions contemplated by the Loan Documents and in order to grant, preserve, protect and perfect the validity and first priority of the security interests created or intended to be created by the Security Documents. The Borrower will cause any subsequently acquired or organized Material Subsidiary to become a Loan Party by executing the Guarantee and Collateral Agreement and each applicable Security Document in favor of the Collateral Agent. In addition, except with respect to which, in the reasonable judgment of the Administrative Agent (confirmed in writing by written notice to the Borrower), the cost or other consequences (including any Tax consequence) of doing so shall be excessive in view of the benefits to be obtained by the Lenders therefrom and subject to applicable limitations set forth in the Security Documents, from time to time, the Borrower will, at its cost and expense, promptly secure the Obligations by pledging or creating, or causing to be pledged or created, perfected security interests with respect to such of its assets and properties as the Administrative Agent or the Required Lenders shall designate (it being understood that it is the intent of the parties that the Obligations shall be secured by substantially all the assets of Parent, the Borrower and the Subsidiary Guarantors (including properties acquired subsequent to the Closing Date), except this Section 5.12 shall not require Parent, the Borrower or any Subsidiary Guarantor to (a) pledge (i) more than 65% of the outstanding voting Equity Interests in any Foreign Subsidiary, (ii) any Equity Interest in any Non-Significant Subsidiary or (iii) any Equity Interest in any Permitted Syndication Subsidiary, any Securitization Subsidiary or any Permitted Joint Venture Subsidiary to the extent the pledge of the Equity Interest in such Subsidiary is prohibited by any applicable Contractual Obligation or requirement of law, or (b) grant security interests in any asset that (i) would result in the violation of the enforceable anti-assignment provision of any contract, or would be prohibited by or would violate applicable law or contractual provisions (including any right of first refusal) or would otherwise result in termination or any forfeiture under any contract, (ii) is a vehicle or other asset subject to certificate of title, (iii) require perfection through control agreements (including, to the extent required in the relevant jurisdiction for deposit accounts and investment property), (iv) are minority Equity Interests or (v) is permitted to be so excluded under the Guarantee and Collateral Agreement. Such security interests and Liens will be created under the Security Documents and other security agreements, mortgages, deeds of trust and other instruments and documents in form and substance satisfactory to the Collateral Agent, and the Borrower shall deliver or cause to be delivered to the Lenders all such instruments and documents (including legal opinions, title insurance policies and lien searches) as the Collateral Agent shall reasonably request to evidence compliance with this Section. Any requirement to mortgage real property that is acquired after the Closing Date pursuant to this Section 5.12 shall be limited to real property owned in fee by a Loan Party that (i) has a fair market value equal to or exceeding $10,000,000, (ii) is not subject to a Lien permitted under Section 6.02(c) or (n) (for so long as such Lien exists), and (iii) the Borrower does not intend to sell within six months of the acquisition thereof pursuant to clause (i) or (xi) of Section 6.05(b). No appraisals, environmental reports or surveys shall be required to be obtained in connection with any mortgage of real property pursuant to this Section 5.12.

 


 

The Borrower agrees to provide such evidence as the Collateral Agent shall reasonably request as to the perfection and priority status of each such security interest and Lien.
     SECTION 5.13. Proceeds of Certain Dispositions. If, as a result of the receipt of any cash proceeds by Parent, the Borrower or any Subsidiary in connection with any sale, transfer, lease or other disposition of any asset the Borrower would be required by the terms of the Senior Note Indenture or the documentation governing any other Material Indebtedness that is unsecured or secured by Liens junior to the Liens securing the Obligations to make an offer to purchase any of the Indebtedness thereunder, then, prior to the first day on which the Borrower would be required to commence such an offer to purchase, (i) prepay Loans in accordance with Section 2.12 or 2.13, provided that the Borrower may use a portion of such cash proceeds to prepay or repurchase Pari Passu Debt secured by Liens on the Collateral having the same priority as the Liens securing the Obligations to the extent any applicable credit agreement, indenture or other agreement governing such Pari Passu Debt requires the Borrower to prepay or make an offer to purchase such Pari Passu Debt with such cash proceeds, in each case in an amount not to exceed the product of (A) the amount of such cash proceeds and (B) a fraction, the numerator of which is the outstanding principal amount of such Pari Passu Debt and the denominator of which is the sum of the outstanding principal amount of such Pari Passu Debt and the outstanding principal amount of Term Loans, or (ii) acquire assets in a manner that is permitted hereby, in each case in a manner that will eliminate any such requirement to make such an offer to purchase.
     SECTION 5.14. Operation of Facilities. Use commercially reasonable efforts to operate, and cause the Subsidiaries to operate, the Facilities owned, leased or operated by Parent, the Borrower or any of the Subsidiaries now or in the future in a manner believed by the Borrower to be consistent with prevailing health care industry standards in the locations where the Facilities exist from time to time, except to the extent failure to do so would not have a Material Adverse Effect.
ARTICLE VI
Negative Covenants
     Each of Parent and the Borrower covenants and agrees with each Lender that, so long as this Agreement shall remain in effect and until the Commitments have been terminated and the principal of and interest on each Loan, all Fees and all other expenses or amounts payable under any Loan Document have been paid in full and all Letters of Credit have been cancelled or have expired and all amounts drawn thereunder have been reimbursed in full or other arrangements acceptable to the Issuing Bank and the Administrative Agent have been made with respect thereto, unless the Required Lenders shall otherwise consent in writing, neither Parent nor the Borrower will, nor will they cause or permit any of the Subsidiaries to:
     SECTION 6.01. Indebtedness. Incur, create, assume or permit to exist any Indebtedness, except:
     (a) Indebtedness existing on the Closing Date and set forth in Schedule 6.01 and any extensions, renewals, refinancings or replacements of such Indebtedness to the extent the principal amount of such Indebtedness is not increased (except by an amount equal to the unpaid accrued interest and premium thereon plus other reasonable amounts paid and

 


 

fees and expenses incurred in connection with such extension, renewal, refinancing or replacement), neither the final maturity nor the weighted average life to maturity of such Indebtedness is decreased, such Indebtedness, if subordinated to the Obligations, remains so subordinated on terms no less favorable to the Lenders, and the obligors thereof, if not the original obligors in respect of such Indebtedness, are Loan Parties;
     (b) Indebtedness created hereunder and under the other Loan Documents;
     (c) intercompany Indebtedness of Parent, the Borrower and the Subsidiaries to the extent permitted by Section 6.04(c);
     (d) Indebtedness of the Borrower or any Subsidiary incurred to finance the acquisition, construction or improvement of any fixed or capital assets, and extensions, renewals, refinancings and replacements of any such Indebtedness that do not increase the outstanding principal amount thereof (except by an amount equal to the unpaid accrued interest and premium thereon plus other reasonable amounts paid and fees and expenses incurred in connection with such extension, renewal, refinancing or replacement); provided that (i) such Indebtedness is incurred prior to or within 270 days after such acquisition or the completion of such construction or improvement and (ii) the aggregate principal amount of Indebtedness permitted by this Section 6.01(d), when combined with the aggregate principal amount of all Capital Lease Obligations and Synthetic Lease Obligations incurred pursuant to Section 6.01(e), shall not exceed $200,000,000 at any time outstanding;
     (e) Capital Lease Obligations and Synthetic Lease Obligations in an aggregate principal amount, when combined with the aggregate principal amount of all Indebtedness incurred pursuant to Section 6.01(d), not in excess of $200,000,000 at any time outstanding;
     (f) Indebtedness (including Capital Lease Obligations) of any Subsidiary secured by one or more Facilities owned or leased by such Subsidiary, and extensions, renewals, refinancings and replacements of any such Indebtedness that do not increase the outstanding principal amount thereof (except by an amount equal to the unpaid accrued interest and premium thereon plus other reasonable amounts paid and fees and expenses incurred in connection with such extension, renewal, refinancing or replacement); provided that (i) when incurred, such Indebtedness shall not exceed the fair market value of the Facilities securing the same and (ii) the aggregate principal amount of all such Indebtedness incurred pursuant to this Section 6.01(f) shall not exceed $250,000,000 at any time outstanding (such Indebtedness meeting the criteria of this Section 6.01(f) being referred to herein as “Permitted Real Estate Indebtedness”);
     (g) Indebtedness under performance bonds, bid bonds, appeal bonds, surety bonds and completion guarantees and similar obligations, or with respect to workers’ compensation claims, in each case incurred in the ordinary course of business, including those incurred to secure health, safety and environmental obligations in the ordinary course of business;
     (h) Indebtedness incurred pursuant to the Senior Note Indenture and any extensions, renewals, refinancings or replacements of such Indebtedness to the extent the

 


 

principal amount of such Indebtedness is not increased (other than to the extent of any premiums, interest or costs and expenses incurred in connection therewith), neither the final maturity nor the weighted average life to maturity of such Indebtedness is decreased, and the obligors thereof, if not the original obligors in respect of such Indebtedness, are Loan Parties;
     (i) Indebtedness in respect of Hedging Agreements permitted by Section 6.04(g);
     (j) Cash Management Obligations;
     (k) Indebtedness incurred by Foreign Subsidiaries in an aggregate principal amount not exceeding $75,000,000 at any time outstanding;
     (l) Indebtedness pursuant to any Permitted Receivables Transaction incurred in accordance with Section 6.05(b);
     (m) Indebtedness incurred to finance, or assumed in connection with, one or more Permitted Acquisitions and any extensions, renewals, refinancings or replacements of such Indebtedness to the extent the principal amount of such Indebtedness is not increased (except by an amount equal to the unpaid accrued interest and premium thereon plus other reasonable amounts paid and fees and expenses incurred in connection with such extension, renewal, refinancing or replacement), neither the final maturity nor the weighted average life to maturity of such Indebtedness is decreased, such Indebtedness, if subordinated to the Obligations, remains so subordinated on terms no less favorable to the Lenders, and the obligors thereof, if not the original obligors in respect of such Indebtedness, are Loan Parties, so long as both immediately prior and after giving effect thereto, no Default shall exist or result therefrom, provided that no Indebtedness may be incurred under this Section 6.01(m) if as a result thereof the aggregate principal amount of Indebtedness incurred and outstanding under this Section 6.01(m) would exceed $500,000,000 unless (x) the Leverage Ratio Condition would be satisfied and (y) the Liquidity Condition would be satisfied;
     (n) Indebtedness owed to a seller in a Permitted Acquisition or a Permitted Joint Venture or to a buyer in a disposition permitted under Section 6.05 that (i) relates to post-closing adjustments with respect to accounts receivable, accounts payable, net worth and/or similar items or (ii) relates to indemnities granted to the seller or buyer in such transactions;
     (o) Permitted Additional Debt;
     (p) Indebtedness in the nature of letters of credit (other than Letters of Credit issued pursuant to this Agreement) issued for the account of Parent, the Borrower or any Subsidiary (and related reimbursement obligations) not to exceed an aggregate face amount of $30,000,000;
     (q) without duplication of any other Indebtedness, non-cash accruals of interest, accretion or amortization of original issue discount and/or pay-in-kind interest on Indebtedness otherwise permitted hereunder;

 


 

     (r) from and after the Revolving Credit Termination Date, Indebtedness to finance the general needs of the Borrower and the Subsidiaries incurred after the Revolving Credit Termination Date in an aggregate principal amount not to exceed $750,000,000 at any time outstanding, provided that the Borrower shall have (i) repaid all Revolving Loans and Swingline Loans and reimbursed, if any, all L/C Disbursements and made arrangements acceptable to the Issuing Bank and the Administrative Agent with respect to any outstanding Letters of Credit and (ii) paid all related fees and expenses, each in accordance with the terms of this Agreement;
     (s) Indebtedness consisting of obligations to pay insurance premiums;
     (t) except as otherwise expressly provided herein, Guarantees by Parent, the Borrower or the Subsidiaries of Indebtedness of Parent, the Borrower and the Subsidiaries permitted to be incurred hereunder;
     (u) other unsecured Indebtedness of the Borrower or the Subsidiaries in an aggregate principal amount not exceeding $400,000,000 at any time outstanding; and
     (v) Pari Passu Debt, provided that, either (i) at the time of incurrence of such Pari Passu Debt, and after giving effect thereto and to the use of the proceeds thereof, (A) no Default or Event of Default shall have occurred and be continuing and (B) the Secured Leverage Ratio Condition shall be satisfied or (ii) not later than the fifth Business Day following the incurrence thereof, 100% of the Net Cash Proceeds thereof are used by the Borrower to prepay Term Loans in the manner set forth in Section 2.13(g).
     SECTION 6.02. Liens. Create, incur, assume or permit to exist any Lien on any property or assets (including Equity Interests or other securities of any person, including the Borrower or any Subsidiary) now owned or hereafter acquired by it or on any income or revenues or rights in respect of any thereof, except:
     (a) Liens on property or assets of the Borrower and the Subsidiaries existing on the Closing Date and set forth in Schedule 6.02; provided that such Liens shall secure only those obligations which they secured on the Closing Date and extensions, renewals and replacements thereof permitted hereunder;
     (b) any Lien created under the Loan Documents;
     (c) any Lien existing on any property or asset prior to the acquisition thereof by the Borrower or any Subsidiary or existing on any property or assets of any person that becomes a Subsidiary after the Closing Date prior to the time such person becomes a Subsidiary, as the case may be; provided that (i) such Lien is not created in contemplation of or in connection with such acquisition or such person becoming a Subsidiary, (ii) such Lien does not apply to any other property or assets of Parent, the Borrower or any Subsidiary (other than affixed or incorporated into the property covered by such Lien) and (iii) such Lien secures only those obligations which it secures on the date of such acquisition or the date such person becomes a Subsidiary, as the case may be, and any extensions, renewals, refinancings or replacements of such obligations;

 


 

     (d) Liens, assessments or governmental charges or claims for taxes not yet delinquent or which are not required to be paid pursuant to Section 5.03;
     (e) carriers’, warehousemen’s, mechanics’, materialmen’s, repairmen’s or other like Liens arising in the ordinary course of business and securing obligations that are not delinquent or which are not required to be paid under Section 5.03;
     (f) Liens incurred and pledges and deposits made in the ordinary course of business in connection with any self-retention or self-insurance, or with respect to workmen’s compensation, unemployment insurance, general liability, medical malpractice, professional liability or property insurance and other social security laws or regulations;
     (g) deposits to secure the performance of bids, trade contracts (other than for Indebtedness), leases (other than Capital Lease Obligations), statutory obligations, surety and appeal bonds, government contracts, performance bonds and other obligations of a like nature incurred in the ordinary course of business;
     (h) zoning restrictions, easements, rights-of-way, rights of first refusal, restrictions on use of real property, minor defects or irregularities in title and other similar charges or encumbrances which, in the aggregate, do not interfere in any material respect with the business of the Borrower and the Subsidiaries, taken as a whole;
     (i) zoning, building codes and other land use laws, regulations and ordinances regulating the use or occupancy of real property or the activities conducted thereon which are imposed by any Governmental Authority having jurisdiction over such real property which are not violated by the current use or occupancy of such real property or the operation of the business of the Borrower or any of the Subsidiaries or any violation of which would not have a Material Adverse Effect;
     (j) ground leases in respect of real property on which Facilities owned or leased by the Borrower or any of the Subsidiaries are located;
     (k) any interest or title of a lessor or secured by a lessor’s interest under any lease permitted hereunder;
     (l) leases or subleases granted to others not interfering in any material respect with the business of the Borrower and the Subsidiaries, taken as a whole;
     (m) Liens in favor of customs and revenue authorities arising as a matter of law to secure payment of customs duties in connection with the importation of goods;
     (n) Liens securing Indebtedness to finance the acquisition, construction or improvement of fixed or capital assets; provided that (i) such security interests secure Indebtedness permitted by Section 6.01, (ii) such security interests are incurred, and the Indebtedness secured thereby is created, within 270 days after such acquisition, construction or improvement, and (iii) such security interests do not apply to any other property or assets of the Borrower or any Subsidiary, except for accessions to the property financed with the proceeds of such Indebtedness and the proceeds and the

 


 

products thereof; provided that individual financings of equipment provided by one lender may be cross-collateralized to other financings of equipment provided by such lender secured by a Lien permissibly incurred pursuant to this Section 6.02(n);
     (o) Liens arising out of judgments or awards that do not constitute an Event of Default under paragraph (i) of Article VII;
     (p) Liens pursuant to Permitted Receivables Transactions incurred in accordance with Section 6.05(b), including Liens on the assets of any Securitization Subsidiary created pursuant to any such Permitted Receivables Transaction and Liens incurred by the Borrower and the Subsidiaries on Receivables to secure obligations owing by them in respect of any such Permitted Receivables Transaction, provided that any Receivables not transferred to a Securitization Subsidiary in connection with such Permitted Receivables Transaction to the extent constituting intercompany indebtedness required to be pledged pursuant to the Guarantee and Collateral Agreement shall be and remain subject to the perfected first priority Lien and security interest granted to the Collateral Agent in favor of the Lenders in accordance with the Guarantee and Collateral Agreement;
     (q) Liens on assets of Foreign Subsidiaries; provided that (i) such Liens do not extend to, or encumber, assets that constitute Collateral or the Equity Interests of the Borrower or any of the Domestic Subsidiaries, and (ii) such Liens extending to the assets of any Foreign Subsidiary secure only Indebtedness incurred by such Foreign Subsidiary pursuant to Section 6.01(k);
     (r) Liens (i) of a collecting bank arising under Section 4-210 of the Uniform Commercial Code on items in the course of collection, (ii) attaching to commodity trading accounts or other commodities brokerage accounts incurred in the ordinary course of business; and (iii) in favor of a banking institution arising as a matter of law encumbering deposits (including the right of set off);
     (s) Liens on one or more Facilities owned or leased by any Subsidiary to secure Permitted Real Estate Indebtedness incurred by such Subsidiary pursuant to Section 6.01(f);
     (t) Liens that are contractual rights of set-off (i) relating to the establishment of depository relations with banks not given in connection with the issuance of Indebtedness, (ii) relating to pooled deposit or sweep accounts of Parent, the Borrower or any Subsidiary to permit satisfaction of overdraft or similar obligations incurred in the ordinary course of business of Parent, the Borrower and the Subsidiaries or (iii) relating to purchase orders and other agreements entered into with customers of Parent, the Borrower or any Subsidiary in the ordinary course of business;
     (u) Liens arising out of conditional sale, title retention, consignment or similar arrangements for the sale or purchase of goods entered into by the Borrower or any of the Subsidiaries in the ordinary course of business permitted hereunder;
     (v) Liens solely on any cash earnest money deposits made by Parent, the Borrower or any of the Subsidiaries in connection with any letter of intent or purchase agreement permitted hereunder;

 


 

     (w) Liens securing insurance premiums financing arrangements, provided that such Liens are limited to the applicable unearned insurance premiums;
     (x) other Liens that do not, individually or in the aggregate, secure obligations (or encumber property with a fair market value) in excess of $150,000,000 at any one time;
     (y) Liens on the Collateral which (i) secure Indebtedness incurred pursuant to Section 6.01(r) and (ii) have the same priority as, or junior priority to, the Liens securing the Obligations; and
     (z) Liens on the Collateral which (i) secure Pari Passu Debt Obligations and (ii) have the same priority as, or junior priority to, the Liens securing the Obligations.
     SECTION 6.03. Sale and Lease-Back Transactions. Enter into any arrangement, directly or indirectly, with any person whereby it shall sell or transfer any property, real or personal, used or useful in its business, whether now owned or hereafter acquired, and thereafter rent or lease such property or other property which it intends to use for substantially the same purpose or purposes as the property being sold or transferred unless (a) the sale or transfer of such property is permitted by Section 6.05 and (b) any Capital Lease Obligations, Synthetic Lease Obligations, Permitted Real Estate Indebtedness or Liens arising in connection therewith are permitted by Sections 6.01 and 6.02, as the case may be.
     SECTION 6.04. Investments, Loans and Advances. Purchase, hold or acquire any Equity Interests, evidences of indebtedness or other securities of, make or permit to exist any loans or advances to, or make or permit to exist any investment or any other interest in, any other person, except:
     (a) (i) investments by Parent, the Borrower and the Subsidiaries existing on the Closing Date in the Borrower and the Subsidiaries, (ii) additional investments by Parent, the Borrower and the Subsidiaries in the Borrower and the Subsidiaries and any Unrestricted Subsidiaries and (iii) additional investments by Parent, the Borrower and the Subsidiaries in Permitted Joint Ventures (subject to the limitations on such investments referred to in the definition of the term “Permitted Joint Ventures”); provided that (x) any Equity Interests held by a Loan Party shall be pledged to the extent required by Section 5.12 and the Guarantee and Collateral Agreement and (y) any such investments made pursuant to clause (ii) above made by a Loan Party to a Subsidiary that is not a Loan Party, or made by Parent, the Borrower or any Subsidiary to an Unrestricted Subsidiary, may only be made if (A) no Default or Event of Default shall have occurred and be continuing and (B) the aggregate amount of all such investments made by Loan Parties to Subsidiaries that are not Loan Parties, or by Parent, the Borrower or any Subsidiary to an Unrestricted Subsidiary and outstanding at any time (without regard to any write-downs or write-offs thereof, and valued net in the case of intercompany loans) shall not exceed $500,000,000 plus the amount of dividends, distributions and other returns of capital actually received in cash by any Loan Party with respect to any such investments; provided further, that, prior to the aggregate amount of all such investments outstanding at any time exceeding $300,000,000 at any time outstanding, the Leverage Ratio Condition and the Liquidity Condition would each be satisfied; for purposes of the foregoing, if the Borrower designates a Subsidiary as an Unrestricted Subsidiary in accordance with the definition of the term “Unrestricted Subsidiary”, the Borrower will

 


 

be deemed to have made an investment at that time in the resulting Unrestricted Subsidiary in an aggregate amount equal to the fair market value of the net assets of such Unrestricted Subsidiary;
     (b) Permitted Investments;
     (c) (i) loans or advances in respect of intercompany accounts attributable to the operation of the Borrower’s cash management system (including with respect to intercompany self-insurance arrangements), (ii) loans or advances made by the Borrower or any of the Subsidiaries to a Permitted Syndication Subsidiary for working capital needs evidenced by a promissory note that is pledged to the Collateral Agent so long as such loans or advances constitute Indebtedness of the primary obligor that is not subordinate to any other Indebtedness of such obligor, and (iii) loans or advances made by Parent to the Borrower or any Subsidiary, the Borrower to Parent or any Subsidiary and by any Subsidiary to Parent, the Borrower or any other Subsidiary; provided, however, that (x) any such loans and advances made by a Loan Party that are evidenced by a promissory note shall be pledged to the Collateral Agent for the ratable benefit of the Secured Parties pursuant to the Guarantee and Collateral Agreement (and any such loans and advances made by a Loan Party to a Subsidiary that is not a Loan Party shall be so evidenced and pledged) and (y) any such loan or advance made by a Loan Party to a Subsidiary that is not a Loan Party or by Parent, the Borrower or any Subsidiary to an Unrestricted Subsidiary shall be subject to the requirements and limitations described in clause (y) of the proviso to Section 6.04(a), except to the extent that (1) such loan or advance shall be secured by a fully perfected, first-priority Lien on substantially all of the assets of the recipient of such loan or advance and its subsidiaries (in each case of a type that would have constituted Collateral if such recipient were party to the applicable Security Documents) and (2) such Lien is collaterally assigned to the Collateral Agent for the benefit of the Secured Parties, all on terms reasonably satisfactory to the Collateral Agent;
     (d) investments received in connection with the bankruptcy or reorganization of, or settlement of delinquent accounts and disputes with, customers and suppliers, in each case in the ordinary course of business;
     (e) the Borrower and the Subsidiaries may make loans and advances in the ordinary course of business to their respective employees, officers, consultants and agents (including payroll advances, travel and entertainment advances and relocation loans in the ordinary course of business to employees, officers and agents of the Borrower or any such Subsidiary (or to any physician or other health care professional associated with or agreeing to become associated with Parent, the Borrower or any Subsidiary or any Hospital owned or leased or operated by the Borrower or any Subsidiary (“Health Care Associates”));
     (f) Guarantees to third parties made in the ordinary course of business in connection with the relocation of employees or agents of Health Care Associates of the Borrower or any of the Subsidiaries;
     (g) the Borrower and the Subsidiaries may enter into Hedging Agreements that are not speculative in nature;

 


 

     (h) the Borrower or any Subsidiary may acquire (including by any lease that contains upfront payments and/or buyout options) all or substantially all the assets of a person or line of business of such person, or directly acquire and beneficially own (and retain the right to vote) more than 50% of the aggregate ordinary voting power and aggregate equity value represented by the outstanding capital stock or other Equity Interests of any acquired or newly formed corporation or other entity that acquires or leases such person, division or line of business (referred to herein as the “Acquired Entity”); provided that (i) as of the consummation thereof, such acquisition shall have been approved by the board of directors of the Acquired Entity (ii) the Acquired Entity shall be in a similar, related, incidental or complementary line of business as that of the Borrower and the Subsidiaries as conducted during the current and most recent calendar year; (iii) at the time of such transaction (A) both before and after giving effect thereto, no Default or Event of Default shall have occurred and be continuing, (B) if the total consideration paid in connection with such acquisition and any other acquisitions pursuant to this Section 6.04(h) (including any Indebtedness of the Acquired Entity that is assumed by the Borrower or any Subsidiary following such acquisition and any payments following such acquisition pursuant to earn-out provisions or similar obligations) shall exceed $500,000,000 in the aggregate (excluding the total consideration paid in respect of Permitted Acquisitions listed on Schedule 6.04(h) and consideration consisting of, or funded with the proceeds of, Qualified Capital Stock), then (1) the Leverage Ratio Condition would be satisfied and (2) the Liquidity Condition would be satisfied, (C) the Borrower shall have delivered a certificate of a Financial Officer, certifying as to the foregoing and containing reasonably detailed calculations in support thereof, in form and substance reasonably satisfactory to the Administrative Agent, (D) the Borrower shall comply, and shall cause the Acquired Entity to comply, with the applicable provisions of Section 5.12 and the Security Documents within a period after consummation of such transaction agreed to by the Administrative Agent, and (E) the aggregate consideration paid in connection with all such acquisitions of Acquired Entities that become Foreign Subsidiaries (or, in the case of an acquisition of assets, are not directly acquired by Loan Parties), shall not exceed $300,000,000 (any acquisition of an Acquired Entity meeting all the applicable criteria of this Section 6.04(h) being referred to herein as a “Permitted Acquisition”);
     (i) Permitted Joint Ventures;
     (j) investments in a Permitted Syndication Subsidiary in connection with a Permitted Syndication Transaction made pursuant to Section 6.05(b);
     (k) investments in any Securitization Subsidiary or other person as required pursuant to the terms and conditions of any Permitted Receivables Transaction made pursuant to Section 6.05(b);
     (l) the Borrower or any of the Subsidiaries may acquire and hold Receivables owing to it or Parent, if created or acquired in the ordinary course of business and payable or dischargeable in accordance with customary trade terms;
     (m) investments to the extent that payment for such investments is made with issuances of or the cash proceeds from the issuance of Equity Interests of Parent;

 


 

     (n) extensions of trade credit and purchases of equipment and inventory in the ordinary course of business;
     (o) loans and advances to Parent in lieu of, and not in excess of the amount of, dividends to the extent permitted to be made to Parent in accordance with Section 6.06;
     (p) investments in the ordinary course of business consisting of endorsements for collection or deposit and customary trade arrangements with customers consistent with past practices;
     (q) investments by Parent, the Borrower and the Subsidiaries in any Captive Insurance Subsidiary in an aggregate amount not to exceed 150% of the minimum amount of capital required under the laws of the jurisdiction in which such Captive Insurance Subsidiary is formed (plus any excess capital generated as a result of any such prior investment that would result in an unfavorable tax or reimbursement impact if distributed), and other investments in any Captive Insurance Subsidiary to cover reasonable general corporate and overhead expenses of such Captive Insurance Subsidiary;
     (r) investments by any Captive Insurance Subsidiary;
     (s) investments in any Captive Insurance Subsidiary in connection with a push down by the Borrower of insurance reserves;
     (t) investments held by a person (including by way of acquisition, merger or consolidation) after the Closing Date otherwise in accordance with this Section 6.04 to the extent that such investments were not made in contemplation of or in connection with such acquisition, merger or consolidation and were in existence on the date of such acquisition, merger or consolidation;
     (u) investments in minority interests existing on the Closing Date; and
     (v) in addition to investments permitted by paragraphs (a) through (w) above, additional investments, loans and advances by the Borrower and the Subsidiaries so long as the aggregate outstanding amount of investments, loans and advances pursuant to this paragraph (w) (determined without regard to any write-downs or write-offs of such investments, loans and advances) does not exceed $100,000,000 in the aggregate at any time.
     It is understood and agreed that, in the event that any investment is made by the Borrower or any Subsidiary in any person through substantially concurrent interim transfers of any amount through one or more other Subsidiaries, then such other substantially concurrent interim transfers shall be disregarded for purposes of this Section 6.04.
     SECTION 6.05. Mergers, Consolidations, Sales of Assets and Acquisitions. (a) Merge into or consolidate with any other person, or permit any other person to merge into or consolidate with it, or sell, transfer, lease or otherwise dispose of (in one transaction or in a series of transactions) all or substantially all the assets (whether now owned or hereafter acquired) of the Borrower or less than all the Equity Interests of any Subsidiary (other than pursuant to any

 


 

Permitted Interest Transfer or transfers of Equity Interests of any Subsidiary to a Loan Party or by a Subsidiary that is not a Subsidiary Guarantor to any Subsidiary), or purchase or otherwise acquire (in one transaction or a series of transactions) all or substantially all of the assets of any other person, except that (i) the Borrower and any Subsidiary may purchase and sell inventory in the ordinary course of business and (ii) if at the time thereof and immediately after giving effect thereto no Event of Default or Default shall have occurred and be continuing (x) any wholly owned Subsidiary may merge into the Borrower in a transaction in which the Borrower is the surviving corporation, (y) any Subsidiary may merge into or consolidate with any other Subsidiary in a transaction in which the surviving entity is a Subsidiary (provided that (A) if any party to any such transaction is a Loan Party, the surviving entity of such transaction shall be a Loan Party and (B) to the extent any person other than the Borrower or a wholly owned Subsidiary receives any consideration in connection therewith, then such transaction shall be considered as an investment under the applicable paragraph of Section 6.04) and (z) the Borrower and the Subsidiaries may make Permitted Acquisitions or any other investment, loan or advance permitted pursuant to Section 6.04 (including by merger), and may enter into Permitted Joint Ventures.
     (b) Make any Asset Sale otherwise permitted under paragraph (a) above unless such Asset Sale is:
     (i) for consideration that is at least equal to the fair market value of the assets being sold, transferred, leased or disposed of; provided that (x) for any disposition of assets with a fair market value of more than $50,000,000, at least 75% of such consideration is cash and (y) the fair market value of all assets sold, transferred, leased or disposed of (other than assets which are sold, transferred, leased or disposed of in order to comply with any requirement, rule or regulation of, or order by, or agreement with, any Governmental Authority in connection with a Permitted Acquisition) pursuant to this clause (b)(i) shall not exceed $300,000,000 in any fiscal year, provided further that, prior to the Incremental Asset Sale Termination Date, such annual amount shall be increased by an aggregate amount not to exceed $750,000,000;
     (ii) a Receivables Transaction, provided that (x) the material terms and conditions and the structure of such Receivables Transaction have been approved by the Administrative Agent (such approval not to be unreasonably withheld or delayed), (y) any Liens granted in connection with such Receivables Transaction shall comply with the terms of Section 6.02(p) and (z) the aggregate Receivables Transaction Amount outstanding at any time in respect of all Receivables Transactions does not exceed $2,000,000,000 (any Receivables Transaction meeting all the criteria of this Section 6.05(b)(ii) being referred to herein as a “Permitted Receivables Transaction”);
     (iii) a Syndication Transaction, provided that the aggregate amount or value of the consideration received by any Permitted Syndication Subsidiary and/or the Borrower and the other Subsidiaries from third parties in connection with such Syndication Transaction (or series of Syndication Transactions), except for the Syndication Transactions listed on Schedule 6.05(b) (the “Syndication Proceeds”), when added to the aggregate Syndication Proceeds from all previous Permitted Syndications on or after the Closing Date does not exceed $200,000,000 (any Syndication Transaction meeting the criteria of this Section 6.05(b)(iii) being referred to herein as a “Permitted Syndication Transaction”);

 


 

     (iv) any Permitted Interest Transfer;
     (v) for the sale or other disposition consummated by the Borrower or any of the Subsidiaries after the Closing Date of assets constituting a subsidiary or business unit or units of the Borrower or the Subsidiaries (including a Facility) or the interest of the Borrower or the Subsidiaries therein, provided that (i) such sale or other disposition shall be made for fair value on an arm’s-length basis and (ii) the consideration received for such sale or other disposition constitutes or would constitute a Permitted Acquisition, Permitted Joint Venture or Permitted Syndication Subsidiary in accordance with the definition thereof;
     (vi) the Borrower and the Subsidiaries may abandon, allow to lapse or otherwise dispose of intangible property that the Borrower or such Subsidiary shall determine in its reasonable business judgment is immaterial to the conduct of its business;
     (vii) forgiveness of any loans or advances made pursuant to Section 6.04(e);
     (viii) transfers of property subject to casualty or a condemnation proceeding;
     (ix) Restricted Payments permitted pursuant to Section 6.06; or
     (x) for the sale or other disposition of real estate and related assets (other than Hospitals and Receivables) for the fair market value thereof in cash, in an aggregate amount not to exceed $300,000,000.
     SECTION 6.06. Restricted Payments; Restrictive Agreements. (a) Declare or make, or agree to declare or make, directly or indirectly, any Restricted Payment (including pursuant to any Synthetic Purchase Agreement), or incur any obligation (contingent or otherwise) to do so; provided, however, that
     (i) any Subsidiary may declare and pay dividends or make other distributions ratably to its equity holders;
     (ii) Parent may distribute the Equity Interests of a Spinout Subsidiary pursuant to a Spinout Transaction;
     (iii) so long as no Event of Default or Default shall have occurred and be continuing or would result therefrom, the Borrower may, or the Borrower may make distributions to Parent so that Parent may, repurchase its Equity Interests owned by current or former employees, directors or consultants of Parent, the Borrower or the Subsidiaries or make payments to employees, directors or consultants of Parent, the Borrower or the Subsidiaries in connection with the exercise of stock options, stock appreciation rights or similar equity incentives or equity based incentives pursuant to management incentive plans in an aggregate amount not to exceed $40,000,000 in any fiscal year;
     (iv) the Borrower may make Restricted Payments to Parent (x) to the extent necessary to pay general corporate and overhead expenses incurred by Parent in the ordinary course of business (including legal, accounting and similar expenses) and expenses necessary to maintain its status as a publicly held corporation, and (y) in an

 


 

amount necessary to pay the Tax liabilities of Parent; provided, however, that all Restricted Payments made to Parent pursuant to this clause (iii) are used by Parent for the purposes specified herein within 20 days of the receipt thereof;
     (v) in addition to Restricted Payments permitted by clauses (i) through (iv) above, so long as no Event of Default or Default shall have occurred and be continuing or would result therefrom, the Borrower may make other Restricted Payments, and Parent may make Restricted Payments, in an aggregate principal amount from the Restatement Effective Date not to exceed $50,000,000 less the amount of payments made from and after the Restatement Effective Date pursuant to Section 6.09(b)(i);
     (vi) the Borrower may net shares under employee benefits plans to settle option price payments owed by employees and directors with respect thereto and to settle employees’ and directors’ Federal, state and income tax liabilities (if any) related thereto;
     (vii) so long as (A) no Event of Default or Default shall have occurred and be continuing or would result therefrom and (B) at the time of and after giving effect thereto, the Secured Leverage Ratio shall not be greater than 3.0 to 1.0, the Borrower may make other Restricted Payments, and Parent may make Restricted Payments, in an amount not to exceed the Available Amount at the time such Restricted Payment is made; and
     (viii) so long as no Event of Default or Default shall have occurred and be continuing or would result therefrom, the Borrower may, or the Borrower may make distributions to Parent so that Parent may, (A) repurchase any of its Equity Interests, or (B) make payments to employees, directors or consultants of Parent, the Borrower or the Subsidiaries in connection with the exercise of stock options, stock appreciation rights or similar equity incentives or equity based incentives pursuant to management incentive plans, in each case in an aggregate amount not to exceed the Received Exercise Proceeds Amount at the time such Restricted Payment is made.
     (b) Enter into, incur or permit to exist any agreement or other arrangement that prohibits, restricts or imposes any condition upon (i) the ability of Parent, the Borrower or any Subsidiary (other than any Permitted Joint Venture Subsidiary) to create, incur or permit to exist any Lien upon any of its property or assets to secure the Obligations, or (ii) the ability of any Subsidiary (other than any Permitted Joint Venture Subsidiary) to pay dividends or other distributions with respect to any of its Equity Interests or to make or repay loans or advances to the Borrower or any other Subsidiary or to Guarantee Indebtedness of the Borrower or any other Subsidiary; provided (x) that the foregoing shall not apply to restrictions and conditions (A) imposed by law or by any Loan Document or the Senior Note Indenture, (B) contained in agreements relating to the sale of a Subsidiary or other assets pending such sale, provided such restrictions and conditions apply only to the Subsidiary or assets that are to be sold and such sale is permitted hereunder, (C) imposed on any Foreign Subsidiary by the terms of any Indebtedness of such Foreign Subsidiary permitted to be incurred hereunder, (D) imposed pursuant to other Indebtedness incurred pursuant to Section 6.01 with such encumbrances and restrictions that, taken as a whole, are not more restrictive than the terms hereof, (E) contained in any agreement relating to a Permitted Receivables Transaction if such restrictions or encumbrances apply only to the relevant Permitted Receivables Transaction and are required pursuant to the terms and conditions of such Permitted Receivables Transaction, (F) on Permitted Joint Ventures or other joint ventures permitted under Section 6.04 and Permitted Syndication Subsidiaries imposed by

 


 

the terms of the agreements governing the same, (G) applicable to an Acquired Entity at the time such Acquired Entity became a Subsidiary, so long as such restriction or encumbrance was not created in contemplation of or in connection with such Acquired Entity becoming a Subsidiary and apply only to such Acquired Entity and (H) imposed by any credit agreement, indenture or other agreement governing Pari Passu Debt, so long as such restrictions and conditions are not less favorable to the Lenders than to the holders of such Pari Passu Debt; and (y) clause (i) of the foregoing shall not apply to restrictions or conditions (A) that are customary provisions in leases and other contracts restricting the assignment thereof and any right of first refusal and (B) imposed by any agreement relating to secured Indebtedness permitted by this Agreement if such restrictions or conditions apply only to the property or assets securing such Indebtedness.
     SECTION 6.07. Transactions with Affiliates. Except for (a) transactions between or among Parent and its Subsidiaries or described on Schedule 6.07 and (b) the sale, transfer or other disposition by Parent, the Borrower or any Subsidiary in compliance with Section 6.05(b)(i) of real property owned by it to any Spinout Subsidiary pursuant to a Spinout Transaction, sell or transfer any property or assets to, or purchase or acquire any property or assets from, or otherwise engage in any other transactions with, any of its Affiliates, except (i) the Borrower or any Subsidiary may engage in any of the foregoing transactions on terms and conditions not less favorable to the Borrower or such Subsidiary than could be obtained on an arm’s-length basis from unrelated third parties, (ii) the Borrower and the Subsidiaries may make (x) investments, loans and advances and (y) Restricted Payments, permitted by Section 6.04 and Section 6.06, respectively, (iii) the Borrower may engage in Receivables Transactions, (iv) any issuance of Equity Interests by Parent otherwise permitted hereunder, (v) any issuance of Equity Interests, or other payments, awards or grants in cash, securities or otherwise pursuant to, or the funding of, employment arrangements, stock options and stock ownership plans, or indemnities provided on behalf of employees or directors and approved by the board of directors or senior management of Parent and (vi) the payment of reasonable fees to directors of Parent, the Borrower and the Subsidiaries who are not employees of Parent, the Borrower or the Subsidiaries.
     SECTION 6.08. Business of Parent, Borrower and Subsidiaries. Engage at any time in any business or business activity other than the business currently conducted by it and business activities reasonably similar, incidental or complementary thereto and reasonable extensions thereof.
     SECTION 6.09. Other Indebtedness. (a) Permit any waiver, supplement, modification, amendment, termination or release of the Senior Notes Indenture or any waiver, supplement, modification or amendment of any indenture, instrument or agreement pursuant to which any subordinated Material Indebtedness of Parent, the Borrower or any of the Subsidiaries is outstanding if the effect of such waiver, supplement, modification, amendment, termination or release would materially increase the obligations of the obligor or confer additional material rights on the holder of such Indebtedness in a manner adverse to the Lenders.
     (b) Make any distribution, whether in cash, property, securities or a combination thereof, other than regular scheduled payments of principal and interest as and when due (to the extent not prohibited by applicable subordination provisions), in respect of, or pay, or commit to pay, or directly or indirectly (including pursuant to any Synthetic Purchase Agreement) redeem, repurchase, retire or otherwise acquire for consideration, or set apart any sum for the aforesaid purposes, any Senior Notes or subordinated Indebtedness (other than intercompany

 


 

Indebtedness); provided, however, that, so long as no Default or Event of Default shall have occurred and be continuing at the date of such redemption, repurchase, retirement or other acquisition for consideration, or would result therefrom, Parent, the Borrower or any Subsidiary may redeem, repurchase, retire or otherwise acquire for consideration (i) from and after the Restatement Effective Date, Senior Notes and subordinated Indebtedness for an aggregate price not in excess of (A) $50,000,000 less (B) the amount of Restricted Payments made from and after the Restatement Effective Date pursuant to clause (v) of Section 6.06(a), (ii) Senior Notes with the proceeds of or in exchange for (A) refinancing Indebtedness otherwise permitted pursuant to Section 6.01(h) or (B) the issuance of Equity Interests, (iii) subordinated Indebtedness with the proceeds of or in exchange for (A) subordinated Indebtedness that is permitted pursuant to Section 6.01 and is subordinated on terms not materially less advantageous to the Lenders than those of the Indebtedness being redeemed, repurchased, retired or otherwise acquired for consideration or (B) the issuance of Equity Interests or (iv) Senior Notes and subordinated Indebtedness so long as (A) the amount paid in respect thereof does not exceed the Available Amount at the time paid and (B) at the time of and after giving effect thereto, the Secured Leverage Ratio shall not be greater than 3.0 to 1.0.
     SECTION 6.10. Practice Guarantees. Enter into Practice Guarantees with a term of 30 months or longer in an aggregate amount in excess of $150,000,000 in effect at any time with respect to all such Practice Guarantees.
     SECTION 6.11. Capital Expenditures. Permit the aggregate amount of Capital Expenditures (other than Replacement Capital Expenditures) made by Parent, the Borrower and the Subsidiaries in any period set forth below to exceed the greater of (a) in the case of any fiscal year beginning on or after January 1, 2008, 5.5% of consolidated net revenues of Parent, the Borrower and the Subsidiaries for the immediately preceding fiscal year (as set forth in the financial statements delivered pursuant to Section 5.04(a) with respect to such fiscal year) and (b) the amount set forth below for such period (such greater amount, the “Permitted Capital Expenditure Amount”):
         
Period   Amount
 
       
Closing Date through December 31, 2007
  $ 475,000,000  
January 1, 2008 through December 31, 2008
  $ 800,000,000  
January 1, 2009 through December 31, 2009
  $ 800,000,000  
January 1, 2010 through December 31, 2010
  $ 850,000,000  
January 1, 2011 through December 31, 2011
  $ 925,000,000  
January 1, 2012 through December 31, 2012
  $ 1,100,000,000  
January 1, 2013 through December 31, 2013
  $ 1,100,000,000  
Each fiscal year thereafter
  $ 1,100,000,000  
     In any year in which a Permitted Acquisition occurs, the Permitted Capital Expenditure Amount in respect of such fiscal year shall be increased (but not decreased) by an amount equal to 5.5% of the net revenues generated by the Acquired Entity acquired during the preceding fiscal year of such Acquired Entity (pro rated based on the number of days remaining in such fiscal year). In addition, to the extent any portion of the Permitted Capital Expenditure Amount for any fiscal year (as the same may have been increased pursuant to the preceding sentence) is not fully expended during such fiscal year, then 50% of the amount not so expended may be carried forward to and used in succeeding fiscal years. In addition, for any fiscal year, the

 


 

amount of Capital Expenditures that would otherwise be permitted in such fiscal year pursuant to this Section 6.11 may be increased by an amount not to exceed 50% of the Permitted Capital Expenditure Amount for the immediately succeeding fiscal year (the “CapEx Pull-Forward Amount”). The actual CapEx Pull-Forward Amount in respect of any such fiscal year shall reduce, on a dollar-for-dollar basis, the amount of Capital Expenditures that would have been permitted to be made in the immediately succeeding fiscal year. In addition, for any fiscal year, the amount of Capital Expenditures that would otherwise be permitted in such fiscal year pursuant to this Section 6.11 may be increased by an amount not to exceed $200,000,000 if, at the time of such expenditure, both before and after giving pro forma effect thereto, (x) no Default or Event of Default shall have occurred and be continuing and (y) the Leverage Ratio is less than 4.50 to 1.00.
     SECTION 6.12. Interest Coverage Ratio. Permit the Interest Coverage Ratio for any period of four consecutive fiscal quarters, in each case taken as one accounting period, ending during any period set forth below to be less than the ratio set forth opposite such period below:
         
Period   Ratio  
 
       
September 30, 2007 through September 30, 2009
    1.75 to 1.00  
October 1, 2009 through September 30, 2011
    2.00 to 1.00  
October 1, 2011 through September 30, 2012
    2.25 to 1.00  
Thereafter
    2.50 to 1.00  
     SECTION 6.13. Maximum Leverage Ratio. Permit the Leverage Ratio as of the last day of any fiscal quarter ending during a period set forth below to be greater than the ratio set forth opposite such period below:
         
Period   Ratio  
 
       
September 30, 2007 through March 31, 2009
    7.25 to 1.00  
April 1, 2009 through June 30, 2009
    7.00 to 1.00  
July 1, 2009 through September 30, 2009
    6.75 to 1.00  
October 1, 2009 through September 30, 2010
    6.50 to 1.00  
October 1, 2010 through September 30, 2011
    6.00 to 1.00  
October 1, 2011 through September 30, 2012
    5.50 to 1.00  
Thereafter
    5.00 to 1.00  
     SECTION 6.14. Fiscal Year. With respect to Parent and the Borrower, change their fiscal year-end to a date other than December 31.
ARTICLE VII
Events of Default
     In case of the happening of any of the following events (“Events of Default”):

 


 

     (a) any representation, warranty or statement made or deemed made by any Loan Party herein or in any other Loan Document or any certificate delivered or required to be delivered pursuant hereto or thereto shall prove to be untrue in any material respect on the date as of which it was made or deemed made;
     (b) default shall be made in the payment of any principal of any Loan or the reimbursement with respect to any L/C Disbursement when and as the same shall become due and payable, whether at the due date thereof or at a date fixed for prepayment thereof or by acceleration thereof or otherwise;
     (c) default shall be made in the payment of any interest on any Loan or any Fee or L/C Disbursement or any other amount (other than an amount referred to in (b) above) due under any Loan Document, when and as the same shall become due and payable, and such default shall continue unremedied for a period of five Business Days;
     (d) default shall be made in the due observance or performance by Parent, the Borrower or any Subsidiary of any covenant, condition or agreement contained in Section 5.01(a) (with respect to Parent and the Borrower only), 5.05(a) or 5.08 or in Article VI;
     (e) default shall be made in the due observance or performance by Parent, the Borrower or any Subsidiary of any covenant or agreement contained in any Loan Document (other than those specified in (b), (c) or (d) above) and such default shall continue unremedied for a period of 30 days after notice thereof from the Administrative Agent or any Lender to the Borrower;
     (f) (i) Parent, the Borrower or any Subsidiary shall fail to pay any principal, interest or other amount due in respect of any Material Indebtedness, when and as the same shall become due and payable (after giving effect to any grace period) or (ii) any other event or condition occurs that results in any Material Indebtedness becoming due prior to its scheduled maturity or that enables or permits (with or without the giving of notice, the lapse of time or both) the holder or holders of any Material Indebtedness or any trustee or agent on its or their behalf to cause any Material Indebtedness to become due, or to require the prepayment, repurchase, redemption or defeasance thereof, prior to its scheduled maturity or that results in the termination or permits any counterparty to terminate any Hedging Agreement the obligations under which constitute Material Indebtedness; provided that this clause (ii) shall not apply to secured Indebtedness that becomes due as a result of the voluntary sale or transfer of the property or assets securing such Indebtedness;
     (g) an involuntary proceeding shall be commenced or an involuntary petition shall be filed in a court of competent jurisdiction seeking (i) relief in respect of Parent, the Borrower or any Subsidiary (other than a Non-Significant Subsidiary within the meaning of clause (a) of the definition thereof), or of a substantial part of the property or assets of Parent, the Borrower or a Subsidiary (other than a Non-Significant Subsidiary within the meaning of clause (a) of the definition thereof), under Title 11 of the United States Code, as now constituted or hereafter amended, or any other Federal, state or foreign bankruptcy, insolvency, receivership or similar law, (ii) the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for Parent, the Borrower or

 


 

any Subsidiary (other than a Non-Significant Subsidiary within the meaning of clause (a) of the definition thereof) or for a substantial part of the property or assets of Parent, the Borrower or a Subsidiary or (iii) the winding-up or liquidation of Parent, the Borrower or any Subsidiary (other than a Non-Significant Subsidiary within the meaning of clause (a) of the definition thereof); and such proceeding or petition shall continue undismissed for 60 days or an order or decree approving or ordering any of the foregoing shall be entered;
     (h) Parent, the Borrower or any Subsidiary (other than a Non-Significant Subsidiary within the meaning of clause (a) of the definition thereof) shall (i) voluntarily commence any proceeding or file any petition seeking relief under Title 11 of the United States Code, as now constituted or hereafter amended, or any other Federal, state or foreign bankruptcy, insolvency, receivership or similar law, (ii) consent to the institution of any proceeding or the filing of any petition described in (g) above, (iii) apply for or consent to the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for Parent, the Borrower or any Subsidiary (other than a Non-Significant Subsidiary within the meaning of clause (a) of the definition thereof) or for a substantial part of the property or assets of Parent, the Borrower or any Subsidiary (other than a Non-Significant Subsidiary within the meaning of clause (a) of the definition thereof), (iv) file an answer admitting the material allegations of a petition filed against it in any such proceeding, (v) make a general assignment for the benefit of creditors, (vi) become unable, admit in writing its inability or fail generally to pay its debts as they become due or (vii) take any corporate action for the purpose of effecting any of the foregoing;
     (i) one or more judgments shall be rendered against Parent, the Borrower, any Subsidiary or any combination thereof (not paid or fully covered by insurance) and the same shall remain undischarged for a period of 30 consecutive days during which execution shall not be effectively stayed, or any action shall be legally taken by a judgment creditor to levy upon assets or properties of Parent, the Borrower or any Subsidiary to enforce any such judgment and such judgment is for the payment of money in an aggregate amount in excess of $50,000,000;
     (j) an ERISA Event shall have occurred that, in the opinion of the Required Lenders, when taken together with all other such ERISA Events, could reasonably be expected to result in liability of the Borrower and its ERISA Affiliates in an aggregate amount exceeding $50,000,000;
     (k) any Guarantee under the Guarantee and Collateral Agreement for any reason shall cease to be in full force and effect (other than in accordance with its terms), or any Guarantor shall deny in writing that it has any further liability under the Guarantee and Collateral Agreement (other than as a result of the discharge of such Guarantor in accordance with the terms of the Loan Documents);
     (l) any security interest purported to be created by any Security Document with respect to any Collateral with an aggregate fair market value in excess of $50,000,000 shall cease to be, or shall be asserted by the Borrower or any other Loan Party not to be, a valid, perfected (subject to the qualifications set forth in Section 3.19(a)), first priority (except as otherwise expressly provided in this Agreement or such Security Document) security interest in the securities, assets or properties covered thereby, except to the extent that any such loss of perfection or priority results from the failure of the Collateral

 


 

Agent to maintain possession of certificates representing securities pledged under the Guarantee and Collateral Agreement or any other act or omission by the Collateral Agent and except to the extent that such loss is covered by a lender’s title insurance policy and the related insurer does not deny that such loss is covered by such title insurance policy;
     (m) the Indebtedness under any subordinated Indebtedness of Parent, the Borrower or any Subsidiary constituting Material Indebtedness shall cease (or any Loan Party or an Affiliate of any Loan Party shall so assert), for any reason, to be validly subordinated to the Obligations as provided in the agreements evidencing such subordinated Indebtedness;
     (n) there shall have occurred a Change in Control;
     (o) on any date, any Pari Passu Debt that at the time would constitute Material Indebtedness and that has a final stated maturity date within 91 days of such date shall remain outstanding; or
     (p) so long as any Pari Passu Debt is outstanding, any Pari Passu Intercreditor Agreement shall cease to be effective or cease to be legally valid and binding, or otherwise not be effective to create the rights and obligations purported to be created thereunder, unless the same (i) results directly from the action or inaction of the Collateral Agent or (ii) is not materially adverse to the Lenders;
     then, and in every such event (other than an event with respect to Parent or the Borrower described in paragraph (g) or (h) above), and at any time thereafter during the continuance of such event, the Administrative Agent, at the request of the Required Lenders shall, by notice to the Borrower, take either or both of the following actions, at the same or different times: (i) terminate forthwith the Commitments and (ii) declare the Loans then outstanding to be forthwith due and payable in whole or in part, whereupon the principal of the Loans so declared to be due and payable, together with accrued interest thereon and any unpaid accrued Fees and all other liabilities of the Borrower accrued hereunder and under any other Loan Document, shall become forthwith due and payable, without presentment, demand, protest or any other notice of any kind, all of which are hereby expressly waived by the Borrower, anything contained herein or in any other Loan Document to the contrary notwithstanding; and in any event with respect to Parent or the Borrower described in paragraph (g) or (h) above, the Commitments shall automatically terminate and the principal of the Loans then outstanding, together with accrued interest thereon and any unpaid accrued Fees and all other liabilities of the Borrower accrued hereunder and under any other Loan Document, shall automatically become due and payable, without presentment, demand, protest or any other notice of any kind, all of which are hereby expressly waived by the Borrower, anything contained herein or in any other Loan Document to the contrary notwithstanding.
     Notwithstanding anything to the contrary contained in this Article VII, upon the request of the Borrower made in writing to the Administrative Agent, in the event of any Event of Default under any covenant set forth in Section 6.12 or 6.13 and until the expiration of the tenth Business Day after the date on which financial statements are required to be delivered with respect to the applicable fiscal quarter hereunder, Parent may issue Qualified Capital Stock and elect to treat all or any portion of the net cash proceeds thereof as having increased Consolidated EBITDA with respect to such applicable quarter solely for the purpose of determining actual and

 


 

pro forma compliance with Sections 6.12 and 6.13 at the end of such applicable quarter and applicable subsequent periods and for purposes of determining whether the Leverage Ratio Condition has been satisfied and not for any other purpose of this Agreement (including determining the Applicable Percentage) provided that (a) such proceeds (i) are actually received by Parent and contributed to the Borrower no later than ten days after the date on which financial statements are required to be delivered with respect to such fiscal quarter hereunder and (ii) do not exceed the aggregate amount necessary to cause Parent to be in compliance with the covenants under Sections 6.12 or 6.13 for any applicable period and (b) in each period of four fiscal quarters, there shall be at least two fiscal quarters in which no such right to cure permitted by this paragraph is utilized.
ARTICLE VIII
The Administrative Agent and the Collateral Agent
     Each of the Lenders and the Issuing Bank hereby irrevocably appoints the Administrative Agent and the Collateral Agent (for purposes of this Article VIII, the Administrative Agent and the Collateral Agent are referred to collectively as the “Agents”) its agent and authorizes the Agents to take such actions on its behalf and to exercise such powers as are delegated to such Agent by the terms of the Loan Documents, together with such actions and powers as are reasonably incidental thereto. Without limiting the generality of the foregoing, the Agents are hereby expressly authorized to execute any and all documents (including releases) with respect to the Collateral and the rights of the Secured Parties with respect thereto, as contemplated by and in accordance with the provisions of this Agreement and the Security Documents.
     The bank serving as the Administrative Agent and/or the Collateral Agent hereunder shall have the same rights and powers in its capacity as a Lender as any other Lender and may exercise the same as though it were not an Agent, and such bank and its Affiliates may accept deposits from, lend money to and generally engage in any kind of business with Parent, the Borrower or any Subsidiary or other Affiliate thereof as if it were not an Agent hereunder.
     Neither Agent shall have any duties or obligations except those expressly set forth in the Loan Documents. Without limiting the generality of the foregoing, (a) neither Agent shall be subject to any fiduciary or other implied duties, regardless of whether a Default has occurred and is continuing, (b) neither Agent shall have any duty to take any discretionary action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated hereby that such Agent is instructed in writing to exercise by the Required Lenders (or such other number or percentage of the Lenders as shall be necessary under the circumstances as provided in Section 9.08), and (c) except as expressly set forth in the Loan Documents, neither Agent shall have any duty to disclose, nor shall it be liable for the failure to disclose, any information relating to Parent, the Borrower or any of the Subsidiaries that is communicated to or obtained by the bank serving as Administrative Agent and/or Collateral Agent or any of its Affiliates in any capacity. Neither Agent shall be liable for any action taken or not taken by it with the consent or at the request of the Required Lenders (or such other number or percentage of the Lenders as shall be necessary under the circumstances as provided in Section 9.08) or in the absence of its own gross negligence or willful misconduct. Neither Agent shall be deemed to have knowledge of any Default unless and until written notice thereof is given to such Agent by Parent, the Borrower or a Lender, and neither Agent shall be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or representation made in or in connection

 


 

with any Loan Document, (ii) the contents of any certificate, report or other document delivered thereunder or in connection therewith, (iii) the performance or observance of any of the covenants, agreements or other terms or conditions set forth in any Loan Document, (iv) the validity, enforceability, effectiveness or genuineness of any Loan Document or any other agreement, instrument or document, or (v) the satisfaction of any condition set forth in Article IV or elsewhere in any Loan Document, other than to confirm receipt of items expressly required to be delivered to such Agent.
     Each Agent shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request, certificate, consent, statement, instrument, document or other writing believed by it to be genuine and to have been signed or sent by the proper person. Each Agent may also rely upon any statement made to it orally or by telephone and believed by it to have been made by the proper person, and shall not incur any liability for relying thereon. Each Agent may consult with legal counsel (who may be counsel for the Borrower), independent accountants and other experts selected by it, and shall not be liable for any action taken or not taken by it in accordance with the advice of any such counsel, accountants or experts.
     Each Agent may perform any and all its duties and exercise its rights and powers by or through any one or more sub-agents appointed by it. Each Agent and any such sub-agent may perform any and all its duties and exercise its rights and powers by or through their respective Related Parties. The exculpatory provisions of the preceding paragraphs shall apply to any such sub-agent and to the Related Parties of each Agent and any such sub-agent, and shall apply to their respective activities in connection with the syndication of the Credit Facilities as well as activities as Agent.
     Subject to the appointment and acceptance of a successor Agent as provided below, either Agent may resign at any time by notifying the Lenders, the Issuing Bank and the Borrower. Upon any such resignation, the Required Lenders shall have the right, with the consent (not to be unreasonably withheld or delayed) of the Borrower, to appoint a successor; provided that during the existence and continuation of an Event of Default pursuant to paragraph (b), (c), (g) or (h) of Article VII, no consent of the Borrower shall be required. If no successor shall have been so appointed by the Required Lenders and shall have accepted such appointment within 30 days after the retiring Agent gives notice of its resignation, then the retiring Agent may, on behalf of the Lenders and the Issuing Bank, appoint a successor Agent which shall be a bank with an office in New York, New York, having a combined capital and surplus of at least $1,000,000,000, or an Affiliate of any such bank and, so long as no Event of Default pursuant to paragraph (b), (c), (g) or (h) of Article VII shall have occurred and be continuing, reasonably acceptable to the Borrower. Upon the acceptance of its appointment as Agent hereunder by a successor, such successor shall succeed to and become vested with all the rights, powers, privileges and duties of the retiring Agent, and the retiring Agent shall be discharged from its duties and obligations hereunder. The fees payable by the Borrower to a successor Agent shall be the same as those payable to its predecessor unless otherwise agreed between the Borrower and such successor. After an Agent’s resignation hereunder, the provisions of this Article and Section 9.05 shall continue in effect for the benefit of such retiring Agent, its sub-agents and their respective Related Parties in respect of any actions taken or omitted to be taken by any of them while acting as Agent.
     Each Lender acknowledges that it has, independently and without reliance upon the Agents or any other Lender and based on such documents and information as it has deemed

 


 

appropriate, made its own credit analysis and decision to enter into this Agreement. Each Lender also acknowledges that it will, independently and without reliance upon the Agents or any other Lender and based on such documents and information as it shall from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or based upon this Agreement or any other Loan Document, any related agreement or any document furnished hereunder or thereunder.
ARTICLE IX
Miscellaneous
     SECTION 9.01. Notices. Notices and other communications provided for herein shall be in writing and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by fax, as follows:
     (a) if to the Borrower or Parent, to it at Community Health Systems, Inc., 4000 Meridian Boulevard, Franklin, Tennessee 37067, Attention of the Chief Financial Officer (Fax No. (615) 373-9704);
     (b) if to the Administrative Agent, to Credit Suisse AG, Eleven Madison Avenue, New York, NY 10010, Attention of Agency Group (Fax No. (212) 325-8304), Email: agency.loanops@credit-suisse.com; and
     (c) if to a Lender, to it at its address (or fax number) set forth on Schedule 2.01 or in the Assignment and Acceptance pursuant to which such Lender shall have become a party hereto.
     All notices and other communications given to any party hereto in accordance with the provisions of this Agreement shall be deemed to have been given on the date of receipt if delivered by hand or overnight courier service or sent by fax or on the date five Business Days after dispatch by certified or registered mail if mailed, in each case delivered, sent or mailed (properly addressed) to such party as provided in this Section 9.01 or in accordance with the latest unrevoked direction from such party given in accordance with this Section 9.01. As agreed to among Parent, the Borrower, the Administrative Agent and the applicable Lenders from time to time, notices and other communications may also be delivered by e-mail to the e-mail address of a representative of the applicable person provided from time to time by such person.
     Parent and the Borrower hereby acknowledge that (a) the Administrative Agent will make available to the Lenders and the Issuing Bank materials and/or information provided by or on behalf of the Borrower hereunder (collectively, the “Borrower Materials”) by posting the Borrower Materials on Intralinks or another similar electronic system (the “Platform”) and (b) certain of the Lenders may be “public-side” Lenders (i.e., Lenders that do not wish to receive material non-public information with respect to each Borrower or its securities) (each, a “Public Lender”). Parent and the Borrower hereby agree that (i) all Borrower Materials that are to be made available to Public Lenders shall be clearly and conspicuously marked “PUBLIC” which, at a minimum, shall mean that the word “PUBLIC” shall appear prominently on the first page thereof; (ii) by marking Borrower Materials “PUBLIC,” the Borrower shall be deemed to have authorized the Administrative Agent and the Lenders to treat such Borrower Materials as not containing any material non-public information with respect to Parent and the Borrower or its securities for purposes of foreign, United States Federal and state securities laws (provided,

 


 

however, that to the extent such Borrower Materials constitute Information, they shall be treated as set forth in Section 9.17); (iii) all Borrower Materials marked “PUBLIC” are permitted to be made available through a portion of the Platform designated as “Public Investor” and (iv) the Administrative Agent shall be entitled to treat any Borrower Materials that are not marked “PUBLIC” as being suitable only for posting on a portion of the Platform not marked as “Public Investor”. Notwithstanding the foregoing, the following Borrower Materials shall be marked “PUBLIC”, unless Parent or the Borrower notifies the Administrative Agent promptly that any such document contains material non-public information: (A) the Loan Documents and (B) any notification of changes in the terms of the Credit Facilities.
     Each Public Lender agrees to cause at least one individual at or on behalf of such Public Lender to at all times have selected the “Private Side Information” or similar designation on the content declaration screen of the Platform in order to enable such Public Lender or its delegate, in accordance with such Public Lender’s compliance procedures and applicable law, including foreign, United States Federal and state securities laws, to make reference to Communications that are not made available through the “Public Side Information” portion of the Platform and that may contain material non-public information with respect to Parent or the Borrower or its securities for purposes of foreign, United States Federal or state securities laws.
     THE PLATFORM IS PROVIDED “AS IS” AND “AS AVAILABLE”. NEITHER THE ADMINISTRATIVE AGENT NOR ANY OF ITS RELATED PARTIES WARRANTS THE ACCURACY OR COMPLETENESS OF THE COMMUNICATIONS OR THE ADEQUACY OF THE PLATFORM AND EACH EXPRESSLY DISCLAIMS LIABILITY FOR ERRORS OR OMISSIONS IN THE COMMUNICATIONS. NO WARRANTY OF ANY KIND, EXPRESS, IMPLIED OR STATUTORY, INCLUDING ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT OF THIRD PARTY RIGHTS OR FREEDOM FROM VIRUSES OR OTHER CODE DEFECTS IS MADE BY THE ADMINISTRATIVE AGENT OR ANY OF ITS RELATED PARTIES IN CONNECTION WITH THE COMMUNICATIONS OR THE PLATFORM. IN NO EVENT SHALL THE ADMINISTRATIVE AGENT OR ANY OF ITS RELATED PARTIES HAVE ANY LIABILITY TO ANY LOAN PARTY, ANY LENDER OR ANY OTHER PERSON FOR DAMAGES OF ANY KIND, WHETHER OR NOT BASED ON STRICT LIABILITY AND INCLUDING DIRECT OR INDIRECT, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES, LOSSES OR EXPENSES (WHETHER IN TORT, CONTRACT OR OTHERWISE) ARISING OUT OF ANY LOAN PARTY’S OR THE ADMINISTRATIVE AGENT’S TRANSMISSION OF COMMUNICATIONS THROUGH THE INTERNET, EXCEPT TO THE EXTENT THE LIABILITY OF ANY SUCH PERSON IS FOUND IN A FINAL RULING BY A COURT OF COMPETENT JURISDICTION TO HAVE RESULTED PRIMARILY FROM SUCH PERSON’S GROSS NEGLIGENCE OR WILLFUL MISCONDUCT.
     The Administrative Agent agrees that the receipt of the Communications by the Administrative Agent at its e-mail address set forth above shall constitute effective delivery of the Communications to the Administrative Agent for purposes of the Loan Documents. Each Lender agrees that receipt of notice to it (as provided in the next sentence) specifying that the Communications have been posted to the Platform shall constitute effective delivery of the Communications to such Lender for purposes of the Loan Documents. Each Lender agrees to notify the Administrative Agent in writing (including by electronic communication) from time to

 


 

time of such Lender’s e-mail address to which the foregoing notice may be sent by electronic transmission and that the foregoing notice may be sent to such e-mail address.
     Nothing herein shall prejudice the right of the Administrative Agent or any Lender to give any notice or other communication pursuant to any Loan Document in any other manner specified in such Loan Document.
     SECTION 9.02. Survival of Agreement. All covenants, agreements, representations and warranties made by the Borrower or Parent herein and in the certificates or other instruments prepared or delivered in connection with or pursuant to this Agreement or any other Loan Document shall be considered to have been relied upon by the Lenders and the Issuing Bank and shall survive the making by the Lenders of the Loans and the issuance of Letters of Credit by the Issuing Bank, regardless of any investigation made by the Lenders or the Issuing Bank or on their behalf, and shall continue in full force and effect as long as the principal of or any accrued interest on any Loan or any Fee or any other amount payable under this Agreement or any other Loan Document is outstanding and unpaid or any Letter of Credit is outstanding and so long as the Commitments have not been terminated. The provisions of Sections 2.14, 2.16, 2.20, 9.05 and 9.18 shall remain operative and in full force and effect regardless of the expiration of the term of this Agreement, the consummation of the transactions contemplated hereby, the repayment of any of the Loans, the expiration of the Commitments, the expiration of any Letter of Credit, the invalidity or unenforceability of any term or provision of this Agreement or any other Loan Document, or any investigation made by or on behalf of the Administrative Agent, the Collateral Agent, any Lender or the Issuing Bank.
     SECTION 9.03. Binding Effect. This Agreement shall become effective as provided in the Amendment and Restatement Agreement.
     SECTION 9.04. Successors and Assigns. (a) Whenever in this Agreement any of the parties hereto is referred to, such reference shall be deemed to include the permitted successors and assigns of such party; and all covenants, promises and agreements by or on behalf of the Borrower, Parent, the Administrative Agent, the Collateral Agent, the Issuing Bank or the Lenders that are contained in this Agreement shall bind and inure to the benefit of their respective successors and assigns.
     (b) Each Lender may assign to one or more Eligible Assignees all or a portion of its interests, rights and obligations under this Agreement (including all or a portion of its Commitment and the Loans at the time owing to it), with notice to the Borrower and the prior written consent of the Administrative Agent (not to be unreasonably withheld or delayed); provided, however, that (i) in the case of an assignment of a Revolving Credit Commitment, each of the Borrower, the Issuing Bank and the Swingline Lender must also give its prior written consent to such assignment (which consent shall not be unreasonably withheld or delayed) (provided, that the consent of the Borrower shall not be required to any such assignment made to another Lender or an Affiliate of a Lender or after the occurrence and during the continuance of any Event of Default referred to in paragraph (b), (c), (g) or (h) of Article VII), (ii) the amount of the Commitment or Loans of the assigning Lender subject to each such assignment (determined as of the date the Assignment and Acceptance with respect to such assignment is delivered to the Administrative Agent) shall be not less than (x) $1,000,000 (with respect to an assignment of Term Loans) and (y) $5,000,000 (with respect to an assignment of Revolving Credit Commitments or Revolving Loans) (or, in any case, if less, the entire remaining amount of such

 


 

Lender’s Commitment or Loans of the relevant Class), (iii) the parties to each such assignment shall execute and deliver to the Administrative Agent an Assignment and Acceptance via an electronic settlement system acceptable to the Administrative Agent (or, if previously agreed with the Administrative Agent, manually), and shall pay to the Administrative Agent a processing and recordation fee of $3,500 (which fee may be waived or reduced in the sole discretion of the Administrative Agent), and (iv) the assignee, if it shall not be a Lender, shall deliver to the Administrative Agent an Administrative Questionnaire and all applicable tax forms. Upon acceptance and recording pursuant to paragraph (e) of this Section 9.04, from and after the effective date specified in each Assignment and Acceptance, (A) the assignee thereunder shall be a party hereto and, to the extent of the interest assigned by such Assignment and Acceptance, have the rights and obligations of a Lender under this Agreement and (B) the assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment and Acceptance, be released from its obligations under this Agreement (and, in the case of an Assignment and Acceptance covering all or the remaining portion of an assigning Lender’s rights and obligations under this Agreement, such Lender shall cease to be a party hereto but shall continue to be entitled to the benefits of Sections 2.14, 2.16, 2.20 and 9.05, as well as to any Fees accrued for its account and not yet paid).
     (c) By executing and delivering an Assignment and Acceptance, the assigning Lender thereunder and the assignee thereunder shall be deemed to confirm to and agree with each other and the other parties hereto as follows: (i) such assigning Lender warrants that it is the legal and beneficial owner of the interest being assigned thereby free and clear of any adverse claim and that its Term Loan Commitment and Revolving Credit Commitment, and the outstanding balances of its Term Loans and Revolving Loans, in each case without giving effect to assignments thereof which have not become effective, are as set forth in such Assignment and Acceptance, (ii) except as set forth in (i) above, such assigning Lender makes no representation or warranty and assumes no responsibility with respect to any statements, warranties or representations made in or in connection with this Agreement, or the execution, legality, validity, enforceability, genuineness, sufficiency or value of this Agreement, any other Loan Document or any other instrument or document furnished pursuant hereto, or the financial condition of the Borrower or any Subsidiary or the performance or observance by the Borrower or any Subsidiary of any of its obligations under this Agreement, any other Loan Document or any other instrument or document furnished pursuant hereto; (iii) such assignee represents and warrants that it is an Eligible Assignee and is legally authorized to enter into such Assignment and Acceptance; (iv) such assignee confirms that it has received a copy of this Agreement, together with copies of the most recent financial statements referred to in Section 3.05 or delivered pursuant to Section 5.04 and such other documents and information as it has deemed appropriate to make its own credit analysis and decision to enter into such Assignment and Acceptance; (v) such assignee will independently and without reliance upon the Administrative Agent, the Collateral Agent, such assigning Lender or any other Lender and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under this Agreement; (vi) such assignee appoints and authorizes the Administrative Agent and the Collateral Agent to take such action as agent on its behalf and to exercise such powers under this Agreement as are delegated to the Administrative Agent and the Collateral Agent, respectively, by the terms hereof, together with such powers as are reasonably incidental thereto; and (vii) such assignee agrees that it will perform in accordance with their terms all the obligations which by the terms of this Agreement are required to be performed by it as a Lender.

 


 

     (d) The Administrative Agent, acting for this purpose as an agent of the Borrower, shall maintain at one of its offices in The City of New York a copy of each Assignment and Acceptance delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitment of, and principal amount of the Loans owing to, each Lender pursuant to the terms hereof from time to time (the “Register”). The entries in the Register shall be conclusive and the Borrower, the Administrative Agent, the Issuing Bank, the Collateral Agent and the Lenders may treat each person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the contrary. The Register shall be available for inspection by the Borrower, the Issuing Bank, the Collateral Agent and any Lender, at any reasonable time and from time to time upon reasonable prior notice.
     (e) Upon its receipt of, and consent to, a duly completed Assignment and Acceptance executed by an assigning Lender and an assignee, an Administrative Questionnaire completed in respect of the assignee (unless the assignee shall already be a Lender hereunder), the processing and recordation fee referred to in paragraph (b) above, if applicable, and the written consent of the Administrative Agent and, if required, the Borrower, the Swingline Lender and the Issuing Bank to such assignment and any applicable tax forms, the Administrative Agent shall promptly (i) accept such Assignment and Acceptance and (ii) record the information contained therein in the Register. No assignment shall be effective unless it has been recorded in the Register as provided in this paragraph (e).
     (f) Each Lender may without the consent of the Borrower, the Swingline Lender, the Issuing Bank or the Administrative Agent sell participations to one or more banks or other persons in all or a portion of its rights and obligations under this Agreement (including all or a portion of its Commitment and the Loans owing to it); provided, however, that (i) such Lender’s obligations under this Agreement shall remain unchanged, (ii) such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations, (iii) the participating banks or other persons shall be entitled to the benefit of the cost protection provisions contained in Sections 2.14, 2.16 and 2.20 to the same extent as if they were Lenders (but, with respect to any particular participant, to no greater extent than the Lender that sold the participation to such participant) and (iv) the Borrower, the Administrative Agent, the Issuing Bank and the Lenders shall continue to deal solely and directly with such Lender in connection with such Lender’s rights and obligations under this Agreement, and such Lender shall retain the sole right to enforce the obligations of the Borrower relating to the Loans or L/C Disbursements and to approve any amendment, modification or waiver of any provision of this Agreement (other than amendments, modifications or waivers decreasing any fees payable to such participating bank or person hereunder or the amount of principal of or the rate at which interest is payable on the Loans in which such participating bank or person has an interest, extending any scheduled principal payment date or date fixed for the payment of interest on the Loans in which such participating bank or person has an interest, increasing or extending the Commitments in which such participating bank or person has an interest or releasing any Subsidiary Guarantor (other than pursuant to the terms thereof or in connection with the sale of such Subsidiary Guarantor in a transaction permitted by Section 6.05) or all or substantially all of the Collateral).
     (g) Any Lender or participant may, in connection with any assignment or participation or proposed assignment or participation pursuant to this Section 9.04, disclose to the assignee or participant or proposed assignee or participant any information relating to the Borrower

 


 

furnished to such Lender by or on behalf of the Borrower; provided that, prior to any such disclosure of information designated by the Borrower as confidential, each such assignee or participant or proposed assignee or participant shall execute an agreement whereby such assignee or participant shall agree (subject to customary exceptions) to preserve the confidentiality of such confidential information on terms no less restrictive than those applicable to the Lenders pursuant to Section 9.17.
     (h) Any Lender may at any time assign all or any portion of its rights under this Agreement to secure extensions of credit to such Lender or in support of obligations owed by such Lender; provided that no such assignment shall release a Lender from any of its obligations hereunder or substitute any such assignee for such Lender as a party hereto.
     (i) Notwithstanding anything to the contrary contained herein, any Lender (a “Granting Lender”) may grant to a special purpose funding vehicle (an “SPC”), identified as such in writing from time to time by the Granting Lender to the Administrative Agent and the Borrower, the option to provide to the Borrower all or any part of any Loan that such Granting Lender would otherwise be obligated to make to the Borrower pursuant to this Agreement; provided that (i) nothing herein shall constitute a commitment by any SPC to make any Loan and (ii) if an SPC elects not to exercise such option or otherwise fails to provide all or any part of such Loan, the Granting Lender shall be obligated to make such Loan pursuant to the terms hereof. The making of a Loan by an SPC hereunder shall utilize the Commitment of the Granting Lender to the same extent, and as if, such Loan were made by such Granting Lender. Each party hereto hereby agrees that no SPC shall be liable for any indemnity or similar payment obligation under this Agreement (all liability for which shall remain with the Granting Lender). In furtherance of the foregoing, each party hereto hereby agrees (which agreement shall survive the termination of this Agreement) that, prior to the date that is one year and one day after the payment in full of all outstanding commercial paper or other senior indebtedness of any SPC, it will not institute against, or join any other person in instituting against, such SPC any bankruptcy, reorganization, arrangement, insolvency or liquidation proceedings under the laws of the United States or any State thereof. In addition, notwithstanding anything to the contrary contained in this Section 9.04, any SPC may (i) with notice to, but without the prior written consent of, the Borrower and the Administrative Agent and without paying any processing fee therefor, assign all or a portion of its interests in any Loans to the Granting Lender or to any financial institutions (consented to by the Borrower and Administrative Agent) providing liquidity and/or credit support to or for the account of such SPC to support the funding or maintenance of Loans and (ii) disclose on a confidential basis any non-public information relating to its Loans to any investor, potential investor, rating agency, commercial paper dealer, collateral manager, servicer or provider of any surety, guarantee or credit or liquidity enhancement to such SPC.
     (j) Neither Parent nor the Borrower shall assign or delegate any of its rights or duties hereunder without the prior written consent of the Administrative Agent, the Issuing Bank and each Lender, and any attempted assignment without such consent shall be null and void.
     (k) In the event that any Revolving Credit Lender shall become a Defaulting Lender or S&P, Moody’s and Thompson’s BankWatch (or InsuranceWatch Ratings Service, in the case of Lenders that are insurance companies (or Best’s Insurance Reports, if such insurance company is not rated by Insurance Watch Ratings Service)) shall, after the date that any Lender becomes a Revolving Credit Lender, downgrade the long-term certificate of deposit ratings of such Lender, and the resulting ratings shall be below BBB-, Baa3 and C (or BB, in the case of a Lender that is

 


 

an insurance company (or B, in the case of an insurance company not rated by InsuranceWatch Ratings Service)) (or, with respect to any Revolving Credit Lender that is not rated by any such ratings service or provider, the Issuing Bank or the Swingline Lender shall have reasonably determined that there has occurred a material adverse change in the financial condition of any such Lender, or a material impairment of the ability of any such Lender to perform its obligations hereunder, as compared to such condition or ability as of the date that any such Lender became a Revolving Credit Lender) then the Issuing Bank and the Swingline Lender shall have the right, but not the obligation, at its own expense, upon notice to such Lender and the Administrative Agent, to replace such Lender with an assignee (in accordance with and subject to the restrictions contained in paragraph (b) above), and such Lender hereby agrees to transfer and assign without recourse (in accordance with and subject to the restrictions contained in paragraph (b) above) all its interests, rights and obligations in respect of its Revolving Credit Commitment to such assignee; provided, however, that (i) no such assignment shall conflict with any law, rule and regulation or order of any Governmental Authority and (ii) the Issuing Bank, the Swingline Lender or such assignee, as the case may be, shall pay to such Lender in immediately available funds on the date of such assignment the principal of and interest accrued to the date of payment on the Loans made by such Lender hereunder and all other amounts accrued for such Lender’s account or owed to it hereunder.
     SECTION 9.05. Expenses; Indemnity. (a) The Borrower and Parent agree, jointly and severally, to pay all reasonable out-of-pocket expenses incurred by the Administrative Agent, the Collateral Agent, the Issuing Bank and the Swingline Lender in connection with the syndication of the Credit Facilities and the preparation and administration of this Agreement and the other Loan Documents or in connection with any amendments, modifications or waivers of the provisions hereof or thereof (whether or not the transactions hereby or thereby contemplated shall be consummated) or incurred by the Administrative Agent, the Collateral Agent or any Lender in connection with the enforcement or protection of its rights in connection with this Agreement and the other Loan Documents or in connection with the Loans made or Letters of Credit issued hereunder, including the fees, charges and disbursements of Cravath, Swaine & Moore LLP, counsel for the Administrative Agent and the Collateral Agent, and, in connection with any such enforcement or protection, the fees, charges and disbursements of one counsel in each relevant jurisdiction (and any such additional counsel, if necessary, as a result of actual or potential conflicts of interest) for the Administrative Agent, the Collateral Agent and the Lenders.
     (b) The Borrower and Parent agree, jointly and severally, to indemnify the Administrative Agent, the Collateral Agent, each Lender, the Issuing Bank and each Related Party of any of the foregoing persons (each such person being called an “Indemnitee”) against, and to hold each Indemnitee harmless from, any and all actual losses, claims, damages, liabilities, penalties and related reasonable out-of-pocket expenses, including reasonable fees, charges and disbursements of one counsel in each relevant jurisdiction (and any such additional counsel, if necessary, as a result of actual or potential conflicts of interest) for all Indemnitees, incurred by or asserted against any Indemnitee arising out of, in any way connected with, or as a result of (i) the execution or delivery of this Agreement or any other Loan Document or any agreement or instrument contemplated thereby, the performance by the parties thereto of their respective obligations thereunder or the consummation of the Transactions and the other transactions contemplated thereby (including the syndication of the Credit Facilities), (ii) the use of the proceeds of the Loans or issuance of Letters of Credit, (iii) any claim, litigation,

 


 

investigation or proceeding relating to any of the foregoing, whether or not any Indemnitee is a party thereto (and regardless of whether such matter is initiated by a third party or by the Borrower, any other Loan Party or any of their respective Affiliates), or (iv) any actual or alleged presence or Release of Hazardous Materials on any property currently or formerly owned or operated by the Borrower or any of the Subsidiaries, or any Environmental Liability related in any way to the Borrower or the Subsidiaries; provided that such indemnity shall not, as to any Indemnitee, be available to the extent that such losses, claims, damages, liabilities, penalties or related expenses are determined by a court of competent jurisdiction by final judgment to have resulted primarily from the gross negligence or willful misconduct of such Indemnitee.
     (c) To the extent that Parent and the Borrower fail to pay any amount required to be paid by them to the Administrative Agent, the Collateral Agent, the Issuing Bank or the Swingline Lender under paragraph (a) or (b) of this Section, each Lender severally agrees to pay to the Administrative Agent, the Collateral Agent, the Issuing Bank or the Swingline Lender, as the case may be, such Lender’s pro rata share (determined as of the time that the applicable unreimbursed expense or indemnity payment is sought) of such unpaid amount; provided that the unreimbursed expense or indemnified loss, claim, damage, liability or related expense, as the case may be, was incurred by or asserted against the Administrative Agent, the Collateral Agent, the Issuing Bank or the Swingline Lender in its capacity as such. For purposes hereof, a Lender’s “pro rata share” shall be determined based upon its share of the sum of the Aggregate Revolving Credit Exposure, outstanding Term Loans and unused Commitments at the time.
     (d) To the extent permitted by applicable law, neither Parent nor the Borrower nor any Indemnitee shall assert, and each hereby waives, any claim against any Indemnitee or Parent and the Borrower and each of their respective Affiliates, as applicable, on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) arising out of, in connection with, or as a result of, this Agreement or any agreement or instrument contemplated hereby, the Transactions, any Loan or Letter of Credit or the use of the proceeds thereof.
     (e) The provisions of this Section 9.05 shall remain operative and in full force and effect regardless of the expiration of the term of this Agreement, the consummation of the transactions contemplated hereby, the repayment of any of the Loans, the expiration of the Commitments, the expiration of any Letter of Credit, the invalidity or unenforceability of any term or provision of this Agreement or any other Loan Document, or any investigation made by or on behalf of the Administrative Agent, the Collateral Agent, any Lender or the Issuing Bank. All amounts due under this Section 9.05 shall be payable, within 30 days of written demand therefor with a reasonably detailed summary of the amounts claimed.
     SECTION 9.06. Right of Setoff. If an Event of Default shall have occurred and be continuing, each Lender or an Affiliate of such Lender is hereby authorized at any time and from time to time, except to the extent prohibited by law, to set off and apply any and all deposits (general or special, time or demand, provisional or final) at any time held and other indebtedness at any time owing by such Lender or an Affiliate of such Lender to or for the credit or the account of the Borrower or Parent against any of and all the obligations of the Borrower or Parent now or hereafter existing under this Agreement and other Loan Documents held by such Lender, provided that at such time such obligations are due or payable. The rights of each Lender and Affiliates of such Lender under this Section 9.06 are in addition to other rights and

 


 

remedies (including other rights of setoff) which such Lender or an Affiliate of such Lender may have.
     SECTION 9.07. Applicable Law. THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS (OTHER THAN LETTERS OF CREDIT AND AS EXPRESSLY SET FORTH IN OTHER LOAN DOCUMENTS) SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW YORK. EACH LETTER OF CREDIT SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED IN ACCORDANCE WITH, THE LAWS OR RULES DESIGNATED IN SUCH LETTER OF CREDIT, OR IF NO SUCH LAWS OR RULES ARE DESIGNATED, THE UNIFORM CUSTOMS AND PRACTICE FOR DOCUMENTARY CREDITS MOST RECENTLY PUBLISHED AND IN EFFECT, ON THE DATE SUCH LETTER OF CREDIT WAS ISSUED, BY THE INTERNATIONAL CHAMBER OF COMMERCE (THE “UNIFORM CUSTOMS”) AND, AS TO MATTERS NOT GOVERNED BY THE UNIFORM CUSTOMS, THE LAWS OF THE STATE OF NEW YORK.
     SECTION 9.08. Waivers; Amendment. (a) No failure or delay of the Administrative Agent, the Collateral Agent, any Lender or the Issuing Bank in exercising any power or right hereunder or under any other Loan Document shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such a right or power, preclude any other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the Administrative Agent, the Collateral Agent, the Issuing Bank and the Lenders hereunder and under the other Loan Documents are cumulative and are not exclusive of any rights or remedies that they would otherwise have. No waiver of any provision of this Agreement or any other Loan Document or consent to any departure by the Borrower or any other Loan Party therefrom shall in any event be effective unless the same shall be permitted by paragraph (b) below, and then such waiver or consent shall be effective only in the specific instance and for the purpose for which given. No notice or demand on the Borrower or Parent in any case shall entitle the Borrower or Parent to any other or further notice or demand in similar or other circumstances.
     (b) Neither this Agreement nor any provision hereof, may be waived, amended or modified except pursuant to an agreement or agreements in writing entered into by the Borrower, Parent and the Required Lenders; provided, however, that no such agreement shall (i) decrease the principal amount of, or extend the maturity of or any scheduled principal payment date or date for the payment of any interest on any Loan or any date for reimbursement of an L/C Disbursement, or waive or excuse any such payment or any part thereof, or decrease the rate of interest on any Loan or L/C Disbursement, without the prior written consent of each Lender directly adversely affected thereby, (ii) increase or extend the Commitment or decrease or extend the date for payment of any Fees of any Lender without the prior written consent of such Lender, (iii) amend or modify the pro rata requirements of Section 2.17, the provisions of Section 9.04(j) or the provisions of this Section or release all or substantially all of the value of the Subsidiary Guarantors (other than pursuant to the terms hereof or thereof or in connection with the sale of such Subsidiary Guarantor in a transaction permitted by Section 6.05) or all or substantially all of the Collateral, without the prior written consent of each Lender, (iv) change the provisions of any Loan Document in a manner that by its terms adversely affects the rights in respect of payments due to Lenders holding Loans of one Class differently from the rights of Lenders holding Loans of any other Class without the prior written consent of Lenders holding a

 


 

majority in interest of the outstanding Loans and unused Commitments of each adversely affected Class, (v) modify the protections afforded to an SPC pursuant to the provisions of Section 9.04(i) without the written consent of such SPC or (vi) reduce the percentage contained in the definition of the term “Required Lenders” without the prior written consent of each Lender (it being understood that with the consent of the Required Lenders, additional extensions of credit pursuant to this Agreement may be included in the determination of the Required Lenders on substantially the same basis as the Term Loan Commitments and Revolving Credit Commitments on the date hereof); provided further that no such agreement shall amend, modify or otherwise affect the rights or duties of the Administrative Agent, the Collateral Agent, the Issuing Bank or the Swingline Lender hereunder or under any other Loan Document without the prior written consent of the Administrative Agent, the Collateral Agent, the Issuing Bank or the Swingline Lender.
     SECTION 9.09. Certain Releases of Guarantees and Security Interests. (a) Subject to the terms of any Pari Passu Intercreditor Agreement, upon the closing of any Asset Sale consisting of the sale of all of the Equity Interests of any Subsidiary Guarantor permitted pursuant to Section 6.05, (i) the obligations of such Subsidiary Guarantor pursuant to the Guarantee and Collateral Agreement shall automatically be discharged and released without any further action by the Administrative Agent or any Lender, and (ii) the Administrative Agent and the Lenders will, upon the request and at the sole expense of the Borrower, execute and deliver any instrument or other document in a form acceptable to the Administrative Agent which may reasonably be required to evidence such discharge and release, all without representation, recourse or warranty.
     (b) Subject to the terms of any Pari Passu Intercreditor Agreement, upon the closing of any Asset Sale consisting of the sale of Equity Interests of any Subsidiary Guarantor or any other Subsidiary of the Borrower permitted pursuant to Section 6.05, (i) the Collateral Agent shall release to the Borrower, without representation, warranty or recourse, express or implied, the pledged Equity Interests of such Subsidiary Guarantor or other Subsidiary, as applicable, held by it, (ii) the Collateral Agent shall release its security interest in all Collateral of such Subsidiary, including any Mortgages, and (iii) the Collateral Agent will, upon the request and at the sole expense of the Borrower, execute and deliver any instrument or other document in a form acceptable to the Collateral Agent which may reasonably be required to evidence such release.
     (c) Subject to the terms of any Pari Passu Intercreditor Agreement, upon consummation by the Borrower or any Subsidiary of a Permitted Interest Transfer or designation of an Unrestricted Subsidiary in accordance with the terms hereof, (i) the Collateral Agent shall release to the Borrower, without representation, warranty or recourse, express or implied, those Equity Interests of the Subsidiary that are the subject of such Permitted Interest Transfer or designation in accordance with clauses (i) and (ii) of Section 9.09(b) and shall release any pledged note theretofore pledged to the extent such note is being discharged in connection with such Permitted Interest Transfer or designation, and (ii) if such Subsidiary whose shares are the subject of such Permitted Interest Transfer or designation is a Subsidiary Guarantor, the obligations of such Subsidiary under its Guarantee shall automatically be discharged and released in accordance with clauses (i) and (ii) of Section 9.09(a) and any Lien granted by such Subsidiary under the Loan Documents shall automatically be discharged and released.
     (d) Subject to the terms of any Pari Passu Intercreditor Agreement, the Collateral Agent will, upon the request and at the sole expense of the Borrower, execute and deliver any

 


 

instrument or other document in a form acceptable to the Collateral Agent which may be reasonably be required to discharge and release, all without representation, recourse or warranty, any Lien on any Collateral granted to or held by the Collateral Agent under any Loan Document (i) upon termination of the Commitments and payment in full of the principal and interest on each Loan, all Fees and all other expenses or amounts payable under any Loan Document and cancellation or expiration of all Letters of Credit and reimbursement of all amounts drawn thereunder in full (or other arrangements having been entered into with respect thereto acceptable to the Issuing Bank and the Administrative Agent), (ii) that is sold or to be sold as part of or in connection with any sale permitted hereunder to a Person other than the Borrower or any Subsidiary Guarantor, and upon consummation by the Borrower or any Subsidiary of any such disposition, any Lien granted by the Borrower or such Subsidiary under the Loan Documents on such Collateral shall automatically be discharged and released, and (iii) the Administrative Agent and the Lenders will, upon the request and at the sole expense of the Borrower, execute and deliver any instrument or other document in a form acceptable to the Administrative Agent which may reasonably be required to evidence such discharge and release, all without representation, recourse or warranty.
     (e) Subject to the terms of any Pari Passu Intercreditor Agreement, upon notification by the Borrower to the Collateral Agent that a Subsidiary Guarantor is a Non-Significant Subsidiary, and would not be required to become a Guarantor in accordance with the terms hereof, the Collateral Agent shall release the obligations of such Subsidiary under its Guarantee and shall release and discharge any Lien granted by such Subsidiary Guarantor under the Loan Documents in accordance with clauses (i) and (ii) of Section 9.09(a).
     SECTION 9.10. Interest Rate Limitation. Notwithstanding anything herein to the contrary, if at any time the interest rate applicable to any Loan or participation in any L/C Disbursement, together with all fees, charges and other amounts which are treated as interest on such Loan or participation in such L/C Disbursement under applicable law (collectively the “Charges”), shall exceed the maximum lawful rate (the “Maximum Rate”) which may be contracted for, charged, taken, received or reserved by the Lender holding such Loan or participation in accordance with applicable law, the rate of interest payable in respect of such Loan or participation hereunder, together with all Charges payable in respect thereof, shall be limited to the Maximum Rate and, to the extent lawful, the interest and Charges that would have been payable in respect of such Loan or participation but were not payable as a result of the operation of this Section 9.10 shall be cumulated and the interest and Charges payable to such Lender in respect of other Loans or participations or periods shall be increased (but not above the Maximum Rate therefor) until such cumulated amount, together with interest thereon at the Federal Funds Effective Rate to the date of repayment, shall have been received by such Lender.
     SECTION 9.11. Entire Agreement. This Agreement, the Fee Letter and the other Loan Documents constitute the entire contract between the parties relative to the subject matter hereof. Any other previous agreement among the parties with respect to the subject matter hereof is superseded by this Agreement and the other Loan Documents. Nothing in this Agreement or in the other Loan Documents, expressed or implied, is intended to confer upon any person (other than the parties hereto and thereto, their respective successors and assigns permitted hereunder (including any Affiliate of the Issuing Bank that issues any Letter of Credit) and, to the extent expressly contemplated hereby, the Related Parties of each of the Administrative Agent, the

 


 

Collateral Agent, the Issuing Bank and the Lenders) any rights, remedies, obligations or liabilities under or by reason of this Agreement or the other Loan Documents.
     SECTION 9.12. WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY OF THE OTHER LOAN DOCUMENTS. EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS, AS APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 9.12.
     SECTION 9.13. Severability. In the event any one or more of the provisions contained in this Agreement or in any other Loan Document should be held invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein and therein shall not in any way be affected or impaired thereby (it being understood that the invalidity of a particular provision in a particular jurisdiction shall not in and of itself affect the validity of such provision in any other jurisdiction). The parties shall endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions.
     SECTION 9.14. Counterparts. This Agreement may be executed in counterparts (and by different parties hereto on different counterparts), each of which shall constitute an original but all of which when taken together shall constitute a single contract, and shall become effective as provided in Section 9.03. Delivery of an executed signature page to this Agreement by facsimile transmission shall be as effective as delivery of a manually signed counterpart of this Agreement.
     SECTION 9.15. Headings. Article and Section headings and the Table of Contents used herein are for convenience of reference only, are not part of this Agreement and are not to affect the construction of, or to be taken into consideration in interpreting, this Agreement.
     SECTION 9.16. Jurisdiction; Consent to Service of Process. (a) Each of Parent and the Borrower hereby irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of any New York State court or Federal court of the United States of America sitting in New York City, and any appellate court from any thereof, in any action or proceeding arising out of or relating to this Agreement or the other Loan Documents, or for recognition or enforcement of any judgment, and each of the parties hereto hereby irrevocably and unconditionally agrees that all claims in respect of any such action or proceeding may be heard and determined in such New York State or, to the extent permitted by law, in such Federal court. Each of the parties hereto agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. Nothing in this Agreement shall affect any right that the Administrative Agent, the Collateral Agent, the Issuing Bank or any Lender may otherwise have

 


 

to bring any action or proceeding relating to this Agreement or the other Loan Documents against the Borrower, Parent or their respective properties in the courts of any jurisdiction.
     (b) Each of Parent and the Borrower hereby irrevocably and unconditionally waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Agreement or the other Loan Documents in any New York State or Federal court. Each of the parties hereto hereby irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court.
     (c) Each party to this Agreement irrevocably consents to service of process in the manner provided for notices in Section 9.01. Nothing in this Agreement will affect the right of any party to this Agreement to serve process in any other manner permitted by law.
     SECTION 9.17. Confidentiality. Each of the Administrative Agent, the Collateral Agent, the Issuing Bank and the Lenders agrees to maintain the confidentiality of the Information (as defined below), except that Information may be disclosed (a) to its and its Affiliates’ officers, directors, employees and agents, including accountants, legal counsel and other advisors (it being understood that the persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential), (b) to the extent requested by any regulatory authority or quasi-regulatory authority (such as the National Association of Insurance Commissioners), (c) to the extent required by applicable laws or regulations or by any subpoena or similar legal process, (d) in connection with the exercise of any remedies hereunder or under the other Loan Documents or any suit, action or proceeding relating to the enforcement of its rights hereunder or thereunder, (e) subject to an agreement containing provisions substantially the same as those of this Section 9.17, to (i) any actual or prospective assignee of or participant in any of its rights or obligations under this Agreement and the other Loan Documents or (ii) any actual or prospective counterparty (or its advisors) to any swap or derivative transaction relating to the Borrower or any Subsidiary or any of their respective obligations, (f) with the consent of the Borrower or (g) to the extent such Information becomes publicly available other than as a result of a breach of this Section 9.17. For the purposes of this Section, “Information” shall mean all information received from the Borrower or Parent and related to the Borrower or Parent or their business, other than any such information that was available to the Administrative Agent, the Collateral Agent, the Issuing Bank or any Lender on a nonconfidential basis prior to its disclosure by the Borrower or Parent; provided that any Lender, the Administrative Agent, the Collateral Agent or the Issuing Bank shall give Parent prior notice of any disclosure pursuant to clause (c) to the extent permissible. Any person required to maintain the confidentiality of Information as provided in this Section 9.17 shall be considered to have complied with its obligation to do so if such person has exercised the same degree of care to maintain the confidentiality of such Information as such person would accord its own confidential information.
     SECTION 9.18. USA PATRIOT Act Notice. Each Lender and the Administrative Agent (for itself and not on behalf of any Lender) hereby notifies Parent and the Borrower that pursuant to the requirements of the USA PATRIOT Act, it is required to obtain, verify and record information that identifies Parent and the Borrower, which information includes the name and address of Parent and the Borrower and other information that will allow such Lender or the Administrative Agent, as applicable, to identify Parent and the Borrower in accordance with the USA PATRIOT Act.

 


 

     SECTION 9.19. Effect of Certain Inaccuracies. In the event that any financial statement or certificate delivered pursuant to Section 5.04(a) or (b) and Section 5.04(c), respectively, is inaccurate within one year after delivery thereof, and such inaccuracy, if corrected, would have led to the application of a higher Applicable Percentage or a higher Commitment Fee for any period (an “Applicable Period”) than the Applicable Percentage or Commitment Fee applied for such Applicable Period, then (i) the Borrower shall promptly deliver to the Administrative Agent a corrected financial statement and a corrected compliance certificate for such Applicable Period, (ii) the Applicable Percentage and the Commitment Fee shall be determined based on the corrected compliance certificate for such Applicable Period, and (iii) the Borrower shall promptly pay to the Administrative Agent (for the accounts of the applicable Lenders during the Applicable Period or their successors and assigns) the accrued additional interest or additional Commitment Fees (or both) owing as a result of such increased Applicable Percentage or Commitment Fee for such Applicable Period. This Section 9.19 shall not limit the rights of the Administrative Agent or the Lenders with respect to Section 2.07 or Article VII.
     SECTION 9.20. Pari Passu Obligations. (a) Each Lender and each Issuing Bank acknowledges that Pari Passu Debt Obligations may be secured by Liens on the Collateral having the same priority as, or junior priority to, the Liens securing the Obligations and hereby consents thereto.
     (b) In connection with the incurrence by the Borrower or any Subsidiary of Pari Passu Debt, each Lender and each Issuing Bank (i) acknowledges that, at the request of the Borrower, each of the Administrative Agent and/or the Collateral Agent shall enter into one or more Pari Passu Intercreditor Agreements, (ii) authorizes and directs each Agent to execute and deliver any Pari Passu Intercreditor Agreement and any documents relating thereto, in each case on behalf of such Lender or Issuing Bank and without any further consent, authorization or other action by such Lender or Issuing Bank, (iii) authorizes and directs each Agent to act as its representative under, and in connection with, any Pari Passu Intercreditor Agreement, (iv) acknowledges that any Pari Passu Intercreditor Agreement may contain provisions that permit or require the Liens securing the Obligations and the Pari Passu Debt Obligations to be granted in favor of a single collateral agent trustee, which may not be the Administrative Agent or the Collateral Agent (a “Shared Collateral Agent”), (v) acknowledges that any Pari Passu Intercreditor Agreement may provide that the holders of a majority in aggregate principal amount of Obligations and Pari Passu Debt Obligations, voting as a single class, may direct the Shared Collateral Agent with respect to enforcement or the actions concerning the Collateral, and (vi) agrees that, upon the execution and delivery thereof, it will be bound by the provisions of any Pari Passu Intercreditor Agreement as if it were a signatory thereto and will take no actions contrary to the provisions thereof. Each Lender and each Issuing Bank further authorizes and directs each Agent to enter into such amendments, supplements or other modifications to any Pari Passu Intercreditor Agreement as are reasonably acceptable to the Administrative Agent in order to (A) enable any extension, renewal, refinancing, replacement or additional incurrence of any Loans or any Pari Passu Debt permitted under this Agreement and (B) provide for the Pari Passu Debt Obligations thereunder to be secured by Liens on the Collateral having the same priority as, or junior priority to, the Liens on the Collateral securing the Obligations, in each case on behalf of such Lender or such Issuing Bank and without any further consent, authorization or other action by such Lender or such Issuing Bank.

 


 

     (c) Each Lender and each Issuing Bank (i) acknowledges that, at the request of the Borrower, each of the Administrative Agent and the Collateral Agent shall, to the extent required by the terms of (or in order to implement the provisions of) any Pari Passu Intercreditor Agreement, delegate, assign and/or transfer any or all of its rights, duties, remedies, powers or obligations with respect to the Collateral to a Shared Collateral Agent and (ii) hereby consents to any such delegation, assignment or transfer. The exculpatory provisions of Article VIII shall apply to any Shared Collateral Agent and to the Related Parties thereof, and shall apply to their respective activities in connection with the Collateral and with any Pari Passu Intercreditor Agreement or any other Loan Documents.
     (d) Each Lender and each Issuing Bank (i) acknowledges that, at the request of the Borrower, each of the Administrative Agent and/or the Collateral Agent shall (A) amend, substitute, supplement or otherwise modify the Guarantee and Collateral Agreement, (B) amend, substitute, replace, supplement or otherwise modify any other Security Document, (C) enter into additional Security Documents and (D) take such further actions as are reasonably incidental to the foregoing, in each case as are reasonably acceptable to the Administrative Agent and the Collateral Agent in order to (1) enable the Borrower or any Subsidiary to incur Pari Passu Debt otherwise permitted to be waived hereunder and (2) provide for the Pari Passu Debt Obligations thereunder to be secured, in accordance with the terms of any Pari Passu Intercreditor Agreement, by Liens on the Collateral having the same priority as, or junior priority to, the Liens on the Collateral securing the Obligations, (ii) authorizes and directs each Agent to execute and deliver any such amendments, supplements, agreements and other documents, in each case on behalf of such Lender or Issuing Bank and without any further consent, authorization or other action by such Lender or Issuing Bank and (iii) agrees that, upon the execution and delivery thereof, it will be bound by the provisions of such amendments, supplements, agreements and other documents as if it were a signatory thereto and will take no actions contrary to the provisions thereof.
     (e) Without limiting the foregoing, no Secured Party shall have any right individually to realize upon any of the Collateral or to enforce any Guarantee of the Obligations, it being understood and agreed that all powers, rights and remedies under the Loan Documents may be exercised solely by the Agents on behalf of the Secured Parties in accordance with the terms thereof (subject, in the case of the Collateral, to the provisions of any Pari Passu Intercreditor Agreement). In the event of a foreclosure by the Collateral Agent or any Shared Collateral Agent on any of the Collateral pursuant to a public or private sale or other disposition, any Lender may be the purchaser of any or all of such Collateral at any such sale or other disposition, and such Collateral Agent or Shared Collateral Agent, as agent for and representative of the Secured Parties (but not any Lender or Lenders in its or their respective individual capacities) shall be entitled, for the purpose of bidding and making settlement or payment of the purchase price for all or any portion of the Collateral sold at any such sale, to use and apply any of the Obligations as a credit on account of the purchase price for any Collateral payable by such Collateral Agent or Shared Collateral Agent on behalf of the Secured Parties at such sale or other disposition. Each Secured Party, whether or not a party hereto, will be deemed, by its acceptance of the benefits of the Collateral and of the Guarantees of the Obligations provided under the Loan Documents, to have agreed to the foregoing provisions. The provisions of this paragraph are for the sole benefit of the Lenders and shall not afford any right to, or constitute a defense available to, any Loan Party.

 


 

Schedule 1.01(a)
Existing Letters of Credit
1. Irrevocable Letter of Credit outstanding as of the date hereof under the Original Credit Agreement.
                 
LC Number   Beneficiary   Maturity   Gross Amount
SM413504
  Louisiana Patient's Compensation   07/20/10   $ 125,000.00  
SM416221
  City of McCaysville   03/19/10     357,730.00  
SM200963
  The Doctors Company   11/22/10     100,000.00  
SM201505
  Secretary US Department of Education   12/31/09     183,000.00  
SM209374
  Secretary/US Department of Education   07/27/10     604,500.00  
 
               
Total
          $ 1,370,230.00  

 


 

Schedule 1.01(b)
Subsidiary Guarantors
1.   Abilene Hospital, LLC
2.   Abilene Merger, LLC
3.   Anna Hospital Corporation
4.   Arizona DH, LLC
5.   Berwick Hospital Company, LLC
6.   BH Trans Company, LLC
7.   Big Bend Hospital Corporation
8.   Big Spring Hospital Corporation
9.   Birmingham Holdings, LLC
10.   Birmingham Holdings II, LLC
11.   Bluefield Holdings, LLC
12.   Bluefield Hospital Company, LLC
13.   Bluffton Health System LLC
14.   Brownsville Hospital Corporation
15.   Brownwood Hospital, L.P.
16.   Brownwood Medical Center, LLC
17.   Carlsbad Medical Center, LLC
18.   Centre Hospital Corporation
19.   CHHS Holdings, LLC
20.   CHS Kentucky Holdings, LLC
21.   CHS Pennsylvania Holdings, LLC
22.   CHS Virginia Holdings, LLC
23.   CHS Washington Holdings, LLC
24.   Claremore Regional Hospital, LLC
25.   Clarksville Holdings, LLC
26.   Cleveland Hospital Corporation
27.   Cleveland Regional Medical Center, L.P.
28.   Cleveland Tennessee Hospital Company, LLC
29.   Clinton Hospital Corporation
30.   Coatesville Hospital Corporation
31.   College Station Hospital, L.P.
32.   College Station Medical Center, LLC
33.   College Station Merger, LLC
34.   Community GP Corp.
35.   Community Health Investment Company, LLC
36.   Community LP Corp.
37.   CP Hospital GP, LLC
38.   CPLP, LLC
39.   Crestwood Hospital, LP, LLC
40.   Crestwood Hospital, LLC
41.   CSMC, LLC
42.   CSRA Holdings, LLC
43.   Deaconess Holdings, LLC
44.   Deaconess Hospital Holdings, LLC

 


 

45.   Deming Hospital Corporation
46.   Desert Hospital Holdings, LLC
47.   Detar Hospital, LLC
48.   DHSC, LLC
49.   DHFW Holdings, LLC
50.   Dukes Health System, LLC
51.   Dyersburg Hospital Corporation
52.   Emporia Hospital Corporation
53.   Evanston Hospital Corporation
54.   Fallbrook Hospital Corporation
55.   Foley Hospital Corporation
56.   Forrest City Arkansas Hospital Company, LLC
57.   Forrest City Clinic Company, LLC
58.   Forrest City Hospital Corporation
59.   Fort Payne Hospital Corporation
60.   Frankfort Health Partner, Inc.
61.   Franklin Hospital Corporation
62.   Gadsden Regional Medical Center, LLC
63.   Galesburg Hospital Corporation
64.   Granbury Hospital Corporation
65.   Granite City Hospital Corporation
66.   Granite City Illinois Hospital Company, LLC
67.   Greenville Hospital Corporation
68.   GRMC Holdings, LLC
69.   Hallmark Healthcare Company, LLC
70.   Hobbs Medco, LLC
71.   Hospital of Barstow, Inc.
72.   Hospital of Fulton, Inc.
73.   Hospital of Louisa, Inc.
74.   Hospital of Morristown, Inc.
75.   Jackson Hospital Corporation (KY)
76.   Jackson Hospital Corporation (TN)
77.   Jourdanton Hospital Corporation
78.   Kay County Hospital Corporation
79.   Kay County Oklahoma Hospital Company, LLC
80.   Kirksville Hospital Company, LLC
81.   Lakeway Hospital Corporation
82.   Lancaster Hospital Corporation
83.   Las Cruces Medical Center, LLC
84.   Lea Regional Hospital, LLC
85.   Lexington Hospital Corporation
86.   Longview Merger, LLC
87.   LRH, LLC
88.   Lutheran Health Network of Indiana, LLC
89.   Marion Hospital Corporation
90.   Martin Hospital Corporation
91.   Massillon Community Health System LLC
92.   Massillon Health System LLC

 


 

93.   Massillon Holdings, LLC
94.   McKenzie Tennessee Hospital Company, LLC
95.   McNairy Hospital Corporation
96.   MCSA, L.L.C.
97.   Medical Center of Brownwood, LLC
98.   Merger Legacy Holdings, LLC
99.   MMC of Nevada, LLC
100.   Moberly Hospital Company, LLC
101.   MWMC Holdings, LLC
102.   National Healthcare of Leesville, Inc.
103.   National Healthcare of Mt. Vernon, Inc.
104.   National Healthcare of Newport, Inc.
105.   Navarro Hospital, L.P.
106.   Navarro Regional, LLC
107.   NC-DSH, LLC
108.   Northampton Hospital Company, LLC
109.   Northwest Hospital, LLC
 
110.   NOV Holdings, LLC
 
111.   NRH, LLC
 
112.   Oak Hill Hospital Corporation
 
113.   Oro Valley Hospital, LLC
 
114.   Palmer-Wasilla Health System, LLC
 
115.   Payson Hospital Corporation
 
116.   Pennsylvania Hospital Company, LLC
 
117.   Phillips Hospital Corporation
 
118.   Phoenixville Hospital Company, LLC
 
119.   Pottstown Hospital Company, LLC
 
120.   QHG Georgia Holdings, Inc.
 
121.   QHG Georgia Holdings II, LLC
 
122.   QHG Georgia, LP
 
123.   QHG of Barberton, Inc.
 
124.   QHG of Bluffton Company, LLC
 
125.   QHG of Clinton County, Inc.
 
126.   QHG of Enterprise, Inc.
 
127.   QHG of Forrest County, Inc.
 
128.   QHG of Fort Wayne Company, LLC
 
129.   QHG of Hattiesburg, Inc.
 
130.   QHG of Massillon, Inc.
 
131.   QHG of South Carolina, Inc.
 
132.   QHG of Spartanburg, Inc.
 
133.   QHG of Springdale, Inc.
 
134.   QHG of Warsaw Company, LLC
 
135.   Quorum Health Resources, LLC
 
136.   Red Bud Hospital Corporation
 
137.   Red Bud Illinois Hospital Company, LLC
 
138.   Regional Hospital of Longview, LLC
 
139.   River Region Medical Corporation
 
140.   Roswell Hospital Corporation

 


 

141.   Russell County Medical Center, Inc.
 
142.   Ruston Hospital Corporation
 
143.   Ruston Louisiana Hospital Company, LLC
 
144.   SACMC, LLC
 
145.   Salem Hospital Corporation
 
146.   San Angelo Community Medical Center, LLC
 
147.   San Angelo Medical, LLC
 
148.   San Miguel Hospital Corporation
 
149.   Shelbyville Hospital Corporation
 
150.   Siloam Springs Arkansas Hospital Company, LLC
 
151.   Siloam Springs Holdings, LLC
 
152.   SouthCrest, L.L.C.
 
153.   Southern Texas Medical Center, LLC
 
154.   Spokane Valley Washington Hospital Company, LLC
 
155.   Spokane Washington Hospital Company, LLC
 
156.   Tennyson Holdings, LLC
 
157.   Tooele Hospital Corporation
 
158.   Triad Healthcare Corporation
 
159.   Triad Holdings III, LLC
 
160.   Triad Holdings IV, LLC
 
161.   Triad Holdings V, LLC
 
162.   Triad Nevada Holdings, LLC
 
163.   Triad of Alabama, LLC
 
164.   Triad of Oregon, LLC
 
165.   Triad-ARMC, LLC
 
166.   Triad-Denton Hospital GP, LLC
 
167.   Triad-Denton Hospital, L.P.
 
168.   Triad-El Dorado, Inc.
 
169.   Triad-Navarro Regional Hospital Subsidiary, LLC
 
170.   Triad-South Tulsa Hospital Company, Inc.
 
171.   VHC Medical, LLC
 
172.   Vicksburg Healthcare, LLC
 
173.   Victoria Hospital, LLC
 
174.   Victoria of Texas, L.P.
 
175.   Virginia Hospital Company, LLC
 
176.   Warren Ohio Hospital Company, LLC
 
177.   Warren Ohio Rehab Hospital Company, LLC
 
178.   Watsonville Hospital Corporation
 
179.   Waukegan Hospital Corporation
 
180.   Waukegan Illinois Hospital Company, LLC
 
181.   Weatherford Hospital Corporation
 
182.   Weatherford Texas Hospital Company, LLC
 
183.   Webb Hospital Corporation
 
184.   Webb Hospital Holdings, LLC
 
185.   Wesley Health System, LLC
 
186.   West Grove Hospital Company, LLC
 
187.   WHMC, LLC
 
188.   Wilkes-Barre Behavioral Hospital Company, LLC

 


 

189.   Wilkes-Barre Holdings, LLC
 
190.   Wilkes-Barre Hospital Company, LLC
 
191.   Williamston Hospital Corporation
 
192.   Women & Children’s Hospital, LLC
 
193.   Woodland Heights Medical Center, LLC
 
194.   Woodward Health System, LLC
 
195.   Youngstown Ohio Hospital Company, LLC

 


 

Schedule 1.01(c)
Mortgaged Property
     
Hospital Name/Address (County)   Corporate Owner
 
   
DeKalb Regional Medical Center
200 Medical Center Drive
P.O. Box 680778
Fort Payne, AL 35968 (Dekalb)
  Fort Payne Hospital Corporation (AL)
 
   
Flowers Hospital
4370 West Main Street
Dothan, AL 36305 (Houston)
  Triad of Alabama, LLC (DE)
 
   
Gadsden Regional Medical Center
1007 Goodyear Avenue
Gadsden, AL 35903 (Etowah)
  Gadsden Regional Medical Center, LLC (DE)
 
   
Medical Center Enterprise
400 North Edwards St.
Enterprise, AL 36330 (Coffee)
  QHG of Enterprise, Inc. (AL)
 
   
Northwest Hospital
6200 N. LaCholla Blvd.
Tucson, AZ 85755 (Pima)
  Northwest Hospital, LLC (DE)
 
   
Northwest Hospital Oro Valley
1551 E. Tangerine Rd.
Oro Valley, AZ 85755 (Pima)
  Oro Valley Hospital, LLC (DE)
 
   
Watsonville Community Hospital
75 Nielson Street
Watsonville, CA 95076 (Santa Cruz)
  Watsonville Hospital Corporation (DE)
 
   
Galesburg Cottage Hospital
695 N. Kellogg St.
Galesburg, IL 61401 (Knox)
  Galesburg Hospital Corporation (IL)
 
   
Gateway Regional Medical Center
2100 Madison Avenue
Granite City, IL 62040 (Madison)
  Granite City Illinois Hospital Company, LLC (IL)
 
   
Heartland Regional Medical Center
3333 West DeYoung
Marion, IL 62959 (Williamson)
  Marion Hospital Corporation (IL)
 
   
Vista Medical Center (includes East and West)
1324 N. Sheridan Road
Waukegan, IL 60085 (Lake)
  Waukegan Illinois Hospital Company, LLC (IL)
 
   
Bluffton Regional Medical Center
303 South Main Street
Bluffton, IN 46714 (Wells)
  Bluffton Health System, LLC (DE)

 


 

     
Hospital Name/Address (County)   Corporate Owner
 
   
Dukes Memorial Hospital
275 W. 12th Street
Peru, IN 46970 (Miami)
  Dukes Health System, LLC (DE)
 
   
Women and Children’s Hospital
4200 Nelson Road
Lake Charles, LA 70605 (Calcasieu)
  Women and Children’s Hospital, LLC (DE)
 
   
River Region Health System
2100 Highway 61 North/1111 N.
Frontage Road
Vicksburg, MS 39183 (Warren)
  Vicksburg Healthcare, LLC (DE)
 
   
Wesley Medical Center
5001 Hardy Street
Hattiesburg, MS 39402 (Lamar)
  Wesley Health System, Inc. (DE)
 
   
Moberly Regional Medical Center
1515 Union Avenue
Moberly, MO 65270 (Randolph)
  Moberly Hospital Company, LLC (DE)
 
   
Mesa View Regional Hospital
1299 Bertha Howe Avenue
Mesquite, NV 89027 (Clark)
  MMC of Nevada, LLC (DE)
 
   
The Memorial Hospital of Salem County
310 Woodstown Road
Salem, NJ 08079 (Salem)
  Salem Hospital Corporation (NJ)
 
   
Alta Vista Regional Hospital
104 Legion Drive
Las Vegas, NM 87701 (San Miguel)
  San Miguel Hospital Corporation (NM)
 
   
Carlsbad Medical Center

2430 West Pierce
Carlsbad, NM 88220 (Eddy)
  Carlsbad Medical Center, LLC (DE)
 
   
Eastern New Mexico Medical Center

405 West Country Club Road
Roswell, NM 88201 (Chaves)
  Roswell Hospital Corporation (NM)
 
   
Lea Regional Medical Center
5419 N. Lovington Highway
Hobbs, NM 88240 (Lea)
  Lea Regional Hospital, LLC (DE)

 


 

     
Hospital Name/Address (County)   Corporate Owner
 
   
MountainView Regional Medical Center
4311 East Lohman Avenue
Las Cruces, NM 88011 (Dona Ana)
  Las Cruces Medical Center, LLC (DE)
 
   
Affinity Medical Center1
875 Eighth Street NE
Massillon, OH 44646 (Stark)
  DHSC, LLC (DE)
 
   
Hillside Rehabilitation Hospital2
8747 Squires Lane NE
Warren, OH 44484 (Trumbull)
  Warren Ohio Rehab Hospital Company, LLC (DE)
 
   
Northside Medical Center3
500 Gypsy Lane
Youngstown, OH 44501 (Trumbull and Mahoning)
  Youngstown Ohio Hospital Company, LLC (DE)
 
   
Trumbull Memorial Hospital4
1350 East Market Street
Warren, OH 44482 (Trumbull)
  Warren Ohio Hospital Company, LLC (DE)
 
   
Claremore Regional Hospital
1202 N. Muskogee Place
Claremore, OK 74017 (Rogers)
  Claremore Regional Hospital, LLC (DE)
 
   
Ponca City Medical Center
1900 North 14th Street
Ponca City, OK 74601 (Kay)
  Kay County Oklahoma Hospital Company, LLC (OK)
 
   
SouthCrest Hospital
8801 South 101st East Ave.
Tulsa, OK 74133 (Tulsa)
  SouthCrest, L.L.C. (DE)
 
   
Berwick Hospital Center
701 East 16th Street
Berwick, PA 18603 (Columbia)
  Berwick Hospital Company, LLC (DE)
 
   
Brandywine Hospital
201 Reeceville Rd.
Coatesville, PA 19320 (Chester)
  Coatesville Hospital Corporation (PA)
 
   
Easton Hospital
250 South 21st Street
Easton, PA 18042-3892 (Northampton)
  Northampton Hospital Company, LLC (DE)
 
1   This facility is in the process of being mortgaged. It should be mortgaged by December 31, 2010.
 
2   This facility is in the process of being mortgaged. It should be mortgaged by December 31, 2010.
 
3   This facility is in the process of being mortgaged. It should be mortgaged by December 31, 2010.
 
4   This facility is in the process of being mortgaged. It should be mortgaged by December 31, 2010.

 


 

     
Hospital Name/Address (County)   Corporate Owner
 
   
Jennersville Regional Hospital
1015 West Baltimore Pike
West Grove, PA 19390 (Chester)
  West Grove Hospital Company, LLC (DE)
 
   
Lock Haven Hospital
24 Cree Drive
Lock Haven, PA 17745-2699 (Washington)
  Clinton Hospital Corporation (PA)
 
   
Phoenixville Hospital
140 Nutt Road
Phoenixville, PA 19460 (Chester)
  Phoenixville Hospital Company, LLC (DE)
 
   
Pottstown Memorial Medical Center
1600 East High Street
Pottstown, PA 19464 (Montgomery)
  Pottstown Hospital Company, LLC (DE)
 
   
Wilkes-Barre General Hospital
575 North River Street
Wilkes-Barre, PA 18764 (Luzerne and Wyoming)
  Wilkes-Barre Hospital Company, LLC (DE)
Wilkes-Barre Behavioral Hospital Company, LLC
(DE)
 
   
Carolinas Hospital System
805 Pamplico Highway
Florence, SC 29505 (Florence)
  QHG of South Carolina, Inc. (SC)
 
   
Marion Regional Hospital
2829 East Highway 76
Mullins, SC 29574 (Marion and Horry)
  QHG of South Carolina, Inc. (SC)
 
   
Springs Memorial Hospital
800 W. Meeting Street
Lancaster, SC 29720 (Lancaster)
  Lancaster Hospital Corporation (DE)
 
   
Dyersburg Regional Medical Center
400 Tickle Street
Dyersburg, TN 38024 (Dyer)
  Dyersburg Hospital Corporation (TN)
 
   
Lakeway Regional Hospital
726 McFarland Street
Morristown, TN 37814 (Hamblen)
  Hospital of Morristown, Inc. (TN)
 
   
SkyRidge Medical Center (includes Cleveland)
2305 Chambliss Avenue
Cleveland, TN 37320 (Bradley)
  National Healthcare of Cleveland, Inc. (TN)
 
   
Volunteer Community Hospital
161 Mt. Pelia Road
Martin, TN 38237 (Weakley)
  Martin Hospital Corporation (TN)
 
   
College Station Medical Center
1604 Rock Prairie
College Station, TX 77845 (Brazos)
  College Station Hospital, L.P. (DE)
 
   
DeTar Hospital Navarro
506 E. San Antonio Street
Victoria, TX 77901 (Victoria)
  Victoria of Texas, L.P. (DE)

 


 

     
Hospital Name/Address (County)   Corporate Owner
 
   
DeTar Hospital North
101 Medical Drive
Victoria, TX 77904 (Victoria)
  Victoria of Texas, L.P. (DE)
 
   
Scenic Mountain Medical Center
1601 West Eleventh Place
Big Spring, TX 79720 (Howard)
  Big Spring Hospital Corporation (TX)
 
   
South Texas Regional Medical Center
1905 Highway 97 E
Jourdanton, TX 78026 (Atascosa)
  Jourdanton Hospital Corporation (TX)
 
   
Mountain West Medical Center
2055 N. Main
Tooele, UT 84074-2794 (Tooele)
  Tooele Hospital Corporation (UT)
 
   
Southern Virginia Regional Medical Center
727 North Main Street
Emporia, VA 23847 (Greensville)
  Emporia Hospital Corporation (VA)
 
   
Southampton Memorial Hospital
100 Fairview Drive
Franklin, VA 23851 (Southampton)
  Franklin Hospital Corporation (VA)
 
   
Deaconess Medical Center
800 West Fifth Avenue
Spokane, WA 99204 (Spokane)
  Spokane Washington Hospital Company, LLC (DE)
 
   
Valley Hospital and Medical Center
12606 East Mission
Spokane Valley, WA 99216 (Spokane)
  Spokane Valley Washington Hospital Company (DE)
 
   
Bluefield Regional Medical Center
500 Cherry Street
Bluefield, WV 24701 (Mercer)
  Bluefield Hospital Company, LLC (DE)
 
   
Northwest Medical Center of Benton County5
3000 Medical Center Pkwy.
Bentonville, AR 72712 (Benton)
  QHG of Springdale, Inc. (AR)
 
   
Regional Hospital of Jackson6
367 Hospital Blvd.
Jackson, TN 38305 (Madison)
  Jackson, Tennessee Hospital Company, LLC (TN)
 
   
Greenbrier Valley Medical Center7
202 Maplewood Avenue
Ronceverte, WV 24970 (Greenbrier)
  Greenbrier VMC, LLC (DE)
 
5   This mortgage is in the process of being released. It should be released by December 31, 2010.
 
6   This mortgage is in the process of being released. It should be released by December 31, 2010.

 


 

7   This mortgage is in the process of being released. It should be released by December 31, 2010.

 


 

Schedule 1.01(d)
Hospitals
Abilene, Texas
Abilene Regional Medical Center
6250 Highway 83/84
Abilene, TX 79606
(Taylor)
ARMC, L.P.(DE)
Massillon, Ohio
Affinity Medical Center
875 Eighth Street, N.E.
(P.O. Box 805)
Massillon, OH 44648
(Stark)
DHSC, LLC (DE)
Las Vegas, New Mexico
Alta Vista Regional Hospital
104 Legion Drive
Las Vegas, NM 87701
(San Miguel)
San Miguel Hospital Corporation (NM)
Barstow, California
Barstow Community Hospital
555 South 7th Street
Barstow, CA 92311
(San Bernadino)
Hospital of Barstow, Inc. (DE)
Berwick, Pennsylvania
Berwick Hospital Center
701 East 16th Street
Berwick, PA 18603
(Columbia)
Berwick Hospital Company, LLC (DE)
Alpine, Texas
Big Bend Regional Medical Center
2600 Highway 118 North
Alpine, TX 79830
(Brewster)
Big Bend Hospital Corporation (TX)
Bluefield, West Virginia
Bluefield Regional Medical Center
500 Cherry St.
Bluefield, WV 24701
(Mercer)
Bluefield Hospital Company, LLC
Bluffton, Indiana
Bluffton Regional Medical Center
303 S. Main Street
Bluffton, IN 46714
(Wells)
Bluffton Health System, LLC (DE)
Coatesville, Pennsylvania
Brandywine Hospital
201 Reeceville Rd.
Coatesville, PA 19320
(Chester)
Coatesville Hospital Corporation (PA)
Brownwood, Texas
Brownwood Regional Medical Center
1501 Burnet Drive
(P.O. Box 760 / zip 76804)
Brownwood, TX 76801
(Brown)
Brownwood Hospital L.P. (DE)
Leesville, Louisiana
Byrd Regional Hospital
1020 Fertitta Blvd.
Leesville, LA 71446
(Vernon Parish)
National Healthcare of Leesville, Inc. (DE)
Carlsbad, New Mexico
Carlsbad Medical Center
2430 W. Pierce
Carlsbad, NM 88220
(Eddy)
Carlsbad Medical Center, LLC (DE)

 


 

Florence, South Carolina
Carolinas Hospital System
805 Pamplico Hwy
Florence, SC 29505
(Florence)
QHG of South Carolina, Inc (SC)
Cedar Park, Texas
Cedar Park Regional Medical Center
1401 Medical Parkway
Cedar Park, TX 78613
(Williamson)
Cedar Park Health System, L.P. (DE)
Centre, Alabama
Cherokee Medical Center
400 Northwood Drive
Centre, AL 35960
(Centre)
Centre Hospital Corporation (AL)
Cheraw, South Carolina
Chesterfield General Hospital
Highway 9 West (P.O. Box 151)
Cheraw, SC 29520
(Chesterfield)
Chesterfield/Marlboro, L.P. (DE)
Philadelphia, Pennsylvania
Chestnut Hill Hospital
8835 Germantown Avenue
Philadelphia, PA 19118
(Montgomery)
CHHS Hospital Company, LLC (DE)
Claremore, Oklahoma
Claremore Regional Hospital
1202 N. Muskogee Place
Claremore, OK 74017
(Rogers)
Claremore Regional Hospital, LLC (DE)
Cleveland, Texas
Cleveland Regional Medical Center
300 E. Crockett
Cleveland, TX 77327
(Liberty)
Cleveland Regional Medical Center, L.P. (DE)
College Station, Texas
College Station Medical Center
(P.O. Box 10000 / zip 77842)
College Station, TX 77845
(Brazos)
College Station Hospital, LP (DE)
Huntsville, Alabama
Crestwood Medical Center
One Hospital Drive SW
Huntsville, AL 35801
(Madison)
Crestwood Healthcare, L.P. (DE)
Mt. Vernon, Illinois
Crossroads Community Hospital
#8 Doctor’s Park Road
Mt. Vernon, IL 62864
(Jefferson)
National Healthcare of Mt. Vernon, Inc. (DE)
Oklahoma City, Oklahoma
Deaconess Hospital
5501 N. Portland Avenue
Oklahoma City, OK 73112-2099
(Oklahoma)
Deaconess Health System, LLC (DE)
Spokane, Washington
Deaconess Medical Center
800 W. 5th Avenue
Spokane, WA 99204
(Spokane)
Spokane Washington Hospital Company, LLC (DE)
Fort Payne, Alabama
DeKalb Regional Medical Center
200 Medical Center Drive
P. O. Box 680778
Fort Payne, AL 35968
(DeKalb)
Fort Payne Hospital Corporation (AL)
Victoria, Texas
DeTar Hospital North
101 Medical Drive
Victoria, TX 77904
(Victoria)
Victoria of Texas, L.P. (DE)

 


 

Victoria, Texas
DeTar Hospital Navarro
506 E. San Antonio Street
Victoria, TX 77901
(Victoria)
Victoria of Texas, L.P. (DE)
Peru, Indiana
Dukes Memorial Hospital
275 West 12th Street
Peru, IN 46970-1698
(Miami)
Dukes Health System, LLC (DE)
Fort Wayne, Indiana
Dupont Hospital
2520 E. Dupont Road
Fort Wayne, IN 46825
(Allen)
Dupont Hospital, LLC (DE)
Dyersburg, Tennessee
Dyersburg Regional Medical Center
400 Tickle Street
Dyersburg, TN 38024
(Dyer)
Dyersburg Hospital Corporation (TN)
Roswell, New Mexico
Eastern New Mexico Medical Center
405 West Country Club Road
Roswell, NM 88201
(Chaves)
Roswell Hospital Corporation (NM)
Easton, Pennsylvania
Easton Hospital
250 South 21st Street
Easton, PA 18042-3892
(Northampton)
Northampton Hospital Company, LLC (DE)
Evanston, Wyoming
Evanston Regional Hospital
190 Arrowhead Drive
Evanston, WY 82930
(Uinta)
Evanston Hospital Corporation (WY)
Fallbrook, California
Fallbrook Hospital
624 East Elder
Fallbrook, CA 92028
(San Diego)
Fallbrook Hospital Corporation (DE)
Blue Ridge, Georgia
Fannin Regional Hospital
2855 Old Highway 5, North
Blue Ridge, GA 30513
(Fannin)
Blue Ridge Georgia Hospital Company, LLC (DE)
Dothan, Alabama
Flowers Hospital
4370 West Main Street
Dothan, AL 36305
(Houston)
Triad of Alabama, LLC (DE)
Forrest City, Arkansas
Forrest City Medical Center
1601 Newcastle Road
Forrest City, AR 72336
(Saint Francis)
Forrest City Arkansas Hospital Company, LLC (AR)
Gadsden, Alabama
Gadsden Regional Medical Center
1007 Goodyear Avenue
Gadsden, AL 35903
(Etowah)
Gadsden Regional Medical Center, LLC (DE)
Galesburg, Illinois
Galesburg Cottage Hospital
695 N. Kellogg St.
Galesburg, IL 61401
(Knox)
Galesburg Hospital Corporation (IL)
Clarksville, Tennessee
Gateway Medical Center
651 Dunlop Lane
PO Box 31629
Clarksville, TN 37040
(Montgomery)
Clarksville Health System, G.P. (DE)

 


 

Granite City, Illinois
Gateway Regional Medical Center
2100 Madison Avenue
Granite City, IL 62040
(Madison)
Granite City Illinois Hospital Company, LLC (IL)
Ronceverte, West Virginia
Greenbrier Valley Medical Center
202 Maplewood Avenue
(P.O. Box 497)
Ronceverte, WV 24970
(Greenbrier)
Greenbrier VMC, LLC (DE)
Newport, Arkansas
Harris Hospital
1205 McLain
Newport, AR 72112
(Jackson)
National Healthcare of Newport, Inc. (DE)
Brownsville, Tennessee
Haywood Park Community Hospital
2545 N. Washington Ave.
Brownsville, TN 38012
(Haywood)
Brownsville Hospital Corporation (TN)
Marion, Illinois
Heartland Regional Medical Center
3333 West DeYoung
Marion, IL 62959
(Williamson)
Marion Hospital Corporation (IL)
Helena, Arkansas
Helena Regional Medical Center
1801 Martin Luther King Drive / PO Box 788
Helena , AR 72342
(Phillips)
Phillips Hospital Corporation (AR)
Lexington, Tennessee
Henderson County Community Hospital
200 West Church St.
Lexington, TN 38351
(Henderson)
Lexington Hospital Corporation (TN)
Shelbyville, Tennessee
Heritage Medical Center
2835 Hwy. 23IN
Shelbyville, TN 37160
(Bedford)
Shelbyville Hospital Corporation (TN)
Hillsboro, Texas
Hill Regional Hospital
101 Circle Drive
Hillsboro, TX 76645
(Hill)
NHCI of Hillsboro, Inc. (TX)
West Grove, Pennsylvania
Jennersville Regional Hospital
1015 West Baltimore Pike
West Grove, PA. 19390
(Chester)
West Grove Hospital Company, LLC (DE)
Jackson, Kentucky
Kentucky River Medical Center
540 Jetts Drive
Jackson, KY 41339
Breathitt)
Jackson Hospital Corporation (KY)
Warsaw, Indiana
Kosciusko Community Hospital
2101 East DuBois Drive
Warsaw, IN 46580
(Kosciusko)
Warsaw Health System, LLC (DE)
Greenville, Alabama
L.V. Stabler Memorial Hospital
29 L.V. Stabler Drive
Greenville, AL 36037
(Butler)
Greenville Hospital Corporation (AL)
Granbury, Texas
Lake Granbury Medical Center
1310 Paluxy Road
Granbury, TX 76048
(Hood)
Granbury Hospital Corporation (TX)

 


 

Lake Wales, Florida
Lake Wales Medical Center
410 South 11th Street
Lake Wales, FL 33853
(Polk)
Lake Wales Hospital Corporation (FL)
Morristown, Tennessee
Lakeway Regional Hospital
726 McFarland Street
Morristown, TN 37814
(Hamblen)
Hospital of Morristown, Inc. (TN)
Laredo, Texas
Laredo Medical Center
1700 East Saunders
Laredo, TX 78041
(Webb)
Laredo Texas Hospital Company, L.P. (TX)
Hobbs, New Mexico
Lea Regional Medical Center
5419 N. Lovington Hwy
(P.O. Box 3000)
Hobbs, NM 88240
(Lea)
Lea Regional Hospital, LLC (DE)
Lock Haven, Pennsylvania
Lock Haven Hospital
24 Cree Drive
Lock Haven, PA 17745-2699
(Washington)
Clinton Hospital Corporation (PA)
Longview, Texas
Longview Regional Medical Center
2901 N. Fourth Street
(P.O. Box 14000 / zip 75607)
Longview, TX 75605
(Gregg)
Longview Medical Center, L.P. (DE)
Fort Wayne, Indiana
Lutheran Hospital
7950 W. Jefferson Blvd.
Fort Wayne, IN 46804
(Allen)
IOM Health System, L.P. (IN)
McKenzie, Tennessee
McKenzie Regional Hospital
161 Hospital Dr.
McKenzie, TN 38201
(Carroll)
McKenzie Tennessee Hospital Company, LLC (DE)
Springfield, Oregon
McKenzie-Willamette Medical Center
1460 G Street
Springfield, OR 97477
(Lane)
McKenzie-Willamette Regional Medical
Center Associates, LLC (DE)
Selmer, Tennessee
McNairy Regional Hospital
705 Poplar Ave.
Selmer, TN 38375
(McNairy)
McNairy Hospital Corporation (TN)
Mullins, SC
Marion Regional Hospital
2829 East Hwy 76
Mullins, SC 29574
(Marion)
QHG of South Carolina, Inc (SC)
Bennettsville, South Carolina
Marlboro Park Hospital
1138 Cheraw Hwy (P.O. Box 738)
Bennettsville, SC 29512
(Marlboro)
Chesterfield/Marlboro, L.P. (DE)
Williamston, North Carolina
Martin General Hospital
310 S. McCaskey Road
Williamston, NC 27892
(Martin)
Williamston Hospital Corporation (NC)
Spartanburg, South Carolina
Mary Black Health System
1700 Skylyn Drive
Spartanburg, SC 29307
(Spartanburg)
Mary Black Health System, LLC (DE)

 


 

Palmer, Alaska
Mat-Su Regional Medical Center
2500 S. Woodworth Loop (P.O. Box 1687)
Palmer, AK 99645
(Matanuska-Susitna Borough)
Mat-Su Valley Medical Center, LLC (AK)
Enterprise, Alabama
Medical Center Enterprise
400 North Edwards Street
Enterprise, AL 36330
(Coffee)
QHG of Enterprise, Inc. (AL)
El Dorado, Arkansas
Medical Center of South Arkansas
700 W. Grove Street
El Dorado, AR 71730
(Union)
MCSA, LLC (AR)
Salem, New Jersey
The Memorial Hospital of Salem County
310 Woodstown Road
Salem, NJ 08079
(Salem)
Salem Hospital Corporation (NJ)
Mesquite, Nevada
Mesa View Regional Hospital
1299 Bertha Howe Avenue
(P.O. Box 3540 / zip 89024-3540)
Mesquite, NV 89027
(Clark)
MMC of Nevada, LLC (DE)
Deming, New Mexico
Mimbres Memorial Hospital
900 W. Ash Street
Deming, NM 88030
(Luna)
Deming Hospital Corporation (NM)
Moberly, Missouri
Moberly Regional Medical Center
1515 Union Avenue
Moberly, MO 65270
(Randolph)
Moberly Hospital Company, LLC (DE)
Tooele, Utah
Mountain West Medical Center
2055 N. Main
Tooele, UT 84074-2794
(Tooele)
Tooele Hospital Corporation (UT)
Las Cruces, New Mexico
MountainView Regional Medical Center
4311 East Lohman Avenue
Las Cruces, NM 88011
(Dona Ana)
Las Cruces Medical Center, LLC (DE)
Corsicana, Texas
Navarro Regional Hospital
3201 W. Highway 22
Corsicana, TX 75110
(Navarro)
Navarro Hospital, L.P. (DE)
Crestview, Florida
North Okaloosa Medical Center
151 Redstone Avenue, S.E.
Crestview, FL 32539-6026
(Okaloosa)
Crestview Hospital Corporation (FL)
Kirksville, Missouri
Northeast Regional Medical Center
315 S. Osteopathy
Kirksville, MO 63501
(Adair)
Kirksville Missouri Hospital Co., LLC (MO)
Ruston, Louisiana
Northern Louisiana Medical Center
401 East Vaughn Avenue
Ruston, LA 71270
(Lincoln Parish)
Ruston Louisiana Hospital Company, LLC (DE)
Youngstown, Ohio
Northside Medical Center
500 Gypsy Lane
Youngstown, OH
(Mahoning)
Youngstown Ohio Hospital Company, LLC

 


 

Tucson, Arizona
Northwest Medical Center
6200 N. LaCholla Blvd.
Tucson, AZ 85741
(Pima)
Northwest Hospital, LLC (DE)
Bentonville, Arkansas
Northwest Medical Center — Bentonville
3000 Medical Center Pkwy.
Bentonville, AR 72712
(Benton)
Northwest Arkansas Hospitals, LLC (DE)
Springdale, Arkansas
Northwest Medical Center — Springdale
609 W. Maple
Springdale, AR 72764
(Washington and Benton)
Northwest Arkansas Hospitals, LLC (DE)
Oro Valley, Arizona
Oro Valley Hospital
1551 E. Tangerine Road
Oro Valley, AZ 85755
(Pima)
Oro Valley Hospital, LLC (DE)
Fort Wayne, IN
The Orthopedic Hospital of Lutheran Health Network
700 Broadway
Fort Wayne, IN 46802
(Allen)
Lutheran Musculoskeletal Center, LLC (DE)
Fulton, Kentucky
Parkway Regional Hospital
2000 Holiday Lane (P.O. Box 866)
Fulton, KY 42041
(Fulton)
Hospital of Fulton, Inc. (KY)
Payson, Arizona
Payson Regional Medical Center
807 South Ponderosa
Payson, AZ 85541
(Gila)
Payson Hospital Corporation (AZ)
Phoenixville, Pennsylvania
Phoenixville Hospital
140 Nutt Road
Phoenixville, PA 19460
(Chester)
Phoenixville Hospital Company, LLC (DE)
Oak Hill, West Virginia
Plateau Medical Center
430 Main Street
Oak Hill, WV 25901
(Fayette)
Oak Hill Hospital Corporation (WV)
Ponca City, Oklahoma
Ponca City Medical Center
1900 North 14th Street
Ponca City, OK 74601
(Kay and Osage)
Kay County Oklahoma Hospital Company, LLC (OK)
Valparaiso, Indiana
Porter
814 LaPorte Avenue
Valparaiso, IN 46383
(Porter)
Porter Hospital, LLC (DE)
Pottstown, Pennsylvania
Pottstown Memorial Medical Center
1600 East High Street
Pottstown, PA 19464
(Montgomery)
Pottstown Hospital Company, LLC (DE)
Red Bud, Illinois
Red Bud Regional Hospital
325 Spring Street
Red Bud, IL 62278
(Randolph)
Red Bud Illinois Hospital Company, LLC (IL)
Jackson, Tennessee
Regional Hospital of Jackson
367 Hospital Blvd.
Jackson, TN 38305
(Madison)
Jackson, Tennessee Hospital Company, LLC (TN)

 


 

Vicksburg, Mississippi
River Region Health System
2100 Highway 61 North
Vicksburg, MS 39183
(Warren)
Vicksburg Healthcare, LLC (DE)
San Angelo, Texas
San Angelo Community Medical Center
3501 Knickerbocker Road
San Angelo, TX 76904
(Tom Green)
San Angelo Hospital, L.P. (DE)
Big Spring, Texas
Scenic Mountain Medical Center
1601 West Eleventh Place
Big Spring, TX 79720
(Howard)
Big Spring Hospital Corporation (TX)
Siloam Springs, AR
Siloam Springs Memorial Hospital
205 E. Jefferson Street
Siloam Springs, AR 72761
(Benton)
Siloam Springs Arkansas Hospital Company, LLC (DE)
Cleveland, Tennessee
SkyRidge Medical Center
2305 Chambliss Avenue
Cleveland, TN 37311
(Bradley)
Cleveland Tennessee Hospital Company, LLC (DE)
Foley, Alabama
South Baldwin Regional Medical Center
1613 North McKenzie Street
Foley, AL 36535
(Baldwin)
Foley Hospital Corporation (AL)
Jourdanton, Texas
South Texas Regional Medical Center
1905 Highway 97 E
Jourdanton, TX 78026
(Atascosa)
Jourdanton Hospital Corporation (TX)
Franklin, Virginia
Southampton Memorial Hospital
100 Fairview Drive
Franklin, VA 23851
(Franklin)
Franklin Hospital Corporation (VA)
Tulsa, Oklahoma
SouthCrest Hospital
8801 S. 101st East Avenue
Tulsa, OK 74133
(Tulsa)
SouthCrest, LLC (OK)
Emporia, Virginia
Southern Virginia Regional Medical Center
727 North Main Street
Emporia, VA 23847
(Emporia)
Emporia Hospital Corporation (VA)
Petersburg, Virginia
Southside Regional Medical Center
200 Medical Park Blvd.
Petersburg, VA 23805
(Petersburg)
Petersburg Hospital Company, LLC (VA)
Lancaster, South Carolina
Springs Memorial Hospital
800 W. Meeting Street
Lancaster, SC 29720
(Lancaster)
Lancaster Hospital Corporation (DE)
Fort Wayne, Indiana
St. Joseph Hospital
700 Broadway
Fort Wayne, IN 46802
(Allen)
St. Joseph Health System, LLC (DE)
Sunbury, Pennsylvania
Sunbury Community Hospital
350 N. Eleventh Street (P. O. Box 737)
Sunbury, PA 17801
(Northumberland)
Sunbury Hospital Company, LLC (DE)

 


 

Louisa, Kentucky
Three Rivers Medical Center
2483 Highway 644 (P.O. Box 769)
Louisa, KY 41230
(Lawrence)
Hospital of Louisa, Inc. (KY)
Augusta, Georgia
Trinity Hospital of Augusta
2260 Wrightsboro Road
Augusta, GA 30904
(Richmond)
Augusta Hospital, LLC (DE)
Birmingham, Alabama
Trinity Medical Center
800 Montclair Road
Birmingham, AL 35213
(Jefferson)
Affinity Hospital, LLC (DE)
Warren, Ohio
Trumbull Memorial Hospital
1350 E. Market St.
Warren, OH
(Trumbull)
Warren Ohio Hospital Company, LLC
Spokane Valley, Washington
Valley Hospital and Medical Center
12606 East Mission Avenue
Spokane Valley, WA 99216
(Spokane)
Spokane Valley Washington Hospital Company, LLC (DE)
Waukegan, Illinois
Vista Medical Center
1324 N. Sheridan Road
Waukegan, IL 60085
(Lake County)
Waukegan Illinois Hospital Company, LLC (IL)
Martin, Tennessee
Volunteer Community Hospital
161 Mt. Pelia Road
Martin, TN 38237
(Weakley)
Martin Hospital Corporation (TN)
Watsonville, California
Watsonville Community Hospital
75 Nielson Street
Watsonville, CA 95076
(Santa Cruz)
Watsonville Hospital Corporation (DE)
Weatherford, Texas
Weatherford Regional Medical Center
713 E. Anderson Street
Weatherford, TX 76086
(Parker)
Weatherford Texas Hospital Company, LLC (TX)
Hattiesburg, Mississippi
Wesley Medical Center
5001 Hardy Street
Hattiesburg, MS 39402
(Forrest)
Wesley Health System, LLC (DE)
Bullhead City, Arizona
Western Arizona Regional Medical Center
2735 Silver Creek Road
Bullhead City, AZ 86442
(Mohave)
Bullhead City Hospital Corporation (AZ)
Johnson, Arkansas
Willow Creek Women’s Hospital
4301 Greathouse Springs Rd.
(P.O. Box 544)
Johnson, AR 72741
(Washington)
Northwest Arkansas Hospitals, LLC (DE)
Wilkes — Barre, Pennsylvania
Wilkes-Barre General Hospital
575 North River Street
Wilkes-Barre, PA 18764-0001
(Luzerne)
Wilkes-Barre Hospital Company, LLC (DE)
Lake Charles, Louisiana
Women & Children’s Hospital
4200 Nelson Road
Lake Charles, LA 70605
(Calcasieu)
Women & Children’s Hospital, LLC (DE)

 


 

Lufkin, Texas
Woodland Heights Medical Center
505 S. John Redditt Drive
(P.O. Box 150610 / zip 75915)
Lufkin, TX 75904
(Angelina)
Piney Woods Healthcare System, L.P. (DE)
Woodward, Oklahoma
Woodward Regional Hospital
900 17th Street
Woodward, OK 73801
(Woodward)
Woodward Health System, LLC (DE)

 


 

Schedule 1.01(e)
Certain Permitted Joint Ventures
1. Cleveland Regional Medical Center, L.P. (Cleveland, TX)
2. Sunbury Hospital Corporation (Sunbury, PA)

 


 

Schedule 1.01(f)
Certain Subsidiaries
None.

 


 

Schedule 2.01
Lenders and Commitments
                                 
    Revolving Credit     Term Loan     Delayed Draw     Total Lender  
Lender   Commitment     Commitment     Commitment     Commitment  
Credit Suisse
  $ 52,500,000     $ 2,526,569,800     $ 162,768,000     $ 2,741,837,800  
Wachovia
    52,500,000       1,676,851,200       110,592,000       1,839,943,200  
Merrill Lynch & Co.
    45,000,000       242,600,000       16,000,000       303,600,000  
JP Morgan
    45,000,000       242,600,000       16,000,000       303,600,000  
Citicorp N.A. Inc.
    40,000,000       151,625,000       10,000,000       201,625,000  
GE Healthcare Financial Services
    40,000,000       151,625,000       10,000,000       201,625,000  
Goldman Sachs
    40,000,000       151,625,000       10,000,000       201,625,000  
Sun Trust
    40,000,000       151,625,000       10,000,000       201,625,000  
Key Bank, N.A.
    25,000,000       92,000,000       8,000,000       125,000,000  
Calyon
    25,000,000       97,646,500       6,440,000       129,086,500  
Bank of Nova Scotia
    25,000,000       97,646,500       6,440,000       129,086,500  
UBS
    25,000,000       92,000,000       8,000,000       125,000,000  
National City
    25,000,000       97,646,500       6,440,000       129,086,500  
Fifth/Third Bank
    25,000,000       97,646,500       6,440,000       129,086,500  
Barclays Capital
    25,000,000       97,646,500       6,440,000       129,086,500  
ABN AMRO/LaSalle Bank
    25,000,000       97,646,500       6,440,000       129,086,500  
Sovereign Bank
    40,000,000       0       0       40,000,000  
Wells Fargo Foothill
    25,000,000       0       0       25,000,000  
Mizuho Corporate Bank, Ltd
    25,000,000       0       0       25,000,000  

 


 

                                 
    Revolving Credit     Term Loan     Delayed Draw     Total Lender  
Lender   Commitment     Commitment     Commitment     Commitment  
United Overseas Bank
    20,000,000       0       0       20,000,000  
Bank of Oklahoma
    10,000,000       0       0       10,000,000  
Bayern LB (Bayerische Landesbank)
    10,000,000       0       0       10,000,000  
Carolina First
    10,000,000       0       0       10,000,000  
Raymond James Bank
    10,000,000       0       0       10,000,000  
Regions Bank/AmSouth
    10,000,000       0       0       10,000,000  
Commerzbank
    8,500,000       0       0       8,500,000  
FirstBank
    7,500,000       0       0       7,500,000  
Bank of Nashville
    5,000,000       0       0       5,000,000  
Siemens Financial Services Inc.
    5,000,000       0       0       5,000,000  
State Bank of India
    5,000,000       0       0       5,000,000  
Banco Espirito Santo
    4,000,000       0       0       4,000,000  
TOTAL COMMITMENT
  $ 750,000,000     $ 6,065,000,000     $ 400,000,000     $ 7,215,000,000  

 


 

Schedule 3.08
Subsidiaries
         
    Percentage
Legal Entity   Owned
5300 Grand Limited Partnership
    69 %
Abilene Hospital, LLC
    100 %
Abilene Merger, LLC
    100 %
Affinity Health Systems, LLC
    99.5 %
Affinity Hospital, LLC
    99.5 %
Affinity Orthopedic Services, LLC
    100 %
Affinity Physician Services, LLC
    100 %
Affinity Skilled Nursing, LLC
    100 %
Aiken Home Care Services, LLC
    100 %
Alaska Physicians Services, LLC
    100 %
Alice Hospital, LLC
    100 %
Alice Surgeons, LLC
    100 %
Ambulance Services of Dyersburg, Inc.
    100 %
Ambulance Services of Forrest City, LLC
    100 %
Ambulance Services of Lexington, Inc.
    100 %
Ambulance Services of McKenzie, Inc.
    100 %
Ambulance Services of McNairy, Inc.
    100 %
Ambulance Services of Tooele, LLC
    100 %
American Health Facilities Development, LLC
    100 %
Anesthesiology Group of Hattiesburg, LLC
    100 %
Angelo Community Healthcare Services, Inc.
    100 %
Anna Clinic Corp.
    100 %
Anna Home Care Services, LLC
    100 %
Anna Hospital Corporation
    100 %
APS Medical, LLC
    100 %
Arizona ASC Management, Inc.
    100 %
Arizona DH, LLC
    100 %
Arizona Medco, LLC
    100 %
ARMC, L.P.
    87.562 %
Arusha LLC
    67.50 %
Augusta Health System, LLC
    65.52 %
Augusta Home Care Services, LLC
    100 %
Augusta Hospital, LLC
    65.52 %
Augusta Physician Services, LLC
    100 %
Barberton Health System, LLC
    100 %
Barberton Physician Services, LLC
    100 %
Barstow Healthcare Management, Inc.
    100 %
Beauco, LLC
    100 %
Beaumont Medical Center, L.P.
    100 %
Beaumont Regional, LLC
    100 %
Berwick Clinic Company, LLC
    100 %
Berwick Clinic Corp.
    100 %
Berwick Home Care Services, LLC
    100 %
Berwick Home Health Private Care, Inc.
    100 %
Berwick Hospital Company, LLC
    100 %
BH Trans Company, LLC
    100 %
Big Bend Home Care Services, LLC
    100 %

 


 

         
    Percentage
Legal Entity   Owned
Big Bend Hospital Corporation
    100 %
Big Spring Hospital Corporation
    100 %
Birmingham Holdings, LLC
    100 %
Birmingham Holdings II, LLC
    100 %
Bluefield Clinic Company, LLC
    100 %
Bluefield HBP Medical Group, LLC
    100 %
Bluefield Holdings, LLC
    100 %
Bluefield Hospital Company, LLC
    100 %
Blue Ridge Georgia Hospital Company, LLC
    98.21 %
Bluffton Health System, LLC
    100 %
Bluffton Physician Services, LLC
    100 %
Brandywine Hospital Malpractice Assistance Fund, Inc.
    100 %
Broken Arrow Medical Group, LLC
    100 %
Brooklyn Medical Associates, LLC
    100 %
Brownsville Clinic Corp.
    100 %
Brownsville Hospital Corporation
    100 %
Brownwood Hospital, L.P.
    100 %
Brownwood Medical Center, LLC
    100 %
Bullhead City Clinic Corp.
    100 %
Bullhead City Hospital Corporation
    98.89 %
Bullhead City Hospital Investment Corporation
    98.89 $
Bullhead City Imaging Corporation
    100 %
Byrd Medical Clinic, Inc.
    100 %
Cardiology Associates of Spokane, LLC
    100 %
Cardiology Associates of Tri-cities, LLC
    100 %
Carlsbad Medical Center, LLC
    100 %
Carolina Surgery Center, LLC
    52.27 %
Carolinas Medical Alliance, Inc.
    100 %
Carolinas OB/GYN Medical Group, LLC
    100 %
Cedar Park Health System, L.P.
    80 %
Center for Adult Healthcare, LLC
    100 %
Central Alabama Physician Services, Inc.
    100 %
Centre Clinic Corp.
    100 %
Centre Home Care Corporation
    100 %
Centre Hospital Corporation
    100 %
Centre RHC Corp.
    100 %
Chesterfield Clinic Corp.
    100 %
Chesterfield/Marlboro, L.P.
    100 %
Chestnut Hill Clinic Company, LLC
    85 %
Chestnut Hill Health System, LLC
    85 %
CHHS ALF Company, LLC
    85 %
CHHS Development Company, LLC
    85 %
CHHS Holdings, LLC
    100 %
CHHS Hospital Company, LLC
    85 %
CHHS Rehab Company, LLC
    85 %
CHS Kentucky Holdings, LLC
    100 %
CHS Pennsylvania Holdings, LLC
    100 %
CHS Realty Holdings I, Inc.
    100 %
CHS Realty Holdings II, Inc.
    100 %
CHS Realty Holdings Joint Venture
    100 %
CHS Utah Holdings, LLC
    100 %
CHS Virginia Holdings, LLC
    100 %

 


 

         
    Percentage
Legal Entity   Owned
CHS Washington Holdings, LLC
    100 %
CHS/Community Health Systems, Inc.
    100 %
CHSPSC Leasing, Inc.
    100 %
Claremore Anesthesia, LLC
    100 %
Claremore Diagnostic Center, LLC
    100 %
Claremore Internal Medicine, LLC
    100 %
Claremore Physicians, LLC
    100 %
Claremore Regional Hospital, LLC
    100 %
Clarksville Health System, G.P.
    80 %
Clarksville Holdings, LLC
    100 %
Clarksville Home Care Services, LLC
    80 %
Clarksville Physicians Services, G.P.
    80 %
Cleveland Clinic Corp.
    100 %
Cleveland Home Care Services, LLC
    100 %
Cleveland Hospital Corporation
    100 %
Cleveland Medical Clinic, Inc.
    100 %
Cleveland PHO, Inc.
    100 %
Cleveland Regional Medical Center, L.P.
    100 %
Cleveland Tennessee Hospital Company, LLC
    100 %
Clinton County Health System, LLC
    100 %
Clinton Hospital Corporation
    100 %
Coatesville Cardiology Clinic, LLC
    100 %
Coatesville Clinic Company, LLC
    100 %
Coatesville Hospital Corporation
    100 %
C-OK, LLC
    100 %
College Station Hospital, L.P.
    100 %
College Station Medical Center, LLC
    100 %
College Station Merger, LLC
    100 %
College Station RHC Company, LLC
    100 %
Community GP Corp.
    100 %
Community Health Care Partners, Inc.
    100 %
Community Health Investment Company, LLC
    100 %
Community Health Network, Inc.
    100 %
Community Health Physicians Operations Holding Company, LLC
    100 %
Community Health Systems Foundation
    100 %
Community Health Systems Professional Services Corporation
    100 %
Community Health Systems Professional Services Corporation Political Action Committee
    100 %
Community Health United Home Care, LLC
    100 %
Community Insurance Group SPC, LTD.
    100 %
Community LP Corp.
    100 %
Community Network Solutions, LLC
    100 %
Coronado Hospital, LLC
    100 %
Coronado Medical, LLC
    100 %
Cottage Home Options, L.L.C.
    100 %
Coventry Clinic Company, LLC
    100 %
CP Hospital G.P., LLC
    100 %
CPLP, LLC
    100 %
Crestview Hospital Corporation
    98.81 %
Crestview Professional Condominiums Association, Inc.
    63.7 %
Crestview Surgery Center, L.P.
    100 %
Crestwood Healthcare, L.P.
    86.11 %

 


 

         
    Percentage
Legal Entity   Owned
Crestwood Hospital, L.P. LLC
    100 %
Crestwood Hospital, LLC
    100 %
Crestwood Surgery Center, LLC
    86.11 %
Crossroads Home Care Services, LLC
    100 %
Crossroads Physician Corp.
    100 %
CSMC, LLC
    100 %
CSRA Holdings, LLC
    100 %
Dallas Physician Practice, L.P.
    100 %
Dallas Phy Service, LLC
    100 %
Day Surgery, Inc.
    100 %
DCF
    100 %
Deaconess Clinical Associates, Inc.
    96.55 %
Deaconess Health System, LLC
    96.55 %
Deaconess Holdings, LLC
    100 %
Deaconess Hospital Holdings, LLC
    100 %
Deaconess Metropolitan Physicians, LLC
    100 %
Deaconess Physician Services, LLC
    100 %
Deming Clinic Corporation
    100 %
Deming Home Care Services, LLC
    100 %
Deming Hospital Corporation
    100 %
Desert Hospital Holdings, LLC
    100 %
DeTar Hospital, LLC
    100 %
DFW Physerv, LLC
    100 %
DH Cardiology, LLC
    100 %
DHFW Holdings, LLC
    100 %
DHSC, LLC
    100 %
Diagnostic Imaging Management of Brandywine Valley, LLC
    100 %
Diagnostic Imaging of Brandywine Valley, LP
    100 %
Doctors Hospital Physician Services, LLC
    100 %
Doctors Medical Center, LLC
    100 %
Doctors of Laredo, LLC
    100 %
Dukes Health System, LLC
    100 %
Dukes Physician Services, LLC
    100 %
Dupont Hospital, LLC
    72.03 %
Dyersburg Clinic Corp.
    100 %
Dyersburg Home Care Services, LLC
    100 %
Dyersburg Hospital Corporation
    100 %
East Tennessee Clinic Corp.
    100 %
East Tennessee Health Systems, Inc.
    100 %
Easton Hospital Malpractice Assistance Fund, Inc.
    100 %
E.D. Clinics, LLC
    100 %
Edge Medical Clinic, Inc.
    100 %
Edwardsville Ambulatory Surgery Center, L.L.C.
    68.44 %
El Dorado Home Care Services, LLC
    100 %
El Dorado Surgery Center, L.P.
    61.20 %
EL MED, LLC
    100 %
Eligibility Screening Services, LLC
    100 %
Empire Health Services
    100 %
Emporia Clinic Corp.
    100 %
Emporia Home Care Services, LLC
    100 %
Emporia Hospital Corporation
    100 %

 


 

         
    Percentage
Legal Entity   Owned
Enterprise Clinic, LLC
    100 %
Eufaula Clinic Corp.
    100 %
Eufaula Hospital Corporation
    100 %
Evanston Clinic Corp.
    100 %
Evanston Hospital Corporation
    100 %
Fallbrook Home Care Services, LLC
    100 %
Fallbrook Hospital Corporation
    100 %
Family Home Care, Inc.
    100 %
Fannin Regional Orthopaedic Center, Inc.
    100 %
First Choice Health Network, Inc.
    8.33 %
Florence ASC Management, LLC
    100 %
Florence Home Care Services, LLC
    100 %
Flowers Real Estate Holdings, LLC
    100 %
Foley Clinic Corp.
    100 %
Foley Home Health Corporation
    100 %
Foley Hospital Corporation
    100 %
Forrest City Arkansas Hospital Company, LLC
    100 %
Forrest City Clinic Company, LLC
    100 %
Forrest City Hospital Corporation
    100 %
Fort Payne Clinic Corp.
    100 %
Fort Payne Home Care Corporation
    100 %
Fort Payne Hospital Corporation
    100 %
Fort Payne RHC Corp.
    100 %
Frankfort Health Partner, Inc.
    100 %
Franklin Clinic Corp.
    100 %
Franklin Home Care Services, LLC
    100 %
Franklin Hospital Corporation
    100 %
Fulton Home Care Services, LLC
    100 %
Gadsden Home Care Services, LLC
    100 %
Gadsden Regional Medical Center, LLC
    100 %
Gadsden Regional Physician Group Practice, LLC
    100 %
Gadsden Regional Primary Care, LLC
    100 %
Galesburg Home Care Corporation
    100 %
Galesburg Hospital Corporation
    100 %
Galesburg In-Home Assistance, Inc.
    100 %
Galesburg Professional Services, LLC
    100 %
Gateway Malpractice Assistance Fund, Inc.
    100 %
Gateway Medical Services, Inc.
    100 %
GCMC, LLC
    100 %
GH Texas, LLC
    100 %
Granbury Hospital Corporation
    100 %
Granbury Texas Hospital Investment Corporation
    100 %
Granite City ASC Investment Company, LLC
    100 %
Granite City Clinic Corp.
    100 %
Granite City Home Care Services, LLC
    100 %
Granite City Hospital Corporation
    100 %
Granite City Illinois Hospital Company, LLC
    100 %
Granite City Orthopedic Physicians Company, LLC
    100 %
Granite City Physicians Corp.
    100 %
GRB Real Estate, LLC
    100 %
Great Plains Medical Foundation
    96.55 %
Greenbrier Valley Anesthesia, LLC
    100 %

 


 

         
    Percentage
Legal Entity   Owned
Greenbrier Valley Emergency Physicians, LLC
    100 %
Greenbrier VMC, LLC
    96.01 %
Greenville Clinic Corp.
    100 %
Greenville Hospital Corporation
    100 %
GRMC Holdings, LLC
    100 %
Gulf Coast Hospital, L.P.
    100 %
Gulf Coast Medical Center, LLC
    100 %
Hallmark Healthcare Company, LLC
    100 %
Harris Managed Services, Inc.
    100 %
Harris Medical Clinics, Inc.
    100 %
Hattiesburg ASC-GP, LLC
    100 %
Hattiesburg Home Care Services, LLC
    100 %
Haven Clinton Medical Associates, LLC
    100 %
HDP Woodland Heights, L.P.
    100 %
HDP Woodland Property, LLC
    100 %
HDPWH, LLC
    100 %
Health Care of Forsyth County, Inc.
    100 %
Healthwest Holdings, Inc.
    100 %
Heartland Malpractice Assistance Fund, Inc.
    100 %
Heartland Regional Health Systems, LLC
    100 %
Heartland Rural Healthcare, LLC
    100 %
Helena Home Care Services, LLC
    100 %
Hidden Valley Medical Center, Inc.
    100 %
Highland Health Systems, Inc.
    100 %
Hill Regional Clinic Corp.
    100 %
Hill Regional Medical Group
    100 %
Hobbs Medco, LLC
    100 %
Hobbs Physician Practice, LLC
    100 %
Hood Medical Group
    100 %
Hood Medical Services, Inc.
    100 %
Hospital of Barstow, Inc.
    100 %
Hospital of Fulton, Inc.
    100 %
Hospital of Louisa, Inc.
    100 %
Hospital of Morristown, Inc.
    100 %
Hot Springs Outpatient Surgery Center, G.P.
    100 %
HTI Tucson Rehabilitation, Inc.
    100 %
Humble Texas Home Care Corporation
    100 %
Huntington Associates
    100 %
INACTCO, Inc.
    100 %
In-Home Assistance, L.L.C.
    100 %
In-Home Medical Equipment Supplies and Services, Inc.
    100 %
Innovative Recoveries, LLC
    100 %
IOM Health System, L.P.
    83.92 %
Jackson Home Care Services, LLC
    100 %
Jackson Hospital Corporation (KY)
    100 %
Jackson Hospital Corporation (TN)
    100 %
Jackson Physician Corp.
    100 %
Jackson, Tennessee Hospital Company, LLC
    97.10 %
Jennersville Regional Hospital Malpractice Assistance Fund, Inc.
    100 %
Jennersville Family Medicine, LLC
    100 %
Jonesboro Real Property, LLC
    100 %
Jourdanton Home Care Services, LLC
    100 %

 


 

         
    Percentage
Legal Entity   Owned
Jourdanton Hospital Corporation
    100 %
Kay County Clinic Company, LLC
    100 %
Kay County Hospital Corporation
    100 %
Kay County Oklahoma Hospital Company, LLC
    100 %
Kentucky River HBP, LLC
    100 %
Kentucky River Physician Corporation
    100 %
Kirksville Academic Medicine, LLC
    100 %
Kirksville Clinic Corp.
    100 %
Kirksville Home Care Services, LLC
    100 %
Kirksville Hospital Company, LLC
    100 %
Kirksville Missouri Hospital Company, LLC
    82.49 %
Kirksville Physical Therapy Services, LLC
    100 %
Knox Clinic Corp.
    100 %
Kosciusko Medical Group, LLC
    100 %
Lake Area Physician Services, LLC
    100 %
Lake Area Surgicare A Partnership in Commendam
    63.25 %
Lake Wales Clinic Corp.
    100 %
Lake Wales Hospital Corporation
    93.15 %
Lake Wales Hospital Investment Corporation
    93.15 %
Lakeland Home Care Services, LLC
    100 %
Lakeway Hospital Corporation
    100 %
Lancaster Clinic Corp.
    100 %
Lancaster Home Care Services, LLC
    100 %
Lancaster Hospital Corporation
    100 %
Lancaster Imaging Center, LLC
    51 %
Laredo Hospital, L.P.
    100 %
Laredo Texas Hospital Company, L.P.
    94.66 %
Las Cruces ASC-GP, LLC
    100 %
Las Cruces Medical Center, LLC
    100 %
Las Cruces Physician Services, LLC
    100 %
Las Cruces Surgery Center, L.P.
    77.69 %
Lea Regional Hospital, LLC
    100 %
Leesville Surgery Center, LLC
    62.07 %
Lexington Clinic Corp.
    100 %
Lexington Family Physicians, LLC
    100 %
Lexington Home Care Services, LLC
    100 %
Lexington Hospital Corporation
    100 %
Lindenhurst Illinois Hospital Company, LLC
    100 %
Lock Haven Clinic Company, LLC
    100 %
Lock Haven Home Care Services, LLC
    100 %
Logan Hospital Corporation
    100 %
Logan, West Virginia Hospital Company, LLC
    100 %
Longview Medical Center, L.P.
    73.98 %
Longview Merger, LLC
    100 %
Louisa Home Care Services, LLC
    100 %
LRH, LLC
    100 %
LS Psychiatric, LLC
    100 %
Lutheran Health Network CBO, LLC
    100 %
Lutheran Health Network Investors, LLC
    83.92 %
Lutheran Health Network of Indiana, LLC
    100 %
Lutheran Medical Group, LLC
    100 %
Lutheran Musculoskeletal Center, LLC
    60 %

 


 

         
    Percentage
Legal Entity   Owned
Lutheran TRMA Network, LLC
    42 %
Madison Clinic Corp.
    100 %
Madison Hospital, LLC
    100 %
Marion Hospital Corporation
    100 %
Marion Physician Services, LLC
    100 %
Marlboro Clinic Corp.
    100 %
Martin Clinic Corp.
    100 %
Martin Hospital Corporation
    100 %
Mary Black Health System, LLC
    97.53 %
Mary Black Medical Office Building Limited Partnership
    97.53 %
Mary Black MOB II, L.P.
    97.53 %
Mary Black Physician Services, LLC
    100 %
Mary Black Physicians Group, LLC
    100 %
Massillon Community Health System LLC
    100 %
Massillon Health System LLC
    100 %
Massillon Holdings, LLC
    100 %
Mat-Su Regional ASC GP, LLC
    100 %
Mat-Su Regional Surgery Center, L.P.
    100 %
Mat-Su Valley II, LLC
    75 %
Mat-Su Valley III, LLC
    75 %
Mat-Su Valley Medical Center, LLC
    74.386 %
MCI Panhandle Surgical, L.P.
    100 %
McKenzie Clinic Corp.
    100 %
McKenzie Physician Services, LLC
    100 %
McKenzie Tennessee Hospital Company, LLC
    100 %
McKenzie-Willamette Regional Medical Center Associates, LLC
    90.51 %
McNairy Clinic Corp.
    100 %
McNairy Hospital Corporation
    100 %
MCSA, L.L.C.
    100 %
Medical Center at Terrell, LLC
    100 %
Medical Center of Brownwood, LLC
    100 %
Medical Holdings, Inc.
    100 %
Medstat, LLC
    100 %
Memorial Hospital of Salem Malpractice Assistance Fund, Inc.
    100 %
Memorial Hospital, LLC
    100 %
Memorial Management, Inc.
    100 %
Merger Legacy Holdings, LLC
    100 %
Mesa View Physical Rehabilitation, LLC
    50 %
Mesa View PT, LLC
    100 %
Mesquite Clinic Management Company, LLC
    100 %
MHS Ambulatory Surgery Center, Inc.
    100 %
Mid-Plains, LLC
    100 %
Minot Health Services, Inc.
    100 %
Mission Bay Memorial Hospital, LLC
    100 %
MMC OF Nevada, LLC
    100 %
Moberly HBP Medical Group, LLC
    100 %
Moberly Hospital Company, LLC
    100 %
Moberly Medical Clinics, Inc.
    100 %
Moberly Physicians Corp.
    100 %
Mohave Imaging Center, LLC
    100 %
Morristown Clinic Corp.
    100 %
Morristown Professional Centers, Inc.
    100 %

 


 

         
    Percentage
Legal Entity   Owned
Morristown Surgery Center, LLC
    100 %
MWMC Holdings, LLC
    100 %
National Healthcare of England Arkansas, Inc.
    100 %
National Healthcare of Holmes County, Inc.
    100 %
National Healthcare of Leesville, Inc.
    100 %
National Healthcare of Mt. Vernon, Inc.
    100 %
National Healthcare of Newport, Inc.
    100 %
Navarro Hospital, L.P.
    100 %
Navarro Regional, LLC
    100 %
NC-CSH, Inc.
    100 %
NC-DSH, LLC
    100 %
Neurospine-Pain Surgery Center, LLC
    20 %
Newport Home Care Services, LLC
    100 %
NHCI of Hillsboro, Inc.
    100 %
North Okaloosa Clinic Corp.
    100 %
North Okaloosa Home Health Corp.
    100 %
North Okaloosa Medical Corp.
    95.81 %
North Okaloosa Surgery Venture Corp.
    100 %
Northampton Clinic Company, LLC
    100 %
Northampton Home Care, LLC
    100 %
Northampton Hospital Company, LLC
    100 %
Northampton Physician Services Corp.
    100 %
Northampton Urgent Care, LLC
    100 %
Northeast Medical Center, L.P.
    100 %
Northern Indiana Oncology Center of Porter Memorial Hospital, LLC
    95.2 %
Northwest Allied Physicians, LLC
    100 %
Northwest Arkansas Employees, LLC
    100 %
Northwest Arkansas Hospitals, LLC
    99.32 %
Northwest Benton County Physician Services, LLC
    100 %
Northwest Cardiology, LLC
    100 %
Northwest Hospital, LLC
    100 %
Northwest Indiana Health System, LLC
    90.84 %
Northwest Marana Hospital, LLC
    100 %
Northwest Medical Center CT/MRI at Marana, LLC
    100 %
Northwest Physicians, LLC
    100 %
Northwest Rancho Vistoso Imaging Services, LLC
    100 %
Northwest Tucson ASC-GP, LLC
    100 %
Northwest Tucson Surgery Center, L.P.
    57.42 %
NOV Holdings, LLC
    100 %
NRH, LLC
    100 %
Oak Hill Clinic Corp.
    100 %
Oak Hill Hospital Corporation
    100 %
Oklahoma City ASC-GP, LLC
    100 %
Oklahoma City Home Care Services, LLC
    100 %
Olive Branch Clinic Corp.
    100 %
Olive Branch Hospital, Inc.
    100 %
Open MRI of Wharton, LLP
    100 %
Oro Valley Hospital, LLC
    100 %
Pacific East Division Office, L.P.
    100 %
Pacific Group ASC, Inc.
    100 %
Pacific Physicians Services, LLC
    100 %
Pain Management Joint Venture, LLP
    50 %

 


 

         
    Percentage
Legal Entity   Owned
Palm Drive Hospital, L.P.
    100 %
Palm Drive Medical Center, LLC
    100 %
Palmer-Wasilla Health System, LLC
    100 %
Palmetto Women’s Care, LLC
    100 %
Pampa Hospital, L.P.
    100 %
Pampa Medical Center, LLC
    100 %
Panhandle Medical Center, LLC
    100 %
Panhandle Property, LLC
    100 %
Panhandle Surgical Hospital, L.P.
    100 %
Panhandle, LLC
    100 %
Parkway Regional Medical Clinic, Inc.
    100 %
Payson Healthcare Management, Inc.
    100 %
Payson Home Care Services, LLC
    100 %
Payson Hospital Corporation
    100 %
PDMC, LLC
    100 %
Pecos Valley of New Mexico, LLC
    100 %
Peerless Healthcare, LLC
    100 %
Pennsylvania Hospital Company, LLC
    100 %
Petersburg Clinic Company, LLC
    100 %
Petersburg Home Care Services, LLC
    100 %
Petersburg Hospital Company, LLC
    99.29 %
Phillips and Coker OB-GYN, LLC
    100 %
Phillips Clinic Corp.
    100 %
Phillips Hospital Corporation
    100 %
Phoenix Surgical, LLC
    100 %
Phoenixville Clinic Company, LLC
    100 %
Phoenixville Hospital Company, LLC
    100 %
Phoenixville Hospital Malpractice Assistance Fund, Inc.
    100 %
Phoenixville Specialty Clinics, LLC
    100 %
Physician Practice Support, Inc.
    100 %
Physicians and Surgeons Hospital of Alice, L.P.
    100 %
Piney Woods Healthcare System, L.P.
    91.36 %
Plymouth Hospital Corporation
    100 %
Polk Medical Services, Inc.
    100 %
Ponca City Home Care Services, Inc.
    100 %
Porter Health Services, LLC
    100 %
Porter Hospital, LLC
    90.84 %
Porter Physician Services, LLC
    100 %
Pottstown Clinic Company, LLC
    100 %
Pottstown Home Care Services, LLC
    100 %
Pottstown Hospital Company, LLC
    100 %
Pottstown Hospital Corporation
    100 %
Pottstown Imaging Company, LLC
    100 %
Pottstown Memorial Malpractice Assistance Fund, Inc.
    100 %
PremierCare of Northwest Arkansas, LLC
    79.6 %
PremierCare Super PHO, LLC
    100 %
Procure Solutions, LLC
    100 %
Professional Account Services, Inc.
    100 %
QHG Georgia Holdings, Inc.
    100 %
QHG Georgia Holdings II, LLC
    100 %
QHG Georgia, LP
    100 %
QHG of Barberton, Inc.
    100 %

 


 

         
    Percentage
Legal Entity   Owned
QHG of Bluffton Company, LLC
    100 %
QHG of Clinton County, Inc.
    100 %
QHG of Enterprise, Inc.
    100 %
QHG of Forrest County, Inc.
    100 %
QHG of Fort Wayne Company, LLC
    100 %
QHG of Hattiesburg, Inc.
    100 %
QHG of Kenmare, Inc.
    100 %
QHG of Lake City, Inc.
    100 %
QHG of Massillon, Inc.
    100 %
QHG of Minot, Inc.
    100 %
QHG of Ohio, Inc.
    100 %
QHG of South Carolina, Inc.
    100 %
QHG of Spartanburg, Inc.
    100 %
QHG of Springdale, Inc.
    100 %
QHG of Texas, Inc.
    100 %
QHG of Warsaw Company, LLC
    100 %
QHR Intensive Resources, LLC
    100 %
QHR International, LLC
    100 %
QS of Okmulgee, LLC
    100 %
Quorum ELF, Inc.
    100 %
Quorum Health Resources, LLC
    100 %
Quorum Health Services, Inc.
    100 %
Quorum Purchasing Advantage, LLC
    100 %
Quorum Solutions, LLC
    100 %
Red Bud Clinic Corp.
    100 %
Red Bud Home Care Services, LLC
    100 %
Red Bud Hospital Corporation
    100 %
Red Bud Illinois Hospital Company, LLC
    100 %
Red Bud Physician Group, LLC
    100 %
Regional Cancer Treatment Center, Ltd.
    12.78 %
Regional Employee Assistance Program
    100 %
Regional Hospital of Longview, LLC
    100 %
Regional Surgical Services, LLC
    82.1 %
Rehab Hospital of Fort Wayne General Partnership
    83.92 %
River Region Medical Corporation
    100 %
River to River Heart Group, LLC
    100 %
Rockwood Clinic, P.S.
    50 %
Rockwood Clinic Real Estate Holdings, LLC
    100 %
Ronceverte Physician Group, LLC
    100 %
Roswell Clinic Corp.
    100 %
Roswell Community Hospital Investment Corporation
    100 %
Roswell Hospital Corporation
    100 %
Russell County Clinic Corp.
    100 %
Russell County Medical Center, Inc.
    100 %
Ruston Clinic Company, LLC
    100 %
Ruston Hospital Corporation
    100 %
Ruston Louisiana Hospital Company, LLC
    100 %
SACMC, LLC
    100 %
Salem Clinic Corp.
    100 %
Salem Home Care Services, LLC
    100 %
Salem Hospital Corporation
    100 %

 


 

         
    Percentage
Legal Entity   Owned
Salem Medical Professionals, P.C.
  0% (100% control)
Samaritan Surgicenters of Arizona II, L.L.C.
    100 %
San Angelo Community Medical Center, LLC
    100 %
San Angelo Hospital, L.P.
    93.62 %
San Angelo Medical, LLC
    100 %
San Diego Hospital, L.P.
    100 %
San Leandro Hospital, L.P.
    100 %
San Leandro Medical Center, LLC
    100 %
San Leandro, LLC
    100 %
San Miguel Clinic Corp.
    100 %
San Miguel Hospital Corporation
    100 %
Scenic Managed Services, Inc.
    100 %
Schuylkill Internal Medicine Associates, LLC
    100 %
SDH, LLC
    100 %
Sebastopol, LLC
    100 %
Senior Circle Association
    100 %
Shelby Alabama Real Estate, LLC
    100 %
Shelbyville Clinic Corp.
    100 %
Shelbyville Home Care Services, LLC
    100 %
Shelbyville Hospital Corporation
    100 %
Sherman Hospital, L.P.
    100 %
Sherman Medical Center, LLC
    100 %
Siloam Springs Arkansas Hospital Company, LLC
    100 %
Siloam Springs Clinic Company, LLC
    100 %
Siloam Springs Holdings, LLC
    100 %
Silsbee Doctors Hospital, L.P.
    100 %
Silsbee Medical Center, LLC
    100 %
Silsbee Texas, LLC
    100 %
Silver Creek MRI, LLC
    51 %
SJ Home Care, LLC
    100 %
SkyRidge Clinical Associates, LLC
    100 %
SLH, LLC
    100 %
SMMC Medical Group
    100 %
Software Sales Corp.
    100 %
South Alabama Managed Care Contracting, Inc.
    100 %
South Alabama Medical Management Services, Inc.
    100 %
South Alabama Physician Services, Inc.
    100 %
South Arkansas Clinic, LLC
    100 %
South Arkansas Physician Services, LLC
    100 %
South Tulsa Medical Group, LLC
    100 %
SouthCrest, L.L.C.
    100 %
SouthCrest Anesthesia Group, LLC
    100 %
SouthCrest Medical Group, LLC
    100 %
SouthCrest Surgery Center, L.P.
    79.385 %
Southeast Alabama Maternity Care, LLC
    62.50 %
Southern Illinois Medical Care Associates, LLC
    100 %
Southern Texas Medical Center, LLC
    100 %
Southside Physician Network, LLC
    100 %
Spokane Home Care Services, LLC
    100 %
Spokane Valley Washington Hospital Company, LLC
    100 %
Spokane Washington Hospital Company, LLC
    100 %

 


 

         
    Percentage
Legal Entity   Owned
Springdale Home Care Services, LLC
    100 %
Springfield Oregon Holdings, LLC
    100 %
Sprocket Medical Management, LLC
    100 %
St. Joseph Health System, LLC
    83.92 %
St. Joseph Medical Group, Inc.
    100 %
Sunbury Clinic Company, LLC
    100 %
Sunbury Hospital Company, LLC
    73.26 %
Surgical Center of Amarillo, LLC
    100 %
Surgical Center of Carlsbad, LLC
    100 %
Surgicare of Independence, Inc.
    100 %
Surgicare of San Leandro, Inc.
    100 %
Surgicare of Sherman, Inc.
    100 %
Surgicare of Victoria, Inc.
    100 %
Surgicare of Victoria, Ltd.
    100 %
Surgicare Outpatient Center of Lake Charles, Inc.
    100 %
Surgicenter of Johnson County, Inc.
    100 %
Surgicenters of America, Inc.
    100 %
SVRMC-HBP, LLC
    100 %
Tennyson Holdings, LLC
    100 %
Terrell Hospital, L.P.
    100 %
Terrell Medical Center, LLC
    100 %
The Surgery Center of Salem County, L.L.C.
    90.90 %
The Vicksburg Clinic, LLC
    100 %
Three Rivers Medical Clinics, Inc.
    100 %
Timberland Medical Group
    100 %
Tooele Clinic Corp.
    100 %
Tooele Home Care Services, LLC
    100 %
Tooele Hospital Corporation
    100 %
Triad Corporate Services Limited Partnership
    100 %
Triad CSGP, LLC
    100 %
Triad CSLP, LLC
    100 %
Triad Healthcare Corporation
    100 %
Triad Healthcare System of Phoenix, L.P.
    100 %
Triad Holdings III, LLC
    100 %
Triad Holdings IV, LLC
    100 %
Triad Holdings V, LLC
    100 %
Triad Holdings VI, Inc.
    100 %
Triad Indiana Holdings, LLC
    83.92 %
Triad Medical Center at Terrell Subsidiary, LLC
    100 %
Triad Nevada Holdings, LLC
    100 %
Triad of Alabama, LLC
    100 %
Triad of Arizona (L.P.), Inc.
    100 %
Triad of Oregon, LLC
    100 %
Triad of Phoenix, Inc.
    100 %
Triad RC, Inc.
    100 %
Triad Texas, LLC
    100 %
Triad-Arizona I, Inc.
    100 %
Triad-ARMC, LLC
    100 %
Triad-Denton Hospital GP, LLC
    100 %
Triad-Denton Hospital, L.P.
    100 %
Triad-El Dorado, Inc.
    100 %
Triad-Navarro Regional Hospital Subsidiary, LLC
    100 %

 


 

         
    Percentage
Legal Entity   Owned
Triad-South Tulsa Hospital Company, Inc.
    100 %
Triad-Willow Creek, LLC
    100 %
Tri-Irish, Inc.
    100 %
Tri-World, LLC
    100 %
TROSCO, LLC
    100 %
Troy Hospital Corporation
    100 %
Tuscora Park Medical Specialists, LLC
    100 %
VHC Holdings, LLC
    100 %
VHC Medical, LLC
    100 %
Vicksburg Healthcare, LLC
    100 %
Vicksburg Surgical Center, LLC
    100 %
Victoria Texas Home Care Services, LLC
    100 %
Victoria Hospital, LLC
    100 %
Victoria of Texas, L.P.
    100 %
Village Medical Center Associates, LLC
    100 %
Virginia Hospital Company, LLC
    100 %
WA-SPOK DH CRNA, LLC
    100 %
WA-SPOK DH Urgent Care, LLC
    100 %
WA-SPOK Kidney Care, LLC
    100 %
WA-SPOK Medical Care, LLC
    100 %
WA-SPOK Primary Care, LLC
    100 %
WA-SPOK Pulmonary & Critical Care, LLC
    100 %
WA-SPOK VH CRNA, LLC
    100 %
WA-SPOK VH Urgent Care, LLC
    100 %
WAMC, LLC
    100 %
Warren Ohio Hospital Company, LLC
    100 %
Warren Ohio Rehab Hospital Company, LLC
    100 %
Warsaw Health System, LLC
    99.03 %
Washington Clinic Corp.
    100 %
Washington Hospital Corporation
    100 %
Washington Physician Corp.
    100 %
Watsonville Hospital Corporation
    100 %
Waukegan Clinic Corp.
    100 %
Waukegan Hospice Corp.
    100 %
Waukegan Hospital Corporation
    100 %
Waukegan Illinois Hospital Company, LLC
    100 %
Weatherford Home Care Services, LLC
    100 %
Weatherford Hospital Corporation
    100 %
Weatherford Texas Hospital Company, LLC
    100 %
Webb County Texas Home Care Services, LLC
    100 %
Webb Hospital Corporation
    100 %
Webb Hospital Holdings, LLC
    100 %
Wesley Health System, LLC
    100 %
Wesley HealthTrust, Inc.
    100 %
Wesley Physician Services, LLC
    100 %
West Anaheim Hospital, L.P.
    100 %
West Anaheim Medical Center, LLC
    100 %
West Anaheim, LLC
    100 %
West Grove Clinic Company, LLC
    100 %
West Grove Family Practice, LLC
    100 %
West Grove Home Care, LLC
    100 %
West Grove Hospital Company, LLC
    100 %

 


 

         
    Percentage
Legal Entity   Owned
West Virginia MS, LLC
    100 %
Western Arizona Regional Home Health and Hospice, Inc.
    100 %
Wharton Medco, LLC
    100 %
WHMC, LLC
    100 %
Wichita Falls Texas Home Care Corporation
    100 %
Wichita Falls Texas Private Duty Corporation
    100 %
Wilkes-Barre Academic Medicine, LLC
    100 %
Wilkes-Barre Behavioral Hospital Company, LLC
    100 %
Wilkes-Barre Behavioral Ventures, LLC
    100 %
Wilkes-Barre Clinic Company, LLC
    100 %
Wilkes-Barre Community Residential Unit, LLC
    100 %
Wilkes-Barre Holdings, LLC
    100 %
Wilkes-Barre Home Care Services, LLC
    100 %
Wilkes-Barre Hospital Company, LLC
    100 %
Wilkes-Barre Personal Care Services, LLC
    100 %
Wilkes-Barre Skilled Nursing Services, LLC
    100 %
Willamette Community Medical Group, LLC
    100 %
Williamston Clinic Corp.
    100 %
Williamston Hospital Corporation
    100 %
Wiregrass Clinic, LLC
    100 %
Women & Children’s Hospital, LLC
    100 %
Women’s Health Partners, LLC
    100 %
Woodland Heights Medical Center, LLC
    100 %
Woodward Clinic Company, LLC
    100 %
Woodward Health System, LLC
    100 %
Woodward Home Care Services, LLC
    100 %
Youngstown Ohio Hospital Company, LLC
    100 %
Youngstown Ohio Laboratory Services Company, LLC
    100 %
Youngstown Ohio Outpatient Services Company, LLC
    100 %
Youngstown Ohio Physician Services Company, LLC
    100 %
Youngstown Ohio PSC, LLC
    100 %

 


 

Schedule 3.18
Insurance
1. Hospital Liability Insurance
    This policy provides comprehensive general liability, medical professional liability, contractual liability, personal injury liability, druggists’ liability, and employment practices liability insurance. The policy period is June 1, 2010 to June 1, 2011. The policy is written on a claims-made basis, with retroactive date of September 1, 1986 for Legacy facilities and January 1, 2008 for all Triad facilities acquired on July 25, 2007 (CHS07). This policy, shared by all of the CHS affiliate facilities, provides a $4.750 million per occurrence limit excess of a $250,000 “self-insured” retention (SIR). The policy is written by Community Insurance Group, SPC, Ltd. (CIG). The policy number is 274/CIG10.
    Excess insurance is provided by Zurich American (Steadfast Insurance Company) with limits of $20 million per occurrence/$20 million annual aggregate, excess a $5 million/$10 million SIR buffer excess $5 million each & every self insured retention. The policy period is June 1, 2010 to June 1, 2011. This liability umbrella policy is written on a claims-made basis, with retroactive date of September 1, 1986 for Legacy facilities and January 1, 2002 for all Triad facilities acquired by CHS on July 25, 2007 (CHS07). (This umbrella also provides excess automobile, employers’ liability, helipad liability, non-owned aviation). The policy number is HPC534683705.
    An excess liability policy with AWAC Bermuda provides limits of $25 million per occurrence/$25 million annual aggregate, excess $25 million with the same excess provisions. The policy period is June 1, 2010 to June 1, 2011. The policy number is C002071/001.
    An excess policy with Endurance of Bermuda provides $15 million per occurrence/$15 million annual aggregate, excess $50 million with the same excess provisions. The policy number is P010840001.
    An excess liability policy with Illinois Union/ACE provides limits of $10 million per occurrence/$10 million annual aggregate, excess $65 million with the same excess provisions. The policy number is XHLG21820374003. A punitive wrap policy with Ace Bermuda provides punitive damages coverage for the Ace US layer of $10 million, excess $65 million.
    An excess liability policy with Swiss Re provides limits of $25 million per occurrence/$25 million annual aggregate, excess $75 million with the same excess provisions. The policy number is Q31000139.
    An excess liability policy with London Lexington provides limits of $25million per occurrence/ $25 million annual aggregate, excess $100 million with the same excess

 


 

    provisions. The policy is retroacive to January 1, 2008 for CHS Legacy and January 1, 2002 for CHS07. The policy number is Q31000142.
    An excess liability policy with One Beacon provides limits of $25 million per occurrence/ $25 million annual aggregate, excess $125 million. The policy retroactive date is January 1, 2008 for CHS and January 1, 2002 for CHS07. The policy number is MPX-2241110.
    An excess liability policy with Chaucer- Lloyds of London provides limits of $25 million per occurrence.$25 million annual aggregate, excess $150 million. The policy retroactive date is January 1, 2008 for CHS and January 1, 2002 for CHS07. The policy number is Q3100141.
    An excess liability policy with XL Bermuda provides limits of $25 million per occurrence/$25 million annual aggregate, excess $175 million. The policy retroactive date is June 1, 2010. The policy number is XLUMB-604250.
    All policies above Zurich have a drop down provision to $5 million in the event underlying limits are exhausted, except for a batch occurrence which is $25 million.
    Total limits are $200,000,000.
    The State of PA requires first dollar professional liability insurance coverage through a PA licensed carrier and participation in the State Fund. Therefore, effective March 1, 2002, Berwick is insured through a PA fronted policy with CNA for professional liability limits of $500,000/$2,500,000 retroactive to March 1, 1999 for claims not reported prior to March 1, 2002; and the Fund with limits to $1.2M. Effective October 1, 2002, Jennersville, Easton, and Brandywine are in the same program. This change is retro to June 11, 2001 for Brandywine and October 1, 2001 for Easton and Jennersville for claims not reported prior to October 1, 2002. Lock Haven is in this program effective August 1, 2002, Pottstown effective July 1, 2003, Phoenixville effective August 1, 2004, Chestnut Hill effective March 1, 2005, Sunbury effective October 1, 2005, and Wilkes-Barre effective May 1, 2009. CIG provides coverage over the Fund.
    Effective August 1, 2000, the Louisiana hospital, Byrd Regional, became a member of the Louisiana Patients’ Compensation Fund. Other Louisiana hospitals in the Fund are Northern Louisiana Medical Center and Women and Childrens’ Hospital. These hospitals are insured in CHS’ program for the 1st $100,000 of each medical malpractice claim and the Fund provides coverage from $100,000 to the statutory cap of $500,000.
    All Indiana hospitals are enrolled in the Indiana PCF. These hospitals have a fronted policy with Zurich for professional liability limits of $250,000/$7.5M. The Fund then provides coverage up to a statutory cap of $1,250,000. Policy dates are May 1, 2010-May 1, 2011. Policy # HPC925981303.

 


 

    Other fronting polices obtained to comply with state statutes include a MS/FL front for $250,000 for FL hospitals and $1M for MS physicians written on a claims made basis with CNA. This is PL only- no GL. The policy is # HAZ1034387183-7.
    Steadfast (Zurich) also writes an AL fronted GL policy for $1M/$2M to cover an MOB in Huntsville, AL. The policy # is HPC655087401.
2. Workers’ Compensation and Employers Liability Insurance
    Workers’ Compensation and Employers Liability insurance is purchased to comply with CHS affiliates’ obligations under state and federal workers’ compensation laws. The policy period is December 1, 2009 to December 1, 2010. Statutory limits apply to Workers’ Compensation. Employers Liability limits are $1 million each employee per accident/$1 million occupational disease aggregate/$1 million by disease each occurrence. This is a large deductible program with a $300,000 deductible. The policy is written by Zurich, policy number WC 3730423-06.
    All Texas facilities have entered into an Opted-Out ERISA Plan in lieu of a statutory work comp program effective December 1, 2001 for CHS and October 1, 2007 for CHS07. The TX facilities maintain a $500,000 self-insured retention for all employee injuries. An excess policy has been purchased with North American Capacity Insurance Company for coverage above this self-insured retention up to $10 million per occurrence/ $25 million aggregate. The policy period for this excess policy is December 1, 2009-December 1, 2010. The policy number is EEG0000240-01.
    An Ohio Excess Workers’ Comp policy is written with Zurich with statutory limits to sit over the $350,000 self-insured retention. The effective dates are July 1, 2009-July 1, 2010. The policy # is EWS 2347095-07.
3. Automobile Liability and Physical Damage Coverage — Primary
    Automobile Liability coverage is purchased to pay all sums CHS affiliates are legally liable to pay as damages because of bodily injury or property damage caused by an accident and resulting from the ownership, maintenance or use of a covered auto, including hired and non-owned autos. Hired and non-owned autos coverage is excess of any other available limits including employees’ personal vehicles while in use on company business. The policies have a $2 million CSL of Liability limit/$2 million CSL of Uninsured Motorists Liability limit. There is a $10,000 deductible for liability on the policy for the hospitals and a $250,000 deductible for Corporate. Physical Damage coverage is only on vehicles 2003 and newer and all ambulances. The deductible is $2,500. The policy period is December 1, 2009-December 1, 2010. The policies are written by Zurich. The policy number is BAP 3730425-06.

 


 

4. Employment Practices Liability
    Zurich provides a policy that covers Employment Practices Liability. This policy provides limits of $20 million, excess $5 million self-insured retention. A punitive wrap policy for these limits is purchased from Hanseatic Insurance Company (Bermuda) Limited. The policy period is June 1, 2010 to June 1, 2011. The policy is written on a claims-made basis, retroactive to May 11, 1999 for CHS07 facilities and to June 1, 2003 for Legacy facilities. The policy numbers are Zurich- EPL 9130847-03 and Hanseatic- HIPD202075.
    An excess EPL policy is written by Axis. It provides limits of $10 million excess $25 million. A punitive wrap policy for these limits is purchased from Axis Bermuda. Policy dates are June 1, 2010 to June 1, 2011. The policy is written on a claims-made basis, retroactive to May 11, 2000 for CHS07 facilities and to June 1, 2003 for CHS facilities. The policy numbers are Axis- MAN17596/01/2010 and Axis Bermuda- 113606110QA.
5. Property
    A property policy is purchased to protect CHS affiliates from direct damage to owned/leased properties. It also provides for the loss of income or increased operating expenses as the result of a direct damage loss. The property damage portion of the policy is written on a replacement value basis. Policy limits are $750,000,000. The policy includes a $250 million total earthquake limit for all locations except CA, and those facilities located in the New Madrid Seismic Zone and the Pacific Northwest Seismic Zone, which have a $25 million sublimit and a 5% deductible. For “wind locations” there are 3- 5% wind deductibles. There is a $250 million total flood limit for all facilities not located in a flood plain. For those in flood plains, the limits and deductibles vary from $100,000-$500,000. All other deductibles vary (by peril) from $50,000 to $100,000. Terrorism coverage is included. The policy is written by FM Global with coverage dates of March 1, 2010 — March 1, 2011. The policy number is JC803.
    Kentucky River Medical Center, 540 Jetts Drive, Jackson, KY is situated in a flood plain (zone A) and is eligible for flood coverage through the National Flood Insurance Program (NFIP). Coverage has been purchased essentially to “buy down” the deductible in the FM Global policy of $500,000 building and $500,000 contents to a deductible of $5,000. Valuation of this policy is actual cash value. The policy is written through Hartford Insurance Company, policy number 01486140002008. The policy period is March 14, 2010 to March 14, 2011.
6. Fidelity/Crime
    Crime coverage is purchased for acts of employee dishonesty, forgery or alteration, theft, disappearance or destruction, robbery and safe burglary, computer fraud, wire transfers, and money order or counterfeit currency at a limit of $20 million dollars. The crime policy is provided by National Union Fire Insurance Company with a deductible of

 


 

    $500,000. The coverage dates are July 25, 2010 to July 25, 2011. The policy number is 025828043.
    An excess policy is purchased through Zurich with limits of $10 million excess $20 million. The policy dates are the same. The policy number is FID 9156612 02.
7. Fiduciary Liability
    A Pension and Welfare Benefit Plan Fiduciaries’ and Administrators’ Liability Insurance Policy is purchased to cover the administrators of the employee benefit plans. The policy period is July 25, 2010 to July 25, 2011. This is claims-made coverage. Primary limits are $10 million combined single limit with a $150,000 deductible for Indemnifiable Loss; $2.5M Employer Securities Claims. The carrier is Travelers. The policy number is EC03200711.
    1st excess policy is with XL with limits of $10 million excess $10 million. The policy number is ELU117891100.
    2nd excess policy is with RLI with limits of $10 million excess $20 million. The policy number is EPG0008245.
    3rd excess policy is with Axis with limits of $10 million excess $30 million. The policy number is MAN734112012010.
    4th excess policy is with National Union with limits of $10 million excess $40 million. The policy number is 025890052.
    Total limits are $50 million.
8. Directors and Officers Insurance and Company Reimbursement Policy
    CHS’ Directors and Officers Liability insurance policies provide coverage for Corporate Directors and Officers, members of Hospital Governing Boards, and members of the Physician Advisory Counsel. The policy period is November 18, 2009 to November 18, 2010. Policy limits are $100 million and are provided through ten layers of coverage. The primary policy is written through AIG (National Union) and provides a $10 million limit with a $2.5M SIR. The policy number is TBD.
    1st excess policy with limits of $10M excess $10M is provided by Zurich through policy number TBD.
    2nd excess policy with limits of $10M excess $20M is provided by Liberty Mutual through policy number TBD
    3rd excess policy with limits of $10M excess $30M is provided by XL Specialty through policy number TBD.

 


 

    4th excess policy with limits of $10M excess $40M is provided by XL (Bermuda) through policy number TBD, Side A DIC coverage only.
    5th excess policy with limits of $10M excess $50M, Side A DIC coverage only, is provided by Allied World Assurance through policy number TBD.
    6th excess policy with limits of $10M excess $60M is provided by Axis, Side A DIC coverage only, with a policy number TBD.
    7th excess policy with limits of $10M excess $70M is provided by Continental Casualty, Side A DIC coverage only, through policy number TBD.
    8th excess policy with limits of $10M excess $80M is provided by Berkley, Side A DIC coverage only, through policy number TBD.
    Finally, 9th excess policy with limits of $10M excess $90M, Side A DIC coverage only, is provided by Chubb through policy number TBD.
9. Environmental Impairment Liability Policy/ Storage Tanks
    This policy provides payment for damages to personal property, or environmental injury arising out of environmental impairment from underground & aboveground storage tanks. It will also pay for clean up resulting from pollution liability arising from said storage tank. It also provides pollution coverage including incidents involving mold, lead, and asbestos. The policy period is September 1, 2009 to September 1, 2012. The policy limits are $5 million per occurrence/$20 million annual aggregate, with a $50,000 deductible. The carrier is Zurich. The policy number is EPC 6552482-00.
10. Owned & Non-Owned Aviation Liability/ Helipad Liability
    This policy provides payment for bodily injury and property damage including passengers for the owned air ambulance helicopter and the 5 CHS leased/owned aircraft. The policy is provided by Global Aerospace for a liability policy limit of $100,000,000 per occurrence for the helicopter with a deductible of $10,000 Not in Motion/3% of the Insured Value in Motion coverage. The policy period is June 11, 2010-June 11, 2011. The policy number is BH 10035634. The policy also provides $100,000,000 limits for the Beech King Air, and $125,000,000 limits for the three Hawkers and the Citation.
    A helipad liability policy provides coverage for any helipad premises owned or used by the facility. The policy is provided by Global Aerospace for a limit of $10,000.000 per occurrence with a $50,000 deductible for each and every loss. The policy number is BH 10035634. The policy period is June 11, 2010-June 11, 2011.

 


 

11. Employed Physician Professional Liability Insurance
    Professional liability insurance is procured and maintained for all employed physicians. The master policy, shared by all of the CHS affiliate employed physicians, is written on a claims-made basis in the amount of $1,000,000 per occurrence/$3,000,000 in the aggregate, or limits that meet statutory requirements, for professional medical services provided. This primary insurance is obtained through Community Insurance Group, SPC, Ltd. The policy period is June 1, 2010 to June 1, 2011. The policy number is 274/CIG/PHY10. Employed physicians are insured under the liability policy with Community Insurance Group, SPC, Ltd. (described in section 1) with limits of $4 million per occurrence, excess of the $1 million primary policy provided by CIG. The employed physicians are also provided coverage on the excess liability policies.
    A number of employed physicians are insured under individual commercial policies purchased by their employer. These policies have varying effective dates.

 


 

Schedules 3.19(a)
UCC Filing Offices
             
        Jurisdiction of    
    Entity Name   Formation   Filing Office
1.
  Centre Hospital Corporation   Alabama   Secretary of State of the State of Alabama
2.
  Foley Hospital Corporation   Alabama   Secretary of State of the State of Alabama
3.
  Fort Payne Hospital Corporation   Alabama   Secretary of State of the State of Alabama
4.
  Greenville Hospital Corporation   Alabama   Secretary of State of the State of Alabama
5.
  QHG of Enterprise, Inc.   Alabama   Secretary of State of the State of Alabama
6.
  QHG of Springdale, Inc.   Alabama   Secretary of State of the State of Alabama
7.
  Payson Hospital Corporation   Arizona   Secretary of State of the State of Arizona
8.
  Forrest City Arkansas Hospital Corporation   Arkansas   Secretary of State of the State of Alabama
9.
  Forrest City Clinic Company, LLC   Arkansas   Secretary of State of the State of Alabama
10.
  Forrest City Hospital Corporation   Arkansas   Secretary of State of the State of Alabama
11.
  MCSA, L.L.C.   Arkansas   Secretary of State of the State of Arkansas
12.
  Phillips Hospital Corporation   Arkansas   Secretary of State of the State of Alabama
13.
  Triad-El Dorado, Inc.   Arkansas   Secretary of State of the State of Alabama
14.
  Abilene Hospital, Inc.   Delaware   Secretary of State of the State of Delaware
15.
  Abilene Merger, LLC   Delaware   Secretary of State of the State of Delaware
16.
  Arizone DH, LLC   Delaware   Secretary of State of the State of Delaware
17.
  Berwick Hospital Company, LLC   Delaware   Secretary of State of the State of Delaware
18.
  BH Trans Company, LLC   Delaware   Secretary of State of the State of Delaware
19.
  Birmingham Holdings II, LLC   Delaware   Secretary of State of the State of Delaware
20.
  Birmingham Holdings, LLC   Delaware   Secretary of State of the State of Delaware
21.
  Bluefield Holdings, LLC   Delaware   Secretary of State of the State of Delaware
22.
  Bluefield Hospital Company, LLC   Delaware   Secretary of State of the State of Delaware
23.
  Bluffton Health System, LLC   Delaware   Secretary of State of the State of Delaware
24.
  Brownwood Hospital, L.P.   Delaware   Secretary of State of the State of Delaware
25.
  Brownwood Medical Center, LLC   Delaware   Secretary of State of the State of Delaware
26.
  Carlsbad Medical Center, LLC   Delaware   Secretary of State of the State of Delaware
27.
  CHHS Holdings, LLC   Delaware   Secretary of State of the State of Delaware
28.
  CHS Kentucky Holdings, LLC   Delaware   Secretary of State of the State of Delaware
29.
  CHS Pennsylvania Holdings, LLC   Delaware   Secretary of State of the State of Delaware
30.
  CHS Virginia Holdings, LLC   Delaware   Secretary of State of the State of Delaware
31.
  CHS Washington Holdings, LLC   Delaware   Secretary of State of the State of Delaware
32.
  Claremore Reginal Hospital, LLC   Delaware   Secretary of State of the State of Delaware

 


 

             
        Jurisdiction of    
    Entity Name   Formation   Filing Office
33.
  Clarksville Holdings, LLC   Delaware   Secretary of State of the State of Delaware
34.
  Cleveland Regional Medical Center, L.P.   Delaware   Secretary of State of the State of Delaware
35.
  Cleveland Tennessee Hospital Company, LLC   Delaware   Secretary of State of the State of Delaware
36.
  College Station Hospital, L.P.   Delaware   Secretary of State of the State of Delaware
37.
  College Station Medical Center, LLC   Delaware   Secretary of State of the State of Delaware
38.
  College Station Merger, LLC   Delaware   Secretary of State of the State of Delaware
39.
  Community GP Corp.   Delaware   Secretary of State of the State of Delaware
40.
  Community Health Investment Company, LLC   Delaware   Secretary of State of the State of Delaware
41.
  Community Health Systems, Inc.   Delaware   Secretary of State of the State of Delaware
42.
  Community LP Corp.   Delaware   Secretary of State of the State of Delaware
43.
  CP Hospital GP, LLC   Delaware   Secretary of State of the State of Delaware
44.
  CPLP, LLC   Delaware   Secretary of State of the State of Delaware
45.
  Crestwood Hospital LP, LLC   Delaware   Secretary of State of the State of Delaware
46.
  Crestwood Hospital, LLC   Delaware   Secretary of State of the State of Delaware
47.
  CSMC, LLC   Delaware   Secretary of State of the State of Delaware
48.
  CSRA Holdings, LLC   Delaware   Secretary of State of the State of Delaware
49.
  Deaconess Holdings,LLC   Delaware   Secretary of State of the State of Delaware
50.
  Deaconess Hospital Holdings, LLC   Delaware   Secretary of State of the State of Delaware
51.
  Desert Hospital Holdings, LLC   Delaware   Secretary of State of the State of Delaware
52.
  Detar Hospital, LLC   Delaware   Secretary of State of the State of Delaware
53.
  DHFW Holdings, LLC   Delaware   Secretary of State of the State of Delaware
54.
  DHSC, LLC   Delaware   Secretary of State of the State of Delaware
55.
  Dukes Health System, LLC   Delaware   Secretary of State of the State of Delaware
56.
  Fallbrook Hospital Corporation   Delaware   Secretary of State of the State of Delaware
57.
  Gadsden Regional Medical Center, LLC   Delaware   Secretary of State of the State of Delaware
58.
  GRMC Holdings, LLC   Delaware   Secretary of State of the State of Delaware
59.
  Hallmark Healthcare Company, LLC   Delaware   Secretary of State of the State of Delaware
60.
  Hobbs Medco, LLC   Delaware   Secretary of State of the State of Delaware
61.
  Hospital of Barstow, Inc.   Delaware   Secretary of State of the State of Delaware
62.
  Kirksville Hospital Company, LLC   Delaware   Secretary of State of the State of Delaware
63.
  Lancaster Hospital Corporation   Delaware   Secretary of State of the State of Delaware
64.
  Las Cruces Medical Center, LLC   Delaware   Secretary of State of the State of Delaware
65.
  Lea Regional Hospital, LLC   Delaware   Secretary of State of the State of Delaware
66.
  Longview Merger, LLC   Delaware   Secretary of State of the State of Delaware

 


 

             
        Jurisdiction of    
    Entity Name   Formation   Filing Office
67.
  LRH, LLC   Delaware   Secretary of State of the State of Delaware
68.
  Lutheran Health Network of Indiana, LLC   Delaware   Secretary of State of the State of Delaware
69.
  Massillon Community Health System LLC   Delaware   Secretary of State of the State of Delaware
70.
  Massillon Health System LLC   Delaware   Secretary of State of the State of Delaware
71.
  Massillon Holdings, LLC   Delaware   Secretary of State of the State of Delaware
72.
  McKenzie Tennessee Hospital Company, LLC   Delaware   Secretary of State of the State of Delaware
73.
  Medical Center of Brownwood, LLC   Delaware   Secretary of State of the State of Delaware
74.
  Merger Legacy Holdings, LLC   Delaware   Secretary of State of the State of Delaware
75.
  MMC of Nevada, LLC   Delaware   Secretary of State of the State of Delaware
76.
  Moberly Hospital Company, LLC   Delaware   Secretary of State of the State of Delaware
77.
  MWMC Holdings, LLC   Delaware   Secretary of State of the State of Delaware
78.
  National Healthcare of Leesville, Inc.   Delaware   Secretary of State of the State of Delaware
79.
  National Healthcare of Mt. Vernon, Inc.   Delaware   Secretary of State of the State of Delaware
80.
  National Healthcare of Newport, Inc.   Delaware   Secretary of State of the State of Delaware
81.
  Navarro Hospital, L.P.   Delaware   Secretary of State of the State of Delaware
82.
  Navarro Regional, LLC   Delaware   Secretary of State of the State of Delaware
83.
  Northampton Hospital Company, LLC   Delaware   Secretary of State of the State of Delaware
84.
  Northwest Hospital, LLC   Delaware   Secretary of State of the State of Delaware
85.
  NOV Holdings, LLC   Delaware   Secretary of State of the State of Delaware
86.
  NRH, LLC   Delaware   Secretary of State of the State of Delaware
87.
  Oro Valley Hospital, LLC   Delaware   Secretary of State of the State of Delaware
88.
  Palmer-Wasilla Health System, LLC   Delaware   Secretary of State of the State of Delaware
89.
  Pennsylvania Hospital Company, LLC   Delaware   Secretary of State of the State of Delaware
90.
  Pennsylvania Hospital Company, LLC   Delaware   Secretary of State of the State of Delaware
91.
  Phoenixville Hospital Company, LLC   Delaware   Secretary of State of the State of Delaware
92.
  Pottstown Hospital Company, LLC   Delaware   Secretary of State of the State of Delaware
93.
  QHG Georgia Holdings II, LLC   Delaware   Secretary of State of the State of Delaware
94.
  QHG of Bluffton Company, LLC.   Delaware   Secretary of State of the State of Delaware
95.
  QHG of Fort Wayne Company, LLC   Delaware   Secretary of State of the State of Delaware
96.
  QHG of Warsaw Company, LLC   Delaware   Secretary of State of the State of Delaware
97.
  Quorum Health Resources, LLC   Delaware   Secretary of State of the State of Delaware
98.
  Regional Hospital of Longview, LLC   Delaware   Secretary of State of the State of Delaware
99.
  Ruston Hospital Corporation   Delaware   Secretary of State of the State of Delaware
100.
  SACMC, LLC   Delaware   Secretary of State of the State of Delaware

 


 

             
        Jurisdiction of    
    Entity Name   Formation   Filing Office
101.
  San Angelo Community Medical Center, LLC   Delaware   Secretary of State of the State of Delaware
102.
  San Angelo Medical, LLC   Delaware   Secretary of State of the State of Delaware
103.
  Siloam Springs Arkansas Hospital Company, LLC   Delaware   Secretary of State of the State of Delaware
104.
  Siloam Springs Holdings, LLC   Delaware   Secretary of State of the State of Delaware
105.
  Southern Texas Medical Center, LLC   Delaware   Secretary of State of the State of Delaware
106.
  Spokane Valley Washington Hospital Company, LLC   Delaware   Secretary of State of the State of Delaware
107.
  Spokane Washington Hospital Company, LLC   Delaware   Secretary of State of the State of Delaware
108.
  Tennyson Holdings, Inc.   Delaware   Secretary of State of the State of Delaware
109.
  Triad Healthcare Corporation   Delaware   Secretary of State of the State of Delaware
110.
  Triad Holdings III, LLC   Delaware   Secretary of State of the State of Delaware
111.
  Triad Holdings IV, LLC   Delaware   Secretary of State of the State of Delaware
112.
  Triad Holdings V, LLC   Delaware   Secretary of State of the State of Delaware
113.
  Triad Nevada Holdings, LLC   Delaware   Secretary of State of the State of Delaware
114.
  Triad of Alabama, LLC   Delaware   Secretary of State of the State of Delaware
115.
  Triad of Oregon, LLC   Delaware   Secretary of State of the State of Delaware
116.
  Triad-Denton Hospital GP, LLC   Delaware   Secretary of State of the State of Delaware
117.
  Triad-Denton Hospital, L.P.   Delaware   Secretary of State of the State of Delaware
118.
  Triad-Navarro Regional Hospital Subsidiary, LLC   Delaware   Secretary of State of the State of Delaware
119.
  Trian-ARMC, LLC   Delaware   Secretary of State of the State of Delaware
120.
  VHC Medical   Delaware   Secretary of State of the State of Delaware
121.
  Vicksburg Healthcare, LLC   Delaware   Secretary of State of the State of Delaware
122.
  Victoria Hospital, LLC   Delaware   Secretary of State of the State of Delaware
123.
  Victoria of Texas, L.P.   Delaware   Secretary of State of the State of Delaware
124.
  Warren Ohio Hospital Company, LLC   Delaware   Secretary of State of the State of Delaware
125.
  Warren Ohio Rehab Hospital Company, LLC   Delaware   Secretary of State of the State of Delaware
126.
  Watsonville Hospital Corporation   Delaware   Secretary of State of the State of Delaware
127.
  Webb Hospital Corporation   Delaware   Secretary of State of the State of Delaware
128.
  Webb Hospital Holdings, LLC   Delaware   Secretary of State of the State of Delaware
129.
  Wesley Health System, LLC   Delaware   Secretary of State of the State of Delaware
130.
  West Grove Hospital Company, LLC   Delaware   Secretary of State of the State of Delaware
131.
  WHMC, LLC   Delaware   Secretary of State of the State of Delaware

 


 

             
        Jurisdiction of    
    Entity Name   Formation   Filing Office
132.
  Wilkes-Barre Behavioral Hospital Company, LLC   Delaware   Secretary of State of the State of Delaware
133.
  Wilkes-Barre Holdings, LLC   Delaware   Secretary of State of the State of Delaware
134.
  Wilkes-Barre Hospital Company, LLC   Delaware   Secretary of State of the State of Delaware
135.
  Women & Children’s Hospital, LLC   Delaware   Secretary of State of the State of Delaware
136.
  Woodland Heights Medical Center, LLC   Delaware   Secretary of State of the State of Delaware
137.
  Woodward Health System, LLC   Delaware   Secretary of State of the State of Delaware
138.
  Youngstown Ohio Hospital Company, LLC   Delaware   Secretary of State of the State of Delaware
139.
  QHG Georgia Holdings, Inc.   Georgia   Office of the Clerk of any Superior Court
140.
  QHG Georgia, LP   Georgia   Office of the Clerk of any Superior Court
141.
  Anna Hospital Corporation   Illinois   Secretary of State of the State of Illinois
142.
  Galesburg Hospital Corporation   Illinois   Secretary of State of the State of Illinois
143.
  Granite City Hospital Corporation   Illinois   Secretary of State of the State of Illinois
144.
  Granite City Illinois Hospital Company, LLC   Illinois   Secretary of State of the State of Illinois
145.
  Marion Hospital Corporation   Illinois   Secretary of State of the State of Illinois
146.
  Red Bud Hospital Corporation   Illinois   Secretary of State of the State of Illinois
147.
  Red Bud Illinois Hospital Company, LLC   Illinois   Secretary of State of the State of Illinois
148.
  Waukegan Hospital Corporation   Illinois   Secretary of State of the State of Illinois
149.
  Waukegan Illinois Hospital Company, LLC   Illinois   Secretary of State of the State of Illinois
150.
  Frankfort Health Partner, Inc.   Indiana   Secretary of State of the State of Indiana
151.
  QHG of Clinton County, Inc.   Indiana   Secretary of State of the State of Indiana
152.
  Hospital of Fulton, Inc.   Kentucky   Secretary of State of the State of Kentucky
153.
  Hospital of Louisa, Inc.   Kentucky   Secretary of State of the State of Kentucky
154.
  Jackson Hospital Corporation   Kentucky   Secretary of State of the State of Kentucky
155.
  Ruston Louisiana Hospital Company, LLC   Louisiana   Recorder of Mortgages of Orleans Parish or Clerk of Court of any other parish
156.
  QHG of Forrest County, Inc.   Mississippi   Secretary of State of the State of Mississippi
157.
  QHG of Hattiesburg, Inc.   Mississippi   Secretary of State of the State of Mississippi
158.
  River Region Medical Corporation   Mississippi   Secretary of State of the State of Mississippi
159.
  NC-DSH, LLC   Nevada   Secretary of State of the State of Nevada
160.
  Salem Hospital Corporation   New Jersey   New Jersey Department of Treasury/Division of Revenue
161.
  Deming Hospital Corporation   New Mexico   Secretary of State of the State of New Mexico

 


 

             
        Jurisdiction of    
    Entity Name   Formation   Filing Office
162.
  Roswell Hospital Corporation   New Mexico   Secretary of State of the State of New Mexico
163.
  San Miguel Hospital Corporation   New Mexico   Secretary of State of the State of New Mexico
164.
  Williamston Hospital Corporation   North Carolina   Secretary of State of the State of North Carolina
165.
  QHG of Barberton, Inc.   Ohio   Secretary of State of the State of Ohio
166.
  QHG of Massillon, Inc.   Ohio   Secretary of State of the State of Ohio
167.
  Kay County Hospital Corporation   Oklahoma   Secretary of State of the State of Oklahoma
168.
  Kay County Oklahoma Hospital Company, LLC   Oklahoma   Secretary of State of the State of Oklahoma
169.
  SouthCrest, L.L.C.   Oklahoma   County Clerk of Oklahoma County
170.
  Triad-South Tulsa Hospital Company, Inc.   Oklahoma   County Clerk of Oklahoma County
171.
  Clinton Hospital Corporation   Pennsylvania   Secretary of the Commonwealth
172.
  Coatesville Hospital Corporation   Pennsylvania   Secretary of the Commonwealth
173.
  QHG of South Carolina, Inc.   South Carolina   Secretary of State of the State of South Carolina
174.
  QHG of Spartanburg, Inc.   South Carolina   Secretary of State of the State of South Carolina
175.
  Browsville Hospital Corporation   Tennessee   Secretary of State of the State of Tennessee
176.
  Cleveland Hospital Corporation   Tennessee   Secretary of State of the State of Tennessee
177.
  Dyersburg Hospital Corporation   Tennessee   Secretary of State of the State of Tennessee
178.
  Hospital of Morristown, Inc.   Tennessee   Secretary of State of the State of Tennessee
179.
  Jackson Hospital Corporation   Tennessee   Secretary of State of the State of Tennessee
180.
  Lakeway Hospital Corporation   Tennessee   Secretary of State of the State of Tennessee
181.
  Lexington Hospital Corporation   Tennessee   Secretary of State of the State of Tennessee
182.
  Martin Hospital Corporation   Tennessee   Secretary of State of the State of Tennessee
183.
  McNairy Hospital Corporation   Tennessee   Secretary of State of the State of Tennessee
184.
  Shelbyville Hospital Corporation   Tennessee   Secretary of State of the State of Tennessee
185.
  Big Bend Hospital Corporation   Texas   Secretary of State of the State of Texas
186.
  Big Spring Hospital Corporation   Texas   Secretary of State of the State of Texas
187.
  Granbury Hospital Corporation   Texas   Secretary of State of the State of Texas
188.
  Jourdanton Hospital Corporation   Texas   Secretary of State of the State of Texas
189.
  Weatherford Hospital Corporation   Texas   Secretary of State of the State of Texas
190.
  Weatherford Texas Hospital Company, LLC   Texas   Secretary of State of the State of Texas
191.
  Tooele Hospital Corporation   Utah   Division of Corporations and Commercial Code
192.
  Emporia Hospital Corporation   Virginia   State Corporation Commission

 


 

             
        Jurisdiction of    
    Entity Name   Formation   Filing Office
193.
  Franklin Hospital Corporation   Virginia   State Corporation Commission
194.
  Russell County Medical Center, Inc.   Virginia   State Corporation Commission
195.
  Virginia Hospital Company, LLC   Virginia   State Corporation Commission
196.
  Oak Hill Hospital Corporation   West Virginia   Secretary of State of the State of West Virginia
197.
  Evanston Hospital Corporation   Wyoming   Secretary of State of the State of Wyoming

 


 

Schedule 3.19(c)
Mortgage Filing Offices
     
Hospital Name/Address (County)   Corporate Owner
DeKalb Regional Medical Center
  Fort Payne Hospital Corporation (AL)
200 Medical Center Drive
   
P.O. Box 680778
   
Fort Payne, AL 35968 (Dekalb)
   
 
   
Flowers Hospital
  Triad of Alabama, LLC (DE)
4370 West Main Street
   
Dothan, AL 36305 (Houston)
   
 
   
Gadsden Regional Medical Center
  Gadsden Regional Medical Center, LLC (DE)
1007 Goodyear Avenue
   
Gadsden, AL 35903 (Etowah)
   
 
   
Medical Center Enterprise
  QHG of Enterprise, Inc. (AL)
400 North Edwards St.
   
Enterprise, AL 36330 (Coffee)
   
 
   
Northwest Hospital
  Northwest Hospital, LLC (DE)
6200 N. LaCholla Blvd.
   
Tucson, AZ 85755 (Pima)
   
 
   
Northwest Hospital Oro Valley
  Oro Valley Hospital, LLC (DE)
1551 E. Tangerine Rd.
   
Oro Valley, AZ 85755 (Pima)
   
 
   
Watsonville Community Hospital
  Watsonville Hospital Corporation (DE)
75 Nielson Street
   
Watsonville, CA 95076 (Santa Cruz)
   
 
   
Galesburg Cottage Hospital
  Galesburg Hospital Corporation (IL)
695 N. Kellogg St.
   
Galesburg, IL 61401 (Knox)
   
 
   
Gateway Regional Medical Center
  Granite City Illinois Hospital Company, LLC (IL)
2100 Madison Avenue
   
Granite City, IL 62040 (Madison)
   
 
   
Heartland Regional Medical Center
  Marion Hospital Corporation (IL)
3333 West DeYoung
   
Marion, IL 62959 (Williamson)
   
 
   
Vista Medical Center (includes East and West)
  Waukegan Illinois Hospital Company, LLC (IL)
1324 N. Sheridan Road
   
Waukegan, IL 60085 (Lake)
   

 


 

     
Hospital Name/Address (County)   Corporate Owner
Bluffton Regional Medical Center
  Bluffton Health System, LLC (DE)
303 South Main Street
   
Bluffton, IN 46714 (Wells)
   
 
   
Dukes Memorial Hospital
  Dukes Health System, LLC (DE)
275 W. 12th Street
   
Peru, IN 46970 (Miami)
   
 
   
Women and Children’s Hospital
  Women and Children’s Hospital, LLC (DE)
4200 Nelson Road
   
Lake Charles, LA 70605 (Calcasieu)
   
 
   
River Region Health System
  Vicksburg Healthcare, LLC (DE)
2100 Highway 61 North/1111 N.
   
Frontage Road
   
Vicksburg, MS 39183 (Warren)
   
 
   
Wesley Medical Center
  Wesley Health System, Inc. (DE)
5001 Hardy Street
   
Hattiesburg, MS 39402 (Lamar)
   
 
   
Moberly Regional Medical Center
  Moberly Hospital Company, LLC (DE)
1515 Union Avenue
   
Moberly, MO 65270 (Randolph)
   
 
   
Mesa View Regional Hospital
  MMC of Nevada, LLC (DE)
1299 Bertha Howe Avenue
   
Mesquite, NV 89027 (Clark)
   
 
   
The Memorial Hospital of Salem County
  Salem Hospital Corporation (NJ)
310 Woodstown Road
   
Salem, NJ 08079 (Salem)
   
 
   
Alta Vista Regional Hospital
  San Miguel Hospital Corporation (NM)
104 Legion Drive
   
Las Vegas, NM 87701 (San Miguel)
   
 
   
Carlsbad Medical Center
  Carlsbad Medical Center, LLC (DE)
2430 West Pierce
   
Carlsbad, NM 88220 (Eddy)
   
 
   
Eastern New Mexico Medical Center
  Roswell Hospital Corporation (NM)
405 West Country Club Road
   
Roswell, NM 88201 (Chaves)
   
 
   
Lea Regional Medical Center
  Lea Regional Hospital, LLC (DE)
5419 N. Lovington Highway
   
Hobbs, NM 88240 (Lea)
   
 
   
MountainView Regional Medical Center
  Las Cruces Medical Center, LLC (DE)
4311 East Lohman Avenue
   
Las Cruces, NM 88011 (Dona Ana)
   

 


 

     
Hospital Name/Address (County)   Corporate Owner
Affinity Medical Center8
  DHSC, LLC (DE)
875 Eighth Street NE
   
Massillon, OH 44646 (Stark)
   
 
   
Hillside Rehabilitation Hospital9
  Warren Ohio Rehab Hospital Company, LLC (DE)
8747 Squires Lane NE
   
Warren, OH 44484 (Trumbull)
   
 
   
Northside Medical Center10
  Youngstown Ohio Hospital Company, LLC (DE)
500 Gypsy Lane
   
Youngstown, OH 44501 (Trumbull and Mahoning)
   
 
   
Trumbull Memorial Hospital11
  Warren Ohio Hospital Company, LLC (DE)
1350 East Market Street
   
Warren, OH 44482 (Trumbull)
   
 
   
Claremore Regional Hospital
  Claremore Regional Hospital, LLC (DE)
1202 N. Muskogee Place
   
Claremore, OK 74017 (Rogers)
   
 
   
Ponca City Medical Center
  Kay County Oklahoma Hospital Company, LLC (OK)
1900 North 14th Street
   
Ponca City, OK 74601 (Kay)
   
 
   
SouthCrest Hospital
  SouthCrest, L.L.C. (DE)
8801 South 101st East Ave.
   
Tulsa, OK 74133 (Tulsa)
   
 
   
Berwick Hospital Center
  Berwick Hospital Company, LLC (DE)
701 East 16th Street
   
Berwick, PA 18603 (Columbia)
   
 
   
Brandywine Hospital
  Coatesville Hospital Corporation (PA)
201 Reeceville Rd.
   
Coatesville, PA 19320 (Chester)
   
 
   
Easton Hospital
  Northampton Hospital Company, LLC (DE)
250 South 21st Street
   
Easton, PA 18042-3892 (Northampton)
   
 
   
Jennersville Regional Hospital
  West Grove Hospital Company, LLC (DE)
1015 West Baltimore Pike
   
West Grove, PA 19390 (Chester)
   
 
8   This facility is in the process of being mortgaged. It should be mortgaged by December 31, 2010.
 
9   This facility is in the process of being mortgaged. It should be mortgaged by December 31, 2010.
 
10   This facility is in the process of being mortgaged. It should be mortgaged by December 31, 2010.
 
11   This facility is in the process of being mortgaged. It should be mortgaged by December 31, 2010.

 


 

     
Hospital Name/Address (County)   Corporate Owner
Lock Haven Hospital
  Clinton Hospital Corporation (PA)
24 Cree Drive
   
Lock Haven, PA 17745-2699 (Washington)
   
 
   
Phoenixville Hospital
  Phoenixville Hospital Company, LLC (DE)
140 Nutt Road
   
Phoenixville, PA 19460 (Chester)
   
 
   
Pottstown Memorial Medical Center
  Pottstown Hospital Company, LLC (DE)
1600 East High Street
   
Pottstown, PA 19464 (Montgomery)
   
 
   
Wilkes-Barre General Hospital
  Wilkes-Barre Hospital Company, LLC (DE)
575 North River Street
  Wilkes-Barre Behavioral Hospital Company, LLC (DE)
Wilkes-Barre, PA 18764 (Luzerne and Wyoming)
   
 
   
Carolinas Hospital System
  QHG of South Carolina, Inc. (SC)
805 Pamplico Highway
   
Florence, SC 29505 (Florence)
   
 
   
Marion Regional Hospital
  QHG of South Carolina, Inc. (SC)
2829 East Highway 76
   
Mullins, SC 29574 (Marion and Horry)
   
 
   
Springs Memorial Hospital
  Lancaster Hospital Corporation (DE)
800 W. Meeting Street
   
Lancaster, SC 29720 (Lancaster)
   
 
   
Dyersburg Regional Medical Center
  Dyersburg Hospital Corporation (TN)
400 Tickle Street
   
Dyersburg, TN 38024 (Dyer)
   
 
   
Lakeway Regional Hospital
  Hospital of Morristown, Inc. (TN)
726 McFarland Street
   
Morristown, TN 37814 (Hamblen)
   
 
   
SkyRidge Medical Center (includes Cleveland)
  National Healthcare of Cleveland, Inc. (TN)
2305 Chambliss Avenue
   
Cleveland, TN 37320 (Bradley)
   
 
   
Volunteer Community Hospital
  Martin Hospital Corporation (TN)
161 Mt. Pelia Road
   
Martin, TN 38237 (Weakley)
   
 
   
College Station Medical Center
  College Station Hospital, L.P. (DE)
1604 Rock Prairie
   
College Station, TX 77845 (Brazos)
   
 
   
DeTar Hospital Navarro
  Victoria of Texas, L.P. (DE)
506 E. San Antonio Street
   
Victoria, TX 77901 (Victoria)
   

 


 

     
Hospital Name/Address (County)   Corporate Owner
DeTar Hospital North
  Victoria of Texas, L.P. (DE)
101 Medical Drive
   
Victoria, TX 77904 (Victoria)
   
 
   
Scenic Mountain Medical Center
  Big Spring Hospital Corporation (TX)
1601 West Eleventh Place
   
Big Spring, TX 79720 (Howard)
   
 
   
South Texas Regional Medical Center
  Jourdanton Hospital Corporation (TX)
1905 Highway 97 E
   
Jourdanton, TX 78026 (Atascosa)
   
 
   
Mountain West Medical Center
  Tooele Hospital Corporation (UT)
2055 N. Main
   
Tooele, UT 84074-2794 (Tooele)
   
 
   
Southern Virginia Regional Medical Center
  Emporia Hospital Corporation (VA)
727 North Main Street
   
Emporia, VA 23847 (Greensville)
   
 
   
Southampton Memorial Hospital
  Franklin Hospital Corporation (VA)
100 Fairview Drive
   
Franklin, VA 23851 (Southampton)
   
 
   
Deaconess Medical Center
  Spokane Washington Hospital Company, LLC (DE)
800 West Fifth Avenue
   
Spokane, WA 99204 (Spokane)
   
 
   
Valley Hospital and Medical Center
  Spokane Valley Washington Hospital Company (DE)
12606 East Mission
   
Spokane Valley, WA 99216 (Spokane)
   
 
   
Bluefield Regional Medical Center
  Bluefield Hospital Company, LLC (DE)
500 Cherry Street
   
Bluefield, WV 24701 (Mercer)
   
 
   
Northwest Medical Center of Benton County12
  QHG of Springdale, Inc. (AR)
3000 Medical Center Pkwy.
   
Bentonville, AR 72712 (Benton)
   
 
   
Regional Hospital of Jackson13
  Jackson, Tennessee Hospital Company, LLC (TN)
367 Hospital Blvd.
   
Jackson, TN 38305 (Madison)
   
 
   
Greenbrier Valley Medical Center14
  Greenbrier VMC, LLC (DE)
202 Maplewood Avenue
   
Ronceverte, WV 24970 (Greenbrier)
   
 
12   This mortgage is in the process of being released. It should be released by December 31, 2010.
 
13   This mortgage is in the process of being released. It should be released by December 31, 2010.
 
14   This mortgage is in the process of being released. It should be released by December 31, 2010.

 


 

Schedule 3.21
Collective Bargaining Agreements
             
        Agreement    
City, State   Union/   Expiration    
Facility   Affiliation   Date   Type of Employees in Unit
Watsonville, CA

Watsonville Community Hospital
  “CalTech” California Technical Employees Coalition   1/31/10; currently in negotiations   LVNs, Radiology Technicians, Respiratory Care Practitioners, Physical Therapy Assistants, Nuclear Medicine Technologists and Cardiovascular Technologists
 
           
Watsonville, CA
  “C.N.A.”
California Nurses Association
  3/31/10; currently in negotiations   Registered Nurses
 
           
Watsonville, CA
  “S.E.I.U.”,
United Healthcare Workers
  7/31/09; currently in negotiations   Service and Maintenance Employees
 
           
Watsonville, CA
  “S.E.I.U.”,
United Healthcare Workers
  7/31/09; currently in negotiations   Professional Employees (Clinical Laboratory Scientists)
 
           
Watsonville, CA
  Teamsters Local 912   4/30/10; currently in negotiations   Office and Clerical (HIM, Business Office, Registration)
 
           
Easton, PA

Easton Hospital
  “U.I.U.”
United Independent Union, Local 2
  6/1/13   Two separate agreements—One agreement covering Registered Nurses and a separate Agreement covering Licensed Practical Nurses
 
           
Pottstown, PA

Potttstown Memorial Medical Center
  District 1199P S.E.I.U.   8/31/12   Virtually all nonexempt employees, excluding RNs
 
           
Palmer, Alaska

MatSu Regional Medical Center
  I.B.E.W.
Local 1547
  2/28/11   Virtually all nonexempt employees, excluding RNs

 


 

             
        Agreement    
City, State   Union/   Expiration    
Facility   Affiliation   Date   Type of Employees in Unit
Springfield, Oregon

McKenzie Willamette Medical Center
  Oregon Nurses Association   12/31/10   RNs and LPNs
 
           
Springfield, Oregon

McKenzie Willamette Medical Center
  S.E.I.U.
Local 49
  6/30/10; currently in negotiations   Virtually all nonexempt employees, excluding RNs
 
           
Spokane , WA

Deaconess Medical Center
  SMEA
Spokane Medical Engineers’ Association
  2/28/10; currently in negotiations   Plant Maintenance Engineers and Biomedical Engineers
 
           
Spokane , WA

Deaconess Medical Center
  S.E.I.U.
1199NW
“Service”
  5/1/13   Service and Clerical employees
 
           
Spokane , WA

Deaconess Medical Center
  S.E.I.U.
1199NW
“Technical”
  8/1/13   Technical employees, including, OR Techs, OB Techs, Radiology, Cardiovascular Techs, Respiratory Therapists, Echo Technologists, Nuclear Medicine Technicians, LVNs
 
           
Spokane , WA

Valley Hospital and Medical Center
  S.E.I.U.
1199NW
“RN”
  1/1/13   RNs only
 
           
Spokane , WA

Valley Hospital and Medical Center
  S.E.I.U.
1199NW
“Service”
  5/1/13   Service and Clerical employees
 
           
Spokane , WA

Valley Hospital and Medical Center
  S.E.I.U.
1199NW
“Technical”
  8/1/13   Technical employees, including, OR Techs, OB Techs, Radiology, Cardiovascular Techs, Respiratory Therapists, Echo Technologists, Nuclear Medicine Technicians, LVNs
 
           
Wilkes-Barre, PA

Wilkes- Barre General Hospital
  P.A.S.N.A.P.   7/1/09; currently in negotiations   RNs

 


 

             
        Agreement    
City, State   Union/   Expiration    
Facility   Affiliation   Date   Type of Employees in Unit
Youngstown/Warren, Ohio

Forum Health Hillside Hospital
  O.N.A.
Ohio Nurses Association
  7/31/11   RNs
 
           
Youngstown/Warren, Ohio

Forum Health Northside Hospital
  O.N.A.
Ohio Nurses Association
  7/31/11   RNs
 
           
Youngstown/Warren, Ohio

Forum Health Trumbull County Hospital
  S.E.I.U.
“Professional”
  3/31/12   Medical Technologists (Lab, Blood Bank, etc.), Lab Section Heads, Clinical Dietitian, Medical Social Worker, Physical Therapist, Staff/Lead Pharmacist, all other professional employees excluding RNs
 
           
Youngstown/Warren, Ohio

Forum Health Trumbull County Hospital
  S.E.I.U.
“Technical”
  3/31/12   Radiology Tech, CT Tech, Ultrasound Tech, CV Tech, Special Procedures Tech, Surgery Tech, LPN
 
           
Youngstown/Warren, Ohio

Forum Health Northside Hospital
  S.E.I.U.
“Technical”
  3/31/12   Radiology Tech, CT Tech, Ultrasound Tech, CV Tech, Special Procedures Tech, Mammography Tech, Oncology Tech
 
           
Youngstown/Warren, Ohio

Forum Health Trumbull Hospital Patient Financial Services
  S.E.I.U.
“Support/
Business Office”
  3/31/12   Accountant, Accounting Clerk. Business Office and IS Clerks, Mail Clerks
 
           
Youngstown/Warren, Ohio

Forum Health Trumbull County Hospital
  AFSCME
“Trumbull RN”
  10/31/12   RNs

 


 

             
        Agreement    
City, State   Union/   Expiration    
Facility   Affiliation   Date   Type of Employees in Unit
Youngstown/Warren, Ohio

Forum Health Trumbull County Hospital
  AFSCME
“Trumbull
Non-professional”
  3/31/13   Service, Maintenance and Clerical, Pharmacy Techs, MLT and Medical Technologist, PT Assistant, OT Aides, OR Techs etc.
 
           
Youngstown/Warren, Ohio

Forum Health Hillside Hospital
  AFSCME
“Hillside
Non-professional”
  3/31/13   Service, Maintenance and Clerical, LPNs, Pharmacy Techs, MLT and Medical Technologist, PT Assistant, OT Aides, OR Techs etc.
 
           
Youngstown/Warren, Ohio

Forum Health Northside Hospital
  S.E.I.U.
“Non-professional Unit”

“WRCS Basic Unit”
  3/31/14   Service, Maintenance and Clerical, LPNs, Pharmacy Techs, Unit Clerks, Surgical Assistant, etc.
 
           
Youngstown/Warren, Ohio

Forum Health Northside Hospital
  S.E.I.U.
“Professional”
  3/31/15   Medical Technologists (Lab, Blood Bank, etc.), Lab Section Heads, Clinical Dietitian, Medical Social Worker, Physical Therapist, Staff/Lead Pharmacist, all other professional employees excluding RNs
 
           
Youngstown/Warren, Ohio

Forum Health Outreach Lab
  S.E.I.U.
“Non-Professional”
  10/31/14   Phlebotomists, Clerical

 


 

ADDITIONAL FACILITIES WITH ORGANIZED LABOR PRESENCE, BUT NO CBA
         
    Union/    
City, State Facility   Affiliation   Type of Employees in “Unit”
Jackson, KY

Kentucky River Medical Center
  United Steelworkers of America, AFL-CIO

Negotiations suspended pending N.L.R.B. proceedings
  Virtually all non-exempt employees, excluding Office Clerical employees
 
       
Las Vegas, NM

Alta Vista Regional Medical Center
  National Union of Hospital and Healthcare employees, District 1199NM

Certification of Union is the subject of a “Petition for Review” filed in the U. S. Court of Appeals for the D. C. Circuit
  Virtually all non-exempt employees, excluding physicians
 
       
Deming, NM

Mimbres Memorial Hospital
  United Steelworkers of America, AFL-CIO

Union has abandoned representation of employees in N.L.R.B. proceedings since 2007
  Virtually all non-exempt employees, excluding RN’s

 


 

Schedule 6.01
Existing Indebtedness
                 
            Principal  
    CHS Entity   Description of Property Leased   Outstanding  
    Corporate Debt  
 
       
1  
 
           
2      
Northwestern Mutual Mortgage (Corporate HQ)
    23,435  
       
 
     
3      
Total Corporate Debt
    23,435  
       
 
       
    Equipment Leases  
 
       
4   Blue Ridge, GA  
Equipment Leases
    1,783  
5   Cheraw, SC  
Equipment Leases
    6  
6   Decatur, IL  
Equipment Leases
    83  
7   Farmington, MO  
Equipment Leases
    224  
8   Fulton, KY  
Equipment Leases
    8,000  
9   Galesburg, IL  
Equipment Leases
    13  
10   Granbury, TX  
Equipment Leases
    667  
11   Granite City, IL  
Equipment Leases
    (4 )
12   Las Vegas, NM  
Equipment Leases
    49  
13   Lexington, TN  
Equipment Leases
    27  
14   Morristown, TN  
Equipment Leases
    109  
15   Petersburg, VA  
Equipment Leases
    6,455  
16   Philadelphia, PA  
Equipment Leases
    444  
17   Roswell, NM  
Equipment Leases
    736  
18   Ruston, LA  
Equipment Leases
    (11 )

 


 

                 
            Principal  
    CHS Entity   Description of Property Leased   Outstanding  
19   Salem, NJ  
Equipment Leases
    (22 )
20   Salem, NJ  
Equipment Leases
    80  
21   Shelbyville, TN  
Equipment Leases
    3,317  
22   Sparta, TN  
Equipment Leases
    17  
23   Sunbury, PA  
Equipment Leases
    473  
24   Valporaiso, IN  
Equipment Leases
    1,296  
25   Watsonville, CA  
Equipment Leases
    72  
13   Weatherford, TX  
Equipment Leases
    136  
27   Wichita Falls, TX  
Equipment Leases
    9  
       
 
     
       
Total Equipment Leases
    23,956  

 


 

                 
            Principal  
    CHS Entity   Description of Property Leased   Outstanding  
28   Berwick, PA  
Physician Loans
    81  
29   Big Springs, TX  
Physician Loans
    73  
30   Blue Ridge, GA  
Physician Loans
    15  
31   Bullhead City, AZ  
Physician Loans
    38  
32   Cheraw, SC  
Physician Loans
    26  
33   Cleveland, TN  
Physician Loans
    7  
34   Cleveland, TX  
Physician Loans
    61  
35   Coatesville, PA  
Physician Loans
    85  
36   Crestview, FL  
Physician Loans
    59  
37   Cullman, AL  
Physician Loans
    64  
38   Decatur, AL  
Physician Loans
    11  
39   Dyersburg, TN  
Physician Loans
    10  
40   Easton, PA  
Physician Loans
    23  
41   Fallbrook, CA  
Physician Loans
    69  
42   Foley, AL  
Physician Loans
    72  
43   Franklin, VA  
Physician Loans
    4  
44   Granbury, TX  
Physician Loans
    56  
45   Hartselle, AL  
Physician Loans
    27  
46   Helena, AR  
Physician Loans
    27  
47   Hillsboro, TX  
Physician Loans
    60  
48   Jourdanton, TX  
Physician Loans
    31  
49   Kirksville, MO  
Physician Loans
    66  
50   Lake Wales, FL  
Physician Loans
    3  
51   Lancaster, SC  
Physician Loans
    72  
52   Laredo, TX  
Physician Loans
    8  

 


 

                 
            Principal  
    CHS Entity   Description of Property Leased   Outstanding  
53   Las Vegas, NM  
Physician Loans
    27  
54   Lebanon, VA  
Physician Loans
    1  
55   Leesville, LA  
Physician Loans
    26  
56   Louisa, KY  
Physician Loans
    143  
57   Moberly, MO  
Physician Loans
    23  
58   Payson, AZ  
Physician Loans
    116  
59   Petersburg, VA  
Physician Loans
    31  
60   Philadelphia, PA  
Physician Loans
    0  
61   Plaquemine, LA  
Physician Loans
    73  
79   Pottstown, PA  
Physician Loans
    75  
80   Roswell, NM  
Physician Loans
    54  
81   Salem, NJ  
Physician Loans
    26  
82   Selmer, TN  
Physician Loans
    60  
83   Tooele, UT  
Physician Loans
    12  
84   Watsonville, CA  
Physician Loans
    6  
85   Weatherford, TX  
Physician Loans
    42  
86   West Grove, PA  
Physician Loans
    15  
       
 
     
       
Total Physician Loans
    1,488  

 


 

                 
            Principal  
    CHS Entity   Description of Property Leased   Outstanding  
    Other Debt  
 
       
87   Granite City, IL  
Other Facility Debt
    (126 )
88   Granite City, IL  
Other Facility Debt
    126  
89   Granite City, IL  
Bank Notes
    280  
90   Corporate  
Other Corporate Debt
    8,810  
91   Lockhaven, PA  
Patient Funds Liability
    20  
92   Salem, NJ  
Other Facility Debt
    (45,591 )
93   Salem, NJ  
Other Facility Debt
    45,591  
94   Salem, NJ  
Sovereign Bank Notes
    9  
       
 
     
95      
Total Other
    9,118  
       
 
     
96      
Total Facility Debt
    57,997  
       
 
     
 
*   Debt aggregated by major type per facility.

 


 

Triad
Schedule 6.01: Existing Indebtedness
         
Capital Leases
       
St. Mary’s Regional Medical Center
    81,498  
Dukes Memorial Hospital
    1,948  
Dukes Memorial Hospital
    51,578  
Dukes Memorial Hospital
    14,303  
Triad Corporate Offices
    170,370  
Massillon Hospital
    5,542  
Augusta Hospital, LLC
    5,907  
Willamette Community Medical Group
    3,758,073  
 
     
Subtotal
    4,089,219  
 
       
Other Debt
       
Gadsden Regional Medical Center
    353,489  
River Regional Medical Center
    209,003  
Woodward Regional Hospital
    648,241  
Massillon Hospital
    4,341,705  
Massillon Hospital
    328,529  
 
     
Subtotal
    5,880,967  
 
Total Capital Leases and Other Debt
    9,970,186  
 
 
       
Patient Loan Programs
       
HELP
    14,098,676  
AccessOne
    4,822,644  
Tower
    4,173,028  
Barberton
    318,889  
CB&T
    89,779  
 
     
Subtotal
    23,503,016  

 


 

         
Other Guarantees
       
Medical Imaging
       
Capitalized lease
    77,277  
Other debt
    1,701,753  
Fort Wayne Cardiac Ctr, LLC Capital lease
    784,004  
San Angelo Surgery Center Equipment note
    346,028  
Term loan
    272,384  
Line of Credit commitment
    154,007  
 
     
Subtotal
    3,335,453  

 


 

Schedule 6.02
Existing Liens
                     
            TYPE        
            OF   FILE NO. &    
DEBTOR   SECURED PARTY   JURISDICTION   UCC   DATE   COLLATERAL
Jackson Hospital Corporation f/k/a Kentucky River Medical Center, Inc.

155 Franklin Road
Brentwood, TN 37027
  National Health Investors, Inc.

100 Vine Street
Murfreesboro, TN 37130
  State of Kentucky   UCC-1   2001-1736257-34
11/26/2001

Continuation:
07/19/2006
  Security interest in all accounts, equipment, building materials, ledgers, and proceeds from the collateral including insurance proceeds, now owned or arising from the debtor’s leasehold interest, ownership, and operation of Kentucky River Medical Center located at Jetts Drive, Jackson, KY.
 
                   
National Healthcare of Mt. Vernon, Inc.

155 Franklin Rd., Suite 400
Brentwood, TN 37027-4600
  National Health Investors, Inc.

100 E. Vine Street
Murfreesboro, TN 37130
  Secretary of State, DE   UCC-1   4051389 7
02/11/2004
  To the extent that they are attached to the Land (Schedule 1), the landlord has security interest in all accounts, accounts receivable, chattel paper, and other receivables; security interest in central supplies, linen and other inventories; beds, towels, televisions, and other equipments. (UCC references Crossroads Community Hospital).
 
                   
Cleveland Regional Medical Center, L.P.

c/o Dynamic Health, Inc.
2049 Century Park East,
Suite 3330
Los Angeles, CA 90067
  AHP of Texas

c/o American Health
Properties, Inc.
6400 South Fiddler’s
Green Circle, #1800
Englewood, CO 80111
  Secretary of State, DE   UCC-1   9403554
03/15/1994

Continuation:
01/28/1999
02/27/2004
  All accounts, equipment and auxiliary parts, accessories, medicines, medical supplies, office supplies, other inventory supplies, fixtures, core receivables, deposits, fidelity and performance bonds, books and records, and insurance proceeds. (Refers to Security and Pledge Agreement between Cleveland Regional Medical Center, L.P. and AHP of Texas dated as of 12/31/1999).

 


 

                     
            TYPE        
            OF   FILE NO. &    
DEBTOR   SECURED PARTY   JURISDICTION   UCC   DATE   COLLATERAL
CHS Community Health Systems, Inc.

155 Franklin Road
Brentwood, TN 37027
  Fleet Capital Leasing Healthcare Finance (a division of Fleet Business Credit, LLC)

299 Cherry Hill Road Parsippany, NJ 07054
  Secretary of State, DE   UCC-1   3035792 4
02/10/2003
  Any property financed under Master Lease No. 2598 including medical equipment, office furniture and equipment, computer equipment, telecommunications equipment, video/audio equipment, and other support systems and equipments.
 
                   
Cleveland Regional Medical Center, L.P.

155 Franklin Road
Brentwood, TN 37027

Additional debtor:
Chesterfield/Marlboro, L.P.

155 Franklin Road
Brentwood, TN 37027
  Texas HCP Holding, L.P., a Delaware limited partnership

3760 Kilroy Airport Way,
Suite 300
Long Beach, CA 90806

Additional secured party:
HCPI Trust, a Maryland
Real Estate Investment Trust

3760 Kilroy Airport Way,
Suite 300
Long Beach, CA 90806
  Secretary of State, DE   UCC-1   5200794 7
06/29/2005
  All machinery, furniture and equipment, inventory, supplies, accounts related to and other personal property used or useful in the use of the health care facilities located n the real property related to (i) Cleveland Facility, Liberty County, Texas, (ii) Cheraw Facility, Chesterfield County, South Carolina, and (iii) Bennettsville Facility, Marlboro County, South Carolina.
 
                   
Cleveland Regional Medical Center, L.P.

155 Franklin Road
Brentwood, TN 37027

Additional debtor:
Chesterfield/Marlboro, L.P.

155 Franklin Road
Brentwood, TN 37027
  Texas HCP Holding, L.P., a Delaware limited partnership

3760 Kilroy Airport Way,
Suite 300
Long Beach, CA 90806

Additional secured party:
HCPI Trust, a Maryland
Real Estate Investment Trust

3760 Kilroy Airport Way,
Suite 300
Long Beach, CA 90806
  Secretary of State, DE   UCC-1   5200787 1
06/29/2005
  All improvements, related rights and fixtures, and personal property, tangible or intangible and any additions to, substitutions for, changes in, or replacements of the whole or any part thereof, including all buildings, structures, Fixtures and other improvements related to (i) Cleveland Facility, Liberty County, Texas, (ii) Cheraw Facility, Chesterfield County, South Carolina, and (iii) Bennettsville Facility, Marlboro County, South Carolina.

 


 

                     
            TYPE        
            OF   FILE NO. &    
DEBTOR   SECURED PARTY   JURISDICTION   UCC   DATE   COLLATERAL
Granbury Hospital Corporation

155 Franklin Road
Brentwood, TN 37027
  Fleet Capital Leasing Healthcare Finance (a division of Fleet Business Credit, LLC)

299 Cherry Hill Road Parsippany, NJ 07054
  Texas   UCC-1   02-0011105858
11/30/2001

Continuation:
10/03/2006
  Any property financed under Master Lease No. 2278 including medical equipment, office furniture and equipment, computer equipment, telecommunications equipment, video/audio equipment, and other support systems and equipments.
 
                   
Boyer Evanston Medical Office Building, L.C.

90 South 400 West, Suite 200
Salt Lake City, UT 84101

Additional debtor:
Evanston Hospital Corporation

196 Arrowhead Drive
Evanston, WY 82930
  Prudential Mortgage
Capital Company, LLC

Four Embarcadero Center,
27th Floor
San Francisco, CA 94111

Fully assigned to
(09/26/2005):
Prudential Mortgage
Capital Funding, LLC

100 Mulberry Street,
GC4, 9th Floor
Newark, NJ 07102
  Utah   UCC-1   2005-26506023
09/15/2005
  All improvements, related rights and fixtures, and personal property, tangible or intangible and any additions to, substitutions for, changes in, or replacements of the whole or any part thereof, including all buildings, structures, Fixtures and other improvements related to (i) Evanston Medical Office Building Addition (References PMCC Loan No. TTMLS 406105518).
 
                   
Carlsbad Medical Center, LLC

c/o Triad Hospital, Inc.
13455 Noel Road
Suite 2000
Dallas, TX 20815
  General Electric Capital Corporation

2 Wisconsin Circle,
Suite 400
Chevy Chase, MD 20815
  Secretary of State, DE   UCC-1   2294460 5
11/22/2002
  Rents, income, receipts, revenues, issues, profits, and prepayments that are attached to the real property described in Exhibit A (a parcel of land related to the Guadalupe Medical Center Subdivision, New Mexico); accounts, contract rights, general intangibles, chattel paper, documents, instruments, deposit accounts, letter of credit rights, commercial tort claims and all books and records, to the extent they pertain to the Leases or Rents of the real property; all proceeds, products, replacements, additions, substitutions, renewals and accessions of and to the Leases and Rents.

 


 

                     
            TYPE        
            OF   FILE NO. &    
DEBTOR   SECURED PARTY   JURISDICTION   UCC   DATE   COLLATERAL
Massillon Heath System LLC

400 Austin Ave. NW
Massillon, OH 44645

Additional debtor:
Doctors Hospital of Stark County

400 Austin Ave. NW
Massillon, OH 44645
  H.E.L.P. Financial Corporation

765 Wing Street
Auburn Hills, MI 48170
  Massillon Health System LLC:
Secretary of State, DE

Doctors Hospital of Stark County: OH
  UCC-1   3302348 1
11/18/2003
  Patient loans, whether installment or revolving, evidenced by a revolving credit agreement or other loan agreement, in which the debtor is the lender, and which are assigned to the secured party.

 


 

Schedule 6.04(h)
Certain Permitted Acquisitions
1.   Spokane, Washington (Empire Health Services)

 


 

Schedule 6.05(b)
Certain Syndication Transactions
1.   Wesley Health System, LLC (Hattiesburg, MS)
 
2.   Piney Woods Healthcare System, L.P. (Lufkin, TAX) (second offering)
 
3.   McKenzie-Willamette Regional Medical Center Associates, LLC (Springfield, OR) (supplemental offering)
 
4.   NOV Holdings, LLC (Tucson, AZ — 2 hospitals)
 
5.   Kay County Oklahoma Hospital Company, LLC (Ponca City, OK)
 
6.   Petersburg Hospital Company, LLC (Petersburg, VA)
 
7.   Laredo-Texas Hospital Company, LLC (Laredo, TX) (second offering)
 
8.   Northwest Indiana Health System, LLC (Valpraiso, IN)
 
9.   National Healthcare of Mt. Vernon, Inc. (Crossroads Community)
 
10.   Coatesville, PA
 
11.   Westgrove, PA
 
12.   Easton, PA
 
13.   Salem, NJ
 
14.   Abilene, TX
 
15.   Las Cruces, NM
 
16.   Victoria, TX
 
17.   Ft. Wayne, IN (Lutheran)

 


 

Schedule 6.07
Certain Affiliate Transactions
None.

 


 

EXHIBIT A
FORM OF
CHS/COMMUNITY HEALTH SYSTEMS, INC.
ADMINISTRATIVE QUESTIONNAIRE
Please accurately complete the following information and return via Fax to the attention of Agency Administration at Credit Suisse AG as soon as possible, at Fax No. (212) 322-2291.
LENDER LEGAL NAME TO APPEAR IN DOCUMENTATION:
GENERAL INFORMATION — DOMESTIC LENDING OFFICE:
Institution Name:
 
     
Street Address:
   
 
   
     
City, State, Zip Code:
   
 
   
GENERAL INFORMATION — EURODOLLAR LENDING OFFICE:
     
Institution Name:
   
 
   
     
Street Address:
   
 
   
     
City, State, Zip Code:
   
 
   
POST-CLOSING, ONGOING CREDIT CONTACTS/NOTIFICATION METHODS:
CREDIT CONTACTS:
     
Primary Contact:
   
 
   
     
Street Address:
   
 
   
     
City, State, Zip Code:
   
 
   
     
Phone Number:
   
 
   
     
Fax Number:
   
 
   
     
Backup Contact:
   
 
   
     
Street Address:
   
 
   
     
City, State, Zip Code:
   
 
   

 


 

     
Phone Number:
   
 
   
     
Fax Number:
   
 
   
TAX WITHHOLDING:
          United States Person                                                          Y           N                                  (as defined in Section 7701(a)(30) of the Code)
          Enclose Form W-8 or W-9, as applicable
         
          Tax ID Number
       
 
       
POST-CLOSING, ONGOING ADMIN. CONTACTS / NOTIFICATION METHODS:
ADMINISTRATIVE CONTACTS — BORROWINGS, PAYDOWNS, FEES, ETC.
     
Contact:
   
 
   
     
Street Address:
   
 
   
     
City, State, Zip Code:
   
 
   
     
Phone Number:
   
 
   
     
Fax Number:
   
 
   
PAYMENT INSTRUCTIONS:
     
Name of Bank to which funds are to be transferred:
   
 
   
 
     
Routing Transit/ABA number of Bank to which funds are to be transferred:
   
 
   
     
Name of Account, if applicable:
   
 
   
     
Account Number:
   
 
   
     
Additional information:
   
 
   
 
MAILINGS:
Please specify the person to whom the Borrower should send financial and compliance information received subsequent to the closing (if different from primary credit contact):

 


 

     
Name:
   
 
   
     
Street Address:
   
 
   
     
City, State, Zip Code:
   
 
   
It is very important that all the above information be accurately completed and that this questionnaire be returned to the person specified in the introductory paragraph of this questionnaire as soon as possible. If there is someone other than yourself who should receive this questionnaire, please notify us of that person’s name and Fax number and we will Fax a copy of the questionnaire. If you have any questions about this form, please call Agency Administration at Credit Suisse AG.

 


 

EXHIBIT B
FORM OF
ASSIGNMENT AND ACCEPTANCE
     Reference is made to the Credit Agreement dated as of July 25, 2007, as amended and restated as of November 5, 2010 (as further amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), among CHS/Community Health Systems, Inc., a Delaware corporation (the “Borrower”), Community Health Systems, Inc. (“Parent”), a Delaware corporation, the Lenders (as defined in Article I of the Credit Agreement), and Credit Suisse AG, as administrative agent (in such capacity, the “Administrative Agent”) and as collateral agent for the Lenders. Terms defined in the Credit Agreement are used herein with the same meanings.
     1. The Assignor hereby sells and assigns, without recourse, to the Assignee, and the Assignee hereby purchases and assumes, without recourse, from the Assignor, effective as of the Effective Date set forth below (but not prior to the registration of the information contained herein in the Register pursuant to Section 9.04(d) of the Credit Agreement), the interests set forth below (the “Assigned Interest”) in the Assignor’s rights and obligations under the Credit Agreement and the other Loan Documents, including, without limitation, the amounts and percentages set forth below of (i) the Commitments of the Assignor on the Effective Date and (ii) the Loans owing to the Assignor which are outstanding on the Effective Date. Each of the Assignor and the Assignee hereby makes and agrees to be bound by all the representations, warranties and agreements set forth in Section 9.04(c) of the Credit Agreement, a copy of which has been received by each such party. From and after the Effective Date (i) the Assignee shall be a party to and be bound by the provisions of the Credit Agreement and, to the extent of the interests assigned by this Assignment and Acceptance, have the rights and obligations of a Lender thereunder and under the Loan Documents and (ii) the Assignor shall, to the extent of the interests assigned by this Assignment and Acceptance, relinquish its rights and be released from its obligations under the Credit Agreement.
     2. This Assignment and Acceptance is being delivered to the Administrative Agent together with (i) if the Assignee is organized under the laws of a jurisdiction outside the United States, any forms referred to in Section 2.20(e) of the Credit Agreement, duly completed and executed by such Assignee, (ii) if the Assignee is not already a Lender under the Credit Agreement, a completed Administrative Questionnaire and (iii) unless waived or reduced in the sole discretion of the Administrative Agent, a processing and recordation fee of $3,500.15
 
15   Only one such fee shall be payable in the case of concurrent assignments to persons that, after giving effect to such assignments, will be Related Funds.

 


 

     3. This Assignment and Acceptance shall be governed by and construed in accordance with the laws of the State of New York.
Date of Assignment:
Legal Name of Assignor (“Assignor”):
Legal Name of Assignee (“Assignee”):
Assignee’s Address for Notices:
Effective Date of Assignment (“Effective Date”):
         
        Percentage of Loans/Commitments
        of the applicable Class Assigned
        (set forth, to at least 8 decimals, as
Class of       a percentage of the aggregate
Loans/Commitments   Principal Amount   Loans and Commitments, of the
Assigned   Assigned   applicable Class, of all Lenders)
         
    $   %
    $   %
[Remainder of Page Intentionally Left Blank]

 


 

Accepted
         
  CREDIT SUISSE AG, as Administrative Agent[, Swingline Lender and Issuing Bank],16
 
 
       by:      
    Name:      
    Title:      
 
     
             
    Name:      
    Title:      
 
  [CHS/COMMUNITY HEALTH SYTEMS, INC.],
 
 
       by:      
    Name:      
    Title:   ]17   
 
  [COMMUNITY HEALTH SYSTEMS, INC.],
 
 
       by:      
    Name:      
    Title:    
 
 
16   Consent of Swingline Lender and Issuing Bank only required in the case of an assignment of a Revolving Credit Commitment.
 
17   Consent of the Borrower is only required in the case of an assignment of a Revolving Credit Commitment; provided, that the consent of the Borrower shall not be required for any assignment (a) made to another Lender, an Affiliate of a Lender or a Related Fund of a Lender or (b) after the occurrence and during the continuance of any Event of Default.

 


 

The terms set forth above are
hereby agreed to:
         
                                                                , as Assignor,
 
 
  by:      
    Name:      
    Title:      
 
                                                                , as Assignee,
 
 
  by:      
    Name:      
    Title:      
 

 


 

EXHIBIT C
FORM OF
BORROWING REQUEST
Credit Suisse AG, as Administrative Agent for
     the Lenders referred to below,
Eleven Madison Avenue
New York, New York 10010
Attention: Agency Group
[DATE]18
Ladies and Gentlemen:
     The undersigned, CHS/Community Health Systems, Inc., a Delaware corporation, (the “Borrower”), refers to the Credit Agreement dated as of July 25, 2007, as amended and restated as of November 5, 2010 (as further amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), among the Borrower, Community Health Systems, Inc., a Delaware corporation, the lenders from time to time party thereto (the “Lenders”) and Credit Suisse AG, as administrative agent (in such capacity, the “Administrative Agent”) and collateral agent for the Lenders. Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the Credit Agreement. The Borrower hereby gives the Administrative Agent notice pursuant to Section 2.03 of the Credit Agreement that it requests a Borrowing under the Credit Agreement, and in connection therewith sets forth below the terms on which such Borrowing is requested to be made:
(A)   Type of Borrowing19                     
 
(B)   Date of Borrowing20                     
 
(C)   Account Number and Location                     
 
(D)   Principal Amount of Borrowing                     
 
18   The Administrative Agent must be notified irrevocably by telephone (a) in the case of a Eurodollar Borrowing, not later than 12:00 (noon) (New York City time), three Business Days before a proposed Borrowing and (b) in the case of an ABR Borrowing, not later than 12:00 (noon) (New York City time), one Business Day before a proposed Borrowing, in each case to be confirmed promptly by hand delivery or fax of a Borrowing Request to the Administrative Agent.
 
19   Specify whether such Borrowing is to be a Term Borrowing or a Revolving Credit Borrowing, and whether such Borrowing is to be a Eurodollar Borrowing or an ABR Borrowing.
 
20   Date of Borrowing must be a Business Day.

 


 

(E)   Interest Period21                     
     The Borrower shall indemnify each Lender against any loss or expense that such Lender may sustain or incur as a consequence of (a) any event, other than a default by such Lender in the performance of its obligations hereunder, which results in (i) such Lender receiving or being deemed to receive any amount on account of the principal of any Eurodollar Loan prior to the end of the Interest Period in effect therefor, (ii) the conversion of any Eurodollar Loan to an ABR Loan, or the conversion of the Interest Period with respect to any Eurodollar Loan, in each case other than on the last day of the Interest Period in effect therefor, or (iii) any Eurodollar Loan to be made by such Lender (including any Eurodollar Loan to be made pursuant to a conversion or continuation of such Loan) not being made after notice of such Loan shall have been given by the Borrower hereunder (any of the events referred to in this paragraph being called a “Breakage Event”) or (b) any default in the making of any payment or prepayment of any Eurodollar Loan required to be made hereunder. In the case of any Breakage Event, such loss shall include an amount equal to the excess, as reasonably determined by such Lender, of (i) its cost of obtaining funds for the Eurodollar Loan that is the subject of such Breakage Event for the period from the date of such Breakage Event to the last day of the Interest Period in effect (or that would have been in effect) for such Loan over (ii) the amount of interest likely to be realized by such Lender in redeploying the funds released or not utilized by reason of such Breakage Event for such period. A certificate of any Lender setting forth any amount or amounts which such Lender is entitled to receive pursuant to this paragraph shall be delivered to the Borrower and shall be conclusive absent manifest error.
     The Borrower hereby represents and warrants to the Administrative Agent and the Lenders that, on the date of this Borrowing Request and on the date of the related Borrowing, the conditions to lending specified in paragraphs (b) and (c) of Section 4.01 of the Credit Agreement have been satisfied.
         
  CHS/COMMUNITY HEALTH SYSTEMS, INC.,
 
 
       by      
    Name:      
    Title:      
 
 
21   If such Borrowing is to be a Eurodollar Borrowing, specify the Interest Period with respect thereto.

 


 

EXHIBIT D
 
MORTGAGE, ASSIGNMENT OF LEASES AND RENTS, SECURITY AGREEMENT
AND FINANCING STATEMENT
From
[NAME OF MORTGAGOR]
To
CREDIT SUISSE AG
 
Dated:                     , 2010
Premises: [City], [State]
                     County
 
 

 


 

THIS MORTGAGE, ASSIGNMENT OF LEASES AND RENTS, SECURITY AGREEMENT AND FINANCING STATEMENT dated as of                     , 20[] (this “Mortgage”), by [           ], a [           ] corporation, having an office at [           ] (the “Mortgagor”), to CREDIT SUISSE AG, a bank organized under the laws of Switzerland, having an office at Eleven Madison Avenue, New York, New York 10010 (the “Mortgagee”) as Collateral Agent for the Secured Parties (as such terms are defined below).
WITNESSETH THAT:
     Reference is made to (i) the Credit Agreement dated as of July 25, 2007, as amended and restated as of November 5, 2010 (as further amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), among CHS/Community Health Systems, Inc., a Delaware corporation (the “Borrower”), Community Health Systems, Inc., a Delaware corporation (“Parent”), the lenders from time to time party thereto (the “Lenders”) and Credit Suisse AG as administrative agent (the “Administrative Agent”) for the Lenders, collateral agent (the “Collateral Agent”) for the Secured Parties, swingline lender (the “Swingline Lender”) and issuing bank (the “Issuing Bank”) with respect to any letters of credit (the “Letters of Credit”) issued pursuant to the terms of the Credit Agreement and (ii) the Guarantee and Collateral Agreement dated as of July 25, 2007, as amended and restated as of November 5, 2010 (as further amended, supplemented or otherwise modified from time to time, the “Guarantee and Collateral Agreement”) among Parent, the Borrower, the Subsidiaries identified therein and the Collateral Agent. Capitalized terms used but not defined herein have the meanings given to them in the Credit Agreement and the Guarantee and Collateral Agreement.
     In the Credit Agreement, (i) the Lenders have agreed to make term loans (the “Term Loans”) and revolving loans (the “Revolving Loans”) to the Borrower, (ii) the Swingline Lender has agreed to make swingline loans (the “Swingline Loans”, together with Term Loans and Revolving Loans, the “Loans”) to the Borrower and (iii) the Issuing Bank has issued or agreed to issue from time to time Letters of Credit for the account of the Borrower, in each case pursuant to, upon the terms, and subject to the conditions specified in, the Credit Agreement. Amounts paid in respect of Term Loans may not be reborrowed. Subject to the terms of the Credit Agreement, Borrower may borrow, prepay and reborrow Revolving Loans.
     Mortgagor is a wholly-owned direct or indirect Subsidiary of the Borrower and will derive substantial benefit from the making of the Loans by the Lenders and the issuance of the Letters of Credit by the Issuing Bank. In order to induce the Lenders to make Loans and the Issuing Bank to issue Letters of Credit, the Mortgagor has agreed to guarantee, among other things, the due and punctual payment and performance of all of the obligations of the Borrower under the Credit Agreement pursuant to the terms of the Guarantee and Collateral Agreement.

 


 

     The obligations of the Lenders to make Loans and of the Issuing Bank to issue Letters of Credit are conditioned upon, among other things, the execution and delivery by the Mortgagor of this Mortgage in the form hereof to secure the Obligations.
     As used in this Mortgage, the term “Secured Parties” shall mean (a) the Lenders, (b) the Administrative Agent, (c) the Collateral Agent, (d) any Issuing Bank, (e) each counterparty to any Hedging Agreement with a Loan Party that either (i) is in effect on the Closing Date if such counterparty is the Administrative Agent, a Lender or an Affiliate of the Administrative Agent or a Lender as of the Closing Date or (ii) is entered into after the Closing Date if such counterparty is the Administrative Agent, a Lender or an Affiliate of the Administrative Agent or a Lender at the time such Hedging Agreement is entered into, (f) each counterparty to any arrangement with Parent, the Borrower or any Subsidiary Guarantor in respect of Cash Management Obligations in effect on the Closing Date or entered into after the Closing Date, (g) the beneficiaries of each indemnification obligation undertaken by any Loan Party under any Loan Document and (h) the successors and assigns of each of the foregoing.
     Pursuant to the requirements of the Credit Agreement, the Mortgagor is granting this Mortgage to create a lien on and a security interest in the Mortgaged Property (as hereinafter defined) to secure the performance and payment by the Mortgagor of the Obligations. The Credit Agreement also requires the granting by other Loan Parties of mortgages, deeds of trust and/or deeds to secure debt (the “Other Mortgages”) that create liens on and security interests in certain real and personal property other than the Mortgaged Property to secure the performance of the Obligations.
Granting Clauses
     NOW, THEREFORE, IN CONSIDERATION OF the foregoing and in order to secure the due and punctual payment and performance of the Obligations for the benefit of the Secured Parties, Mortgagor hereby grants, conveys, mortgages, assigns and pledges to the Mortgagee, a mortgage lien on and a security interest in, all the following described property (the “Mortgaged Property”) whether now owned or held or hereafter acquired:
     (1) the land more particularly described on Exhibit A hereto (the “Land”), together with all rights appurtenant thereto, including the easements over certain other adjoining land granted by any easement agreements, covenant or restrictive agreements and all air rights, mineral rights, water rights, oil and gas rights and development rights, if any, relating thereto, and also together with all of the other easements, rights, privileges, interests, hereditaments and appurtenances thereunto belonging or in any way appertaining and all of the estate, right, title, interest, claim or demand whatsoever of Mortgagor therein and in the streets and ways adjacent thereto, either in law or in equity, in possession or expectancy, now or hereafter acquired (the “Premises”);
     (2) all buildings, improvements, structures, paving, parking areas, walkways and landscaping now or hereafter erected or located upon the Land, and all fixtures of every kind and type affixed to the Premises or attached to or forming part of any

 


 

structures, buildings or improvements and replacements thereof now or hereafter erected or located upon the Land (the “Improvements”);
     (3) all apparatus, movable appliances, building materials, equipment, fittings, furnishings, furniture, machinery and other articles of tangible personal property of every kind and nature, and replacements thereof, now or at any time hereafter placed upon or used in any way in connection with the use, enjoyment, occupancy or operation of the Improvements or the Premises, including all of Mortgagor’s books and records relating thereto and including all pumps, tanks, goods, machinery, tools, equipment, lifts (including fire sprinklers and alarm systems, fire prevention or control systems, cleaning rigs, air conditioning, heating, boilers, refrigerating, electronic monitoring, water, loading, unloading, lighting, power, sanitation, waste removal, entertainment, communications, computers, recreational, window or structural, maintenance, truck or car repair and all other equipment of every kind), restaurant, bar and all other indoor or outdoor furniture (including tables, chairs, booths, serving stands, planters, desks, sofas, racks, shelves, lockers and cabinets), bar equipment, glasses, cutlery, uniforms, linens, memorabilia and other decorative items, furnishings, appliances, supplies, inventory, rugs, carpets and other floor coverings, draperies, drapery rods and brackets, awnings, venetian blinds, partitions, chandeliers and other lighting fixtures, freezers, refrigerators, walk-in coolers, signs (indoor and outdoor), computer systems, cash registers and inventory control systems, and all other apparatus, equipment, furniture, furnishings, and articles used in connection with the use or operation of the Improvements or the Premises, it being understood that the enumeration of any specific articles of property shall in no way result in or be held to exclude any items of property not specifically mentioned (the property referred to in this subparagraph (3), the “Personal Property”);
     (4) all general intangibles owned by Mortgagor and relating to design, development, operation, management and use of the Premises or the Improvements, all certificates of occupancy, zoning variances, building, use or other permits, approvals, authorizations and consents obtained from and all materials prepared for filing or filed with any governmental agency in connection with the development, use, operation or management of the Premises and Improvements, all construction, service, engineering, consulting, leasing, architectural and other similar contracts concerning the design, construction, management, operation, occupancy and/or use of the Premises and Improvements, all architectural drawings, plans, specifications, soil tests, feasibility studies, appraisals, environmental studies, engineering reports and similar materials relating to any portion of or all of the Premises and Improvements, and all payment and performance bonds or warranties or guarantees relating to the Premises or the Improvements, all to the extent assignable (the “Permits, Plans and Warranties”);
     (5) all now or hereafter existing leases or licenses (under which Mortgagor is landlord or licensor) and subleases (under which Mortgagor is sublandlord), concession, management, mineral or other agreements of a similar kind that permit the use or occupancy of the Premises or the Improvements for any purpose in return for any payment, or the extraction or taking of any gas, oil, water or other minerals

 


 

from the Premises in return for payment of any fee, rent or royalty (collectively, “Leases”), and all agreements or contracts for the sale or other disposition of all or any part of the Premises or the Improvements, now or hereafter entered into by Mortgagor, together with all charges, fees, income, issues, profits, receipts, rents, revenues or royalties payable thereunder (“Rents”);
     (6) all real estate tax refunds and all proceeds of the conversion, voluntary or involuntary, of any of the Mortgaged Property into cash or liquidated claims (“Proceeds”), including Proceeds of insurance maintained by the Mortgagor and condemnation awards, any awards that may become due by reason of the taking by eminent domain or any transfer in lieu thereof of the whole or any part of the Premises or Improvements or any rights appurtenant thereto, and any awards for change of grade of streets, together with any and all moneys now or hereafter on deposit for the payment of real estate taxes, assessments or common area charges levied against the Mortgaged Property, unearned premiums on policies of fire and other insurance maintained by the Mortgagor covering any interest in the Mortgaged Property or required by the Credit Agreement; and
     (7) all extensions, improvements, betterments, renewals, substitutes and replacements of and all additions and appurtenances to, the Land, the Premises, the Improvements, the Personal Property, the Permits, Plans and Warranties and the Leases, hereinafter acquired by or released to the Mortgagor or constructed, assembled or placed by the Mortgagor on the Land, the Premises or the Improvements, and all conversions of the security constituted thereby, immediately upon such acquisition, release, construction, assembling, placement or conversion, as the case may be, and in each such case, without any further mortgage, deed of trust, conveyance, assignment or other act by the Mortgagor, all of which shall become subject to the lien of this Mortgage as fully and completely, and with the same effect, as though now owned by the Mortgagor and specifically described herein.
     TO HAVE AND TO HOLD the Mortgaged Property unto the Mortgagee, its successors and assigns, for the ratable benefit of the Secured Parties, forever, subject only to the Liens set forth in Section 6.02 of the Credit Agreement, including, for the avoidance of uncertainty, those Liens set forth in Sections 6.02(h), (i) and (l) of the Credit Agreement and to satisfaction and release as provided in Section 3.04.
ARTICLE I
Representations, Warranties and Covenants of Mortgagor
     Mortgagor agrees, covenants, represents and/or warrants as follows:
     SECTION 1.01. Title, Mortgage Lien. (a) Mortgagor has good and marketable fee simple title to the Mortgaged Property, subject only to the Liens set forth in Section 6.02 of the Credit Agreement, including, for the avoidance of uncertainty, those Liens set forth in Sections 6.02(h), (i) and (l) of the Credit Agreement.

 


 

     (b) The execution and delivery of this Mortgage is within Mortgagor’s corporate powers and has been duly authorized by all necessary corporate and, if required, stockholder action. This Mortgage has been duly executed and delivered by Mortgagor and constitutes a legal, valid and binding obligation of Mortgagor, enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors’ rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law.
     (c) The execution, delivery and recordation of this Mortgage (i) do not require any consent or approval of, registration or filing with, or any other action by, any Governmental Authority, except such as have been obtained or made and are in full force and effect and except filings necessary to perfect the lien of this Mortgage, (ii) will not violate any applicable law or regulation or the charter, by-laws or other organizational documents of Mortgagor or any order of any Governmental Authority, (iii) will not violate or result in a default under any indenture, agreement or other instrument binding upon Mortgagor or its assets, or give rise to a right thereunder to require any payment to be made by Mortgagor, and (iv) will not result in the creation or imposition of any Lien on any asset of Mortgagor, except the lien of this Mortgage.
     (d) This Mortgage and the Uniform Commercial Code Financing Statements described in Section 1.09 of this Mortgage, when duly recorded in the public records will create a valid, perfected and enforceable lien upon and security interest in all of the Mortgaged Property.
     (e) Mortgagor will forever warrant and defend its title to the Mortgaged Property, the rights of Mortgagee therein under this Mortgage and the validity and priority of the lien of this Mortgage thereon against the claims of all persons and parties except those having rights under the Liens set forth in Section 6.02 of the Credit Agreement to the extent of those rights.
     SECTION 1.02. Credit Agreement. This Mortgage is given pursuant to the Credit Agreement. Mortgagor expressly covenants and agrees to pay when due, and to timely perform, and to cause the other Loan Parties to pay when due, and to timely perform, the Obligations in accordance with their terms.
     SECTION 1.03. Payment of Taxes, and Other Obligations. (a) Mortgagor will pay and discharge from time to time prior to the time when the same shall become delinquent, and before any interest or penalty accrues thereon or attaches thereto, all Taxes and other obligations with respect to the Mortgaged Property or any part thereof or upon the Rents from the Mortgaged Property or arising in respect of the occupancy, use or possession thereof in accordance with, and to the extent required by, the Credit Agreement.
     (b) In the event of the passage of any state, Federal, municipal or other governmental law, order, rule or regulation subsequent to the date hereof (i) deducting from the value of real property for the purpose of taxation any lien or encumbrance thereon or in any manner changing or modifying the laws now in force governing the taxation of this Mortgage or debts secured by mortgages or deeds of trust (other than laws governing income, franchise and similar taxes generally) or the manner of collecting taxes thereon and (ii) imposing a tax

 


 

to be paid by Mortgagee, either directly or indirectly, on this Mortgage or any of the Loan Documents, or requiring an amount of taxes to be withheld or deducted therefrom, Mortgagor will promptly (i) notify Mortgagee of such event, (ii) enter into such further instruments as Mortgagee may determine are reasonably necessary or desirable to obligate Mortgagor to make any additional payments necessary to put the Lenders and Secured Parties in the same financial position they would have been if such law, order, rule or regulation had not been passed and (iii) make such additional payments to Mortgagee for the benefit of the Lenders and Secured Parties.
     SECTION 1.04. Maintenance of Mortgaged Property. Mortgagor will maintain the Improvements and the Personal Property in the manner required by the Credit Agreement.
     SECTION 1.05. Insurance. Mortgagor will keep or cause to be kept the Improvements and Personal Property insured against such risks, and in the manner, described in Section 4.03(l) of the Guarantee and Collateral Agreement and shall purchase such additional insurance as may be required from time to time pursuant to Section 5.02 of the Credit Agreement. Federal Emergency Management Agency Standard Flood Hazard Determination Forms will be purchased by Mortgagor for each Mortgaged Property on which Improvements are located. If any portion of Improvements constituting part of the Mortgaged Property is located in an area identified as a special flood hazard area by Federal Emergency Management Agency or other applicable agency, Mortgagor will purchase flood insurance in an amount reasonably satisfactory to Mortgagee, but in no event less than the maximum limit of coverage available under the National Flood Insurance Act of 1968, as amended.
     SECTION 1.06. Casualty Condemnation/Eminent Domain. Mortgagor shall give Mortgagee prompt written notice of any casualty or other damage to the Mortgaged Property or any proceeding for the taking of the Mortgaged Property or any portion thereof or interest therein under power of eminent domain or by condemnation or any similar proceeding in accordance with, and to the extent required by, the Credit Agreement. Any Net Cash Proceeds received by or on behalf of the Mortgagor in respect of any such casualty, damage or taking shall constitute trust funds held by the Mortgagor for the benefit of the Secured Parties to be applied to repair, restore or replace the Mortgaged Property or, if a prepayment event shall occur with respect to any such Net Cash Proceeds, to be applied in accordance with the Credit Agreement.
     SECTION 1.07. Assignment of Leases and Rents. (a) Mortgagor hereby irrevocably and absolutely grants, transfers and assigns all of its right title and interest in all Leases, together with any and all extensions and renewals thereof for purposes of securing and discharging the performance by Mortgagor of the Obligations. Mortgagor has not assigned or executed any assignment of, and will not assign or execute any assignment of, any Leases or the Rents payable thereunder to anyone other than Mortgagee.
     (b) Except for those Leases set forth in Section 6.02(l) of the Credit Agreement, all Leases shall be subordinate to the lien of this Mortgage. Except for those Leases set forth in Section 6.02(l) of the Credit Agreement, Mortgagor will not enter into, modify or amend any

 


 

Lease if such Lease, as entered into, modified or amended, will not be subordinate to the lien of this Mortgage.
     (c) Subject to Section 1.07(d), Mortgagor has assigned and transferred to Mortgagee all of Mortgagor’s right, title and interest in and to the Rents now or hereafter arising from each Lease heretofore or hereafter made or agreed to by Mortgagor, it being intended that this assignment establish, subject to Section 1.07(d), an absolute transfer and assignment of all Rents and all Leases to Mortgagee and not merely to grant a security interest therein. Subject to Section 1.07(d), Mortgagee may in Mortgagor’s name and stead (with or without first taking possession of any of the Mortgaged Property personally or by receiver as provided herein) operate the Mortgaged Property and rent, lease or let all or any portion of any of the Mortgaged Property to any party or parties at such rental and upon such terms as Mortgagee shall, in its sole discretion, determine, and may collect and have the benefit of all of said Rents arising from or accruing at any time thereafter or that may thereafter become due under any Lease.
     (d) So long as an Event of Default shall not have occurred and be continuing, Mortgagee will not exercise any of its rights under Section 1.07(c), and Mortgagor shall receive and collect the Rents accruing under any Lease; but after the happening and during the continuance of any Event of Default, Mortgagee may, at its option, receive and collect all Rents and enter upon the Premises and Improvements through its officers, agents, employees or attorneys for such purpose and for the operation and maintenance thereof. Mortgagor hereby irrevocably authorizes and directs each tenant, if any, and each successor, if any, to the interest of any tenant under any Lease, respectively, to rely upon any notice of an Event of Default sent by Mortgagee to any such tenant or any of such tenant’s successors in interest, and thereafter to pay Rents to Mortgagee without any obligation or right to inquire as to whether an Event of Default actually exists and even if some notice to the contrary is received from the Mortgagor, who shall have no right or claim against any such tenant or successor in interest for any such Rents so paid to Mortgagee. Each tenant or any of such tenant’s successors in interest from whom Mortgagee or any officer, agent, attorney or employee of Mortgagee shall have collected any Rents, shall be authorized to pay Rents to Mortgagor only after such tenant or any of their successors in interest shall have received written notice from Mortgagee (such notice to promptly be sent by Mortgagee once an Event of Default is no longer occurring) that the Event of Default is no longer continuing, unless and until a further notice of an Event of Default is given by Mortgagee to such tenant or any of its successors in interest.
     (e) Mortgagee will not become a mortgagee in possession so long as it does not enter or take actual possession of the Mortgaged Property. In addition, Mortgagee shall not be responsible or liable for performing any of the obligations of the landlord under any Lease, for any waste by any tenant, or others, for any dangerous or defective conditions of any of the Mortgaged Property, for negligence in the management, upkeep, repair or control of any of the Mortgaged Property or any other act or omission by any other person.
     (f) Mortgagor shall furnish to Mortgagee, within 30 days after a request by Mortgagee to do so, a written statement containing the names of all tenants, subtenants and

 


 

concessionaires of the Premises or Improvements, the terms of any Lease, the space occupied and the rentals and/or other amounts payable thereunder.
     SECTION 1.08. Restrictions on Transfers and Encumbrances. Mortgagor shall not directly or indirectly sell, convey, divest, alienate, assign, lease, sublease, license, mortgage, pledge, encumber or otherwise transfer, create, consent to or suffer the creation of any lien, charge or other form of encumbrance upon any interest in or any part of the Mortgaged Property (other than resulting from a condemnation), or engage in any common, cooperative, joint, time-sharing or other congregate ownership of all or part thereof, except in each case in accordance with and to the extent permitted by the Credit Agreement; provided, that Mortgagor may, in the ordinary course of business and in accordance with reasonable commercial standards, enter into easement or covenant agreements that relate to and/or benefit the operation of the Mortgaged Property and that do not materially and adversely affect the value, use or operation of the Mortgaged Property. If any of the foregoing transfers or encumbrances results in an event requiring prepayment of the Loans in accordance with the terms of the Credit Agreement, any Net Cash Proceeds received by or on behalf of the Mortgagor in respect thereof shall constitute trust funds to be held by the Mortgagor for the benefit of the Secured Parties and applied in accordance with the Credit Agreement.
     SECTION 1.09. Security Agreement. This Mortgage is both a mortgage of real property and a grant of a security interest in personal property, and shall constitute and serve as a “Security Agreement” within the meaning of the uniform commercial code as adopted in the state wherein the Premises are located (“UCC”). Mortgagor has hereby granted unto Mortgagee a security interest in and to all the Mortgaged Property described in this Mortgage that is not real property, and simultaneously with the recording of this Mortgage, Mortgagor has filed or will file UCC financing statements, and will file continuation statements prior to the lapse thereof, at the appropriate offices in the jurisdiction of formation of the Mortgagor to perfect the security interest granted by this Mortgage in all the Mortgaged Property that is not real property. Mortgagor hereby appoints Mortgagee as its true and lawful attorney-in-fact and agent, for Mortgagor and in its name, place and stead, in any and all capacities, to execute any document and to file the same in the appropriate offices (to the extent it may lawfully do so), and to perform each and every act and thing reasonably requisite and necessary to be done to perfect the security interest contemplated by the preceding sentence. Mortgagee shall have all rights with respect to the part of the Mortgaged Property that is the subject of a security interest afforded by the UCC in addition to, but not in limitation of, the other rights afforded Mortgagee hereunder and under the Guarantee and Collateral Agreement.
     SECTION 1.10. Filing and Recording. Mortgagor will cause this Mortgage, the UCC financing statements referred to in Section 1.09, any other security instrument creating a security interest in or evidencing the lien hereof upon the Mortgaged Property and each UCC continuation statement and instrument of further assurance to be filed, registered or recorded and, if necessary, refiled, rerecorded and reregistered, in such manner and in such places as may be required by any present or future law in order to publish notice of and fully to perfect the lien hereof upon, and the security interest of Mortgagee in, the Mortgaged Property until this Mortgage is terminated and released in full in accordance with Section 3.04 hereof. Mortgagor will pay all filing, registration and recording fees, all Federal, state,

 


 

county and municipal recording, documentary or intangible taxes and other taxes, duties, imposts, assessments and charges, and all reasonable expenses incidental to or arising out of or in connection with the execution, delivery and recording of this Mortgage, UCC continuation statements any mortgage supplemental hereto, any security instrument with respect to the Personal Property, Permits, Plans and Warranties and Proceeds or any instrument of further assurance.
     SECTION 1.11. Further Assurances. Upon reasonable demand by Mortgagee, Mortgagor will, at the cost of Mortgagor and without expense to Mortgagee, do, execute, acknowledge and deliver all such further acts, deeds, conveyances, mortgages, assignments, notices of assignment, transfers and assurances as Mortgagee shall from time to time reasonably require for the better assuring, conveying, assigning, transferring and confirming unto Mortgagee the property and rights hereby conveyed or assigned or intended now or hereafter so to be, or which Mortgagor may be or may hereafter become bound to convey or assign to Mortgagee, or for carrying out the intention or facilitating the performance of the terms of this Mortgage, or for filing, registering or recording this Mortgage, and on demand, Mortgagor will also execute and deliver and hereby appoints Mortgagee as its true and lawful attorney-in-fact and agent, for Mortgagor and in its name, place and stead, in any and all capacities, to execute and file to the extent it may lawfully do so, one or more financing statements, chattel mortgages or comparable security instruments reasonably requested by Mortgagee to evidence more effectively the lien hereof upon the Personal Property and to perform each and every act and thing requisite and necessary to be done to accomplish the same.
     SECTION 1.12. Additions to Mortgaged Property. All right, title and interest of Mortgagor in and to all extensions, improvements, betterments, renewals, substitutions and replacements of, and all additions and appurtenances to, the Mortgaged Property hereafter acquired by or released to Mortgagor or constructed, assembled or placed by Mortgagor upon the Premises or the Improvements, and all conversions of the security constituted thereby, immediately upon such acquisition, release, construction, assembling, placement or conversion, as the case may be, and in each such case without any further mortgage, conveyance, assignment or other act by Mortgagor, shall become subject to the lien and security interest of this Mortgage as fully and completely and with the same effect as though now owned by Mortgagor and specifically described in the grant of the Mortgaged Property above, but at any and all times Mortgagor will execute and deliver to Mortgagee any and all such further assurances, mortgages, conveyances or assignments thereof as Mortgagee may reasonably require for the purpose of expressly and specifically subjecting the same to the lien and security interest of this Mortgage.
     SECTION 1.13. No Claims Against Mortgagee. Nothing contained in this Mortgage shall constitute any consent or request by Mortgagee, express or implied, for the performance of any labor or services or the furnishing of any materials or other property in respect of the Mortgaged Property or any part thereof, nor as giving Mortgagor any right, power or authority to contract for or permit the performance of any labor or services or the furnishing of any materials or other property in such fashion as would permit the making of any claim against Mortgagee in respect thereof.

 


 

     SECTION 1.14. Fixture Filing. (a) Certain portions of the Mortgaged Property are or will become “fixtures” (as that term is defined in the UCC) on the Land, and this Mortgage, upon being filed for record in the real estate records of the county wherein such fixtures are situated, shall operate also as a financing statement filed as a fixture filing in accordance with the applicable provisions of said UCC upon such portions of the Mortgaged Property that are or become fixtures.
     (b) The real property to which the fixtures relate is described in Exhibit A attached hereto. The record owner of the real property described in Exhibit A attached hereto is Mortgagor. The name, type of organization and jurisdiction of organization of the debtor for purposes of this financing statement are the name, type of organization and jurisdiction of organization of the Mortgagor set forth in the first paragraph of this Mortgage, and the name of the secured party for purposes of this financing statement is the name of the Mortgagee set forth in the first paragraph of this Mortgage. The mailing address of the Mortgagor/debtor is the address of the Mortgagor set forth in the first paragraph of this Mortgage. The mailing address of the Mortgagee/secured party from which information concerning the security interest hereunder may be obtained is the address of the Mortgagee set forth in the first paragraph of this Mortgage. Mortgagor’s organizational identification number is [                    ].
ARTICLE II
Defaults and Remedies
     SECTION 2.01. Events of Default. Any Event of Default under the Credit Agreement (as such term is defined therein) shall constitute an Event of Default under this Mortgage.
     SECTION 2.02. Demand for Payment. If an Event of Default shall occur and be continuing, then, upon written demand of Mortgagee, Mortgagor will pay to Mortgagee all amounts due hereunder and under the Credit Agreement and the Guarantee and Collateral Agreement and such further amount as shall be sufficient to cover the out-of-pocket costs and expenses of collection, including attorneys’ fees, disbursements and expenses incurred by Mortgagee, and Mortgagee shall be entitled and empowered to institute an action or proceedings at law or in equity for the collection of the sums so due and unpaid, to prosecute any such action or proceedings to judgment or final decree, to enforce any such judgment or final decree against Mortgagor and to collect, in any manner provided by law, all moneys adjudged or decreed to be payable.
     SECTION 2.03. Rights To Take Possession, Operate and Apply Revenues. (a) If an Event of Default shall occur and be continuing, Mortgagor shall, upon demand of Mortgagee, forthwith surrender to Mortgagee actual possession of the Mortgaged Property and, if and to the extent not prohibited by applicable law, Mortgagee itself, or by such officers or agents as it may appoint, may then enter and take possession of all the Mortgaged Property without the appointment of a receiver or an application therefor, exclude Mortgagor

 


 

and its agents and employees wholly therefrom, and have access to the books, papers and accounts of Mortgagor.
     (b) If Mortgagor shall for any reason fail to surrender or deliver the Mortgaged Property or any part thereof after such demand by Mortgagee, Mortgagee may to the extent not prohibited by applicable law, obtain a judgment or decree conferring upon Mortgagee the right to immediate possession or requiring Mortgagor to deliver immediate possession of the Mortgaged Property to Mortgagee, to the entry of which judgment or decree Mortgagor hereby specifically consents. Mortgagor will pay to Mortgagee, upon demand, all reasonable expenses of obtaining such judgment or decree, including reasonable compensation to Mortgagee’s attorneys and agents with interest thereon at the rate per annum applicable to overdue amounts under the Credit Agreement as provided in Section 2.07 of the Credit Agreement (the “Interest Rate”); and all such expenses and compensation shall, until paid, be secured by this Mortgage.
     (c) Upon every such entry or taking of possession, Mortgagee may, to the extent not prohibited by applicable law, hold, store, use, operate, manage and control the Mortgaged Property, conduct the business thereof and, from time to time, (i) make all necessary and proper maintenance, repairs, renewals, replacements, additions, betterments and improvements thereto and thereon, (ii) purchase or otherwise acquire additional fixtures, personalty and other property that are reasonably necessary for the operation of the business, (iii) insure or keep the Mortgaged Property insured, (iv) manage and operate the Mortgaged Property and exercise all the rights and powers of Mortgagor to the same extent as Mortgagor could in its own name or otherwise with respect to the same, or (v) enter into any and all agreements with respect to the exercise by others of any of the powers herein granted Mortgagee, all as may from time to time be directed or determined by Mortgagee to reasonably be in its best interest and Mortgagor hereby appoints Mortgagee as its true and lawful attorney-in-fact and agent, for Mortgagor and in its name, place and stead, in any and all capacities, to perform any of the foregoing acts. Mortgagee may collect and receive all the Rents, issues, profits and revenues from the Mortgaged Property, including those past due as well as those accruing thereafter, and, after deducting (i) all out-of-pocket expenses of taking, holding, managing and operating the Mortgaged Property (including compensation for the services of all persons employed for such purposes), (ii) the out-of-pocket costs of all such maintenance, repairs, renewals, replacements, additions, betterments, improvements, purchases and acquisitions, (iii) the costs of insurance, (iv) such taxes, assessments and other similar charges as Mortgagee may at its option pay, (v) other proper charges upon the Mortgaged Property or any part thereof and (vi) the compensation, expenses and disbursements of the attorneys and agents of Mortgagee, Mortgagee shall apply the remainder of the moneys and proceeds so received first to the payment of the Mortgagee for the satisfaction of the Obligations, and second, if there is any surplus, to Mortgagor, subject to the entitlement of others thereto under applicable law.
     (d) Whenever, before any sale of the Mortgaged Property under Section 2.06, all Obligations that are then due shall have been paid and all Events of Default fully cured, Mortgagee will surrender possession of the Mortgaged Property back to Mortgagor, its successors or assigns. The same right of taking possession shall, however, arise again if any subsequent Event of Default shall occur and be continuing.

 


 

     SECTION 2.04. Right To Cure Mortgagor’s Failure to Perform. Should Mortgagor fail in the payment, performance or observance of any term, covenant or condition required by this Mortgage or the Credit Agreement (with respect to the Mortgaged Property), Mortgagee may pay, perform or observe the same, and all payments made or costs or expenses incurred by Mortgagee in connection therewith shall be secured hereby and shall be, without demand, immediately repaid by Mortgagor to Mortgagee with interest thereon at the Interest Rate. Mortgagee shall be the judge using reasonable discretion of the necessity for any such actions and of the amounts to be paid. Mortgagee is hereby empowered to enter and to authorize others to enter upon the Premises or the Improvements or any part thereof for the purpose of performing or observing any such defaulted term, covenant or condition without having any obligation to so perform or observe and without thereby becoming liable to Mortgagor, to any person in possession holding under Mortgagor or to any other person; provided, however, that except in the case of an emergency, Mortgagee will provide reasonable advance notice of such entry, such entry shall be conducted in a reasonable manner and Mortgagee shall use reasonable efforts to endeavor to minimize the amount of disturbance to the Mortgagor’s possession of the Mortgaged Property.
     SECTION 2.05. Right to a Receiver. If an Event of Default shall occur and be continuing, Mortgagee, upon application to a court of competent jurisdiction, shall be entitled as a matter of right to the appointment of a receiver to take possession of and to operate the Mortgaged Property and to collect and apply the Rents. The receiver shall have all of the rights and powers permitted under the laws of the state wherein the Mortgaged Property is located. Mortgagor shall pay to Mortgagee upon demand all reasonable out-of-pocket expenses, including receiver’s fees, reasonable attorney’s fees and disbursements, costs and agent’s compensation incurred pursuant to the provisions of this Section 2.05; and all such expenses shall be secured by this Mortgage and shall be, without demand, immediately repaid by Mortgagor to Mortgagee with interest thereon at the Interest Rate.
     SECTION 2.06. Foreclosure and Sale. (a) If an Event of Default shall occur and be continuing, Mortgagee may elect to sell the Mortgaged Property or any part of the Mortgaged Property by exercise of the power of foreclosure or of sale granted to Mortgagee by applicable law or this Mortgage. In such case, Mortgagee may commence a civil action to foreclose this Mortgage, or it may proceed and sell the Mortgaged Property to satisfy any Obligation. Mortgagee or an officer appointed by a judgment of foreclosure to sell the Mortgaged Property, may sell all or such parts of the Mortgaged Property as may be chosen by Mortgagee at the time and place of sale fixed by it in a notice of sale, either as a whole or in separate lots, parcels or items as Mortgagee shall deem expedient, and in such order as it may determine, at public auction to the highest bidder. Mortgagee or an officer appointed by a judgment of foreclosure to sell the Mortgaged Property may postpone any foreclosure or other sale of all or any portion of the Mortgaged Property by public announcement at such time and place of sale, and from time to time thereafter may postpone such sale by public announcement or subsequently noticed sale. Without further notice, Mortgagee or an officer appointed to sell the Mortgaged Property may make such sale at the time fixed by the last postponement, or may, in its discretion, give a new notice of sale. Any person, including Mortgagor or Mortgagee or any designee or affiliate thereof, may purchase at such sale.

 


 

     (b) The Mortgaged Property may be sold subject to unpaid taxes and the Liens set forth in Section 6.02 of the Credit Agreement, and, after deducting all costs, fees and out-of-pocket expenses of Mortgagee (including costs of evidence of title in connection with the sale), Mortgagee or an officer that makes any sale shall apply the proceeds of sale in the manner set forth in Section 2.08.
     (c) Any foreclosure or other sale of less than the whole of the Mortgaged Property or any defective or irregular sale made hereunder shall not exhaust the power of foreclosure or of sale provided for herein; and subsequent sales may be made hereunder until the Obligations have been satisfied, or the entirety of the Mortgaged Property has been sold.
     (d) If an Event of Default shall occur and be continuing, Mortgagee may instead of, or in addition to, exercising the rights described in Section 2.06(a) above and either with or without entry or taking possession as herein permitted, proceed by a suit or suits in law or in equity or by any other appropriate proceeding or remedy (i) to specifically enforce payment of some or all of the Obligations, or the performance of any term, covenant, condition or agreement of this Mortgage or any other Loan Document or any other right, or (ii) to pursue any other remedy available to Mortgagee, all as Mortgagee shall determine most effectual for such purposes.
     SECTION 2.07. Other Remedies. (a) In case an Event of Default shall occur and be continuing, Mortgagee may also exercise, to the extent not prohibited by law, any or all of the remedies available to a secured party under the UCC.
     (b) In connection with a sale of the Mortgaged Property or any Personal Property and the application of the proceeds of sale as provided in Section 2.08, Mortgagee shall be entitled to enforce payment of and to receive up to the principal amount of the Obligations, plus all other charges, payments and costs due under this Mortgage, and to recover a deficiency judgment for any portion of the aggregate principal amount of the Obligations remaining unpaid, with interest.
     SECTION 2.08. Application of Sale Proceeds and Rents. After any foreclosure sale of all or any of the Mortgaged Property, Mortgagee shall receive and apply the proceeds of the sale together with any Rents that may have been collected and any other sums that then may be held by Mortgagee under this Mortgage as follows:
     FIRST, to the payment of all out-of-pocket costs and expenses incurred by the Administrative Agent or the Mortgagee (in their respective capacities as such hereunder or under any other Loan Document) in connection with such collection, sale, foreclosure or realization or otherwise in connection with this Mortgage, any other Loan Document or any of the Obligations, including all court costs and the fees and expenses of its agents and legal counsel, the repayment of all advances made by the Administrative Agent and/or the Mortgagee hereunder or under any other Loan Document on behalf of any Mortgagor and any other out-of-pocket costs or expenses incurred in connection with the exercise of any right or remedy hereunder or under any other Loan Document;

 


 

     SECOND, to the payment in full of Unfunded Advances/Participations (the amounts so applied to be distributed between or among the Administrative Agent, the Swingline Lender and any Issuing Bank pro rata in accordance with the amounts of Unfunded Advances/Participations owed to them on the date of any such distribution);
     THIRD, to the payment in full of all other Obligations (the amounts so applied to be distributed among the Secured Parties pro rata in accordance with the amounts of the Obligations owed to them on the date of any such distribution);
     FOURTH, to the Mortgagor, its successors or assigns, or as a court of competent jurisdiction may otherwise direct.
The Mortgagee shall have absolute discretion as to the time of application of any such proceeds, moneys or balances in accordance with this Mortgage. Upon any sale of the Mortgaged Property by the Mortgagee (including pursuant to a power of sale granted by statute or under a judicial proceeding), the receipt of the Mortgagee or of the officer making the sale shall be a sufficient discharge to the purchaser or purchasers of the Mortgaged Property so sold and such purchaser or purchasers shall not be obligated to see to the application of any part of the purchase money paid over to the Mortgagee or such officer or be answerable in any way for the misapplication thereof.
     SECTION 2.09. Mortgagor as Tenant Holding Over. If Mortgagor remains in possession of any of the Mortgaged Property after any foreclosure sale by Mortgagee, at Mortgagee’s election Mortgagor shall be deemed a tenant holding over and shall forthwith surrender possession to the purchaser or purchasers at such sale or be summarily dispossessed or evicted according to provisions of law applicable to tenants holding over.
     SECTION 2.10. Waiver of Appraisement, Valuation, Stay, Extension and Redemption Laws. Mortgagor waives, to the extent not prohibited by law, (i) the benefit of all laws now existing or that hereafter may be enacted (x) providing for any appraisement or valuation of any portion of the Mortgaged Property and/or (y) in any way extending the time for the enforcement or the collection of amounts due under any of the Obligations or creating or extending a period of redemption from any sale made in collecting said debt or any other amounts due Mortgagee, (ii) any right to at any time insist upon, plead, claim or take the benefit or advantage of any law now or hereafter in force providing for any homestead exemption, stay, statute of limitations, extension or redemption, or sale of the Mortgaged Property as separate tracts, units or estates or as a single parcel in the event of foreclosure or notice of deficiency, and (iii) all rights of redemption, valuation, appraisement, stay of execution, notice of election to mature or declare due the whole of or each of the Obligations and marshaling in the event of foreclosure of this Mortgage.
     SECTION 2.11. Discontinuance of Proceedings. In case Mortgagee shall proceed to enforce any right, power or remedy under this Mortgage by foreclosure, entry or otherwise, and such proceedings shall be discontinued or abandoned for any reason, or shall be determined adversely to Mortgagee, then and in every such case Mortgagor and

 


 

Mortgagee shall be restored to their former positions and rights hereunder, and all rights, powers and remedies of Mortgagee shall continue as if no such proceeding had been taken.
     SECTION 2.12. Suits To Protect the Mortgaged Property. Mortgagee shall have power (a) to institute and maintain suits and proceedings to prevent any impairment of the Mortgaged Property by any acts that may be unlawful or in violation of this Mortgage, (b) to preserve or protect its interest in the Mortgaged Property and in the Rents arising therefrom and (c) to restrain the enforcement of or compliance with any legislation or other governmental enactment, rule or order that may be unconstitutional or otherwise invalid if the enforcement of or compliance with such enactment, rule or order would impair the security or be prejudicial to the interest of Mortgagee hereunder.
     SECTION 2.13. Filing Proofs of Claim. In case of any receivership, insolvency, bankruptcy, reorganization, arrangement, adjustment, composition or other proceedings affecting Mortgagor, Mortgagee shall, to the extent permitted by law, be entitled to file such proofs of claim and other documents as may be necessary or advisable in order to have the claims of Mortgagee allowed in such proceedings for the Obligations secured by this Mortgage at the date of the institution of such proceedings and for any interest accrued, late charges and additional interest or other amounts due or that may become due and payable hereunder after such date.
     SECTION 2.14. Possession by Mortgagee. Notwithstanding the appointment of any receiver, liquidator or trustee of Mortgagor, any of its property or the Mortgaged Property, Mortgagee shall be entitled, to the extent not prohibited by law, to remain in possession and control of all parts of the Mortgaged Property now or hereafter granted under this Mortgage to Mortgagee in accordance with the terms hereof and applicable law.
     SECTION 2.15. Waiver. (a) No delay or failure by Mortgagee to exercise any right, power or remedy accruing upon any breach or Event of Default shall exhaust or impair any such right, power or remedy or be construed to be a waiver of any such breach or Event of Default or acquiescence therein; and every right, power and remedy given by this Mortgage to Mortgagee may be exercised from time to time and as often as may be deemed expedient by Mortgagee. No consent or waiver by Mortgagee to or of any breach or Event of Default by Mortgagor in the performance of the Obligations shall be deemed or construed to be a consent or waiver to or of any other breach or Event of Default in the performance of the same or of any other Obligations by Mortgagor hereunder. No failure on the part of Mortgagee to complain of any act or failure to act or to declare an Event of Default, irrespective of how long such failure continues, shall constitute a waiver by Mortgagee of its rights hereunder or impair any rights, powers or remedies consequent on any future Event of Default by Mortgagor.
     (b) Even if Mortgagee (i) grants some forbearance or an extension of time for the payment of any sums secured hereby, (ii) takes other or additional security for the payment of any sums secured hereby, (iii) waives or does not exercise some right granted herein or under the Loan Documents, (iv) releases a part of the Mortgaged Property from this Mortgage, (v) agrees to change some of the terms, covenants, conditions or agreements of any of the Loan Documents, (vi) consents to the filing of a map, plat or replat affecting the

 


 

Premises, (vii) consents to the granting of an easement or other right affecting the Premises or (viii) makes or consents to an agreement subordinating Mortgagee’s lien on the Mortgaged Property hereunder; no such act or omission shall preclude Mortgagee from exercising any other right, power or privilege herein granted or intended to be granted in the event of any breach or Event of Default then made or of any subsequent default; nor, except as otherwise expressly provided in an instrument executed by Mortgagee, shall this Mortgage be altered thereby. In the event of the sale or transfer by operation of law or otherwise of all or part of the Mortgaged Property, Mortgagee is hereby authorized and empowered to deal with any vendee or transferee with reference to the Mortgaged Property secured hereby, or with reference to any of the terms, covenants, conditions or agreements hereof, as fully and to the same extent as it might deal with the original parties hereto and without in any way releasing or discharging any liabilities, obligations or undertakings.
     SECTION 2.16. Waiver of Trial by Jury. To the fullest extent permitted by applicable law, Mortgagor and Mortgagee each hereby irrevocably and unconditionally waive trial by jury in any action, claim, suit or proceeding relating to this Mortgage and for any counterclaim brought therein. Mortgagor hereby waives all rights to interpose any counterclaim in any suit brought by Mortgagee hereunder and all rights to have any such suit consolidated with any separate suit, action or proceeding.
     SECTION 2.17. Remedies Cumulative. No right, power or remedy conferred upon or reserved to Mortgagee by this Mortgage is intended to be exclusive of any other right, power or remedy, and each and every such right, power and remedy shall be cumulative and concurrent and in addition to any other right, power and remedy given hereunder or now or hereafter existing at law or in equity or by statute.
ARTICLE III
Miscellaneous
     SECTION 3.01. Partial Invalidity. In the event any one or more of the provisions contained in this Mortgage shall for any reason be held to be invalid, illegal or unenforceable in any respect, such validity, illegality or unenforceability shall, at the option of Mortgagee, not affect any other provision of this Mortgage, and this Mortgage shall be construed as if such invalid, illegal or unenforceable provision had never been contained herein or therein.
     SECTION 3.02. Notices. All notices and communications hereunder shall be in writing and given to Mortgagor in accordance with the terms of the Credit Agreement at the address set forth on the first page of this Mortgage and to the Mortgagee as provided in the Credit Agreement.
     SECTION 3.03. Successors and Assigns. All of the grants, covenants, terms, provisions and conditions herein shall run with the Premises and the Improvements and shall apply to, bind and inure to, the benefit of the permitted successors and assigns of Mortgagor and the successors and assigns of Mortgagee.

 


 

     SECTION 3.04. Satisfaction and Cancelation. (a) The conveyance to Mortgagee of the Mortgaged Property as security created and consummated by this Mortgage shall terminate and be null and void when all the Obligations have been indefeasibly paid in full and the Lenders have no further commitment to lend under the Credit Agreement, the aggregate L/C Exposure has been reduced to zero and the Issuing Bank has no further obligation to issue Letters of Credit under the Credit Agreement.
     (b) Mortgagor shall automatically be released from its obligations hereunder upon the consummation of (i) any transaction permitted by the Credit Agreement as a result of which Mortgagor ceases to be a Subsidiary or (ii) any Permitted Receivables Transaction or a Permitted Securitization Transaction consummated after the date hereof as a result of which Mortgagor becomes a Permitted Syndication Subsidiary or Securitization Subsidiary.
     (c) Upon any sale or other transfer by Mortgagor of any Collateral that is permitted under the Credit Agreement to any person that is not the Borrower or a Guarantor, or, upon the effectiveness of any written consent to the release of the Security Interest granted hereby in any Collateral pursuant to Section 9.09 of the Credit Agreement, the Security Interest in such Collateral shall be automatically released; provided that, upon the consummation after the date hereof of any Permitted Receivables Transaction or a Permitted Securitization Transaction, the Security Interest in the Equity Interests of the Subsidiary that is the subject of such Permitted Receivables Transaction or a Permitted Securitization Transaction, as the case may be, shall be automatically released to the extent the pledge of the Equity Interests in such Subsidiary is prohibited by any applicable Contractual Obligation or requirement of law.
     (d) In connection with any termination or release pursuant to paragraph (a), (b) or (c) above, the Mortgagee shall promptly execute and deliver to Mortgagor, at Mortgagor’s expense, a release of this Mortgage and all Uniform Commercial Code termination statements and similar documents that Mortgagor shall reasonably request to evidence such termination or release. Any execution and delivery of documents pursuant to this Section 3.04 shall be without recourse to or representation or warranty by the Mortgagee or any Secured Party. Without limiting the provisions of Section 7.06 of the Guarantee and Collateral Agreement, the Borrower shall reimburse the Mortgagee upon demand for all reasonable out of pocket expenses, including the fees, charges and expenses of counsel, incurred by it in connection with any action contemplated by this Section 3.04.
     SECTION 3.05. Definitions. As used in this Mortgage, the singular shall include the plural as the context requires and the following words and phrases shall have the following meanings: (a) “including” shall mean “including but not limited to”; (b) “provisions” shall mean “provisions, terms, covenants and/or conditions”; (c) “lien” shall mean “lien, charge, encumbrance, security interest, mortgage or deed of trust”; (d) “obligation” shall mean “obligation, duty, covenant and/or condition”; and (e) “any of the Mortgaged Property” shall mean “the Mortgaged Property or any part thereof or interest therein”. Any act that Mortgagee is permitted to perform hereunder may be performed at any time and from time to time by Mortgagee or any person or entity designated by Mortgagee. Any act that is prohibited to Mortgagor hereunder is also prohibited to all lessees of any of the Mortgaged Property. Each appointment of Mortgagee as attorney-in-fact for Mortgagor

 


 

under the Mortgage is irrevocable, with power of substitution and coupled with an interest. Subject to the applicable provisions hereof, Mortgagee has the right to refuse to grant its consent, approval or acceptance or to indicate its satisfaction, in its sole discretion, whenever such consent, approval, acceptance or satisfaction is required hereunder.
     SECTION 3.06. Multisite Real Estate Transaction. Mortgagor acknowledges that this Mortgage is one of a number of Other Mortgages and Security Documents that secure the Obligations. Mortgagor agrees that the lien of this Mortgage shall be absolute and unconditional and shall not in any manner be affected or impaired by any acts or omissions whatsoever of Mortgagee, and without limiting the generality of the foregoing, the lien hereof shall not be impaired by any acceptance by the Mortgagee of any security for or guarantees of any of the Obligations hereby secured, or by any failure, neglect or omission on the part of Mortgagee to realize upon or protect any Obligation or indebtedness hereby secured or any collateral security therefor including the Other Mortgages and other Security Documents. The lien hereof shall not in any manner be impaired or affected by any release (except as to the property released), sale, pledge, surrender, compromise, settlement, renewal, extension, indulgence, alteration, changing, modification or disposition of any of the Obligations secured or of any of the collateral security therefor, including the Other Mortgages and other Security Documents or of any guarantee thereof, and Mortgagee may at its discretion foreclose, exercise any power of sale, or exercise any other remedy available to it under any or all of the Other Mortgages and other Security Documents without first exercising or enforcing any of its rights and remedies hereunder. Such exercise of Mortgagee’s rights and remedies under any or all of the Other Mortgages and other Security Documents shall not in any manner impair the indebtedness hereby secured or the lien of this Mortgage and any exercise of the rights or remedies of Mortgagee hereunder shall not impair the lien of any of the Other Mortgages and other Security Documents or any of Mortgagee’s rights and remedies thereunder. Mortgagor specifically consents and agrees that Mortgagee may exercise its rights and remedies hereunder and under the Other Mortgages and other Security Documents separately or concurrently and in any order that it may deem appropriate and waives any rights of subrogation.
     SECTION 3.07. No Oral Modification. This Mortgage may not be changed or terminated orally. Any agreement made by Mortgagor and Mortgagee after the date of this Mortgage relating to this Mortgage shall be superior to the rights of the holder of any intervening or subordinate Mortgage, lien or encumbrance.
ARTICLE IV
Particular Provisions
     This Mortgage is subject to the following provisions relating to the particular laws of the state wherein the Premises are located:
     SECTION 4.01. Applicable Law; Certain Particular Provisions. This Mortgage shall be governed by and construed in accordance with the internal law of the state where the

 


 

Mortgaged Property is located, except that Mortgagor expressly acknowledges that by their terms, the Credit Agreement and other Loan Documents (aside from those Other Mortgages to be recorded outside New York) shall be governed by the internal law of the State of New York, without regard to principles of conflict of law. Mortgagor and Mortgagee agree to submit to jurisdiction and the laying of venue for any suit on this Mortgage in the state where the Mortgaged Property is located. The terms and provisions set forth in Appendix A attached hereto are hereby incorporated by reference as though fully set forth herein. In the event of any conflict between the terms and provisions contained in the body of this Mortgage and the terms and provisions set forth in Appendix A, the terms and provisions set forth in Appendix A shall govern and control.

 


 

     IN WITNESS WHEREOF, this Mortgage has been duly executed and delivered to Mortgagee by Mortgagor on the date of the acknowledgment attached hereto.
         
  [NAME OF MORTGAGOR], a [             ] corporation,
 
 
       by      
    Name:   Rachel A. Seifert   
    Title:   Senior Vice President and Secretary   
 
         
  Attest:
 
 
  by:      
    Name:      
    Title:      
 
[Corporate Seal]

 


 

[ADD LOCAL FORM OF ACKNOWLEDGMENT]

 


 

Exhibit A
to Mortgage
Description of the Land

 


 

Local Law Provisions
     1. Notwithstanding anything else contained in this Mortgage, (i) the maximum principal debt or obligation which is, or under any contingency may be secured at the date of execution hereof or any time thereafter by this Mortgage is $7,215,000,000 (the “Secured Amount”), (ii) this Mortgage shall also secure amounts other than the principal debt or obligation to the extent permitted by the Tax Law without payment of additional recording tax and (iii) so long as the aggregate amount of the Obligations exceeds the Secured Amount, any payments and repayments of the Obligations shall not be deemed to be applied against, or to reduce, the Secured Amount.22
     2. [Other relevant local law provisions to be provided by local counsel.]
 
22   Applicable only in mortgage tax states. This is the New York language—local counsel to advise whether it needs to be modified in other mortgage tax states.

 

exv10w3
Exhibit 10.3
AMENDED AND RESTATED
GUARANTEE AND COLLATERAL AGREEMENT
dated as of
July 25, 2007
as amended and restated as of November 5, 2010
among
CHS/COMMUNITY HEALTH SYSTEMS, INC.,
COMMUNITY HEALTH SYSTEMS, INC.,
the Subsidiaries of the Borrower
from time to time party hereto
and
CREDIT SUISSE AG,
as Collateral Agent
Notwithstanding any other provision contained herein, this Agreement, the Liens created hereby and the rights, remedies, duties and obligations provided for herein are expressly subject in all respects to the terms of any Pari Passu Intercreditor Agreement (as defined in, and entered into in accordance with the provisions of, the Credit Agreement referred to herein). In the event of any conflict or inconsistency between the provisions of this Agreement and the terms of any Pari Passu Intercreditor Agreement, the terms of such Pari Passu Intercreditor Agreement shall control.


 

 

TABLE OF CONTENTS
         
    Page  
 
       
ARTICLE I
 
       
Definitions
 
       
SECTION 1.01. Credit Agreement
    2  
SECTION 1.02. Other Defined Terms
    2  
 
       
ARTICLE II
 
       
Guarantee
 
       
SECTION 2.01. Guarantee
    7  
SECTION 2.02. Guarantee of Payment
    7  
SECTION 2.03. No Limitations, Etc
    7  
SECTION 2.04. Reinstatement
    8  
SECTION 2.05. Agreement To Pay; Subrogation
    9  
SECTION 2.06. Information
    9  
 
       
ARTICLE III
 
       
Pledge of Securities
 
       
SECTION 3.01. Pledge
    9  
SECTION 3.02. Delivery of the Pledged Collateral
    10  
SECTION 3.03. Representations, Warranties and Covenants
    11  
SECTION 3.04. Certification of Limited Liability Company Interests and Limited Partnership Interests
    12  
SECTION 3.05. Registration in Nominee Name; Denominations
    12  
SECTION 3.06. Voting Rights; Dividends and Interest, Etc
    12  
 
       
ARTICLE IV
 
       
Security Interests in Personal Property
 
       
SECTION 4.01. Security Interest
    15  
SECTION 4.02. Representations and Warranties
    17  
SECTION 4.03. Covenants
    19  
SECTION 4.04. Other Actions
    23  
SECTION 4.05. Covenants Regarding Patent, Trademark and Copyright Collateral
    24  


 

ii

         
    Page  
ARTICLE V
 
       
Remedies
 
       
SECTION 5.01. Remedies Upon Default
    26  
SECTION 5.02. Application of Proceeds
    27  
SECTION 5.03. Grant of License to Use Intellectual Property
    28  
SECTION 5.04. Securities Act, Etc
    28  
 
       
ARTICLE VI
 
       
Indemnity, Subrogation and Subordination
 
       
SECTION 6.01. Indemnity and Subrogation
    29  
SECTION 6.02. Contribution and Subrogation
    30  
SECTION 6.03. Subordination
    30  
 
       
ARTICLE VII
 
       
Miscellaneous
 
       
SECTION 7.01. Notices
    30  
SECTION 7.02. Security Interest Absolute
    31  
SECTION 7.03. Survival of Agreement
    31  
SECTION 7.04. Binding Effect; Several Agreement
    31  
SECTION 7.05. Successors and Assigns
    32  
SECTION 7.06. Collateral Agent’s Fees and Expenses; Indemnification
    32  
SECTION 7.07. Collateral Agent Appointed Attorney-in-Fact
    33  
SECTION 7.08. Applicable Law
    33  
SECTION 7.09. Waivers; Amendment
    34  
SECTION 7.10. WAIVER OF JURY TRIAL
    34  
SECTION 7.11. Severability
    35  
SECTION 7.12. Counterparts
    35  
SECTION 7.13. Headings
    35  
SECTION 7.14. Jurisdiction; Consent to Service of Process
    35  
SECTION 7.15. Termination or Release
    36  
SECTION 7.16. Additional Subsidiaries
    37  
SECTION 7.17. Right of Setoff
    37  


 

iii

     
Schedules
   
 
   
Schedule I
  Exact Legal Names of Each Grantor
Schedule II
  Subsidiary Guarantors
Schedule III
  Equity Interests; Stock Ownership; Pledged Debt Securities
Schedule IV
  Debt Instruments; Advances
Schedule V
  Mortgage Filings
Schedule VI
  Intellectual Property
Schedule VII
  Commercial Tort Claims
 
   
Exhibits
   
 
   
Exhibit A
  Form of Supplement


 

 

     GUARANTEE AND COLLATERAL AGREEMENT dated as of July 25, 2007, as amended and restated as of November 5, 2010 (this “Agreement”), among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation (the “Borrower”), COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation (“Parent”), the Subsidiaries from time to time party hereto and CREDIT SUISSE AG (“Credit Suisse”), as collateral agent (in such capacity, the “Collateral Agent”).
PRELIMINARY STATEMENT
          Reference is made to (a) the Credit Agreement dated as of July 25, 2007 (as amended, restated, supplemented or otherwise modified prior to the date hereof, the “Existing Credit Agreement”), among the Borrower, Parent, the lenders from time to time party thereto (each, a “Lender” and collectively, the “Lenders”) and Credit Suisse AG (formerly known as Credit Suisse), as administrative agent (in such capacity, the “Administrative Agent”) and Collateral Agent, (b) the Guarantee and Collateral Agreement dated as of July 25, 2007 (as amended, restated, supplemented or otherwise modified prior to the date hereof, the Existing Guarantee and Collateral Agreement), among the Borrower, Parent, the Subsidiaries of the Borrower from time to time party thereto and the Collateral Agent, (c) any Pari Passu Agreements (such term and each other capitalized term used but not defined in this preliminary statement having the meaning given or ascribed to it in Article I) and (d) any Pari Passu Intercreditor Agreements.
          The Lenders and the Issuing Bank have extended and have agreed to extend credit to the Borrower pursuant to, and upon the terms and conditions specified in, the Existing Credit Agreement. Concurrent with the execution and delivery of this Agreement, the Existing Credit Agreement will be amended and restated (such amended and restated agreement, as the same may be further amended, restated, supplemented or otherwise modified from time to time being referred to herein as the “Credit Agreement”). The effectiveness of the Credit Agreement is conditioned upon, among other things, the execution and delivery of this Agreement.
          Additionally, to the extent permitted by the Credit Agreement, the Grantors may from time to time enter into Pari Passu Agreements, and the Obligations owed to the holders of Pari Passu Debt may be secured hereunder on a pari passu basis with the Bank Loan Obligations. Following the incurrence by any Grantor of any Pari Passu Debt, this Agreement shall be subject to any Pari Passu Intercreditor Agreement then in effect.
          Each Guarantor is an Affiliate of the Borrower, will derive substantial benefits from the extension of credit to the Borrower pursuant to the Credit Agreement and is willing to execute and deliver this Agreement in order to induce the Lenders and the Issuing Bank to extend such credit and in consideration for credit previously extended. Parent, the Borrowers and the Subsidiary Guarantors desire to amend and


 

 

 2
restate the Existing Guarantee and Collateral Agreement in the form hereof to, among other things, reaffirm their obligations under the Existing Guarantee and Collateral Agreement and to make certain amendments thereto. Accordingly, the parties hereto agree as follows:
ARTICLE I
Definitions
          SECTION 1.01. Credit Agreement. (a) Capitalized terms used in this Agreement and not otherwise defined herein have the meanings set forth in the Credit Agreement. All capitalized terms defined in the New York UCC (as such term is defined herein) and not defined in this Agreement have the meanings specified therein. All references to the Uniform Commercial Code shall mean the New York UCC.
          (b) The rules of construction specified in Section 1.02 of the Credit Agreement also apply to this Agreement.
          SECTION 1.02. Other Defined Terms. As used in this Agreement, the following terms have the meanings specified below:
          “Accounts Receivable” shall mean all Accounts and all right, title and interest in any returned goods, together with all rights, titles, securities and guarantees with respect thereto, including any rights to stoppage in transit, replevin, reclamation and resales, and all related security interests, liens and pledges, whether voluntary or involuntary, in each case whether now existing or owned or hereafter arising or acquired.
          “Administrative Agent” shall have the meaning assigned to such term in the preliminary statement.
          “Article 9 Collateral” shall have the meaning assigned to such term in Section 4.01.
          “Bank Loan Obligations” shall mean (a) the Loan Document Obligations and (b) the due and punctual payment and performance of all obligations of each Loan Party under each Hedging Agreement or Cash Management Arrangement that (i) is in effect on the Closing Date with a counterparty that is the Administrative Agent or a Lender or an Affiliate of the Administrative Agent or a Lender as of the Closing Date or (ii) is entered into after the Closing Date with any counterparty that is the Administrative Agent or a Lender or an Affiliate of the Administrative Agent or a Lender at the time such Hedging Agreement or Cash Management Arrangement is entered into; provided, however, that the aggregate amount of obligations under Cash Management Arrangements that shall constitute “Bank Loan Obligations” hereunder shall not exceed $200,000,000 at any time.


 

3

          “Bank Loan Secured Parties” shall mean (a) the Administrative Agent, (b) the Collateral Agent, (c) any Issuing Bank, (d) the Lenders (e) each counterparty to any Hedging Agreement or Cash Management Arrangement with a Loan Party that either (i) is in effect on the Closing Date if such counterparty is the Administrative Agent, a Lender or an Affiliate of the Administrative Agent or a Lender as of the Closing Date or (ii) is entered into after the Closing Date if such counterparty is the Administrative Agent, a Lender or an Affiliate of the Administrative Agent or a Lender at the time such Hedging Agreement or Cash Management Arrangement is entered into, (f) the beneficiaries of each indemnification obligation undertaken by any Loan Party under any Loan Document and (g) the successors and permitted assigns of each of the foregoing.
          “Borrower” shall have the meaning assigned to such term in the preamble.
          “Cash Management Arrangements” shall mean overdraft protections, netting services and similar arrangements arising from treasury, depository and cash management services, any automated clearing house transfers of funds or any credit card or similar services, in each case in the ordinary course of business.
          “Collateral” shall mean the Article 9 Collateral and the Pledged Collateral.
          “Collateral Agent” shall have the meaning assigned to such term in the preamble.
          “Copyright License” shall mean any written agreement, now or hereafter in effect, granting any right to any third person under any registered copyright now or hereafter owned by any Grantor or that such Grantor otherwise has the right to license, or granting any right to any Grantor under any registered copyright now or hereafter owned by any third person, and all rights of such Grantor under any such agreement.
          “Copyrights” shall mean all of the following now owned or hereafter acquired by any Grantor: (a) all registered copyright rights in any work subject to the copyright laws of the United States or any other country, whether as author, assignee, transferee or otherwise, and (b) all registrations and applications for registration of any such copyright in the United States or any other country, including registrations, recordings, supplemental registrations and pending applications for registration in the United States Copyright Office (or any successor office or any similar office in any other country), including those registered and pending copyrights listed on Schedule VI.
          “Event of Default” shall mean any Event of Default under and as defined in (a) the Credit Agreement or (b) any Pari Passu Agreement, as the context requires, provided that any notice, lapse of time or other condition precedent to the occurrence of such Event of Default in the relevant instrument shall have been satisfied.
          “Federal Securities Laws” shall have the meaning assigned to such term in Section 5.04.


 

4

          “General Intangibles” shall mean all choses in action and causes of action and all other intangible personal property of any Grantor of every kind and nature (other than Accounts) now owned or hereafter acquired by any Grantor, including all rights and interests in partnerships, limited partnerships, limited liability companies and other unincorporated entities, corporate or other business records, indemnification claims, contract rights (including rights under leases, whether entered into as lessor or lessee, Hedging Agreements and other agreements), Intellectual Property, goodwill, registrations, franchises, tax refund claims and any letter of credit, guarantee, claim, security interest or other security held by or granted to any Grantor to secure payment by an Account Debtor of any of the Accounts.
          “Grantors” shall mean the Borrower and the Guarantors.
          “Guarantors” shall mean Parent and the Subsidiary Guarantors.
          “Intellectual Property” shall mean all intellectual property of any Grantor of every kind and nature now owned or hereafter acquired by any Grantor, including inventions, designs, Patents, Copyrights, Licenses, Trademarks, trade secrets, confidential or proprietary technical and business information, know-how, show-how or other data or information, software and databases and all embodiments or fixations thereof and related documentation and registrations, and all additions and improvements to any of the foregoing.
          “License” shall mean any Patent License, Trademark License, Copyright License or other license or sublicense agreement relating to Intellectual Property to which any Grantor is a party, including those listed on Schedule VI.
          “Loan Document Obligations” shall mean (a) the due and punctual payment of (i) the principal of and interest (including interest accruing during the pendency of any bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether allowed or allowable in such proceeding) on the Loans, when and as due, whether at maturity, by acceleration, upon one or more dates set for prepayment or otherwise, (ii) each payment required to be made by the Borrower under the Credit Agreement in respect of any Letter of Credit, when and as due, including payments in respect of reimbursement of disbursements, interest thereon and obligations to provide cash collateral, and (iii) all other monetary obligations of the Borrower to any of the Secured Parties under the Credit Agreement and each of the other Loan Documents, including fees, costs, expenses and indemnities, whether primary, secondary, direct, contingent, fixed or otherwise (including monetary obligations incurred during the pendency of any bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether allowed or allowable in such proceeding), (b) the due and punctual performance of all other obligations of the Borrower under or pursuant to the Credit Agreement and each of the other Loan Documents, and (c) the due and punctual payment and performance of all the obligations of each other Loan Party under or pursuant to this Agreement and each of the other Loan Documents.


 

5

          “New York UCC” shall mean the Uniform Commercial Code as from time to time in effect in the State of New York.
          “Obligations” shall mean (a) the Bank Loan Obligations and (b) the Pari Passu Debt Obligations.
          “Parent” shall have the meaning assigned to such term in the preamble.
          “Pari Passu Agreement” shall mean any indenture, credit agreement or other agreement, document or instrument, if any, pursuant to which any Grantor has or will incur, assume or otherwise become liable for, Pari Passu Debt Obligations; provided that, in each case, the Indebtedness and other obligations thereunder have been designated as Pari Passu Debt Obligations pursuant to and in accordance with Section 7.09(c).
          “Pari Passu Debt Obligations” shall mean all advances to, and debts, liabilities, obligations, covenants and duties of, any Grantor arising under any Pari Passu Agreement, whether direct or indirect (including those acquired by assumption), absolute or contingent, due or to become due, now existing or hereafter arising (including monetary obligations incurred during the pendency of any bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether allowed or allowable in such proceeding), in each case, that have been designated as Pari Passu Debt Obligations pursuant to and in accordance with Section 7.09(c).
          “Pari Passu Representative” shall mean, for any Series of Pari Passu Debt, the Representative named for such Series in accordance with Section 7.09(c).
          “Pari Passu Secured Parties” shall mean (a) the holders of any Pari Passu Debt Obligations and (b) any Pari Passu Representative with respect thereto.
          “Patent License” shall mean any written agreement, now or hereafter in effect, granting to any third person any right to make, use or sell any invention on which a Patent, now or hereafter owned by any Grantor or that any Grantor otherwise has the right to license, is in existence, or granting to any Grantor any right to make, use or sell any invention on which a Patent, now or hereafter owned by any third person, is in existence, and all rights of any Grantor under any such agreement.
          “Patents” shall mean all of the following now owned or hereafter acquired by any Grantor: (a) all letters patent of the United States or the equivalent thereof in any other country, all registrations and recordings thereof, and all applications for letters patent of the United States or the equivalent thereof in any other country, including registrations, recordings and pending applications in the United States Patent and Trademark Office (or any successor or any similar offices in any other country), including those listed on Schedule VI, and (b) all reissues, continuations, divisions, continuations-in-part, renewals or extensions thereof, and the inventions disclosed or claimed therein, including the right to exclude others from making, using and/or selling the inventions disclosed or claimed therein.


 

6

          “Pledged Collateral” shall have the meaning assigned to such term in Section 3.01.
          “Pledged Debt Securities” shall have the meaning assigned to such term in Section 3.01.
          “Pledged Securities” shall mean any promissory notes, stock certificates or other securities now or hereafter included in the Pledged Collateral, including all certificates, instruments or other documents representing or evidencing any Pledged Collateral.
          “Pledged Stock” shall have the meaning assigned to such term in Section 3.01.
          “Representative” shall mean (a) in the case of the Bank Loan Obligations, the Administrative Agent, and (b) in the case of any Series of Pari Passu Debt Obligations, the Representative named for such Series in accordance with Section 7.09(c).
          “Secured Parties” shall mean the Bank Loan Secured Parties and any Pari Passu Secured Parties.
          “Security Interest” shall have the meaning assigned to such term in Section 4.01.
          “Series” shall mean (a) the Bank Loan Obligations and (b) any Pari Passu Debt Obligations which are represented by a common Representative.
          “Subsidiary Guarantors” shall mean (a) the Subsidiaries identified on Schedule II hereto as Subsidiary Guarantors and (b) each other Subsidiary that becomes a party to this Agreement as a Subsidiary Guarantor after the Restatement Effective Date.
          “Trademark License” shall mean any written agreement, now or hereafter in effect, granting to any third person any right to use any trademark now or hereafter owned by any Grantor or that any Grantor otherwise has the right to license, or granting to any Grantor any right to use any trademark now or hereafter owned by any third person, and all rights of any Grantor under any such agreement.
          “Trademarks” shall mean all of the following now owned or hereafter acquired by any Grantor: (a) all registered trademarks, service marks, trade names, corporate names, company names, business names, fictitious business names, trade styles, trade dress, logos, other source or business identifiers, designs and general intangibles of like nature, now existing or hereafter adopted or acquired, all registrations and recordings thereof, and all registration and recording applications filed in connection therewith, including registrations and applications for registration (other than intent-to-use applications) in the United States Patent and Trademark Office (or any successor office) or any similar offices in any State of the United States, and all extensions or


 

7

renewals thereof, including those listed on Schedule VI, and (b) all goodwill associated therewith or symbolized thereby.
          “Unfunded Advances/Participations” shall mean (a) with respect to the Administrative Agent, the aggregate amount, if any (i) made available to the Borrower on the assumption that each Lender has made its portion of the applicable Borrowing available to the Administrative Agent as contemplated by Section 2.02(d) of the Credit Agreement and (ii) with respect to which a corresponding amount shall not in fact have been returned to the Administrative Agent by the Borrower or made available to the Administrative Agent by any such Lender, (b) with respect to the Swingline Lender, the aggregate amount, if any, of participations in respect of any outstanding Swingline Loan that shall not have been funded by the Revolving Credit Lenders in accordance with Section 2.22(e) of the Credit Agreement and (c) with respect to any Issuing Bank, the aggregate amount, if any, of participations in respect of any outstanding L/C Disbursement that shall not have been funded by the Revolving Credit Lenders in accordance with Sections 2.23(d) and 2.02(f) of the Credit Agreement.
ARTICLE II
Guarantee
          SECTION 2.01. Guarantee. Each Guarantor unconditionally guarantees, jointly with the other Guarantors and severally, as a primary obligor and not merely as a surety, the due and punctual payment and performance of the Obligations. Each Guarantor further agrees that the Obligations may be extended or renewed, in whole or in part, without notice to or further assent from it, and that it will remain bound upon its guarantee notwithstanding any extension or renewal of any Obligation, and hereby waives any provision of applicable law to the contrary that may be waived by such Guarantor. Each Guarantor waives presentment to, demand of payment from and protest to the Borrower or any other Loan Party of any Obligation, and also waives notice of acceptance of its guarantee and notice of protest for nonpayment.
          SECTION 2.02. Guarantee of Payment. Each Guarantor further agrees that its guarantee hereunder constitutes a guarantee of payment when due and not of collection, and waives any right to require that any resort be had by the Collateral Agent or any other Secured Party to any security held for the payment of the Obligations or credit on the books of the Collateral Agent or any other Secured Party in favor of the Borrower or any other person.
          SECTION 2.03. No Limitations, Etc. (a) Except for termination of a Guarantor’s obligations hereunder as expressly provided in Section 7.15, the obligations of each Guarantor hereunder shall not be subject to any reduction, limitation, impairment or termination for any reason, including any claim of waiver, release, surrender, alteration or compromise, and shall not be subject to any defense or setoff, counterclaim, recoupment or termination whatsoever by reason of the invalidity, illegality or unenforceability of the Obligations or otherwise. Without limiting the generality of the


 

8

foregoing, the obligations of each Guarantor hereunder shall not be discharged or impaired or otherwise affected by (i) the failure of the Collateral Agent or any other Secured Party to assert any claim or demand or to enforce any right or remedy under the provisions of any Pari Passu Agreement, any Loan Document or otherwise, (ii) any rescission, waiver, amendment or modification of, or any release from any of the terms or provisions of, any Pari Passu Agreement, any Loan Document or any other agreement, including with respect to any other Guarantor under this Agreement, (iii) the release of, or any impairment of or failure to perfect any Lien on or security interest in, any security held by the Collateral Agent or any other Secured Party for the Obligations or any of them, (iv) any default, failure or delay, wilful or otherwise, in the performance of the Obligations or (v) any other act or omission that may or might in any manner or to any extent vary the risk of any Guarantor or otherwise operate as a discharge of any Guarantor as a matter of law or equity (other than the indefeasible payment in full in cash of all the Obligations (other than unasserted contingent indemnity obligations)). To the fullest extent permitted by applicable law, each Guarantor expressly authorizes the Collateral Agent to take and hold security for the payment and performance of the Obligations, to exchange, waive or release any or all such security (with or without consideration), to enforce or apply such security and direct the order and manner of any sale thereof in its sole discretion or to release or substitute any one or more other guarantors or obligors upon or in respect of the Obligations, all without affecting the obligations of any Guarantor hereunder.
          (b) To the fullest extent permitted by applicable law, each Guarantor waives any defense based on or arising out of any defense of the Borrower or any other Loan Party or the unenforceability of the Obligations or any part thereof from any cause, or the cessation from any cause of the liability of the Borrower or any other Loan Party, other than the payment in full in cash of all the Obligations. To the fullest extent permitted by applicable law, upon the occurrence and during the continuance of an Event of Default, the Collateral Agent and the other Secured Parties may, at their election, foreclose on any security held by one or more of them by one or more judicial or nonjudicial sales, accept an assignment of any such security in lieu of foreclosure, compromise or adjust any part of the Obligations, make any other accommodation with the Borrower or any other Loan Party or exercise any other right or remedy available to them against the Borrower or any other Loan Party, without adversely affecting or impairing in any way the liability of any Guarantor hereunder except to the extent the Obligations have been paid in full in cash. To the fullest extent permitted by applicable law, each Guarantor waives any defense arising out of any such election even though such election operates, pursuant to applicable law, to impair or to extinguish any right of reimbursement or subrogation or other right or remedy of such Guarantor against the Borrower or any other Loan Party, as the case may be, or any security.
          SECTION 2.04. Reinstatement. Each Guarantor agrees that its guarantee hereunder shall continue to be effective or be reinstated, as the case may be, if at any time payment, or any part thereof, of any Obligation is rescinded or must otherwise be restored by the Collateral Agent or any other Secured Party upon the bankruptcy or reorganization of the Borrower, any other Loan Party or otherwise.


 

9

          SECTION 2.05. Agreement To Pay; Subrogation. In furtherance of the foregoing and not in limitation of any other right that the Collateral Agent or any other Secured Party has at law or in equity against any Guarantor by virtue hereof, upon the failure of the Borrower or any other Loan Party to pay any Obligation owed by such party when and as the same shall become due, whether at maturity, by acceleration, after notice of prepayment or otherwise, each Guarantor hereby promises to and will, promptly upon written notice thereof from the Collateral Agent, forthwith pay, or cause to be paid, to the Collateral Agent for distribution to the applicable Secured Parties in cash the amount of such unpaid Obligation. Upon payment by any Guarantor of any sums to the Collateral Agent as provided above, all rights of such Guarantor against the Borrower or any other Guarantor arising as a result thereof by way of right of subrogation, contribution, reimbursement, indemnity or otherwise shall in all respects be subject to Article VI.
          SECTION 2.06. Information. Each Guarantor assumes all responsibility for being and keeping itself informed of the Borrower’s and each other Loan Party’s financial condition and assets and of all other circumstances bearing upon the risk of nonpayment of the Obligations and the nature, scope and extent of the risks that such Guarantor assumes and incurs hereunder, and agrees that neither the Collateral Agent nor any other Secured Party will have any duty to advise such Guarantor of information known to it or any of them regarding such circumstances or risks.
ARTICLE III
Pledge of Securities
          SECTION 3.01. Pledge. (a) As security for the payment or performance, as the case may be, in full of the Obligations, each Grantor hereby assigns and pledges to the Collateral Agent, its successors and permitted assigns, for the ratable benefit of the Secured Parties, and hereby grants to the Collateral Agent, its successors and permitted assigns, for the ratable benefit of the Secured Parties, a security interest in, all of such Grantor’s right, title and interest in, to and under (a)(i) the Equity Interests owned by such Grantor on the date hereof (including all such Equity Interests listed on Schedule III), (ii) any other Equity Interests obtained in the future by such Grantor and (iii) the certificates representing all such Equity Interests (all the foregoing collectively referred to herein as the “Pledged Stock”); (provided, however, that the Pledged Stock shall not include (A) more than 65% of the outstanding voting Equity Interests in any Foreign Subsidiary, (B) any Equity Interest in any Non-Significant Subsidiary, (C) any Equity Interest in any Permitted Syndication Subsidiary, any Securitization Subsidiary or any Permitted Joint Venture Subsidiary to the extent the pledge of the Equity Interest in such Subsidiary is prohibited by any applicable Contractual Obligation or requirement of law), or (D) any minority Equity Interests, (b)(i) the debt securities held by such Grantor on the date hereof (including all such debt securities listed opposite the name of such Grantor on Schedule III), (ii) any debt securities in the future issued to such Grantor and (iii) the promissory notes and any other instruments evidencing such debt securities (excluding any promissory notes issued by employees of any Grantor) (all the foregoing collectively referred to herein as the “Pledged Debt Securities”), (c) all other property


 

10

that may be delivered to and held by the Collateral Agent pursuant to the terms of this Section 3.01, (d) subject to Section 3.06, all payments of principal or interest, dividends, cash, instruments and other property from time to time received, receivable or otherwise distributed in respect of, in exchange for or upon the conversion of, and all other Proceeds received in respect of, the securities referred to in clauses (a) and (b) above, (e) subject to Section 3.06, all rights and privileges of such Grantor with respect to the securities and other property referred to in clauses (a), (b), (c) and (d) above, and (f) all Proceeds of any of the foregoing (the items referred to in clauses (a) through (f) above being collectively referred to as the “Pledged Collateral”).
          (b) Notwithstanding anything herein to the contrary, in the event that a registration statement with respect to any Series of Pari Passu Debt has been filed with the SEC and is effective, the “Pledged Stock” securing any such Series shall, at all times while such registration statement remains effective, automatically be deemed not to include any Equity Interests which, if pledged to secure such Series, would require the Borrower to file separate financial statements for any Subsidiary with the SEC. The limitation provided for in this paragraph (b) shall not be applied to the Bank Loan Obligations or to any Series of Pari Passu Debt for which no such registration statement has been filed or is effective.
          TO HAVE AND TO HOLD the Pledged Collateral, together with all right, title, interest, powers, privileges and preferences pertaining or incidental thereto, unto the Collateral Agent, its successors and permitted assigns, for the ratable benefit of the Secured Parties, forever; subject, however, to the terms, covenants and conditions hereinafter set forth.
          SECTION 3.02. Delivery of the Pledged Collateral. (a) Each Grantor agrees promptly to deliver or cause to be delivered to the Collateral Agent any and all certificates, promissory notes, instruments or other documents representing or evidencing Pledged Securities (other than Pledged Debt Securities with a face amount less than $1,000,000).
          (b) Each Grantor agrees promptly to deliver or cause to be delivered to the Collateral Agent any and all Pledged Debt Securities with a face amount in excess of $1,000,000.
          (c) Upon delivery to the Collateral Agent, (i) any certificate, instrument or document representing or evidencing Pledged Securities shall be accompanied by undated stock powers duly executed in blank or other undated instruments of transfer satisfactory to the Collateral Agent and duly executed in blank and by such other instruments and documents as the Collateral Agent may reasonably request and (ii) all other property comprising part of the Pledged Collateral shall be accompanied by proper instruments of assignment duly executed by the applicable Grantor and such other instruments or documents as the Collateral Agent may reasonably request. Each delivery of Pledged Securities shall be accompanied by a schedule describing the applicable securities, which schedule shall be attached hereto as Schedule III and made a part hereof; provided that failure to attach any such schedule hereto shall not affect the


 

11

validity of the pledge of such Pledged Securities. Each schedule so delivered shall supplement any prior schedules so delivered.
          SECTION 3.03. Representations, Warranties and Covenants. The Grantors jointly and severally represent, warrant and covenant to and with the Collateral Agent, for the benefit of the Secured Parties, that:
     (a) As of the Restatement Effective Date, Schedule III correctly sets forth the percentage of the issued and outstanding shares of each class of the Equity Interests of the issuer thereof represented by such Pledged Stock and includes all Equity Interests, debt securities and promissory notes required to be pledged hereunder (to the extent not waived or extended in accordance with the terms of the Credit Agreement);
     (b) as of the Restatement Effective Date, Schedule IV correctly sets forth all promissory notes and other evidence of indebtedness required to be pledged hereunder including all intercompany notes between Parent and any subsidiary of Parent and any subsidiary of Parent and any other such subsidiary;
     (c) the Pledged Stock and Pledged Debt Securities have been duly and validly authorized and issued by the issuers thereof and (i) in the case of Pledged Stock, are fully paid and nonassessable and (ii) in the case of Pledged Debt Securities, are legal, valid and binding obligations of the issuers thereof;
     (d) except for the security interests granted hereunder (or otherwise permitted under the Credit Agreement or the other Loan Documents), each Grantor (i) is and, subject to any transfers made in compliance with the Credit Agreement, will continue to be the direct owner, beneficially and of record, of the Pledged Securities indicated on Schedule III as owned by such Grantor, (ii) holds the same free and clear of all Liens other than Liens permitted by Section 6.02 of the Credit Agreement, and (iii) will not create or permit to exist any security interest in or other Lien on, the Pledged Collateral, other than transfers made in compliance with the Credit Agreement or the other Loan Documents;
     (e) except for restrictions and limitations imposed by any Pari Passu Agreement, the Loan Documents or securities or other laws generally, the Pledged Collateral is and will continue to be freely transferable and assignable, and none of the Pledged Collateral is or will be subject to any option, right of first refusal, shareholders agreement, charter or by-law provisions or contractual restriction of any nature that might prohibit, impair, delay or otherwise affect the pledge of such Pledged Collateral hereunder, the sale or disposition thereof pursuant hereto or the exercise by the Collateral Agent of rights and remedies hereunder other than Liens permitted by Section 6.02 of the Credit Agreement;
     (f) each Grantor (i) has the power and authority to pledge the Pledged Collateral pledged by it hereunder in the manner hereby done or contemplated and (ii) will defend its title or interest thereto or therein against any and all Liens (other than any


 

12

Lien created or permitted by the Loan Documents or any Pari Passu Agreement), however arising, of all persons whomsoever;
     (g) no material consent or approval of any Governmental Authority or, any securities exchange was or is necessary to the validity of the pledge effected hereby (other than such as have been obtained and are in full force and effect);
     (h) by virtue of the execution and delivery by each Grantor of this Agreement, when any Pledged Securities are delivered to the Collateral Agent in accordance with this Agreement, the Collateral Agent will obtain a legal, valid and perfected first priority lien upon and security interest in such Pledged Securities as security for the payment and performance of the Obligations; and
     (i) the pledge effected hereby is effective to vest in the Collateral Agent, for the ratable benefit of the Secured Parties, the rights of the Collateral Agent in the Pledged Collateral as set forth herein.
          SECTION 3.04. Certification of Limited Liability Company Interests and Limited Partnership Interests. If any Pledged Collateral is not a security pursuant to Section 8-103 of the UCC, no Grantor shall take any action that, under such Section, converts such Pledged Collateral into a security without causing the issuer thereof to issue to it certificates or instruments evidencing such Pledged Collateral, which it shall promptly deliver to the Collateral Agent as provided in Section 3.02.
          SECTION 3.05. Registration in Nominee Name; Denominations. The Collateral Agent, on behalf of the Secured Parties, shall have the right (in its sole and absolute discretion), upon the occurrence and during the continuance of an Event of Default, to hold the Pledged Securities in its own name as pledgee, the name of its nominee (as pledgee or as sub-agent) or the name of the applicable Grantor, endorsed or assigned in blank or in favor of the Collateral Agent. Each Grantor will promptly give to the Collateral Agent copies of any material written notices or other material written communications received by it with respect to Pledged Securities in its capacity as the registered owner thereof. After the occurrence and during the continuance of an Event of Default, the Collateral Agent shall at all times have the right to exchange the certificates representing Pledged Securities for certificates of smaller or larger denominations for any purpose consistent with this Agreement.
          SECTION 3.06. Voting Rights; Dividends and Interest, Etc. (a) Unless and until an Event of Default shall have occurred and be continuing and the Collateral Agent shall have given the Grantors notice of its intent to exercise its rights under this Agreement (which notice shall be deemed to have been given immediately upon the occurrence of an Event of Default under paragraph (g) or (h) of Article VII of the Credit Agreement):
     (i) Each Grantor shall be entitled to exercise any and all voting and/or other consensual rights and powers inuring to an owner of Pledged Securities or any part thereof for any purpose consistent with the terms of


 

13

this Agreement, the Credit Agreement and the other Loan Documents; provided, however, that such rights and powers shall not be exercised in any manner that could reasonably be expected to materially and adversely affect the rights inuring to a holder of any Pledged Securities or the rights and remedies of any of the Collateral Agent or the other Secured Parties under this Agreement, any Pari Passu Agreement, the Credit Agreement or any other Loan Document or the ability of the Secured Parties to exercise the same.
     (ii) The Collateral Agent shall execute and deliver to each Grantor, or cause to be executed and delivered to each Grantor, all such proxies, powers of attorney and other instruments as such Grantor may reasonably request for the purpose of enabling such Grantor to exercise the voting and/or consensual rights and powers it is entitled to exercise pursuant to paragraph (i) above.
     (iii) Each Grantor shall be entitled to receive and retain any and all dividends, interest, principal and other distributions paid on or distributed in respect of the Pledged Securities to the extent and only to the extent that such dividends, interest, principal and other distributions are permitted by, and otherwise paid or distributed in accordance with, the terms and conditions of the Credit Agreement, the other Loan Documents, and any Pari Passu Agreement, and applicable law; provided, however, that any noncash dividends, interest, principal or other distributions that would constitute Pledged Stock or Pledged Debt Securities, whether resulting from a subdivision, combination or reclassification of the outstanding Equity Interests of the issuer of any Pledged Securities or received in exchange for Pledged Securities or any part thereof, or in redemption thereof, or as a result of any merger, consolidation, acquisition or other exchange of assets to which such issuer may be a party or otherwise, shall be and become part of the Pledged Collateral, and, if received by any Grantor, shall not be commingled by such Grantor with any of its other funds or property but shall be held separate and apart therefrom, shall be held in trust for the ratable benefit of the Secured Parties and shall be forthwith delivered to the Collateral Agent in the same form as so received (with any necessary endorsement or instrument of assignment). This paragraph (iii) shall not apply to dividends between or among the Borrower, the Guarantors and any Subsidiaries only of property subject to a perfected security interest under this Agreement.
          (b) To the fullest extent permitted by applicable law, upon the occurrence and during the continuance of an Event of Default, after the Collateral Agent shall have notified (or shall be deemed to have notified pursuant to Section 3.06(a)) the Grantors of the suspension of their rights under paragraph (a)(iii) of this Section 3.06, then all rights of any Grantor to dividends, interest, principal or other distributions that such Grantor is authorized to receive pursuant to paragraph (a)(iii) of this Section 3.06 shall cease, and all such rights shall thereupon become vested in the Collateral Agent, which shall have the


 

14

sole and exclusive right and authority to receive and retain such dividends, interest, principal or other distributions. All dividends, interest, principal or other distributions received by any Grantor contrary to the provisions of this Section 3.06 shall be held in trust for the benefit of the Collateral Agent, shall be segregated from other property or funds of such Grantor and shall be forthwith delivered to the Collateral Agent upon demand in the same form as so received (with any necessary endorsement or instrument of assignment). Any and all money and other property paid over to or received by the Collateral Agent pursuant to the provisions of this paragraph (b) shall be retained by the Collateral Agent in an account to be established by the Collateral Agent upon receipt of such money or other property and shall be applied in accordance with the provisions of Section 5.02. After all Events of Default have been cured or waived and each applicable Grantor has delivered to the Administrative Agent certificates to that effect, the Collateral Agent shall, promptly after all such Events of Default have been cured or waived, repay to each applicable Grantor (without interest) all dividends, interest, principal or other distributions that such Grantor would otherwise be permitted to retain pursuant to the terms of paragraph (a)(iii) of this Section 3.06 and that remain in such account.
          (c) Upon the occurrence and during the continuance of an Event of Default, after the Collateral Agent shall have notified (or shall be deemed to have notified pursuant to Section 3.06(a)) the Grantors of the suspension of their rights under paragraph (a)(i) of this Section 3.06, then all rights of any Grantor to exercise the voting and consensual rights and powers it is entitled to exercise pursuant to paragraph (a)(i) of this Section 3.06, and the obligations of the Collateral Agent under paragraph (a)(ii) of this Section 3.06, shall cease, and, subject to compliance with any applicable healthcare laws, all such rights shall thereupon become vested in the Collateral Agent, which shall have the sole and exclusive right and authority to exercise such voting and consensual rights and powers; provided that, unless otherwise directed by the Required Lenders, the Collateral Agent shall have the right from time to time following and during the continuance of an Event of Default to permit the Grantors to exercise such rights. After all Events of Default have been cured or waived and each applicable Grantor has delivered to the Administrative Agent a certificate to that effect, such voting and consensual rights shall automatically vest in the applicable Grantor, and the Collateral Agent shall (1) take such steps reasonably requested by the applicable Grantor, at such Grantor’s expense, to allow all Pledged Securities registered under its name to be registered under the name of the applicable Grantor and (2) promptly repay to each applicable Grantor (without interest) all dividends, interest, principal or other distributions that such Grantor would otherwise have been permitted to retain pursuant to the terms of paragraph (a) of this Section 3.06 that were not applied to repay the Obligations.
          (d) Any notice given by the Collateral Agent to the Grantors exercising its rights under paragraph (a) of this Section 3.06 (i) may be given by telephone if promptly confirmed in writing, (ii) may be given to one or more of the Grantors at the same or different times and (iii) may suspend the rights of the Grantors under paragraph (a)(i) or paragraph (a)(iii) in part without suspending all such rights (as specified by the Collateral Agent in its sole and absolute discretion) and without waiving or otherwise affecting the


 

15

Collateral Agent’s rights to give additional notices from time to time suspending other rights so long as an Event of Default has occurred and is continuing.
ARTICLE IV
Security Interests in Personal Property
          SECTION 4.01. Security Interest. (a) As security for the payment or performance, as the case may be, in full of the Obligations, each Grantor hereby assigns and pledges to the Collateral Agent, its successors and permitted assigns, for the ratable benefit of the Secured Parties, and hereby grants to the Collateral Agent, its successors and permitted assigns, for the ratable benefit of the Secured Parties, a security interest (the “Security Interest”), in all right, title or interest in or to any and all of the following assets and properties now owned or at any time hereafter acquired by such Grantor or in which such Grantor now has or at any time in the future may acquire any right, title or interest (collectively, the “Article 9 Collateral”):
     (i) all Accounts;
     (ii) all Chattel Paper;
     (iii) all Documents;
     (iv) all Equipment;
     (v) all General Intangibles;
     (vi) all Instruments;
     (vii) all Inventory;
     (viii) all Investment Property;
     (ix) all Letter-of-Credit Rights;
     (x) all Commercial Tort Claims;
     (xi) all books and records pertaining to the Article 9 Collateral; and
     (xii) to the extent not otherwise included, all Proceeds and products of any and all of the foregoing and all collateral security and guarantees given by any person with respect to any of the foregoing.
          Notwithstanding anything herein to the contrary, in no event shall the Collateral include, and no Grantor shall be deemed to have granted a security interest in any (I) General Intangible, Instrument, license, property right, permit or any other contract or agreement to which a Grantor is a party or any of its rights or interests thereunder if and for so long as the grant of such security interest shall constitute or result


 

16

in (x) the abandonment, invalidation or unenforceability of any right, title or interest of the Grantor therein, (y) a violation of a valid and enforceable restriction in respect of such General Intangible, Instrument, license, property right, permit or any other contract or agreement or other such rights (1) in favor of a third party or (2) under any law, regulation, permit, order or decree of any Governmental Authority or (z) a breach or termination (or result in any party thereto having the right to terminate) pursuant to the terms of, or a default under, such General Intangible, Instrument, license, property right, permit or any other contract or agreement (other than to the extent that any such term would be rendered ineffective pursuant to Section 9-406, 9-407, 9-408 or 9-409 of the New York UCC or any other applicable law or principles of equity); provided, however, that such security interest shall attach immediately at such time as the condition causing such abandonment, invalidation, unenforceability or breach or termination, as the case may be, shall be remedied and, to the extent severable, shall attach immediately to any portion of such General Intangible, Instrument, license, property right, permit or any other contract or agreement that does not result in any of the consequences specified in the immediately preceding clause (x), (y) or (z) including, any proceeds of such General Intangible, Instrument, license, property rights, permit or any other contract or agreement; (II) more than 65% of the outstanding voting Equity Interests in any Foreign Subsidiary, (III) any Equity Interest in any Non-Significant Subsidiary, (IV) any Equity Interest in any Permitted Syndication Subsidiary, any Securitization Subsidiary or any Permitted Joint Venture Subsidiary to the extent the pledge of the Equity Interest in such Subsidiary is prohibited by any applicable Contractual Obligation or requirement of law, (V) any vehicle or other asset subject to certificate of title, (VI) any asset that requires perfection through control agreements (including, to the extent required in the relevant jurisdiction for deposit accounts and investment property), (VII) any minority Equity Interests, (VIII) any assets with respect to which the Collateral Agent shall reasonably determine that the cost of creating and/or perfecting a security interest therein is excessive in relation to the benefit to the Secured Parties or that the granting or perfection of a security interest therein would violate applicable law or regulation, (IX) any assets (other than any General Intangible, Instrument, license, property right, permit or any other contract or agreement) owned by any Grantor that are subject to a Lien permitted by Section 6.02(c) or (n) of the Credit Agreement, to the extent and for so long as such Lien exists and the terms of the Indebtedness or other obligations secured thereby prevent the grant of a security interest in such assets hereunder and (X) in the event that a registration statement with respect to any Series of Pari Passu Debt Obligations has been filed with the SEC and is effective, solely with respect to such Series, any Equity Interests which, if part of the Collateral securing such Series, would require the Borrower to file separate financial statements for any Subsidiary with the SEC (but, for the avoidance of doubt, such Equity Interests shall at all times continue to secure the Bank Loan Obligations and all other Series to the extent provided for in this Agreement).
          (b) Each Grantor hereby irrevocably authorizes the Collateral Agent at any time and from time to time to file in any relevant jurisdiction any initial financing statements (including fixture filings) with respect to the Article 9 Collateral or any part thereof and amendments thereto that (i) indicate the Article 9 Collateral as “all assets” of such Grantor or words of similar effect, and (ii) contain the information required by Article 9 of the Uniform Commercial Code of each applicable jurisdiction for the filing


 

17

of any financing statement or amendment, including (A) whether such Grantor is an organization, the type of organization and any organizational identification number issued to such Grantor and (B) in the case of a financing statement filed as a fixture filing, a sufficient description of the real property to which such Article 9 Collateral relates. Each Grantor agrees to provide such information to the Collateral Agent promptly upon request.
          (c) Each Grantor also ratifies its authorization for the Collateral Agent to file in any relevant jurisdiction any initial financing statements or amendments thereto if filed prior to the Restatement Effective Date.
          The Collateral Agent is further authorized to file with the United States Patent and Trademark Office or United States Copyright Office (or any successor office) such documents as may be necessary or advisable for the purpose of perfecting, confirming, continuing, enforcing or protecting the Security Interest granted by each Grantor, without the signature of any Grantor, and naming any Grantor or the Grantors as debtors and the Collateral Agent as secured party.
          (d) The Security Interest is granted as security only and shall not subject the Collateral Agent or any other Secured Party to, or in any way alter or modify, any obligation or liability of any Grantor with respect to or arising out of the Article 9 Collateral.
          SECTION 4.02. Representations and Warranties. The Grantors jointly and severally represent and warrant to the Collateral Agent and the Secured Parties that:
     (a) Each Grantor has good and valid rights in and marketable title to the Article 9 Collateral with respect to which it has purported to grant a Security Interest hereunder and has full power and authority to grant to the Collateral Agent, for the ratable benefit of the Secured Parties, the Security Interest in such Article 9 Collateral pursuant hereto and to execute, deliver and perform its obligations in accordance with the terms of this Agreement, without the consent or approval of any other person other than any consent or approval that has been obtained or any other consent where the failure to obtain such consent could not reasonably be expected to have a Material Adverse Effect.
     (b) The Schedules attached hereto have been duly prepared and completed and the information set forth therein (including (x) the exact legal name of each Grantor in Schedule I and (y) the jurisdiction of organization of each Grantor in Schedule I) is true and correct in all material respects as of the Restatement Effective Date. Uniform Commercial Code financing statements (including fixture filings, as applicable) or other appropriate filings, recordings or registrations containing a description of the Article 9 Collateral have been prepared by the Collateral Agent based upon the information provided to the Administrative Agent and the Secured Parties in the applicable Schedules attached hereto for filing in each governmental, municipal or other office specified in Schedule I (or specified by notice from the Borrower to the Administrative Agent after the Restatement Effective Date in the case of filings, recordings or registrations required by Sections 5.06 or 5.12 of the Credit Agreement), which are all the filings, recordings


 

18

and registrations (other than filings required to be made in the United States Patent and Trademark Office and the United States Copyright Office in order to perfect the Security Interest in the Article 9 Collateral consisting of United States Patents, Trademarks and Copyrights (to the extent that perfection can be achieved by such filings)) that are necessary to publish notice of and protect the validity of and to establish a legal, valid and perfected security interest in favor of the Collateral Agent (for the ratable benefit of the Secured Parties) in respect of all Article 9 Collateral in which the Security Interest may be perfected by filing, recording or registration in the United States (or any political subdivision thereof) and its territories and possessions, and no further or subsequent filing, refiling, recording, rerecording, registration or reregistration is necessary in any such jurisdiction, except as provided under applicable law with respect to the filing of continuation statements. Each Grantor represents and warrants that a fully executed short form agreement in form and substance reasonably satisfactory to the Collateral Agent, and containing a description of all Article 9 Collateral consisting of pending and issued United States Patents and United States Trademarks and United States Copyrights will be delivered to the Collateral Agent as of or prior to the Restatement Effective Date for timely recording with the United States Patent and Trademark Office and the United States Copyright Office pursuant to 35 U.S.C. §261, 15 U.S.C. §1060 or 17 U.S.C. §205 and the regulations thereunder.
     (c) As of the Restatement Effective Date, Schedule I correctly sets forth (i) the exact legal name of each Grantor, as such name appears in its respective certificate of formation; (ii) the jurisdiction of formation of each Grantor that is a registered organization; (iii) the Organizational Identification Number, if any, issued by the jurisdiction of formation of each Grantor that is a registered organization; (iv) the chief executive office of each Grantor; and (v) all locations where Grantor maintains any material books or records relating to any Accounts Receivables.
     (d) As of the Restatement Effective Date, Schedule V correctly sets forth, with respect to each Mortgaged Property, (i) the exact name of the person that owns such property as such name appears in its certificate of formation or other organizational document; (ii) if different from the name identified pursuant to clause (i), the exact name of the current record owner of such property reflected in the records of the filing office for such property identified pursuant to the following clause (iii); and (iii) the filing office in which a mortgage with respect to such property must be filed or recorded in order for the Collateral Agent to obtain a perfected security interest therein.
     (e) As of the Restatement Effective Date, Schedule VI correctly sets forth, in proper form for filing with (a) the United States Patent and Trademark Office a list of each issued and pending Patents and Trademarks, including, as applicable, the name of the registered owner and the registration number of each Patent and Trademark owned by any Grantor and (b) the United States Copyright Office a list of each Copyright, including the name of the registered owner and the registration number of each Copyright owned by any Grantor.
     (f) The Security Interest constitutes (i) a legal and valid security interest in all Article 9 Collateral securing the payment and performance of the Obligations, (ii) subject


 

19

to the qualifications and filings described in Section 4.02(b) (including payment of applicable fees in connection therewith), a perfected security interest in all Article 9 Collateral in which and to the extent a security interest may be perfected by filing, recording or registering a financing statement or analogous document in the United States (or any political subdivision thereof) and its territories and possessions pursuant to the Uniform Commercial Code or other applicable law in such jurisdictions and (iii) a security interest that shall be perfected in all Article 9 Collateral in which a security interest may be perfected upon the receipt and recording of this Agreement with the United States Patent and Trademark Office and the United States Copyright Office, as applicable. The Security Interest is and shall be prior to any other Lien on any of the Article 9 Collateral, other than Liens expressly permitted pursuant to Section 6.02 of the Credit Agreement or the other Loan Documents that have priority as a matter of law.
     (g) The Article 9 Collateral is owned by the Grantors free and clear of any Lien, except for Liens expressly permitted pursuant to Section 6.02 of the Credit Agreement or the other Loan Documents. No Grantor has filed or consented to the filing of (i) any financing statement or analogous document under the Uniform Commercial Code or any other applicable laws covering any Article 9 Collateral, (ii) any assignment in which any Grantor assigns any Collateral or any security agreement or similar instrument covering any Article 9 Collateral with the United States Patent and Trademark Office or the United States Copyright Office, (iii) any notice under the Assignment of Claims Act, or (iv) any assignment in which any Grantor assigns any Article 9 Collateral or any security agreement or similar instrument covering any Article 9 Collateral with any foreign governmental, municipal or other office, which financing statement or analogous document, assignment, security agreement or similar instrument is still in effect, except, in each case, for Liens expressly permitted pursuant to Section 6.02 of the Credit Agreement or the other Loan Documents. As of the Restatement Effective Date, no Grantor holds any Commercial Tort Claims in an amount in excess of $5,000,000 except as indicated on Schedule VII.
          SECTION 4.03. Covenants. (a) Each Grantor agrees promptly to notify the Collateral Agent in writing of any change in (i) its legal name and/or address, (ii) its identity or type of organization or corporate structure, (iii) its Federal Taxpayer Identification Number or organizational identification number or (iv) its jurisdiction of organization. Each Grantor agrees promptly to provide the Collateral Agent with certified organizational documents reflecting any of the changes described in the first sentence of this paragraph. Each Grantor agrees not to effect or permit any change referred to in the preceding sentence unless all filings have been made under the Uniform Commercial Code or otherwise that are required in order for the Collateral Agent to continue at all times following such change to have a valid, legal and perfected first priority security interest in all the Article 9 Collateral. Each Grantor agrees promptly to notify the Collateral Agent if any material portion of the Article 9 Collateral owned or held by such Grantor is damaged or destroyed.
          (b) Each Grantor agrees to maintain, at its own cost and expense, such complete and accurate records (in all material respects) with respect to the Article 9 Collateral owned by it as is consistent with its current practices and in accordance with


 

20

such prudent and standard practices used in industries that are the same as or similar to those in which such Grantor is engaged, but in any event to include complete accounting records (in all material respects) indicating all material payments and proceeds received with respect to any part of the Article 9 Collateral.
          (c) Each year, at the time of delivery of annual financial statements with respect to the preceding fiscal year pursuant to Section 5.04(a) of the Credit Agreement, the Borrower shall deliver to the Collateral Agent a certificate executed by a Responsible Officer of the Borrower setting forth in the format of Schedule VI all Intellectual Property of any Grantor in existence on the date thereof that, if it had existed on the Restatement Effective Date, would have been required to be listed in such Schedule, and not then listed on such Schedules or previously so identified to the Collateral Agent.
          (d) Each Grantor shall, at its own expense, take any and all commercially reasonable actions necessary to defend title to the Article 9 Collateral against all persons and to defend the Security Interest of the Collateral Agent in the Article 9 Collateral and the priority thereof against any Lien not expressly permitted pursuant to Section 6.02 of the Credit Agreement.
          (e) Each Grantor agrees, at its own expense, promptly to execute, acknowledge, deliver and cause to be duly filed all such further instruments and documents and take all such actions as the Collateral Agent may from time to time reasonably request to obtain, preserve, protect and perfect (to the extent that perfection can be achieved under any applicable law by such filings and actions) the Security Interest and the rights and remedies created hereby, including the payment of any fees and Taxes required in connection with the execution and delivery of this Agreement, the granting of the Security Interest and the filing of any financing or continuation statements (including fixture filings) or other documents in connection herewith or therewith. If any amount payable to any Grantor under or in connection with any of the Article 9 Collateral shall be or become evidenced by any promissory note or other instrument with a face amount in excess of $1,000,000, such note or instrument shall be promptly pledged and delivered to the Collateral Agent, duly endorsed in a manner reasonably satisfactory to the Collateral Agent.
          Without limiting the generality of the foregoing, each Grantor hereby authorizes the Collateral Agent, with prompt notice thereof to the Grantors, to supplement this Agreement by supplementing Schedule VI or adding additional schedules hereto to identify specifically any asset or item of a Grantor that may, in the Collateral Agent’s reasonable judgment, constitute Copyrights, Licenses, Patents or Trademarks; provided that any Grantor shall have the right, exercisable within 30 days after it has been notified by the Collateral Agent of the specific identification of such Collateral, to advise the Collateral Agent in writing of any inaccuracy of the representations and warranties made by such Grantor hereunder with respect to such Collateral. Each Grantor agrees that it will use its commercially reasonable efforts to take such action as shall be necessary, and which the Collateral Agent may from time to time reasonably request, in order that all representations and warranties hereunder shall be true and correct in all material respects with respect to such Collateral within 45 days


 

21

after the date it has been notified by the Collateral Agent of the specific identification of such Collateral and any such request.
          (f) The Collateral Agent and such persons as the Collateral Agent may designate shall have the right to inspect, subject to a reasonable prior notice to each Grantor, the Article 9 Collateral, all records related thereto (and to make extracts and copies from such records) and the premises upon which any of the Article 9 Collateral is located, to discuss the applicable Grantor’s affairs with the officers of such Grantor and its independent accountants and to verify the existence, validity, amount, quality, quantity, value, condition and status of, or any other matter relating to, the Article 9 Collateral, including, in the case of Accounts or other Article 9 Collateral in the possession of any third person, after the occurrence and during the continuance of an Event of Default, by contacting Account Debtors or the third person possessing such Article 9 Collateral for the purpose of making such a verification, subject in each case to the requirements of applicable law, including healthcare laws, data privacy and third party confidentiality obligations all at the expense of the Borrower; provided that, excluding any such visits and inspections during the continuation of an Event of Default, only one such visit during any fiscal year shall be at the Borrower’s expense. The Collateral Agent shall have the absolute right to share any information it gains from such inspection or verification with any Secured Party, subject in each case to the requirements of applicable law, including healthcare laws, data privacy and third party confidentiality obligations.
          (g) At its option, upon the occurrence and during the continuation of a Default or an Event of Default, the Collateral Agent may with five Business Days’, prior written notice to the relevant Grantor discharge past due Taxes, assessments, charges, fees, Liens, security interests or other encumbrances at any time levied or placed on the Article 9 Collateral and not expressly permitted pursuant to Section 5.03 or Section 6.02 of the Credit Agreement, and may pay for the maintenance and preservation of the Article 9 Collateral to the extent any Grantor fails to do so as required by the Credit Agreement or this Agreement, and each Grantor jointly and severally agrees to reimburse the Collateral Agent within five Business Days after written demand for any reasonable payment made or any reasonable expense incurred by the Collateral Agent pursuant to the foregoing authorization; provided, however, that nothing in this paragraph shall be interpreted as excusing any Grantor from the performance of, or imposing any obligation on the Collateral Agent or any Secured Party to cure or perform, any covenants or other promises of any Grantor with respect to Taxes, assessments, charges, fees, Liens, security interests or other encumbrances and maintenance as set forth herein or in the other Loan Documents.
          (h) If at any time any Grantor shall take a security interest in any property of an Account Debtor or any other person valued in excess of $1,000,000 to secure payment and performance of an Account, such Grantor shall promptly assign such security interest to the Collateral Agent for the ratable benefit of the Secured Parties. Such assignment need not be filed of public record unless necessary to continue the perfected status of the security interest against creditors of and transferees from the Account Debtor or other person granting the security interest.


 

22

          (i) Except to the extent otherwise expressly agreed by the Collateral Agent, each Grantor shall remain liable to observe and perform all the conditions and obligations to be observed and performed by it under each contract, agreement or instrument relating to the Article 9 Collateral, all in accordance with the terms and conditions thereof, and each Grantor jointly and severally agrees to indemnify and hold harmless the Collateral Agent and the Secured Parties from and against any and all liability for such performance in accordance with Section 7.06 of this Agreement.
          (j) No Grantor shall make or permit to be made an assignment, pledge or hypothecation of the Article 9 Collateral or shall grant any other Lien in respect of the Article 9 Collateral or permit any notice to be filed under the Assignment of Claims Act, except, in each case, as expressly permitted by Section 6.02 of the Credit Agreement. No Grantor shall make or permit to be made any transfer of the Article 9 Collateral, except as permitted by the Credit Agreement.
          (k) No Grantor will, without the Collateral Agent’s prior written consent, grant any extension of the time of payment of any Accounts included in the Article 9 Collateral, compromise, compound or settle the same for less than the full amount thereof (unless the aggregate amount of such compromised or settled Accounts in any fiscal year is not in excess of $5,000,000), release, wholly or partly, any person liable for the payment thereof (unless the aggregate amount of such compromised or settled Accounts in any fiscal year is not in excess of $5,000,000) or allow any credit or discount whatsoever thereon (unless the aggregate amount of such compromised or settled Accounts in any fiscal year is not in excess of $5,000,000), other than extensions, credits, discounts, compromises, compoundings or settlements in each case granted or made in the ordinary course of business.
          (l) Each Grantor, at its own expense, shall maintain or cause to be maintained insurance covering physical loss or damage to the Inventory and Equipment in accordance with the requirements set forth in Section 5.02 of the Credit Agreement. Each Grantor irrevocably makes, constitutes and appoints the Collateral Agent (and all officers, employees or agents designated by the Collateral Agent) as such Grantor’s true and lawful agent (and attorney-in-fact) for the purpose, upon the occurrence and during the continuance of an Event of Default, of making, settling and adjusting claims in respect of Article 9 Collateral under policies of insurance, endorsing the name of such Grantor on any check, draft, instrument or other item of payment for the proceeds of such policies of insurance and for making all determinations and decisions with respect thereto (provided that the Collateral Agent shall give five Business Days’ prior written notice to such Grantor prior to exercising its rights in such capacity). In the event that any Grantor at any time or times shall fail to obtain or maintain any of the policies of insurance required hereby or under the Credit Agreement or to pay any premium in whole or part relating thereto, the Collateral Agent may, without waiving or releasing any obligation or liability of any Grantor hereunder or any Default or Event of Default, in its sole reasonable discretion, upon notice to the Grantors, obtain and maintain such policies of insurance and pay such premium and take any other actions with respect thereto as the Collateral Agent reasonably deems advisable. All sums disbursed by the Collateral Agent in connection with this paragraph, including reasonable attorneys’ fees, court costs,


 

23

out-of-pocket expenses and other charges relating thereto, shall be payable, within five Business Days of written demand (accompanied by supporting documentation therefor in reasonable detail) by the Grantors to the Collateral Agent and shall be additional Obligations secured hereby.
          SECTION 4.04. Other Actions. In order to further insure the attachment, perfection and priority of, and the ability of the Collateral Agent to enforce, the Security Interest in the Article 9 Collateral, each Grantor agrees, in each case at such Grantor’s own expense, to take the following actions with respect to the following Article 9 Collateral:
     (a) Instruments. If any Grantor shall at any time hold or acquire any Instruments (other than (x) any Instruments in an amount no greater than $1,000,000 and (y) any Instruments representing loans or advances permitted under Section 6.04(c) of the Credit Agreement, to the extent such Instruments represent Indebtedness excluded from the requirements of subclause (ii) of such Section, that have not been pledged hereunder, such Grantor shall forthwith endorse, assign and deliver the same to the Collateral Agent, accompanied by such undated instruments of endorsement, transfer or assignment duly executed in blank as the Collateral Agent may from time to time reasonably request.
     (b) Electronic Chattel Paper and Transferable Records. If any Grantor at any time holds or acquires an interest in any material Electronic Chattel Paper or any material “transferable record”, as that term is defined in Section 201 of the Federal Electronic Signatures in Global and National Commerce Act, or in Section 16 of the Uniform Electronic Transactions Act as in effect in any relevant jurisdiction, such Grantor shall promptly notify the Collateral Agent thereof and, at the reasonable request of the Collateral Agent, shall take such action as the Collateral Agent may reasonably request to vest in the Collateral Agent control under New York UCC Section 9-105 of such Electronic Chattel Paper or control under Section 201 of the Federal Electronic Signatures in Global and National Commerce Act or, as the case may be, Section 16 of the Uniform Electronic Transactions Act, as so in effect in such jurisdiction, of such transferable record. The Collateral Agent agrees with such Grantor that the Collateral Agent will arrange, pursuant to procedures reasonably satisfactory to the Collateral Agent and so long as such procedures will not result in the Collateral Agent’s loss of control, for the Grantor to make alterations to the Electronic Chattel Paper or transferable record permitted under UCC Section 9-105 or, as the case may be, Section 201 of the Federal Electronic Signatures in Global and National Commerce Act or Section 16 of the Uniform Electronic Transactions Act for a party in control to allow without loss of control, unless an Event of Default has occurred and is continuing or would occur after taking into account any action by such Grantor with respect to such Electronic Chattel Paper or transferable record. Notwithstanding the foregoing, no Grantor shall be obligated to deliver to the Collateral Agent any Electronic Chattel Paper held by such Grantor with a face amount less than $1,000,000, provided that the aggregate face amount of the Electronic Chattel Paper so excluded pursuant to this sentence shall not exceed $10,000,000 at any time.


 

24

     (c) Letter-of-Credit Rights. If any Grantor is at any time a beneficiary under a letter of credit with a face amount exceeding $2,000,000 now or hereafter issued in favor of such Grantor, such Grantor shall promptly notify the Collateral Agent thereof and, at the request and option of the Collateral Agent, such Grantor shall, pursuant to an agreement in form and substance reasonably satisfactory to the Collateral Agent, either (i) arrange for the issuer and any confirmer of such letter of credit to consent to an assignment to the Collateral Agent of the proceeds of any drawing under the letter of credit or (ii) arrange for the Collateral Agent to become the transferee beneficiary of the letter of credit, with the Collateral Agent agreeing, in each case, that the proceeds of any drawing under the letter of credit are to be paid to the applicable Grantor unless an Event of Default has occurred or is continuing.
     (d) Commercial Tort Claims. If any Grantor shall at any time hold or acquire a Commercial Tort Claim in an amount reasonably estimated to exceed $5,000,000, the Grantor shall promptly notify the Collateral Agent thereof in a writing signed by such Grantor including a summary description of such claim and grant to the Collateral Agent, for the ratable benefit of the Secured Parties, in such writing a security interest therein and in the proceeds thereof, all upon the terms of this Agreement, with such writing to be in form and substance reasonably satisfactory to the Collateral Agent.
          SECTION 4.05. Covenants Regarding Patent, Trademark and Copyright Collateral. In each case unless otherwise decided by such Grantor in its reasonable business judgment or such Collateral is not material to the business of such Grantor: (a) Each Grantor agrees that it will not, and will not permit any of its licensees to, do any act, or omit to do any act, whereby any Patent that is material to the conduct of such Grantor’s business may become invalidated or dedicated to the public, and agrees that it shall continue to mark any products covered by a Patent with the relevant patent number to the extent necessary and sufficient to establish and preserve its maximum rights under applicable patent laws, to the extent required by applicable law.
          (b) Each Grantor (either itself or through its licensees or its sublicensees) will, for each Trademark material to the conduct of such Grantor’s business, (i) maintain such Trademark in full force free from any claim of abandonment or invalidity for non-use, (ii) maintain the quality of products and services offered under such Trademark, (iii) display such Trademark with notice of Federal or foreign registration to the extent necessary and sufficient to establish and preserve its maximum rights under applicable law, to the extent required by applicable law and (iv) not knowingly use or knowingly permit the use of such Trademark in violation of any third party rights.
          (c) Each Grantor (either itself or through its licensees or sublicensees) will, for each work covered by a material Copyright, continue to publish, reproduce, display, adopt and distribute the work with appropriate copyright notice to the extent necessary and sufficient to establish and preserve its maximum rights under applicable copyright laws, to the extent required by applicable law.
          (d) Each Grantor shall notify the Collateral Agent promptly if it knows that any Patent, Trademark or Copyright material to the conduct of its business has or is


 

25

likely to become abandoned, lost or dedicated to the public, or of any materially adverse determination or development (including the institution of, or any such determination or development in, any proceeding in the United States Patent and Trademark Office, United States Copyright Office or any court or similar office of any country) regarding such Grantor’s ownership of any such Patent, Trademark or Copyright, its right to register the same, or its right to keep and maintain the same.
          (e) If any Grantor, either itself or through any agent, employee, licensee or designee, files an application for any Patent, Trademark or Copyright (or for the registration of any Trademark or Copyright) with the United States Patent and Trademark Office, United States Copyright Office or any office or agency in any political subdivision of the United States, the Grantor shall so notify the Collateral Agent, and, upon request of the Collateral Agent, shall execute and deliver any and all agreements, instruments, documents and papers as the Collateral Agent may reasonably request to evidence the Security Interest in such Patent, Trademark or Copyright, and each Grantor hereby appoints the Collateral Agent as its attorney-in-fact to execute and file such writings for the foregoing purposes, all acts of such attorney being hereby ratified and confirmed.
          (f) Each Grantor will take all necessary steps that are consistent with the practice in any proceeding before the United States Patent and Trademark Office, United States Copyright Office or any office or agency in any political subdivision of the United States, to maintain and pursue each material application relating to the Patents, Trademarks and/or Copyrights (and to obtain the relevant grant or registration) and to maintain each issued Patent and each registration of the Trademarks and Copyrights that is material to the conduct of any Grantor’s business, including timely filings of applications for renewal, affidavits of use, affidavits of incontestability and payment of maintenance fees, and, if consistent with good business judgment, to initiate opposition, interference and cancellation proceedings against third parties.
          (g) In the event that any Grantor knows or has reason to believe that any Article 9 Collateral consisting of a Patent, Trademark or Copyright material to the conduct of any Grantor’s business has been or is about to be infringed, misappropriated or diluted by a third person, such Grantor promptly shall notify the Collateral Agent and shall, if consistent with good business judgment, promptly sue for infringement, misappropriation or dilution and to recover any and all damages for such infringement, misappropriation or dilution, and take such other actions, if consistent with good business judgment, as are reasonably appropriate under the circumstances to protect such Article 9 Collateral.
          (h) Upon the occurrence and during the continuance of an Event of Default, upon the reasonable request of the Collateral Agent, each Grantor shall use its best efforts to obtain all requisite consents or approvals by the licensor of each Copyright License, Patent License or Trademark License, and each other material License, to effect the assignment of all such Grantor’s right, title and interest thereunder to the Collateral Agent, for the ratable benefit of the Secured Parties, or its designee.


 

26

ARTICLE V
Remedies
          SECTION 5.01. Remedies Upon Default. Upon the occurrence and during the continuance of an Event of Default, each Grantor agrees to deliver each item of Collateral to the Collateral Agent on demand, and it is agreed that the Collateral Agent shall have the right to take any of or all the following actions at the same or different times: (a) with respect to any Article 9 Collateral consisting of Intellectual Property, on demand, to cause the Security Interest to become an assignment, transfer and conveyance of any of or all such Article 9 Collateral by the applicable Grantor to the Collateral Agent, or to license or sublicense, whether general, special or otherwise, and whether on an exclusive or nonexclusive basis, any such Article 9 Collateral throughout the world on such terms and conditions and in such manner as the Collateral Agent shall determine (other than in violation of any then-existing licensing arrangements to the extent that waivers cannot be obtained), and (b) with or without legal process and with or without prior notice or demand for performance, to take possession of the Article 9 Collateral and without liability for trespass to enter any premises where the Article 9 Collateral may be located for the purpose of taking possession of or removing the Article 9 Collateral and, generally, to exercise any and all rights afforded to a secured party under the Uniform Commercial Code or other applicable law. Without limiting the generality of the foregoing, each Grantor agrees that the Collateral Agent shall have the right, subject to the requirements of applicable law, including any applicable healthcare laws, to sell or otherwise dispose of all or any part of the Collateral at a public or private sale or at any broker’s board or on any securities exchange, for cash, upon credit or for future delivery as the Collateral Agent shall deem appropriate. The Collateral Agent shall be authorized at any such sale (if it deems it advisable to do so) to restrict the prospective bidders or purchasers to persons who will represent and agree that they are purchasing the Collateral for their own account for investment and not with a view to the distribution or sale thereof, and upon consummation of any such sale the Collateral Agent shall have the right to assign, transfer and deliver to the purchaser or purchasers thereof the Collateral so sold. Each such purchaser at any such sale shall hold the property sold absolutely, free from any claim or right on the part of any Grantor, and each Grantor hereby waives (to the extent permitted by law) all rights of redemption, stay and appraisal which such Grantor now has or may at any time in the future have under any rule of law or statute now existing or hereafter enacted.
          The Collateral Agent shall give each applicable Grantor 10 days’ written notice (which each Grantor agrees is reasonable notice within the meaning of Section 9-611 of the New York UCC or its equivalent in other jurisdictions) of the Collateral Agent’s intention to make any sale of Collateral. Such notice, in the case of a public sale, shall state the time and place for such sale and, in the case of a sale at a broker’s board or on a securities exchange, shall state the board or exchange at which such sale is to be made and the day on which the Collateral, or portion thereof, will first be offered for sale at such board or exchange. Any such public sale shall be held at such time or times within ordinary business hours and at such place or places as the Collateral Agent may fix and state in the notice (if any) of such sale. At any such sale, the


 

27

Collateral, or portion thereof, to be sold may be sold in one lot as an entirety or in separate parcels, as the Collateral Agent may (in its sole and absolute discretion) determine. The Collateral Agent shall not be obligated to make any sale of any Collateral if it shall determine not to do so, regardless of the fact that notice of sale of such Collateral shall have been given. The Collateral Agent may, without notice or publication, adjourn any public or private sale or cause the same to be adjourned from time to time by announcement at the time and place fixed for sale, and such sale may, without further notice, be made at the time and place to which the same was so adjourned. In case any sale of all or any part of the Collateral is made on credit or for future delivery, the Collateral so sold may be retained by the Collateral Agent until the sale price is paid by the purchaser or purchasers thereof, but the Collateral Agent shall not incur any liability in case any such purchaser or purchasers shall fail to take up and pay for the Collateral so sold and, in case of any such failure, such Collateral may be sold again upon like notice. At any public (or, to the extent permitted by law, private) sale made pursuant to this Agreement, any Secured Party may bid for or purchase, free (to the extent permitted by applicable law) from any right of redemption, stay, valuation or appraisal on the part of any Grantor (all said rights being also hereby waived and released to the extent permitted by applicable law), the Collateral or any part thereof offered for sale and may make payment on account thereof by using any claim then due and payable to such Secured Party from any Grantor as a credit against the purchase price, and such Secured Party may, upon compliance with the terms of sale, hold, retain and dispose of such property without further accountability to any Grantor therefor. For purposes hereof, a written agreement to purchase the Collateral or any portion thereof shall be treated as a sale thereof; the Collateral Agent shall be free to carry out such sale pursuant to such agreement and no Grantor shall be entitled to the return of the Collateral or any portion thereof subject thereto, notwithstanding the fact that after the Collateral Agent shall have entered into such an agreement all Events of Default shall have been remedied and the Obligations paid in full. As an alternative to exercising the power of sale herein conferred upon it, the Collateral Agent may proceed by a suit or suits at law or in equity to foreclose this Agreement and to sell the Collateral or any portion thereof pursuant to a judgment or decree of a court or courts having competent jurisdiction or pursuant to a proceeding by a court-appointed receiver. To the fullest extent permitted under applicable law, any sale pursuant to the provisions of this Section 5.01 shall be deemed to conform to the commercially reasonable standards as provided in Section 9-610(b) of the New York UCC or its equivalent in other jurisdictions.
          SECTION 5.02. Application of Proceeds. Subject to the terms of any Pari Passu Intercreditor Agreement, if an Event of Default shall have occurred and is continuing, the Collateral Agent shall apply the proceeds of any collection, sale, foreclosure or other realization upon any Collateral, including any Collateral consisting of cash, as follows:
   FIRST, to the payment of all reasonable out-of-pocket costs and expenses incurred by the Administrative Agent, the Collateral Agent or any other Representative (in their respective capacities as such hereunder or under any other Loan Document or any Pari Passu Agreement, as applicable) in connection with such collection, sale, foreclosure or realization or otherwise in connection with this Agreement, any other Loan


 

28

Document, any Pari Passu Agreement or any of the Obligations, including all court costs and the fees and expenses of its agents and legal counsel, the repayment of all advances made by the Administrative Agent and/or the Collateral Agent hereunder or under any other Loan Document on behalf of any Grantor and any other reasonable out-of-pocket costs or expenses incurred in connection with the exercise of any right or remedy hereunder or under any other Loan Document or any Pari Passu Agreement, as applicable;
   SECOND, to the payment in full of Unfunded Advances/Participations (the amounts so applied to be distributed between or among the Administrative Agent, the Swingline Lender and any Issuing Bank pro rata in accordance with the amounts of Unfunded Advances/Participations owed to them on the date of any such distribution);
   THIRD, to the payment in full of all other Obligations (the amounts so applied to be distributed among the Secured Parties pro rata in accordance with the amounts of the Obligations owed to them on the date of any such distribution);
   FOURTH, to the Grantors, their successors or assigns, or as a court of competent jurisdiction may otherwise direct.
The Collateral Agent shall have absolute discretion as to the time of application of any such proceeds, moneys or balances in accordance with this Agreement. Upon any sale of Collateral by the Collateral Agent (including pursuant to a power of sale granted by statute or under a judicial proceeding), the receipt of the Collateral Agent or of the officer making the sale shall be a sufficient discharge to the purchaser or purchasers of the Collateral so sold and such purchaser or purchasers shall not be obligated to see to the application of any part of the purchase money paid over to the Collateral Agent or such officer or be answerable in any way for the misapplication thereof.
          SECTION 5.03. Grant of License to Use Intellectual Property. For the purpose of enabling the Collateral Agent to exercise rights and remedies under this Agreement at such time as the Collateral Agent shall be lawfully entitled to exercise such rights and remedies, each Grantor hereby grants to the Collateral Agent an irrevocable, nonexclusive license (exercisable without payment of royalty or other compensation to the Grantors), to use, license or sublicense any of the Article 9 Collateral consisting of Intellectual Property now owned or hereafter acquired by such Grantor, and wherever the same may be located, and including in such license access to all media in which any of the licensed items may be recorded or stored and to all computer software and programs used for the compilation or printout thereof. The use of such license by the Collateral Agent may be exercised, at the option of the Collateral Agent, and shall be effective only upon the occurrence and during the continuation of an Event of Default; provided, however, that any license, sublicense or other transaction entered into by the Collateral Agent in accordance herewith shall be binding upon each Grantor notwithstanding any subsequent cure of an Event of Default.
          SECTION 5.04. Securities Act, Etc. In view of the position of the Grantors in relation to the Pledged Collateral, or because of other current or future


 

29

circumstances, a question may arise under the U.S. Securities Act of 1933, as now or hereafter in effect, or any similar statute hereafter enacted analogous in purpose or effect (such Act and any such similar statute as from time to time in effect being called the “Federal Securities Laws”) with respect to any disposition of the Pledged Collateral permitted hereunder. Each Grantor understands that compliance with the Federal Securities Laws might very strictly limit the course of conduct of the Collateral Agent if the Collateral Agent were to attempt to dispose of all or any part of the Pledged Collateral, and might also limit the extent to which or the manner in which any subsequent transferee of any Pledged Collateral could dispose of the same. Similarly, there may be other legal restrictions or limitations affecting the Collateral Agent in any attempt to dispose of all or part of the Pledged Collateral under applicable “blue sky” or other state securities laws or similar laws analogous in purpose or effect. Each Grantor recognizes that in light of such restrictions and limitations the Collateral Agent may, with respect to any sale of the Pledged Collateral, limit the purchasers to those who will agree, among other things, to acquire such Pledged Collateral for their own account, for investment, and not with a view to the distribution or resale thereof. Each Grantor acknowledges and agrees that in light of such restrictions and limitations, the Collateral Agent, in its sole and absolute discretion (a) to the fullest extent permitted by applicable Federal Securities Laws, may proceed to make such a sale whether or not a registration statement for the purpose of registering such Pledged Collateral or part thereof shall have been filed under the Federal Securities Laws and (b) may approach and negotiate with a limited number of potential purchasers (including a single potential purchaser) to effect such sale. Each Grantor acknowledges and agrees that any such sale might result in prices and other terms less favorable to the seller than if such sale were a public sale without such restrictions. In the event of any such sale, the Collateral Agent shall incur no responsibility or liability for selling all or any part of the Pledged Collateral at a price that the Collateral Agent, in its sole and absolute discretion, may in good faith deem reasonable under the circumstances, notwithstanding the possibility that a substantially higher price might have been realized if the sale were deferred until after registration as aforesaid or if more than a limited number of purchasers (or a single purchaser) were approached. The provisions of this Section 5.04 will apply notwithstanding the existence of a public or private market upon which the quotations or sales prices may exceed substantially the price at which the Collateral Agent sells.
ARTICLE VI
Indemnity, Subrogation and Subordination
          SECTION 6.01. Indemnity and Subrogation. In addition to all such rights of indemnity and subrogation as the Guarantors may have under applicable law (but subject to Section 6.03), the Borrower agrees that (a) in the event a payment shall be made by any Guarantor under this Agreement, the Borrower shall indemnify such Guarantor for the full amount of such payment and such Guarantor shall be subrogated to the rights of the person to whom such payment shall have been made to the extent of such payment and (b) in the event any assets of any Guarantor shall be sold pursuant to this Agreement or any other Security Document to satisfy in whole or in part a claim of any


 

30

Secured Party, the Borrower shall indemnify such Guarantor in an amount equal to the greater of the book value or the fair market value of the assets so sold.
          SECTION 6.02. Contribution and Subrogation. Each Guarantor (a “Contributing Guarantor”) agrees (subject to Section 6.03) that, in the event a payment shall be made by any other Guarantor hereunder in respect of any Obligation, or assets of any other Guarantor shall be sold pursuant to any Security Document to satisfy any Obligation owed to any Secured Party, and such other Guarantor (the “Claiming Guarantor”) shall not have been fully indemnified by the Borrower as provided in Section 6.01, the Contributing Guarantor shall indemnify the Claiming Guarantor in an amount equal to (i) the amount of such payment or (ii) the greater of the book value or the fair market value of such assets, as the case may be, in each case multiplied by a fraction of which the numerator shall be the net worth of the Contributing Guarantor on the Closing Date and the denominator shall be the aggregate net worth of all the Guarantors on the Closing Date (or, in the case of any Guarantor becoming a party hereto after the Closing Date, the date on which such party became a Guarantor hereunder). Any Contributing Guarantor making any payment to a Claiming Guarantor pursuant to this Section 6.02 shall be subrogated to the rights of such Claiming Guarantor under Section 6.01 to the extent of such payment.
          SECTION 6.03. Subordination. (a) Notwithstanding any provision of this Agreement to the contrary, all rights of the Guarantors under Sections 6.01 and 6.02 and all other rights of indemnity, contribution or subrogation under applicable law or otherwise shall be fully subordinated to the payment in full in cash of the Obligations (other than contingent indemnification obligations for which no claim has been made). No failure on the part of the Borrower or any Guarantor to make the payments required by Sections 6.01 and 6.02 (or any other payments required under applicable law or otherwise) shall in any respect limit the obligations and liabilities of any Guarantor with respect to its obligations hereunder, and each Guarantor shall remain liable for the full amount of its obligations hereunder.
          (b) The Borrower and each Guarantor hereby agree that all Indebtedness and other monetary obligations owed by it to the Borrower or any Subsidiary shall be fully subordinated to the payment in full in cash of the Obligations; provided that, as long as no Event of Default shall have occurred and be continuing, nothing in this Section 6.03(b) shall prohibit any payments or distributions permitted by the Credit Agreement.
ARTICLE VII
Miscellaneous
          SECTION 7.01. Notices. All communications and notices hereunder shall (except as otherwise expressly permitted herein) be in writing and given as provided in Section 9.01 of the Credit Agreement. All communications and notices hereunder to any Subsidiary Guarantor shall be given to it in care of the Borrower as provided in Section 9.01 of the Credit Agreement.

 


 

31
               SECTION 7.02. Security Interest Absolute. All rights of the Collateral Agent hereunder, the Security Interest, the grant of a security interest in the Pledged Collateral and all obligations of each Grantor hereunder shall be absolute and unconditional irrespective of (a) any lack of validity or enforceability of the Credit Agreement, any other Loan Document, any Pari Passu Agreement, any agreement with respect to any of the Obligations or any other agreement or instrument relating to any of the foregoing, (b) any change in the time, manner or place of payment of, or in any other term of, all or any of the Obligations, or any other amendment or waiver of or any consent to any departure from the Credit Agreement, any other Loan Document or any other agreement or instrument relating to the foregoing, (c) any exchange, release or non-perfection of any Lien on other collateral, or any release or amendment or waiver of or consent under or departure from any guarantee, securing or guaranteeing all or any of the Obligations, or (d) any other circumstance that might otherwise constitute a defense available to, or a discharge of, any Grantor in respect of the Obligations or this Agreement.
               SECTION 7.03. Survival of Agreement. All covenants, agreements, representations and warranties made by the Loan Parties in the Loan Documents and in the certificates or other instruments prepared or delivered in connection with or pursuant to this Agreement or any other Loan Document shall be considered to have been relied upon by the Lenders, the Issuing Bank and the other Secured Parties and shall survive the execution and delivery of the Loan Documents and of any Pari Passu Agreement in connection with any Series of Pari Passu Debt and the making of any Loans and issuance of any Letters of Credit, regardless of any investigation made by any Lender, any Issuing Bank or any other Secured Party or on their behalf and notwithstanding that the Collateral Agent, any Issuing Bank, any Lender or any other Secured Party may have had notice or knowledge of any Default or incorrect representation or warranty at the time any credit is extended under the Credit Agreement or any Pari Passu Agreement, and shall continue in full force and effect as long as the principal of or any accrued interest on any Loan or any Pari Passu Debt, or any fee or any other amount payable under any Loan Document or any Pari Passu Agreement is outstanding and unpaid or the aggregate L/C Exposure does not equal zero (except for outstanding Letters of Credit subject to arrangements satisfactory to the Administrative Agent and the Issuing Bank) and so long as the Commitments have not expired or terminated.
               SECTION 7.04. Binding Effect; Several Agreement. This Agreement shall become effective as to any Loan Party when a counterpart hereof executed on behalf of such Loan Party shall have been delivered to the Collateral Agent and a counterpart hereof shall have been executed on behalf of the Collateral Agent, and thereafter shall be binding upon such Loan Party and the Collateral Agent and their respective permitted successors and assigns, and shall inure to the benefit of such Loan Party, the Collateral Agent and the other Secured Parties and their respective successors and permitted assigns, except that no Loan Party shall have the right to assign or transfer its rights or obligations hereunder or any interest herein or in the Collateral (and any such assignment or transfer shall be void) except as expressly contemplated or permitted by this Agreement or the Credit Agreement. This Agreement shall be construed as a separate agreement with respect to each Loan Party and may be amended, modified,


 

32

supplemented, waived or released with respect to any Loan Party without the approval of any other Loan Party and without affecting the obligations of any other Loan Party hereunder.
               SECTION 7.05. Successors and Assigns. Whenever in this Agreement any of the parties hereto is referred to, such reference shall be deemed to include the permitted successors and permitted assigns of such party; and all covenants, promises and agreements by or on behalf of any Grantor or the Collateral Agent that are contained in this Agreement shall bind and inure to the benefit of their respective successors and permitted assigns.
               SECTION 7.06. Collateral Agent’s Fees and Expenses; Indemnification. (a) The parties hereto agree that the Collateral Agent shall be entitled to reimbursement of its expenses incurred hereunder as provided in Section 9.05 of the Credit Agreement.
               (b) Without limitation or duplication of its indemnification obligations under the other Loan Documents or any Pari Passu Agreement, each Grantor jointly and severally agrees to indemnify the Collateral Agent and the other Indemnitees against, and hold each Indemnitee harmless from, any and all actual losses, claims, damages, liabilities, penalties and related reasonable out of pocket expenses, including the reasonable fees, charges and disbursements of one counsel in each relevant jurisdiction (and any such additional counsel, if necessary, as a result of actual or potential conflicts of interest) for all Indemnitees, incurred by or asserted against any Indemnitee arising out of, in any way connected with, or as a result of, the execution, delivery or performance of this Agreement or any agreement or instrument contemplated hereby or any claim, litigation, investigation or proceeding relating to any of the foregoing or to the Collateral, regardless of whether any Indemnitee is a party thereto or whether initiated by a third party or by a Loan Party or any Affiliate thereof; provided, however, that such indemnity shall not, as to any Indemnitee, be available to the extent that such losses, claims, damages, liabilities, penalties or related expenses are determined by a court of competent jurisdiction by final judgment to have resulted from the gross negligence or wilful misconduct of such Indemnitee. To the extent permitted by applicable law, neither any Grantor nor the Collateral Agent nor any Indemnitee shall assert, and each hereby waives any claim against any Indemnitee, any Grantor and the Collateral Agent, on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) arising out of, in connection with, or as a result of, this Agreement or any agreement or instrument contemplated hereby, the Transactions, any Loan or Letter of Credit or the use of proceeds thereof.
               (c) Any such amounts payable as provided hereunder or under any Pari Passu Agreement shall be additional Obligations secured hereby and by the other Security Documents. The provisions of this Section 7.06 shall remain operative and in full force and effect regardless of the termination of this Agreement, any other Loan Document or any Pari Passu Agreement, the consummation of the transactions contemplated hereby, the repayment of any of the Obligations, the invalidity or unenforceability of any term or provision of this Agreement, any other Loan Document or any Pari Passu Agreement, or any investigation made by or on behalf of the Collateral


 

33

Agent or any other Secured Party. All amounts due under this Section 7.06 shall be payable within 30 days after written demand therefor and shall bear interest, on and from the date of demand, at the rate specified in Section 2.06(a) of the Credit Agreement.
               SECTION 7.07. Collateral Agent Appointed Attorney-in-Fact. Each Grantor hereby appoints the Collateral Agent as the attorney-in-fact of such Grantor for the purpose of carrying out the provisions of this Agreement and taking any action and executing any instrument that the Collateral Agent may deem necessary or advisable to accomplish the purposes hereof, which appointment is irrevocable and coupled with an interest. Without limiting the generality of the foregoing, the Collateral Agent shall have the right, upon the occurrence and during the continuance of an Event of Default, with full power of substitution either in the Collateral Agent’s name or in the name of such Grantor (provided, that to the extent written notice is not required hereunder, the Collateral Agent shall use commercially reasonable efforts to provide notice to such Grantor, though its rights hereunder are not conditioned thereon) (a) to receive, endorse, assign and/or deliver any and all notes, acceptances, checks, drafts, money orders or other evidences of payment relating to the Collateral or any part thereof, (b) upon three Business Days’ prior written notice to such Grantor, to demand, collect, receive payment of, give receipt for and give discharges and releases of all or any of the Collateral, (c) to sign the name of any Grantor on any invoice or bill of lading relating to any of the Collateral, (d) upon three Business Days’ prior written notice to such Grantor, to send verifications of Accounts Receivable to any Account Debtor, (e) to commence and prosecute any and all suits, actions or proceedings at law or in equity in any court of competent jurisdiction to collect or otherwise realize on all or any of the Collateral or to enforce any rights in respect of any Collateral, (f) to settle, compromise, compound, adjust or defend any actions, suits or proceedings relating to all or any of the Collateral, (g) upon three Business Days’ prior written notice to such Grantor, to notify, or to require any Grantor to notify, Account Debtors to make payment directly to the Collateral Agent, and (h) to use, sell, assign, transfer, pledge, make any agreement with respect to or otherwise deal with all or any of the Collateral, and to do all other acts and things necessary to carry out the purposes of this Agreement in accordance with its terms, as fully and completely as though the Collateral Agent were the absolute owner of the Collateral for all purposes; provided, however, that nothing herein contained shall be construed as requiring or obligating the Collateral Agent to make any commitment or to make any inquiry as to the nature or sufficiency of any payment received by the Collateral Agent, or to present or file any claim or notice, or to take any action with respect to the Collateral or any part thereof or the moneys due or to become due in respect thereof or any property covered thereby. The Collateral Agent and the other Secured Parties shall be accountable only for amounts actually received as a result of the exercise of the powers granted to them herein, and neither they nor their officers, directors, employees or agents shall be responsible to any Grantor for any act or failure to act hereunder, except for their own gross negligence, wilful misconduct or bad faith.
               SECTION 7.08. Applicable Law. THIS AGREEMENT SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW YORK.


 

34

               SECTION 7.09. Waivers; Amendment. (a) No failure or delay by the Collateral Agent, the Administrative Agent, any Issuing Bank, any Lender or any other Secured Party in exercising any right or power hereunder or under any other Loan Document shall operate as a waiver hereof or thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such a right or power, preclude any other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the Collateral Agent, the Administrative Agent, the Issuing Banks, the Lenders and the other Secured Parties hereunder and under the other Loan Documents and any Pari Passu Agreements are cumulative and are not exclusive of any rights or remedies that they would otherwise have. No waiver of any provision of any Loan Document or any Pari Passu Agreement or consent to any departure by any Loan Party therefrom shall in any event be effective unless the same shall be permitted by paragraph (b) of this Section 7.09, and then such waiver or consent shall be effective only in the specific instance and for the purpose for which given. Without limiting the generality of the foregoing, the making of a Loan or issuance of a Letter of Credit shall not be construed as a waiver of any Default, regardless of whether the Collateral Agent, any Lender or any Issuing Bank may have had notice or knowledge of such Default at the time. No notice or demand on any Loan Party in any case shall entitle any Loan Party to any other or further notice or demand in similar or other circumstances.
               (b) Subject to the terms of any Pari Passu Intercreditor Agreement, neither this Agreement nor any provision hereof may be waived, amended or modified except pursuant to an agreement or agreements in writing entered into by the Collateral Agent (acting at the direction, or with the consent, of the Required Lenders) and the Loan Party or Loan Parties with respect to which such waiver, amendment or modification is to apply, subject to any consent required in accordance with Section 9.08 of the Credit Agreement.
               (c) So long as permitted by the Loan Documents and the Pari Passu Agreements then in effect, the Borrower may from time to time designate Indebtedness and other obligations at the time of the assumption or incurrence thereof to be secured on a pari passu basis with the then outstanding Obligations as Pari Passu Debt Obligations hereunder by delivering to the Collateral Agent and each Representative a certificate signed by a Financial Officer of the Borrower (i) identifying the Indebtedness and other obligations so designated and the aggregate principal amount or face amount thereof, (ii) stating that such Indebtedness and other obligations are designated as Pari Passu Debt Obligations for purposes hereof, (iii) representing that such designation of such Indebtedness and other obligations as Pari Passu Debt Obligations complies with the terms of the Loan Documents and the Pari Passu Agreements then outstanding and (iv) specifying the name and address of the Representative for such Indebtedness and other obligations. Upon such delivery, the Collateral Agent shall act hereunder for the benefit of all Secured Parties, including any Secured Parties that hold any Pari Passu Debt Obligations so designated.
               SECTION 7.10. WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY


 

35

APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY OF THE OTHER LOAN DOCUMENTS. EACH PARTY HERETO HEREBY (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS, AS APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 7.10.
               SECTION 7.11. Severability. In the event any one or more of the provisions contained in this Agreement or in any other Loan Document should be held invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein and therein shall not in any way be affected or impaired thereby (it being understood that the invalidity of a particular provision in a particular jurisdiction shall not in and of itself affect the validity of such provision in any other jurisdiction). The parties shall endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions.
               SECTION 7.12. Counterparts. This Agreement may be executed in counterparts (and by different parties hereto on different counterparts), each of which shall constitute an original but all of which when taken together shall constitute a single contract, and shall become effective as provided in Section 7.04. Delivery of an executed signature page to this Agreement by facsimile transmission or electronic transmission shall be as effective as delivery of a manually signed counterpart of this Agreement.
               SECTION 7.13. Headings. Article and Section headings and the Table of Contents used herein are for convenience of reference only, are not part of this Agreement and are not to affect the construction of, or to be taken into consideration in interpreting, this Agreement.
               SECTION 7.14. Jurisdiction; Consent to Service of Process. (a) Each of the parties hereto hereby irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of any New York State court or Federal court of the United States of America, sitting in New York City, and any appellate court from any thereof, in any action or proceeding arising out of or relating to this Agreement or any other Loan Document, or for recognition or enforcement of any judgment, and each of the parties hereto hereby irrevocably and unconditionally agrees that all claims in respect of any such action or proceeding may be heard and determined in such New York State or, to the extent permitted by law, in such Federal court. Each of the parties hereto agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided


 

36

by law. Nothing in this Agreement or any other Loan Document shall affect any right that the Collateral Agent, the Administrative Agent, any Issuing Bank or any Lender may otherwise have to bring any action or proceeding relating to this Agreement or any other Loan Document against any Grantor or its properties in the courts of any jurisdiction.
               (b) Each of the parties hereto hereby irrevocably and unconditionally waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Agreement or any other Loan Document in any court referred to in paragraph (a) of this Section 7.14. Each of the parties hereto hereby irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court.
               (c) Each of the parties hereto hereby irrevocably consents to service of process in the manner provided for notices in Section 7.01. Nothing in this Agreement or any other Loan Document will affect the right of any party hereto to serve process in any other manner permitted by law.
               SECTION 7.15. Termination or Release. (a) This Agreement, the guarantees made herein, the Security Interest, the pledge of the Pledged Collateral and all other security interests granted hereby shall automatically terminate and be released when all the Obligations (other than contingent indemnification obligations for which no claim has been made) have been paid in full in cash and the Lenders and Pari Passu Secured Parties have no further commitment to lend under the Credit Agreement or the Pari Passu Agreements, respectively, the aggregate L/C Exposure has been reduced to zero (or the only outstanding Letters of Credit have become subject to arrangements reasonably satisfactory to the Administrative Agent and the Issuing Bank) and the Issuing Banks have no further obligations to issue Letters of Credit under the Credit Agreement.
               (b) A Subsidiary Guarantor shall automatically be released from its obligations hereunder and the Security Interests created hereunder in the Collateral of such Subsidiary Guarantor shall be automatically released upon the consummation of any transaction permitted by the Credit Agreement and the other Pari Passu Agreements (or consented to in writing pursuant to Section 9.08 of the Credit Agreement and the analogous provision of any Pari Passu Agreement) as a result of which such Subsidiary Guarantor ceases to be a Subsidiary, or in accordance with Section 9.09(c) of the Credit Agreement and the analogous provision of any Pari Passu Agreement.
               (c) Upon any sale or other transfer by any Grantor of any Collateral that is permitted under the Credit Agreement and the other Pari Passu Agreements to any person that is not the Borrower or a Guarantor (including any Permitted Receivables Transaction or Permitted Securitization Transaction), or, upon the effectiveness of any written consent to the release of the Security Interest granted hereby in any Collateral pursuant to Section 9.08 of the Credit Agreement and the analogous provision of the Pari Passu Agreements, the Security Interest in such Collateral shall be automatically released.


 

37

               (d) Upon notification by the Borrower to the Collateral Agent that a Subsidiary Guarantor is a Non-Significant Subsidiary, and would not be required to become a Guarantor in accordance with the Credit Agreement or any Pari Passu Agreement, the Collateral Agent shall release the obligations of such Subsidiary hereunder and the Security Interests created hereunder in the Collateral of such Subsidiary Guarantor.
               (e) In connection with any termination or release pursuant to paragraph (a), (b) or (c) above, the Collateral Agent shall promptly execute and deliver to any Grantor, at such Grantor’s expense, all Uniform Commercial Code termination statements and similar documents that such Grantor shall reasonably request to evidence such termination or release, and all assignments or other instruments of transfer as may be necessary to reassign to such Grantor all rights, titles and interests in any relevant Intellectual Property as may have been assigned to the Collateral Agent and/or its designees, subject to any disposition thereof that may have been made by the Collateral Agent and/or its designees in accordance with the terms of this Agreement, and all rights and license granted to the Collateral Agent and/or its designees in or to any such Intellectual Property pursuant to this Agreement shall automatically and immediately terminate and all rights shall automatically and immediately revert to such Grantor. Any execution and delivery of documents pursuant to this Section 7.15 shall be without recourse to or representation or warranty by the Collateral Agent or any Secured Party. Without limiting the provisions of Section 7.06, the Borrower shall reimburse the Collateral Agent upon demand for all costs and out of pocket expenses, including the reasonable fees, charges and expenses of counsel, incurred by it in connection with any action contemplated by this Section 7.15.
               SECTION 7.16. Additional Subsidiaries. Any Subsidiary that is required to become a party hereto pursuant to Section 5.12 of the Credit Agreement or the analogous provision of any Pari Passu Agreement shall enter into this Agreement as a Subsidiary Guarantor and a Grantor upon becoming such a Subsidiary. Upon execution and delivery by the Collateral Agent and such Subsidiary of a supplement in the form of Exhibit A hereto, such Subsidiary shall become a Subsidiary Guarantor and a Grantor hereunder with the same force and effect as if originally named as a Subsidiary Guarantor and a Grantor herein. The execution and delivery of any such instrument shall not require the consent of any other Loan Party hereunder. The rights and obligations of each Loan Party hereunder shall remain in full force and effect notwithstanding the addition of any new Loan Party as a party to this Agreement.
               SECTION 7.17. Right of Setoff. If an Event of Default shall have occurred and is continuing, each Secured Party and its Affiliates hereby are authorized at any time and from time to time, to the fullest extent permitted by law, to set off and apply any and all Collateral (including any deposits (general or special, time or demand, provisional or final (other than tax accounts, trust accounts or payroll accounts))) at any time held and other obligations at any time owing by such Secured Party or any of its Affiliates to or for the credit or the account of any Grantor against any and all of the obligations of such Grantor now or hereafter existing under this Agreement, the other Loan Documents and any Pari Passu Agreements held by such Secured Party, provided


 

38

that at such time such obligations are due or payable. The rights of each Secured Party and its Affiliates under this Section 7.17 are in addition to other rights and remedies (including other rights of setoff) which such Secured Party or its Affiliates may have. The applicable Secured Party shall notify such Grantor and the Collateral Agent of any such setoff and application made by such Secured Party, provided that any failure to give or any delay in giving such notice shall not affect the validity of any such setoff and application under this Section.
[Remainder of page intentionally left blank]

 


 

Schedule I to the Guarantee and
Collateral Agreement
EXACT LEGAL NAMES AND OTHER INFORMATION
                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
1.
  Centre Hospital Corporation   AL     245-901     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Cherokee Medical Center
400 Northwood Drive
Centre, AL 35960

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
2.
  Foley Hospital Corporation   AL     208-366     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  South Baldwin Regional Medical Center
1613 North McKenzie Street
Foley, AL 36535

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
3.
  Fort Payne Hospital Corporation   AL     245-903     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  DeKalb Regional Medical Center
200 Medical Center Drive
P. O. Box 680778
Fort Payne, AL 35968

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
4.
  Greenville Hospital Corporation   AL     168-429     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  L.V. Stabler Memorial Hospital
29 L.V. Stabler Drive
Greenville, AL 36037

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
5.
  QHG of Enterprise, Inc.   AL     176-166     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Medical Center Enterprise
400 North Edwards Street
Enterprise, AL 36330

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
6.
  Forrest City Arkansas Hospital Company, LLC   AR     800076780     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Forrest City Medical Center
1601 Newcastle Road
Forrest City, AR 72336

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
7.
  Forrest City Clinic Company, LLC   AR     800094406     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  PPSI
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
8.
  Forrest City Hospital Corporation   AR     800076787     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
9.
  MCSA, L.L.C.   AR     100129761     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Medical Center of South Arkansas
700 W. Grove Street
El Dorado, AR 71730

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
10.
  Phillips Hospital Corporation   AR     100208457     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Helena Regional Medical Center
1801 Martin Luther King
Drive / PO Box 788
Helena , AR 72342

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
11.
  QHG of Springdale, Inc.   AR     100163444     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
12.
  Triad-El Dorado, Inc.   AR     100129067     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
13.
  Payson Hospital Corporation   AZ     0808024-0     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Payson Regional Medical Center
807 South Ponderosa
Payson, AZ 85541

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
14.
  Abilene Hospital, LLC   DE     3561884     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
15.
  Abilene Merger, LLC   DE     3561879     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
16.
  Arizona DH, LLC   DE     3249754     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
17.
  Berwick Hospital Company, LLC   DE     4447833     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Berwick Hospital Center
701 East 16th Street
Berwick, PA 18603

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
18.
  BH Trans Company, LLC   DE     4447835     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
19.
  Birmingham Holdings II, LLC   DE     4559514     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
20.
  Birmingham Holdings, LLC   DE     4014204     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
21.
  Bluefield Holdings, LLC   DE     4812809     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
22.
  Bluefield Hospital Company, LLC   DE     4812810     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Bluefield Regional Medical Center
500 Cherry St.
Bluefield, WV 24701

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
23.
  Bluffton Health System, LLC   DE     3089523     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Bluffton Regional Medical Center
303 S. Main Street
Bluffton, IN 46714

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
24.
  Brownwood Hospital, L.P.   DE     2967928     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Brownwood Regional Medical Center
1501 Burnet Drive
Brownwood, TX 76801

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
25.
  Brownwood Medical Center, LLC   DE     2964283     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
26.
  Carlsbad Medical Center, LLC   DE     2964276     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Carlsbad Medical Center
2430 W. Pierce
Carlsbad, NM 88220

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
27.
  CHHS Holdings, LLC   DE     3914324     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
28.
  CHS Kentucky Holdings, LLC   DE     4474752     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
29.
  CHS Pennsylvania Holdings, LLC   DE     4474748     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
30.
  CHS Virginia Holdings, LLC   DE     4474750     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
31.
  CHS Washington Holdings, LLC   DE     4593658     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
32.
  CHS/Community Health Systems, Inc.   DE     2057824     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
33.
  Claremore Regional Hospital, LLC   DE     2955684     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Claremore Regional Hospital
1202 N. Muskogee Place
Claremore, OK 74017

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
34.
  Clarksville Holdings, LLC   DE     4014187     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
35.
  Cleveland Regional Medical Center, L.P.   DE     2364708     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Cleveland Regional Medical Center
300 E. Crockett
Cleveland, TX 77327

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
36.
  Cleveland Tennessee Hospital Company, LLC   DE     4589625     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  SkyRidge Medical Center
2305 Chambliss Avenue
Cleveland, TN 37311

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
37.
  College Station Hospital, L.P.   DE     2967943     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  College Station Medical Center
1604 Rock Prairie Road
College Station, TX 77840

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
38.
  College Station Medical Center, LLC   DE     2964215     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
39.
  College Station Merger, LLC   DE     3000998     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
40.
  Community GP Corp.   DE     2642128     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
41.
  Community Health Investment Company, LLC   DE     2066922     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
42.
  Community Health Systems, Inc.   DE     2631063     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
43.
  Community LP Corp.   DE     2642129     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
44.
  CP Hospital GP, LLC   DE     4072307     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
45.
  CPLP, LLC   DE     4072308     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
46.
  Crestwood Hospital LP, LLC   DE     2964362     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
47.
  Crestwood Hospital, LLC   DE     3000931     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
48.
  CSMC, LLC   DE     2964231     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
49.
  CSRA Holdings, LLC   DE     4180039     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
50.
  Deaconess Holdings, LLC   DE     2575694     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
51.
  Deaconess Hospital Holdings, LLC   DE     3931158     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
52.
  Desert Hospital Holdings, LLC   DE     4272332     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
53.
  Detar Hospital, LLC   DE     2947802     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
54.
  DHFW Holdings, LLC   DE     4562267     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
55.
  DHSC, LLC   DE     3973263     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Affinity Medical Center
875 Eighth Street, NE
Massillon, OH 44648

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
56.
  Dukes Health System, LLC   DE     3575662     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Dukes Memorial Hospital
275 West 12th Street
Peru, IN 46970-1698

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
57.
  Fallbrook Hospital Corporation   DE     2921444     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Fallbrook Hospital
624 East Elder
Fallbrook, CA 92028

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
58.
  Gadsden Regional Medical Center, LLC   DE     4275573     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Gadsden Regional Medical Center
1007 Goodyear Avenue
Gadsden, AL 35903

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
59.
  GRMC Holdings, LLC   DE     4272335     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  5800 Tennyson Parkway
Plano, Texas 75024
 
                       
60.
  Hallmark Healthcare Company, LLC   DE     924764     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
61.
  Hobbs Medco, LLC   DE     3000933     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
62.
  Hospital of Barstow, Inc.   DE     2318485     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Barstow Community Hospital
555 South 7th Street
Barstow, CA 92311

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
63.
  Kirksville Hospital Company, LLC   DE     4447853     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
64.
  Lancaster Hospital Corporation   DE     2436981     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Ponca City Medical Center
1900 North 14th Street
Ponca City, OK 74601

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
65.
  Las Cruces Medical Center, LLC   DE     3306969     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  MountainView Regional Medical Center
4311 East Lohman Avenue
Las Cruces, NM 88011

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
66.
  Lea Regional Hospital, LLC   DE     2964402     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Lea Regional Medical Center
5419 N. Lovington Hwy
Hobbs, NM 88240

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
67.
  Longview Merger, LLC   DE     3000918     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
68.
  LRH, LLC   DE     2964430     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
69.
  Lutheran Health Network of Indiana, LLC   DE     2964221     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
70.
  Massillon Community Health System LLC   DE     35755701     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
71.
  Massillon Health System LLC   DE     2662406     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
72.
  Massillon Holdings, LLC   DE     4688840     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
73.
  McKenzie Tennessee Hospital Company, LLC   DE     4455045     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  McKenzie Regional Hospital
161 Hospital Dr. McKenzie,
TN 38201

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
74.
  Medical Center of Brownwood, LLC   DE     2964442     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
75.
  Merger Legacy Holdings, LLC   DE     4754964     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
76.
  MMC of Nevada, LLC   DE     3540578     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Mesa View Regional Hospital
1299 Bertha Howe Avenue
Mesquite, NV 89027

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
77.
  Moberly Hospital Company, LLC   DE     4447851     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Moberly Regional Medical Center
1515 Union Avenue
Moberly, MO 65270

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
78.
  MWMC Holdings, LLC   DE     4259348     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
79.
  National Healthcare of Leesville, Inc.   DE     2101020     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Byrd Regional Hospital
1020 Fertitta Blvd.
Leesville, LA 71446

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
80.
  National Healthcare of
Mt. Vernon, Inc.
  DE     2063507     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Crossroads Community Hospital
#8 Doctor’s Park Road
Mt. Vernon, IL 62864

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
81.
  National Healthcare of Newport, Inc.   DE     2062708     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Harris Hospital
1205 McLain
Newport, AR 72112

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
82.
  Navarro Hospital, L.P.   DE     2964396     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Navarro Regional Hospital
3201 W. Highway 22
Corsicana, TX 75110

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
83.
  Navarro Regional, LLC   DE     2964393     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
84.
  Northampton Hospital Company, LLC   DE     4442353     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Easton Hospital
250 South 21st Street
Easton, PA 18042-3892

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
85.
  Northwest Hospital, LLC   DE     2964436     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Northwest Medical Center
6200 N. LaCholla Blvd.
Tucson, AZ 85741

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
86.
  NOV Holdings, LLC   DE     4272333     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
87.
  NRH, LLC   DE     2964428     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
88.
  Oro Valley Hospital, LLC   DE     3575660     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Oro Valley Hospital
1551 E. Tangerine Road
Oro Valley, AZ 85755

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
89.
  Palmer-Wasilla Health System, LLC   DE     2964382     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
90.
  Pennsylvania Hospital Company, LLC   DE     3657509     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
91.
  Phoenixville Hospital Company, LLC   DE     3796044     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Phoenixville Hospital
140 Nutt Road
Phoenixville, PA 19460

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
92.
  Pottstown Hospital Company, LLC   DE     3657514     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Pottstown Memorial Medical Center
1600 East High Street
Pottstown, PA 19464

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
93.
  QHG Georgia Holdings II, LLC   DE     4754966     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
94.
  QHG of Bluffton Company, LLC   DE     4474767     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
95.
  QHG of Fort Wayne Company, LLC   DE     4474773     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
96.
  QHG of Warsaw Company, LLC   DE     4474770     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
97.
  Quorum Health Resources, LLC   DE     2908225     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
98.
  Regional Hospital of Longview, LLC   DE     2964549     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
99.
  Ruston Hospital Corporation   DE     4270743     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
100.
  Ruston Louisiana Hospital Company, LLC   DE     4270657     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Northern Louisiana Medical Center
401 East Vaughn Avenue
Ruston, LA 71270

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
101.
  SACMC, LLC   DE     2964570     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
102.
  San Angelo Community Medical Center, LLC   DE     2964587     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
103.
  San Angelo Medical, LLC   DE     3001078     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
104.
  Siloam Springs Arkansas Hospital
Company, LLC
  DE     4617628     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Siloam Springs Memorial Hospital
205 E. Jefferson Street
Siloam Springs, AR 72761

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
105.
  Siloam Springs Holdings, LLC   DE     4617627     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
106.
  Southern Texas Medical Center, LLC   DE     3001009     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
107.
  Spokane Valley Washington Hospital
Company, LLC
  DE     4447178     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Valley Hospital and Medical Center
12606 East Mission Avenue
Spokane Valley, WA 99216

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
108.
  Spokane Washington Hospital Company, LLC   DE     4436798     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Deaconess Medical Center
800 W. 5th Avenue
Spokane, WA 99204

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
109.
  Tennyson Holdings, LLC   DE     4075793     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
110.
  Triad Healthcare Corporation   DE     3035153     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
111.
  Triad Holdings III, LLC   DE     3037153     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
112.
  Triad Holdings IV, LLC   DE     2984727     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
113.
  Triad Holdings V, LLC   DE     2226797     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
114.
  Triad Nevada Holdings, LLC   DE     4474764     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
115.
  Triad of Alabama, LLC   DE     2964867     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Flowers Hospital
4370 West Main Street
Dothan, AL 36305

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
116.
  Triad of Oregon, LLC   DE     2969100     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
117.
  Triad-ARMC, LLC   DE     3561894     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
118.
  Triad-Denton Hospital GP, LLC   DE     3249751     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
119.
  Triad-Denton Hospital, L.P.   DE     3249752     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
120.
  Triad-Navarro Regional Hospital
Subsidiary, LLC
  DE     3036964     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
121.
  VHC Medical, LLC   DE     3001003     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
122.
  Vicksburg Healthcare, LLC   DE     2939229     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  River Region Health System
2100 Highway 61 North
Vicksburg, MS 39183

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
123.
  Victoria Hospital, LLC   DE     2948658     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
124.
  Victoria of Texas, L.P.   DE     2949026     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  DeTar Hospital North
101 Medical Drive
Victoria, TX 77904

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
125.
  Warren Ohio Hospital Company, LLC   DE     4856127     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Trumball Memorial Hospital
1350 E. Market St.
Warren, OH 44483

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
126.
  Warren Ohio Rehab Hospital Company, LLC   DE     4856131     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Hillside Rehabilitation Hospital
8747 Squires Lane
Warren, OH 44484

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
127.
  Watsonville Hospital Corporation   DE     2872860     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Watsonville Community Hospital
75 Nielson Street
Watsonville, CA 95076

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
128.
  Webb Hospital Corporation   DE     3695172     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
129.
  Webb Hospital Holdings, LLC   DE     3695131     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
130.
  Wesley Health System, LLC   DE     2770969     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Wesley Medical Center
5001 Hardy Street
Hattiesburg, MS 39402

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
131.
  West Grove Hospital Company, LLC   DE     4442356     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Jennersville Regional Hospital
1015 West Baltimore Pike
West Grove, PA 19390

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
132.
  WHMC, LLC   DE     2964658     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
133.
  Wilkes-Barre Behavioral Hospital Company., LLC   DE     4617621     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  562 Wyoming Avenue
Kingston, PA 18704

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
134.
  Wilkes-Barre Holdings, LLC   DE     4617617     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
135.
  Wilkes-Barre Hospital Company, LLC   DE     4617619     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Wilkes-Barre General Hospital
575 North River Street
Wilkes-Barre, PA 18764

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
136.
  Women & Children’s Hospital, LLC   DE     2964655     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Women & Children’s Hospital
4200 Nelson Road
Lake Charles, LA 70605

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
137.
  Woodland Heights Medical Center, LLC   DE     2964611     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
138.
  Woodward Health System, LLC   DE     2964411     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Woodward Regional Hospital
900 17th Street
Woodward, OK 73801

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
139.
  Youngstown Ohio Hospital Company, LLC   DE     4848328     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Northside Medical Center
500 Gypsy Lane
Youngstown, OH 44504

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
140.
  QHG Georgia Holdings, Inc.   GA     K815327     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
141.
  QHG Georgia, LP   GA     K815977     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
142.
  Anna Hospital Corporation   IL     61552979     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Union County Hospital
517 North Main
Anna, IL 62906

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
143.
  Galesburg Hospital Corporation   IL     63372153     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Galesburg Cottage Hospital
695 N. Kellogg St.
Galesburg, IL 61401

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
144.
  Granite City Hospital Corporation   IL     61746633     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
145.
  Granite City Illinois Hospital
Company, LLC
  IL     585904     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Gateway Regional Medical Center
2100 Madison Avenue
Granite City, IL 62040

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
146.
  Marion Hospital Corporation   IL     58955876     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Heartland Regional Medical Center
3333 West DeYoung
Marion, IL 62959

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
147.
  Red Bud Hospital Corporation   IL     61627014     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
148.
  Red Bud Illinois Hospital Company, LLC   IL     556424     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Red Bud Regional Hospital
325 Spring Street
Red Bud, IL 62278

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
149.
  Waukegan Hospital Corporation   IL     64625918     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
150.
  Waukegan Illinois Hospital Company, LLC   IL     1715232     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Vista Medical Center
(includes East and West)
1324 N. Sheridan Road
Waukegan, IL 60085

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
151.
  Frankfort Health Partner, Inc.   IN     1997030055     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
152.
  QHG of Clinton County, Inc.   IN     1997020547     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
153.
  Hospital of Fulton, Inc.   KY     299733     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Parkway Regional Hospital
2000 Holiday Lane (P.O. Box 866)
Fulton, KY 42041

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
154.
  Hospital of Louisa, Inc.   KY     314079     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Three Rivers Medical Center
2483 Highway 644 (P.O. Box 769)
Louisa, KY 41230

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
155.
  Jackson Hospital Corporation   KY     402625     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Kentucky River Medical Center
540 Jetts Drive
Jackson, KY 41339

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
156.
  QHG of Forrest County, Inc.   MS     644555     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
157.
  QHG of Hattiesburg, Inc.   MS     644553     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
158.
  River Region Medical Corporation   MS     631781     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
159.
  Williamston Hospital Corporation   NC     466901     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Martin General Hospital
310 S. McCaskey Road
Williamston, NC 27892

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
160.
  Salem Hospital Corporation   NJ     100863665     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  The Memorial Hospital of Salem County
310 Woodstown Road
Salem, NJ 08079

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
161.
  Deming Hospital Corporation   NM     1773365     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Mimbres Memorial Hospital
900 W. Ash Street
Deming, NM 88030

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
162.
  Roswell Hospital Corporation   NM     1913540     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Eastern New Mexico Medical Center
405 West Country Club Road
Roswell, NM 88201

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
163.
  San Miguel Hospital Corporation   NM     2027670     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Alta Vista Regional Hospital
104 Legion Drive
Las Vegas, NM 87701

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
164.
  NC-DSH, LLC   NV     C11431-1993     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
165.
  QHG of Barberton, Inc.   OH     949250     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
166.
  QHG of Massillon, Inc.   OH     949249     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
167.
  Kay County Hospital Corporation   OK     1912092200     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
168.
  Kay County Oklahoma Hospital Company, LLC   OK     3512092198     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Ponca City Medical Center
1900 North 14th Street
Ponca City, OK 74601

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
169.
  SouthCrest, L.L.C.   OK     3500580138     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
170.
  Triad-South Tulsa Hospital Company, Inc.   OK     1900579084     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
171.
  Clinton Hospital Corporation   PA     3049114     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Lock Haven Hospital
24 Cree Drive
Lock Haven, PA 17745-2699

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
172.
  Coatesville Hospital Corporation   PA     2987105     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Brandywine Hospital
201 Reeceville Rd.
Coatesville, PA 19320

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
173.
  QHG of South Carolina, Inc.   SC   Do not issue   Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Carolinas Hospital System
805 Pamplico Hwy
Florence, SC 29505

Marion Regional Hospital
2829 East Hwy 76
Mullins, SC 29574

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
174.
  QHG of Spartanburg, Inc.   SC   Do not issue   Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
175.
  Brownsville Hospital Corporation   TN     435829     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Haywood Park Community Hospital
2545 N. Washington Ave.
Brownsville, TN 38012

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
176.
  Cleveland Hospital Corporation   TN     289046     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
177.
  Dyersburg Hospital Corporation   TN     435828     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Dyersburg Regional Medical Center
400 Tickle Street
Dyersburg, TN 38024

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
178.
  Hospital of Morristown, Inc.   TN     264618     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Lakeway Regional Hospital
726 McFarland Street
Morristown, TN 37814

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
179.
  Jackson Hospital Corporation   TN     435834     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
180.
  Lakeway Hospital Corporation   TN     278113     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
181.
  Lexington Hospital Corporation   TN     435830     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Henderson County Community Hospital
200 West Church St.
Lexington, TN 38351

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
182.
  Martin Hospital Corporation   TN     435833     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Volunteer Community Hospital
161 Mt. Pelia Road
Martin, TN 38237

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
183.
  McNairy Hospital Corporation   TN     435832     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  McNairy Regional Hospital
705 Poplar Ave.
Selmer, TN 38375

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
184.
  Shelbyville Hospital Corporation   TN     494640     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Heritage Medical Center
2835 Hwy 23IN
Shelbyville, TN 37160

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
185.
  Big Bend Hospital Corporation   TX     145339600     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Big Bend Regional Medical Center
2600 Highway 118 North
Alpine, TX 79830

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
186.
  Big Spring Hospital Corporation   TX     133735500     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Scenic Mountain Medical Center
1601 West Eleventh Place
Big Spring, TX 79720

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
187.
  Granbury Hospital Corporation   TX     142527600     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Lake Granbury Medical Center
1310 Paluxy Road
Granbury, TX 76048

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
188.
  Jourdanton Hospital Corporation   TX     800001865     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  South Texas Regional Medical Center
1905 Highway 97 E
Jourdanton, TX 78026

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
189.
  Weatherford Hospital Corporation   TX     800718212     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
190.
  Weatherford Texas Hospital Company, LLC   TX     800718224     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Weatherford Regional Medical Center
713 E. Anderson Street
Weatherford, TX 76086

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
191.
  Tooele Hospital Corporation   UT     1424668-0142     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Mountain West Medical Center
2055 N. Main
Tooele, UT 84074-2794

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
192.
  Emporia Hospital Corporation   VA     0514489-4     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Southern Virginia Regional Medical Center
727 North Main Street
Emporia, VA 23847

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027

 


 

                         
        Jurisdiction            
        of   Organizational   Chief Executive    
    Entity Name   Formation   ID’s   Office   Accounts Receivable
193.
  Franklin Hospital Corporation   VA     0529059-8     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Southampton Memorial Hospital
100 Fairview Drive
Franklin, VA 23851

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
194.
  Russell County Medical Center, Inc.   VA     0379489-8     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
195.
  Virginia Hospital Company, LLC   VA     S097163-2     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  N/A
 
                       
196.
  Oak Hill Hospital Corporation   WV     46241     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Plateau Medical Center
430 Main Street
Oak Hill, WV 25901

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027
 
                       
197.
  Evanston Hospital Corporation   WY     1999-000349020     Community Health Systems
4000 Meridian Blvd.
Franklin, TN 37067
  Evanston Regional Hospital
190 Arrowhead Drive
Evanston, WY 82930

Professional Account Services, Inc.
7000 Commerce Way, Suite 100
Brentwood, TN 37027

 


 

Schedule II to the Guarantee and
Collateral Agreement
SUBSIDIARY GUARANTORS
1.   Abilene Hospital, LLC
 
2.   Abilene Merger, LLC
 
3.   Anna Hospital Corporation
 
4.   Arizona DH, LLC
 
5.   Berwick Hospital Company, LLC
 
6.   BH Trans Company, LLC
 
7.   Big Bend Hospital Corporation
 
8.   Big Spring Hospital Corporation
 
9.   Birmingham Holdings, LLC
 
10.   Birmingham Holdings II, LLC
 
11.   Bluefield Holdings, LLC
 
12.   Bluefield Hospital Company, LLC
 
13.   Bluffton Health System LLC
 
14.   Brownsville Hospital Corporation
 
15.   Brownwood Hospital, L.P.
 
16.   Brownwood Medical Center, LLC
 
17.   Carlsbad Medical Center, LLC
 
18.   Centre Hospital Corporation
 
19.   CHHS Holdings, LLC
 
20.   CHS Kentucky Holdings, LLC
 
21.   CHS Pennsylvania Holdings, LLC
 
22.   CHS Virginia Holdings, LLC
 
23.   CHS Washington Holdings, LLC
 
24.   Claremore Regional Hospital, LLC
 
25.   Clarksville Holdings, LLC
 
26.   Cleveland Hospital Corporation
 
27.   Cleveland Regional Medical Center, L.P.
 
28.   Cleveland Tennessee Hospital Company, LLC
 
29.   Clinton Hospital Corporation
 
30.   Coatesville Hospital Corporation
 
31.   College Station Hospital, L.P.
 
32.   College Station Medical Center, LLC
 
33.   College Station Merger, LLC
 
34.   Community GP Corp.
 
35.   Community Health Investment Company, LLC
 
36.   Community LP Corp.
 
37.   CP Hospital GP, LLC
 
38.   CPLP, LLC
 
39.   Crestwood Hospital, LP, LLC
 
40.   Crestwood Hospital, LLC
 
41.   CSMC, LLC
 
42.   CSRA Holdings, LLC
 
43.   Deaconess Holdings, LLC
 
44.   Deaconess Hospital Holdings, LLC
 
45.   Deming Hospital Corporation

 


 

46.   Desert Hospital Holdings, LLC
 
47.   Detar Hospital, LLC
 
48.   DHSC, LLC
 
49.   DHFW Holdings, LLC
 
50.   Dukes Health System, LLC
 
51.   Dyersburg Hospital Corporation
 
52.   Emporia Hospital Corporation
 
53.   Evanston Hospital Corporation
 
54.   Fallbrook Hospital Corporation
 
55.   Foley Hospital Corporation
 
56.   Forrest City Arkansas Hospital Company, LLC
 
57.   Forrest City Clinic Company, LLC
 
58.   Forrest City Hospital Corporation
 
59.   Fort Payne Hospital Corporation
 
60.   Frankfort Health Partner, Inc.
 
61.   Franklin Hospital Corporation
 
62.   Gadsden Regional Medical Center, LLC
 
63.   Galesburg Hospital Corporation
 
64.   Granbury Hospital Corporation
 
65.   Granite City Hospital Corporation
 
66.   Granite City Illinois Hospital Company, LLC
 
67.   Greenville Hospital Corporation
 
68.   GRMC Holdings, LLC
 
69.   Hallmark Healthcare Company, LLC
 
70.   Hobbs Medco, LLC
 
71.   Hospital of Barstow, Inc.
 
72.   Hospital of Fulton, Inc.
 
73.   Hospital of Louisa, Inc.
 
74.   Hospital of Morristown, Inc.
 
75.   Jackson Hospital Corporation (KY)
 
76.   Jackson Hospital Corporation (TN)
 
77.   Jourdanton Hospital Corporation
 
78.   Kay County Hospital Corporation
 
79.   Kay County Oklahoma Hospital Company, LLC
 
80.   Kirksville Hospital Company, LLC
 
81.   Lakeway Hospital Corporation
 
82.   Lancaster Hospital Corporation
 
83.   Las Cruces Medical Center, LLC
 
84.   Lea Regional Hospital, LLC
 
85.   Lexington Hospital Corporation
 
86.   Longview Merger, LLC
 
87.   LRH, LLC
 
88.   Lutheran Health Network of Indiana, LLC
 
89.   Marion Hospital Corporation
 
90.   Martin Hospital Corporation
 
91.   Massillon Community Health System LLC

 


 

92.   Massillon Health System LLC
 
93.   Massillon Holdings, LLC
 
94.   McKenzie Tennessee Hospital Company, LLC
 
95.   McNairy Hospital Corporation
 
96.   MCSA, L.L.C.
 
97.   Medical Center of Brownwood, LLC
 
98.   Merger Legacy Holdings, LLC
 
99.   MMC of Nevada, LLC
 
100.   Moberly Hospital Company, LLC
 
101.   MWMC Holdings, LLC
 
102.   National Healthcare of Leesville, Inc.
 
103.   National Healthcare of Mt. Vernon, Inc.
 
104.   National Healthcare of Newport, Inc.
 
105.   Navarro Hospital, L.P.
 
106.   Navarro Regional, LLC
 
107.   NC-DSH, LLC
 
108.   Northampton Hospital Company, LLC
 
109.   Northwest Hospital, LLC
 
110.   NOV Holdings, LLC
 
111.   NRH, LLC
 
112.   Oak Hill Hospital Corporation
 
113.   Oro Valley Hospital, LLC
 
114.   Palmer-Wasilla Health System, LLC
 
115.   Payson Hospital Corporation
 
116.   Pennsylvania Hospital Company, LLC
 
117.   Phillips Hospital Corporation
 
118.   Phoenixville Hospital Company, LLC
 
119.   Pottstown Hospital Company, LLC
 
120.   QHG Georgia Holdings, Inc.
 
121.   QHG Georgia Holdings II, LLC
 
122.   QHG Georgia, LP
 
123.   QHG of Barberton, Inc.
 
124.   QHG of Bluffton Company, LLC
 
125.   QHG of Clinton County, Inc.
 
126.   QHG of Enterprise, Inc.
 
127.   QHG of Forrest County, Inc.
 
128.   QHG of Fort Wayne Company, LLC
 
129.   QHG of Hattiesburg, Inc.
 
130.   QHG of Massillon, Inc.
 
131.   QHG of South Carolina, Inc.
 
132.   QHG of Spartanburg, Inc.
 
133.   QHG of Springdale, Inc.
 
134.   QHG of Warsaw Company, LLC
 
135.   Quorum Health Resources, LLC
 
136.   Red Bud Hospital Corporation
 
137.   Red Bud Illinois Hospital Company, LLC

 


 

138.   Regional Hospital of Longview, LLC
 
139.   River Region Medical Corporation
 
140.   Roswell Hospital Corporation
 
141.   Russell County Medical Center, Inc.
 
142.   Ruston Hospital Corporation
 
143.   Ruston Louisiana Hospital Company, LLC
 
144.   SACMC, LLC
 
145.   Salem Hospital Corporation
 
146.   San Angelo Community Medical Center, LLC
 
147.   San Angelo Medical, LLC
 
148.   San Miguel Hospital Corporation
 
149.   Shelbyville Hospital Corporation
 
150.   Siloam Springs Arkansas Hospital Company, LLC
 
151.   Siloam Springs Holdings, LLC
 
152.   SouthCrest, L.L.C.
 
153.   Southern Texas Medical Center, LLC
 
154.   Spokane Valley Washington Hospital Company, LLC
 
155.   Spokane Washington Hospital Company, LLC
 
156.   Tennyson Holdings, LLC
 
157.   Tooele Hospital Corporation
 
158.   Triad Healthcare Corporation
 
159.   Triad Holdings III, LLC
 
160.   Triad Holdings IV, LLC
 
161.   Triad Holdings V, LLC
 
162.   Triad Nevada Holdings, LLC
 
163.   Triad of Alabama, LLC
 
164.   Triad of Oregon, LLC
 
165.   Triad-ARMC, LLC
 
166.   Triad-Denton Hospital GP, LLC
 
167.   Triad-Denton Hospital, L.P.
 
168.   Triad-El Dorado, Inc.
 
169.   Triad-Navarro Regional Hospital Subsidiary, LLC
 
170.   Triad-South Tulsa Hospital Company, Inc.
 
171.   VHC Medical, LLC
 
172.   Vicksburg Healthcare, LLC
 
173.   Victoria Hospital, LLC
 
174.   Victoria of Texas, L.P.
 
175.   Virginia Hospital Company, LLC
 
176.   Warren Ohio Hospital Company, LLC
 
177.   Warren Ohio Rehab Hospital Company, LLC
 
178.   Watsonville Hospital Corporation
 
179.   Waukegan Hospital Corporation
 
180.   Waukegan Illinois Hospital Company, LLC
 
181.   Weatherford Hospital Corporation
 
182.   Weatherford Texas Hospital Company, LLC
 
183.   Webb Hospital Corporation

 


 

184.   Webb Hospital Holdings, LLC
 
185.   Wesley Health System, LLC
 
186.   West Grove Hospital Company, LLC
 
187.   WHMC, LLC
 
188.   Wilkes-Barre Behavioral Hospital Company, LLC
 
189.   Wilkes-Barre Holdings, LLC
 
190.   Wilkes-Barre Hospital Company, LLC
 
191.   Williamston Hospital Corporation
 
192.   Women & Children’s Hospital, LLC
 
193.   Woodland Heights Medical Center, LLC
 
194.   Woodward Health System, LLC
 
195.   Youngstown Ohio Hospital Company, LLC

 


 

Schedule III to the Guarantee and
Collateral Agreement
EQUITY INTERESTS
PLEDGED EQUITY SECURITIES
GUARANTORS
                                 
                Number and           % of
                Class of Equity   Certificate   Equity
    Issuer   State   Owner   Interest   Number   Interest
1.
  Centre Hospital Corporation   AL   Community Health Investment Company, LLC   1,000 Common     2       100 %
2.
  Foley Hospital Corporation   AL   Community Health Investment Company, LLC   1,000 Common     2       100 %
3.
  Fort Payne Hospital Corporation   AL   Community Health Investment Company, LLC   1,000 Common     2       100 %
4.
  Greenville Hospital Corporation   AL   Community Health Investment Company, LLC   1,000 Common     3       100 %
5.
  QHG of Enterprise, Inc.   AL   Triad Holdings V, LLC   1,000 Common     2       100 %
6.
  Forrest City Arkansas Hospital Company, LLC   AR   Forrest City Hospital Corporation   100% Limited Liability Company Interest     2       100 %
7.
  Forrest City Clinic Company, LLC   AR   Forrest City Hospital Corporation   100% Limited Liability Company Interest     1       100 %
8.
  Forrest City Hospital Corporation   AR   Community Health Investment Company, LLC   1,000 Common     2       100 %
9.
  MCSA, L.L.C.   AR   Triad — El Dorado, Inc.   100 Units     1       100 %
10.
  Phillips Hospital Corporation   AR   Community Health Investment Company, LLC   1,000 Common     2       100 %
11.
  QHG of Springdale, Inc.   AR   Triad Holdings V, LLC   1,000 Common     2       100 %
12.
  Triad-El Dorado, Inc.   AR   Triad Holdings III, LLC   1,000 Common     4       100 %
13.
  Payson Hospital Corporation   AZ   Community Health Investment Company, LLC   1,000 Common     2       100 %
14.
  Abilene Hospital, LLC   DE   Abilene Merger, LLC   100% Limited Liability Company Interest             100 %

 


 

                                 
                Number and           % of
                Class of Equity   Certificate   Equity
    Issuer   State   Owner   Interest   Number   Interest
15.
  Abilene Merger, LLC   DE   Triad Holdings V, LLC   100% Limited Liability Company Interest             100 %
16.
  Arizona DH, LLC   DE   Triad Holdings III, LLC   100% Limited Liability Company Interest             100 %
17.
  Berwick Hospital Company, LLC   DE   Community Health Investment Company, LLC   100 Units     1       100 %
18.
  BH Trans Company, LLC   DE   Coatesville Hospital Corporation   100 Units     1       100 %
19.
  Birmingham Holdings II, LLC   DE   Tennyson Holdings, LLC   100 Common     1       100 %
20.
  Birmingham Holdings, LLC   DE   Tennyson Holdings, LLC   100% Limited Liability Company Interest     2       100 %
21.
  Bluefield Holdings, LLC   DE   Community Health Investment Company, LLC   100 Common     1       100 %
22.
  Bluefield Hospital Company, LLC   DE   Bluefield Holdings, LLC   100 Common     1       100 %
23.
  Bluffton Health System, LLC   DE   Frankfort Health Partner, Inc.   1% Limited Liability Company Interest             1 %
 
          QHG of Bluffton Company, LLC   99% Limited Liability Company Interest             99 %
24.
  Brownwood Hospital, L.P.   DE   Brownwood Medical Center, LLC   1% General Partner Interest             1 %
 
          Medical Center of Brownwood, LLC   99% Limited Partner Interest             99 %
25.
  Brownwood Medical Center, LLC   DE   Southern Texas Medical Center, LLC   100% Limited Liability Company Interest             100 %
26.
  Carlsbad Medical Center, LLC   DE   Triad Holdings V, LLC   100% Limited Liability Company Interest     2       100 %

 


 

                                 
                Number and           % of
                Class of Equity   Certificate   Equity
    Issuer   State   Owner   Interest   Number   Interest
27.
  CHHS Holdings, LLC   DE   CHS Pennsylvania Holdings, LLC   1% Limited Liability Company Interest     4       1 %
 
          Hallmark Healthcare Company, LLC (successor to Hallmark Healthcare Corporation)   1% Limited Liability Company Interest     2       1 %
 
          Pennsylvania Hospital Company, LLC   98% Limited Liability Company Interest     3       98 %
28.
  CHS Kentucky Holdings, LLC   DE   Community Health Investment Company, LLC   100 Common     1       100 %
29.
  CHS Pennsylvania Holdings, LLC   DE   Pennsylvania Company, LLC   100 Common     1       100 %
30.
  CHS Virginia Holdings, LLC   DE   Virginia Hospital Company, LLC   100 Common     1       100 %
31.
  CHS Washington Holdings, LLC   DE   Community Health Investment Company, LLC   100 Common     1       100 %
32.
  CHS/Community Health Systems, Inc.   DE   Community Health Systems, Inc.   1,000 Common     2       100 %
33.
  Claremore Regional Hospital, LLC   DE   Triad Holdings IV, LLC   100% Limited Liability Company Interest     N/A       100 %
34.
  Clarksville Holdings, LLC   DE   River Region Medical Corporation   100% Limited Liability Company Interest     N/A       100 %
35.
  Cleveland Regional Medical Center, L.P.   DE   Community GP Corp.   0.5% General Partner Interest     N/A       0.5 %
 
          Community LP Corp.   99.5% Limited Partner Interest     N/A       99.5 %
36.
  Cleveland Tennessee Hospital Company, LLC   DE   Cleveland Hospital Corporation   100 Common     1       100 %
37.
  College Station Hospital, L.P.   DE   College Station Medical Center, LLC   1% General Partner Interest     N/A       1 %
 
          CSMC, LLC   99% Limited Partner Interest     N/A       99 %

 


 

                                 
                Number and           % of
                Class of Equity   Certificate   Equity
    Issuer   State   Owner   Interest   Number   Interest
38.
  College Station Medical Center, LLC   DE   College Station Merger, LLC   100% Limited Liability Company Interest     N/A       100 %
39.
  College Station Merger, LLC   DE   Tennyson Holdings, LLC   100% Limited Liability Company Interest     N/A       100 %
40.
  Community GP Corp.   DE   Community Health Investment Company, LLC   1,000 Common     3       100 %
41.
  Community Health Investment Company, LLC   DE   CHS/Community Health Systems, Inc.   100 Units     1       100 %
42.
  Community LP Corp.   DE   Community Health Investment Company, LLC   1,000 Common     3       100 %
43.
  CP Hospital GP, LLC   DE   Tennyson Holdings, LLC   100% Limited Liability Company Interest     N/A       100 %
44.
  CPLP, LLC   DE   Tennyson Holdings, LLC   100% Limited Liability Company Interest     N/A       100 %
45.
  Crestwood Hospital LP, LLC   DE   Crestwood Hospital, LLC   100% Limited Liability Company Interest     N/A       100 %
46.
  Crestwood Hospital, LLC   DE   Triad Holdings III, LLC   100% Limited Liability Company Interest     N/A       100 %
47.
  CSMC, LLC   DE   College Station Merger, LLC   100% Limited Liability Company Interest     N/A       100 %
48.
  CSRA Holdings, LLC   DE   QHG Georgia Holdings, Inc.   100% Limited Liability Company Interest     N/A       100 %
49.
  Deaconess Holdings, LLC   DE   Triad Holdings IV, LLC   100% Limited Liability Company Interest     N/A       100 %

 


 

                                 
                Number and           % of
                Class of Equity   Certificate   Equity
    Issuer   State   Owner   Interest   Number   Interest
50.
  Deaconess Hospital Holdings, LLC   DE   Deaconess Holdings, LLC   80% Limited Liability Company Interest     N/A       80 %
51.
  Desert Hospital Holdings, LLC   DE   Triad Holdings V, LLC   100% Limited Liability Company Interest     2       100 %
52.
  Detar Hospital, LLC   DE   VHC Medical, LLC   100% Limited Liability Company Interest     N/A       100 %
53.
  DHFW Holdings, LLC   DE   Frankfort Health Partner, Inc.   1 Common     2       1 %
 
          QHG of Fort Wayne Company, LLC   99 Common     1       99 %
54.
  DHSC, LLC   DE   Massillon Community Health System LLC   100% Limited Liability Company Interest     N/A       100 %
55.
  Dukes Health System, LLC   DE   QHG of Clinton County, Inc.   100% Limited Liability Company Interest     N/A       100 %
56.
  Fallbrook Hospital Corporation   DE   Community Health Investment Company, LLC   1,000 Common     2       100 %
57.
  Gadsden Regional Medical Center, LLC   DE   GRMC Holdings, LLC   100% Limited Liability Company Interest     N/A       100 %
58.
  GRMC Holdings, LLC   DE   Tennyson Holdings, LLC   100% Limited Liability Company Interest     2       100 %
59.
  Hallmark Healthcare Company, LLC   DE   CHS/Community Health Systems, Inc.   100% Limited Liability Company Interest     1       100 %
60.
  Hobbs Medco, LLC   DE   Triad Holdings V, LLC   100% Limited Liability Company Interest     2       100 %
61.
  Hospital of Barstow, Inc.   DE   Community Health Investment Company, LLC   1,000 Common     3       100 %

 


 

                                 
                Number and           % of
                Class of Equity   Certificate   Equity
    Issuer   State   Owner   Interest   Number   Interest
62.
  Kirksville Hospital Company, LLC   DE   Community Health Investment Company, LLC   100 Units     1       100 %
63.
  Lancaster Hospital Corporation   DE   Community Health Investment Company, LLC   1,000 Common     4       100 %
64.
  Las Cruces Medical Center, LLC   DE   Triad Holdings V, LLC   100% Limited Liability Company Interest     2       100 %
65.
  Lea Regional Hospital, LLC   DE   Hobbs Medco, LLC   100% Limited Liability Company Interest     N/A       100 %
66.
  Longview Merger, LLC   DE   Tennyson Holdings, LLC   100% Limited Liability Company Interest     N/A       100 %
67.
  LRH, LLC   DE   Longview Merger, LLC   100% Limited Liability Company Interest     N/A       100 %
68.
  Lutheran Health Network of Indiana, LLC   DE   Tennyson Holdings, LLC   100% Limited Liability Company Interest     2       100 %
69.
  Massillon Community Health System LLC   DE   Massillon Holdings, LLC   1 Units     2       1 %
 
          Massillon Health System LLC   99 Units     1       99 %
70.
  Massillon Health System LLC   DE   QHG of Massillon, Inc.   100% Limited Liability Company Interest     N/A       100 %
71.
  Massillon Holdings, LLC   DE   QHG of Massillon, Inc.   100 Units     1       100 %
72.
  McKenzie Tennessee Hospital Company, LLC   DE   Community Health Investment Company, LLC   100 Units     1       100 %
73.
  Medical Center of Brownwood, LLC   DE   Southern Texas Medical Center, LLC   100% Limited Liability Company Interest     N/A       100 %
74.
  Merger Legacy Holdings, LLC   DE   Triad Healthcare Corporation   100 Units     2       100 %

 


 

                                 
                Number and           % of
                Class of Equity   Certificate   Equity
    Issuer   State   Owner   Interest   Number   Interest
75.
  MMC of Nevada, LLC   DE   Tennyson Holdings, LLC   100% Limited Liability Company Interest     N/A       100 %
76.
  Moberly Hospital Company, LLC   DE   Community Health Investment Company, LLC   100 Units     1       100 %
77.
  MWMC Holdings, LLC   DE   Triad of Oregon, LLC   990 Units     1       99 %
 
          Triad Holdings V, LLC   10 Units     2       1 %
78.
  National Healthcare of Leesville, Inc.   DE   Hallmark Healthcare Company, LLC   1,000 Common     5       100 %
79.
  National Healthcare of Mt. Vernon, Inc.   DE   Hallmark Healthcare Company, LLC (successor to Hallmark Holdings Corp.)   1,000 Common     3       100 %
80.
  National Healthcare of Newport, Inc.   DE   Hallmark Healthcare Company, LLC   1,000 Common     4       100 %
81.
  Navarro Hospital, L.P.   DE   Navarro Regional, LLC   1% General Partner Interest     N/A       1 %
 
          NRH, LLC   99% Limited Partner Interest     N/A       99 %
82.
  Navarro Regional, LLC   DE   Triad-Navarro Regional Hospital Subsidiary, LLC   100% Limited Liability Company Interest     N/A       100 %
83.
  Northampton Hospital Company, LLC   DE   Merger Legacy Holdings, LLC   100 Units     2       100 %
84.
  Northwest Hospital, LLC   DE   NOV Holdings, LLC   100% Limited Liability Company Interest     N/A       100 %
85.
  NOV Holdings, LLC   DE   Desert Hospital Holdings, LLC   100% Limited Liability Company Interest     N/A       100 %
86.
  NRH, LLC   DE   Triad-Navarro Regional Hospital Subsidiary, LLC   100% Limited Liability Company Interest     N/A       100 %
87.
  Oro Valley Hospital, LLC   DE   NOV Holdings, LLC   100% Limited Liability Company Interest     N/A       100 %

 


 

                                 
                Number and           % of
                Class of Equity   Certificate   Equity
    Issuer   State   Owner   Interest   Number   Interest
88.
  Palmer-Wasilla Health System, LLC   DE   Triad Holdings IV, LLC   100% Limited Liability Company Interest     N/A       100 %
89.
  Pennsylvania Hospital Company, LLC   DE   CHS/Community Health Systems, Inc.   100% Limited Liability Company Interest     1       100 %
90.
  Phoenixville Hospital Company, LLC   DE   CHS Pennsylvania Holdings, LLC   1% Limited Liability Company Interest     4       1 %
 
          Hallmark Healthcare Company, LLC (successor to Hallmark Healthcare Corp.)   1% Limited Liability Company Interest     2       1 %
 
          Pennsylvania Hospital Company, LLC   98% Limited Liability Company Interest     3       98 %
91.
  Pottstown Hospital Company, LLC   DE   CHS Pennsylvania Holdings, LLC   1% Limited Liability Company Interest     4       1 %
 
          Hallmark Healthcare Company, LLC (successor to Hallmark Healthcare Corp.)   1% Limited Liability Company Interest     2       1 %
 
          Pennsylvania Hospital Company, LLC   98% Limited Liability Company Interest     3       98 %
92.
  QHG Georgia Holdings II, LLC   DE   QHG Georgia Holdings, Inc.   100 Units     1       100 %
93.
  QHG of Bluffton Company, LLC   DE   Tennyson Holdings, LLC   100 Units     1       100 %
94.
  QHG of Fort Wayne Company, LLC   DE   Tennyson Holdings, LLC   100 Units     1       100 %
95.
  QHG of Warsaw Company, LLC   DE   Tennyson Holdings, LLC   100 Units     1       100 %
96.
  Quorum Health Resources, LLC   DE   Triad Healthcare Corporation   100% Limited Liability Company Interest     N/A       100 %

 


 

                                 
                Number and           % of
                Class of Equity   Certificate   Equity
    Issuer   State   Owner   Interest   Number   Interest
97.
  Regional Hospital of Longview, LLC   DE   Longview Merger, LLC   100% Limited Liability Company Interest     N/A       100 %
98.
  Ruston Hospital Corporation   DE   Community Health Investment Company, LLC   1,000 Common     1       100 %
99.
  Ruston Louisiana Hospital Company, LLC   DE   Ruston Hospital Corporation   100% Limited Liability Company Interest     2       100 %
100.
  SACMC, LLC   DE   San Angelo Medical, LLC   100% Limited Liability Company Interest     N/A       100 %
101.
  San Angelo Community Medical Center, LLC   DE   San Angelo Medical, LLC   100% Limited Liability Company Interest     N/A       100 %
102.
  San Angelo Medical, LLC   DE   Triad Holdings V, LLC   100% Limited Liability Company Interest     2       100 %
103.
  Siloam Springs Arkansas Hospital Company, LLC   DE   Siloam Springs Holdings, LLC   100 Units     1       100 %
104.
  Siloam Springs Holdings, LLC   DE   Community Health Investment Company, LLC   100 Units     1       100 %
105.
  Southern Texas Medical Center, LLC   DE   Tennyson Holdings, LLC   100% Limited Liability Company Interest     N/A       100 %
106.
  Spokane Valley Washington Hospital Company, LLC   DE   CHS Washington Holdings, LLC   100 Units     1       100 %
107.
  Spokane Washington Hospital Company, LLC   DE   CHS Washington Holdings, LLC   100 Units     1       100 %
108.
  Tennyson Holdings, LLC   DE   Triad Healthcare Corporation   100 Units     1       100 %
109.
  Triad Healthcare Corporation   DE   CHS/Community Health Systems, Inc.   1,000 Common     4       100 %
110.
  Triad Holdings III, LLC   DE   Triad Holdings IV, LLC   100% Limited Liability Company Interest     N/A       100 %

 


 

                                 
                Number and           % of
                Class of Equity   Certificate   Equity
    Issuer   State   Owner   Interest   Number   Interest
111.
  Triad Holdings IV, LLC   DE   Tennyson Holdings, LLC   100% Limited Liability Company Interest     N/A       100 %
112.
  Triad Holdings V, LLC   DE   Tennyson Holdings, LLC   100% Limited Liability Company Interest     N/A       100 %
113.
  Triad Nevada Holdings, LLC   DE   NC-DSH, LLC   100 Units     1       100 %
114.
  Triad of Alabama, LLC   DE   Tennyson Holdings, LLC   100% Limited Liability Company Interest     2       100 %
115.
  Triad of Oregon, LLC   DE   Tennyson Holdings, LLC   100% Limited Liability Company Interest     N/A       100 %
116.
  Triad-ARMC, LLC   DE   Abilene Merger, LLC   100% Limited Liability Company Interest     N/A       100 %
117.
  Triad-Denton Hospital GP, LLC   DE   Triad Holdings III, LLC   100% Limited Liability Company Interest     N/A       100 %
118.
  Triad-Denton Hospital, L.P.   DE   Triad-Denton Hospital GP, LLC   1% General Partner Interest     N/A       1 %
 
          Arizona DH, LLC   99% Limited Partner Interest     N/A       99 %
119.
  Triad-Navarro Regional Hospital Subsidiary, LLC   DE   Tennyson Holdings, LLC   100% Limited Liability Company Interest     N/A       100 %
120.
  VHC Medical, LLC   DE   Triad Holdings III, LLC   100% Limited Liability Company Interest     N/A       100 %
121.
  Vicksburg Healthcare, LLC   DE   River Regional Medical Corporation   100% Limited Liability Company Interest     N/A       100 %
122.
  Victoria Hospital, LLC   DE   VHC Medical, LLC   100% Limited Liability Company Interest     N/A       100 %
123.
  Victoria of Texas, L.P.   DE   Detar Hospital, LLC   1% General Partner Interest     N/A       1 %
 
          Victoria Hospital, LLC   99% Limited Partner Interest     N/A       1 %

 


 

                                 
                Number and           % of
                Class of Equity   Certificate   Equity
    Issuer   State   Owner   Interest   Number   Interest
124.
  Warren Ohio Hospital Company, LLC   DE   Community Health Investment Company, LLC   100 Units     1       100 %
125.
  Warren Ohio Rehab Hospital Company, LLC   DE   Community Health Investment Company, LLC   100 Units     1       100 %
126.
  Watsonville Hospital Corporation   DE   Community Health Investment Company, LLC   1,000 Common     2       100 %
127.
  Webb Hospital Corporation   DE   Community Health Investment Company, LLC (successor to CHS Holdings Corp.)   1,000 Common     1       100 %
128.
  Webb Hospital Holdings, LLC   DE   Webb Hospital Corporation   100% Limited Liability Company Interest     1       100 %
129.
  Wesley Health System, LLC   DE   QHG of Forrest County, Inc.   5% Limited Liability Company Interest     N/A       5 %
 
          QHG of Hattiesburg, Inc.   95% Limited Liability Company Interest     N/A       95 %
130.
  West Grove Hospital Company, LLC   DE   Community Health Investment Company, LLC   100 Units     1       100 %
131.
  WHMC, LLC   DE   Triad Holdings V, LLC   100% Limited Liability Company Interest     2       100 %
132.
  Wilkes-Barre Behavioral Hospital Company, LLC   DE   Wilkes-Barre Holdings, LLC   100 Units     1       100 %
133.
  Wilkes-Barre Holdings, LLC   DE   Community Health Investment Company, LLC   100 Units     1       10 %
134.
  Wilkes-Barre Hospital Company, LLC   DE   Wilkes-Barre Holdings, LLC   100 Units     1       100 %
135.
  Women & Children’s Hospital, LLC   DE   Triad Holdings IV, LLC   100% Limited Liability Company Interest     N/A       100 %

 


 

                                 
                Number and           % of
                Class of Equity   Certificate   Equity
    Issuer   State   Owner   Interest   Number   Interest
136.
  Woodland Heights Medical Center, LLC   DE   Triad Holdings V, LLC   100% Limited Liability Company Interest     2       100 %
137.
  Woodward Health System, LLC   DE   Triad Holdings IV, LLC   100% Limited Liability Company Interest     N/A       100 %
138.
  Youngstown Ohio Hospital Company, LLC   DE   Community Health Investment Company, LLC   100 Units     1       100 %
139.
  QHG Georgia Holdings, Inc.   GA   Triad Holdings V, LLC   1,000 Common     2       100 %
140.
  QHG Georgia, LP   GA   QHG Georgia Holdings II, LLC   1% General Partner Interest     N/A       1 %
 
          NC-DSH, LLC   99% Limited Partner Interest     N/A       99 %
141.
  Anna Hospital Corporation   IL   Community Health Investment Company, LLC   1,000 Common     2       100 %
142.
  Galesburg Hospital Corporation   IL   Community Health Investment Company, LLC   1,000 Common     2       100 %
143.
  Granite City Hospital Corporation   IL   Community Health Investment Company, LLC   1,000 Common     2       100 %
144.
  Granite City Illinois Hospital Company, LLC   IL   Granite City Hospital Corporation   100% Limited Liability Company Interest     1       100 %
145.
  Marion Hospital Corporation   IL   Community Health Investment Company, LLC (successor to CHS Holdings Corp.)   1,000 Common     1       100 %
146.
  Red Bud Hospital Corporation   IL   Community Health Investment Company, LLC   1,000 Common     2       100 %
147.
  Red Bud Illinois Hospital Company, LLC   IL   Red Bud Hospital Corporation   100% Limited Liability Company Interest     1       100 %
148.
  Waukegan Hospital Corporation   IL   Community Health Investment Company, LLC   1,000 Common     2       100 %

 


 

                                 
                Number and           % of
                Class of Equity   Certificate   Equity
    Issuer   State   Owner   Interest   Number   Interest
149.
  Waukegan Illinois Hospital Company, LLC   IL   Waukegan Hospital Corporation   100% Limited Liability Company Interest     2       100 %
150.
  Frankfort Health Partner, Inc.   IN   Tennyson Holdings, LLC   1,000 Common     3       100 %
151.
  QHG of Clinton County, Inc.   IN   Tennyson Holdings, LLC   1,000 Common     3       100 %
152.
  Hospital of Fulton, Inc.   KY   CHS Kentucky Holdings, LLC   1,000 Common     5       100 %
153.
  Hospital of Louisa, Inc.   KY   CHS Kentucky Holdings, LLC   1,000 Common     5       100 %
154.
  Jackson Hospital Corporation   KY   CHS Kentucky Holdings, LLC   1,000 Common     3       100 %
155.
  QHG of Forrest County, Inc.   MS   Triad Holdings V, LLC   1,000 Common     2       100 %
156.
  QHG of Hattiesburg, Inc.   MS   Triad Holdings V, LLC   1,000 Common     2       100 %
157.
  River Region Medical Corporation   MS   Triad Holdings V, LLC   5,949,472 Common     2       100 %
158.
  Williamston Hospital Corporation   NC   Community Health Investment Company, LLC   1,000 Common     2       100 %
159.
  Salem Hospital Corporation   NJ   Community Health Investment Company, LLC   1,000 Common     2       100 %
160.
  Deming Hospital Corporation   NM   Community Health Investment Company, LLC   1,000 Common     3       100 %
161.
  Roswell Hospital Corporation   NM   Community Health Investment Company, LLC   1,000 Common     2       100 %
162.
  San Miguel Hospital Corporation   NM   Community Health Investment Company, LLC   1,000 Common     2       100 %
163.
  NC-DSH, LLC   NV   QHG Georgia Holdings, Inc.   100 Units     3       100 %
164.
  QHG of Barberton, Inc.   OH   Triad Holdings V, LLC   1,000 Common     2       100 %
165.
  QHG of Massillon, Inc.   OH   Triad Holdings V, LLC   1,000 Common     2       100 %
166.
  Kay County Hospital Corporation   OK   Community Health Investment Company, LLC   1,000 Common     2       100 %
167.
  Kay County Oklahoma Hospital Company, LLC   OK   Kay County Hospital Corporation   100% Limited Liability Company Interest     2       100 %

 


 

                                 
                Number and           % of
                Class of Equity   Certificate   Equity
    Issuer   State   Owner   Interest   Number   Interest
168.
  SouthCrest, L.L.C.   OK   Triad-South Tulsa Hospital Company, Inc.   100% Limited Liability Company Interest     N/A       100 %
169.
  Triad-South Tulsa Hospital Company, Inc.   OK   Triad Holdings III, LLC   1,000 Common     5       100 %
170.
  Clinton Hospital Corporation   PA   Community Health Investment Company, LLC   1,000 Common     2       100 %
171.
  Coatesville Hospital Corporation   PA   Community Health Investment Company, LLC   1,000 Common     2       100 %
172.
  QHG of South Carolina, Inc.   SC   Triad Holdings V, LLC   1,000 Common     2       100 %
173.
  QHG of Spartanburg, Inc.   SC   Triad Holdings V, LLC   1,000 Common     2       100 %
174.
  Brownsville Hospital Corporation   TN   Community Health Investment Company, LLC   1,000 Common     2       100 %
175.
  Cleveland Hospital Corporation   TN   Hallmark Healthcare Company, LLC   1,981,000 Common     48       100 %
176.
  Dyersburg Hospital Corporation   TN   Community Health Investment Company, LLC   1,000 Common     2       100 %
177.
  Hospital of Morristown, Inc.   TN   Lakeway Hospital Corporation   1,000 Common     5       100 %
178.
  Jackson Hospital Corporation   TN   Community Health Investment Company, LLC   1,000 Common     3       100 %
179.
  Lakeway Hospital Corporation   TN   Community Health Investment Company, LLC   1 Share     52       100 %
180.
  Lexington Hospital Corporation   TN   Community Health Investment Company, LLC   1,000 Common     2       100 %
181.
  Martin Hospital Corporation   TN   Community Health Investment Company, LLC   1,000 Common     2       100 %
182.
  McNairy Hospital Corporation   TN   Community Health Investment Company, LLC   1,000 Common     2       100 %
183.
  Shelbyville Hospital Corporation   TN   Community Health Investment Company, LLC   1,000 Common     2       100 %
184.
  Big Bend Hospital Corporation   TX   Community Health Investment Company, LLC   1,000 Common     2       100 %

 


 

                                 
                Number and           % of
                Class of Equity   Certificate   Equity
    Issuer   State   Owner   Interest   Number   Interest
185.
  Big Spring Hospital Corporation   TX   Community Health Investment Company, LLC   1,000 Common     3       100 %
186.
  Granbury Hospital Corporation   TX   Community Health Investment Company, LLC   1,000 Common     3       100 %
187.
  Jourdanton Hospital Corporation   TX   Community Health Investment Company, LLC   1,000 Common     2       100 %
188.
  Weatherford Hospital Corporation   TX   Community Health Investment Company, LLC   1,000 Common     3       100 %
189.
  Weatherford Texas Hospital Company, LLC   TX   Weatherford Hospital Corporation   100% Limited Liability Company Interest     2       100 %
190.
  Tooele Hospital Corporation   UT   Community Health Investment Company, LLC   1,000 Common     2       100 %
191.
  Emporia Hospital Corporation   VA   Community Health Investment Company, LLC   1,000 Common     2       100 %
192.
  Franklin Hospital Corporation   VA   Community Health Investment Company, LLC   1,000 Common     2       100 %
193.
  Russell County Medical Center, Inc.   VA   Community Health Investment Company, LLC   1,000 Common     4       100 %
194.
  Virginia Hospital Company, LLC   VA   CHS/Community Health Systems, Inc.   100% Limited Liability Company Interest     1       100 %
195.
  Oak Hill Hospital Corporation   WV   Community Health Investment Company, LLC   1,000 Common     2       100 %
196.
  Evanston Hospital Corporation   WY   Community Health Investment Company, LLC   1,000 Common     1       100 %

 


 

PLEDGED PERMITTED SYNDICATION SUBSIDIARIES
                                     
                Number and           % of
                Class of Equity   Certificate   Equity
    Issuer   State   Owner   Interest   Number   Interest
1.
  Mat-Su Valley Medical Center, LLC   AK   Palmer-Wasilla Health System, LLC   19340.25 Units     2       74.386 %
2.
  Affinity Health System, LLC   DE   Birmingham Holdings II, LLC   78 Units     2       1 %
 
          Birmingham Holdings , LLC   7,683 Units     1       98.5 %
3.
  ARMC, L.P.   DE   Triad-ARMC, LLC   41 General Partner Units     1       1.02 %
 
          Abilene Hospital, LLC   3,497.8 Limited Partner Units     2       86.56 %
4.
  Augusta Health System, LLC   DE   CSRA Holdings, LLC   1,638 Units     147       65.52 %
5.
  Bullhead City Hospital Investment Corporation   DE   Community Health Investment Company, LLC   5,000 Common     16       98.89 %
6.
  Blue Ridge Georgia Hospital Company, LLC   DE   Community Health Investment Company, LLC   1,152 Units     1       98.21 %
7.
  Cedar Park Health System, L.P.   DE   CP Hospital GP, LLC   1% General Partner Interest     N/A       1 %
 
          CPLP, LLC   79% Limited Partner Interest     N/A       79 %
8.
  Clarksville Health System, G.P.   DE   Clarksville Holdings, LLC   80% General Partner Interest     N/A       80 %
9.
  Chestnut Hill Health System, LLC   DE   CHHS Holdings, LLC   85% Limited Liability Company Interest     N/A       85 %
10.
  Crestwood Healthcare, L.P.   DE   Crestwood Hospital, LLC   1,544 General Partner Units     N/A       25.66 %
 
          Crestwood Hospital LP, LLC   3,638 Limited Partner Units     N/A       60.45 %
11.
  Deaconess Health System, LLC   DE   Oklahoma City ASC-GP, LLC   1,282 Units     53       7.63 %
 
          Deaconess Hospital Holdings, LLC   14,943 Units     1       88.92 %
12.
  DuPont Hospital, LLC   DE   DHFW Holdings, LLC   72.03% Limited Liability Company Interest     N/A       72.03 %
13.
  Greenbrier VMC, LLC   DE   Triad Holdings III, LLC   5,024 Units     1       96.01 %
14.
  Longview Medical Center, L.P.   DE   Regional Hospital of Longview, LLC   26 General Partner Units     N/A       1.00 %
 
          LRH, LLC   1,893 Limited Partner Units     N/A       72.98 %

 


 

                                     
                Number and           % of
                Class of Equity   Certificate   Equity
    Issuer   State   Owner   Interest   Number   Interest
15.
  Lutheran Health Network Investors, LLC   DE   QHG of Fort Wayne Company, LLC   969 Units   3 and 147     2.44 %
 
          DHFW Holdings, LLC   2,299 Units   2 and 148     5.80 %
 
          Lutheran Health Network of Indiana, LLC   30,918 Units   1 and 195     77.98 %
16.
  Lutheran Musculoskeletal Center, LLC   DE   Lutheran Health Network of Indiana, LLC   3,345 Units     18       60 %
17.
  Mary Black Health System, LLC   DE   QHG of Spartanburg, Inc.     24,796.36       N/A       97.53 %
18.
  McKenzie-Willamette Regional Medical Center Associates, LLC   DE   MWMC Holdings, LLC   90.51% Limited Liability Company Interest     N/A       90.51 %
19.
  Northwest Arkansas Hospitals, LLC   DE   QHG of Springdale, Inc.   11,196.3 Units   1,4 and 5     99.32 %
20.
  Northwest Indiana Health Systems, LLC   DE   Lutheran Health Network of Indiana, LLC   8,335.9 Units     1       90.86 %
21.
  Piney Woods Healthcare System, L.P.   DE   Woodland Heights Medical Center, LLC   56.47 General Partner Units     N/A       1 %
 
          WHMC, LLC   5,086.13 Limited Partner Units     N/A       90.36 %
22.
  San Angelo Hospital, L.P.   DE   San Angelo Community Medical Center, LLC   42 General Partner Units     1       0.94 %
 
          SACMC, LLC   4,158 Limited Partner Units     2       95.65 %
23.
  Sunbury Hospital Corporation   DE   Community Health Investment Company, LLC   600 Common     28       73.26 %
24.
  Warsaw Health System, LLC, LLC   DE   Frankfort Health Partner, Inc.   105 Units     2       0.99 %
 
          QHG of Warsaw Company, LLC   10,383 Units     1       98.05 %
25.
  Lake Wales Hospital Investment Corporation   FL   Community Health Investment Company, LLC   1,932 Common     28       93.15 %
26.
  North Okaloosa Medical Corp.   FL   Community Health Investment Company, LLC   3,421,000 Common     72       95.27 %
27.
  Kirksville Missouri Hospital Company, LLC   MO   Kirksvillle Hospital Company, LLC   5,400 Units     33       82.49 %

 


 

                                     
                Number and           % of
                Class of Equity   Certificate   Equity
    Issuer   State   Owner   Interest   Number   Interest
28.
  Jackson, Tennessee Hospital Company, LLC   TN   Jackson Hospital Corporation   2,542 Units     1       97.1 %
29.
  Laredo Texas Hospital Company, L.P.   TX   Webb Hospital Corporation   4 General Partner Units     1       0.16 %
 
          Webb Hospital Holdings, LLC   23,768 Limited Partner Units     48       94.659 %
30.
  Petersburg Hospital Company, LLC   VA   CHS Virginia Holdings, LLC   78 Units     6       0.99 %
 
          Community Health Investment Company, LLC   78 Units     7       0.99 %
 
          Virginia Hospital Company, LLC   7,644 Units     5       97.31 %

 


 

PLEDGED DEBT SECURITIES
             
Term Note
           
Jackson, Tennessee Hospital company, LLC
  March 1, 2010   $ 38,130,000  
 
      $ 15,000,000  
Northwest Arkansas Hospitals, LLC
  June 1, 2009   $ 24,510,014  
Lutheran Health Network Investors, LLC
  October 1, 2008   $ 499,200,000  
Crestwood healthcare, LP
  May 1, 2008   $ 40,000,000  
Petersburg Hospital Company, LLC
  November 1, 2009   $ 110,309,370  
Blue Ridge Georgia Hospital Company, LLC
  February 1, 2010   $ 17,049,174  
Greenbrier VMC, LLC
  December 2009   $ 75,014,936  
Cedar Park Health System, LP
  March 1, 2010   $ 22,500,000  
 
           
Revolving Line of Credit
           
Northwest Arkansas Hospitals, LLC
  June 1, 2009   $ 10,000,000  
Petersburg Hospital Company, LLC
  November 1, 2009   $ 10,000,000  
San Angelo Hospital, LP
  April 1, 2009   $ 10,000,000  
Crestwood Healthcare, LP
  October 1, 2007   $ 38,000,000  
Crestwood Healthcare, LP
  October 1, 2007   $ 38,000,000  
Blue Ridge Georgia Hospital Company, LLC
  February 1, 2010   $ 10,000,000  
Greenbrier VMC, LLC
  December 1, 2009   $ 10,000,000  
 
           
Capital Contribution Promissory Note
           
Clarksville Holdings, LLC
  February 1, 2006   $ 125,000,000  
 
           
Loan Agreement
           
Crestwood Healthcare, LP
  May 1, 2008   $ 40,000,000  
Cedar Park Health System, LP
  March 1, 2010   $ 22,500,000  
 
           
Security Agreement
           
Crestwood Healthcare, LP
  May 1, 2008   $ 40,000,000  
Cedar Park Health System, LP
  March 1, 2010   $ 22,500,000  
 
           
Revolving Credit and Cash Management Agreement
           
Crestwood Healthcare, LP
  October 1, 2007   $ 38,000,000  
 
Assignment and Assumption of Loan Agreement
           
Triad Corporate Services, LP
  February 1, 2006   $ 25,000,000  
 
           
Amended and Restated Loan Agreement
           
Clarksville Health System, GP
  February 1, 2006   $ 25,000,000  
 
           
Amended and Restated Security Agreement
           
Clarksville Health System, GP
  September 30, 2009   $ 27,200,000  

 


 

             
Amended and Restated Promissory Note
           
Clarksville Health System, GP
  September 30, 2009   $ 27,200,000  
 
           
Promissory Note
           
Fannin Regional Hospital, Inc.
  July 25, 2007   $ 200,000,000  
Weatherford Texas Hospital Company, LLC
  July 25, 2007   $ 200,000,000  
Hospital of Fulton, Inc.
  July 25, 2007   $ 200,000,000  
Hospital of Barstow, Inc.
  July 25, 2007   $ 200,000,000  
Hospital of Morristown, Inc.
  July 25, 2007   $ 200,000,000  
Hospital of Louisa, Inc.
  July 25, 2007   $ 200,000,000  
Moberly Hospital Company, LLC
  July 25, 2007   $ 200,000,000  
Greenville Hospital Corporation
  July 25, 2007   $ 200,000,000  
National Healthcare of Leesville, Inc.
  July 25, 2007   $ 200,000,000  
Anna Hospital Corporation
  July 25, 2007   $ 200,000,000  
Ruston Hospital Corporation
  July 25, 2007   $ 200,000,000  
National Healthcare of Cleveland, Inc.
  July 25, 2007   $ 200,000,000  
National Healthcare of Newport, Inc.
  July 25, 2007   $ 200,000,000  
National Healthcare of Mt. Vernon, Inc.
  July 25, 2007   $ 200,000,000  
NHCI of Hillsboro, Inc.
  July 25, 2007   $ 200,000,000  
Big Spring Hospital Corporation
  July 25, 2007   $ 200,000,000  
Porter Hospital Corporation
  July 25, 2007   $ 200,000,000  
Lancaster Hospital Corporation
  July 25, 2007   $ 200,000,000  
Jackson Hospital Corporation
  July 25, 2007   $ 200,000,000  
Crestview Hospital Corporation
  July 25, 2007   $ 200,000,000  
Deming Hospital Corporation
  July 25, 2007   $ 200,000,000  
Marion Hospital Corporation
  July 25, 2007   $ 200,000,000  
Chesterfield/Marlboro, LP (Chesterfield)
  July 25, 2007   $ 200,000,000  
Chesterfield/Marlboro, LP (Marlboro)
  July 25, 2007   $ 200,000,000  
Cleveland Regional Medical Center
  July 25, 2007   $ 200,000,000  
Granbury Hospital Corporation
  July 25, 2007   $ 200,000,000  
Payson Hospital Corporation
  July 25, 2007   $ 200,000,000  
Roswell Hospital Corporation
  July 25, 2007   $ 200,000,000  
Watsonville Hospital Corporation
  July 25, 2007   $ 200,000,000  
Fallbrook Hospital Corporation
  July 25, 2007   $ 200,000,000  
Williamson Hospital Corporation
  July 25, 2007   $ 200,000,000  
Berwick Hospital Company, LLC
  July 25, 2007   $ 200,000,000  
Emporia Hospital Corporation
  July 25, 2007   $ 200,000,000  
Big Bend Corporation
  July 25, 2007   $ 200,000,000  
Evanston Hospital Corporation
  July 25, 2007   $ 200,000,000  
San Miguel Hospital Corporation
  July 25, 2007   $ 200,000,000  
Franklin Hospital Corporation
  July 25, 2007   $ 200,000,000  
Bullhead City Hospital
  July 25, 2007   $ 200,000,000  
Foley Hospital Corporation
  July 25, 2007   $ 200,000,000  
Tooele Hospital Corporation
  July 25, 2007   $ 200,000,000  
Kirksville Missouri Hospital Company
  July 25, 2007   $ 200,000,000  
Coatesville Hospital Corporation
  July 25, 2007   $ 200,000,000  

 


 

             
Red Bud Hospital Corporation
  July 25, 2007   $ 200,000,000  
Northampton Hospital Company
  July 25, 2007   $ 200,000,000  
West Grove Hospital Company
  July 25, 2007   $ 200,000,000  
Jourdanton Hospital Corporation
  July 25, 2007   $ 200,000,000  
Granite City Hospital Corporation
  July 25, 2007   $ 200,000,000  
Salem Hospital Corporation
  July 25, 2007   $ 200,000,000  
Clinton Hospital Corporation
  July 25, 2007   $ 200,000,000  
Oak Hill Hospital Corporation
  July 25, 2007   $ 200,000,000  
Phillips Hospital Corporation
  July 25, 2007   $ 200,000,000  
Lake Wales Hospital Corporation
  July 25, 2007   $ 200,000,000  
Jackson Hospital Corporation
  July 25, 2007   $ 200,000,000  
Dyersburg Hospital corporation
  July 25, 2007   $ 200,000,000  
Lexington Hospital Corporation
  July 25, 2007   $ 200,000,000  
McKenzie Tennessee Hospital company
  July 25, 2007   $ 200,000,000  
McNairy Hospital Corporation
  July 25, 2007   $ 200,000,000  
Martin Hospital Corporation
  July 25, 2007   $ 200,000,000  
Brownsville Hospital Corporation
  July 25, 2007   $ 200,000,000  
Waukegan Hospital Corporation
  July 25, 2007   $ 200,000,000  
Pottstown Hospital Company, LLC
  July 25, 2007   $ 200,000,000  
Petersburg Hospital Company, LLC
  July 25, 2007   $ 200,000,000  
Webb Hospital Corporation
  July 25, 2007   $ 200,000,000  
Galesburg Hospital Corporation
  July 25, 2007   $ 200,000,000  
Phoenixville Hospital Company
  July 25, 2007   $ 200,000,000  
Chestnut Hospital Company, LLC
  July 25, 2007   $ 200,000,000  
Shelbyville Hospital Corporation
  July 25, 2007   $ 200,000,000  
Sunbury Hospital Company, LLC
  July 25, 2007   $ 200,000,000  
Kay County Hospital Corporation
  July 25, 2007   $ 200,000,000  
Forrest City Hospital Corporation
  July 25, 2007   $ 200,000,000  
Centre Hospital Corporation
  July 25, 2007   $ 200,000,000  
Fort Payne Hospital Corporation
  July 25, 2007   $ 200,000,000  
 
           
Triad Healthcare Corporation (Note B)
  July 25, 2007   $ 1,500,000,000  
Triad Healthcare Corporation (Note B)
  July 25, 2007   $ 3,000  

 


 

Schedule IV to the Guarantee and
Collateral Agreement
DEBT INSTRUMENTS; ADVANCES
See Schedule III Pledged Debt Securities.

 


 

Schedule V to the Guarantee and
Collateral Agreement
MORTGAGE FILINGS
     
Hospital Name/Address (County)   Corporate Owner
DeKalb Regional Medical Center
200 Medical Center Drive
P.O. Box 680778
Fort Payne, AL 35968 (Dekalb)
  Fort Payne Hospital Corporation (AL)
Flowers Hospital
4370 West Main Street
Dothan, AL 36305 (Houston)
  Triad of Alabama, LLC (DE)
Gadsden Regional Medical Center
1007 Goodyear Avenue
Gadsden, AL 35903 (Etowah)
  Gadsden Regional Medical Center, LLC (DE)
Medical Center Enterprise
400 North Edwards St.
Enterprise, AL 36330 (Coffee)
  QHG of Enterprise, Inc. (AL)
Northwest Hospital
6200 N. LaCholla Blvd.
Tucson, AZ 85755 (Pima)
  Northwest Hospital, LLC (DE)
Northwest Hospital Oro Valley
1551 E. Tangerine Rd.
Oro Valley, AZ 85755 (Pima)
  Oro Valley Hospital, LLC (DE)
Watsonville Community Hospital
75 Nielson Street
Watsonville, CA 95076 (Santa Cruz)
  Watsonville Hospital Corporation (DE)
Galesburg Cottage Hospital
695 N. Kellogg St.
Galesburg, IL 61401 (Knox)
  Galesburg Hospital Corporation (IL)
Gateway Regional Medical Center
2100 Madison Avenue
Granite City, IL 62040 (Madison)
  Granite City Illinois Hospital Company, LLC (IL)
Heartland Regional Medical Center
3333 West DeYoung
Marion, IL 62959 (Williamson)
  Marion Hospital Corporation (IL)
Vista Medical Center (includes East and West)
1324 N. Sheridan Road
Waukegan, IL 60085 (Lake)
  Waukegan Illinois Hospital Company, LLC (IL)

 


 

     
Hospital Name/Address (County)   Corporate Owner
Bluffton Regional Medical Center
303 South Main Street
Bluffton, IN 46714 (Wells)
  Bluffton Health System, LLC (DE)
Dukes Memorial Hospital
275 W. 12th Street
Peru, IN 46970 (Miami)
  Dukes Health System, LLC (DE)
Women and Children’s Hospital
4200 Nelson Road
Lake Charles, LA 70605 (Calcasieu)
  Women and Children’s Hospital, LLC (DE)
River Region Health System
2100 Highway 61 North/1111 N.
Frontage Road
Vicksburg, MS 39183 (Warren)
  Vicksburg Healthcare, LLC (DE)
Wesley Medical Center
5001 Hardy Street
Hattiesburg, MS 39402 (Lamar)
  Wesley Health System, Inc. (DE)
Moberly Regional Medical Center
1515 Union Avenue
Moberly, MO 65270 (Randolph)
  Moberly Hospital Company, LLC (DE)
Mesa View Regional Hospital
1299 Bertha Howe Avenue
Mesquite, NV 89027 (Clark)
  MMC of Nevada, LLC (DE)
The Memorial Hospital of Salem County
310 Woodstown Road
Salem, NJ 08079 (Salem)
  Salem Hospital Corporation (NJ)
Alta Vista Regional Hospital
104 Legion Drive
Las Vegas, NM 87701 (San Miguel)
  San Miguel Hospital Corporation (NM)
Carlsbad Medical Center
2430 West Pierce
Carlsbad, NM 88220 (Eddy)
  Carlsbad Medical Center, LLC (DE)
Eastern New Mexico Medical Center
405 West Country Club Road
Roswell, NM 88201 (Chaves)
  Roswell Hospital Corporation (NM)
Lea Regional Medical Center
5419 N. Lovington Highway
Hobbs, NM 88240 (Lea)
  Lea Regional Hospital, LLC (DE)

 


 

     
Hospital Name/Address (County)   Corporate Owner
MountainView Regional Medical Center
4311 East Lohman Avenue
Las Cruces, NM 88011 (Dona Ana)
  Las Cruces Medical Center, LLC (DE)
Affinity Medical Center1
875 Eighth Street NE
Massillon, OH 44646 (Stark)
  DHSC, LLC (DE)
Hillside Rehabilitation Hospital2
8747 Squires Lane NE
Warren, OH 44484 (Trumbull)
  Warren Ohio Rehab Hospital Company, LLC (DE)
Northside Medical Center3
500 Gypsy Lane
Youngstown, OH 44501 (Trumbull and Mahoning)
  Youngstown Ohio Hospital Company, LLC (DE)
Trumbull Memorial Hospital4
1350 East Market Street
Warren, OH 44482 (Trumbull)
  Warren Ohio Hospital Company, LLC (DE)
Claremore Regional Hospital
1202 N. Muskogee Place
Claremore, OK 74017 (Rogers)
  Claremore Regional Hospital, LLC (DE)
Ponca City Medical Center
1900 North 14th Street
Ponca City, OK 74601 (Kay)
  Kay County Oklahoma Hospital Company, LLC (OK)
SouthCrest Hospital
8801 South 101st East Ave.
Tulsa, OK 74133 (Tulsa)
  SouthCrest, L.L.C. (DE)
Berwick Hospital Center
701 East 16th Street
Berwick, PA 18603 (Columbia)
  Berwick Hospital Company, LLC (DE)
Brandywine Hospital
201 Reeceville Rd.
Coatesville, PA 19320 (Chester)
  Coatesville Hospital Corporation (PA)
 
1   This facility is in the process of being mortgaged. It should be mortgaged by December 31, 2010.
 
2   This facility is in the process of being mortgaged. It should be mortgaged by December 31, 2010.
 
3   This facility is in the process of being mortgaged. It should be mortgaged by December 31, 2010.
 
4   This facility is in the process of being mortgaged. It should be mortgaged by December 31, 2010.

 


 

     
Hospital Name/Address (County)   Corporate Owner
Easton Hospital
250 South 21st Street
Easton, PA 18042-3892 (Northampton)
  Northampton Hospital Company, LLC (DE)
Jennersville Regional Hospital
1015 West Baltimore Pike
West Grove, PA 19390 (Chester)
  West Grove Hospital Company, LLC (DE)
Lock Haven Hospital
24 Cree Drive
Lock Haven, PA 17745-2699 (Washington)
  Clinton Hospital Corporation (PA)
Phoenixville Hospital
140 Nutt Road
Phoenixville, PA 19460 (Chester)
  Phoenixville Hospital Company, LLC (DE)
Pottstown Memorial Medical Center
1600 East High Street
Pottstown, PA 19464 (Montgomery)
  Pottstown Hospital Company, LLC (DE)
Wilkes-Barre General Hospital
575 North River Street
Wilkes-Barre, PA 18764 (Luzerne and Wyoming)
  Wilkes-Barre Hospital Company, LLC (DE)
Wilkes-Barre Behavioral Hospital Company, LLC (DE)
Carolinas Hospital System
805 Pamplico Highway
Florence, SC 29505 (Florence)
  QHG of South Carolina, Inc. (SC)
Marion Regional Hospital
2829 East Highway 76
Mullins, SC 29574 (Marion and Horry)
  QHG of South Carolina, Inc. (SC)
Springs Memorial Hospital
800 W. Meeting Street
Lancaster, SC 29720 (Lancaster)
  Lancaster Hospital Corporation (DE)
Dyersburg Regional Medical Center
400 Tickle Street
Dyersburg, TN 38024 (Dyer)
  Dyersburg Hospital Corporation (TN)
Lakeway Regional Hospital
726 McFarland Street
Morristown, TN 37814 (Hamblen)
  Hospital of Morristown, Inc. (TN)
SkyRidge Medical Center (includes Cleveland)
2305 Chambliss Avenue
Cleveland, TN 37320 (Bradley)
  National Healthcare of Cleveland, Inc. (TN)

 


 

     
Hospital Name/Address (County)   Corporate Owner
Volunteer Community Hospital
161 Mt. Pelia Road
Martin, TN 38237 (Weakley)
  Martin Hospital Corporation (TN)
College Station Medical Center
1604 Rock Prairie
College Station, TX 77845 (Brazos)
  College Station Hospital, L.P. (DE)
DeTar Hospital Navarro
506 E. San Antonio Street
Victoria, TX 77901 (Victoria)
  Victoria of Texas, L.P. (DE)
DeTar Hospital North
101 Medical Drive
Victoria, TX 77904 (Victoria)
  Victoria of Texas, L.P. (DE)
Scenic Mountain Medical Center
1601 West Eleventh Place
Big Spring, TX 79720 (Howard)
  Big Spring Hospital Corporation (TX)
South Texas Regional Medical Center
1905 Highway 97 E
Jourdanton, TX 78026 (Atascosa)
  Jourdanton Hospital Corporation (TX)
Mountain West Medical Center
2055 N. Main
Tooele, UT 84074-2794 (Tooele)
  Tooele Hospital Corporation (UT)
Southern Virginia Regional Medical Center
727 North Main Street
Emporia, VA 23847 (Greensville)
  Emporia Hospital Corporation (VA)
Southampton Memorial Hospital
100 Fairview Drive
Franklin, VA 23851 (Southampton)
  Franklin Hospital Corporation (VA)
Deaconess Medical Center
800 West Fifth Avenue
Spokane, WA 99204 (Spokane)
  Spokane Washington Hospital Company, LLC (DE)
Valley Hospital and Medical Center
12606 East Mission
Spokane Valley, WA 99216 (Spokane)
  Spokane Valley Washington Hospital Company (DE)
Bluefield Regional Medical Center
500 Cherry Street
Bluefield, WV 24701 (Mercer)
  Bluefield Hospital Company, LLC (DE)

 


 

     
Hospital Name/Address (County)   Corporate Owner
Northwest Medical Center of Benton County 5
3000 Medical Center Pkwy.
Bentonville, AR 72712 (Benton)
  QHG of Springdale, Inc. (AR)
Regional Hospital of Jackson6
367 Hospital Blvd.
Jackson, TN 38305 (Madison)
  Jackson, Tennessee Hospital Company, LLC (TN)
Greenbrier Valley Medical Center7
202 Maplewood Avenue
Ronceverte, WV 24970 (Greenbrier)
  Greenbrier VMC, LLC (DE)
 
5   This mortgage is in the process of being released. It should be released by December 31, 2010.
 
6   This mortgage is in the process of being released. It should be released by December 31, 2010.
 
7   This mortgage is in the process of being released. It should be released by December 31, 2010.

 


 

Schedule VI to the Guarantee and
Collateral Agreement
U.S. COPYRIGHTS OWNED BY GRANTORS
U.S. Copyright Registrations
             
Title   Grantor   Reg. No.   Author
Failure Mode and Effects Analysis: Neuraxial Anesthesia and Anticoagulation
  CHS Washington
Holdings, LLC
  TXu001152745
12/8/2003
  Empire Health
Services
Quality Profile: Trended Data from 1992 through September 1996
  CHS Washington
Holdings, LLC
  TXu000779488
1/7/1997
  Empire Health Services (author Norwood, Cynthia Ellen and Stark, Sharilyn Su as a work for hire)
Arthritis: Education and Exercise
  Northwest Hospital,
LLC
  TX0002267273   Northwest Physical Therapy and Occupational Therapy
Northwest Osteoporosis Center Osteoporosis Prevention and Treatment Guidelines
  Northwest Hospital,
LLC
  TX0004915182   n/a
Med-Info Health Care Protocols and Manuals
  Northwest Hospital,
LLC
  TXu000281933   n/a
Pending U.S. Copyright Applications for Registration
             
Title   Author   Class   Date Filed
VANTAGE SCORECARD
(ATIBA)
  Atiba Software, LLC/Community Health Systems, Inc., 4000 Meridian Blvd., Franklin, TN 37067       Pending on 3/25/09, applications are taking upwards of 16 mos. to register
SURGIPOINTE V.1.0.4
  Quorum Health Resources,
LLC
105 Continental Place
Brentwood, TN 37027
      Pending

 


 

Non-U.S. Copyright Registrations
[List in alphabetical order by country/numerical order by Registration No. within each country.]
             
Country   Title   Reg. No.   Author
NONE            
Non-U.S. Pending Copyright Applications for Registration
[List in alphabetical order by country.]
                 
Country   Title   Author   Class   Date Filed
NONE                

 


 

LICENSES
[Make a separate page of Schedule VIII for each Grantor, and state if any Grantor is not a party to a license/sublicense.]
I. Licenses/Sublicenses of [Name of Grantor] as Licensor/Sublicensor on Date Hereof
A. Copyrights
[List U.S. copyrights in numerical order by Registration No. List non-U.S. copyrights by country in alphabetical order with Registration Nos. within each country in numerical order.]
U.S. Copyrights
                 
        Title of        
Licensee Name   Date of License/   U.S.        
and Address   Sublicense   Copyright   Author   Reg. No.
NONE                
Non-U.S. Copyrights
                     
        Date of   Title of        
    Licensee Name   License/   Non-U.S.        
Country   and Address   Sublicense   Copyrights   Author   Reg. No.
NONE                    

 


 

B. Patents
[List U.S. patent Nos. and U.S. patent application Nos. in numerical order. List non-U.S. patent Nos. and non-U.S. application in alphabetical order by country, with numbers within each country in numerical order.]
U.S. Patents
             
Licensee Name   Date of License/        
and Address   Sublicense   Issue Date   Patent No.
NONE            
U.S. Patent Applications
             
Licensee Name   Date of License/        
and Address   Sublicense   Date Filed   Application No.
NONE            
Non-U.S. Patents
                 
    Licensee Name   Date of License/   Issue   Non-U.S.
Country   and Address   Sublicense   Date   Patent No.
NONE                
Non-U.S. Patent Applications
                 
    Licensee Name   Date of License/   Date    
Country   and Address   Sublicense   Filed   Application No.
NONE                

 


 

C. Trademarks
[List U.S. trademark Nos. and U.S. trademark application Nos. in numerical order. List non-U.S. trademark Nos. and non-U.S. application Nos. with trademark Nos. within each country in numerical order.]
U.S. Federal Trademarks
                 
Licensee Name   Date of License/            
and Address   Sublicense   Mark   Reg. Date   Reg. No.
NONE                
U.S. State Trademarks
                 
Licensee Name   Date of License/            
and Address   Sublicense   Mark   Reg. Date   Reg. No.
NONE                
U.S. Trademark Applications
                 
Licensee Name   Date of License/            
and Address   Sublicense   U.S. Mark   Date Filed   Application No.
NONE                
Non-U.S. Trademarks
                     
    Licensee Name   Date of License/   Non-U.S.        
Country   and Address   Sublicense   Mark   Reg. Date   Reg. No.
NONE                    

 


 

Non-U.S. Trademark Applications
                     
    Licensee Name   Date of License/   Non-U.S.   Date    
Country   and Address   Sublicense   Mark   Filed   Application No.
NONE                    

 


 

D. Others
         
Licensee Name   Date of License/   Subject
and Address   Sublicense   Matter
NONE        

 


 

II. Licenses/Sublicenses of [Name of Grantor] as Licensee/Sublicensee on Date Hereof
A. Copyrights
[List U.S. copyrights in numerical order by Registration No. List non-U.S. copyrights by country in alphabetical order, with Registration Nos. within each country in numerical order.]
U.S. Copyrights
                 
Licensor Name and   Date of License/   Title of        
Address   Sublicense   U.S. Copyright   Author   Reg. No.
                 
NONE
Non-U.S. Copyrights
                     
        Date of   Title of        
    Licensor Name   License/   Non-U.S.        
Country   and Address   Sublicense   Copyrights   Author   Reg. No.
                     
NONE

 


 

B. Patents
[List U.S. patent Nos. and U.S. patent application Nos. in numerical order. List non-U.S. patent Nos. and non-U.S. application Nos. in alphabetical order by country with patent Nos. within each country in numerical order.]
U.S. Patents
             
    Date of        
Licensor Name   License/        
and Address   Sublicense   Issue Date   Patent No.
             
NONE
U.S. Patent Applications
             
Licensor Name   Date of License/        
and Address   Sublicense   Date Filed   Application No.
             
NONE
Non-U.S. Patents
                 
    Licensor Name   Date of License/   Issue   Non-U.S.
Country   and Address   Sublicense   Date   Patent No.
                 
NONE
Non-U.S. Patent Applications
                 
    Licensor Name   Date of License/   Date    
Country   and Address   Sublicense   Filed   Application No.
                 
NONE

 


 

C. Trademarks
[List U.S. trademark Nos. and U.S. trademark application Nos. in numerical order. List non-U.S. trademark Nos. and non-U.S. application Nos. with trademark Nos. within each country in numerical order.]
U.S. Trademarks
                 
Licensor Name   Date of License/            
and Address   Sublicense   U.S. Mark   Reg. Date   Reg. No.
                 
NONE
U.S. Trademark Applications
                 
Licensor Name   Date of License/       Date    
and Address   Sublicense   U.S. Mark   Filed   Application No.
                 
NONE
Non-U.S. Trademarks
                     
    Licensor Name   Date of License/   Non-U.S.        
Country   and Address   Sublicense   Mark   Reg. Date   Reg. No.
                     
NONE
Non-U.S. Trademark Applications
                     
    Licensor Name   Date of License/   Non-U.S.   Date    
Country   and Address   Sublicense   Mark   Filed   Application No.
                     
NONE

 


 

D. Others
         
    Date of License/    
Licensor Name and Address   Sublicense   Subject Matter
         
NONE

 


 

PATENTS OWNED BY [NAME OF GRANTOR]
[Make a separate page of Schedule VIII for each Grantor and state if no patents are owned. List in numerical order by Patent No./Patent Application No.]
U.S. Patents
     
Patent No.   Issue Date
     
NONE
U.S. Patent Applications
     
Patent Application No.   Filing Date
     
NONE
Non-U.S. Patents
[List non-U.S. patents and non-U.S. patent applications by country in alphabetical order, with patent Nos. and patent application Nos. within each country in numerical order.]
         
Country   Issue Date   Patent No.
         
NONE
Non-U.S. Patent Applications
         
Country   Filing Date   Patent Application No.
         
NONE

 


 

TRADEMARK/TRADE NAMES OWNED BY CHS/COMMUNITY HEALTH
SYSTEMS, INC. OR COMMUNITY HEALTH SYSTEMS PROFESSIONAL
SERVICES CORPORATION
U.S. Trademark Registrations
                 
Registered Owner   U.S. Mark   Reg. Date   Reg. No.
CHS/Community Health Systems, Inc.
  (CHS LOGO)   7/23/1996     1988032  
 
               
CHS/Community Health Systems, Inc.
  A TIP-TOP MATERNITY CLUB   4/10/2001     2442377  
 
               
CHS/Community Health Systems, Inc.
  (COMMUNITY CARES LOGO)

Class 035
  6/26/2001     2463770  
 
               
CHS/Community Health Systems, Inc.
  (COMMUNITY CARES LOGO)

Class 041
  10/30/2001     2501702  
 
               
CHS/Community Health Systems, Inc.
  COMMUNITY CARES Standard Character CL 35   6/26/2001     2463771  
 
               
CHS/Community Health Systems, Inc.
  COMMUNITY CARES standard character CL 41   10/23/2001     2499955  
 
               
Community Health Systems, Inc.
  (HEALTHY WOMAN LOGO)   9/28/2010     3852138  

 


 

U.S. Trademark Applications
         
Mark   Filing Date   Application No.
         
NONE
State Trademark Registrations
[List in alphabetical order by state/numerical order by trademark No. within each state.]
                 
State   Registered Owner   U.S. Mark   Reg. Date   Reg. No.
Tennessee
  Community Health Systems Professional Services Corporation   COMMUNITY HEALTH SYSTEMS   12/12/2003   N/A
Non-U.S. Trademark Registrations
[List non-U.S. trademarks and non-U.S. trademark applications by country in alphabetical order, with Registration Nos. and application Nos. within each country in numerical order.]
             
Country   Mark   Reg. Date   Reg. No.
             
NONE
Non-U.S. Trademark Applications
             
Country   Mark   Application Date   Application No.
             
NONE
Trade Names
     
Country(s) Where Used   Trade Names
     
NONE

 


 

TRADEMARK/TRADE NAMES OWNED BY CHS WASHINGTON HOLDINGS LLC
U.S. Trademark Registrations
             
Country   Mark   Reg. Date   Reg. No.
             
NONE
U.S. Trademark Applications
             
Registered Owner   U.S. Mark   Reg. Date   Reg. No.
             
             
CHS Washington Holdings LLC
  HEALTHCARE NORTHWEST INTEGRATED DELIVERY SYSTEM Filed 2/5/2010            S.N. 77/929467
State Trademark Registrations
Non-U.S. Trademark Registrations
             
Country   Mark   Reg. Date   Reg. No.
             
NONE
Non-U.S. Trademark Applications
             
Country   Mark   Application Date   Application No.
             
NONE

 


 

Trade Names
     
Country(s) Where Used   Trade Names
     
NONE

 


 

TRADEMARK/TRADE NAMES OWNED BY TRIAD HOSPITALS, INC.
Listed in numerical order by trademark Registration No.
U.S. Trademark Registrations
                 
Mark   Reg. No.   Reg. Date
SENIORITY. A BENEFIT THAT ONLY COMES WITH AGE
    1424413       1/6/87  
NORTHWEST HEALTH & Design
    2274627       8/31/99  
Flame Design (Device Only)
    2406094       11/21/00  
GATEWAY HEALTH FOUNDATION
    2411367       12/5/00  
TRIAD HOSPITALS
    2538496       2/12/02  
(Device only) (Triangle Design #2)
    2547773       3/12/02  
(Device Only) (Triangle Design)
    2556500       4/2/02  
GATEWAY HEALTH SYSTEM
    2727444       6/17/03  
GATEWAY HOME CARE
    2750685       8/12/03  
GATEWAY MEDICAL CENTER
    2775950       10/21/03  
GATEWAY MEDICAL CLINIC
    2775951       10/21/03  
TRIAD HOSPITALS, INC.
    2923520       2/1/05  
SOUTHCREST TULSA’S HEART HOSPITAL
    2976999       7/26/05  
VICTORIA’S HEART TEAM
    2982492       8/2/05  
QMRG QHR MATERIEL RESOURCE GROUP
    2988029       8/23/05  
WOODLAND HEIGHTS MEDICAL CENTER
    3023638       12/6/05  
THE HEART CENTER AT WOODLAND HEIGHTS
    3023639       12/6/05  
THE DIAGNOSTIC CENTER AT WOODLAND HEIGHTS
    3023642       12/6/05  

 


 

                 
Mark   Reg. No.   Reg. Date
SLEEP DISORDERS LABORATORY AT WOODLAND HEIGHTS
    3023643       12/6/05  
REHABILITATION CENTER WOODLAND HEIGHTS
    3023644       12/6/05  
PREFERRED LABS
    3027743       12/13/05  
REDIMED
    3037881       1/3/06  
REDISPORT
    3055189       1/31/06  
QHR
    3074195       3/28/06  
BLUFFTON REGIONAL MEDICAL CENTER
    3077966       4/4/06  
WOMEN’S IMAGING AT KOSCIUSKO COMMUNITY HOSPITAL
    3081005       4/11/06  
SURGICENTER AT KOSCIUSKO COMMUNITY HOSPITAL
    3081006       4/11/06  
KOSCIUSKO COMMUNITY HOSPITAL HEALTH WELLNESS CENTER & Design
    3086868       4/25/06  
REHABILTIATION HOSPITAL OF FORT WAYNE
    3111485       7/4/06  
MEDSTAT URGENT CARE & OCUPATIONAL HEALTH
    3119372       7/25/06  
KCH REGIONAL REHABILITATION CENTER
    3119373       7/25/06  
GOODMOMS
    3123507       8/1/06  
GOODMOMS A GOOD START FOR NEW MOTHERS
    3123515       8/1/06  
LUTHERAN HEART PAVILION
    3131393       8/15/06  
CENTER OF HOPE CANCER CARE AT KOSCIUSKO COMMUNITY & Design
    3137998       9/5/06  
MRY BLACK HEALTH SYSTEM & Design
    3140091       9/5/06  
LUTHERAN CHILDREN’S HOSPITAL
    3144409       9/19/06  
LUTHERAN HOSPITAL OF INDIANA
    3144410       9/19/06  

 


 

                 
Mark   Reg. No.   Reg. Date
MAT-SU REGIONAL MEDICAL CENTER
    3150152       9/26/06  
QHR
    3153336       10/10/06  
LUTHERAN HEART CENTER
    3156408       10/17/06  
INDIANA HERNIA INSTITUTE
    3161126       10/17/60  
LUTHERAN SLEEP DISORDERS CENTER
    3166943       10/31/06  
(Device Only) (Leaf Design)
    3167543       11/7/06  
ST. JOSEPH BEHAVIORAL HEALTH
    3179375       12/5/06  
LUTHERAN HEALTH NETWORK
    3185051       12/12/06  
BIRTHPLACE AT KOSCIUSKO COMMUNITY HOSPITAL & Design
    3185595       12/19/06  
INNOVATIVE RECOVERIES
    3191986       1/2/07  
QHR QUORUM HEALTH RESOURCES
    3257760       7/3/07  
NORTHWEST HEALTH SYSTEM
    77071179       10/30/07  
NORTHWEST HEALTH SYSTEM (Design ONLY)
    77071364       8/28/07  
NOTHWEST HEALTH SYSTEM & Design
    77071371       10/30/07  
FAMILY TREE HEALTHCARE
    77152862       1/1/08  
CLAREMORE REGIONAL HOSPITAL
    77153203       1/1/08  
SOUTHCREST HOSPITAL
    77154224       1/1/08  
(LOGO)
    77299147       6/10/08  
THOUGHTFUL CARE
    77224736       5/27/08  
LABCARE PLUS
    78675592       9/25/07  
LABCARE PLUS & Design
    78675717       9/25/07  
TRINITY MEDICAL CENTER
    78800401       10/23/07  
TRINITY MEDICAL CENTER & Design
    78800407       10/23/07  

 


 

U.S. Trademark Applications
Listed in numerical order by trademark Application/Serial No.
         
 
  Application    
         
Mark   Serial No.   Filing Date
         
NONE
State Trademark Registrations
Listed in alphabetical order by state/numerical order by trademark No. within each state.
                         
State   Mark   Reg. No.   Reg. Date
AL  
TRINITY MEDICAL CENTER
    110-141       8/4/06  
GA  
TRINITY HOSPITAL OF AUGUSTA
    S-23495       6/26/07  
IN  
DUPONT HOSPITAL
    2007-0022       1/4/07  
IN  
DUKES MEMORIAL
    2007-0023       1/4/07  
IN  
ST. JOSEPH SLEEP DISORDERS CENTER
    20070104-09739       1/4/07  
IN  
INDIANA HERNIA INSTITUTE
    20070117-09801       1/4/07  
OH  
AFFINITY MEDICAL CENTER
    1657525       10/30/06  
TX  
THE SLEEP DISORDERS LABORATORY AT WOODLAND HEIGHTS
    800415454       12/31/05  
TX  
THE DIAGNOSTIC CENTER AT WOODLAND HEIGHTS
    800415458       1/25/05  
TX  
THE REHABILITATION CENTER AT WOODLAND HEIGHTS
    800415461       1/25/05  

 


 

                         
State   Mark   Reg. No.   Reg. Date
TX  
WOODLAND HEIGHTS MEDICAL CENTER
    800415465       1/25/05  
TX  
THE HEART CENTER AT WOODLAND HEIGHTS
    800415473       1/5/05  
TX  
GULF COAST MEDICAL CENTER ACTIVE ADVANTAGE
    800525572       8/25/05  
Pending State Trademark Registration Applications
Listed in alphabetical order by state/chronological order by filing date within each state.
Pending State Trademark/Service Mark Applications
         
State
  Mark   Filed Date
         
NONE

 


 

TRADEMARK/TRADE NAMES OWNED BY QUORUM HEALTH RESOURCES.
U.S. Trademark Registrations
             
Registered Owner   U.S. Mark   Reg. Date   Reg. No.
Quorum Health Resources
4000 Meridian Blvd.,
Franklin, TN 3706
  QHR   3/28/2006   78185269
 
           
Quorum Health Resources
4000 Meridian Blvd.,
Franklin, TN 37067
  QHR   10/10/2006   78648513
 
           
Quorum Health Resources
4000 Meridian Blvd.,
Franklin, TN 37067
  (QHR LOGO)   7/3/2007   78648505
 
           
Quorum Health Resources
4000 Meridian Blvd.,
Franklin, TN 37067
  (SURVIVE AND THRIVE LOGO)   11/27/2007   78693798
 
           
Quorum Health Resources
4000 Meridian Blvd.,
Franklin, TN 37067
  (QMRG LOGO)   8/23/2005   78230967
 
           
Quorum Health Resources, LLC
4000 Meridian Blvd.
Franklin, TN 37067
  (QHR LOGO)   1/12/2010   S.N. 77/560736
 
           
Quorum Health Resources, LLC
4000 Meridian Blvd.
Franklin, TN 37067
  (IRG LOGO)   6/5/2009   S.N. 77/561131
 
           
Quorum Health Resources, LLC
4000 Meridian Blvd.
Franklin, TN 37067
  (QHR LOGO)   12/1/2009   3719929

 


 

U.S. Trademark Applications
             
Registered Owner   U.S. Mark   Reg. Date   Reg. No.
Quorum Health Resources
4000 Meridian Blvd.,
Franklin, TN 37067
  (SURGIPOINTE LOGO)   Pending
(approved for
  S.N. 77/450026
    publication  
    8/1/2008)  
 
           
Quorum Health Resources, LLC
105 Continental Place
Brentwood, TN 37027
  (QUORUM LOGO)   Filed 1/11/2010   S.N. 77/909121
 
           
Quorum Health Resources, LLC (DE LLC)
4000 Meridian Blvd.,
Franklin, TN 37067
  (QHR INTENSIVE RESOURCES LOGO)   Filed 6/17/2010   S.N. 85/065583
 
           
Quorum Health Resources, LLC (DE LLC)
4000 Meridian Blvd.,
Franklin, TN 37067
  (REFORM READY LOGO)   Filed 9/22/2010   S.N. 85/135699
State Trademark Registrations
NONE
Pending State Trademark Registration Applications
NONE

 


 

Schedule VII to the Guarantee and Collateral Agreement
COMMERCIAL TORT CLAIMS
Southcrest, L.L.C. v. Bovis Lend Lease, Inc, Gould Turner Group, P.C and Carlisle Syntec, Inc. (Case No. 10CV-362-CVE-FHM): Suit pending in U.S. District Court for the Northern District of Oklahoma against general contractor, architect and roofing subcontractor for negligent construction of SouthCrest Hospital and several additions thereto between 1997 and 2001.

 


 

Exhibit A to the Guarantee and
Collateral Agreement
     SUPPLEMENT NO. [] (this “Supplement”) dated as of [], 20[] to the Guarantee and Collateral Agreement dated as of July 25, 2007, as amended and restated as of November 5, 2010 (the “Guarantee and Collateral Agreement”), among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation (the “Borrower”), COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation (“Parent”), each Subsidiary from time to time party thereto (each such Subsidiary individually a “Subsidiary Guarantor” and collectively, the “Subsidiary Guarantors”; the Subsidiary Guarantors, the Borrower and Parent are referred to collectively herein as the “Grantors”) and CREDIT SUISSE AG (together with its affiliates “Credit Suisse”), as administrative agent and as collateral agent (in such capacity, the “Collateral Agent”) for the Secured Parties (as defined therein).
          A. Reference is made to the Credit Agreement dated as of July 25, 2007, as amended and restated as of November 5, 2010 (as further amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), among the Borrower, Parent, the lenders from time to time party thereto (the “Lenders”) and Credit Suisse AG (formerly known as Credit Suisse), as administrative agent for the Lenders and as Collateral Agent.
          B. Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the Credit Agreement or the Guarantee and Collateral Agreement referred to therein, as applicable.
          C. The Grantors have entered into the Guarantee and Collateral Agreement in order to induce the Lenders to make Loans and the Issuing Banks to issue Letters of Credit. Section 7.16 of the Guarantee and Collateral Agreement provides that additional Subsidiaries may become Subsidiary Guarantors and Grantors under the Guarantee and Collateral Agreement by execution and delivery of an instrument in the form of this Supplement. The undersigned Subsidiary (the “New Subsidiary”) is executing this Supplement in accordance with the requirements of the Credit Agreement to become a Subsidiary Guarantor and a Grantor under the Guarantee and Collateral Agreement in order to induce the Lenders to make additional Loans and the Issuing Banks to issue additional Letters of Credit and as consideration for Loans previously made and Letters of Credit previously issued.
          Accordingly, the Collateral Agent and the New Subsidiary agree as follows:
          SECTION 1. In accordance with Section 7.16 of the Guarantee and Collateral Agreement, the New Subsidiary by its signature below becomes a Grantor and Subsidiary Guarantor under the Guarantee and Collateral Agreement with the same force and effect as if originally named therein as a Grantor and Subsidiary Guarantor and the

 


 

 A-2 
New Subsidiary hereby (a) agrees to all the terms and provisions of the Guarantee and Collateral Agreement applicable to it as a Grantor and Subsidiary Guarantor thereunder and (b) represents and warrants that the representations and warranties made by it as a Grantor and Subsidiary Guarantor thereunder are true and correct in all material respects on and as of the date hereof. In furtherance of the foregoing, the New Subsidiary, as security for the payment and performance in full of the Obligations (as defined in the Guarantee and Collateral Agreement), does hereby create and grant to the Collateral Agent, its successors and assigns, for the ratable benefit of the Secured Parties, their successors and assigns, a security interest in and lien on all of the New Subsidiary’s right, title and interest in and to the Collateral (as defined in the Guarantee and Collateral Agreement) of the New Subsidiary. Each reference to a “Grantor” or a “Subsidiary Guarantor” in the Guarantee and Collateral Agreement shall be deemed to include the New Subsidiary. The Guarantee and Collateral Agreement is hereby incorporated herein by reference.
          SECTION 2. The New Subsidiary represents and warrants to the Collateral Agent and the other Secured Parties that this Supplement has been duly authorized, executed and delivered by it and constitutes its legal, valid and binding obligation, enforceable against it in accordance with its terms.
          SECTION 3. This Supplement may be executed in counterparts (and by different parties hereto on different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Supplement shall become effective when the Collateral Agent shall have received counterparts of this Supplement that, when taken together, bear the signatures of the New Subsidiary and the Collateral Agent. Delivery of an executed signature page to this Supplement by facsimile transmission shall be as effective as delivery of a manually signed counterpart of this Supplement.
          SECTION 4. The New Subsidiary hereby represents and warrants that as of the date hereof (a) set forth on Schedule I attached hereto is a true and correct schedule of (i) any and all Equity Interests and Pledged Debt Securities now owned by the New Subsidiary and required to be pledged under the Guarantee and Collateral Agreement and (ii) any and all Intellectual Property now owned by the New Subsidiary and that would have been required to be listed on Schedule V to the Guarantee and Collateral Agreement on the Restatement Effective Date and (b) set forth under its signature hereto, is the true and correct legal name of the New Subsidiary and its jurisdiction of organization.
          SECTION 5. Except as expressly supplemented hereby, the Guarantee and Collateral Agreement shall remain in full force and effect.
          SECTION 6. THIS SUPPLEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.
          SECTION 7. In case any one or more of the provisions contained in this Supplement should be held invalid, illegal or unenforceable in any respect, the validity,

 


 

 A-3 
legality and enforceability of the remaining provisions contained herein and in the Guarantee and Collateral Agreement shall not in any way be affected or impaired thereby (it being understood that the invalidity of a particular provision in a particular jurisdiction shall not in and of itself affect the validity of such provision in any other jurisdiction). The parties hereto shall endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions.
          SECTION 8. All communications and notices hereunder shall (except as otherwise expressly permitted by the Guarantee and Collateral Agreement) be in writing and given as provided in Section 9.01 of the Credit Agreement. All communications and notices hereunder to the New Subsidiary shall be given to it in care of the Borrower as provided in Section 9.01 of the Credit Agreement.
          SECTION 9. The New Subsidiary agrees to reimburse the Collateral Agent for its reasonable out-of-pocket expenses in connection with this Supplement, including the reasonable fees, other charges and disbursements of one counsel for the Collateral Agent in each relevant jurisdiction.

 


 

 A-4 
          IN WITNESS WHEREOF, the New Subsidiary and the Collateral Agent have duly executed this Supplement to the Guarantee and Collateral Agreement as of the day and year first above written.
             
  [NAME OF NEW SUBSIDIARY],    
 
           
 
  by        
 
           
 
     
 
Name:
   
 
           
 
      Title:    
 
           
 
      Address:    
 
           
 
      Legal Name:    
 
           
 
      Jurisdiction of Formation:    
 
           
  CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, as
Collateral Agent,
   
 
           
 
  by        
 
           
 
     
 
Name:
   
 
           
 
      Title:    
 
           
 
  by        
 
           
 
     
 
Name:
   
 
           
 
      Title:    

 


 

Collateral of the New Subsidiary
EQUITY INTERESTS
                 
            Number and   Percentage
    Number of   Registered   Class of   of Equity
Issuer   Certificate   Owner   Equity Interest   Interests
                 
PLEDGED DEBT SECURITIES
             
    Principal        
Issuer   Amount   Date of Note   Maturity Date
             

 


 

INTELLECTUAL PROPERTY
[Follow format of Schedule III to the
Guarantee and Collateral Agreement.]

 

exv99w1
Exhibit 99.1
(CHS LOGO)
COMMUNITY HEALTH SYSTEMS, INC. ANNOUNCES
AMENDMENT AND EXTENSION OF CREDIT AGREEMENT
FRANKLIN, Tenn., (November 8, 2010) — Community Health Systems, Inc. (NYSE: CYH) (the “Company”) today announced that on November 5, 2010, it and its wholly-owned subsidiary CHS/Community Health Systems, Inc. entered into an amendment and restatement (the “Amendment”) of their existing credit agreement, dated as of July 25, 2007 (as amended and restated, the “Credit Agreement”).
     The Amendment extends by two and a half years (until January 25, 2017, subject to customary acceleration events) the maturity date of $1.5 billion of the existing term loans under the Credit Agreement of lenders who elected to extend. The maturity date (July 25, 2014) of the balance of the term loans, approximately $4.5 billion, is unchanged by the Amendment. The Amendment increases the pricing on the extended term loans to LIBOR + 350 basis points and amends certain other terms and conditions.
     Located in the Nashville, Tennessee, suburb of Franklin, Community Health Systems, Inc. is the largest publicly-traded hospital company in the United States and a leading operator of general acute care hospitals in non-urban and mid-size markets throughout the country. Through its subsidiaries, the Company currently owns, leases or operates 126 hospitals in 29 states with an aggregate of approximately 19,400 licensed beds. Its hospitals offer a broad range of inpatient and surgical services, outpatient treatment and skilled nursing care. In addition, through its subsidiary Quorum Health Resources, LLC, the Company provides management and consulting services to approximately 150 independent non-affiliated general acute care hospitals located throughout the United States. Shares in Community Health Systems, Inc. are traded on the New York Stock Exchange under the symbol “CYH.”
     Statements contained in this news release regarding credit agreement amendments, their impact on the Company, and other events may include forward-looking statements that involve risks and uncertainties. Actual future events or results may differ materially from these statements. Readers are referred to the documents filed by the Company with the Securities and Exchange Commission, specifically the most recent filings which identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements, including execution of our growth, acquisition, and business strategies. These and other applicable risks are summarized under the caption “risk factors” in the Company’s Securities and Exchange Commission filings. The Company undertakes no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
     
Investor Contact:
  W. Larry Cash
 
  Executive Vice President
 
    and Chief Financial Officer
 
  615-465-7000
-END-